0001413329-23-000201.txt : 20231026 0001413329-23-000201.hdr.sgml : 20231026 20231026084347 ACCESSION NUMBER: 0001413329-23-000201 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 129 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231026 DATE AS OF CHANGE: 20231026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Philip Morris International Inc. CENTRAL INDEX KEY: 0001413329 STANDARD INDUSTRIAL CLASSIFICATION: CIGARETTES [2111] IRS NUMBER: 133435103 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33708 FILM NUMBER: 231347615 BUSINESS ADDRESS: STREET 1: 677 WASHINGTON BLVD, STE. 1100 CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 203-905-2410 MAIL ADDRESS: STREET 1: 677 WASHINGTON BLVD, STE. 1100 CITY: STAMFORD STATE: CT ZIP: 06901 10-Q 1 pm-20230930.htm 10-Q pm-20230930
000141332912/312023Q3FALSEhttp://fasb.org/us-gaap/2023#InterestIncomeExpenseNethttp://fasb.org/us-gaap/2023#InterestIncomeExpenseNet00014133292023-01-012023-09-300001413329us-gaap:CommonStockMember2023-01-012023-09-300001413329pm:A3.600Notesdue2023Member2023-01-012023-09-300001413329pm:A2.875Notesdue20241Member2023-01-012023-09-300001413329pm:A2.875Notesdue20242Member2023-01-012023-09-300001413329pm:A0.625Notesdue2024Member2023-01-012023-09-300001413329pm:A3.250Notesdue2024Member2023-01-012023-09-300001413329pm:A2.750Notesdue2025Member2023-01-012023-09-300001413329pm:A3.375Notesdue2025Member2023-01-012023-09-300001413329pm:A2.750Notesdue2026Member2023-01-012023-09-300001413329pm:A2.875Notesdue2026Member2023-01-012023-09-300001413329pm:A0.125Notesdue2026Member2023-01-012023-09-300001413329pm:A3.125Notesdue2027Member2023-01-012023-09-300001413329pm:A3.125Notesdue2028Member2023-01-012023-09-300001413329pm:A2.875Notesdue2029Member2023-01-012023-09-300001413329pm:A3.375Notesdue2029Member2023-01-012023-09-300001413329pm:A0.800Notesdue2031Member2023-01-012023-09-300001413329pm:A3.125Notesdue2033Member2023-01-012023-09-300001413329pm:A2.000Notesdue2036Member2023-01-012023-09-300001413329pm:A1.875Notesdue2037Member2023-01-012023-09-300001413329pm:A6.375Notesdue2038Member2023-01-012023-09-300001413329pm:A1.450Notesdue2039Member2023-01-012023-09-300001413329pm:A4.375Notesdue2041Member2023-01-012023-09-300001413329pm:A4.500Notesdue2042Member2023-01-012023-09-300001413329pm:A3.875Notesdue2042Member2023-01-012023-09-300001413329pm:A4.125Notesdue2043Member2023-01-012023-09-300001413329pm:A4.875Notesdue2043Member2023-01-012023-09-300001413329pm:A4.250Notesdue2044Member2023-01-012023-09-3000014133292023-10-20xbrli:sharesiso4217:USD00014133292022-01-012022-09-30iso4217:USDxbrli:shares0001413329us-gaap:RelatedPartyMember2023-01-012023-09-300001413329us-gaap:RelatedPartyMember2022-01-012022-09-300001413329pm:EAAUPMIDFSegmentMembercountry:KR2023-01-012023-09-3000014133292023-07-012023-09-3000014133292022-07-012022-09-300001413329us-gaap:RelatedPartyMember2023-07-012023-09-300001413329us-gaap:RelatedPartyMember2022-07-012022-09-3000014133292023-09-3000014133292022-12-310001413329us-gaap:RelatedPartyMember2023-09-300001413329us-gaap:RelatedPartyMember2022-12-310001413329pm:SwedishMatchABMember2023-01-012023-09-300001413329pm:SwedishMatchABMember2022-01-012022-09-3000014133292021-12-3100014133292022-09-300001413329us-gaap:CommonStockMember2021-12-310001413329us-gaap:AdditionalPaidInCapitalMember2021-12-310001413329us-gaap:RetainedEarningsMember2021-12-310001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001413329us-gaap:TreasuryStockCommonMember2021-12-310001413329us-gaap:NoncontrollingInterestMember2021-12-310001413329us-gaap:RetainedEarningsMember2022-01-012022-09-300001413329us-gaap:NoncontrollingInterestMember2022-01-012022-09-300001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300001413329us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-300001413329us-gaap:TreasuryStockCommonMember2022-01-012022-09-300001413329us-gaap:CommonStockMember2022-09-300001413329us-gaap:AdditionalPaidInCapitalMember2022-09-300001413329us-gaap:RetainedEarningsMember2022-09-300001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001413329us-gaap:TreasuryStockCommonMember2022-09-300001413329us-gaap:NoncontrollingInterestMember2022-09-300001413329us-gaap:CommonStockMember2022-12-310001413329us-gaap:AdditionalPaidInCapitalMember2022-12-310001413329us-gaap:RetainedEarningsMember2022-12-310001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001413329us-gaap:TreasuryStockCommonMember2022-12-310001413329us-gaap:NoncontrollingInterestMember2022-12-310001413329us-gaap:RetainedEarningsMember2023-01-012023-09-300001413329us-gaap:NoncontrollingInterestMember2023-01-012023-09-300001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001413329us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001413329us-gaap:TreasuryStockCommonMember2023-01-012023-09-300001413329us-gaap:CommonStockMember2023-09-300001413329us-gaap:AdditionalPaidInCapitalMember2023-09-300001413329us-gaap:RetainedEarningsMember2023-09-300001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001413329us-gaap:TreasuryStockCommonMember2023-09-300001413329us-gaap:NoncontrollingInterestMember2023-09-300001413329us-gaap:CommonStockMember2022-06-300001413329us-gaap:AdditionalPaidInCapitalMember2022-06-300001413329us-gaap:RetainedEarningsMember2022-06-300001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001413329us-gaap:TreasuryStockCommonMember2022-06-300001413329us-gaap:NoncontrollingInterestMember2022-06-3000014133292022-06-300001413329us-gaap:RetainedEarningsMember2022-07-012022-09-300001413329us-gaap:NoncontrollingInterestMember2022-07-012022-09-300001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001413329us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001413329us-gaap:TreasuryStockCommonMember2022-07-012022-09-300001413329us-gaap:CommonStockMember2023-06-300001413329us-gaap:AdditionalPaidInCapitalMember2023-06-300001413329us-gaap:RetainedEarningsMember2023-06-300001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001413329us-gaap:TreasuryStockCommonMember2023-06-300001413329us-gaap:NoncontrollingInterestMember2023-06-3000014133292023-06-300001413329us-gaap:RetainedEarningsMember2023-07-012023-09-300001413329us-gaap:NoncontrollingInterestMember2023-07-012023-09-300001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001413329us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001413329us-gaap:TreasuryStockCommonMember2023-07-012023-09-300001413329pm:GeographicalSegmentMember2023-01-012023-09-30pm:segment0001413329pm:GeographicalSegmentMember2022-01-012022-12-310001413329pm:NoncontrollingInterestPurchasePhilipMorrisTtnMamulleriSanayiVeTicaretAMember2022-03-31xbrli:pure0001413329pm:NoncontrollingInterestPurchasePhilipMorrisPazarlamaVeSatAMember2022-03-310001413329pm:NoncontrollingInterestPurchaseMember2022-01-012022-03-310001413329pm:NoncontrollingInterestPurchaseMember2022-03-310001413329us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-3100014133292023-01-012023-01-310001413329us-gaap:AdditionalPaidInCapitalMember2023-01-012023-01-310001413329us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-01-310001413329pm:SwedishMatchABMember2022-11-110001413329pm:SwedishMatchABMember2022-12-310001413329pm:SwedishMatchABMember2022-11-112022-11-110001413329pm:SwedishMatchABMember2022-11-112022-12-310001413329pm:SwedishMatchABMember2023-02-170001413329pm:SwedishMatchABMember2023-09-122023-09-12iso4217:SEKxbrli:shares0001413329pm:SwedishMatchABMember2022-11-112023-09-300001413329pm:SwedishMatchABMember2023-09-300001413329pm:SwedishMatchABMember2022-11-122023-03-310001413329pm:SwedishMatchABMember2022-10-012022-12-310001413329us-gaap:TrademarksMemberpm:SwedishMatchABMember2023-09-302023-09-300001413329us-gaap:TrademarksMemberpm:SwedishMatchABMembersrt:MinimumMember2023-09-302023-09-300001413329us-gaap:TrademarksMembersrt:MaximumMemberpm:SwedishMatchABMember2023-09-302023-09-300001413329us-gaap:TrademarksMemberpm:SwedishMatchABMember2023-09-302023-09-300001413329us-gaap:TechnologyBasedIntangibleAssetsMemberpm:SwedishMatchABMember2023-09-302023-09-300001413329us-gaap:CustomerRelationshipsMemberpm:SwedishMatchABMembersrt:MinimumMember2023-09-302023-09-300001413329srt:MaximumMemberus-gaap:CustomerRelationshipsMemberpm:SwedishMatchABMember2023-09-302023-09-300001413329us-gaap:CustomerRelationshipsMemberpm:SwedishMatchABMember2023-09-302023-09-300001413329pm:SwedishMatchABMember2022-01-012022-12-310001413329srt:ProFormaMemberpm:PMIAndSwedishMatchMember2022-01-012022-12-310001413329srt:ProFormaMemberpm:PMIAndSwedishMatchMember2021-01-012021-12-310001413329pm:PMIAndSwedishMatchMember2022-01-012022-12-310001413329pm:PMIAndSwedishMatchMember2021-01-012021-12-310001413329pm:AltriaGroupMember2022-10-200001413329pm:AltriaGroupMember2023-07-140001413329country:UApm:WarInUkraineMember2023-09-300001413329country:RUpm:WarInUkraineMember2023-09-300001413329country:UApm:WarInUkraineMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001413329country:UApm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2023-01-012023-09-300001413329country:UApm:WarInUkraineMember2023-01-012023-09-300001413329country:UApm:WarInUkraineMemberus-gaap:CostOfSalesMember2022-01-012022-09-300001413329country:UApm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2022-01-012022-09-300001413329country:UApm:WarInUkraineMember2022-01-012022-09-300001413329country:RUpm:WarInUkraineMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001413329country:RUpm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2023-01-012023-09-300001413329country:RUpm:WarInUkraineMember2023-01-012023-09-300001413329country:RUpm:WarInUkraineMemberus-gaap:CostOfSalesMember2022-01-012022-09-300001413329country:RUpm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2022-01-012022-09-300001413329country:RUpm:WarInUkraineMember2022-01-012022-09-300001413329pm:WarInUkraineMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001413329pm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2023-01-012023-09-300001413329pm:WarInUkraineMember2023-01-012023-09-300001413329pm:WarInUkraineMemberus-gaap:CostOfSalesMember2022-01-012022-09-300001413329pm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2022-01-012022-09-300001413329pm:WarInUkraineMember2022-01-012022-09-300001413329country:UApm:WarInUkraineMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001413329country:UApm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2023-07-012023-09-300001413329country:UApm:WarInUkraineMember2023-07-012023-09-300001413329country:UApm:WarInUkraineMemberus-gaap:CostOfSalesMember2022-07-012022-09-300001413329country:UApm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2022-07-012022-09-300001413329country:UApm:WarInUkraineMember2022-07-012022-09-300001413329country:RUpm:WarInUkraineMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001413329country:RUpm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2023-07-012023-09-300001413329country:RUpm:WarInUkraineMember2023-07-012023-09-300001413329country:RUpm:WarInUkraineMemberus-gaap:CostOfSalesMember2022-07-012022-09-300001413329country:RUpm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2022-07-012022-09-300001413329country:RUpm:WarInUkraineMember2022-07-012022-09-300001413329pm:WarInUkraineMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001413329pm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2023-07-012023-09-300001413329pm:WarInUkraineMember2023-07-012023-09-300001413329pm:WarInUkraineMemberus-gaap:CostOfSalesMember2022-07-012022-09-300001413329pm:WarInUkraineMemberpm:MarketingAdministrationAndResearchCostsMember2022-07-012022-09-300001413329pm:WarInUkraineMember2022-07-012022-09-300001413329pm:A2022PerformanceIncentivePlanMember2022-05-310001413329pm:A2022PerformanceIncentivePlanMember2023-09-300001413329pm:A2017NonEmployeeDirectorsPlanMember2017-05-310001413329pm:A2017NonEmployeeDirectorsPlanMember2023-09-300001413329us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001413329us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001413329us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001413329us-gaap:RestrictedStockUnitsRSUMember2022-07-012022-09-300001413329us-gaap:RestrictedStockUnitsRSUMember2023-09-30pm:year0001413329us-gaap:RestrictedStockUnitsRSUMemberpm:GrantDateFairValueMember2023-01-012023-09-300001413329pm:FairValueMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001413329us-gaap:PerformanceSharesMember2023-01-012023-09-300001413329us-gaap:PerformanceSharesMember2023-09-30pm:performanceMetric0001413329us-gaap:PerformanceSharesMembersrt:MinimumMember2023-01-012023-09-300001413329srt:MaximumMemberus-gaap:PerformanceSharesMember2023-01-012023-09-300001413329pm:PerformanceShareUnitsOtherPerformanceMetricsMember2023-01-012023-09-300001413329pm:PerformanceShareUnitsTSRPerformanceMetricMember2023-01-012023-09-300001413329us-gaap:PerformanceSharesMember2022-01-012022-09-300001413329pm:PerformanceShareUnitsOtherPerformanceMetricsMember2022-01-012022-09-300001413329pm:PerformanceShareUnitsTSRPerformanceMetricMember2022-01-012022-09-300001413329pm:GrantDateFairValueMemberus-gaap:PerformanceSharesMember2023-01-012023-09-300001413329pm:FairValueMemberus-gaap:PerformanceSharesMember2023-01-012023-09-300001413329us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-09-300001413329us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-09-300001413329us-gaap:PensionPlansDefinedBenefitMember2023-07-012023-09-300001413329us-gaap:PensionPlansDefinedBenefitMember2022-07-012022-09-300001413329pm:PostemploymentBenefitPlansMember2023-01-012023-09-300001413329pm:PostemploymentBenefitPlansMember2022-01-012022-09-300001413329pm:PostemploymentBenefitPlansMember2023-07-012023-09-300001413329pm:PostemploymentBenefitPlansMember2022-07-012022-09-300001413329us-gaap:PostretirementBenefitCostsMember2023-01-012023-09-300001413329us-gaap:PostretirementBenefitCostsMember2022-01-012022-09-300001413329us-gaap:PostretirementBenefitCostsMember2023-07-012023-09-300001413329us-gaap:PostretirementBenefitCostsMember2022-07-012022-09-3000014133292022-04-012022-06-300001413329pm:WellnessAndHealthcareSegmentMember2023-01-012023-09-300001413329us-gaap:InProcessResearchAndDevelopmentMember2023-01-012023-09-300001413329pm:EuropeSegmentMember2022-12-310001413329pm:SSEACISMEASegmentMember2022-12-310001413329pm:EAAUPMIDFSegmentMember2022-12-310001413329pm:AmericasSegmentMember2022-12-310001413329pm:SwedishMatchABSegmentMember2022-12-310001413329pm:WellnessAndHealthcareSegmentMember2022-12-310001413329pm:EuropeSegmentMember2023-01-012023-09-300001413329pm:SSEACISMEASegmentMember2023-01-012023-09-300001413329pm:EAAUPMIDFSegmentMember2023-01-012023-09-300001413329pm:AmericasSegmentMember2023-01-012023-09-300001413329pm:SwedishMatchABSegmentMember2023-01-012023-09-300001413329pm:EuropeSegmentMember2023-09-300001413329pm:SSEACISMEASegmentMember2023-09-300001413329pm:EAAUPMIDFSegmentMember2023-09-300001413329pm:AmericasSegmentMember2023-09-300001413329pm:SwedishMatchABSegmentMember2023-09-300001413329pm:WellnessAndHealthcareSegmentMember2023-09-300001413329us-gaap:TrademarksMember2023-09-300001413329us-gaap:TrademarksMember2022-12-310001413329us-gaap:DevelopedTechnologyRightsMember2023-09-300001413329us-gaap:DevelopedTechnologyRightsMember2022-12-310001413329us-gaap:OtherIntangibleAssetsMember2023-09-300001413329us-gaap:OtherIntangibleAssetsMember2022-12-310001413329us-gaap:CostOfSalesMember2023-01-012023-09-300001413329pm:MarketingAdministrationAndResearchCostsMember2023-01-012023-09-300001413329us-gaap:DevelopedTechnologyRightsMemberpm:WellnessAndHealthcareSegmentMember2022-09-300001413329us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001413329us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001413329us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001413329us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001413329us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2023-09-300001413329us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2022-12-310001413329us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-09-300001413329us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-12-310001413329us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001413329us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001413329pm:OtherAccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001413329pm:OtherAccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001413329us-gaap:OtherAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001413329us-gaap:OtherAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001413329us-gaap:OtherLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001413329us-gaap:OtherLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001413329us-gaap:InterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001413329us-gaap:InterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001413329us-gaap:InterestRateContractMemberpm:OtherAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001413329us-gaap:InterestRateContractMemberpm:OtherAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001413329us-gaap:OtherAssetsMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001413329us-gaap:OtherAssetsMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001413329us-gaap:OtherLiabilitiesMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001413329us-gaap:OtherLiabilitiesMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001413329us-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2023-09-300001413329us-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2022-12-310001413329pm:OtherAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2023-09-300001413329pm:OtherAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2022-12-310001413329us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2023-09-300001413329us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2022-12-310001413329us-gaap:NondesignatedMemberpm:OtherAccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMember2023-09-300001413329us-gaap:NondesignatedMemberpm:OtherAccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMember2022-12-310001413329us-gaap:OtherAssetsMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-09-300001413329us-gaap:OtherAssetsMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-12-310001413329us-gaap:OtherLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-09-300001413329us-gaap:OtherLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-12-310001413329us-gaap:ForeignExchangeContractMember2023-01-012023-09-300001413329us-gaap:ForeignExchangeContractMember2022-01-012022-09-300001413329us-gaap:ForeignExchangeContractMemberus-gaap:SalesMember2023-01-012023-09-300001413329us-gaap:ForeignExchangeContractMemberus-gaap:SalesMember2022-01-012022-09-300001413329us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2023-01-012023-09-300001413329us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2022-01-012022-09-300001413329pm:MarketingAdministrationAndResearchCostsMemberus-gaap:ForeignExchangeContractMember2023-01-012023-09-300001413329pm:MarketingAdministrationAndResearchCostsMemberus-gaap:ForeignExchangeContractMember2022-01-012022-09-300001413329us-gaap:InterestExpenseMemberus-gaap:ForeignExchangeContractMember2023-01-012023-09-300001413329us-gaap:InterestExpenseMemberus-gaap:ForeignExchangeContractMember2022-01-012022-09-300001413329us-gaap:InterestRateContractMember2023-01-012023-09-300001413329us-gaap:InterestRateContractMember2022-01-012022-09-300001413329us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMember2023-01-012023-09-300001413329us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMember2022-01-012022-09-300001413329us-gaap:CommodityContractMember2023-01-012023-09-300001413329us-gaap:CommodityContractMember2022-01-012022-09-300001413329us-gaap:CostOfSalesMemberus-gaap:CommodityContractMember2023-01-012023-09-300001413329us-gaap:CostOfSalesMemberus-gaap:CommodityContractMember2022-01-012022-09-300001413329us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001413329us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300001413329us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001413329us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300001413329us-gaap:InterestExpenseMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-01-012023-09-300001413329us-gaap:InterestExpenseMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-01-012022-09-300001413329us-gaap:NondesignatedMemberpm:MarketingAdministrationAndResearchCostsMemberus-gaap:ForeignExchangeContractMember2023-01-012023-09-300001413329us-gaap:NondesignatedMemberpm:MarketingAdministrationAndResearchCostsMemberus-gaap:ForeignExchangeContractMember2022-01-012022-09-300001413329us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-01-012023-09-300001413329us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-01-012022-09-300001413329us-gaap:ForeignExchangeContractMember2023-07-012023-09-300001413329us-gaap:ForeignExchangeContractMember2022-07-012022-09-300001413329us-gaap:ForeignExchangeContractMemberus-gaap:SalesMember2023-07-012023-09-300001413329us-gaap:ForeignExchangeContractMemberus-gaap:SalesMember2022-07-012022-09-300001413329us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2023-07-012023-09-300001413329us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2022-07-012022-09-300001413329pm:MarketingAdministrationAndResearchCostsMemberus-gaap:ForeignExchangeContractMember2023-07-012023-09-300001413329pm:MarketingAdministrationAndResearchCostsMemberus-gaap:ForeignExchangeContractMember2022-07-012022-09-300001413329us-gaap:InterestExpenseMemberus-gaap:ForeignExchangeContractMember2023-07-012023-09-300001413329us-gaap:InterestExpenseMemberus-gaap:ForeignExchangeContractMember2022-07-012022-09-300001413329us-gaap:InterestRateContractMember2023-07-012023-09-300001413329us-gaap:InterestRateContractMember2022-07-012022-09-300001413329us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMember2023-07-012023-09-300001413329us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMember2022-07-012022-09-300001413329us-gaap:CommodityContractMember2023-07-012023-09-300001413329us-gaap:CommodityContractMember2022-07-012022-09-300001413329us-gaap:CostOfSalesMemberus-gaap:CommodityContractMember2023-07-012023-09-300001413329us-gaap:CostOfSalesMemberus-gaap:CommodityContractMember2022-07-012022-09-300001413329us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300001413329us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-012022-09-300001413329us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300001413329us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-012022-09-300001413329us-gaap:InterestExpenseMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-07-012023-09-300001413329us-gaap:InterestExpenseMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-07-012022-09-300001413329us-gaap:NondesignatedMemberpm:MarketingAdministrationAndResearchCostsMemberus-gaap:ForeignExchangeContractMember2023-07-012023-09-300001413329us-gaap:NondesignatedMemberpm:MarketingAdministrationAndResearchCostsMemberus-gaap:ForeignExchangeContractMember2022-07-012022-09-300001413329us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-07-012023-09-300001413329us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-07-012022-09-300001413329us-gaap:FairValueHedgingMember2023-09-300001413329us-gaap:NetInvestmentHedgingMemberpm:ForeignDebtMember2023-01-012023-09-300001413329us-gaap:NetInvestmentHedgingMemberpm:ForeignDebtMember2022-01-012022-09-300001413329us-gaap:NetInvestmentHedgingMemberpm:ForeignDebtMember2023-07-012023-09-300001413329us-gaap:NetInvestmentHedgingMemberpm:ForeignDebtMember2022-07-012022-09-300001413329us-gaap:OtherComprehensiveIncomeMember2022-12-310001413329us-gaap:OtherComprehensiveIncomeMember2021-12-310001413329us-gaap:OtherComprehensiveIncomeMember2023-06-300001413329us-gaap:OtherComprehensiveIncomeMember2022-06-300001413329us-gaap:OtherComprehensiveIncomeMember2023-01-012023-09-300001413329us-gaap:OtherComprehensiveIncomeMember2022-01-012022-09-300001413329us-gaap:OtherComprehensiveIncomeMember2023-07-012023-09-300001413329us-gaap:OtherComprehensiveIncomeMember2022-07-012022-09-300001413329us-gaap:OtherComprehensiveIncomeMember2023-09-300001413329us-gaap:OtherComprehensiveIncomeMember2022-09-300001413329us-gaap:ForeignExchangeContractMember2023-09-300001413329us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2023-09-300001413329pm:EuropeSegmentMember2022-01-012022-09-300001413329pm:EuropeSegmentMember2023-07-012023-09-300001413329pm:EuropeSegmentMember2022-07-012022-09-300001413329pm:SSEACISMEASegmentMember2022-01-012022-09-300001413329pm:SSEACISMEASegmentMember2023-07-012023-09-300001413329pm:SSEACISMEASegmentMember2022-07-012022-09-300001413329pm:EAAUPMIDFSegmentMember2022-01-012022-09-300001413329pm:EAAUPMIDFSegmentMember2023-07-012023-09-300001413329pm:EAAUPMIDFSegmentMember2022-07-012022-09-300001413329pm:AmericasSegmentMember2022-01-012022-09-300001413329pm:AmericasSegmentMember2023-07-012023-09-300001413329pm:AmericasSegmentMember2022-07-012022-09-300001413329pm:SwedishMatchABSegmentMember2022-01-012022-09-300001413329pm:SwedishMatchABSegmentMember2023-07-012023-09-300001413329pm:SwedishMatchABSegmentMember2022-07-012022-09-300001413329pm:WellnessAndHealthcareSegmentMember2022-01-012022-09-300001413329pm:WellnessAndHealthcareSegmentMember2023-07-012023-09-300001413329pm:WellnessAndHealthcareSegmentMember2022-07-012022-09-300001413329pm:EuropeSegmentMemberpm:CombustibleTobaccoProductsMember2023-01-012023-09-300001413329pm:EuropeSegmentMemberpm:CombustibleTobaccoProductsMember2022-01-012022-09-300001413329pm:EuropeSegmentMemberpm:CombustibleTobaccoProductsMember2023-07-012023-09-300001413329pm:EuropeSegmentMemberpm:CombustibleTobaccoProductsMember2022-07-012022-09-300001413329pm:SSEACISMEASegmentMemberpm:CombustibleTobaccoProductsMember2023-01-012023-09-300001413329pm:SSEACISMEASegmentMemberpm:CombustibleTobaccoProductsMember2022-01-012022-09-300001413329pm:SSEACISMEASegmentMemberpm:CombustibleTobaccoProductsMember2023-07-012023-09-300001413329pm:SSEACISMEASegmentMemberpm:CombustibleTobaccoProductsMember2022-07-012022-09-300001413329pm:EAAUPMIDFSegmentMemberpm:CombustibleTobaccoProductsMember2023-01-012023-09-300001413329pm:EAAUPMIDFSegmentMemberpm:CombustibleTobaccoProductsMember2022-01-012022-09-300001413329pm:EAAUPMIDFSegmentMemberpm:CombustibleTobaccoProductsMember2023-07-012023-09-300001413329pm:EAAUPMIDFSegmentMemberpm:CombustibleTobaccoProductsMember2022-07-012022-09-300001413329pm:AmericasSegmentMemberpm:CombustibleTobaccoProductsMember2023-01-012023-09-300001413329pm:AmericasSegmentMemberpm:CombustibleTobaccoProductsMember2022-01-012022-09-300001413329pm:AmericasSegmentMemberpm:CombustibleTobaccoProductsMember2023-07-012023-09-300001413329pm:AmericasSegmentMemberpm:CombustibleTobaccoProductsMember2022-07-012022-09-300001413329pm:SwedishMatchABSegmentMemberpm:CombustibleTobaccoProductsMember2023-01-012023-09-300001413329pm:SwedishMatchABSegmentMemberpm:CombustibleTobaccoProductsMember2022-01-012022-09-300001413329pm:SwedishMatchABSegmentMemberpm:CombustibleTobaccoProductsMember2023-07-012023-09-300001413329pm:SwedishMatchABSegmentMemberpm:CombustibleTobaccoProductsMember2022-07-012022-09-300001413329pm:CombustibleTobaccoProductsMember2023-01-012023-09-300001413329pm:CombustibleTobaccoProductsMember2022-01-012022-09-300001413329pm:CombustibleTobaccoProductsMember2023-07-012023-09-300001413329pm:CombustibleTobaccoProductsMember2022-07-012022-09-300001413329pm:SmokeFreeProductsMemberpm:EuropeSegmentMember2023-01-012023-09-300001413329pm:SmokeFreeProductsMemberpm:EuropeSegmentMember2022-01-012022-09-300001413329pm:SmokeFreeProductsMemberpm:EuropeSegmentMember2023-07-012023-09-300001413329pm:SmokeFreeProductsMemberpm:EuropeSegmentMember2022-07-012022-09-300001413329pm:SSEACISMEASegmentMemberpm:SmokeFreeProductsMember2023-01-012023-09-300001413329pm:SSEACISMEASegmentMemberpm:SmokeFreeProductsMember2022-01-012022-09-300001413329pm:SSEACISMEASegmentMemberpm:SmokeFreeProductsMember2023-07-012023-09-300001413329pm:SSEACISMEASegmentMemberpm:SmokeFreeProductsMember2022-07-012022-09-300001413329pm:SmokeFreeProductsMemberpm:EAAUPMIDFSegmentMember2023-01-012023-09-300001413329pm:SmokeFreeProductsMemberpm:EAAUPMIDFSegmentMember2022-01-012022-09-300001413329pm:SmokeFreeProductsMemberpm:EAAUPMIDFSegmentMember2023-07-012023-09-300001413329pm:SmokeFreeProductsMemberpm:EAAUPMIDFSegmentMember2022-07-012022-09-300001413329pm:AmericasSegmentMemberpm:SmokeFreeProductsMember2023-01-012023-09-300001413329pm:AmericasSegmentMemberpm:SmokeFreeProductsMember2022-01-012022-09-300001413329pm:AmericasSegmentMemberpm:SmokeFreeProductsMember2023-07-012023-09-300001413329pm:AmericasSegmentMemberpm:SmokeFreeProductsMember2022-07-012022-09-300001413329pm:SwedishMatchABSegmentMemberpm:SmokeFreeProductsMember2023-01-012023-09-300001413329pm:SwedishMatchABSegmentMemberpm:SmokeFreeProductsMember2022-01-012022-09-300001413329pm:SwedishMatchABSegmentMemberpm:SmokeFreeProductsMember2023-07-012023-09-300001413329pm:SwedishMatchABSegmentMemberpm:SmokeFreeProductsMember2022-07-012022-09-300001413329pm:SmokeFreeProductsMemberpm:SmokeFreeProductsExcludingWellnessAndHealthcareMember2023-01-012023-09-300001413329pm:SmokeFreeProductsMemberpm:SmokeFreeProductsExcludingWellnessAndHealthcareMember2022-01-012022-09-300001413329pm:SmokeFreeProductsMemberpm:SmokeFreeProductsExcludingWellnessAndHealthcareMember2023-07-012023-09-300001413329pm:SmokeFreeProductsMemberpm:SmokeFreeProductsExcludingWellnessAndHealthcareMember2022-07-012022-09-300001413329pm:SmokeFreeProductsMemberpm:WellnessAndHealthcareSegmentMember2023-01-012023-09-300001413329pm:SmokeFreeProductsMemberpm:WellnessAndHealthcareSegmentMember2022-01-012022-09-300001413329pm:SmokeFreeProductsMemberpm:WellnessAndHealthcareSegmentMember2023-07-012023-09-300001413329pm:SmokeFreeProductsMemberpm:WellnessAndHealthcareSegmentMember2022-07-012022-09-300001413329pm:SmokeFreeProductsMember2023-01-012023-09-300001413329pm:SmokeFreeProductsMember2022-01-012022-09-300001413329pm:SmokeFreeProductsMember2023-07-012023-09-300001413329pm:SmokeFreeProductsMember2022-07-012022-09-300001413329pm:SSEACISMEASegmentMemberpm:NetRevenuesMember2023-01-012023-03-310001413329pm:MarketingAdministrationAndResearchCostsMember2023-07-012023-09-300001413329pm:MarketingAdministrationAndResearchCostsMemberpm:EuropeSegmentMember2023-01-012023-09-300001413329pm:MarketingAdministrationAndResearchCostsMemberpm:EuropeSegmentMember2023-07-012023-09-300001413329pm:SSEACISMEASegmentMemberpm:MarketingAdministrationAndResearchCostsMember2023-01-012023-09-300001413329pm:SSEACISMEASegmentMemberpm:MarketingAdministrationAndResearchCostsMember2023-07-012023-09-300001413329pm:MarketingAdministrationAndResearchCostsMemberpm:EAAUPMIDFSegmentMember2023-01-012023-09-300001413329pm:MarketingAdministrationAndResearchCostsMemberpm:EAAUPMIDFSegmentMember2023-07-012023-09-300001413329pm:AmericasSegmentMemberpm:MarketingAdministrationAndResearchCostsMember2023-07-012023-09-300001413329pm:AmericasSegmentMemberpm:MarketingAdministrationAndResearchCostsMember2023-01-012023-09-300001413329pm:SmokingAndHealthClassActionsMemberpm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMembercountry:CA2015-05-272015-05-27pm:manufacturer0001413329us-gaap:JudicialRulingMemberpm:SmokingAndHealthClassActionsMemberpm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMemberpm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Membercountry:CA2015-05-272015-05-27iso4217:CAD0001413329us-gaap:JudicialRulingMemberpm:SmokingAndHealthClassActionsMemberpm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMembercountry:CApm:RothmansBensonAndHedgesInc.RBHMember2015-05-272015-05-27pm:plaintiff0001413329pm:SmokingAndHealthClassActionsMembercountry:CApm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMemberpm:RothmansBensonAndHedgesInc.RBHMemberpm:AppellateRulingMember2015-10-012015-10-300001413329pm:ImperialTobaccoLtd.Memberpm:SmokingAndHealthClassActionsMembercountry:CApm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMemberpm:AppellateRulingMember2015-10-012015-10-300001413329us-gaap:JudicialRulingMemberpm:SmokingAndHealthClassActionsMemberpm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMemberpm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Membercountry:CA2019-03-012019-03-010001413329us-gaap:JudicialRulingMemberpm:SmokingAndHealthClassActionsMemberpm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMembercountry:CApm:RothmansBensonAndHedgesInc.RBHMember2019-03-012019-03-010001413329us-gaap:JudicialRulingMemberpm:SmokingAndHealthClassActionsMemberpm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Membercountry:CApm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember2019-03-012019-03-010001413329pm:SmokingAndHealthClassActionsMembercountry:CApm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMemberpm:RothmansBensonAndHedgesInc.RBHMemberpm:AppellateRulingMember2019-03-012019-03-010001413329pm:SmokingAndHealthClassActionsMembercountry:CApm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMemberpm:RothmansBensonAndHedgesInc.RBHMemberpm:AppellateRulingMember2019-01-012019-03-310001413329pm:SmokingAndHealthClassActionsMemberpm:CeciliaLetourneauMembercountry:CA2015-05-272015-05-270001413329us-gaap:JudicialRulingMemberpm:SmokingAndHealthClassActionsMemberpm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Memberpm:CeciliaLetourneauMembercountry:CA2015-05-272015-05-270001413329us-gaap:JudicialRulingMemberpm:SmokingAndHealthClassActionsMemberpm:CeciliaLetourneauMembercountry:CApm:RothmansBensonAndHedgesInc.RBHMember2015-05-272015-05-270001413329us-gaap:JudicialRulingMemberpm:SmokingAndHealthClassActionsMemberpm:CeciliaLetourneauMembercountry:CApm:RothmansBensonAndHedgesInc.RBHMember2019-03-012019-03-010001413329pm:AdamsMembercountry:CAus-gaap:PendingLitigationMember2009-07-102009-07-10pm:cigarette0001413329pm:SuzanneJacklinMembercountry:CAus-gaap:PendingLitigationMember2012-06-202012-06-200001413329pm:CombustibleProductsMemberpm:IndividualSmokingAndHealthCasesMember2023-09-30pm:litigationCase0001413329pm:CombustibleProductsMemberpm:IndividualSmokingAndHealthCasesMember2022-09-300001413329pm:SmokingAndHealthClassActionsMemberpm:CombustibleProductsMember2023-09-300001413329pm:SmokingAndHealthClassActionsMemberpm:CombustibleProductsMember2022-09-300001413329pm:CombustibleProductsMemberpm:HealthCareCostRecoveryActionsMember2023-09-300001413329pm:CombustibleProductsMemberpm:HealthCareCostRecoveryActionsMember2022-09-300001413329pm:CombustibleProductsMemberpm:LabelRelatedClassActionMember2023-09-300001413329pm:CombustibleProductsMemberpm:LabelRelatedClassActionMember2022-09-300001413329pm:CombustibleProductsMemberpm:IndividualLabelRelatedCasesMember2023-09-300001413329pm:CombustibleProductsMemberpm:IndividualLabelRelatedCasesMember2022-09-300001413329pm:CombustibleProductsMemberpm:PublicCivilActionsMember2023-09-300001413329pm:CombustibleProductsMemberpm:PublicCivilActionsMember2022-09-300001413329pm:CaseDecidedInFavorOfPlaintiffMember2023-09-300001413329pm:CasesOnAppealSubjectToAnAppealOrWithThePossibilityToBeAppealedByASubsidiaryOfTheCompanyMember2023-09-300001413329us-gaap:JudicialRulingMembercountry:ARpm:SmokingAndHealthIndividualActionsMemberpm:HugoLespadaMember2016-08-052016-08-05iso4217:ARS0001413329us-gaap:JudicialRulingMemberpm:ClaudiaMilanoMembercountry:ARpm:SmokingAndHealthIndividualActionsMember2021-06-172021-06-170001413329us-gaap:JudicialRulingMemberpm:ClaudiaMilanoMembercountry:ARpm:SmokingAndHealthIndividualActionsMember2021-07-022021-07-020001413329us-gaap:JudicialRulingMemberpm:ClaudiaMilanoMembercountry:ARpm:SmokingAndHealthIndividualActionsMember2021-12-162021-12-160001413329us-gaap:JudicialRulingMembercountry:TRpm:SmokingAndHealthIndividualActionsMemberpm:SenemYilmazelMember2023-06-232023-06-23iso4217:TRY0001413329pm:CombustibleProductsMemberpm:IndividualSmokingAndHealthCasesMembercountry:AR2023-09-300001413329pm:CombustibleProductsMemberpm:IndividualSmokingAndHealthCasesMembercountry:AU2023-09-300001413329pm:CombustibleProductsMemberpm:IndividualSmokingAndHealthCasesMembercountry:CA2023-09-300001413329pm:CombustibleProductsMemberpm:IndividualSmokingAndHealthCasesMembercountry:CL2023-09-300001413329pm:CombustibleProductsMemberpm:IndividualSmokingAndHealthCasesMembercountry:PH2023-09-300001413329pm:CombustibleProductsMemberpm:IndividualSmokingAndHealthCasesMembercountry:TR2023-09-300001413329pm:ScotlandMemberpm:CombustibleProductsMemberpm:IndividualSmokingAndHealthCasesMember2023-09-300001413329country:BRpm:CombustibleProductsMemberpm:HealthCareCostRecoveryActionsMember2023-09-300001413329pm:CombustibleProductsMembercountry:CApm:HealthCareCostRecoveryActionsMember2023-09-300001413329pm:CombustibleProductsMemberpm:HealthCareCostRecoveryActionsMembercountry:KR2023-09-300001413329pm:CombustibleProductsMemberpm:HealthCareCostRecoveryActionsMembercountry:NG2023-09-300001413329pm:TheAttorneyGeneralOfLagosStateMemberpm:HealthCareCostRecoveryActionsMembercountry:NGus-gaap:PendingLitigationMember2008-03-132008-03-130001413329pm:HealthCareCostRecoveryActionsMembercountry:NGpm:TheAttorneyGeneralOfKanoStateMemberus-gaap:PendingLitigationMember2007-05-092007-05-090001413329pm:TheAttorneyGeneralOfGombeStateMemberpm:HealthCareCostRecoveryActionsMembercountry:NGus-gaap:PendingLitigationMember2008-10-172008-10-170001413329pm:TheAttorneyGeneralOfOyoStateMemberpm:HealthCareCostRecoveryActionsMembercountry:NGus-gaap:PendingLitigationMember2007-05-252007-05-250001413329pm:TheAttorneyGeneralOfOgunStateMemberpm:HealthCareCostRecoveryActionsMembercountry:NGus-gaap:PendingLitigationMember2008-02-262008-02-260001413329pm:HealthCareCostRecoveryActionsMembercountry:KR2014-04-142014-04-14pm:patient0001413329country:ITpm:CombustibleProductsMemberpm:IndividualLabelRelatedCasesMember2023-09-300001413329pm:CombustibleProductsMemberpm:IndividualLabelRelatedCasesMembercountry:CL2023-09-300001413329country:VEpm:CombustibleProductsMemberpm:PublicCivilActionsMember2023-09-300001413329pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMembercountry:THpm:OtherLitigationMemberus-gaap:PendingLitigationMember2016-01-182016-01-18pm:defendant0001413329pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMembercountry:THpm:OtherLitigationMember2016-01-182016-01-18iso4217:THB0001413329pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMembercountry:THpm:OtherLitigationMember2019-11-012019-11-300001413329pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMembercountry:THpm:OtherLitigationMember2022-06-012022-06-010001413329pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMembercountry:THpm:OtherLitigationMember2017-01-262017-01-260001413329pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMembercountry:THpm:OtherLitigationMember2020-03-012020-03-310001413329pm:TheSouthKoreanBoardOfAuditAndInspectionMemberpm:OtherLitigationMembercountry:KR2016-11-012017-03-31iso4217:KRW0001413329pm:TheSouthKoreanBoardOfAuditAndInspectionMemberpm:OtherLitigationMembercountry:KR2016-01-012016-12-310001413329pm:TheSouthKoreanBoardOfAuditAndInspectionMemberpm:OtherLitigationMembercountry:KR2017-01-012017-03-310001413329pm:TheSouthKoreanBoardOfAuditAndInspectionMemberpm:OtherLitigationMembercountry:KR2020-01-012020-01-310001413329pm:TheSouthKoreanBoardOfAuditAndInspectionMemberpm:OtherLitigationMembercountry:KR2020-06-012020-06-300001413329pm:EAAUPMIDFSegmentMembercountry:KR2023-04-012023-06-300001413329pm:OtherLitigationMember2022-06-152022-06-150001413329pm:CanadianGovernmentMember2020-10-170001413329pm:CanadianGovernmentMember2022-03-310001413329pm:MedicagoIncMemberus-gaap:FinancialGuaranteeMember2022-08-310001413329country:RU2023-01-012023-09-300001413329country:RU2023-07-012023-09-300001413329pm:SwedishMatchABMember2023-07-012023-09-300001413329srt:ScenarioForecastMembersrt:MinimumMember2023-01-012023-12-310001413329srt:MaximumMembersrt:ScenarioForecastMember2023-01-012023-12-310001413329srt:MinimumMember2023-01-012023-09-300001413329srt:MaximumMember2023-01-012023-09-3000014133292021-10-012021-10-31iso4217:IDR0001413329us-gaap:CommercialPaperMember2023-09-300001413329us-gaap:CommercialPaperMember2022-12-310001413329us-gaap:BankLoanObligationsMember2023-09-300001413329us-gaap:BankLoanObligationsMember2022-12-310001413329pm:UsDollarNotesMember2023-09-300001413329pm:UsDollarNotesMember2022-12-310001413329pm:UsDollarNotesMembersrt:MinimumMember2023-09-300001413329pm:UsDollarNotesMembersrt:MaximumMember2023-09-300001413329pm:UsDollarNotesMember2023-01-012023-09-300001413329pm:UsDollarNotesMember2023-09-300001413329pm:UsDollarNotesMember2022-12-310001413329pm:EuroNotesPayableMemberpm:ForeignCurrencyObligationsMembersrt:MinimumMember2023-09-300001413329srt:MaximumMemberpm:EuroNotesPayableMemberpm:ForeignCurrencyObligationsMember2023-09-300001413329pm:EuroNotesPayableMemberpm:ForeignCurrencyObligationsMember2023-01-012023-09-300001413329pm:EuroNotesPayableMemberpm:ForeignCurrencyObligationsMember2023-09-300001413329pm:EuroNotesPayableMemberpm:ForeignCurrencyObligationsMember2022-12-310001413329pm:SwissFrancNotesMemberpm:ForeignCurrencyObligationsMember2023-01-012023-09-300001413329pm:SwissFrancNotesMemberpm:ForeignCurrencyObligationsMember2023-09-300001413329pm:SwissFrancNotesMemberpm:ForeignCurrencyObligationsMember2022-12-310001413329pm:EuroBankLoanMemberpm:ForeignCurrencyObligationsMember2023-01-012023-09-300001413329pm:EuroBankLoanMemberpm:ForeignCurrencyObligationsMember2023-09-300001413329pm:EuroBankLoanMemberpm:ForeignCurrencyObligationsMember2022-12-310001413329pm:SwedishKronaNotesMemberpm:ForeignCurrencyObligationsMembersrt:MinimumMember2023-09-300001413329srt:MaximumMemberpm:SwedishKronaNotesMemberpm:ForeignCurrencyObligationsMember2023-09-300001413329pm:SwedishKronaNotesMemberpm:ForeignCurrencyObligationsMember2023-01-012023-09-300001413329pm:SwedishKronaNotesMemberpm:ForeignCurrencyObligationsMember2023-09-300001413329pm:SwedishKronaNotesMemberpm:ForeignCurrencyObligationsMember2022-12-310001413329us-gaap:NotesPayableOtherPayablesMemberpm:ForeignCurrencyObligationsMember2023-01-012023-09-300001413329us-gaap:NotesPayableOtherPayablesMemberpm:ForeignCurrencyObligationsMember2023-09-300001413329us-gaap:NotesPayableOtherPayablesMemberpm:ForeignCurrencyObligationsMember2022-12-310001413329us-gaap:FairValueInputsLevel1Member2023-09-300001413329us-gaap:FairValueInputsLevel2Member2023-09-300001413329pm:SeniorUnsecuredBridgeFacilityMember2022-05-112022-05-110001413329pm:SeniorUnsecuredBridgeFacilityMember2022-05-110001413329pm:SeniorUnsecuredTermLoanMember2022-06-23iso4217:EUR0001413329pm:SeniorUnsecuredTermLoanMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2022-06-230001413329pm:SeniorUnsecuredTermLoanMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2022-06-232022-06-230001413329pm:SeniorUnsecuredTermLoanMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMember2022-06-230001413329pm:SeniorUnsecuredBridgeFacilityMember2022-06-230001413329pm:SeniorUnsecuredBridgeFacilityMemberpm:SwedishMatchABMember2022-11-072022-11-100001413329pm:SeniorUnsecuredBridgeFacilityMemberpm:SwedishMatchABMember2022-11-072022-11-070001413329pm:SeniorUnsecuredBridgeFacilityMemberpm:SwedishMatchABMember2022-11-102022-11-100001413329pm:SeniorUnsecuredTermLoanMemberpm:SwedishMatchABMember2022-11-072022-11-070001413329pm:SeniorUnsecuredTermLoanMemberus-gaap:DebtInstrumentRedemptionPeriodOneMemberpm:SwedishMatchABMember2022-11-072022-11-070001413329pm:SeniorUnsecuredTermLoanMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMemberpm:SwedishMatchABMember2022-11-072022-11-070001413329pm:SeniorUnsecuredBridgeFacilityMemberpm:SwedishMatchABMember2022-11-212022-11-210001413329pm:SeniorUnsecuredBridgeFacilityMemberpm:SwedishMatchABMember2023-02-172023-02-170001413329pm:SeniorUnsecuredTermLoanMemberpm:SwedishMatchABMember2022-12-310001413329pm:SeniorUnsecuredTermLoanMemberpm:SwedishMatchABMember2023-09-300001413329pm:USDollarNotes4875DueFebruary2026Member2023-02-280001413329pm:USDollarNotes4875DueFebruary2028Member2023-02-280001413329pm:USDollarNotes5125DueFebruary2030Member2023-02-280001413329pm:USDollarNotes5375DueFebruary2033Member2023-02-280001413329pm:USDollarNotes4875DueFebruary2026Member2023-05-300001413329pm:USDollarNotes4875DueFebruary2028Member2023-05-300001413329pm:USDollarNotes5125DueFebruary2030Member2023-05-300001413329pm:USDollarNotes5375DueFebruary2033Member2023-05-300001413329pm:USDollarNotes5250DueSeptember2028Member2023-09-300001413329pm:USDollarNotes5500DueSeptember2030Member2023-09-300001413329pm:USDollarNotes5625DueSeptember2033Member2023-09-300001413329pm:SeniorUnsecuredBridgeFacilityMember2023-02-172023-02-170001413329pm:ThreeHundredSixtyFourDayRevolvingCreditExpiringJanuary302024Member2023-09-300001413329pm:MultiYearRevolvingCreditFacilityExpiringFebruary102026Member2023-09-300001413329pm:MultiYearRevolvingCreditFacilityExpiringSeptember292026Member2023-09-300001413329pm:MultiYearRevolvingCreditFacilityExpiringFebruary102027Member2022-01-280001413329pm:MultiYearRevolvingCreditFacilityExpiringSeptember292027Member2023-09-200001413329pm:ShortTermCreditArrangementMember2023-09-300001413329pm:ShortTermCreditArrangementMember2022-12-310001413329us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300001413329us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001413329us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300001413329us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300001413329us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001413329us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-300001413329us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-09-300001413329us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001413329us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-300001413329pm:DefiniteLivedIntangiblesAndOtherAssetsMember2023-09-300001413329pm:DefiniteLivedIntangiblesAndOtherAssetsMember2022-12-3100014133292022-01-012022-12-310001413329pm:MegapolisMember2023-09-300001413329pm:EITAMember2023-09-300001413329pm:STAEMMember2023-09-300001413329pm:STAEMMemberpm:EITAMember2023-09-300001413329pm:ManagementEtDeveloppementDesActifsEtDesRessourcesHoldingMADARHoldingMemberpm:STAEMMember2023-09-300001413329pm:EIHMember2023-04-300001413329pm:UTCMember2023-04-300001413329pm:UTCMemberpm:EIHMember2023-04-300001413329pm:RothmansBensonAndHedgesInc.RBHMember2019-03-220001413329pm:TTIMemberpm:PMMMember2023-09-300001413329pm:IPMIndiaMember2023-09-300001413329us-gaap:RelatedPartyMemberpm:MegapolisMember2023-01-012023-09-300001413329us-gaap:RelatedPartyMemberpm:MegapolisMember2022-01-012022-09-300001413329us-gaap:RelatedPartyMemberpm:MegapolisMember2023-07-012023-09-300001413329us-gaap:RelatedPartyMemberpm:MegapolisMember2022-07-012022-09-300001413329us-gaap:RelatedPartyMemberpm:OtherRelatedPartyMember2023-01-012023-09-300001413329us-gaap:RelatedPartyMemberpm:OtherRelatedPartyMember2022-01-012022-09-300001413329us-gaap:RelatedPartyMemberpm:OtherRelatedPartyMember2023-07-012023-09-300001413329us-gaap:RelatedPartyMemberpm:OtherRelatedPartyMember2022-07-012022-09-300001413329pm:OtherRelatedPartyMember2023-01-012023-09-300001413329pm:OtherRelatedPartyMember2022-01-012022-09-300001413329pm:OtherRelatedPartyMember2023-07-012023-09-300001413329pm:OtherRelatedPartyMember2022-07-012022-09-300001413329us-gaap:RelatedPartyMemberpm:MegapolisMember2023-09-300001413329us-gaap:RelatedPartyMemberpm:MegapolisMember2022-12-310001413329us-gaap:RelatedPartyMemberpm:OtherRelatedPartyMember2023-09-300001413329us-gaap:RelatedPartyMemberpm:OtherRelatedPartyMember2022-12-31pm:arrangement0001413329pm:EVaporProductsManufacturingOptimizationMember2023-01-012023-03-310001413329pm:EVaporProductsManufacturingOptimizationMemberus-gaap:ContractTerminationMember2023-01-012023-03-310001413329pm:EVaporProductsManufacturingOptimizationMemberpm:FinanceLeaseTerminationMember2023-01-012023-03-310001413329pm:AssetImpairmentMemberpm:EVaporProductsManufacturingOptimizationMember2023-01-012023-03-310001413329us-gaap:ContractTerminationMemberpm:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001413329us-gaap:ContractTerminationMemberus-gaap:OperatingSegmentsMemberpm:SSEACISMEASegmentMember2023-01-012023-09-300001413329pm:EAAUPMIDFSegmentMemberus-gaap:ContractTerminationMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001413329us-gaap:ContractTerminationMemberus-gaap:OperatingSegmentsMemberpm:AmericasSegmentMember2023-01-012023-09-300001413329us-gaap:ContractTerminationMember2023-01-012023-09-300001413329pm:AssetImpairmentMemberpm:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001413329pm:AssetImpairmentMemberus-gaap:OperatingSegmentsMemberpm:SSEACISMEASegmentMember2023-01-012023-09-300001413329pm:AssetImpairmentMemberpm:EAAUPMIDFSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001413329pm:AssetImpairmentMemberus-gaap:OperatingSegmentsMemberpm:AmericasSegmentMember2023-01-012023-09-300001413329pm:AssetImpairmentMember2023-01-012023-09-300001413329srt:ScenarioForecastMember2023-10-012023-12-310001413329pm:SuppliersUsingSupplyChainFinancingProgramMember2023-09-300001413329pm:SuppliersUsingSupplyChainFinancingProgramMember2022-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One) 
☑
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
OR 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number 001-33708
Philip Morris International Inc.
(Exact name of registrant as specified in its charter)
Virginia13-3435103
(State or other jurisdiction of
    incorporation or organization)		(I.R.S. Employer
    Identification No.)
677 Washington Blvd, Suite 1100StamfordConnecticut06901
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code(203)905-2410
Former name, former address and former fiscal year, if changed since last report

Securities registered pursuant to Section 12(b) of the Act:
Title of each class                    Trading Symbol(s)Name of each exchange on which registered
Common Stock, no par valuePMNew York Stock Exchange
3.600% Notes due 2023PM23ANew York Stock Exchange
2.875% Notes due 2024PM24New York Stock Exchange
2.875% Notes due 2024PM24CNew York Stock Exchange
0.625% Notes due 2024PM24BNew York Stock Exchange
3.250% Notes due 2024PM24ANew York Stock Exchange
2.750% Notes due 2025PM25New York Stock Exchange
3.375% Notes due 2025PM25ANew York Stock Exchange
2.750% Notes due 2026PM26ANew York Stock Exchange
2.875% Notes due 2026PM26New York Stock Exchange
0.125% Notes due 2026PM26BNew York Stock Exchange
3.125% Notes due 2027PM27New York Stock Exchange
3.125% Notes due 2028PM28New York Stock Exchange
2.875% Notes due 2029PM29New York Stock Exchange
3.375% Notes due 2029PM29ANew York Stock Exchange
Title of each class                    Trading Symbol(s)Name of each exchange on which registered
0.800% Notes due 2031PM31New York Stock Exchange
3.125% Notes due 2033PM33New York Stock Exchange
2.000% Notes due 2036PM36New York Stock Exchange
1.875% Notes due 2037PM37ANew York Stock Exchange
6.375% Notes due 2038PM38New York Stock Exchange
1.450% Notes due 2039PM39New York Stock Exchange
4.375% Notes due 2041PM41New York Stock Exchange
4.500% Notes due 2042PM42New York Stock Exchange
3.875% Notes due 2042PM42ANew York Stock Exchange
4.125% Notes due 2043PM43New York Stock Exchange
4.875% Notes due 2043PM43ANew York Stock Exchange
4.250% Notes due 2044PM44New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  þ        No  ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  þ        No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer    þ                        Accelerated filer            ☐  
Non-accelerated filer    ☐                         Smaller reporting company    ☐
                                    Emerging growth company    ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  þ
At October 20, 2023, there were 1,552,405,991 shares outstanding of the registrant’s common stock, no par value per share.
1
PHILIP MORRIS INTERNATIONAL INC.
TABLE OF CONTENTS
 
  Page No.
PART I -
Item 1.
Condensed Consolidated Statements of Earnings for the
Nine Months Ended September 30, 2023 and 2022
Three Months Ended September 30, 2023 and 2022
Condensed Consolidated Statements of Comprehensive Earnings for the
Nine Months Ended September 30, 2023 and 2022
Three Months Ended September 30, 2023 and 2022
Condensed Consolidated Balance Sheets at
September 30, 2023 and December 31, 2022
7 – 8
Condensed Consolidated Statements of Cash Flows for the
Nine Months Ended September 30, 2023 and 2022
9 – 10
Condensed Consolidated Statements of Stockholders’ (Deficit) Equity for the
Nine Months Ended September 30, 2023 and 2022
Three Months Ended September 30, 2023 and 2022
13 – 56
Item 2.
57 – 117
Item 4.
PART II -
Item 1.
Item 1A.
Item 2.
Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
Item 5.
Item 6.

In this report, “PMI,” “we,” “us” and “our” refer to Philip Morris International Inc. and its subsidiaries.

Trademarks and service marks in this report are the registered property of, or licensed by, the subsidiaries of Philip Morris International Inc. and are italicized.
2
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements.
Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Earnings
(in millions of dollars, except per share data)
(Unaudited)
 For the Nine Months Ended September 30,
 20232022
Net revenues 1 & 2 (Note 14)
26,127 23,610 
Cost of sales 3 (Notes 3 & 6)
9,431 8,191 
Gross profit16,696 15,419 
Marketing, administration and research costs 4 (Notes 3, 6, 9, 10 & 17)
8,029 6,097 
Operating income8,667 9,322 
Interest expense, net788 418 
Pension and other employee benefit costs (Note 5)36 16 
Earnings before income taxes7,843 8,888 
Provision for income taxes2,019 1,835 
Equity investments and securities (income)/loss, net(131)20 
Net earnings$5,955 $7,033 
Net earnings attributable to noncontrolling interests338 382 
Net earnings attributable to PMI$5,617 $6,651 

Per share data (Note 8):
Basic earnings per share$3.61 $4.28 
Diluted earnings per share$3.61 $4.27 
(1) Includes net revenues from related parties of $2,631 million and $2,634 million for the nine months ended September 30, 2023 and 2022, respectively
(2) Net of excise tax on products of $37,140 million and $37,028 million for the nine months ended September 30, 2023 and 2022, respectively
(3) Includes an impairment charge for other intangibles of $112 million for the nine months ended September 30, 2022. For further details, see Note 6. Goodwill and Other Intangible Assets, net
(4) Includes an impairment charge for goodwill and other intangibles of $680 million and a charge of $204 million for the South Korea indirect tax charge for the nine months ended September 30, 2023, respectively. For further details, see Note 6. Goodwill and Other Intangible Assets, net and Note 10. Contingencies







See notes to condensed consolidated financial statements.

3



Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Earnings
(in millions of dollars, except per share data)
(Unaudited)
 For the Three Months Ended September 30,
 20232022
Net revenues 1 & 2 (Note 14)
9,141 8,032 
Cost of sales 3 (Notes 3 & 6)
3,165 2,935 
Gross profit5,976 5,097 
Marketing, administration and research costs (Notes 3 & 9)
2,606 2,129 
Operating income3,370 2,968 
Interest expense, net261 138 
Pension and other employee benefit costs (Note 5)8 7 
Earnings before income taxes3,101 2,823 
Provision for income taxes1,031 622 
Equity investments and securities (income)/loss, net(101)(21)
Net earnings2,171 2,222 
Net earnings attributable to noncontrolling interests117 135 
Net earnings attributable to PMI$2,054 $2,087 

Per share data (Note 8):
Basic earnings per share$1.32 $1.34 
Diluted earnings per share$1.32 $1.34 
(1) Includes net revenues from related parties of $857 million and $1,087 million for the three months ended September 30, 2023 and 2022, respectively
(2) Net of excise taxes of $13,092 million and $12,856 million for the three months ended September 30, 2023 and 2022, respectively
(3) Includes an impairment charge for other intangibles of $112 million for the three months ended September 30, 2022. For further details, see Note 6. Goodwill and Other Intangible Assets, net



See notes to condensed consolidated financial statements.
4
Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Earnings
(in millions of dollars)
(Unaudited)

For the Nine Months Ended September 30,
20232022
Net earnings$5,955 $7,033 
Other comprehensive earnings (losses), net of income taxes:
Change in currency translation adjustments:
Unrealized gains (losses), net of income taxes of $(12) in 2023 and $(340) in 2022
(669)(352)
(Gains)/losses transferred to earnings, net of income taxes of $0 in 2023 and 2022
4 — 

Change in net loss and prior service cost:
Net gains (losses) and prior service costs, net of income taxes of $0 in 2023 and $29 in 2022
— 63 
Amortization of net losses, prior service costs and net transition costs, net of income taxes of $(20) in 2023 and $(37) in 2022
59 164 

Change in fair value of derivatives accounted for as hedges:
Gains (losses) recognized, net of income taxes of $(56) in 2023 and $(106) in 2022
304 523 
(Gains) losses transferred to earnings, net of income taxes of $30 in 2023 and $18 in 2022
(155)(106)
Total other comprehensive earnings (losses)(457)292 
Total comprehensive earnings5,498 7,325 
Less comprehensive earnings (losses) attributable to:
Noncontrolling interests139 385 
Comprehensive earnings attributable to PMI$5,359 $6,940 


















See notes to condensed consolidated financial statements.
5
Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Earnings
(in millions of dollars)
(Unaudited)
For the Three Months Ended September 30,
20232022
Net earnings$2,171 $2,222 
Other comprehensive earnings (losses), net of income taxes:
Change in currency translation adjustments:
Unrealized gains (losses), net of income taxes of $(95) in 2023 and $(158) in 2022
158 (571)
(Gains)/losses transferred to earnings, net of income taxes of $0 in 2023 and 2022
2 — 

Change in net loss and prior service cost:
Net gains (losses) and prior service costs, net of income taxes of $0 in 2023 and $(7) in 2022
— 27 
Amortization of net losses, prior service costs and net transition costs, net of income taxes of $(6) in 2023 and $(15) in 2022
18 54 

Change in fair value of derivatives accounted for as hedges:
Gains (losses) recognized, net of income taxes of $(8) in 2023 and $(52) in 2022
58 222 
(Gains) losses transferred to earnings, net of income taxes of $8 in 2023 and $9 in 2022
(51)(51)
Total other comprehensive earnings (losses)185 (319)
Total comprehensive earnings
2,356 1,903 
Less comprehensive earnings (losses) attributable to:
Noncontrolling interests74 61 
Comprehensive earnings attributable to PMI$2,282 $1,842 
















See notes to condensed consolidated financial statements.
6
Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in millions of dollars)
(Unaudited)
 
September 30,
2023		December 31,
2022
ASSETS
Cash and cash equivalents$3,017 $3,207 
Trade receivables (less allowances of $80 in 2023 and $42 in 2022) (1)
3,891 3,850 
Other receivables (less allowances of $33 in 2023 and $32 in 2022)
898 906 

Inventories:
Leaf tobacco1,972 1,674 
Other raw materials2,198 2,028 
Finished product5,475 6,184 
9,645 9,886 
Other current assets1,742 1,770 

Total current assets		19,193 19,619 

Property, plant and equipment, at cost		15,893 15,443 
Less: accumulated depreciation9,010 8,733 
6,883 6,710 
Goodwill (Note 6)16,509 19,655 
Other intangible assets, net (Note 6)9,579 6,732 
Equity investments (Note 14)4,691 4,431 
Deferred income taxes577 603 
Other assets (less allowances of $24 in 2023 and $20 in 2022) (Note 2)
5,495 3,931 
TOTAL ASSETS$62,927 $61,681 

(1) Includes trade receivables from related parties of $655 million and $688 million as of September 30, 2023, and December 31, 2022, respectively (less allowances of $43 million as of September 30, 2023 and $7 million as of December 31, 2022). For further details, see Note 14. Related Parties - Equity Investments and Other.






See notes to condensed consolidated financial statements.
Continued
7
Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (Continued)
(in millions of dollars, except share data)
(Unaudited)
 
September 30,
2023		December 31,
2022
LIABILITIES
Short-term borrowings (Note 12)$2,149 $5,637 
Current portion of long-term debt (Note 12)2,652 2,611 
Accounts payable3,533 4,076 
Accrued liabilities:
Marketing and selling857 695 
Taxes, except income taxes5,853 7,440 
Employment costs1,131 1,168 
Dividends payable2,040 1,990 
Other2,250 2,679 
Income taxes1,082 1,040 
Total current liabilities21,547 27,336 

Long-term debt (Note 12)		42,914 34,875 
Deferred income taxes2,903 1,956 
Employment costs1,915 1,984 
Income taxes and other liabilities1,354 1,841 
Total liabilities70,633 67,992 

Contingencies (Note 10)

STOCKHOLDERS’ (DEFICIT) EQUITY

Common stock, no par value
   (2,109,316,331 shares issued in 2023 and 2022)
— — 
Additional paid-in capital2,253 2,230 
Earnings reinvested in the business33,919 34,289 
Accumulated other comprehensive losses (Note 13)(9,817)(9,559)
26,355 26,960 
Less: cost of repurchased stock
   (556,942,754 and 559,098,620 shares in 2023 and 2022, respectively)
35,788 35,917 
Total PMI stockholders’ deficit(9,433)(8,957)
Noncontrolling interests1,727 2,646 
Total stockholders’ deficit(7,706)(6,311)
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY$62,927 $61,681 





See notes to condensed consolidated financial statements.
8
Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(in millions of dollars)
(Unaudited)
 
 For the Nine Months Ended September 30,
 20232022
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
Net earnings$5,955 $7,033 
Adjustments to reconcile net earnings to operating cash flows:
Depreciation, amortization and impairment of goodwill and other intangibles1,709 898 
Deferred income tax (benefit) provision34 (146)
Asset impairment and exit costs, net of cash paid (Note 17)35 (79)
Cash effects of changes, net of the effects from acquired companies:
Receivables, net (1)
(267)(963)
Inventories(181)793 
Accounts payable(623)275 
Accrued liabilities and other current assets(922)(326)
Income taxes(201)(190)
Pension plan contributions, net of refunds (Note 5)(96)38 
Other459 377 
Net cash provided by operating activities5,902 7,710 
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES
Capital expenditures(1,010)(730)
Altria Group, Inc. agreement (Note 2)(1,775)— 
Equity investments(111)(20)
Net investment hedges and other derivatives (Note 7)(110)634 
Other(24)(35)
Net cash used in investing activities(3,030)(151)
 
(1) Includes amounts from related parties of $(130) million and $(226) million for September 30, 2023 and 2022, respectively













See notes to condensed consolidated financial statements.

Continued
9
Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (Continued)
(in millions of dollars)
(Unaudited)
 
 For the Nine Months Ended September 30,
 20232022
CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES
Short-term borrowing activity by original maturity:
    Net issuances (repayments) - maturities of 90 days or less$356 $2,619 
    Issuances - maturities longer than 90 days1,109 795 
    Repayments - maturities longer than 90 days(554)(795)
Repayments under credit facilities related to Swedish Match AB acquisition(4,430)— 
Long-term debt proceeds9,959 — 
Long-term debt repaid(2,034)(1,979)
Repurchases of common stock— (209)
Dividends paid(5,941)(5,839)
Payments to acquire Swedish Match AB noncontrolling interests (Note 2)(883)— 
Noncontrolling interests activity and Other (Note 2)
(267)(663)
Net cash used in financing activities(2,685)(6,071)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(370)(614)
Cash, cash equivalents and restricted cash (1):
Increase (Decrease)(183)874 
Balance at beginning of period3,217 4,500 
Balance at end of period$3,034 $5,374 

(1) The amounts for cash, cash equivalents and restricted cash shown above include restricted cash of $17 million and $6 million as of September 30, 2023 and 2022, respectively, and $10 million and $4 million as of December 31, 2022 and 2021, respectively, which were included in other current assets in the condensed consolidated balance sheets.







See notes to condensed consolidated financial statements.
10
Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Stockholders’ (Deficit) Equity
For the Nine Months Ended September 30, 2023 and 2022
(in millions of dollars, except per share amounts)
(Unaudited)
 PMI Stockholders’ (Deficit) Equity  
 Common
Stock		Additional
Paid-in
Capital		Earnings
Reinvested in
the
Business		Accumulated
Other
Comprehensive Losses		Cost of
Repurchased
Stock		Noncontrolling
Interests		Total
Balances, January 1, 2022$— $2,225 $33,082 $(9,577)$(35,836)$1,898 $(8,208)
Net earnings6,651 382 7,033 
Other comprehensive earnings (losses), net of income taxes460 (168)292 
Issuance of stock awards 9 117 126 
Dividends declared ($3.77 per share)
(5,868)(5,868)
Dividends paid to noncontrolling interests(368)(368)
Common stock repurchased(199)(199)
Purchase of subsidiary shares from noncontrolling interests (Note 2)(30)(171)(10)(211)
Balances, September 30, 2022$— $2,204 $33,865 $(9,288)$(35,918)$1,734 $(7,403)
Balances, January 1, 2023$— $2,230 $34,289 $(9,559)$(35,917)$2,646 $(6,311)
Net earnings5,617 338 5,955 
Other comprehensive earnings (losses), net of income taxes(438)(19)(457)
Issuance of stock awards 29 129 158 
Dividends declared ($3.84 per share)
(5,987)(5,987)
Dividends paid to noncontrolling interests(407)(407)
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 2)(6)180 (831)(657)
Balances, September 30, 2023$— $2,253 $33,919 $(9,817)$(35,788)$1,727 $(7,706)




See notes to condensed consolidated financial statements.
11
Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Stockholders’ (Deficit) Equity
For the Three Months Ended September 30, 2023 and 2022
(in millions of dollars, except per share amounts)
(Unaudited)
 PMI Stockholders’ (Deficit) Equity  
 Common
Stock		Additional
Paid-in
Capital		Earnings
Reinvested in
the
Business		Accumulated
Other
Comprehensive Losses		Cost of
Repurchased
Stock		Noncontrolling
Interests		Total
Balances, July 1, 2022$— $2,165 $33,755 $(9,043)$(35,921)$1,784 $(7,260)
Net earnings  2,087   135 2,222 
Other comprehensive earnings (losses), net of income taxes   (245) (74)(319)
Issuance of stock awards 39   3  42 
Dividends declared ($1.27 per share)
  (1,977)   (1,977)
Dividends paid to noncontrolling interests     (111)(111)
Balances, September 30, 2022$— $2,204 $33,865 $(9,288)$(35,918)$1,734 $(7,403)
Balances, July 1, 2023$— $2,240 $33,893 $(10,045)$(35,791)$1,743 $(7,960)
Net earnings  2,054   117 2,171 
Other comprehensive earnings (losses), net of income taxes   227  (42)185 
Issuance of stock awards 40   3  43 
Dividends declared ($1.30 per share)
  (2,028)   (2,028)
Dividends paid to noncontrolling interests     (89)(89)
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (27) 1  (2)(28)
Balances, September 30, 2023$— $2,253 $33,919 $(9,817)$(35,788)$1,727 $(7,706)


See notes to condensed consolidated financial statements.
12
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 
Note 1. Background and Basis of Presentation:

Background

Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A. (also referred to herein as the U.S., the United States or the United States of America), whose subsidiaries and affiliates and their licensees are primarily engaged in the manufacture and sale of cigarettes and smoke-free products. Throughout these financial statements, the term "PMI" refers to Philip Morris International Inc. and its subsidiaries.

Smoke-free products (also referred to herein as "SFPs") is the term PMI primarily uses to refer to all of its products that are not combustible tobacco products, such as heat-not-burn, e-vapor, and oral nicotine. In addition, SFPs include wellness and healthcare products, as well as consumer accessories such as lighters and matches.

Reduced-risk products ("RRPs") is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. PMI's RRPs are smoke-free products that contain and/or generate far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.

"Platform 1" is the term PMI uses to refer to PMI’s reduced-risk product that uses a precisely controlled heating device into which a specially designed and proprietary tobacco unit is inserted and heated to generate an aerosol.

Basis of Presentation

The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") and such principles are applied on a consistent basis. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S.GAAP have been omitted. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year.

In the fourth quarter of 2022, PMI acquired a controlling interest of the total issued shares in Swedish Match AB (“Swedish Match”). The operating results of Swedish Match are included in a separate segment. For further details, see Note 2. Acquisitions and Note 9. Segment Reporting.

In the third quarter of 2021, PMI acquired Fertin Pharma A/S, Vectura Group plc. and OtiTopic, Inc. On March 31, 2022, PMI launched a Wellness and Healthcare business consolidating these entities, Vectura Fertin Pharma. The operating results of this business are reported in the Wellness and Healthcare segment. For further details, see Note 9. Segment Reporting.

To further support the growth of PMI's smoke-free business, reinforce consumer centricity, and increase the speed of innovation and deployment, in January 2023, PMI began managing its business in four geographical segments, down from six previously, in addition to its continuing Swedish Match and Wellness and Healthcare segments. The four geographical segments are as follows: Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region ("SSEA, CIS & MEA"); East Asia, Australia, and PMI Duty Free Region ("EA, AU & PMI DF"); and Americas Region.

Certain prior years' amounts have been reclassified to conform with the current year's presentation. As a result of the new regional structure discussed above, certain goodwill amounts under the former six geographical segments were reallocated to the four geographical segments under the new structure. For further details, see Note 6. Goodwill and Other Intangible Assets, net. Following the Swedish Match acquisition and a review of PMI and Swedish Match’s combined product portfolio, PMI reclassified certain of its own products previously reported under its combustible tobacco product category to the newly created smoke-free product category to better reflect the characteristics of these products. For further details, see Note 9. Segment Reporting. These reclassifications did not impact PMI’s consolidated financial position, results of operations or cash flows in any of the periods presented.

These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended December 31, 2022.
13
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 2. Acquisitions:

Transactions With Noncontrolling Interests

Turkey – In the first quarter of 2022, PMI acquired the remaining 25% stake of its holding in Philip Morris Tütün Mamulleri Sanayi ve Ticaret A.Ş. ("PMTM") (formerly Philsa Philip Morris Sabanci Sigara ve Tütüncülük Sanayi ve Ticaret A.Ş.) and 24.75% stake in Philip Morris Pazarlama ve Satiş A.Ş. ("PMPS") (formerly Philip Morris SA, Philip Morris Sabanci Pazarlama ve Satiş A.Ş.) from its Turkish partners, Sabanci Holding for a total acquisition price including transaction costs and remaining dividend entitlements of approximately $223 million. As a result of this acquisition, PMI owned 100% of these Turkish subsidiaries as of December 31, 2022. The purchase of the remaining stakes in these holdings resulted in a decrease to PMI's additional paid-in capital of $30 million and an increase to accumulated other comprehensive losses of $171 million primarily following the reclassification of accumulated currency translation losses from noncontrolling interests to PMI’s accumulated other comprehensive losses during the first quarter of 2022.

In January 2023, PMI sold the acquired stakes of its holdings in PMTM and PMPS to Pioneers Tutun Yatirim Anonim Sirketi (“Pioneers”) for a consideration of approximately $258 million, including transaction costs and dividend entitlements. The sale resulted in an increase to PMI's additional paid-in capital of $36 million and a decrease to accumulated other comprehensive losses of $179 million, following the reclassification of accumulated other comprehensive losses from PMI’s accumulated other comprehensive losses to noncontrolling interests.

Business Combinations

Swedish Match AB – On November 11, 2022 (the acquisition date), Philip Morris Holland Holdings B.V. (“PMHH”), a wholly owned subsidiary of PMI, acquired a controlling interest of 85.87% of the total issued shares in Swedish Match AB (“Swedish Match”) and acquired 94.81% of its outstanding shares as of December 31, 2022. The shares were acquired through acceptances of the tender offer and a series of open market and over-the-counter purchases. PMI funded the acquisition through cash on-hand and debt proceeds, as described in Note 12. Indebtedness. The aggregate cash paid as of the acquisition date was $14,460 million (or $13,976 million net of cash acquired), which was included in investing activities in the consolidated statements of cash flows for the year ended December 31, 2022. The cash paid in connection with the additional purchases of the noncontrolling interests after the acquisition date and through December 31, 2022 amounted to $1,495 million and was included in financing activities in the consolidated statements of cash flows for the year ended December 31, 2022.

In accordance with the Swedish Companies Act, PMI subsequently exercised its right to initiate arbitral proceedings to compulsorily redeem the remaining shares for which acceptances were not received and obtained legal title to 100% of the shares in Swedish Match on February 17, 2023. Cash paid in connection with such legal title, together with an immaterial amount attributable to open market purchases that were executed in December 2022 but settled in January 2023, amounted to $883 million and was included in financing activities in the condensed consolidated statements of cash flows for the nine months ended September 30, 2023. While PMI has paid the referenced amounts and has acquired legal title to the shares, the redemption process will not be complete under the Swedish Companies Act until a final redemption price is determined by an arbitral tribunal. On September 12, 2023, the arbitral tribunal determined the final redemption price to be Swedish krona (SEK) 115.07, which is unchanged from the SEK 115.07 that PMI paid per share in connection with obtaining legal title to the shares. This final redemption price is subject to appeal by the remaining minority shareholders within 60 days. Pending appeal, PMI expects this process to be completed in the fourth quarter of 2023 and believes that the likelihood of additional payments to be made is remote.

Swedish Match is a market leader in oral nicotine delivery with a significant presence in the United States market. The acquisition will accelerate PMI’s transformation to become a smoke-free company with a comprehensive global smoke-free portfolio with leadership positions in heat-not-burn, and the fastest growing category of oral nicotine, with the potential for accelerated international expansion.

14
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The table below summarizes the preliminary purchase price allocation for the fair value of assets acquired and liabilities assumed as of the acquisition date, including the measurement period adjustments made for the first nine months of 2023. PMI is still assessing information received as of the acquisition date and expects to complete the allocation by the end of the measurement period in November 2023.
(in millions)
Recognized as of the acquisition dateMeasurement Period AdjustmentsRecognized as of September 30, 2023
Cash and cash equivalents$484 $— $484 
Trade receivables135 — 135 
Other receivables53 — 53 
Inventories444 (7)437 
Other current assets524 (109)415 
Property, plant and equipment627 50 677 
Other intangible assets 4,512 3,289 7,801 
Other non-current assets214 4 218 
Current portion of long-term debt224 — 224 
Accounts payable120 — 120 
Other current liabilities531 1 532 
Income taxes 14 — 14 
Long-term debt1,126 (5)1,121 
Deferred income taxes 1,253 836 2,089 
Other non-current liabilities187 9 196 
Identifiable net assets acquired3,538 2,386 5,924 
Noncontrolling interest2,379 — 2,379 
Goodwill 13,301 (2,386)10,915 
Total consideration transferred$14,460 $— $14,460 

The total fair value step-up adjustment for inventories was $146 million, of which $125 million was recognized in cost of sales in the fourth quarter of 2022 and the remaining balance in the first quarter of 2023.

The fair value of long-term debt was primarily determined using readily available market prices as of the acquisition date and the total purchase price adjustment of $(107) million is being amortized as an increase to interest expense, net over the lives of the related debt.

Goodwill is primarily attributable to future growth opportunities, anticipated synergies in the U.S. and intangible assets that did not qualify for separate recognition. The goodwill is not deductible for income tax purposes.

Identifiable intangible assets of Swedish Match consist of:
Type Useful LifeEstimated Fair Value (in millions)
TrademarksNon-amortizable$3,133 
TrademarksAmortizable
20 - 30 years
1,067 
Developed technology, including patents10 years113 
Customer relationships
6 - 15 years
3,488 
Total identifiable intangible assets$7,801 

15
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The significant assumptions used in determining the preliminary fair values of the identifiable intangible assets included royalty rates, revenue growth rates, profit margins, customer attrition rates and discount rates.

Trademarks primarily relate to $3,133 million for the ZYN trademark, which has been determined to have an indefinite life due to the fast growth and the leading position of the brand in the U.S. market. All other trademarks have been determined to have a useful life ranging between 20 - 30 years. The trademarks have been valued using the relief from royalty method supported by revenue growth rate assumptions and royalty rates disaggregated at the individual trademark level.

Developed technology, including patents, relates to the nicotine pouch technology of $113 million. These patents have been assigned a useful life of 10 years, which is in line with their protection period and have been valued using the comparable transactions and income methods.

Customer relationships have been valued by categories of customers and geographic locations, namely the U.S. market, Scandinavia, and other markets using the multiple periods excess earnings method. The significant assumptions included customer attrition rates disaggregated at the customer category level, the revenue growth rates, as well as profit margins.

PMI consolidated statements of earnings for the year ended December 31, 2022, include $316 million of net revenues and $(26) million of net losses associated with the results of operations of Swedish Match from the acquisition date to December 31, 2022. The operating results of Swedish Match are included in a separate segment.

Acquisition related transaction costs, which were comprised primarily of regulatory, financial advisory and legal fees, totaled $59 million for the year ended December 31, 2022, and were included in marketing, administration and research costs in the consolidated statements of earnings. Bridge and term loan credit agreement related fees associated with the issuance of debt amounted to $54 million, of which $37 million were capitalized at the acquisition date. The fair value of the noncontrolling interest was based on the tender offer as of the acquisition date.

Under the EU Merger Regulation, approval by the European Commission of PMI's acquisition of Swedish Match was conditional on PMHH's divestiture of Swedish Match's subsidiary, SMD Logistics AB ("SMDL"), following the completion of the offer to tender all shares in Swedish Match to PMHH. As a result, these assets were accounted for as assets held for sale and included within other current assets and other accrued liabilities in PMI’s condensed consolidated balance sheets at March 31, 2023 and December 31, 2022. PMI subsequently sold SMDL on June 30, 2023 and the transaction did not have a material impact on the condensed consolidated statements of earnings for the nine months ended September 30, 2023.

The unaudited pro forma combined financial information was prepared using the acquisition method of accounting and was based on the historical financial information of PMI and Swedish Match. In order to reflect the occurrence of the acquisition on January 1, 2021, as required, the unaudited pro forma financial information includes adjustments to reflect the following:

•incremental amortization expense to be incurred based on the current preliminary fair values of the identifiable intangible assets acquired;
•incremental cost of products sold related to the fair value adjustments associated with acquisition date inventory;
•additional interest expense associated with the issuance of debt to finance the acquisition, including the effects of the related derivative financial instruments designated to hedge interest rate risks as well as economic hedges;
•reclassification of non-recurring acquisition-related costs incurred during the year ended December 31, 2022, to the year ended December 31, 2021;
•impact of a deferred tax cost of $430 million in 2022 and $321 million in 2021 related to the theoretical unrealized foreign currency gains on intercompany loans related to the acquisition financing. These theoretical unrealized pre-tax foreign currency movements were fully offset in the consolidated statements of earnings and were reflected as currency translation adjustments in PMI's consolidated statements of stockholders' (deficit) equity, while the corresponding deferred tax impacts were reflected in PMI's consolidated statements of earnings; and
•other immaterial items (i.e., the alignment of accounting policies from IFRS to US GAAP.)

16
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The unaudited pro forma financial information is not necessarily indicative of what the consolidated results of operations would have been had the acquisition been completed on January 1, 2021. In addition, the unaudited pro forma financial information is not a projection of future results of operations of the combined company, nor does it reflect the expected realization of any synergies or cost savings associated with the acquisition.

The unaudited pro forma financial information is as follows:
For the Years Ended December 31,
(in millions)20222021
Net revenues$33,579 $33,488 
Net earnings attributable to PMI$8,788 $8,495 

Altria Group, Inc. Agreement

On October 20, 2022, PMI announced that it had reached an agreement with Altria Group, Inc. ("Altria") to end the companies' relationship regarding the IQOS commercialization rights in the U.S. as of April 30, 2024. As a result of PMI reacquiring these rights, effective May 1, 2024, PMI will hold the full rights to commercialize IQOS in the U.S. As part of the agreement, PMI agreed to pay a total cash consideration of $2.7 billion, with $1.0 billion paid at the inception of the agreement and the remaining $1.7 billion (plus interest, at a per annum rate equal to six percent (6%)), to be paid by July 2023 at the latest. The cash consideration paid at the inception of the agreement of $1.0 billion has been accounted for within other assets in PMI’s condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022. The remaining consideration of $1.7 billion plus interest was paid to Altria on July 14, 2023 and has been accounted for within other assets in PMI's condensed consolidated balance sheets as of September 30, 2023. PMI will finalize the accounting for this transaction by assigning the consideration to the respective assets in May 2024, when PMI can exercise its ability to commercialize IQOS in the U.S.


Note 3. War in Ukraine:

Since the onset of the war in Ukraine in February 2022, PMI's main priority has been the safety and security of its employees and their families in the country.

Ukraine

PMI temporarily suspended its commercial and manufacturing operations in Ukraine, including the closing of its factory in Kharkiv at the end of February 2022, in order to preserve the safety of its employees. PMI subsequently resumed some retail activities where safety allowed, in order to provide product availability and service to adult consumers, and began to supply the market from production centers outside Ukraine, as well as through a contract manufacturing arrangement. Production at the factory in Kharkiv remains suspended. While the effects of the war are unpredictable and could trigger impairment reviews for long-lived assets, as of September 30, 2023, PMI is unable to estimate the information required to perform impairment analyses (i.e., forecast of revenues, manufacturing and commercial plans). PMI is not aware of any major damage to its production facilities, inventories or other assets in Ukraine. As a result, PMI has not recorded an impairment of long-lived assets. As of September 30, 2023, PMI’s Ukrainian operations had approximately $500 million in total assets, excluding intercompany balances. These total assets included $82 million, $350 million and $28 million in receivables, inventories and property, plant and equipment, respectively.

Russia

PMI has suspended its planned investments in the Russian Federation including all new product launches and commercial, innovation, and manufacturing investments. PMI has also taken steps to scale down its manufacturing operations in Russia amid ongoing supply chain disruptions and the evolving regulatory environment. PMI is continuously assessing the evolving situation in Russia, including recent regulatory constraints in the market that entail very complex terms and conditions that must be met for any divestment transaction to be granted approval by the authorities, and restrictions resulting from international regulations. As a result of PMI continuing operations within Russia as of September 30, 2023, it has not recorded an impairment of long-lived and other assets. However, PMI recorded specific asset write downs in 2022 as referred to in the table below. PMI’s Russian operations as of September 30, 2023 had approximately $2.4 billion in total assets, excluding
17
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
intercompany balances. These total assets included $677 million, $411 million, $838 million, $242 million and $158 million in cash (primarily held in local currency), receivables, inventories, property, plant and equipment and goodwill, respectively. In addition, there was approximately $1,343 million of cumulative foreign currency translation losses reflected in accumulated other comprehensive losses in the condensed consolidated statement of stockholders’ equity as of September 30, 2023.

During the nine months and three months ended September 30, 2023 and 2022, PMI recorded in its condensed consolidated statements of earnings pre-tax charges related to circumstances driven by the war as follows:

(in millions)For the Nine Months Ended September 30, 2023For the Nine Months Ended September 30, 2022
Cost of salesMarketing, administration and research costsTotalCost of salesMarketing, administration and research costsTotal
Ukraine 1
$11 $8 $19 $28 $31 $59 
Russia 2
— — — 18 51 69 
Total$11 $8 $19 $46 $82 $128 
1 The 2023 pre-tax charges were primarily due to the cost of PMI’s humanitarian efforts, which includes salary continuation for its employees. The 2022 pre-tax charges were primarily due to an inventory write-down, additional allowance for receivables and the cost of PMI’s humanitarian efforts, which includes salary continuation for its employees.
2 The pre-tax charges were primarily due to machinery and inventory write downs related to the commercial decisions noted above.

(in millions)For the Three Months Ended September 30, 2023For the Three Months Ended September 30, 2022
Cost of salesMarketing, administration and research costsTotalCost of salesMarketing, administration and research costsTotal
Ukraine 1
$11 $8 $19 $3 $5 $8 
Russia — — — (3)1 (2)
Total$11 $8 $19 $— $6 $6 
1 The pre-tax charges were primarily due to PMI’s humanitarian efforts, which includes salary continuation for its employees.

PMI will continue to monitor the situation as it evolves and will determine if further charges are needed.


Note 4. Stock Plans:

In May 2022, PMI’s shareholders approved the Philip Morris International Inc. 2022 Performance Incentive Plan (the “2022 Plan”). Under the 2022 Plan, PMI may grant to eligible employees restricted shares and restricted share units, performance-based cash incentive awards and performance-based equity awards. Up to 25 million shares of PMI’s common stock may be issued under the 2022 Plan. At September 30, 2023, shares available for grant under the 2022 Plan were 22,165,030.

In May 2017, PMI’s shareholders approved the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors (the “2017 Non-Employee Directors Plan”). A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least 50% of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to 1 million shares of PMI common stock may be awarded under the 2017 Non-Employee Directors Plan. At September 30, 2023, shares available for grant under the plan were 876,226.

18
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Restricted share unit (RSU) awards

During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the weighted-average grant date fair value per share related to RSU awards were as follows:
Number of
Shares
Granted		Weighted-Average Grant Date Fair Value Per RSU Award Granted
20231,756,750 $ 101.96 
20221,579,680 $  104.96 

Compensation expense related to RSU awards was as follows:
Compensation Expense Related to RSU Awards
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023$ 124 $ 38 
2022$ 109 $ 35 

As of September 30, 2023, PMI had $199 million of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically three years after the date of the award, or upon death, disability or reaching the age of 58.

During the nine months ended September 30, 2023, 1,421,086 RSU awards vested. The grant date fair value of all the vested awards was approximately $124 million. The total fair value of RSU awards that vested during the nine months ended September 30, 2023 was approximately $143 million.

Performance share unit (PSU) awards

During the nine months ended September 30, 2023 and 2022, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance metrics, which are predetermined at the time of grant, typically over a three-year performance cycle. The performance metrics for such PSU's granted during the nine months ended September 30, 2023 and 2022 consisted of PMI's Total Shareholder Return ("TSR") relative to a predetermined peer group and on an absolute basis (40% weight), PMI’s currency-neutral compound annual adjusted diluted earnings per share growth rate (30% weight), and a Sustainability Index, which consists of two drivers:

•Product Sustainability (20% weight) measuring progress on PMI's efforts to maximize the benefits of smoke-free products, purposefully phase out cigarettes, seek net positive impact in wellness and healthcare, and reduce post-consumer waste; and

•Operational Sustainability (10% weight) measuring progress on PMI's efforts to tackle climate change, preserve nature, improve the quality of life of people in its supply chain, and foster an empowered, and inclusive workplace.

The aggregate of the weighted performance factors for the three metrics in each such PSU award determines the percentage of PSUs that will vest at the end of the three-year performance cycle. The minimum percentage of such PSUs that can vest is zero, with a target percentage of 100 and a maximum percentage of 200. Each such vested PSU entitles the participant to one share of common stock. An aggregate weighted PSU performance factor of 100 will result in the targeted number of PSUs being vested. At the end of the performance cycle, participants are entitled to an amount equivalent to the accumulated dividends paid on common stock during the performance cycle for the number of shares earned.

19
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the grant date fair value per share related to PSU awards were as follows:
Number of Shares GrantedWeighted-
Average PSU Grant Date 
Fair Value Subject to Other Performance Factors 		Weighted-
Average PSU Grant Date 
Fair Value Subject to TSR Performance Factors
(Per Share)(Per Share)
2023482,360 $ 102.02 $ 133.54 
2022451,790 $  105.07 $ 143.94 

The grant date fair value of the PSU awards subject to the other performance factors was determined by using the market price of PMI’s stock on the date of the grant. The grant date fair value of the PSU market-based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model. The following assumptions were used to determine the grant date fair value of the PSU awards subject to the TSR performance factor:
20232022
Average risk-free interest rate (a)
4.1 %1.6 %
Average expected volatility (b)
24.3 %28.6 %
(a) Based on the U.S. Treasury yield curve.
(b) Determined using the observed historical volatility.

Compensation expense related to PSU awards was as follows:
Compensation Expense Related to PSU Awards
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023$ 51 $ 6 
2022$  44 $  13 

As of September 30, 2023, PMI had $49 million of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the performance cycle of the awards, or upon death, disability or reaching the age of 58.

During the nine months ended September 30, 2023, 902,232 PSU awards vested. The grant date fair value of all the vested awards was approximately $83 million. The total fair value of PSU awards that vested during the nine months ended September 30, 2023 was approximately $91 million.

Note 5. Benefit Plans:

Pension coverage for employees of PMI’s subsidiaries is provided, to the extent deemed appropriate, through separate plans, many of which are governed by local statutory requirements. In addition, PMI provides health care and other benefits to certain U.S. retired employees and certain non-U.S. retired employees. In general, health care benefits for non-U.S. retired employees are covered through local government plans.

20
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Pension and other employee benefit costs per the condensed consolidated statements of earnings consisted of the following:
 For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Net pension costs (income)$(61)$(71)$(24)$(22)
Net postemployment costs88 81 29 27 
Net postretirement costs9 6 3 2 
Total pension and other employee benefit costs$36 $16 $8 $7 

Pension Plans

Components of Net Periodic Benefit Cost

Net periodic pension cost consisted of the following:
 
Pension (1)
 For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Service cost$130 $176 $45 $57 
Interest cost193 58 64 20 
Expected return on plan assets(273)(267)(92)(87)
Amortization:
Net loss21 139 5 45 
Prior service cost (credit)(2)(1)(1)— 
Net periodic pension cost$69 $105 $21 $35 
(1) Primarily non-U.S. based defined benefit retirement plans.

Employer Contributions

PMI makes, and plans to make, contributions, to the extent that they are tax deductible and meet specific funding requirements of its funded pension plans.

Employer contributions of $96 million were made to the pension plans during the nine months ended September 30, 2023. Currently, PMI anticipates making additional contributions during the remainder of 2023 of approximately $39 million to its pension plans, based on current tax and benefit laws. However, this estimate is subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on pension assets, or changes in interest and currency rates.

Employer contributions of $85 million were made to the pension plans during the nine months ended September 30, 2022. During the second quarter of 2022, PMI received a cash refund of $123 million from one of its pension plans due to a change in discount rate and value of assets that resulted in the overfunding of the plan.

21
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 6. Goodwill and Other Intangible Assets, net:

Annual impairment review of goodwill and non-amortizable intangible assets

During the second quarter of 2023, PMI completed its annual review of goodwill and non-amortizable intangible assets for potential impairment. Based on this review, it was determined that the estimated fair value of the Wellness and Healthcare reporting unit was lower than its carrying value. Consequently, PMI recorded a goodwill impairment charge of $665 million, reflecting the impact of reduced estimated future cash flows, which were primarily attributable to clinical trial results that became available in June 2023 for an inhalable aspirin product being developed by the Wellness and Healthcare business. While it was observed that the experimental product had a rapid onset of effect, which is the key medical advantage sought, there was significant variability in inhaled dose among subjects. The study was therefore deemed unsuccessful and, as a result, product design improvements are required. PMI had planned to file a new drug application for this product with the U.S. Food and Drug Administration later this year. However, additional time is now required to evaluate design improvements and the corresponding less certain outcome. The cash flow estimates were also adversely impacted by slower-than-anticipated development of the contract development and manufacturing organization ("CDMO") business, including challenges associated with increased cost related to certain key products. Additionally, as a result of the impairment test of non-amortizable intangible assets, PMI recorded a pre-tax impairment charge of $15 million for an in-process research and development project related to one of PMI's 2021 acquisitions. These impairment charges were recorded within marketing, administration and research costs in the consolidated statements of earnings for the nine months ended September 30, 2023. The goodwill impairment charge is not deductible for income tax purposes.

The Wellness and Healthcare reporting unit's fair value was determined using the discounted cash flow model. PMI will continue to monitor this reporting unit as any changes in assumptions and estimates, unfavorable clinical trial results, failure to obtain regulatory approvals or other market factors could result in additional future goodwill and other intangible asset impairments. Certain Wellness and Healthcare products include components or gases which may be subject to enhanced climate change regulations that could impact the related product development and market strategies. This may also lead to supply disruptions that could result in additional future impairments.

While PMI’s remaining reporting units have fair values substantially in excess of their carrying values, there are still risks related to PMI’s Russian reporting unit’s assets as the fair value of these assets is difficult to predict due to the volatility in foreign currency and commodity markets, supply chain, and current economic, political and social conditions. For more information see Note 3. War in Ukraine. PMI has performed a quantitative impairment assessment for all of its reporting units and non-amortizable intangible assets with the exception of the Swedish Match segment. As the purchase price allocation for the acquisition of Swedish Match is preliminary, PMI has performed a qualitative impairment assessment and concluded that it was not more likely than not that the fair value of the Swedish Match reporting units and its non-amortizable intangible assets were less than the respective carrying amounts.

Goodwill

The movements in goodwill were as follows:
(in millions)Europe
SSEA, CIS & MEA
EA, AU & PMI DF
AmericasSwedish MatchWellness & HealthcareTotal
Balances at December 31, 2022$1,370 $2,869 $493 $615 $13,296 $1,012 $19,655 
Changes due to:
Impairment— — — — — (665)(665)
Currency(13)(34)(9)57 (121)25 (95)
Measurement period adjustments— — — — (2,386)— (2,386)
Balances, September 30, 2023$1,357 $2,835 $484 $672 $10,789 $372 $16,509 

As discussed in Note 1. Background and Basis of Presentation, in January 2023, PMI began managing its business in four geographical segments, Swedish Match segment and Wellness and Healthcare segment. As a result, the December 31, 2022 goodwill balance in the table above included the reclassifications from the former six geographical segments to the four geographical segments under the new structure.
22
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

The decrease in goodwill was primarily due to the measurement period adjustments to the Swedish Match preliminary purchase price allocation (see Note 2, Acquisitions), coupled with the impairment discussed above and currency movements.

At September 30, 2023, goodwill primarily reflects PMI’s business combinations in Greece, Indonesia, Mexico, the Philippines and Serbia, as well as the goodwill from the 2021 acquisitions of Fertin Pharma A/S and Vectura Group plc. and the preliminary purchase price allocation of Swedish Match AB, which was acquired in the fourth quarter of 2022.

Other Intangible Assets

Details of other intangible assets were as follows:
September 30, 2023December 31, 2022
(in millions)Weighted-Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationNetGross Carrying AmountAccumulated AmortizationNet
Non-amortizable intangible assets$4,416 $4,416 $3,346 $3,346 
Amortizable intangible assets:
Trademarks16 years2,158 $740 1,418 2,050 $674 1,376 
Developed technology, including patents7 years718 290 428 975 243 732 
Customer relationships and other12 years3,667 350 3,317 1,390 112 1,278 
Total other intangible assets$10,959 $1,380 $9,579 $7,761 $1,029 $6,732 

Non-amortizable intangible assets substantially consist of trademarks from PMI’s acquisitions in Indonesia and Mexico, as well as the preliminary purchase price allocation associated with the Swedish Match acquisition in 2022, and PMI's business combinations in 2021 (primarily in-process research and development). The increase since December 31, 2022 was due to the measurement period adjustments to the Swedish Match preliminary purchase price allocation in the amount of $1,056 million (see Note 2, Acquisitions), coupled with currency movements of $29 million, partially offset by an impairment for an in-process research and development project related to one of PMI's 2021 acquisitions discussed above.

The increase in the gross carrying amount of amortizable intangible assets from December 31, 2022, was due to the measurement period adjustments to the Swedish Match preliminary purchase price allocation in the amount of $2,233 million (see Note 2, Acquisitions), partially offset by currency movements of $105 million.

The change in the accumulated amortization from December 31, 2022, was mainly due to the 2023 amortization of $368 million, partially offset by currency movements of $17 million. The amortization of intangibles for the nine months ended September 30, 2023 was recorded in cost of sales ($43 million) and in marketing, administration and research costs ($325 million) on PMI's condensed consolidated statements of earnings.
Amortization expense for each of the next five years is estimated to be approximately $460 million or less, assuming no additional transactions occur that require the amortization of intangible assets. This estimate is subject to change based on the finalization of the preliminary purchase price allocation of the Swedish Match acquisition. Additionally, the estimated future amortization expense could significantly increase following the reacquisition of IQOS commercialization rights in the U.S. from Altria Group, Inc (see Note 2, Acquisitions), the accounting for which will depend on the facts and circumstances effective May 1, 2024, when PMI will hold the full rights.


23
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
2022 Impairment of Other Intangibles

In the third quarter of 2022, PMI recorded a pre-tax impairment charge of $112 million, reflecting the impact of general economic and market conditions resulting in a reduction in future estimated cash flows on certain products within the Wellness and Healthcare segment. The impairment reduced the carrying values of developed technology definite-lived intangible assets in the Wellness and Healthcare segment to $308 million as of September 30, 2022. The fair value of these intangible assets was primarily determined using the multi-period excess earnings method. This impairment charge was recorded within cost of sales in the condensed consolidated statements of earnings for the three months and nine months ended September 30, 2022.

Note 7. Financial Instruments:

Overview

PMI operates in markets primarily outside of the United States of America, with manufacturing and sales facilities in various locations around the world and is exposed to risks such as changes in foreign currency exchange rates and interest rates. As a result, PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options (collectively referred to as "foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in foreign currency exchange and interest rates related to net investments in foreign operations, third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Euro, Egyptian pound, Indonesian rupiah, Japanese yen, Mexican peso, Philippine peso, Russian ruble and Swiss franc.

Additionally, certain materials that PMI uses in the manufacturing of its products are exposed to market price risks. PMI uses commodity derivative contracts (“commodity contracts") to manage its exposure to the market price volatility of certain commodity components of these materials.

These foreign exchange contracts, interest rate contracts and commodity contracts are collectively referred to as "derivative contracts". PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Substantially all of PMI's derivative financial instruments are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. While these contracts contain the enforceable right to offset through close-out netting rights, PMI elects to present them on a gross basis in the consolidated balance sheets. Collateral associated with these arrangements is in the form of cash and is unrestricted. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings.

The gross notional amounts for outstanding derivatives at the end of each period were as follows:
(in millions)At September 30, 2023At December 31, 2022
Derivative contracts designated as hedging instruments:
Foreign exchange contracts$18,256 $17,627 
Interest rate contracts1,000 1,019 
Commodity contracts27 — 
Derivative contracts not designated as hedging instruments:
Foreign exchange contracts17,818 21,755 
Total$37,101 $40,401 

24
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The fair value of PMI’s derivative contracts included in the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022, were as follows:
 Derivative AssetsDerivative Liabilities
 Fair ValueFair Value
AtAtAtAt
(in millions)Balance Sheet ClassificationSeptember 30, 2023December 31, 2022Balance Sheet ClassificationSeptember 30, 2023December 31, 2022
Derivative contracts designated as hedging instruments:
Foreign exchange contractsOther current assets$472 $376 Other accrued liabilities$126 $126 
Other assets386 341 Income taxes and other liabilities56 147 
Interest rate contractsOther current assets— — Other accrued liabilities40 27 
Other assets— — Income taxes and other liabilities50 56 
Commodity contractsOther current assets— — Other accrued liabilities2 — 
Derivative contracts not designated as hedging instruments:
Foreign exchange contracts
Other current assets 
241 156 Other accrued liabilities87 165 
Other assets— — Income taxes and other liabilities42 16 
Total gross amount derivatives contracts presented in the condensed consolidated balance sheets $1,099 $873  $403 $537 
Gross amounts not offset in the condensed consolidated balance sheets
Financial instruments(292)(346)(292)(346)
Cash collateral received/pledged(566)(341)(60)(48)
Net amount$241 $186 $51 $143 

PMI assesses the fair value of its derivative contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts, foreign currency swaps and interest rate contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates. The fair value of PMI’s commodity contracts is determined by using the prevailing market spot and futures prices and the respective maturity dates of the instruments. PMI’s derivative contracts have been classified within Level 2 at September 30, 2023 and December 31, 2022.

25
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
For the nine months ended September 30, 2023 and 2022, PMI's derivative contracts impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:
(pre-tax, in millions)For the Nine Months Ended September 30,
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on DerivativesStatement of Earnings
Classification of Gain/(Loss)
on Derivatives		Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into EarningsAmount of Gain/(Loss) Recognized in Earnings
202320222023202220232022
Derivative contracts designated as hedging instruments:
Cash flow hedges:
Foreign exchange contracts$290 $325 Net revenues$112 $151 
Cost of sales— — 
Marketing, administration and research costs52 (17)
Interest expense, net(13)(5)
Interest rate contracts72 304 Interest expense, net34 (5)
Commodity contracts(2)— Cost of sales— — 
Fair value hedges:
Interest rate contracts
Interest expense, net (a)
$(24)$(81)
Net investment hedges (b):
Foreign exchange contracts14 1,088 
Interest expense, net (c)
200 116 
Derivative contracts not designated as hedging instruments:
Foreign exchange contractsInterest expense, net212 56 
Marketing, administration and research costs (d)
154 (160)
Total$374 $1,717 $185 $124 $542 $(69)
(a) The gains (losses) from these contracts are offset by the changes in the fair value of the hedged item
(b) Amount of gains (losses) on hedges of net investments principally related to changes in exchange and interest rates between the Euro and U.S. dollar
(c) Represent the gains for amounts excluded from the effectiveness testing
(d) The gains (losses) from these contracts attributable to changes in foreign currency exchange rates are partially offset by the (losses) and gains generated by the underlying intercompany and third-party loans being hedged
26
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

For the three months ended September 30, 2023 and 2022, PMI's derivative contracts impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:
(pre-tax, in millions)For the Three Months Ended September 30,
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on DerivativesStatement of Earnings
Classification of Gain/(Loss)
on Derivatives		Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into EarningsAmount of Gain/(Loss) Recognized in Earnings
202320222023202220232022
Derivative contracts designated as hedging instruments:
Cash flow hedges:
Foreign exchange contracts$67 $77 Net revenues$73 $70 
Cost of sales— — 
Marketing, administration and research costs(19)(7)
Interest expense, net(7)(2)
Interest rate contracts— 197 Interest expense, net12 (1)
Commodity contracts(1)— Cost of sales— — 
Fair value hedges:
Interest rate contracts
Interest expense, net (a)
$(10)$(24)
Net investment hedges (b):
Foreign exchange contracts453 558 
Interest expense, net (c)
73 48 
Derivative contracts not designated as hedging instruments:
Foreign exchange contractsInterest expense, net60 13 
Marketing, administration and research costs (d)
258 (225)
Total$519 $832 $59 $60 $381 $(188)
(a) The gains (losses) from these contracts are offset by the changes in the fair value of the hedged item
(b) Amount of gains (losses) on hedges of net investments principally related to changes in exchange and interest rates between the Euro and U.S. dollar
(c) Represent the gains for amounts excluded from the effectiveness testing
(d) The gains (losses) from these contracts attributable to changes in foreign currency exchange rates are partially offset by the (losses) and gains generated by the underlying intercompany and third-party loans being hedged


Cash Flow Hedges

PMI has entered into derivative contracts to hedge the foreign currency exchange, interest rate and commodity price risks related to certain forecasted transactions. Gains and losses associated with qualifying cash flow hedge contracts are deferred as components of accumulated other comprehensive losses until the underlying hedged transactions are reported in PMI’s condensed consolidated statements of earnings. As of September 30, 2023, PMI has hedged forecasted transactions with derivative contracts expiring at various dates through May 2028. The impact of these hedges is primarily included in operating cash flows on PMI’s condensed consolidated statements of cash flows.

27
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Fair Value Hedges

PMI has entered into fixed-to-floating interest rate contracts, designated as fair value hedges to minimize exposure to changes in the fair value of fixed rate U.S. dollar-denominated debt that results from fluctuations in benchmark interest rates. For derivative contracts that are designated and qualify as fair value hedges, the gain or loss on the derivative, as well as the offsetting gain or loss on the hedged items attributable to the hedged risk, is recognized in current earnings. The carrying amount of the debt hedged, which includes the cumulative adjustment for fair value gains/losses, as of September 30, 2023 was $906 million, and is recorded in long-term debt in the condensed consolidated balance sheets. The cumulative amount of fair value gains/(losses) included in the carrying amount of the debt hedged was $90 million as of September 30, 2023.

Hedges of Net Investments in Foreign Operations

PMI designates derivative contracts and certain foreign currency denominated debt and other financial instruments as net investment hedges, primarily of its Euro net assets. For the nine months ended September 30, 2023 and 2022, the amount of pre-tax gain/(loss) related to the non-derivative financial instruments, that was reported as a component of accumulated other comprehensive losses within currency translation adjustments, was $51 million and $525 million, respectively. For the three months ended September 30, 2023 and 2022, the amount of pre-tax gain/(loss) related to the non-derivative financial instruments, that was reported as a component of accumulated other comprehensive losses within currency translation adjustments, was $27 million and $267 million, respectively. The premiums paid for, and settlements of, net investment hedges are included in investing cash flows on PMI’s condensed consolidated statements of cash flows.

Other Derivatives

PMI has entered into derivative contracts to hedge the foreign currency exchange and interest rate risks related to intercompany loans between certain subsidiaries, third-party loans and acquisition related transactions. While effective as economic hedges, no hedge accounting is applied for these contracts; therefore, the gains (losses) relating to these contracts are reported in PMI’s condensed consolidated statements of earnings. Acquisition related transactions are included in investing cash flows on PMI’s condensed consolidated statements of cash flows.

Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses

Derivative gains or losses reported in accumulated other comprehensive losses are a result of qualifying hedging activity. Transfers of these gains or losses to earnings are offset by the corresponding gains or losses on the underlying hedged item. Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
 2023202220232022
Gain/(loss) as of beginning of period,$266 $4 $408 $250 
Derivative (gains)/losses transferred to earnings(155)(106)(51)(51)
Change in fair value304 523 58 222 
Gain/(loss) as of September 30,$415 $421 $415 $421 

At September 30, 2023, PMI expects $176 million of derivative gains that are included in accumulated other comprehensive losses to be reclassified to the condensed consolidated statement of earnings within the next 12 months. These gains are expected to be substantially offset by the statement of earnings impact of the respective hedged transactions.
Contingent Features
PMI’s derivative instruments do not contain contingent features.
Credit Exposure and Credit Risk
PMI is exposed to credit loss in the event of non-performance by counterparties. While PMI does not anticipate non-performance, its risk is limited to the fair value of the financial instruments less any cash collateral received or pledged. PMI
28
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
actively monitors its exposure to credit risk through the use of credit approvals and credit limits and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.
Other Investments

A certain PMI investment, which is comprised primarily of money market funds, has been classified within Level 1 and had a fair value of $216 million at September 30, 2023. For the nine months and three months ended September 30, 2023, the unrealized pre-tax gains (losses) on these investments were immaterial.

Note 8. Earnings Per Share:
Basic and diluted earnings per share (“EPS”) were calculated using the following:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
 2023202220232022
Net earnings attributable to PMI$5,617 $6,651 $2,054 $2,087 
Less distributed and undistributed earnings attributable to share-based payment awards
17 18 6 5 
Net earnings for basic and diluted EPS$5,600 $6,633 $2,048 $2,082 
Weighted-average shares for basic EPS1,552 1,550 1,552 1,550 
Plus contingently issuable performance stock units (PSUs)(1)
1 2 2 2 
Weighted-average shares for diluted EPS1,553 1,552 1,554 1,552 
(1) Including rounding adjustment

Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and therefore are included in PMI’s earnings per share calculation pursuant to the two-class method.

For the 2023 and 2022 computations, there were no antidilutive stock awards.

Note 9. Segment Reporting:

PMI’s subsidiaries and affiliates are primarily engaged in the manufacture and sale of cigarettes and smoke-free products, including heat-not-burn, e-vapor and oral nicotine products. Excluding the Wellness and Healthcare segment and the 2022 acquisition of Swedish Match, PMI's segments are generally organized by geographic region and managed by segment managers who are responsible for the operating and financial results of the regions inclusive of combustible tobacco and smoke-free product categories sold in the region. Effective in January 2023, PMI began managing its business in four geographical segments, down from six previously, in addition to its continuing Swedish Match and Wellness and Healthcare segments. The four geographical segments are as follows: Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region ("SSEA, CIS & MEA"); East Asia, Australia, and PMI Duty Free Region ("EA, AU & PMI DF"); and Americas Region. PMI records net revenues and operating income to its geographical segments based upon the geographic area in which the customer resides.

PMI’s chief operating decision maker evaluates geographical segment performance and allocates resources based on regional operating income, which includes results from all product categories sold in each region, excluding Swedish Match and Wellness and Healthcare products. Business operations in the Swedish Match segment and the Wellness and Healthcare segment are evaluated separately.

PMI disaggregates its net revenues from contracts with customers by product category for each of PMI's four geographical segments and for the Swedish Match segment. For the Wellness and Healthcare business, Vectura Fertin Pharma, net revenues from contracts with customers are included in the Wellness and Healthcare segment. PMI believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors.

29
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Segment data were as follows:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023202220232022
Net revenues:
Europe$9,984 $9,805 $3,672 $3,272 
SSEA, CIS & MEA
7,922 7,781 2,777 2,822 
EA, AU & PMI DF
4,771 4,458 1,571 1,407 
Americas1,399 1,367 478 474 
Swedish Match1,814 — 568 — 
Wellness and Healthcare237 199 75 57 
Net revenues$26,127 $23,610 $9,141 $8,032 
Operating income (loss):
Europe$4,446 $4,447 $1,708 $1,415 
SSEA, CIS & MEA
2,371 3,009 801 1,086 
EA, AU & PMI DF
1,920 1,746 753 533 
Americas141 336 5 85 
Swedish Match597 — 140 — 
Wellness and Healthcare(808)(216)(37)(151)
Operating income$8,667 $9,322 $3,370 $2,968 

30
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
PMI's net revenues by product category were as follows:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023202220232022
Net revenues:
Combustible tobacco products:
Europe$6,084 $5,996 $2,160 $1,996 
SSEA, CIS & MEA
6,988 6,852 2,485 2,454 
EA, AU & PMI DF
2,091 2,214 678 692 
Americas1,349 1,296 460 450 
Swedish Match333 — 49 — 
Total combustible tobacco products16,845 16,358 5,832 5,591 
Smoke-free products:
Smoke-free products excluding Wellness and Healthcare:
Europe3,900 3,809 1,512 1,276 
SSEA, CIS & MEA
934 929 292 368 
EA, AU & PMI DF
2,680 2,244 893 715 
Americas50 71 18 24 
Swedish Match1,481 — 519 — 
Total smoke-free products excluding Wellness and Healthcare9,045 7,053 3,234 2,384 
Wellness and Healthcare237 199 75 57 
Total smoke-free products9,282 7,252 3,309 2,441 
Total PMI net revenues$26,127 $23,610 $9,141 $8,032 
Note: Sum of product categories or Regions might not foot to total PMI due to roundings.

Items affecting the comparability of results from operations were as follows:

•Impairment of goodwill and other intangibles – See Note 6. Goodwill and Other Intangible Assets, net for the details of the $680 million goodwill and non-amortizable intangible assets impairment charges included in the Wellness and Healthcare segment for the nine months ended September 30, 2023. For the nine months and three months ended September 30, 2022, PMI recorded an impairment charge related to definite-lived intangible assets of $112 million. This charge was included in the Wellness and Healthcare segment. For further details, see Note 6. Goodwill and Other Intangible Assets, net.
•South Korea indirect tax charge – See Note 10. Contingencies for details of the $204 million pre-tax charge included in the EA, AU & PMI DF segment results for the nine months ended September 30, 2023.
•Termination of distribution arrangement in the Middle East – In the first quarter of 2023, PMI recorded a pre-tax charge of $80 million following the termination of a distribution arrangement in the Middle East. This pre-tax charge was recorded as a reduction of net revenues in the condensed consolidated statements of earnings, and was included in the SSEA, CIS & MEA segment results for the nine months ended September 30, 2023.
•Charges related to the war in Ukraine – In the third quarter of 2023, PMI recorded a pre-tax charge of $19 million related to the war in Ukraine. This charge was included in the condensed consolidated statements of earnings and was included in the Europe segment for the nine months and three months ended September 30, 2023. For the nine months and three months ended September 30, 2022, PMI recorded a pre-tax charge of $128 million and $6 million, respectively. These charges were included in the condensed consolidated statements of earnings and were included in the Europe segment for the nine months and three months ended September 30, 2022. For further details, see Note 3. War in Ukraine.
31
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
•Swedish Match AB acquisition accounting related item – See Note 2. Acquisitions for details of the $18 million pre-tax purchase accounting adjustments related to the sale of acquired inventories stepped up to fair value included in the Swedish Match segment for the nine months ended September 30, 2023.
•Asset impairment and exit costs – See Note 17. Asset Impairment and Exit Costs for details of the $109 million pre-tax charge for the nine months ended September 30, 2023, as well as a breakdown of these costs by segment.
•Termination of agreement with Foundation for a Smoke-Free World – On September 29, 2023, PMI and the Foundation for a Smoke-Free World (the "Foundation") entered into the Final Grant Agreement and Termination of the Second Amended and Restated Pledge Agreement ("Agreement"). Under the terms of the agreement, PMI paid $140 million in the third quarter of 2023 in return for the termination of the pledge agreement between the parties. As a result, in the third quarter of 2023, PMI recorded a pre-tax charge of $140 million commensurate with the early termination of the pledge agreement. The pre-tax charge was recorded in marketing, administration and research costs in the condensed consolidated statements of earnings during the nine months and three months ended September 30, 2023 and was included in the operating results of the following segments for both of these periods: Europe ($62 million); SSEA, CIS & MEA ($44 million); EA, AU & PMI DF ($27 million); and Americas ($7 million).

The third quarter 2023 results of PMI's Swedish Match segment include the impact of financial statement presentation reclassifications recorded on a year-to-date basis primarily associated with the alignment of accounting policies related to the company's post-acquisition evaluation of sales incentives, excise taxes and acquired contracts. Net revenues were unfavorably impacted by these reclassifications, some of which are associated with the first and second quarter of 2023. These reclassifications were not material to the condensed consolidated results of the current period or the period in which they relate.
Following the Swedish Match acquisition and a review of PMI and Swedish Match’s combined product portfolio, PMI reclassified certain of its own products previously reported under its combustible tobacco product category to the newly created smoke-free product category to better reflect the characteristics of these products. This reclassification did not impact PMI’s consolidated financial position, results of operations or cash flows in any of the periods presented.
Net revenues related to combustible tobacco products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of PMI's cigarettes and other tobacco products that are combusted. Other tobacco products primarily include roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos, and do not include smoke-free products.

Net revenues related to smoke-free products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes, if applicable. These net revenue amounts consist of the sale of all of PMI's products that are not combustible tobacco products, such as heat-not-burn, e-vapor, and oral nicotine, also including wellness and healthcare products, as well as consumer accessories such as lighters and matches.

Net revenues related to wellness and healthcare products primarily consist of operating revenues generated from the sale of products primarily associated with inhaled therapeutics, and oral and intra-oral delivery systems that are included in the operating results of PMI's Wellness and Healthcare business, Vectura Fertin Pharma.


32
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 10. Contingencies:
Tobacco-Related Litigation
Legal proceedings covering a wide range of matters are pending or threatened against us, and/or our subsidiaries, and/or our indemnitees in various jurisdictions. Our indemnitees include distributors, licensees, and others that have been named as parties in certain cases and that we have agreed to defend, as well as to pay costs and some or all of judgments, if any, that may be entered against them. Pursuant to the terms of the Distribution Agreement between Altria Group, Inc. (“Altria”) and PMI, PMI will indemnify Altria and Philip Morris USA Inc. (“PM USA”), a U.S. tobacco subsidiary of Altria, for tobacco product claims based in substantial part on products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for tobacco product claims based in substantial part on products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.
It is possible that there could be adverse developments in pending cases against us and our subsidiaries. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation.
Damages claimed in some of the tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. Much of the tobacco-related litigation is in its early stages, and litigation is subject to uncertainty. However, as discussed below, we have to date been largely successful in defending tobacco-related litigation.
We and our subsidiaries record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, except as stated otherwise in this Note 10. Contingencies, while it is reasonably possible that an unfavorable outcome in a case may occur, after assessing the information available to it (i) management has not concluded that it is probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss for any of the pending tobacco-related cases; and (iii) accordingly, no estimated loss has been accrued in the consolidated financial statements for unfavorable outcomes in these cases, if any. Legal defense costs are expensed as incurred.
It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Nevertheless, although litigation is subject to uncertainty, we and each of our subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended. However, we and our subsidiaries may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.    
CCAA Proceedings and Stay of Tobacco-Related Cases Pending in Canada
As a result of the Court of Appeal of Quebec’s decision in both the Létourneau and Blais cases described below, our subsidiary, Rothmans, Benson & Hedges Inc. (“RBH”), and the other defendants, JTI Macdonald Corp., and Imperial Tobacco Canada Limited, sought protection in the Ontario Superior Court of Justice under the Companies’ Creditors Arrangement Act (“CCAA”) on March 22, March 8, and March 12, 2019, respectively. CCAA is a Canadian federal law that permits a Canadian business to restructure its affairs while carrying on its business in the ordinary course. The initial CCAA order made by the Ontario Superior Court on March 22, 2019 authorizes RBH to pay all expenses incurred in carrying on its business in the ordinary course after the CCAA filing, including obligations to employees, vendors, and suppliers. RBH's financial results have been deconsolidated from our consolidated financial statements since March 22, 2019. As part of the CCAA proceedings, there is currently a comprehensive stay up to and including March 29, 2024 of all tobacco-related litigation pending in Canada against RBH and the other defendants, including PMI and our indemnitees (PM USA and Altria), namely, the smoking and health class actions filed in various Canadian provinces and health care cost recovery actions. These proceedings are presented below under the caption “Stayed Litigation — Canada.” Ernst & Young Inc. has been appointed as monitor of RBH in the CCAA proceedings. In accordance with the CCAA process, as the parties work towards a plan of arrangement or compromise in a confidential mediation, it is anticipated that the court will set additional hearings and further extend the stay of proceedings. On April 17, 2019, the Ontario Superior Court ruled that RBH and the other defendants will not be allowed to file an application to the Supreme Court of Canada for leave to appeal the Court of Appeal’s decision in the Létourneau and the Blais cases so long as the comprehensive stay of all tobacco-related litigation in Canada remains in effect and that the time period to file the application would be extended by the stay period. While RBH believes that the findings of liability and damages in both Létourneau and the Blais cases were incorrect, the CCAA proceedings will provide a forum for RBH to seek resolution through a plan of arrangement or compromise of all tobacco-related litigation pending in Canada. It is not possible to predict the resolution of the underlying legal proceedings or the length of the CCAA process.
33
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Stayed Litigation — Canada

Smoking and Health Litigation — Canada

In the first class action pending in Canada, Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais v. Imperial Tobacco Canada Ltd., Rothmans, Benson & Hedges Inc. and JTI-Macdonald Corp., Quebec Superior Court, Canada, filed in November 1998, RBH and other Canadian cigarette manufacturers (Imperial Tobacco Canada Ltd. and JTI-Macdonald Corp.) are defendants. The plaintiffs, an anti-smoking organization and an individual smoker, sought compensatory and punitive damages for each member of the class who suffers allegedly from certain smoking-related diseases. The class was certified in 2005. The trial court issued its judgment on May 27, 2015. The trial court found RBH and two other Canadian manufacturers liable and found that the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.3 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion (approximately $2.26 billion), including pre-judgment interest). In addition, the trial court awarded CAD 90,000 (approximately $66,000) in punitive damages, allocating CAD 30,000 (approximately $22,000) to RBH. The trial court estimated the disease class at 99,957 members. RBH appealed to the Court of Appeal of Quebec. In October 2015, the Court of Appeal ordered RBH to furnish security totaling CAD 226 million (approximately $165 million) to cover both the Létourneau and Blais cases, which RBH has paid in installments through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD 758 million (approximately $553 million) in installments through June 2017. JTI Macdonald Corp. was not required to furnish security in accordance with plaintiffs’ motion. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court’s judgment or upon further order of the Court of Appeal.

On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court’s findings of liability and the compensatory and punitive damages award while reducing the total amount of compensatory damages to approximately CAD 13.5 billion (approximately $9.8 billion), including interest due to the trial court’s error in the calculation of interest. The compensatory damages award is on a joint and several basis with an allocation of 20% to RBH (approximately CAD 2.7 billion (approximately $2.0 billion), including pre-judgment interest). The Court of Appeal upheld the trial court’s findings that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking and by conspiring to prevent consumers from learning of the dangers of smoking. The Court of Appeal further held that the plaintiffs either need not prove, or had adequately proven, that these faults were a cause of the class members’ injuries. In accordance with the judgment, defendants were required to deposit their respective portions of the damages awarded in both the Létourneau case described below and the Blais case, approximately CAD 1.1 billion (approximately $802 million), into trust accounts within 60 days. RBH’s share of the deposit was approximately CAD 257 million (approximately $194 million). PMI recorded a pre-tax charge of $194 million in its consolidated results, representing $142 million net of tax, as tobacco litigation-related expense, in the first quarter of 2019. The charge reflects PMI’s assessment of the portion of the judgment that represents probable and estimable loss prior to the deconsolidation of RBH and corresponds to the trust account deposit required by the judgment.

In the second class action pending in Canada, Cecilia Létourneau v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI-Macdonald Corp., Quebec Superior Court, Canada, filed in September 1998, RBH and other Canadian cigarette manufacturers (Imperial Tobacco Canada Ltd. and JTI-Macdonald Corp.) are defendants.  The plaintiff, an individual smoker, sought compensatory and punitive damages for each member of the class who is deemed addicted to smoking. The class was certified in 2005. The trial court issued its judgment on May 27, 2015. The trial court found RBH and two other Canadian manufacturers liable and awarded a total of CAD 131 million (approximately $96 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to RBH. The trial court estimated the size of the addiction class at 918,000 members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court found that a claims process to allocate the awarded punitive damages to individual class members would be too expensive and difficult to administer. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court’s findings of liability and the total amount of punitive damages awarded allocating CAD 57 million (approximately $42 million), including interest to RBH. See the Blais description above for further detail concerning the security order pertaining to both Létourneau and Blais cases and the impact of the decision on PMI’s financial statements.

RBH and PMI believe the findings of liability and damages in both Létourneau and the Blais cases were incorrect and in contravention of applicable law on several grounds, including the following: (i) defendants had no obligation to warn class members who knew, or should have known, of the risks of smoking; (ii) defendants cannot be liable to class members who
34
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
would have smoked regardless of what warnings were given; and (iii) defendants cannot be liable to all class members given the individual differences among class members.
In the third class action pending in Canada, Kunta v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Winnipeg, Canada, filed June 12, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic obstructive pulmonary disease (“COPD”), severe asthma, and mild reversible lung disease resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products.
In the fourth class action pending in Canada, Adams v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Saskatchewan, Canada, filed July 10, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, emphysema, heart disease, or cancer, as well as restitution of profits.
In the fifth class action pending in Canada, Semple v. Canadian Tobacco Manufacturers' Council, et al., The Supreme Court (trial court), Nova Scotia, Canada, filed June 18, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and COPD resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products.
In the sixth class action pending in Canada, Dorion v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Alberta, Canada, filed June 15, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic bronchitis and severe sinus infections resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. To date, we, our subsidiaries, and our indemnitees have not been properly served with the complaint.
In the seventh class action pending in Canada, McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and heart disease resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from heart disease allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed.

In the eighth class action pending in Canada, Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, the heir to a deceased smoker, alleges that the decedent was addicted to tobacco products and suffered from emphysema resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from chronic respiratory diseases allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. In December 2014, plaintiff filed an amended statement of claim.

In the ninth class action pending in Canada, Suzanne Jacklin v. Canadian Tobacco Manufacturers' Council, et al., Ontario Superior Court of Justice, filed June 20, 2012, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, heart disease, or cancer, as well as restitution of profits.

35
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Health Care Cost Recovery Litigation — Canada
In the first health care cost recovery case pending in Canada, Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001, we, RBH, our indemnitee (PM USA), and other members of the industry are defendants. The plaintiff, the government of the province of British Columbia, brought a claim based upon legislation enacted by the province authorizing the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, resulting from a “tobacco related wrong.”
In the second health care cost recovery case filed in Canada, Her Majesty the Queen in Right of New Brunswick v. Rothmans Inc., et al., Court of Queen's Bench of New Brunswick, Trial Court, New Brunswick, Fredericton, Canada, filed March 13, 2008, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of New Brunswick based on legislation enacted in the province. This legislation is similar to the law introduced in British Columbia that authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the third health care cost recovery case filed in Canada, Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Ontario Superior Court of Justice, Toronto, Canada, filed September 29, 2009, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Ontario based on legislation enacted in the province. This legislation is similar to the laws introduced in British Columbia and New Brunswick that authorize the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the fourth health care cost recovery case filed in Canada, Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, St. Johns, Canada, filed February 8, 2011, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Newfoundland and Labrador based on legislation enacted in the province that is similar to the laws introduced in British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the fifth health care cost recovery case filed in Canada, Attorney General of Quebec v. Imperial Tobacco Limited, et al., Superior Court of Quebec, Canada, filed June 8, 2012, we, RBH, our indemnitee (PM USA), and other members of the industry are defendants. The claim was filed by the government of the province of Quebec based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the sixth health care cost recovery case filed in Canada, Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Supreme Court of Queen's Bench Alberta, Canada, filed June 8, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Alberta based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the seventh health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Manitoba v. Rothmans, Benson & Hedges, Inc., et al., The Queen's Bench, Winnipeg Judicial Centre, Canada, filed May 31, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Manitoba based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the eighth health care cost recovery case filed in Canada, The Government of Saskatchewan v. Rothmans, Benson & Hedges Inc., et al., Queen's Bench, Judicial Centre of Saskatchewan, Canada, filed June 8, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Saskatchewan based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
36
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
In the ninth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Prince Edward Island v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Prince Edward Island (General Section), Canada, filed September 10, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Prince Edward Island based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”

In the tenth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Nova Scotia v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Nova Scotia, Canada, filed January 2, 2015, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Nova Scotia based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
__________
The table below lists the number of tobacco-related cases pertaining to combustible products pending against us and/or our subsidiaries or indemnitees as of September 30, 2023, and September 30, 2022:

Type of Case1
Number of Cases Pending as of September 30, 2023Number of Cases Pending as of September 30, 2022
Individual Smoking and Health Cases4838
Smoking and Health Class Actions99
Health Care Cost Recovery Actions1717
Label-Related Class Actions——
Individual Label-Related Cases56
Public Civil Actions11
______
¹ Includes cases pending in Canada.

Since 1995, when the first tobacco-related litigation was filed against a PMI entity, 538 Smoking and Health, Label-Related, Health Care Cost Recovery, and Public Civil Actions in which we and/or one of our subsidiaries and/or indemnitees were a defendant have been terminated in our favor. Fifteen cases have had decisions in favor of plaintiffs. Ten of these cases have subsequently reached final resolution in our favor and five remain on appeal, or are subject to an appeal, or our subsidiary may file an appeal.




37
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The table below lists the verdict and significant post-trial developments in the five pending cases where a verdict was returned in favor of the plaintiff:
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
May 27, 2015  Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais
  Class Action  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.3 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.26 billion)). The trial court awarded CAD 90,000 (approximately $66,000) in punitive damages, allocating CAD 30,000 (approximately $22,000) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $729 million) of the compensatory damage award, CAD 200 million (approximately $146 million) of which is our subsidiary’s portion, into a trust within 60 days.
  
In June 2015, RBH commenced the appellate process with the Court of Appeal of Quebec. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court's decision. (See “Stayed Litigation — Canada” for further detail.)
38
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
May 27, 2015  Canada/Cecilia Létourneau
  Class Action  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $96 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to RBH. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.
  
In June 2015, RBH commenced the appellate process with the Court of Appeal of Quebec. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court's decision. (See “Stayed Litigation — Canada” for further detail.)
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
August 5, 2016Argentina/Hugo LespadaIndividual Action
On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $314), plus interest, in compensatory and moral damages. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.
On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On May 17, 2021, plaintiff filed a federal extraordinary appeal. On November 1, 2021, the Supreme Court of the Province of Buenos Aires dismissed plaintiff's federal extraordinary appeal. On November 10, 2021, plaintiff filed a direct appeal before the Federal Supreme Court.

39
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
June 17, 2021Argentina/Claudia MilanoIndividual Action
On June 17, 2021, the Civil Court No. 9 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded her smoking cessation treatments, ARS 150,000 (approximately $429), in compensatory and moral damages, and ARS 4,000,000 (approximately $11,435) in punitive damages, plus interest and costs. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.
On July 2, 2021, our subsidiary filed its notice of appeal. In addition, plaintiff filed an appeal challenging the dismissal of the claim for psychological damages. As required by local law, our subsidiary deposited the damages awarded, plus interest and costs, in total ARS 6,114,428 (approximately $17,479), into a court escrow account. Our subsidiary challenged the amount determined by the court. The Civil and Commercial Court of Appeals of Mar del Plata granted our subsidiary's challenge to the escrow amount determined by the trial court. As a result, on December 16, 2021, ARS 893,428 (approximately $2,554) was returned to our subsidiary. If our subsidiary ultimately prevails, the remaining deposited amounts will be returned to our subsidiary. On May 31, 2022, the Civil and Commercial Court of Appeals of Mar del Plata ruled that the statute of limitations barred plaintiff's claim and reversed the trial court's decision. On June 15, 2022, plaintiff filed an extraordinary appeal.

Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
June 23, 2023Turkey/ Senem YilmazelIndividual Action
On June 23, 2023, the Ankara Consumer Court published its decision in favor of plaintiff, the daughter of an individual smoker, against our subsidiary and a BAT subsidiary, awarding her TRY 10,000 (approximately $357) in damages. The trial court found that the plaintiff’s father died as a result of lung cancer and COPD caused by his cigarette consumption.
On September 8, 2023, our subsidiary filed its appeal. On September 25, 2023, the plaintiff filed an appeal challenging the damages amount determined by the court.


40
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Pending claims related to tobacco products generally fall within the following categories:
Smoking and Health Litigation: These cases primarily allege personal injury and are brought by individual plaintiffs or on behalf of a class or purported class of individual plaintiffs. Plaintiffs' allegations of liability in these cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of express and implied warranties, violations of deceptive trade practice laws and consumer protection statutes. Plaintiffs in these cases seek various forms of relief, including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include licit activity, failure to state a claim, lack of defect, lack of proximate cause, assumption of the risk, contributory negligence, and statute of limitations.
As of September 30, 2023, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:

•48 cases brought by individual plaintiffs in Argentina (32), Australia (1), Canada (2), Chile (10), the Philippines (1), Turkey (1) and Scotland (1), compared with 38 such cases on September 30, 2022; and
•9 cases brought on behalf of classes of individual plaintiffs, compared with 9 such cases on September 30, 2022.

The class actions pending in Canada are described above under the caption “Smoking and Health Litigation — Canada.”

Health Care Cost Recovery Litigation: These cases, brought by governmental and non-governmental plaintiffs, seek reimbursement of health care cost expenditures allegedly caused by tobacco products. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including unjust enrichment, negligence, negligent design, strict liability, breach of express and implied warranties, violation of a voluntary undertaking or special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, defective product, failure to warn, sale of cigarettes to minors, and claims under statutes governing competition and deceptive trade practices. Plaintiffs in these cases seek various forms of relief including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, remoteness of injury, failure to state a claim, adequate remedy at law, “unclean hands” (namely, that plaintiffs cannot obtain equitable relief because they participated in, and benefited from, the sale of cigarettes), and statute of limitations.
As of September 30, 2023, there were 17 health care cost recovery cases pending against us, our subsidiaries or indemnitees in Brazil (1), Canada (10), Korea (1) and Nigeria (5), compared with 17 such cases on September 30, 2022.

The health care cost recovery actions pending in Canada are described above under the caption “Health Care Cost Recovery Litigation — Canada.”
In the health care cost recovery case in Brazil, The Attorney General of Brazil v. Souza Cruz Ltda., et al., Federal Trial Court, Porto Alegre, Rio Grande do Sul, Brazil, filed May 21, 2019, we, our subsidiaries, and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases in certain prior years, payment of anticipated costs of treating future alleged smoking-related diseases, and moral damages. Defendants filed answers to the complaint in May 2020.
In the first health care cost recovery case in Nigeria, The Attorney General of Lagos State v. British American Tobacco (Nigeria) Limited, et al., High Court of Lagos State, Lagos, Nigeria, filed March 13, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.
In the second health care cost recovery case in Nigeria, The Attorney General of Kano State v. British American Tobacco (Nigeria) Limited, et al., High Court of Kano State, Kano, Nigeria, filed May 9, 2007, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of challenging the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.
In the third health care cost recovery case in Nigeria, The Attorney General of Gombe State v. British American Tobacco (Nigeria) Limited, et al., High Court of Gombe State, Gombe, Nigeria, filed October 17, 2008, we and other members of the
41
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In February 2011, the court ruled that the plaintiff had not complied with the procedural steps necessary to serve us. As a result of this ruling, plaintiff must re-serve its claim. We have not yet been re-served.
In the fourth health care cost recovery case in Nigeria, The Attorney General of Oyo State, et al., v. British American Tobacco (Nigeria) Limited, et al., High Court of Oyo State, Ibadan, Nigeria, filed May 25, 2007, we and other members of the industry are defendants. Plaintiffs seek reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We challenged service as improper. In June 2010, the court ruled that plaintiffs did not have leave to serve the writ of summons on the defendants and that they must re-serve the writ. We have not yet been re-served.
In the fifth health care cost recovery case in Nigeria, The Attorney General of Ogun State v. British American Tobacco (Nigeria) Limited, et al., High Court of Ogun State, Abeokuta, Nigeria, filed February 26, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In May 2010, the trial court rejected our objections to the court's jurisdiction. We have appealed. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.

In the health care cost recovery case in Korea, the National Health Insurance Service v. KT&G, et. al., filed April 14, 2014, our subsidiary and other Korean manufacturers are defendants. Plaintiff alleges that defendants concealed the health hazards of smoking, marketed to youth, added ingredients to make their products more harmful and addictive, and misled consumers into believing that Lights cigarettes are safer than regular cigarettes. The National Health Insurance Service seeks to recover damages allegedly incurred in treating 3,484 patients with small cell lung cancer, squamous cell lung cancer, and squamous cell laryngeal cancer from 2003 to 2012. The trial court dismissed the case in its entirety on November 20, 2020. The Appellate court granted the Plaintiff a de novo appeal in 2021 and determined that the appellate proceedings will take place in stages: wrongful conduct/product defect allegations first, then causation and finally issues such as standing/direct action.

Label-Related Cases: These cases, now brought only by individual plaintiffs, allege that the use of the descriptor “Lights” or other alleged misrepresentations or omissions of labeling information constitute fraudulent and misleading conduct. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including misrepresentation, deception, and breach of consumer protection laws. Plaintiffs seek various forms of relief including restitution, injunctive relief, and compensatory and other damages. Defenses raised include lack of causation, lack of reliance, assumption of the risk, and statute of limitations.

As of September 30, 2023, there were 5 label-related cases brought by individual plaintiffs in Italy (1) and Chile (4) pending against our subsidiaries, compared with 6 such cases on September 30, 2022.

Public Civil Actions: Claims have been filed either by an individual, or a public or private entity, seeking to protect collective or individual rights, such as the right to health, the right to information or the right to safety. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including product defect, concealment, and misrepresentation. Plaintiffs in these cases seek various forms of relief including injunctive relief such as banning cigarettes, descriptors, smoking in certain places and advertising, as well as implementing communication campaigns and reimbursement of medical expenses incurred by public or private institutions.

As of September 30, 2023, there was 1 public civil action pending against our subsidiary in Venezuela (1), compared with 1 such case on September 30, 2022.

In a public civil action in Venezuela, Federation of Consumers and Users Associations (“FEVACU”), et al. v. National Assembly of Venezuela and the Venezuelan Ministry of Health, Constitutional Chamber of the Venezuelan Supreme Court, filed April 29, 2008, we were not named as a defendant, but the plaintiffs published a notice pursuant to court order, notifying all interested parties to appear in the case. In January 2009, our subsidiary appeared in the case in response to this notice. The plaintiffs purport to represent the right to health of the citizens of Venezuela and claim that the government failed to protect adequately its citizens' right to health. The claim asks the court to order the government to enact stricter regulations on the manufacture and sale of tobacco products. In addition, the plaintiffs ask the court to order companies involved in the tobacco
42
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
industry to allocate a percentage of their “sales or benefits” to establish a fund to pay for the health care costs of treating smoking-related diseases. In October 2008, the court ruled that plaintiffs have standing to file the claim and that the claim meets the threshold admissibility requirements. In December 2012, the court admitted our subsidiary and a subsidiary of British American Tobacco plc as interested third parties. In February 2013, our subsidiary answered the complaint.

Other Litigation

The Department of Special Investigations of the government of Thailand ("DSI") conducted an investigation into alleged underpayment by our subsidiary, Philip Morris (Thailand) Limited ("PM Thailand"), of customs duties and excise taxes relating to imports from the Philippines covering the period 2003-2007. On January 18, 2016, the Public Prosecutor filed charges against our subsidiary and seven former and current employees in the Bangkok Criminal Court alleging that PM Thailand and the individual defendants jointly and with the intention to defraud the Thai government, under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries of cigarettes from the Philippines during the period of July 2003 to June 2006. The government sought a fine of approximately THB 80.8 billion (approximately $2.2 billion). In May 2017, Thailand enacted a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies. Trial in the case began in November 2017 and concluded in September 2019. In November 2019, the trial court found our subsidiary guilty of under-declaration of the prices and imposed a fine of approximately THB 1.2 billion (approximately $32.8 million). The trial court dismissed all charges against the individual defendants. In December 2019, as required by the Thai law, our subsidiary paid the fine. This payment is included in other assets on the condensed consolidated balance sheets and negatively impacted net cash provided by operating activities in the condensed consolidated statements of cash flows in the period of payment. Both our subsidiary and the Public Prosecutor filed an appeal of the trial court's decision. The appellate court issued its decision on the appeals on June 1, 2022. The appellate court affirmed the findings of under-declaration of import prices of cigarettes but reduced the fine to approximately THB 122 million (approximately $3.3 million) finding the trial court erred in its calculation of the under-declaration and fine. The appellate court affirmed the acquittals of the individual defendants. Our subsidiary has appealed the decision to the Supreme Court of Thailand. The Public Prosecutor has also filed an appeal challenging the dismissal of charges against the individual defendants and the amount of the fine imposed. Thailand is required to refund any payment made by our subsidiary in excess of any fine asserted by the courts.

The DSI also conducted an investigation into alleged underpayment by PM Thailand of customs duties and excise taxes relating to imports from Indonesia covering the period 2000-2003. On January 26, 2017, the Public Prosecutor filed charges against PM Thailand and its former Thai employee in the Bangkok Criminal Court alleging that PM Thailand and its former employee jointly and with the intention to defraud the Thai government under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries during the period from January 2002 to July 2003. The government is seeking a fine of approximately THB 19.8 billion (approximately $541 million). In May 2017, Thailand enacted a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law, and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and a Thai court. Trial in the case began in November 2018 and concluded in December 2019. In March 2020, the trial court found our subsidiary guilty of under-declaration of the prices and imposed a fine of approximately THB 130 million (approximately $3.6 million). The trial court dismissed all charges against the individual defendant. In April 2020, as required by Thai law, our subsidiary paid the fine. This payment is included in other assets on the condensed consolidated balance sheets and negatively impacted net cash provided by operating activities in the condensed consolidated statements of cash flows in the period of payment. Our subsidiary filed an appeal of the trial court's decision. In addition, the Public Prosecutor filed an appeal of the trial court's decision challenging the dismissal of charges against the individual defendant and the amount of the fine imposed. The appellate court issued its decision on the appeals on January 31, 2023. The appellate court affirmed the findings of under-declaration of import prices of cigarettes but reduced the fine imposed by the trial court. The appellate court directed the Public Prosecutor to coordinate with customs officials to calculate such reduced fine in accordance with the appellate court’s decision. The appellate court affirmed the acquittal of the individual defendant. Our subsidiary has appealed the decision to the Supreme Court of Thailand. The Public Prosecutor has filed an appeal to the Supreme Court of Thailand challenging the dismissal of charges against the individual defendant and the amount of the fine. Thailand is required to refund any payment made by our subsidiary in excess of any fine assessed by the courts.

43
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The South Korean Board of Audit and Inspection (“BAI”) conducted an audit of certain Korean government agencies and the tobacco industry into whether inventory movements ahead of the January 1, 2015 increase of cigarette-related taxes by tobacco companies, including Philip Morris Korea Inc. ("PM Korea"), our South Korean subsidiary, were in compliance with South Korean tax laws.  In November 2016, the tax authorities completed their audit and assessed allegedly underpaid taxes and penalties.  In order to avoid nonpayment financial costs, PM Korea paid approximately KRW 272 billion (approximately $204 million), of which KRW 100 billion (approximately $75 million) was paid in 2016 and KRW 172 billion (approximately $129 million) was paid in the first quarter of 2017.  These paid amounts negatively impacted net cash provided by operating activities in the condensed consolidated statements of cash flows in the period of payment.  PM Korea appealed the assessments. In January 2020, a trial court ruled that PM Korea did not underpay taxes in the amount of approximately KRW 218 billion (approximately $164 million). The tax authorities appealed this decision to the appellate court. In September 2020, the appellate court upheld the trial court's decision. The tax authorities have appealed to the Supreme Court of South Korea. On July 13, 2023, the Supreme Court reversed the appellate court's decision and remanded the appeals back to the appellate court. Based on the decision issued by the Supreme Court of South Korea on July 13, 2023, management has concluded that an adverse outcome is probable. In June 2020, another trial court ruled that PM Korea did not underpay approximately KRW 54 billion (approximately $40 million) of alleged underpayments. The government agencies appealed this decision. In January 2021, the appellate court upheld the trial court's decision. The government agencies appealed to the Supreme Court of South Korea. Based on the decision issued by the Supreme Court of South Korea on July 13, 2023, management has concluded that an adverse outcome is probable. Consequently, in the second quarter of 2023, PMI recorded a non-cash pre-tax charge of $204 million in marketing, administration and research costs, reflecting the full amount previously paid by PM Korea.

A putative shareholder class action lawsuit, In re Philip Morris International Inc. Securities Litigation, is pending in the United States District Court for the Southern District of New York, purportedly on behalf of purchasers of Philip Morris International Inc. stock between July 26, 2016 and April 18, 2018. The lawsuit names Philip Morris International Inc. and certain officers and employees as defendants and includes allegations that the defendants made false and/or misleading statements and/or failed to disclose information about PMI’s business, operations, financial condition, and prospects, related to product sales of, and alleged irregularities in clinical studies of, PMI’s Platform 1 product. The lawsuit seeks various forms of relief, including damages. In November 2018, the court consolidated three putative shareholder class action lawsuits with similar allegations previously filed in the Southern District of New York (namely, City of Westland Police and Fire Retirement System v. Philip Morris International Inc., et al., Greater Pennsylvania Carpenters’ Pension Fund v. Philip Morris International Inc., et al., and Gilchrist v. Philip Morris International Inc., et al.) into these proceedings. A putative shareholder class action lawsuit, Rubenstahl v. Philip Morris International Inc., et al., that had been previously filed in December 2017 in the United States District Court for the District of New Jersey, was voluntarily dismissed by the plaintiff due to similar allegations in these proceedings. On February 4, 2020, the court granted defendants’ motion in its entirety, dismissing all but one of the plaintiffs’ claims with prejudice.  The court noted that one of plaintiffs’ claims (allegations relating to four non-clinical studies of PMI’s Platform 1 product) did not state a viable claim but allowed plaintiffs to replead that claim by March 3, 2020. On February 18, 2020, the plaintiffs filed a motion for reconsideration of the court's February 4th decision; this motion was denied on September 21, 2020. On September 28, 2020, plaintiffs filed an amended complaint seeking to replead allegations relating to four non-clinical studies of PMI's Platform 1 product. On September 10, 2021, the court granted defendant's motion to dismiss plaintiffs' amended complaint in its entirety. Plaintiffs have filed an appeal with the U.S. Court of Appeal for the Second Circuit. We believe that this lawsuit is without merit and will continue to defend it vigorously.

In April 2020, affiliates of British American Tobacco plc (“BAT”) commenced patent infringement proceedings, RAI Strategic Holdings, Inc., et al. v. Altria Client Services LLC, et al.,  in the federal court in the Eastern District of Virginia, where PMI's subsidiary, Philip Morris Products S.A. ("PMPSA"), as well as Altria Group, Inc.'s subsidiaries, are defendants. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade products in the United States.  In April 2020, BAT affiliates filed a complaint against PMI, PMPSA, Altria Group, Inc., and its subsidiaries before the International Trade Commission ("ITC"). Plaintiffs seek an order to prevent the importation of Platform 1 products into the United States. The ITC evidentiary hearing closed on February 1, 2021. On May 14, 2021, the administrative law judge issued an Initial and Recommended Determination ("ID/RD") finding that the Platform 1 blade products infringe two of the three patents asserted by Plaintiffs, recommending that the ITC issue a Limited Exclusion order against infringing products, and recommending against a cease-and-desist, as well as recommending against a bond pending Presidential review of the ITC's Final Determination ("FD"). Defendants and Plaintiffs filed separate Petitions for Review with the ITC of the ID/RD on May 28, 2021; on July 27, 2021, the ITC granted each of the petitions in part, deciding to review certain issues in the ID/RD. Plaintiffs and Defendants also submitted brief statements of the public interest factors in issue to the ITC on June 15, 2021. On September 29, 2021, the ITC issued its FD finding a violation of section 337 of the U.S. Tariff Act and issued (a) a limited exclusion order against PMPSA, prohibiting, inter alia, the importation of Platform 1 product and infringing components; and (b) a cease-and-desist order
44
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
against Altria Client Services, LLC and its affiliate prohibiting, inter alia, sales of imported Platform 1 products. The ITC predicated the orders on its finding that Platform 1 blade products infringe two patents owned by a BAT affiliate. The ITC also found that Platform 1 blade products do not infringe a third patent owned by a BAT affiliate. The ITC further held that there were insufficient concerns over public interest to prevent the issuance of remedial orders. Following the Presidential Review period, the orders became effective and Defendants filed a petition for review of the FD with the U.S. Court of Appeals for the Federal Circuit. Defendants also filed motions in the ITC and Federal Circuit for a stay of the orders pending disposition of the appeal; the ITC denied the motion on January 20, 2022 and the Federal Circuit denied the motion on January 25, 2022. The Federal Circuit heard oral argument on defendants' appeal of the FD on October 3, 2022 and, on March 31, 2023, the Federal Circuit affirmed the FD. This adverse ruling impacts our ability to import the products and components impacted by the ITC's FD but has an immaterial financial impact. In the Eastern District of Virginia case, the defendants also counterclaimed that BAT infringed their patents relating to certain e-vapor products, seeking damages for, and injunctive relief against, the commercialization of these products by BAT. The trial of Defendant PMPSA’s counterclaims took place from June 8-14, 2022 and, on June 15, 2022, the jury returned a verdict for PMPSA awarding approximately $10.8 million in damages for infringement up to December 31, 2021 of two PMPSA patents by BAT’s affiliate and two of BAT’s e-vapor products; the jury also found BAT’s affiliate did not infringe one of the two PMPSA patents and that the BAT affiliates had failed to prove one of the two PMPSA patents was invalid. PMPSA filed a motion for an injunction or, in the alternative, an ongoing royalty on August 12, 2022. On March 30, 2023, the court denied PMPSA's motion for an injunction and granted PMPSA an ongoing royalty against two of BAT's U.S. e-vapor products. On May 1, 2023, the court entered partial final judgment under Rule 54(b) on PMPSA's claim against BAT's affiliate. That same day, BAT's affiliate filed a notice of appeal to the U.S. Court of Appeals for the Federal Circuit. On May 10, 2023, PMPSA filed a notice of cross-appeal. Upon petition of PMPSA, the Patent Trial and Appeal Board ("PTAB") of the United States Patent and Trademark Office has instituted review of certain claims pertaining to four of the six patents asserted by BAT affiliates in both proceedings. On January 11, 2022, PTAB issued its final decision on one of the two patents underlying the ITC's FD, invalidating all challenged claims of BAT's patent. On March 30, 2022, PTAB issued its final decision on the second of the two patents underlying the ITC's FD, finding the challenged claims patentable. The parties have filed appeals of these PTAB results to the U.S. Court of Appeals for the Federal Circuit. Oral argument was held on July 13, 2023. On July 17, 2023, the Federal Circuit issued a decision summarily affirming PTAB’s decision to invalidate all challenged claims in one of the two patents underlying the ITC’s FD. The Federal Circuit issued the mandate notifying the USPTO to record the invalidity of the challenged claims on August 23, 2023. On September 14, 2023, the Federal Circuit issued a decision affirming the PTAB's decision finding certain claims in the second of the two patents underlying the ITC’s FD patentable.  PMPSA’s counterclaim in the Eastern District of Virginia challenging the validity of the remaining claims in the second of the two patents underlying the ITC’s FD is currently stayed. On July 21, 2022, PMPSA filed a Request for Rehearing of PTAB's November 2020 decision not to institute review of certain claims in the second of the two patents underlying the ITC's FD; PTAB denied the Request on October 13, 2022.

In April 2020, BAT’s affiliate commenced patent infringement proceedings, Nicoventures Trading Limited v. PM GmbH, et al., against PMI’s German subsidiary, Philip Morris GmbH, and PMPSA, in the Regional Court in Munich, Germany. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade products in Germany. In June 2021, the court stayed the proceeding in respect of one of the two patents asserted by BAT’s Affiliate. Following the December 2022 confirmation of the revocation of the other BAT patent by the European Patent Office Board of Appeal, BAT withdrew its initial claim based on that patent; the stayed action based on the second patent remains pending and is stayed pending a possible appeal by BAT of the revocation of that second patent by the European Patent Office.

In September 2020, BAT’s affiliates commenced patent infringement and unfair competition proceedings, RAI Strategic Holdings, Inc., et al. v. Philip Morris Products S.A., et al., against PMPSA. and PMI’s Italian subsidiaries, Philip Morris Manufacturing & Technology Bologna S.p.A. and Philip Morris Italia S.r.l., in the Court of Milan, Italy. Plaintiffs seek damages, as well as injunctive relief against the manufacture in Italy of the Platform 1 blade heated tobacco units allegedly infringing the asserted patents and the commercialization of the Platform 1 blade products in Italy. As part of this proceeding, in October 2020, BAT’s affiliates filed a request based on one of the two asserted patents seeking preliminary injunctive relief against the manufacture and commercialization of the Platform 1 blade products in Italy. In July 2022, the court dismissed plaintiffs’ request for preliminary injunction in its entirety and plaintiffs did not appeal this ruling. The merits proceeding remains pending; the next hearing is currently scheduled to occur in the first quarter of 2024.

In October 2020, BAT’s affiliates commenced patent infringement proceedings, RAI Strategic Holdings, Inc., et al. v. Philip Morris Japan, Limited, et al., against PMI’s Japanese subsidiary, Philip Morris Japan Limited, and a third-party distributor in the Tokyo District Court. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade products in Japan. On December 23, 2022, the Court dismissed BAT’s claims with respect to one of the two patents that it
45
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
asserted, finding no infringement; BAT filed an appeal of this dismissal. On September 21, 2023, the court issued its judgment dismissing BAT's appeal regarding the Beard patent. BAT's claim with respect to the second patent remains pending; the final procedural hearing was held on September 6, 2023, during which the Court closed the proceedings and announced that the judgment would be rendered in the fourth quarter of 2023.

In November 2020, BAT’s affiliates commenced patent infringement proceedings, RAI Strategic Holdings, Inc., et al. v. Philip Morris Romania SRL, et al., against PMI’s Romanian subsidiaries, Philip Morris Romania S.R.L. and Philip Morris Trading S.R.L., and a third-party distributor in the Court of Law of Bucharest, Civil Registry. Plaintiffs seek damages and preliminary and permanent injunctive relief against the manufacture and commercialization of the Platform 1 blade products in Romania. In February 2021, the court dismissed plaintiffs’ request for a preliminary injunction. In April 2021, the appellate court denied plaintiffs' appeal, confirming the dismissal of plaintiffs' request for preliminary injunction. Plaintiffs' proceeding requesting damages and a permanent injunction remains pending before the Court of Law of Bucharest, Civil Registry. In an October 14, 2021 hearing, the court stayed the proceeding.

In March 2021, BAT’s affiliates commenced patent infringement proceedings, RAI Strategic Holdings, Inc., et al. v. Philip Morris Korea, Co., Ltd., against PM Korea in the Seoul Central District Court. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade heated tobacco units in South Korea. On May 30, 2022, the Korean Patent Office issued a decision that all of the challenged claims in the patent asserted by Plaintiffs are invalid; Plaintiffs filed an appeal of this decision. Following BAT’s unsuccessful correction action at the Korean Patent Office, the court held the first hearing in the appeal of the infringement proceeding on September 12, 2023. An additional hearing in the appeal is currently scheduled to occur in the fourth quarter of 2024.

In July, 2021, PMPSA filed a claim at the High Court of Justice of England and Wales against BAT affiliates Nicoventures Trading Limited and British American Tobacco (Investments) Limited seeking revocation of the UK parts of two BAT European patents. In March, the BAT affiliates stated that they would consent to revocation of one of the patents and filed a counterclaim against PMPSA and Philip Morris Limited seeking from the court a declaration that the remaining BAT affiliate patent is infringed by Platform 1 induction products, as well as damages and injunctive relief against the commercialization of the Platform 1 induction products in the U.K. The trial took place from September 21-28, 2022. On October 25, 2023, the Court issued its decision finding that the remaining BAT patent was invalid and not infringed.

Other patent challenges by both parties are pending in various jurisdictions.

We believe that the foregoing proceedings by the affiliates of BAT are without merit and will defend them vigorously.

We are also involved in additional litigation arising in the ordinary course of our business. While the outcomes of these proceedings are uncertain, management does not expect that the ultimate outcomes of other litigation, including any reasonably possible losses in excess of current accruals, will have a material adverse effect on our consolidated results of operations, cash flows or financial position.

Third-Party Guarantees

Until November 1, 2022, Medicago Inc. ("Medicago") was an equity method investee of Philip Morris Investments B.V. (“PMIBV”), a PMI subsidiary. On October 17, 2020, Medicago had entered into a contribution agreement with the Canadian government (the “Contribution Agreement”) whereby the Canadian government agreed to contribute up to CAD 173 million (approximately $131 million on the date of signing) to Medicago, to support its on-going COVID-19 vaccine development and clinical trials ("First Stage"), and for the construction of its Quebec City manufacturing facility ("Second Stage", and together with the First Stage, the “Project”). On March 31, 2022, the Contribution Agreement was amended (the “Contribution Agreement Amendment”) to reflect an additional contribution from the Canadian government up to CAD 27 million (approximately $22 million on the date of signing) to Medicago for the Second Stage. In August 2022, Medicago received the final tranche of the contribution from the Canadian government in relation to the First Stage, confirming thereby the completion of such first stage and consequently reducing by approximately CAD 123 million (approximately $93 million on the date of signing) the Repayment Obligations (as defined below).

PMIBV and Mitsubishi Tanabe Pharma Corporation (“MTPC”) are also parties to the Contribution Agreement and the Contribution Agreement Amendment as guarantors of Medicago’s obligations thereunder on a joint and several basis (“Co-Guarantors”). The Co-Guarantors agreed to repay amounts contributed by the Canadian government plus interest, if Medicago
46
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
fails to do so (the "Repayment Obligations"), and could be responsible for the costs of Medicago’s other obligations (such as the achievement of specific milestones of the Project). The guarantees are in effect through March 31, 2026. Prior to the release of PMIBV from its obligations as guarantor described below, it was reasonably possible that PMI could have been responsible for a portion of those costs and obligations.

On November 1, 2022, PMIBV transferred all of the shares it owned in Medicago to MTPC Holdings Canada Inc., the majority shareholder of Medicago. MTPC assumed and agreed to perform all of PMIBV's obligations under the guarantees and to indemnify and save PMIBV harmless in respect of any and all claims related to the guaranteed obligations. On February 3, 2023, PMI learned through a public announcement that a decision had been taken to cease all operations at Medicago and to proceed with an orderly wind up of Medicago’s business and operations.

On September 27, 2023, the Canadian government released PMIBV from all its obligations as guarantor under the Contribution Agreement and the Contribution Agreement Amendment.


Note 11. Income Taxes:
Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis, and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets.

PMI’s effective tax rates for the nine months and three months ended September 30, 2023 were 25.7% and 33.2%, respectively.

The effective tax rate for the nine months ended September 30, 2023, was unfavorably impacted by: (i) an increase in deferred tax liabilities related to the unremitted earnings of PMI's Russian subsidiaries ($173 million) due to the unilateral suspension of certain Russian double tax treaties by the Russian authorities on August 8, 2023, with respect to certain payments including dividends; (ii) the non-deductible Wellness and Healthcare goodwill impairment charge and (iii) a deferred tax cost for unrealized foreign currency gains on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings ($41 million), while the underlying pre-tax foreign currency movements fully offset in the condensed consolidated statements of earnings and were reflected as currency translation adjustments in its condensed consolidated statements of stockholders' (deficit) equity.

The effective tax rate for the three months ended September 30, 2023 was unfavorably impacted by an increase in deferred tax liabilities related to the unremitted earnings of PMI's Russian subsidiaries ($173 million) and a deferred tax cost for unrealized foreign currency gains on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings ($138 million).

PMI’s effective tax rates for the nine months and three months ended September 30, 2022 were 20.6% and 22.0%, respectively.

The effective tax rate for the nine months ended September 30, 2022, was favorably impacted by changes in earnings mix by taxing jurisdiction and by a reduction in deferred tax liabilities related to pension plan assets ($40 million), as well as a decrease in deferred tax liabilities related to the fair value adjustment of equity securities held by PMI ($13 million). For further details, see Note 14. Related Parties - Equity Investments and Other.

PMI estimates that its full-year 2023 effective tax rate will be approximately 20.5% to 21.5%, excluding discrete tax events. Changes in currency exchange rates, earnings mix by taxing jurisdiction or future legislative or regulatory developments may have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions.

PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years 2019 and onward. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from 3 to 5 years. In October 2021, a subsidiary of PMI in Indonesia, PT Hanjaya Mandala Sampoerna Tbk ("HMS"), received a tax assessment in the amount of 3.8 trillion Indonesian rupiah (approximately $260 million in the period of payment) primarily relating to corporate income taxes on domestic and other intercompany transactions for the years 2017 to 2019. HMS paid the assessment in the fourth quarter of 2021 in order to avoid potential penalties and filed an objection letter with the tax office in January 2022. The amount paid was included in other assets in
47
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
PMI’s condensed consolidated balance sheets at September 30, 2023 and December 31, 2022, and negatively impacted net cash provided by operating activities in the consolidated statements of cash flows in the period of payment.

It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in unrecognized tax benefits along with related interest and penalties. An estimate of any possible change cannot be made at this time.

Note 12. Indebtedness:
Short-term Borrowings:

At September 30, 2023 and December 31, 2022, PMI’s short-term borrowings and related average interest rates consisted of the following:
September 30, 2023December 31, 2022
(in millions)Amount OutstandingAverage RateAmount OutstandingAverage Rate
Commercial paper
$1,928 5.5 %$912 4.4 %
Bank loans
221 9.0 295 7.5 
U.S. dollar credit facility borrowings related to Swedish Match AB acquisition— — 4,430 4.9 
$2,149 $5,637 

Given the mix of PMI's legal entities and their respective local economic environments, the average interest rate for bank loans above can vary significantly from day to day and country to country.

The fair values of PMI’s short-term borrowings, based on current market interest rates, approximate carrying value.

Long-term Debt:

At September 30, 2023 and December 31, 2022, PMI’s long-term debt consisted of the following:

(in millions)September 30, 2023December 31, 2022
U.S. dollar notes, 0.875% to 6.375% (average interest rate 4.433%), due through 2044
$30,733 $22,596 
Foreign currency obligations:
Euro notes, 0.125% to 3.125% (average interest rate 1.877%), due through 2039
8,069 8,116 
Swiss franc note, 1.625%, due 2024
272 378 
Euro credit facility borrowings related to Swedish Match AB acquisition, (average interest rate 4.265%), due through 2027
5,797 5,850 
Swedish krona notes, 1.395% to 5.762% (average interest rate 2.357%), due through 2029
234 343
Other (average interest rate 6.156%), due through 2031 (a)
461 203 
Carrying value of long-term debt45,566 37,486 
Less current portion of long-term debt2,652 2,611 
 $42,914 $34,875 
(a) Includes long-term bank loans at subsidiaries, as well as $40 million and $54 million in finance leases at September 30, 2023 and December 31, 2022, respectively.
48
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

The fair value of PMI’s outstanding long-term debt, which is utilized solely for disclosure purposes, is determined using quotes and market interest rates currently available to PMI for issuances of debt with similar terms and remaining maturities. At September 30, 2023, the fair value of PMI's outstanding long-term debt, excluding the aforementioned finance leases, was as follows:

(in millions)
September 30, 2023
Level 1$36,217 
Level 26,356 
For a description of the fair value hierarchy and the three levels of inputs used to measure fair values, see Item 8, Note 2. Summary of Significant Accounting Policies of PMI's Annual Report on Form 10-K for the year ended December 31, 2022.

Credit Facilities related to the Financing of the Swedish Match Acquisition

In connection with PMI's all-cash recommended public offer to the shareholders of Swedish Match, on May 11, 2022, PMI entered into a credit agreement relating to a 364-day senior unsecured bridge facility. The facility provided for borrowings up to an aggregate principal amount of $17 billion, expiring 364 days after the occurrence of certain events unless extended. On June 23, 2022, PMI entered into a €5.5 billion (approximately $5.8 billion at the date of signing) senior unsecured term loan credit agreement consisting of a €3.0 billion (approximately $3.2 billion at the date of signing) tranche expiring three years after the occurrence of certain events and a €2.5 billion (approximately $2.6 billion at the date of signing) tranche expiring on June 23, 2027. In connection with the term loan facility, the aggregate principal amount of commitments under the 364-day senior unsecured bridge facility was reduced from $17 billion to $11 billion. On November 11, 2022, PMI acquired a controlling interest of 85.87% of the total issued shares in Swedish Match and acquired 94.81% of its outstanding shares as of December 31, 2022. In accordance with the Swedish Companies Act, PMI subsequently exercised its right to compulsorily redeem the remaining shares for which acceptances were not received and obtained legal title to 100% of the shares in Swedish Match on February 17, 2023.

PMI borrowed $8.4 billion under the bridge facility by delivering notices of borrowing for advances of $7.9 billion and $0.5 billion on November 7, 2022 and November 10, 2022, respectively. All amounts borrowed under the bridge facility would become due on November 8, 2023 unless prepaid or such maturity date is extended pursuant to the terms of the bridge facility.
On November 7, 2022, PMI also delivered notices of borrowing for advances totaling €5.5 billion under the term loan facility, of which €3.0 billion will become due on November 9, 2025 and €2.5 billion will become due on June 23, 2027 unless prepaid pursuant to the terms of the credit agreement. On November 21, 2022 and February 17, 2023, PMI repaid $4.0 billion and $4.4 billion, respectively, under the bridge facility. Effective February 20, 2023, the remaining outstanding commitments under the bridge facility were fully canceled and the bridge facility agreement was terminated in accordance with its terms. As of September 30, 2023 and December 31, 2022, the €5.5 billion (approximately $6 billion) term loan facility was fully drawn and remained outstanding. The proceeds under the bridge facility and the term loan facility were used, directly or indirectly, to finance the acquisition, including, the payment of related fees and expenses. For further details on this acquisition, see Note 2. Acquisitions.

49
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Debt Issuances
PMI's debt issuances in the first nine months of 2023 were as follows:
(in millions)
TypeFace Value Interest RateIssuanceMaturity
U.S. dollar notes
(a)
$1,2504.875%February 2023February 2026
U.S. dollar notes
(a)
$1,0004.875%February 2023February 2028
U.S. dollar notes
(a)
$1,5005.125%February 2023February 2030
U.S. dollar notes
(a)
$1,5005.375%February 2023February 2033
U.S. dollar notes(a) (b)$4504.875%May 2023February 2026
U.S. dollar notes(a) (c)$5504.875%May 2023February 2028
U.S. dollar notes(a) (d)$7005.125%May 2023February 2030
U.S. dollar notes(a) (e)$7505.375%May 2023February 2033
U.S. dollar notes(f)$6505.250%September 2023September 2028
U.S. dollar notes(f)$7005.500%September 2023September 2030
U.S. dollar notes(f)$1,0005.625%September 2023September 2033
(a) Interest is payable semi-annually, commencing in August 2023
(b) These notes are a further issuance of the 4.875% notes issued in February 2023
(c) These notes are a further issuance of the 4.875% notes issued in February 2023
(d) These notes are a further issuance of the 5.125% notes issued in February 2023
(e) These notes are a further issuance of the 5.375% notes issued in February 2023
(f) Interest is payable semi-annually, commencing in March 2024

On February 17, 2023, PMI applied a portion of the net proceeds of the debt issuances to prepay $4.4 billion under its bridge facility, which represented all borrowings outstanding under the bridge facility. PMI used a portion of the May 2023 net proceeds to pay the remaining cash consideration due in accordance with the terms of its agreement with Altria. For further details on PMI's agreement with Altria, see Note 2. Acquisitions. The remaining net proceeds of the February and May 2023 offerings, as well as the September 2023 offering have been or will be used for general corporate purposes.

Revolving Credit Facilities:

At September 30, 2023, PMI's total committed revolving credit facilities were as follows:

(in billions)


Type
Committed
Revolving Credit
Facilities
364-day revolving credit, expiring January 30, 2024
$1.8 
Multi-year revolving credit, expiring February 10, 2026 (1)
2.0 
Multi-year revolving credit, expiring September 29, 2026 (2) (3)
2.5 
Total facilities
$6.3 
(1) On January 28, 2022, PMI entered into an agreement, effective February 10, 2022, to amend and extend the term of its $2.0 billion multi-year revolving credit facility, for an additional year covering the period February 11, 2026 to February 10, 2027, in the amount of $1.9 billion.
(2) Includes pricing adjustments that may result in the reduction or increase in both the interest rate and commitment fee under the credit agreement if PMI achieves, or fails to achieve, certain specified targets.
(3) On September 20, 2022, PMI entered into an agreement, effective September 29, 2022, to amend and extend the term of its $2.5 billion multi-year revolving credit facility, for an additional year covering the period September 30, 2026 to September 29, 2027, in the amount of $2.3 billion. On September 20, 2023, PMI entered into an agreement, effective September 29, 2023, to amend and further extend the term to September 29, 2028.
50
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

At September 30, 2023, there were no borrowings under these committed revolving credit facilities, and the entire committed amounts were available for borrowing.

In addition to the committed revolving credit facilities discussed above, PMI maintains certain short-term credit arrangements, including uncommitted credit lines, to primarily meet working capital needs. These credit arrangements amounted to approximately $2.6 billion at September 30, 2023, and approximately $1.9 billion at December 31, 2022. Borrowings under these arrangements and other bank loans amounted to $221 million at September 30, 2023, and $295 million at December 31, 2022.


Note 13. Accumulated Other Comprehensive Losses:
PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:
(Losses) EarningsAtAtAt
(in millions)September 30, 2023December 31, 2022September 30, 2022
Currency translation adjustments$(8,475)$(8,003)$(7,055)
Pension and other benefits(1,757)(1,822)(2,654)
Derivatives accounted for as hedges415 266 421 
Total accumulated other comprehensive losses$(9,817)$(9,559)$(9,288)

Reclassifications from Other Comprehensive Earnings

The movements in accumulated other comprehensive losses and the related tax impact, for each of the components above, that are due to current period activity and reclassifications to the income statement, are shown on the condensed consolidated statements of comprehensive earnings for the nine months and three months ended September 30, 2023 and 2022. For additional information, see Note 2. Acquisitions (Transactions With Noncontrolling Interests) for disclosures related to currency translation adjustments, Note 5. Benefit Plans for disclosures related to PMI's pension and other benefits and Note 7. Financial Instruments for disclosures related to derivative financial instruments.

Note 14. Related Parties - Equity Investments and Other:

Equity Method Investments:

At September 30, 2023 and December 31, 2022, PMI had total equity method investments of $1,238 million and $1,000 million, respectively. Equity method investments are initially recorded at cost. Under the equity method of accounting, the investment is adjusted for PMI's proportionate share of earnings or losses, dividends, capital contributions, changes in ownership interests and movements in currency translation adjustments. The carrying value of our equity method investments at September 30, 2023 and December 31, 2022, exceeded our share of the investees' book value by $881 million and $750 million, respectively. The difference between the investment carrying value and the amount of underlying equity in net assets is mainly attributable to equity method goodwill, convertible debt instruments, and definite-lived intangible assets and other assets. The difference related to the definite-lived intangibles and other assets at September 30, 2023 and December 31, 2022 of $33 million and $35 million, respectively, is amortized on a straight-line basis and is included in Equity investments and securities (income)/loss, net on the condensed consolidated statements of earnings. At September 30, 2023 and December 31, 2022, PMI received year-to-date dividends from equity method investees of $57 million and $9 million, respectively.

PMI holds a 23% equity interest in Megapolis Distribution BV, the holding company of CJSC TK Megapolis, PMI's distributor in Russia (SSEA, CIS & MEA segment), which as of September 30, 2023 had a carrying value of $351 million. While as of September 30, 2023, there have been no impairment indicators based on the business’ performance, there are still risks related to this investment as the fair value of these assets is difficult to predict due to the volatility in foreign currency and commodity markets, supply chain, and current economic, political and social conditions. For more information, see Note 3. War in Ukraine. Additionally, there was approximately $588 million of cumulative foreign currency translation losses associated with Megapolis Distribution BV reflected in accumulated other comprehensive losses in the condensed consolidated statement of stockholders’ equity as of September 30, 2023.
51
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

PMI holds a 49% equity interest in United Arab Emirates-based Emirati Investors-TA (FZC) (“EITA”). PMI holds an approximate 25% economic interest in Société des Tabacs Algéro-Emiratie (“STAEM”), an Algerian joint venture that is 51% owned by EITA and 49% by the Algerian state-owned enterprise Management et Développement des Actifs et des Ressources Holding ("MADAR Holding"), which manufactures and distributes under license some of PMI’s brands (SSEA, CIS & MEA segment).

In April 2023, PMI increased its equity ownership and acquired 66.73% of Egyptian Investment Holding (“EIH”), a United Arab Emirates based company and as a result, acquired an approximate economic interest of 25% in United Tobacco Company ("UTC"). UTC is an entity incorporated in Egypt, which is 38% owned by EIH and manufactures products under license for Philip Morris Misr LCC (“PMM”), an entity incorporated in Egypt which is consolidated in PMI’s financial statements in the SSEA, CIS & MEA segment.

The initial investments in Megapolis Distribution BV, EITA and UTC have been recorded at cost and are included in equity investments on the consolidated balance sheets. Transactions between these equity method investees and PMI subsidiaries are considered to be related-party transactions and are included in the tables below.

Equity securities:

Following the deconsolidation of RBH on March 22, 2019, PMI recorded the continuing investment in RBH, PMI's wholly owned subsidiary in Canada, at fair value of $3,280 million at the date of deconsolidation, within equity investments. Transactions between PMI and RBH are considered to be related party transactions from the date of deconsolidation and are included in the tables below.

The fair value of PMI’s other equity securities, which have been classified within Level 1, was $378 million at September 30, 2023. Unrealized pre-tax gain (loss) of $52 million ($41 million net of tax) on these equity securities was recorded in equity investments and securities (income)/loss, net on the condensed consolidated statements of earnings for the nine months ended September 30, 2023.

Other related parties:

United Arab Emirates-based Trans-Emirates Trading and Investments (FZC) ("TTI") holds a 33% non-controlling interest in Philip Morris Misr LLC ("PMM"), an entity incorporated in Egypt which is consolidated in PMI’s financial statements in the SSEA, CIS & MEA segment. PMM sells, under license, PMI brands in Egypt through an exclusive distribution agreement with a local entity that is also controlled by TTI.

Godfrey Phillips India Ltd ("GPI") is one of the non-controlling interest holders in IPM India, which is a 56.3% owned PMI consolidated subsidiary in the SSEA, CIS & MEA segment. GPI also acts as contract manufacturer and distributor for IPM India.

52
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Financial activity with the above related parties:

PMI’s net revenues and expenses with the above related parties were as follows:
For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Net revenues:
Megapolis Group$1,714 $1,770 $530 $777 
Other917 864 327 310 
Net revenues (a)
$2,631 $2,634 $857 $1,087 
Expenses:
Other$180 $62 $67 $33 
Expenses$180 $62 $67 $33 
(a) Net revenues exclude excise taxes and VAT billed to customers.

PMI’s balance sheet activity with the above related parties was as follows:
(in millions)At September 30, 2023
At December 31, 2022
Receivables:
Megapolis Group$394 $478 
Other261 210 
Receivables$655 $688 
Payables:
Other$33 $31 
Payables$33 $31 
The activities with the above related parties are in the ordinary course of business, and are primarily for distribution, service fees, contract manufacturing and license agreements. PMI eliminated its respective share of all significant intercompany transactions with the equity method investees.

Note 15. Sale of Accounts Receivable:
To mitigate risk and enhance cash and liquidity management, PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of September 30, 2023 and September 30, 2022. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions.

Cumulative trade receivables sold, including excise taxes, for the nine months ended September 30, 2023 and 2022, were $9.4 billion and $8.4 billion, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of September 30, 2023 and September 30, 2022, were $670 million, and $512 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference
53
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the condensed consolidated statements of earnings.

The loss on sale of trade receivables was as follows:

(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023$37 $13 
2022$15 $7 

Note 16. Product Warranty:

PMI's heat-not-burn devices and e-vapor products are subject to standard product warranties generally for a period of 12 months from the date of purchase or such other periods as required by law. PMI generally provides in cost of sales for the estimated cost of warranty in the period the related revenue is recognized. PMI assesses the adequacy of its accrued product warranties and adjusts the amounts as necessary based on actual experience and changes in future estimates. Factors that affect product warranties may vary across markets but typically include device version mix, product failure rates, logistics and service delivery costs, and warranty policies. PMI accounts for its product warranties within other accrued liabilities. At September 30, 2023 and December 31, 2022, these amounts were as follows:
(in millions)As of and For the Nine Months Ended September 30, 2023As of and For the Year Ended December 31, 2022
Balance at beginning of period$104 $113 
Changes due to:
   Warranties issued55 107 
    Settlements (62)(114)
    Currency/Other(2)(2)
Balance at end of period$95 $104 

Note 17. Asset Impairment and Exit Costs:

For the nine months ended September 30, 2023, PMI recorded total pre-tax asset impairment and exit costs of $109 million related to restructuring activities. These pre-tax charges were included in marketing, administration and research costs in the condensed consolidated statements of earnings for the nine months ended September 30, 2023. For the three months ended September 30, 2023, PMI did not record such charges related to restructuring activities. For the nine months and three months ended September 30, 2022, PMI did not record any charges for asset impairment and exit costs related to restructuring activities.

For the nine months ended September 30, 2023, PMI recorded a pre-tax impairment charge on goodwill and other intangibles of $680 million within the Wellness and Healthcare segment. For the nine months and three months ended September 30, 2022, PMI recorded a pre-tax impairment charge on other intangibles of $112 million within the Wellness and Healthcare segment. For further details, see Note 6. Goodwill and Other Intangible Assets, net.

e-Vapor Products Manufacturing Optimization

In the first quarter of 2023, PMI initiated a project to fully outsource and restructure the manufacturing of e-vapor devices and consumables. As a result, PMI recorded pre-tax asset impairment and exit costs of $109 million. This amount included contract termination costs for suppliers of $78 million, including $21 million of embedded finance lease terminations, payable in cash. This amount also included asset impairment costs of $31 million, primarily related to machinery and equipment, which were non-cash charges.
54
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Asset Impairment and Exit Costs by Segment

PMI recorded the following pre-tax asset impairment and exit costs by segment:

(in millions)For the Nine Months Ended September 30,
 2023
Contract termination charges:
Europe$35 
SSEA, CIS & MEA25 
EA, AU & PMI DF15 
Americas3 
Total contract termination charges78 
Asset impairment charges:
Europe14 
SSEA, CIS & MEA9 
EA, AU & PMI DF6 
Americas2 
Total asset impairment charges31 
Asset impairment and exit costs$109 

Movement in Exit Cost Liabilities

The movement in exit cost liabilities for the nine months ended September 30, 2023 was as follows:
(in millions) 
Liability balance, January 1, 2023$40 
Charges, net78 
Cash spent(74)
Currency/other(8)
Liability balance, September 30, 2023$36 

Future cash payments for exit costs incurred to date are anticipated to be substantially paid by the end of 2024, with approximately $6 million expected to be paid in the remainder of 2023.

55
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 18. Leases:

The components of PMI’s lease cost were as follows for the nine months and three months ended September 30, 2023 and 2022:
For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Operating lease cost$199 $187 $66 $61 
Finance lease cost:
Amortization of right-of-use assets37 60 9 13 
Interest on lease liabilities
1 — 1 — 
Short-term lease cost44 45 15 15 
Variable lease cost20 17 6 6 
Total lease cost$301 $309 $97 $95 

                                                                            
Note 19. Supply Chain Financing:

PMI has engaged with unaffiliated global financial institutions that offer a voluntary supply chain financing ("SCF") program to some of our suppliers. Under the SCF program, the suppliers may elect, at their sole discretion, to sell PMI's payment obligations to these financial institutions. The suppliers independently negotiate the sale arrangements directly with these financial institutions. PMI does not participate in these negotiations, nor does it have any economic interest in these agreements, or in the designated suppliers’ voluntary decision to sell PMI's payment obligations to these financial institutions. No guarantees or securities are provided by PMI or any of its subsidiaries under the SCF programs. PMI's obligations to its suppliers, including amounts due and scheduled payment terms are not impacted by the suppliers’ decision to sell amounts under the SCF program. The payment terms of PMI’s suppliers generally do not exceed 120 days. All outstanding payable amounts related to suppliers that are participating in the SCF program are recorded in accounts payable in PMI's condensed consolidated balance sheets. The associated payments are included in cash flows from operating activities within PMI's condensed consolidated statement of cash flows. As of September 30, 2023 and December 31, 2022, the total amount due to suppliers participating in the SCF program was approximately $0.8 billion and $1.1 billion, respectively.






56
Item 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Description of Our Company

We are a leading international tobacco company working to deliver a smoke-free future and to evolve our portfolio for the long term to include products outside of the tobacco and nicotine sector. Our current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, we have invested more than $10.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This investment includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In November 2022, we acquired Swedish Match AB ("Swedish Match") – a leader in oral nicotine delivery – creating a global smoke-free combination led by the companies’ IQOS and ZYN brands. The U.S. Food and Drug Administration ("FDA") has authorized versions of our IQOS Platform 1 devices and consumables, and Swedish Match's General snus, as Modified Risk Tobacco Products (MRTPs). We describe the MRTP orders in more detail in the "Business Environment" section of this Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A").

To further support the growth of our smoke-free business, reinforce consumer centricity, and increase the speed of innovation and deployment, in January 2023, we began managing our business in four geographical segments, down from six previously, in addition to our continuing Swedish Match and Wellness and Healthcare segments. The four geographical segments are as follows: Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region ("SSEA, CIS & MEA"); East Asia, Australia, and PMI Duty Free Region ("EA, AU & PMI DF"); and Americas Region.

Our cigarettes are sold in approximately 175 markets, and in many of these markets they hold the number one or number two market share position. We have a wide range of premium, mid-price and low-price brands. Our portfolio comprises both international and local brands.

Smoke-free products (also referred to herein as "SFPs") is the term we primarily use to refer to all of our products that are not combustible tobacco products, such as heat-not-burn, e-vapor, and oral nicotine. In addition, SFPs include wellness and healthcare products, as well as consumer accessories such as lighters and matches.

In addition to the manufacture and sale of cigarettes, we are engaged in the development and commercialization of reduced-risk products ("RRPs"). RRPs is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking.  We have a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are SFPs that contain and/or generate far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke. IQOS is the leading brand in our SFPs portfolio. As of September 30, 2023, our smoke-free products were available for sale in 82 markets.

In 2021, we laid the foundation for our long-term growth ambitions beyond nicotine in wellness and healthcare, including the milestone acquisitions of Vectura Group plc and Fertin Pharma A/S, which provide essential capabilities for future product development. Now, through our Vectura Fertin Pharma business, with a strong foundation and significant expertise in life sciences, we aim to expand into wellness and healthcare areas.

In 2022, we acquired Swedish Match AB, a market leader in oral nicotine delivery with a significant presence in the United States market. The Swedish Match acquisition is a key milestone in PMI’s transformation to becoming a smoke-free company. Swedish Match already has a leading nicotine pouch franchise in the U.S. under the ZYN brand name. The Swedish Match product portfolio is complementary to our existing portfolio, permitting us to bring together a leading oral nicotine product with the leading heat-not-burn product. By joining forces with Swedish Match, we expect to accelerate the achievement of our joint smoke-free ambitions, switching more adults who would otherwise continue to smoke cigarettes to better alternatives faster than either company could achieve separately. For further details, see Note 2. Acquisitions.

In 2022, we also completed an agreement with Altria Group, Inc. to end our commercial relationship in the U.S. covering IQOS as of April 30, 2024. Thereafter, PMI will hold the full rights to commercialize IQOS in the U.S. On July, 14, 2023, we made the final payment to Altria under the terms of the agreement. For further details, see Note 2. Acquisitions.

We use the term net revenues to refer to our operating revenues from the sale of our products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. Our net revenues and operating income are affected by various factors, including the volume of products we sell, the price of our products, changes in currency exchange
57
rates and the mix of products we sell. Mix is a term used to refer to the proportionate value of premium-price brands to mid-price or low-price brands in any given market (product mix). Mix can also refer to the proportion of shipment volume in more profitable markets versus shipment volume in less profitable markets (geographic mix).

Our cost of sales consists principally of: tobacco leaf, non-tobacco raw materials, labor and manufacturing costs; shipping and handling costs; and the cost of devices produced by third-party electronics manufacturing service providers. Estimated costs associated with device warranty programs are generally provided for in cost of sales in the period the related revenues are recognized.

Our marketing, administration and research costs include the costs of marketing and selling our products, other costs generally not related to the manufacture of our products (including general corporate expenses), and costs incurred to develop new products. The most significant components of our marketing, administration and research costs are marketing and sales expenses and general and administrative expenses.
Philip Morris International Inc. is a legal entity separate and distinct from its direct and indirect subsidiaries. Accordingly, our right, and thus the right of our creditors and stockholders, to participate in any distribution of the assets or earnings of any subsidiary is subject to the prior rights of creditors of such subsidiary, except to the extent that claims of our company itself as a creditor may be recognized. As a holding company, our principal sources of funds, including funds to make payment on our debt securities, are from the receipt of dividends and repayment of debt from our subsidiaries. Our principal wholly owned and majority-owned subsidiaries currently are not limited by long-term debt or other agreements in their ability to pay cash dividends or to make other distributions that are otherwise compliant with law.

Executive Summary
The following executive summary provides the business update and significant highlights from the "Discussion and Analysis" that follows.

War in Ukraine

In Ukraine, our main priority remains the safety and security of our employees and their families in the country. We continue commercial activities in select locations where safety allows, in order to provide product availability and service to adult consumers, and supplies the market from production centers outside Ukraine, as well as through a contract manufacturing arrangement. Production at our factory in Kharkiv remains suspended. On June 20, 2023, we announced the investment of $30 million in a new production facility in the Lviv region, in Western Ukraine. Preparatory work for the facility began in July 2023 and production is expected to commence in the first quarter of 2024. As of September 30, 2023, our Ukrainian operations had approximately $0.5 billion in total assets, excluding intercompany balances.

In Russia, we are continuously assessing the evolving situation in the country. This includes regulatory constraints in the market entailing very complex terms and conditions that must be met for any divestment transaction to be granted approval by the authorities, and restrictions resulting from international regulations. In the event of a divestment, our ability to fully realize the value of the business would likely be subject to material impairment. As of September 30, 2023, our Russian operations had approximately $2.4 billion in total assets, excluding intercompany balances, of which approximately $0.7 billion consisted of cash and equivalents held mostly in local currency (Russian rubles).

Additionally, we hold a 23% equity interest in Megapolis Distribution BV, the holding company of CJSC TK Megapolis, PMI's distributor in Russia. For further details, see Note 14. Related Parties – Equity Investments and Other.

These developments above have and will continue to have a material adverse impact on our business, results of operations, cash flows and financial position, and may result in impairment charges.
For further details, see Note 3. War in Ukraine to our condensed consolidated financial statements, as well as the "Trade Policy" and "Cautionary Factors That May Affect Future Results" sections of this MD&A.



58
Consolidated Operating Results for the Nine Months Ended September 30, 2023

•Net Revenues - Net revenues of $26.1 billion for the nine months ended September 30, 2023 increased by $2.5 billion, or 10.7%, from the comparable 2022 amount. The change in our net revenues from the comparable 2022 amount was driven by the following (variances not to scale with year-to-date results):

5526
For the nine months ended September 30, 2023, net revenues, excluding currency and acquisitions, increased by 7.4%, mainly reflecting: a favorable pricing variance, primarily driven by higher combustible tobacco pricing, partly offset by lower HTU (net) pricing; and favorable volume/mix, mainly driven by higher HTU volume and favorable cigarette mix, partially offset by lower cigarette volume and unfavorable HTU mix. The increase was partly offset by lower fees for certain distribution rights billed to customers in certain markets and a charge to net revenues in 2023 of $80 million following the termination of a distribution arrangement in the Middle East, both shown in "Other". The termination of a distribution arrangement in the Middle East is further described in the following "Diluted Earnings Per Share" discussion.

Net revenues by product category for the nine months ended September 30, 2023 and 2022 are shown below:

6207        6210

59
•Diluted Earnings Per Share - The changes in our reported diluted earnings per share (“diluted EPS”) for the nine months ended September 30, 2023, from the comparable 2022 amounts, were as follows:
Diluted EPS% Change
For the nine months ended September 30, 2022$4.27 
2022 Charges related to the war in Ukraine0.07 
2022 Fair value adjustment for equity security investments0.03 
2022 Amortization of intangibles0.06 
2022 Impairment of goodwill and other intangibles0.06 
2022 Costs associated with Swedish Match AB offer0.13 
2022 Tax items(0.03)
Subtotal of 2022 items0.32 
2023 Charges related to the war in Ukraine(0.01)
2023 Asset impairment and exit costs(0.06)
2023 South Korea indirect tax charge(0.11)
2023 Termination of agreement with Foundation for a Smoke-Free World(0.07)
2023 Fair value adjustment for equity security investments0.02 
2023 Amortization of intangibles(0.18)
2023 Impairment of goodwill and other intangibles(0.44)
2023 Termination of distribution arrangement in the Middle East(0.04)
2023 Swedish Match AB acquisition accounting related item(0.01)
2023 Income tax impact associated with Swedish Match AB financing(0.03)
2023 Tax items (0.11)
Subtotal of 2023 items(1.04)
Currency(0.43)
Interest(0.18)
Change in tax rate0.02 
Operations0.65 
For the nine months ended September 30, 2023$3.61 (15.5)%

Charges related to the war in Ukraine – During the nine months ended September 30, 2022, we recorded a pre-tax charge of $128 million (representing $109 million net of income tax and a diluted EPS charge of $0.07 per share), related to circumstances driven by the war, including machinery and inventory write-downs, additional allowances for receivables and the cost of PMI’s humanitarian efforts. During the nine months ended September 30, 2023, we recorded a pre-tax charge of $19 million (representing $15 million net of income tax and a diluted EPS charge of $0.01 per share), related to circumstances driven by the war, including the cost of PMI’s humanitarian efforts. For further details, see Note 3. War in Ukraine.

Fair value adjustment for equity security investments – During the nine months ended September 30, 2022, we recorded an unfavorable fair value adjustment for our equity security investments in India and Sri Lanka of $47 million after tax (or $0.03 per share decrease in diluted EPS). The fair value adjustment for our equity security investments was included in equity investments and securities (income)/loss, net ($60 million loss) and provision for income taxes ($13 million benefit) on the condensed consolidated statements of earnings for the nine months ended September 30, 2022. During the nine months ended September 30, 2023, we recorded a favorable fair value adjustment for our equity security investments in India and Sri Lanka of $41 million after tax (or $0.02 per share increase in diluted EPS). The fair value adjustment for our equity security investments was included in equity investments and securities (income)/loss, net ($52 million gain) and provision for income taxes ($11 million provision) on the condensed consolidated statements of earnings for the nine months ended September 30, 2023. For further details, see Note 14. Related Parties - Equity Investments and Other.

Amortization of intangibles – During the nine months ended September 30, 2022, we recorded amortization of intangibles expense of $101 million (representing $84 million net of income tax or $0.06 per share decrease in diluted EPS). During the nine months ended September 30, 2023, we recorded amortization of intangible expense of $368 million (representing $285
60
million net of income tax or $0.18 per share decrease in diluted EPS). The higher amortization expense in 2023 was primarily due to increased acquired intangible assets recorded as a result of our acquisitions in 2022. For further details, see Note 6. Goodwill and Other Intangible Assets, net.

Impairment of goodwill and other intangibles – During the nine months ended September 30, 2022, we recorded an impairment charge related to definite-lived intangible assets of $112 million (representing $98 million net of income tax and a diluted EPS charge of $0.06 per share) reflecting the impact of general economic and market conditions resulting in a reduction in future estimated cash flows on certain products within the Wellness and Healthcare segment. This impairment charge was recorded within cost of sales in the condensed consolidated statements of earnings for the nine months ended September 30, 2022.

During the second quarter of 2023, we completed our annual review of goodwill and non-amortizable intangible assets for potential impairment. Based on this review, it was determined that the estimated fair value of the Wellness and Healthcare reporting unit was lower than its carrying value. Consequently, we recorded a total non-cash impairment charge of $680 million (representing a $0.44 per share decrease in diluted EPS) consisting of a goodwill impairment charge of $665 million and a non-amortizable intangible asset pre-tax impairment charge of $15 million for an in-process research and development project related to one of our 2021 acquisitions. The impairment charge was recorded in marketing, administration and research costs in the condensed consolidated statements of earnings during the nine months ended September 30, 2023 and was included in the Wellness and Healthcare segment results.

For further details, see Note 6. Goodwill and Other Intangible Assets, net.

Costs associated with Swedish Match AB offer – During the nine months ended September 30, 2022, we incurred pre-tax costs associated with the Swedish Match offer of $266 million (representing $203 million net of income tax and a diluted EPS charge of $0.13 per share) primarily related to financing costs, derivative financial instruments and certain transaction related costs. These pre-tax costs of $266 million were recorded in marketing, administration and research costs ($269 million expense) and interest expense, net ($3 million gain) on our condensed consolidated statement of earnings for the nine months ended September 30, 2022.

Asset impairment and exit costs – During the nine months ended September 30, 2023, we recorded pre-tax asset impairment and exit costs of $109 million, representing $96 million net of income tax and a diluted EPS charge of $0.06 per share, related to a project to fully outsource and restructure the manufacturing of e-vapor devices and consumables. For further details, see Note 17. Asset Impairment and Exit Costs.

South Korea indirect tax charge – On July 13, 2023, our South Korean subsidiary, PM Korea, received an adverse ruling from the Supreme Court of South Korea related to cases alleging underpayment of excise taxes in connection with a 2015 excise tax increase and subsequent audit by the South Korean Board of Audit and Inspection. The Supreme Court ruling reversed previous decisions that were in PM Korea’s favor at the trial and appellate levels. As a result of the ruling, we concluded that an adverse outcome is probable. Consequently, we recorded a non-cash pre-tax charge of $204 million (representing $174 million net of income tax or $0.11 per share decrease in diluted EPS) in the second quarter results of 2023, reflecting the full amount previously paid by PM Korea. For further details, see Note 10. Contingencies.
Termination of agreement with Foundation for a Smoke-Free World – On September 29, 2023, PMI and the Foundation for a Smoke-Free World (the "Foundation") entered into the Final Grant Agreement and Termination of the Second Amended and Restated Pledge Agreement ("Agreement"). Under the terms of the Agreement, PMI paid $140 million in the third quarter of 2023 in return for the termination of the pledge agreement between the parties. As a result, in the third quarter of 2023, PMI recorded a pre-tax charge of $140 million (representing $111 million net of income tax or $0.07 per share decrease in diluted EPS) commensurate with the early termination of the pledge agreement. The pre-tax charge was recorded in marketing, administration and research costs in the condensed consolidated statements of earnings during the nine months ended September 30, 2023. For further details, see "Other Developments" within the Business Environment section of this MD&A.

Termination of distribution arrangement in the Middle East – Following the termination of a distribution arrangement in the Middle East, we recorded a pre-tax charge of $80 million in the first quarter of 2023 (representing $70 million net of income tax and a diluted EPS charge of $0.04 per share). The pre-tax charge was recorded as a reduction of net revenues in the condensed consolidated statements of earnings and was included in the SSEA, CIS & MEA segment results.

61
Swedish Match AB acquisition accounting related item – During the nine months ended September 30, 2023, we recorded pre-tax purchase accounting adjustments of $18 million related to the sale of acquired inventories stepped up to fair value (representing $13 million net of income tax and a diluted EPS charge of $0.01 per share). These pre-tax adjustments were recorded in cost of sales in the condensed consolidated statements of earnings for the nine months ended September 30, 2023. For further details on the Swedish Match acquisition, see Note 2. Acquisitions.

Income taxes – The 2022 Tax items that increased our 2022 diluted EPS by $0.03 per share in the table above were due to a reduction in deferred tax liabilities related to pension plan assets. The 2023 Income tax impact associated with Swedish Match financing that decreased our 2023 diluted EPS by $0.03 per share in the table above was due to a deferred tax cost for unrealized foreign currency gains on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings, while the underlying pre-tax foreign currency movements fully offset in the condensed consolidated statements of earnings and were reflected as currency translation adjustments in the condensed consolidated statements of stockholders' (deficit) equity at September 30, 2023. The 2023 tax items that decreased our 2023 diluted EPS by $0.11 per share in the table above were due to an increase in deferred tax liabilities related to the unremitted earnings of PMI's Russian subsidiaries due to the unilateral suspension of certain Russian double tax treaties by the Russian authorities on August 8, 2023, with respect to certain payments including dividends. The change in the tax rate that increased our diluted EPS by $0.02 per share in the table above was primarily due to changes in earnings mix by taxing jurisdiction.

Currency – The unfavorable impact of $0.43 per share during the reporting period primarily results from the fluctuations of the U.S. dollar, especially against the Argentine peso, Egyptian pound, Japanese yen, Russian ruble and Swiss franc. This unfavorable currency movement has impacted our profitability across our primary revenue markets and local currency cost bases.

Interest – The unfavorable impact of $0.18 per share from interest in the table above was due primarily to higher interest expense in connection with the Swedish Match acquisition, partially offset by higher net interest income driven by higher interest rates.

Operations – The increase in diluted EPS of $0.65 from our operations in the table above was due primarily to the following segments:

•Swedish Match: Reflecting the 2023 impact following the fourth quarter 2022 acquisition; and
•EA, AU & PMI DF: Favorable volume/mix, favorable pricing and lower supply chain costs;
partially offset by
•Europe: Unfavorable volume/mix, higher marketing, administration and research costs and higher manufacturing costs, partly offset by favorable pricing;
•Americas: Higher marketing, administration and research costs, unfavorable volume/mix and higher manufacturing costs, partly offset by favorable pricing;
•SSEA, CIS & MEA: Higher marketing, administration and research costs, higher manufacturing costs, unfavorable volume/mix and the impact of lower fees for certain distribution rights billed to customers in certain markets, partly offset by favorable pricing; and
•Wellness and Healthcare: Primarily reflecting investments in research and development.

62
Consolidated Operating Results for the Three Months Ended September 30, 2023

•Net Revenues - Net revenues of $9.1 billion for the three months ended September 30, 2023 increased by $1.1 billion, or 13.8%, from the comparable 2022 amount. The change in our net revenues from the comparable 2022 amount was driven by the following (variances not to scale with quarterly results):
289
During the quarter, net revenues, excluding currency and acquisitions, increased by 9.3%, mainly reflecting: a favorable pricing variance, primarily driven by higher combustible tobacco pricing; and favorable volume/mix, mainly driven by higher HTU volume and favorable cigarette mix, partially offset by lower cigarette volume.

Net revenues by product category for the three months ended September 30, 2023 and 2022, are shown below:

740        743

63
•Diluted Earnings Per Share - The changes in our reported diluted EPS for the three months ended September 30, 2023, from the comparable 2022 amounts, were as follows:
Diluted EPS% Change
For the three months ended September 30, 2022$1.34 
2022 Amortization of intangibles0.02 
2022 Impairment of goodwill and other intangibles0.06 
2022 Costs associated with Swedish Match AB offer0.11 
2022 Tax items— 
Subtotal of 2022 items0.19 
2023 Charges related to the war in Ukraine(0.01)
2023 Fair value adjustment for equity security investments0.03 
2023 Amortization of intangibles(0.10)
2023 Termination of agreement with Foundation for a Smoke-Free World(0.07)
2023 Income tax impact associated with Swedish Match AB financing(0.09)
2023 Tax items (0.11)
Subtotal of 2023 items(0.35)
Currency(0.17)
Interest(0.06)
Change in tax rate(0.02)
Operations0.39 
For the three months ended September 30, 2023$1.32 (1.5)%

Amortization of intangibles – During the third quarter of 2022, we recorded amortization of intangible expense of $27 million (representing $21 million net of income tax or $0.02 per share decrease in diluted EPS). During the third quarter of 2023, we recorded amortization of intangibles expense of $205 million (representing $157 million net of income tax or $0.10 per share decrease in diluted EPS). The higher amortization expense in 2023 was primarily due to increased acquired intangible assets recorded as a result of our acquisitions in 2022. For further details, see Note 6. Goodwill and Other Intangible Assets, net.

Impairment of goodwill and other intangibles – During the third quarter of 2022, we recorded an impairment charge related to definite-lived intangible assets of $112 million (representing $98 million net of income tax and a diluted EPS charge of $0.06 per share) reflecting the impact of general economic and market conditions resulting in a reduction in future estimated cash flows on certain products within the Wellness and Healthcare segment. This impairment charge was recorded within cost of sales in the condensed consolidated statements of earnings. For further details, see Note 6. Goodwill and Other Intangible Assets, net.

Costs associated with Swedish Match AB offer – During the third quarter of 2022, we incurred pre-tax costs associated with the Swedish Match offer of $227 million (representing $173 million net of income tax and a diluted EPS charge of $0.11 per share) primarily related to financing costs, derivative financial instruments and certain transaction related costs. These pre-tax costs of $227 million were recorded in marketing, administration and research costs ($217 million expense) and interest expense, net ($10 million expense) on our condensed consolidated statement of earnings for the three months ended September 30, 2022.

Charges related to the war in Ukraine – During the third quarter of 2023, we recorded a pre-tax charge of $19 million (representing $15 million net of income tax and a diluted EPS charge of $0.01 per share), related to circumstances driven by the war, including the cost of PMI’s humanitarian efforts. For further details, see Note 3. War in Ukraine.

Fair value adjustment for equity security investments – During the third quarter of 2023, we recorded a favorable fair value adjustment for our equity security investments in India and Sri Lanka of $51 million after tax (or $0.03 per share increase in diluted EPS). The fair value adjustment for our equity security investments was included in equity investments and securities (income)/loss, net ($65 million gain) and provision for income taxes ($14 million provision) on the condensed consolidated statements of earnings for the three months ended September 30, 2023. For further details, see Note 14. Related Parties - Equity Investments and Other.
64

Termination of agreement with Foundation for a Smoke-Free World – On September 29, 2023, PMI and the Foundation for a Smoke-Free World (the "Foundation") entered into the Final Grant Agreement and Termination of the Second Amended and Restated Pledge Agreement ("Agreement"). Under the terms of the Agreement, PMI paid $140 million in the third quarter of 2023 in return for the termination of the pledge agreement between the parties. As a result, in the third quarter of 2023, PMI recorded a pre-tax charge of $140 million (representing $111 million net of income tax or $0.07 per share decrease in diluted EPS) commensurate with the early termination of the pledge agreement. The pre-tax charge was recorded in marketing, administration and research costs in the condensed consolidated statements of earnings during the three months ended September 30, 2023. For further details, see "Other Developments" within the Business Environment section of this MD&A.

Income taxes – The 2023 Income tax impact associated with Swedish Match financing that decreased our 2023 diluted EPS by $0.09 per share in the table above was due to a deferred tax cost for unrealized foreign currency gains on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings, while the underlying pre-tax foreign currency movements fully offset in the condensed consolidated statements of earnings and were reflected as currency translation adjustments in the condensed consolidated statements of stockholders' (deficit) equity at September 30, 2023. The 2023 tax items that decreased our 2023 diluted EPS by $0.11 per share in the table above were due to an increase in deferred tax liabilities related to the unremitted earnings of PMI's Russian subsidiaries due to the unilateral suspension of certain Russian double tax treaties by the Russian authorities on August 8, 2023, with respect to certain payments including dividends. The change in the tax rate that decreased our diluted EPS by $0.02 per share in the table above was primarily due to changes in earnings mix by taxing jurisdiction.

Currency – The unfavorable impact of $0.17 per share during the reporting period primarily results from the fluctuations of the U.S. dollar, especially against the Argentine peso, Egyptian pound, Japanese yen and Russian ruble. This unfavorable currency movement has impacted our profitability across our primary revenue markets and local currency cost bases.

Interest – The unfavorable impact of $0.06 per share from interest in the table above was due primarily to higher interest expense in connection with the Swedish Match acquisition, partially offset by higher net interest income driven by higher interest rates.

Operations – The increase in diluted EPS of $0.39 from our operations in the table above was due primarily to the following segments:

•Swedish Match: Reflecting the third quarter 2023 impact following the fourth quarter 2022 acquisition;
•EA, AU & PMI DF: Favorable volume/mix and lower supply chain costs;
•Europe: Favorable pricing and favorable volume/mix, partly offset by higher marketing, administration and research costs; and
•SSEA, CIS & MEA: Favorable pricing, partly offset by higher marketing, administration and research costs, higher manufacturing costs and unfavorable volume/mix;
partially offset by
•Americas: Unfavorable volume/mix, and higher marketing, administration and research costs, partly offset by favorable pricing.
For further details, see the “Consolidated Operating Results” and “Operating Results by Business Segment” sections of the following “Discussion and Analysis.”


65
Discussion and Analysis
Critical Accounting Estimates
For information on our critical accounting estimates, see "Critical Accounting Estimates" in the MD&A included in Item 7 of the Annual Report on Form 10-K for the fiscal year ended December 31, 2022.
For our annual review of goodwill and non-amortizable intangible assets for potential impairment completed in the second quarter, we performed a quantitative impairment assessment for all of our reporting units and non-amortizable intangible assets with the exception of the Swedish Match segment. As the purchase price allocation for the acquisition of Swedish Match is preliminary, PMI has performed a qualitative impairment assessment of the Swedish Match segment. See Note 6. Goodwill and Other Intangible Assets, net, for additional details.
Consolidated Operating Results
See pages 106-117 for a discussion of our "Cautionary Factors That May Affect Future Results." Our net revenues and operating income by segment are shown in the table below:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023202220232022
Net revenues:
Europe$9,984 $9,805 $3,672 $3,272 
SSEA, CIS & MEA
7,922 7,781 2,777 2,822 
EA, AU & PMI DF
4,771 4,458 1,571 1,407 
Americas1,399 1,367 478 474 
Swedish Match1,814 — 568 — 
Wellness and Healthcare237 199 75 57 
Net revenues$26,127 $23,610 $9,141 $8,032 
Operating income (loss):
Europe$4,446 $4,447 $1,708 $1,415 
SSEA, CIS & MEA
2,371 3,009 801 1,086 
EA, AU & PMI DF
1,920 1,746 753 533 
Americas141 336 5 85 
Swedish Match597 — 140 — 
Wellness and Healthcare(808)(216)(37)(151)
Operating income$8,667 $9,322 $3,370 $2,968 
66
Our net revenues by product category are shown in the table below:
PMI Net Revenues by Product Category
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
20232022Change20232022Change
Combustible tobacco products
Europe$6,084 $5,996 1.5 %$2,160 $1,996 8.2 %
SSEA, CIS & MEA
6,988 6,852 2.0 %2,485 2,454 1.3 %
EA, AU & PMI DF
2,091 2,214 (5.6)%678 692 (1.9)%
Americas1,349 1,296 4.1 %460 450 2.4 %
Swedish Match333 — — %49 — — %
Total combustible tobacco products16,845 16,358 3.0 %5,832 5,591 4.3 %
Smoke-free products:
Smoke-free products excluding Wellness and Healthcare:
Europe3,900 3,809 2.4 %1,512 1,276 18.5 %
SSEA, CIS & MEA
934 929 0.5 %292 368 (20.6)%
EA, AU & PMI DF
2,680 2,244 19.5 %893 715 24.8 %
Americas50 71 (29.7)%18 24 (27.9)%
Swedish Match1,481 — — %519 — — %
Total smoke-free products excluding Wellness and Healthcare9,045 7,053 28.2 %3,234 2,384 35.7 %
Wellness and Healthcare23719919.1 %755731.6 %
Total smoke-free products9,282 7,252 28.0 %3,309 2,441 35.6 %
Total PMI net revenues$26,127 $23,610 10.7 %$9,141 $8,032 13.8 %
Note: Sum of product categories or Regions might not foot to total PMI due to roundings.

Items affecting the comparability of results from operations were as follows:
•Impairment of goodwill and other intangibles – See Note 6. Goodwill and Other Intangible Assets, net for the details of the $680 million goodwill and non-amortizable intangible assets impairment charges included in the Wellness and Healthcare segment for the nine months ended September 30, 2023. For the nine months and three months ended September 30, 2022, PMI recorded an impairment charge related to definite-lived intangible assets of $112 million. This charge was included in the Wellness and Healthcare segment. For further details, see Note 6. Goodwill and Other Intangible Assets, net.
•South Korea indirect tax charge – See Note 10. Contingencies for details of the $204 million pre-tax charge included in the EA, AU & PMI DF segment results for the nine months ended September 30, 2023.
•Termination of distribution arrangement in the Middle East – In the first quarter of 2023, PMI recorded a pre-tax charge of $80 million following the termination of a distribution arrangement in the Middle East. This pre-tax charge was recorded as a reduction of net revenues in the condensed consolidated statements of earnings, and was included in the SSEA, CIS & MEA segment results for the nine months ended September 30, 2023.
•Charges related to the war in Ukraine – In the third quarter of 2023, PMI recorded a pre-tax charge of $19 million related to the war in Ukraine. This charge was included in the condensed consolidated statements of earnings and was included in the Europe segment for the nine months and three months ended September 30, 2023. For the nine months and three months ended September 30, 2022, PMI recorded a pre-tax charge of $128 million and $6 million, respectively. These charges were included in the condensed consolidated statements of earnings and were included in the Europe segment for the nine months and three months ended September 30, 2022. For further details, see Note 3. War in Ukraine.
67
•Swedish Match AB acquisition accounting related item - See Note 2. Acquisitions for details of the $18 million pre-tax purchase accounting adjustments related to the sale of acquired inventories stepped up to fair value included in the Swedish Match segment for the nine months ended September 30, 2023.
•Asset impairment and exit costs – See Note 17. Asset Impairment and Exit Costs for details of the $109 million pre-tax charges for the nine months ended September 30, 2023, as well as a breakdown of these costs by segment.
•Termination of agreement with Foundation for a Smoke-Free World – On September 29, 2023, PMI and the Foundation for a Smoke-Free World (the "Foundation") entered into the Final Grant Agreement and Termination of the Second Amended and Restated Pledge Agreement ("Agreement"). Under the terms of the agreement, PMI paid $140 million in the third quarter of 2023 in return for the termination of the pledge agreement between the parties. As a result, in the third quarter of 2023, PMI recorded a pre-tax charge of $140 million commensurate with the early termination of the pledge agreement. The pre-tax charge was recorded in marketing, administration and research costs in the condensed consolidated statements of earnings during the nine months and three months ended September 30, 2023 and was included in the operating results of the following segments for both of these periods: Europe ($62 million); SSEA, CIS & MEA ($44 million); EA, AU & PMI DF ($27 million); and Americas ($7 million).
Following the Swedish Match acquisition and a review of PMI and Swedish Match’s combined product portfolio, PMI reclassified certain of its own products previously reported under its combustible tobacco product category to the newly created smoke-free product category to better reflect the characteristics of these products. This reclassification did not impact PMI’s consolidated financial position, results of operations or cash flows in any of the periods presented. For further details, see Note 9. Segment Reporting.

Net revenues related to combustible tobacco products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of our cigarettes and other tobacco products that are combusted. Other tobacco products primarily include roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos and do not include smoke-free products.

Net revenues related to smoke-free products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes, if applicable. These net revenue amounts consist of the sale of all of our products that are not combustible tobacco products, such as heat-not-burn, e-vapor, and oral nicotine products, also including wellness and healthcare products, as well as consumer accessories such as lighters and matches.

Net revenues related to wellness and healthcare products consist of operating revenues generated from the sale of products primarily associated with inhaled therapeutics, and oral and intra-oral delivery systems that are included in the operating results of our Wellness and Healthcare business, Vectura Fertin Pharma.

PMI's heat-not-burn products include licensed KT&G heat-not-burn products.

References to "Cost/Other" in the Consolidated Financial Summary table of total PMI and the six segments throughout this "Discussion and Analysis" reflects the currency-neutral variances of: cost of sales (excluding the volume/mix cost component); marketing, administration and research costs (including asset impairment and exit costs); and amortization and impairment of intangibles. “Cost/Other” also includes the currency-neutral net revenue variance, unrelated to volume/mix and price components, attributable to: fees for certain distribution rights billed to customers in certain markets in the SSEA, CIS & MEA Region and the revenue adjustment for the termination of a distribution arrangement in the Middle East.

68
Our consolidated shipment volume is shown in the table below:
Consolidated Shipment Volume
For the Nine Months Ended September 30,For the Three Months Ended September 30,
Cigarettes and Heated Tobacco Units (million units)20232022Change20232022Change
Cigarettes461,855 467,882 (1.3)%161,137 161,966 (0.5)%
Heated Tobacco Units91,291 77,148 18.3 %32,471 27,508 18.0 %
Total Cigarettes and Heated Tobacco Units553,146 545,030 1.5 %193,608 189,474 2.2 %
Oral Product Shipment Volume (million cans) (1)
Nicotine Pouches295.4 2.7 +100%114.6 0.8 +100%
Snus178.5 12.0 +100%60.3 4.4 +100%
Moist Snuff102.5 — — %33.2 — — %
Other3.3 — — %0.9 — — %
Total Oral Products579.8 14.7 +100%209.0 5.2 +100%
(1) Excluding snuff, snuff leaf and U.S. chew
Note: Sum may not foot to total due to roundings

Following the deconsolidation of our Canadian subsidiary, we continue to report the volume and corresponding royalty revenues of brands sold by RBH for which other PMI subsidiaries are the trademark owners. These include HEETS, Next, Philip Morris and Rooftop. The volume and corresponding royalty revenues of these brands sold by RBH were not material to PMI for all periods presented.

Heated tobacco units ("HTUs") is the term we use to refer to heated tobacco consumables, which include our BLENDS, DELIA, HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro and HEETS FROM MARLBORO (defined collectively as HEETS), Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, SENTIA, TEREA and TEREA CRAFTED, as well as the KT&G-licensed brands, Fiit and Miix (outside of South Korea). HTUs also include zero tobacco heat-not-burn consumables (LEVIA).

Unless otherwise stated, market share for HTUs is defined as the in-market sales volume for HTUs as a percentage of the total estimated industry sales volume for cigarettes and HTUs.

References to total industry, total market, our shipment volume and our market share performance reflect cigarettes and heated tobacco units, unless otherwise stated.

Total industry volume, PMI in-market sales volume and PMI market share for the following geographies include the cigarillo category in Japan: the total international market, EA, AU & PMI DF Region, and Japanese domestic market.

References to total international market, defined as worldwide cigarette and heated tobacco unit volume excluding the United States, total industry, total market and market shares throughout this "Discussion and Analysis" are our estimates for tax-paid products based on the latest available data from a number of internal and external sources and may, in defined instances, exclude China and/or our duty free business.

2022 estimates for total industry volume and market share in certain geographies reflect limitations on the availability and accuracy of industry data during pandemic-related restrictions.

In-market sales ("IMS") is defined as sales to the retail channel, depending on the market and distribution model.

From time to time, PMI’s shipment volumes are subject to the impact of distributor inventory movements (or wholesaler inventory movements in certain markets where PMI does not sell to distributors), and estimated total industry/market volumes are subject to the impact of inventory movements in various trade channels that include estimated trade inventory movements of PMI’s competitors arising from market-specific factors that significantly distort reported volume disclosures. Such factors may include changes to the manufacturing supply chain, shipment methods, consumer demand, timing of excise tax increases or other influences that may affect the timing of sales to customers. In such instances, in addition to reviewing PMI shipment
69
volumes and certain estimated total industry/market volumes on a reported basis, management reviews these measures on an adjusted basis that excludes the impact of distributor and/or estimated trade inventory movements. Management also believes that disclosing PMI shipment volumes and estimated total industry/market volumes in such circumstances on a basis that excludes the impact of distributor and/or estimated trade inventory movements improves the comparability of performance and trends for these measures over different reporting periods.

Key market data regarding total market size, our shipments and market share are shown in the tables below:
For the Nine Months Ended September 30,
PMI Shipments (billion units)
PMI Market Share (%)(2)
MarketTotal Market
(billion units) 		TotalCigaretteHeated Tobacco UnitTotalHeated Tobacco Unit
202320222023202220232022202320222023202220232022
Total (1) (2)
1,929.91,961.1553.1545.0461.9467.991.377.128.327.64.64.0
Europe
France22.724.810.210.810.010.60.20.242.343.70.70.7
Germany (3)
53.054.219.821.117.719.02.22.139.038.75.23.8
Italy55.155.029.130.720.822.28.48.553.754.016.814.3
Poland43.742.918.116.614.313.03.83.641.438.78.78.3
Spain33.034.09.910.69.29.90.80.729.430.32.21.6
SSEA, CIS & MEA
Egypt54.869.018.115.217.414.60.70.533.322.21.60.8
Indonesia219.1230.663.165.663.165.6——28.828.5——
Philippines32.240.418.024.517.824.30.20.256.060.60.50.4
Russia152.0156.748.348.636.537.311.811.331.730.97.97.6
Turkey101.185.650.340.450.340.4——49.847.2——
EA, AU & PMI DF
Australia5.66.62.02.22.02.2——35.433.6——
Japan (2)
111.1110.547.039.513.916.133.023.339.537.526.423.4
South Korea54.355.010.610.66.87.23.83.419.519.27.06.1
Americas
Argentina21.622.513.414.413.414.4——61.963.9——
Mexico21.222.613.214.513.114.40.10.162.264.30.50.4
(1) Market share estimates are calculated using IMS data, unless otherwise stated
(2) Total market and market share estimates include cigarillos in Japan
(3) PMI market share reflects estimated adjusted in-market sales volume share
70
For the Three Months Ended September 30,
PMI Shipments (billion units)
PMI Market Share (%)(2)
MarketTotal Market (billion units)TotalCigaretteHeated Tobacco UnitTotalHeated Tobacco Unit
202320222023202220232022202320222023202220232022
Total (1) (2)
668.3684.2193.6189.5161.1162.032.527.528.928.04.64.1
Europe
France7.68.52.73.52.63.4—0.142.243.30.70.7
Germany (3)
19.320.26.97.36.06.60.90.738.438.34.93.7
Italy19.519.410.410.06.87.23.62.853.453.916.013.7
Poland15.215.46.56.25.24.71.31.542.740.48.79.7
Spain11.912.43.53.63.13.30.30.329.830.62.31.7
SSEA, CIS & MEA
Egypt16.223.06.45.06.14.80.20.240.221.72.00.9
Indonesia77.981.122.523.322.523.3——28.928.8——
Philippines10.513.05.77.85.67.70.10.154.559.90.50.5
Russia55.256.417.117.712.913.74.24.031.231.77.57.3
Turkey37.530.218.914.918.914.9——50.549.1——
EA, AU & PMI DF
Australia1.82.10.70.70.70.7——38.135.1——
Japan (2)
38.238.615.513.24.34.911.28.339.537.926.524.1
South Korea18.819.43.73.72.42.61.31.219.619.07.15.9
Americas
Argentina6.67.64.04.84.04.8——61.263.2——
Mexico7.78.14.95.34.85.2——62.965.10.50.4
(1) Market share estimates are calculated using IMS data, unless otherwise stated
(2) Total market and market share estimates include cigarillos in Japan
(3) PMI market share reflects estimated adjusted in-market sales volume share. Historical HTU adjusted in-market sales volume share: Q4, 2022 (4.7%); Q1, 2023 (5.4%); Q2, 2023 (5.4%). Historical total adjusted in-market sales volume share: Q4, 2022 (39.7%); Q1, 2023 (39.4%); Q2, 2023 (39.2%)

Consolidated Operating Results for the Nine Months Ended September 30, 2023

The following discussion compares our consolidated operating results for the nine months ended September 30, 2023, with the nine months ended September 30, 2022.

Total Market

Estimated international industry volume (excluding China and the U.S.) for cigarettes and HTUs decreased by 1.6% in the first nine months, reflecting declines in the SSEA, CIS & MEA Region, the Europe Region and the Americas Region, partly offset by an increase in the EA, AU & PMI DF Region, as described in the Regional sections of this MD&A.

For the full year 2023, we currently expect an estimated total international industry volume decline for cigarettes and HTUs, excluding China and the U.S., of 1.5% to 2.0%.

71
Shipment Volume
Our total cigarette and HTU shipment volume increased by 1.5%, reflecting an 18.3% increase in HTU shipments across all regions, partly offset by a 1.3% decline in cigarette shipments (due to the Europe, EA, AU & PMI DF, and Americas Regions, partly offset by the SSEA, CIS & MEA Region). Cigarette shipment volume for Marlboro decreased by 2.3% to 179.8 billion units, due primarily to the Philippines.

Our total oral product shipment volume increased by +100%, driven by the Swedish Match acquisition. For comparison purposes, assuming the inclusion of Swedish Match's first nine months 2022 shipment volume prior to our acquisition, total oral product shipment volume increased by 14.4%, primarily reflecting growth in nicotine pouches (particularly in the U.S.), partly offset by a decline for snus (mainly in Scandinavia). Swedish Match's total oral product shipment volume increased by 15.4% versus its corresponding shipments in the first nine months of 2022. Volume comparisons versus Swedish Match's first nine months 2022 results reflect data sourced from its disclosures, available at www.swedishmatch.com/investors.

For the full year 2023, we currently expect a total cigarette and HTU shipment volume growth for PMI of 1.0% to 1.5%.
•HTU shipment volume within the lower half of PMI's previous 125-to-130-billion-unit range, reflecting the impact of a further delayed market launch in Taiwan, very limited growth in Russia and Ukraine, as well as some uncertainty related to inventory levels in the Europe Region, as trade partners adjust to the upcoming HTU flavor ban in the EU;
•A cigarette shipment volume decline of approximately 1.0% to 2.0%;

For the full year 2023, we also expect nicotine pouch shipment volume of 390 to 410 million cans, reflecting the continued outstanding growth of ZYN in the U.S.

Impact of Inventory Movements
Excluding the net favorable impact of estimated distributor inventory movements (primarily driven by HTUs), PMI’s total in-market sales for cigarettes and HTUs increased by 0.9%, reflecting 12.8% growth for HTUs, partly offset by a decline of 1.1% for cigarettes. The net favorable impact of estimated distributor inventory movements for HTUs was driven primarily by Japan (partly reflecting a favorable comparison due to HTU capacity constraints in the prior year period), partially offset by Italy.

Adjusted in-market sales for HTUs increased by 15.2%, including growth in Europe of 19.3% and Japan of 14.9%. Excluding Russia and Ukraine, adjusted in market sales for HTUs increased by 17.9%.

International Share of Market - Cigarette and HTUs (Excluding China and the United States)
Nine Months Year-to-Date
20232022Change (pp)
Total International Market Share (1)
28.3 %27.6 %0.7 
Cigarettes23.7 %23.6 %0.1 
HTU4.6 %4.0 %0.6 
Cigarette over Cigarette Market Share (2)
25.2 %24.9 %0.3 
(1) Defined as PMI's cigarette and heated tobacco unit in-market sales volume as a percentage of total industry cigarette and heated tobacco unit sales volume, excluding China and the U.S., including cigarillos in Japan
(2) Defined as PMI's cigarette in-market sales volume as a percentage of total industry cigarette sales volume, excluding China and the U.S., including cigarillos in Japan
72
Financial Summary
Nine Months Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues (1)
$ 26,127 $ 23,610 10.7 %7.4 %$2,517 $(1,034)$1,814 $1,309 $614 $(186)
Cost of Sales (2)
(9,431)(8,191)(15.1)%(10.3)%(1,240)206 (605)— (652)(189)
Marketing, Administration and Research Costs (3)
(8,029)(6,097)(31.7)%(22.6)%(1,932)56 (612)— — (1,376)
Operating Income$ 8,667 $ 9,322 (7.0)%(5.1)%$(655)$(772)$597 $1,309 $(38)$(1,751)
(1) Cost/Other variance includes charges in 2023 of $80 million following the termination of a distribution arrangement in the Middle East.
(2) Cost/Other variance includes charges in 2023 of $11 million related to the war in Ukraine, more than offset by charges in 2022 of $112 million related to an impairment charge of other intangible assets and $46 million related to the war in Ukraine. For more details, see Note 3. War in Ukraine and Note 6. Goodwill and Other Intangible Assets, net.
(3) Cost/Other variance includes charges in 2023 of $109 million related to asset impairment and exit costs, the South Korea indirect tax charge of $204 million, an impairment charge for goodwill and other intangibles of $680 million, the termination of a pledge agreement with the Foundation for a Smoke-Free World of $140 million, and $8 million related to the war in Ukraine, partially offset by charges in 2022 of $82 million related to the war in Ukraine and $269 million related to costs associated with the Swedish Match AB offer. For more details, see Note 3. War in Ukraine, Note 6. Goodwill and Other Intangible Assets, net, Note 10. Contingencies and Note 17. Asset Impairment and Exit Costs.

For the nine months ended September 30, 2023, net revenues, excluding currency and acquisitions, increased by 7.4%, mainly reflecting: a favorable pricing variance, primarily driven by higher combustible tobacco pricing, partly offset by lower HTU (net) pricing; and favorable volume/mix, mainly driven by higher HTU volume and favorable cigarette mix, partially offset by lower cigarette volume and unfavorable HTU mix. The increase was partly offset by lower fees for certain distribution rights billed to customers in certain markets and a charge to net revenues in 2023 of $80 million following the termination of a distribution arrangement in the Middle East, both shown in "Other".

The unfavorable currency in net revenues was due primarily to the Egyptian pound, Indonesian rupiah, Japanese yen and Russian ruble, partially offset by the Mexican peso.

Net revenues include $9.3 billion in 2023 and $7.3 billion in 2022 related to smoke-free products.

Operating income decreased by 7.0%. Operating income, excluding currency and acquisitions, decreased by 5.1%, primarily reflecting: the 2023 impairment charge for goodwill and other intangibles of $680 million, the impact of 2023 asset impairment and exit costs of $109 million, the termination of a distribution arrangement in the Middle East of $80 million, the South Korea indirect tax charge of $204 million and the termination of a pledge agreement with the Foundation for a Smoke-Free World of $140 million, partly offset by the 2022 charges of $128 million related to the war in Ukraine, the 2022 costs associated with the Swedish Match AB offer of $269 million and $112 million related to an impairment charge of other intangible assets in 2022. In addition to these items, operating income was also negatively impacted by: higher marketing, administration and research costs (primarily due to inflationary impacts, notably related to wages, and lower commercial investments in the prior year period); higher manufacturing costs (primarily due to inflationary impacts, notably related to direct materials, tobacco leaf and energy, partly offset by productivity); and the impact of lower fees for certain distribution rights, as noted for net revenues, partially offset by a favorable pricing variance. Volume/mix was slightly unfavorable, mainly reflecting lower cigarette volume, as well as unfavorable HTU and cigarette mix, largely offset by higher HTU volume.

Amortization expense for each of the next five years is estimated to be approximately $460 million or less, assuming no additional transactions occur that require the amortization of intangible assets. This estimate is subject to change based on the finalization of the preliminary purchase price allocation of the Swedish Match acquisition. Additionally, the estimated future amortization expense could significantly increase following the reacquisition of IQOS commercialization rights in the U.S. from Altria Group, Inc (see Note 2, Acquisitions), the accounting for which will depend on the facts and circumstances effective May 1, 2024, when PMI will hold the full rights.


73

Like many other global companies, we are facing continued global inflationary pressures, primarily impacting cost of sales for our business (notably related to certain direct materials, energy, transportation and logistics) and overall inflationary impacts on marketing, administration and research costs (notably wages). While we expect certain inflationary elements to ease over the course of the year, we anticipate that our 2023 results will likely continue to be impacted by inflationary forces (particularly related to tobacco leaf given the impact of longer inventory durations and higher prices of direct materials). For the nine months ended September 30, 2023, this impact was approximately $500 million. For further details, see "Impact of Inflation on Our Business and Mitigation Efforts" within the Business Environment section of this MD&A.


Interest expense, net, of $788 million increased by $370 million or 88.5%, primarily due to higher interest expense in connection with the Swedish Match acquisition, partially offset by higher net interest income driven by higher interest rates.

Our effective tax rate increased by 5.1 percentage points to 25.7%. For further details, see Note 11. Income Taxes.

Net earnings attributable to PMI of $5.6 billion decreased by $1.0 billion or 15.5%. This decrease was due primarily to lower operating income, higher interest expense, net and a higher effective tax rate, as discussed above. Basic and diluted EPS of $3.61 decreased by 15.7% and 15.5%, respectively. Excluding an unfavorable currency impact of $0.43, diluted EPS decreased by 5.4%.

Consolidated Operating Results for the Three Months Ended September 30, 2023
The following discussion compares our consolidated operating results for the three months ended September 30, 2023, with the three months ended September 30, 2022.

Total Market

During the quarter, estimated international industry volume (excluding China and the U.S.) for cigarettes and HTUs decreased by 2.3% in the third quarter, reflecting declines in the South & Southeast Asia, Commonwealth of Independent States, and Middle East & Africa (SSEA, CIS & MEA) Region, the Europe Region and the Americas Region, partly offset by an increase in the East Asia, Australia & PMI Duty Free (EA, AU & PMI DF) Region, as described in the Regional sections of this MD&A.

Shipment Volume

Our total cigarette and HTU shipment volume increased by 2.2%, reflecting an 18.0% increase in HTU shipments across all regions, partly offset by a 0.5% decline in cigarette shipments (due to the Europe Region, the EA, AU & PMI DF Region and the Americas Region, partially offset by the SSEA, CIS & MEA Region). Cigarette shipment volume for Marlboro decreased by 1.6% to 63.0 billion units, due primarily to the Philippines.

Our total oral product shipment volume increased by +100%, driven by the Swedish Match acquisition. For comparison purposes, assuming the inclusion of Swedish Match's third quarter 2022 shipment volume prior to our acquisition, total oral product shipment volume increased by 19.4%, primarily reflecting growth in nicotine pouches (particularly in the U.S.), partly offset by a decline for snus (mainly in Scandinavia). Swedish Match's total oral product shipment volume increased by 20.5% versus its corresponding shipments in the third quarter of 2022. Volume comparisons versus Swedish Match's third quarter 2022 results reflect data sourced from its disclosures, available at www.swedishmatch.com/investors.

Impact of Inventory Movements

Excluding the net favorable impact of estimated distributor inventory movements (primarily driven by HTUs), PMI’s total in-market sales for cigarettes and HTUs increased by 0.8%, reflecting 10.2% growth for HTUs, partly offset by a decline of 0.7% for cigarettes. The net favorable impact of estimated distributor inventory movements for HTUs was driven primarily by Japan (primarily reflecting the shift from air to sea freight).

Adjusted in-market sales for HTUs increased by 14.4%, including growth in Europe of 16.1%, Japan of 11.7% and limited growth in Russia and Ukraine; excluding these two markets, adjusted in-market sales for HTUs increased by 15.7%.


74


International Share of Market - Cigarette and HTUs (Excluding China and the United States)
Third-Quarter
20232022Change (pp)
Total International Market Share (1)
28.9 %28.0 %0.9 
Cigarettes24.3 %23.9 %0.4 
HTU4.6 %4.1 %0.5 
Cigarette over Cigarette Market Share (2)
25.9 %25.3 %0.6 
(1) Defined as PMI's cigarette and heated tobacco unit in-market sales volume as a percentage of total industry cigarette and heated tobacco unit sales volume, excluding China and the U.S., including cigarillos in Japan
(2) Defined as PMI's cigarette in-market sales volume as a percentage of total industry cigarette sales volume, excluding China and the U.S., including cigarillos in Japan
Financial Summary
Quarters Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues
$ 9,141 $ 8,032 13.8 %9.3 %$1,109 $(209)$568 $513 $265 $(28)
Cost of Sales (1)
(3,165)(2,935)(7.8)%(3.6)%(230)5 (129)— (199)93 
Marketing, Administration and Research Costs (2)
(2,606)(2,129)(22.4)%(4.5)%(477)(83)(299)— — (95)
Operating Income$ 3,370 $ 2,968 13.5 %18.5 %$402 $(287)$140 $513 $66 $(30)
(1) Cost/Other variance includes charges in 2023 of $11 million related to the war in Ukraine, partially offset by charges in 2022 of $112 million related to an impairment charge of other intangible assets. For more details, see Note 3. War in Ukraine and Note 6. Goodwill and Other Intangible Assets, net.
(2) Cost/Other variance includes charges in 2023 related to the termination of a pledge agreement with the Foundation for a Smoke-Free World of $140 million, as well as $8 million of charges related to the war in Ukraine, more than offset by charges in 2022 of $6 million related to the war in Ukraine and $217 million in 2022 related to costs associated with the Swedish Match AB offer. For more details, see Note 3. War in Ukraine.

During the quarter, net revenues, excluding currency and acquisitions, increased by 9.3%, mainly reflecting: a favorable pricing variance, primarily driven by higher combustible tobacco pricing; and favorable volume/mix, mainly driven by higher HTU volume and favorable cigarette mix, partially offset by lower cigarette volume.

The unfavorable currency in net revenues was due primarily to the Egyptian pound, Japanese yen and Russian ruble, partly offset by the Euro.

Net revenues include $3.3 billion in 2023 and $2.4 billion in 2022 related to smoke-free products.

Operating income increased by 13.5%. Operating income, excluding currency and acquisitions, increased by 18.5%, primarily reflecting: the absence of the third quarter 2022 charges of $112 million related to an impairment charge of other intangible assets and the 2022 costs associated with the Swedish Match AB offer of $217 million, partly offset by the 2023 charges related to the termination of a pledge agreement with the Foundation for a Smoke-Free World of $140 million. In addition to these items, operating income was also favorably impacted by: the favorable pricing variance; and favorable volume/mix, mainly driven by higher HTU volume, partly offset by lower cigarette volume and unfavorable cigarette mix; partially offset by higher marketing, administration and research costs (primarily due to inflationary impacts, notably related to wages).

75
Interest expense, net, of $261 million increased by $123 million or 89.1%, primarily due to higher interest expense in connection with the Swedish Match acquisition, partially offset by higher net interest income driven by higher interest rates.

Our effective tax rate increased by 11.2 percentage points to 33.2%. For further details, see Note 11. Income Taxes.

Net earnings attributable to PMI of $2.1 billion decreased by $33 million or 1.6%. This decrease was due primarily to a higher effective tax rate and higher interest expense, net, partly offset by higher operating income, as discussed above. Basic and diluted EPS of $1.32 decreased by 1.5% and 1.5%, respectively. Excluding an unfavorable currency impact of $0.17, diluted EPS increased by 11.2%.



Operating Results by Business Segment

Business Environment
Taxes, Legislation, Regulation and Other Matters Regarding the Manufacture, Marketing, Sale and Use of Tobacco Products
The tobacco industry and our company face a number of challenges that may adversely affect our business, volume, results of operations, cash flows and financial position. These challenges, which are discussed below and in “Cautionary Factors That May Affect Future Results,” include:

•regulatory restrictions on our products, including restrictions on the packaging, marketing, and sale of tobacco or other nicotine-containing products or related devices that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or even ban certain of our products;
•fiscal challenges, such as excessive excise tax increases and discriminatory tax structures;
•illicit trade in cigarettes and other tobacco and nicotine-containing products, including counterfeit, contraband and so-called “illicit whites”;
•intense competition, including from non-tax paid volume by certain local manufacturers;
•pending and threatened litigation as discussed in Note 10. Contingencies; and
•governmental investigations.

Regulatory Restrictions: The tobacco industry operates in a highly regulated environment. The well-known risks of smoking have led regulators to impose significant restrictions and high excise taxes on cigarettes.

Much of the regulation that shapes the business environment in which we operate is driven by the World Health Organization's (the "WHO") Framework Convention on Tobacco Control (the "FCTC"), which entered into force in 2005. The main objective of the FCTC is to establish a global agenda for tobacco regulation, with the purpose of reducing tobacco use. To date, 182 countries and the European Union ("EU") are Parties to the FCTC. The treaty requires Parties to have in place various tobacco control measures and recommends others. The FCTC governing body, the Conference of the Parties (“CoP”), has also adopted non-binding guidelines and policy recommendations related to certain articles of the FCTC that go beyond the text of the treaty. In October 2018, the CoP recognized the need for more scientific assessment and improved reporting to define policy on heated tobacco products. Similar to its previous policy recommendations on e-cigarettes, the CoP invited countries to regulate, restrict or prohibit heated tobacco products, as appropriate under their national laws.

Prior to the Ninth Session of the CoP ("CoP 9") to the FCTC, which took place in November 2021, the WHO and the WHO FCTC Secretariat published two reports on novel and emerging tobacco products. Discussions on these reports have been postponed to the Tenth Session of the CoP ("CoP 10") to be held in November 2023. In August 2023, the WHO Study Group on Tobacco Products Regulation issued its ninth report, including recommendations on nicotine pouches, in line with previous policy recommendations on regulating flavors in tobacco and nicotine products. It is not possible to predict whether or to what extent these developments will be reflected in decisions adopted at CoP 10 following deliberations. The WHO’s reports are not binding on the WHO Member States nor on Parties to the FCTC.

We believe that when better alternatives to cigarettes exist, the discussion should not be whether these alternatives should be made available to the more than one billion people who smoke cigarettes today, but how fast, and within what regulatory framework to maximize their adoption while minimizing unintended use. Therefore, we advocate for regulatory frameworks
76
that are based on a continuum of risk where non-combustible products fall below combustible cigarettes. Product regulation should include measures that encourage and accelerate switching to non-combustible products, for example, by allowing adult consumers who would not otherwise quit smoking cigarettes to receive truthful and non-misleading information about such alternatives to enable them to make informed decisions and by applying uniform product standards to enable manufacturers to demonstrate the reduction in harmful and potentially harmful constituents, as well as the absence of combustion. Regulation should also include specific rules for ingredients, labeling and consumer communication, and should ensure that the public is informed about the health risks of all combustible and non-combustible tobacco and nicotine-containing products. Importantly, regulation must include measures designed to prevent initiation by youth and non-smokers. We support mandated health warnings, minimum age laws, restrictions on advertising, and smoking restrictions in public spaces. We also support regulatory measures that help reduce illicit trade.

Certain measures are discussed in more detail below and in the Reduced-Risk Products (RRPs) section.

Fiscal Challenges: Excessive and disruptive excise, sales and other tax increases and discriminatory tax structures are expected to continue to have an adverse impact on our profitability, due to lower consumption and consumer down-trading to non-premium, discount, other low-price or low-taxed combustible tobacco products such as fine cut tobacco and illicit cigarettes. In addition, in certain jurisdictions, some of our combustible tobacco products are subject to tax structures that discriminate against premium-price products and manufactured cigarettes. We believe that such tax policies undermine public health by encouraging consumers to turn to illicit trade, and ultimately undercut government revenue objectives, disrupt the competitive environment, and encourage criminal activity. Other jurisdictions have imposed, or are seeking to impose, levies or other taxes specifically on tobacco companies, such as taxes on revenues and/or profits.

World Customs Organization Developments: In 2020, the World Customs Organization (the “WCO”) amended the Harmonized System ("HS") nomenclature to introduce dedicated custom codes for novel tobacco and nicotine products, including heated tobacco products, e-cigarettes and other nicotine-containing products. The amendments became effective as of January 1, 2022. The vast majority of countries where our RRPs are commercialized have adopted the amended HS, creating new dedicated customs codes for novel tobacco and nicotine products.

EU Tobacco Products Directive ("TPD"): In April 2014, the EU adopted a significantly revised TPD, which entered into force in May 2016. All EU Member States have adopted laws transposing the TPD.  The TPD sets forth a comprehensive set of regulatory requirements for tobacco products, including:

•health warnings covering 65% of the front and back panels of cigarette packs, with an option for Member States to further standardize tobacco packaging, including the introduction of plain packaging;
•a ban on characterizing flavors in some tobacco products, with a transition period for menthol that expired in May 2020;
•security features and tracking and tracing measures that became effective in May 2019; and
•a framework for the regulation of novel tobacco products and e-cigarettes, including requirements for health warnings and information leaflets, a prohibition on product packaging text related to reduced risk, and the introduction of notification requirements or authorization procedures in advance of commercialization.

In May 2021, the European Commission published its first report on the application of the TPD. The report identifies significant progress made due to the implementation of the TPD and where there is still room for improvement. Most notably, it finds that the EU legislation has enhanced tobacco control, which contributed to protecting the health of EU citizens by providing Member States with strong rules to address the use of tobacco products in the EU. The TPD reportedly achieved the 2% reduction target of the impact assessment with decreased smoking prevalence among youth. The report also concludes that there is scope for improvement in certain areas, such as enforcement at national level, assessment of ingredients, and a better consideration for novel and emerging products.

In November 2021, the European Commission published the implementation roadmap to Europe's Beating Cancer Plan (the "Plan"). According to the Plan, a revision of the TPD is planned for 2024.

EU Tobacco Excise Directive ("TED"): The EU Commission is preparing a legislative proposal for the revision of the 2011 EU Tobacco Excise Directive that may include definitions and tax treatment for novel tobacco and nicotine-containing products, including heated tobacco products, e-cigarettes and nicotine pouches. The proposal, after several delays, could be adopted by the College of Commissioners at the end of 2023 or beginning of 2024. Depending on the adoption date by the College of Commissioners, the proposal will be discussed by the EU Council in the course of 2024-2025. Any final amendments to TED
77
require unanimous agreement by all EU Member States, followed by transposition of TED into national legislation. The potential effective date for any changes to TED, after the transposition in Member States' national legislation, is 2026.

Plain Packaging and Other Packaging Restrictions: Plain packaging legislation bans the use of branding, logos and colors on packaging other than the brand name and variant that may be printed only in specified locations and in a uniform font. To date, plain packaging laws have been adopted in certain markets in all of our operating segments, including the key markets of Australia, France, Saudi Arabia and Turkey. Some countries, such as Canada, Denmark and Israel, adopted plain packaging regulations that apply to all tobacco products, including RRPs. Other countries are also considering plain packaging legislation.

Some countries have adopted, or are considering adopting, packaging restrictions that could have an impact similar to plain packaging. Examples of such restrictions include standardizing the shape and size of packages, prohibiting certain colors or the use of certain descriptive phrases on packaging, and requiring very large graphic health warnings that leave little space for branding.

Restrictions and Bans on the Use of Ingredients: The WHO and others in the public health community have recommended restrictions or total bans on the use of some or all ingredients in tobacco products, including menthol. Broad restrictions and ingredient bans would require us to reformulate our American blend tobacco products and could reduce our ability to differentiate these products in the market in the long term. In many countries, menthol bans would eliminate the entire category of mentholated tobacco products. The EU banned cigarettes and roll-your-own tobacco products with characterizing flavors. Other tobacco products, including heated tobacco products, are currently exempted from this characterizing flavor ban. However, on November 23, 2022, the EU Commission published a delegated directive that will eliminate this exemption. All EU Member States are required to apply the delegated directive as of October 23, 2023, which bans the use of characterizing flavors in heated tobacco products in the EU, impacting a significant proportion of our RRP products currently sold in the EU. While we cannot predict the ultimate impact on our business from this ban, consumer switching to non-flavored products was high in reaction to past bans on flavors in other categories and markets. Therefore, while we believe that short-term volatility is possible, including in year-end trade inventories, we do not expect a significant change in the structural growth of the heated tobacco product category, with consumers switching to non-flavored products partially mitigating the effect of the ban. A majority of member states have transposed this directive, withdrawing the heated tobacco product exemption from the characterizing flavor ban into national law. The remaining markets are expected to adopt this directive in 2024, and we will continue to actively monitor relevant developments in the EU market. Other countries may follow the EU’s approach toward tobacco product ingredients. Turkey banned menthol as of May 2020. Broader ingredient bans have been adopted by Brazil and Canada.

Bans on Display of Tobacco Products at Retail: In a number of our markets, including, but not limited to, Australia and Russia, governments have banned the display of tobacco products at the point of sale. Other countries are considering similar bans.

Bans and Restrictions on Advertising, Marketing, Promotions and Sponsorships: For many years, the FCTC has called for, and countries have imposed, partial or total bans on tobacco advertising, marketing, promotions and sponsorships, including bans and restrictions on advertising on radio and television, in print and on the Internet. The FCTC's non-binding guidelines recommend that governments prohibit all forms of communication with adult smokers.

Restrictions on Product Design: Some members of the public health community are calling for the further standardization of tobacco products by requiring, for example, that cigarettes have a certain minimum diameter, which would amount to a ban on slim cigarettes, or requiring the use of standardized filter and cigarette paper designs. In addition, at its meeting in November 2016, the CoP adopted non-binding guidelines recommending that countries regulate product design features that increase the attractiveness of tobacco products, such as the diameter of cigarettes and the use of flavor capsules.

Restrictions on Public Smoking and Use of Nicotine-Containing Products in Public: The pace and scope of restrictions on the use of our products have increased significantly in most of our markets. Many countries around the world have adopted, or are likely to adopt, regulations that restrict or ban smoking and use of nicotine-containing products in public and/or work places, restaurants, bars and nightclubs. Some public health groups have called for, and some countries, regional governments and municipalities have adopted or proposed, bans on smoking in outdoor places, as well as bans on smoking in cars (typically, when minors are present) and private homes.

Other Regulatory Issues: Some regulators are considering, or in some cases have adopted, regulatory measures designed to reduce the supply of tobacco products. These include regulations intended to reduce the number of retailers selling tobacco products by, for example, reducing the overall number of tobacco retail licenses available or banning the sale of tobacco products within specified distances of certain public facilities. Other regulators are also considering generation sales bans, under which the sale of certain tobacco or nicotine products to people born after a certain year would be prohibited.
78

On December 13, 2022, the New Zealand parliament passed a bill introducing regulatory measures restricting the sale and supply of smoked tobacco products, including reducing the number of retail outlets licensed to sell smoked tobacco products, imposing a maximum limit of nicotine content for smoked tobacco products and prohibiting the sale of smoked tobacco products to anyone born on or after January 1, 2009. These measures are limited to smoked tobacco products and do not apply to heated tobacco products and e-cigarettes. In Mexico, a new law came into force on December 12, 2022, prohibiting imports and exports of certain nicotine and non-nicotine delivery and consumption systems, as well as the consumables used in those systems, including much of our RRP portfolio.

On December 16, 2022, the Mexican Federal Government enacted an implementation regulation for the tobacco control law, which includes (i) a point of sale display ban of tobacco products; (ii) restrictions on where tobacco products can be consumed, and (iii) prohibition to communicate corporate social responsibility programs funded by the tobacco industry.

On January 1, 2023, a law regulating the marketing of nicotine pouches went into effect in Slovakia. The regulatory framework contains a minimum legal age (18 years) to purchase, a nicotine limit, and a labelling requirement. On December 6, 2022, the Dutch Government published a draft bill to ban the commercialization of nicotine pouches in the Netherlands.

On February 15, 2023, a bill amending the Tobacco Hazards Prevention and Control Act was adopted in Taiwan and entered into force on March 22, 2023. It regulates heated tobacco products but bans e-cigarettes. The amendment particularly specifies that designated tobacco products (including heated tobacco products) that are neither cigarettes, cut tobacco, cigars, snuff nor chewing tobacco, must undergo a health risk assessment as part of an authorization system. The Taiwanese central health authority announced on March 22, 2023 that heated tobacco products are designated tobacco products.

On March 27, 2023, the Argentinian Ministry of Health, through publication of Resolution 565/2023 in the Official Gazette, prohibited the import, distribution, commercialization and advertising of heated tobacco products, including related devices. The resolution entered into force on March 28, 2023. The country had previously banned the use of e-cigarettes in 2011.

In a limited number of markets, most notably Japan, we are dependent on governmental approvals that may limit our pricing flexibility.

The EU Single-Use Plastics Directive, which will require tobacco manufacturers and importers to cover the costs of public collection systems for tobacco product filters, under Extended Producer Responsibility ("EPR") schemes, entered into force on July 2, 2019. To date, some member states transposed the Directive into national legislation. By 2024, most EU Member States are expected to bring into force national legislation for mandatory EPR schemes and related EPR costs for tobacco manufacturers and importers. While we cannot predict the impact of this initiative on our business at this time, we are monitoring developments in this area.

In some countries, including in the EU, cigarettes are subject to testing, disclosure and mandatory emissions limits for tar, nicotine, carbon monoxide and other smoke constituents. In the Netherlands, several public health organizations have requested that the Dutch enforcement body enforce the requirements for maximum tar, nicotine, and carbon monoxide ("TNCO") emissions levels for cigarettes using a test method other than the method currently set forth in the EU TPD and transposed into national legislation. This request followed publication of a report by the Dutch State Institute for Public Health & Environment, which found that all cigarette brands sold in the Netherlands exceeded the maximum TNCO levels when measured under an alternative method. The Dutch enforcement body declined the request, and the applicants have challenged such decision in pending legal proceedings in the Netherlands. The case is currently pending before the Trade and Industry Appeals Tribunal in the Netherlands, and a decision is expected in the fourth quarter of 2023. While we cannot predict the outcome, a decision to enforce the existing TNCO ceilings in the Netherlands using the alternative test method could impact a significant portion of the manufactured cigarettes available on the market in the Netherlands and could lead to similar actions in other EU countries.

Illicit Trade: Illicit tobacco trade creates a cheap and unregulated supply of tobacco products, undermines efforts to reduce smoking prevalence, especially among youth, damages legitimate businesses and intellectual property rights, stimulates organized crime, increases corruption and reduces government tax revenue. We generally estimate that, excluding China and the U.S., illicit trade may account for as much as 14% of global cigarette consumption; this includes counterfeit, contraband and the persistent problem of “illicit whites,” which are cigarettes legally purchased in one jurisdiction for the sole purpose of being exported and illegally sold in another jurisdiction where they have no legitimate market. Currently, we estimate that illicit trade in the EU accounted for approximately 8% of total cigarette consumption in 2022.

A number of jurisdictions are considering actions to prevent illicit trade. In November 2012, the FCTC adopted the Protocol to Eliminate Illicit Trade in Tobacco Products (the “Protocol”), which includes supply chain control measures, such as licensing of manufacturers and distributors, enforcement of these control measures in free trade zones, controls on duty free and Internet channels and the implementation of tracking and tracing technologies. To date, 68 Parties, including the EU, have ratified it.
79
The Protocol came into force in September 2018. Since then, implementation in national legislations has been ongoing. In November 2021, the second Meeting of the Parties to the Protocol decided, among other things, to focus on the implementation of a framework for global information sharing to combat illicit tobacco trade and enable the Parties to the Protocol to exchange tracking and tracing information of products in a secure manner. We welcome this decision and expect that other countries will ratify the Protocol.

We devote substantial resources to help prevent illicit trade in combustible tobacco products and RRPs. For example, we engage with governments, our business partners and other stakeholders to implement effective measures to combat illicit trade and, in some instances, pursue legal remedies to protect our intellectual property rights.

The tracking and tracing regulations for cigarettes and roll-your-own products manufactured or destined for the EU became effective on May 20, 2019. The effective date for other tobacco-containing products, including some of our RRPs such as heated tobacco units, is May 20, 2024. While we expect that this regulation will increase our operating expenses, we do not expect this increase to be significant.

In 2009, our Colombian subsidiaries entered into an Investment and Cooperation Agreement with the national and regional governments of Colombia to promote investment in, and cooperation on, anti-contraband and anti-counterfeit efforts. The agreement provides $200 million in funding over a 20-year period to address issues such as combating illegal cigarette trade and increasing the quality and quantity of locally grown tobacco.

In May 2016, PMI launched PMI IMPACT, a global initiative that supports third-party projects dedicated to fighting illicit trade and related crimes such as corruption, organized criminal networks and money laundering. The centerpiece of PMI IMPACT is a council of external independent experts in the fields of law, anti-corruption and law enforcement responsible for evaluating and approving funding proposals for PMI IMPACT grants. PMI has pledged $100 million to fund projects within PMI IMPACT over three funding rounds. The implementation of the grants assigned under the third funding round is ongoing.

Reduced-Risk Products (RRPs)    

Our Approach to RRPs: We recognize that smoking cigarettes causes serious diseases and that the best way to avoid the harm of smoking is to never start or to quit. Nevertheless, it is predicted that by 2025, the number of smokers will remain largely unchanged from the current estimate of 1.1 billion, despite considerable efforts to discourage smoking.

Cigarettes burn tobacco, which produces smoke. As a result of the combustion process, the smoker inhales various toxic substances. In contrast, RRPs do not burn tobacco and therefore contain significantly lower levels of harmful and potentially harmful constituents ("HPHCs") than found in cigarette smoke.

For adult smokers who would otherwise continue to smoke cigarettes, we believe that RRPs, while not risk-free, offer a much better choice. Accordingly, our key strategic priorities are to: (i) develop and commercialize products that present less risk of harm to adult smokers who switch to such products versus continued cigarette smoking; and (ii) educate and encourage current adult smokers who would otherwise continue to smoke cigarettes to switch to those products.

We recognize that this transformation from cigarettes to RRPs will take time and that the speed of transformation will depend in part upon factors beyond our control, such as the willingness of governments, regulators and other policy groups to embrace RRPs, as a desired alternative to continued cigarette smoking. As a leading international cigarette manufacturer, we will continue to accelerate this transformation by using our extensive commercial and distribution infrastructure as an effective platform for the commercialization of our RRPs and communication with adult smokers and trade partners about the substantiated benefits of switching to our RRPs. As long as a significant number of adult smokers continue to smoke cigarettes, responsible leadership of the category is critical. We aim to maintain our competitive position in the cigarette market through selective investment.

While seeking to remain competitive in the cigarette market, we are judiciously reallocating resources from cigarettes to RRPs and are streamlining our cigarette portfolio.

We have a range of RRPs in various stages of development, scientific assessment and commercialization. We are committed to conducting rigorous scientific assessments of our RRP platforms to substantiate that they reduce exposure to HPHCs and, ultimately, that these products present, are likely to present, or have the potential to present less risk of harm to adult smokers who switch to them versus continued cigarette smoking. We draw upon a team of expert scientists and engineers from a broad
80
spectrum of scientific disciplines and our extensive learnings of adult consumer preferences to further develop and assess our RRPs. Our efforts are guided by the following key objectives:

•to develop RRPs that adult smokers who would otherwise continue to smoke cigarettes find to be satisfying alternatives to smoking;
•for those adult smokers, our goal is to offer RRPs with a scientifically substantiated risk-reduction profile that approaches as closely as possible the risk-reduction profile associated with smoking cessation;
•to substantiate the reduction of risk for the individual adult smoker and the reduction of harm to the population as a whole, based on scientific evidence of the highest standard that is made available for scrutiny and review by external independent scientists and relevant regulatory bodies; and
•to advocate for the development of science-based regulatory frameworks for the development and commercialization of RRPs, including the communication of scientifically substantiated information to enable adult smokers to make better choices.

Our RRP Platforms: Our product development is based on the elimination of combustion via tobacco heating and other innovative systems, which we believe are the most promising path to providing a better consumer choice for those who would otherwise continue to smoke cigarettes. We recognize that no single product will appeal to all adult smokers. Therefore, we are developing a portfolio of products intended to appeal to a variety of distinct adult consumer preferences and achieve population harm reduction.

Five PMI-developed or improved RRP platforms are in various stages of development and commercialization readiness:

        Platform 1 uses a precisely controlled heating device incorporating our IQOS HeatControl technology, into which a specially designed and proprietary tobacco unit is inserted and heated to generate an aerosol. We have conducted a series of clinical studies for this platform, the results of which were included in our submissions to the U.S. Food and Drug Administration (“FDA”). In addition to the original version of Platform 1 which relies on a heating technology using a blade, a newer version of Platform 1 is now available using induction instead of heating a blade. All studies referenced above were conducted with the blade version of Platform 1. We believe that there is full comparability between the subsequent Platform 1 versions, and therefore the data from these studies remain valid. In 2022, we also began the initial launch of a heated tobacco product, which utilizes external resistive heating technology and that is commercialized under the BONDS brand.

    Platform 2 used a pressed carbon heat source which, when ignited, generated a nicotine-containing aerosol by heating tobacco. As a result of consumer testing feedback, the design of our current Platform 2 technology has been discontinued. We are assessing alternative designs for this consumer segment.

    Platform 3 uses a nicotine salt and is composed of two parts: (1) a consumable that contains a highly soluble encapsulated nicotine salt powder and (2) a non-electric device that activates it. Once a consumable is inserted into the mechanical device, the nicotine salt powder is aerosolized upon inhalation. The results of our pharmacodynamic study related to this version indicate this product's potential as an acceptable alternative to continued cigarette smoking in terms of product satisfaction. We are working on product modifications to enable adult smokers, who are looking for better alternatives to cigarettes, to switch to a Platform 3 product.

    Platform 4 covers e-vapor products, which are battery-powered devices that produce an aerosol by vaporizing a tobacco-free liquid solution. We developed new e-liquids for our e-vapor products to deliver real tobacco taste satisfaction. Using patented technology, flavors and nicotine are extracted directly from the tobacco leaves and captured in a tobacco-free liquid solution, without having to add flavoring ingredients.

In the first quarter of 2023, we initiated a project to fully outsource and restructure the manufacturing of e-vapor devices and consumables. As a result, PMI recorded pre-tax asset impairment and exit costs of $109 million. We intend to focus on commercializing these products in select markets, with an emphasis on profitability.

We also entered into a licensing agreement with Kaival Brands International, LLC, in June 2022 to distribute an e-vapor product, known in the U.S. as the BIDI® Stick. The agreement grants PMI certain intellectual property rights relating to the premium e-vapor devices and, potentially, other newly developed devices, to permit PMI to manufacture, promote, sell, and distribute the e-vapor device and, to the extent included, other newly developed devices in international markets outside of the U.S.

81
Platform 5 covers snus and modern oral nicotine pouches. Snus refers to dried loose tobacco, or snuff, which is consumed by sniffing the product through the nose, moist loose tobacco which is put in the mouth between the lower or upper lip and gum, and snus pouches which contain ground tobacco, water, salt and flavors. Modern oral nicotine pouches consist of white pre-conditioned pouches containing nicotine derived from tobacco. Users place a pouch between the upper lip and gum and leave it there while the nicotine and flavor are being released. At the end of the use, the user can dispose of the pouch. Nicotine pouches are inherently smoke-free as they are consumed orally, and no combustion process occurs during use. They contain primarily nicotine, flavors, and cellulose substrate. The nicotine used in the pouches is of pharmaceutical-grade like the nicotine used in medicinal products, such as gums and inhalers, while the flavors are approved for use in food in accordance with the product quality standards for nicotine pouches developed by the Swedish Institute for Standards. In 2021, PMI acquired AG Snus Aktieselskab ("AG Snus"), as well as Fertin Pharma A/S, two companies manufacturing and/or marketing nicotine pouches. In 2022, we significantly expanded our Platform 5 products portfolio with the acquisition of Swedish Match. The acquisition also represents an expansion of our RRP presence in the United States market, where Swedish Match's ZYN brand is the leading nicotine pouch franchise.

We aim to expand our brand portfolio and market positions with additional RRPs. In addition, we continue to use our expertise, technology and capabilities to explore new growth opportunities beyond our current business, including products that do not contain nicotine or tobacco.

Commercialization of RRPs: We are developing a multiplatform approach and tailoring our commercialization strategy to the characteristics of each specific market. We focus our commercialization efforts on consumer retail experience, guided consumer trials and customer care, and increasingly, digital communication programs and e-commerce.  In order to accelerate switching to our Platform 1 products, our initial market introductions typically entail one-to-one consumer engagement (in person or by digital means) and device discounts.  These initial commercialization efforts require substantial investment, which we believe will moderate over time and further benefit from the increased use of digital engagement capabilities. During the COVID-19 pandemic, we accelerated our investments in, and pivot to, digital consumer engagement.

As of September 30, 2023, PMI's smoke-free products were available for sale in 82 markets.

In 2014, we introduced our Platform 1 product in pilot city launches in Nagoya, Japan, and in Milan, Italy. Since then, we have continuously expanded our commercialization activities.

Data shows that only a very small percentage of adult smokers who convert to our Platform 1 product switch back to cigarettes.

We have integrated the production of our heated tobacco units into several of our existing manufacturing facilities, are progressing with our plans to build manufacturing capacity for our other RRP platforms, and continue to optimize our manufacturing infrastructure and expand our commercialization activities for new products and markets. We discuss certain risks related to the commercialization and supply of our RRP portfolio in “Cautionary Factors That May Affect Future Results”.

We discuss product warranties in more detail in Note 16. Product Warranty. The significance of warranty claims is dependent on a number of factors, including device version mix, product failure rates, logistics and service delivery costs, and warranty policies, and may increase with the number of devices sold.

On October 20, 2022, PMI announced that it had reached an agreement with Altria Group, Inc., to end the companies' commercial relationship covering Platform 1 in the U.S. as of April 30, 2024. Under this agreement, effective May 1, 2024, PMI will hold the full rights to commercialize Platform 1 in the U.S.- the world’s largest smoke-free market. This agreement provides a clear path to expanding Platform 1's international success in a market where approximately 30 million adults continue to smoke cigarettes.

Our commercialization efforts for the other PMI-developed RRP platforms are as follows:

•In late 2022, we began commercializing our BONDS product in the Philippines and Colombia.

•Since August 2020, we have launched and expanded our portfolio of vaping products (branded VEEV) in 23 markets.

•Following our acquisition of Swedish Match, we have access to a strong portfolio of Swedish Match brands in both the snus and nicotine pouch categories. Swedish Match nicotine pouches are currently available in 25 markets.

82
•In addition to Swedish Match products, we have launched a reformulated version of the already commercialized nicotine pouches bearing the Shiro brand by our affiliate AG Snus in ten markets.

RRP Regulation and Taxation: RRPs contain nicotine and are not risk-free. As we describe in more detail above, we support science-based regulation and taxation of RRPs, and believe that regulation and taxation should differentiate between cigarettes and products that present, are likely to present, or have the potential to present less risk of harm to adult smokers who switch to these products versus continued smoking, and should recognize a continuum of risk for tobacco and other nicotine-containing products. Regulation, as well as industry practices, should reflect the fact that youth should not consume nicotine in any form.

Some governments have banned, or are seeking to ban or severely restrict, emerging tobacco and nicotine-containing products, such as our RRPs, and communication of truthful and non-misleading information about such products.

These regulations might foreclose or unreasonably restrict adult consumer access even to products that might be shown to be a better consumer choice than continuing to smoke cigarettes. Since the COVID-19 pandemic, some governments have been and may continue to be temporarily unable to focus on the development of science-based regulatory frameworks for the development and commercialization of RRPs or on the enforcement or implementation of regulations that are significant to our business.

We oppose blanket bans and unreasonable restrictions of products that have the potential to present less risk of harm compared to continued cigarette smoking. By contrast, we support regulation that sets clear standards for all RRP categories and propels innovation to benefit adult smokers who would otherwise continue to smoke cigarettes.

In the United States, an established regulatory framework for assessing “Modified Risk Tobacco Products” ("MRTP") and “New Tobacco Products” exists under the jurisdiction of the FDA. We submitted to the FDA a Modified Risk Tobacco Product Application (“MRTPA”) for our Platform 1 product in December 2016, and a Premarket Tobacco Product Application (“PMTA”) for our Platform 1 product in March 2017.

On April 30, 2019, the FDA determined that a version of our Platform 1 product, namely, IQOS 2.4 and three related consumables, is appropriate for the protection of public health ("APPH") and authorized it for sale in the United States. The FDA’s decision followed its comprehensive assessment of our PMTA. On December 7, 2020, the FDA reached the same determination for the IQOS 3 device and authorized that version of our Platform 1 product for sale in the United States.

On July 7, 2020, the FDA determined that the available scientific evidence demonstrates that the issuance of an exposure modification order would be appropriate for the promotion of public health and authorized the marketing of a version of our Platform 1 product, namely IQOS 2.4 and three related consumables, as an MRTP. The FDA authorized the marketing of this product in the U.S. with the following information:

"AVAILABLE EVIDENCE TO DATE:

•the IQOS system heats tobacco but does not burn it.
•this significantly reduces the production of harmful and potentially harmful chemicals.
•scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your body’s exposure to harmful or potentially harmful chemicals."

We must request and receive authorization from the FDA in order to continue marketing this product with the same modified exposure information before the order expires in four years from the date of the orders.

The FDA may issue two types of MRTP orders: a “risk modification” order or an “exposure modification” order. We had requested both types of orders for IQOS 2.4 and an initial selection of 3 consumables' variants. After review, the FDA determined that the evidence did not support issuing a "risk modification" order at this time but that it did support issuing an "exposure modification" order for the product. This determination included a finding that issuance of the exposure modification order is expected to benefit the health of the population as a whole. We also received an exposure modification order for IQOS 3. We look forward to working with the FDA to provide any additional information they may require to market Platform 1 products with reduced risk claims.

The FDA’s PMTA and MRTP orders do not mean that the agency “approved” our Platform 1 product. These authorizations are subject to strict marketing, reporting and other requirements, and are not a guarantee that the product will remain authorized, particularly if there is a significant uptake in youth or non-smoker initiation. The FDA will monitor the marketing of the product.
83

On March 18, 2021, we submitted to the FDA a supplemental MRTPA ("sMRTPA") for IQOS 3 requesting authorization to market this version of the device as a MRTP with reduced exposure information like IQOS 2.4. In June 2021, the FDA formally accepted and filed our sMRTPA for substantive scientific review, following a period for the public to provide comments on our application. The FDA authorized our sMRTPA for IQOS 3 by issuing a Modified Risk Granted Order – Exposure Modification on March 11, 2022.

On January 26, 2023, the FDA authorized the marketing of two new tobacco-flavored consumables (Marlboro Sienna HeatSticks and Marlboro Bronze HeatSticks) and a modified version of the authorized Marlboro Amber HeatSticks. These products are line extensions and/or modified versions of the tobacco-flavored consumables for which the FDA had previously issued a marketing granted order. In its assessment, the FDA determined that the three variants of HeatSticks were comparable to the previously authorized tobacco-flavored consumables.

On April 28, 2023, we submitted the Annual Report for the IQOS Tobacco Heating System ("THS") to the FDA. The report included a systematic review of the literature covering publications related to the IQOS THS between March 1, 2022 and February 28, 2023. The report concluded that, although the scientific evidence continues to develop and evolve, the extensive data reviewed confirms that while Heated Tobacco Products (“HTPs”) are not risk-free, the use of HTPs are likely to present less risk of harm for both users and non-users against the well-proven risks of continued cigarette smoking, and therefore continues to support the APPH status of IQOS THS.

On July 5, 2023, we submitted a renewal application to the FDA requesting re-authorization to market the IQOS products with a modified exposure order in the U.S. This renewal request was received by the FDA 360 days prior to the expiration date of the original marketing orders, and in early September 2023, the FDA formally accepted our renewal MRTPAs for review. As our application proceeds through the review process, the FDA may request additional information or conduct subsequent inspections to verify the information we submitted.

On October 20, 2023, we submitted bundled PMTAs for our IQOS ILUMA THS products together with MRTPAs requesting authorization of the exposure reduction marketing order previously granted for IQOS blade versions. We submitted these applications at the same time in order to allow the FDA to evaluate the PMTAs and MRTPAs concurrently.

Some states and municipalities in the U.S. have introduced severe restrictions for the sale of certain e-cigarettes and tobacco products, including those authorized by the FDA. We believe that such restrictions on FDA-authorized products will not advance public health and will unreasonably limit adult consumer access to products that are shown to be a better alternative to continued cigarette smoking.

In March 2020, the FDA issued a final rule to require new text and graphic health warnings on cigarette packs and advertisements. HTPs are technically covered by this rule, however the FDA stated that it would make product-specific decisions about health warnings when issuing or revising individual product or marketing orders. This approach would be consistent with the original marketing order granted for Heatsticks where the FDA required Philip Morris Products S.A. to remove the Surgeon General’s health warning for carbon monoxide from its packaging and advertising, and to use a nicotine addiction health warning instead. Philip Morris Products S.A. is committed to providing adult consumers with complete, accurate, and non-misleading information about possible health risks associated with its products. We shared our views with the FDA on the application of the new warnings to our HTPs. The final rule was the subject of litigation in the U.S. and was vacated nationwide by a federal court in November 2022. Philip Morris Products S.A. was not a party to this litigation.

On March 8, 2023, the FDA proposed new requirements for tobacco product manufacturers regarding the manufacture, design, packing and storage of their products. The FDA stated that these proposed requirements would help protect public health by, among other things, minimizing or preventing contamination and limiting additional risks by ensuring product consistency. The FDA held a public hearing on April 12, 2023, to gather additional comments from stakeholders, including the industry, the scientific community, advocacy groups, and the public. The proposed rule has also been made available for public comment for 180 days. The FDA will review all comments as part of the rulemaking process for this rule. PMI welcomes the FDA’s rule under section 906(e) of the Federal Food, Drug, and Cosmetic Act and plans to share its views with the FDA on this important foundational rule.

FDA actions may influence the regulatory approach of other governments and regulatory agencies.

Currently, national standards in certain countries set minimum quality and safety requirements for heat-not-burn products with technical heat-not-burn specifications and/or methods for demonstrating the absence of combustion. These standards are
84
mandatory in Bahrain, Egypt, Jordan, Saudi Arabia, Tajikistan, Tunisia, the UAE and Uzbekistan, and voluntary in Algeria, Armenia, Colombia, Costa Rica, Dominican Republic, Indonesia, Kazakhstan, Kyrgyzstan, Morocco, the Philippines, Russia, Vietnam, the U.K. and Ukraine. In Japan, a voluntary standard sets minimum safety requirements for tobacco heating devices.

For e-vapor products (e-cigarettes) national standards setting minimum quality and safety requirements have been adopted in several markets. These standards are mandatory in Armenia, Bahrain, China, Egypt, Jordan, New Zealand, United Arab Emirates, and Saudi Arabia and Tajikistan, and voluntary in Costa Rica, France, Kazakhstan, the Philippines, Russia, the U.K. and Ukraine.

Currently, industry standards setting minimum quality and safety requirements for tobacco-free oral nicotine products (nicotine pouches) have been adopted in the U.K., Sweden and Pakistan. These standards are voluntary.

We expect other governments to consider similar product standards for all novel tobacco and nicotine-containing products and encourage making them mandatory.

All EU member states have transposed the EU TPD, including the provisions on novel tobacco products, such as heated tobacco units, and e-cigarettes. Most of the EU member states require a notification submitted six months before the intended placing on the market of such products, while some require pre-market authorizations for the introduction of such products. To date, we have filed a comprehensive dossier summarizing our scientific assessment of our Platform 1 product in over 20 member states.

On March 23, 2023, the Greek Ministry of Health ("MoH") authorized a claim for IQOS with HEETS AMBER to inform Greek IQOS users about reduction in emissions of toxicants when using such product compared to cigarette smoking. The decision authorized the following claim: “The concentration of chemical substances with recognized toxicity produced when using IQOS with HEETS AMBER tobacco sticks is lower compared to conventional smoking. A reduction in the concentration of chemical substances with recognized toxicity does not mean a corresponding reduction in risk for health. The aerosol of this tobacco product contains nicotine and other hazardous chemicals. This tobacco product harms your health and is addictive. The best choice is to quit tobacco and nicotine use altogether.” With this authorization, Greece is the second country officially recognizing the reduction in level of toxicants in the IQOS aerosol compared to cigarette smoke.

On September 12, 2022, Norway rejected a submission for authorization of HEETS as a novel tobacco product. Norway partially transposed the EU TPD under the European Free Trade Association agreement and introduced an authorization system for novel tobacco products following Article 19 of TPD. To date, Norway has not granted authorization of any novel tobacco product, and e-cigarettes and tobacco free nicotine pouches have not been granted access, either.

On October 31, 2019, our Australian subsidiary, Philip Morris Limited (“PML”), submitted an application to the Scheduling Committee of the Therapeutic Goods Administration of Australia (“TGA”) seeking to exempt HTPs from being prohibited in Australia. In August 2020, the TGA issued its decision denying the application and stating that the application did not present compelling evidence to establish a public health benefit from greater access to nicotine in HTPs.

To date, several governmental agencies have published their scientific findings that analyze the harm-reduction potential of certain RRPs versus continuing to smoke cigarettes, including:

In December 2017, at the request of the U.K. Department of Health and Public Health England, the U.K. Committee on Toxicity published its assessment of the risk of heat-not-burn products relative to cigarette smoking. This assessment included analysis of scientific data for two heat-not-burn products, one of which was our Platform 1 product. The assessment concluded that, while still harmful to health, compared with the known risks from cigarettes, heat-not-burn products are probably less harmful. Subsequently, in February 2018, Public Health England published a report stating that the available evidence suggests that heat-not-burn products may be considerably less harmful than cigarettes but more harmful than e-cigarettes.

In May 2018, the German Federal Institute for Risk Assessment (“BfR”) published a study on the Platform 1 aerosol relative to cigarette smoke using the Health Canada Intense Smoking Regimen. BfR found reductions in selected HPHCs in a range of 80-99%. This publication indicates that significant reductions in the levels of selected toxicants are likely to reduce toxicant exposure, which BfR stated might be regarded as a discrete benefit compared to combustible cigarettes.

In May 2018, the Dutch National Institute for Public Health and Environment (“RIVM”) published a factsheet on novel tobacco products that heat rather than burn tobacco, focusing on our Platform 1 product. RIVM analyzed the aerosol generated by our Platform 1 product and concluded that the use of this product, while still harmful to health, is probably less harmful than continuing to smoke cigarettes.

85
In June 2018, the Korean Food and Drug Administration (“KFDA”) issued a statement on products that heat rather than burn tobacco. The KFDA tested three heat-not-burn products, one of which was our Platform 1 product. The KFDA confirmed that the levels of the nine HPHCs tested in the aerosol of these products were on average approximately 90% lower compared to those measured in the cigarette smoke of the top five cigarette brands in South Korea. However, the KFDA stated that it could not establish that the tested heat-not-burn products are less harmful than cigarettes. In October 2018, our Korean subsidiary filed a request with a local court seeking information underlying KFDA’s analysis, conclusions and public statements. In May 2020, the court ordered KFDA to produce certain records. Subsequent to that decision, and after exchanges between the parties, the case was closed.

In August 2018, the Science & Technology Committee of the U.K. House of Commons published a report of its inquiry into e-cigarettes and heat-not-burn products. The report concluded that e-cigarettes are significantly less harmful to health than smoking tobacco. The report also observed that for those smokers who do not accept e-cigarettes, heat-not-burn products may offer a public health benefit despite their relative risk. The report called for a risk-proportionate regulatory environment for both e-cigarettes and heat-not-burn products and noted that e-cigarettes should remain the least taxed, cigarettes the most taxed, with heat-not-burn products falling between the two. The U.K. Committee on Advertising Practice announced the removal of a prohibition of health claims in the advertising of e-cigarettes in the U.K., effective November 2018.

In November 2018, the Eurasian Economic Commission (regulatory body of the Eurasian Union consisting of Armenia, Belarus, Kazakhstan, Kyrgyzstan and Russia) published the results of its commissioned study on novel nicotine-containing products, including our Platform 1 product. The study confirms significantly lower levels of HPHCs in the aerosol generated by this product compared to cigarette smoke.

In January 2019, scientific media published the results of the study of the China National Tobacco Quality Supervision and Test Centre (“CNTQST”) comparing the aerosol generated by our Platform 1 product with cigarette smoke. The CNTQST found that the former contained fewer, and lower levels of, harmful constituents than the latter and concluded that the lower temperature of heating tobacco in our Platform 1 product contributed to the difference. The CNTQST stated that the reduction in emissions of harmful constituents cannot be interpreted as a harm/risk reduction for cigarette smokers in the same proportion.

In April 2020, the Superior Health Council of Belgium (“SHC”) published results of its inquiry into heat-not-burn products. The SHC concluded that heat-not-burn products, while not safe, have a more favorable toxicity profile than cigarettes. However, in light of the uncertainty of such products’ short and long-term impacts, the toxic effects of the dual use with cigarettes, and the existence of approved smoking cessation tools, the SHC recommended that current regulations for cigarettes should apply to heat-not-burn products.

In June 2022, the SHC published new advice on e-cigarettes in which they confirm that e-cigarettes are substantially less harmful than smoking cigarettes and, therefore, a better alternative for smokers. The SHC underlines that the vast majority of the risks of tobacco smoking are not caused by nicotine, but by the harmful substances that are released by the combustion of tobacco. Based on the cited science, the SHC calls for legislation that makes a clear distinction between cigarettes and e-cigarettes by focusing on better informing smokers about the benefits of the lower-risk (but not risk-free) alternative, as well as on protecting non-smokers and young people.

The foregoing scientific findings of government agencies may not be indicative of the measures that the relevant government authorities could take in regulating our products.

We make our scientific findings publicly available for scrutiny and peer review through several channels, including our websites. From time to time, adult consumers, competitors, members of the scientific community, and others inquire into our scientific methodologies, challenge our scientific conclusions or request further study of certain aspects of our RRPs and their health effects. We are committed to a robust and open scientific debate and believe that such debate should be based on accurate and reliable scientific information. We seek to provide accurate and reliable scientific information about our RRPs; nonetheless, we may not be able to prevent third-party dissemination of false, misleading or unsubstantiated information about these products. The dissemination of scientifically unsubstantiated information or studies with a strong confirmation bias by third parties may cause confusion among adult smokers and affect their decision to switch to better alternatives to continued smoking, such as our RRPs.

To date, we have been largely successful in demonstrating to regulators that our heated tobacco units are not cigarettes due to the absence of combustion, and as such, they are generally taxed either as a separate category or as other tobacco products, which typically yields more favorable tax rates than cigarettes. Although we believe that this is sensible from the public health perspective, we cannot guarantee that regulators will continue this approach.

86
There can be no assurance that we will succeed in our efforts to replace cigarettes with RRPs or that regulation will allow us to commercialize RRPs in all markets, to communicate about our RRPs, including making scientifically substantiated risk-reduction claims, or to treat RRPs differently from cigarettes.

Legal Challenges to RRPs: We face various administrative and legal challenges related to certain RRP activities, including allegations concerning product classification, advertising restrictions, corporate communications, product coach activities, scientific substantiation, product liability, and unfair competition.  While we design our programs to comply with relevant regulations, we expect these or similar challenges to continue as we expand our efforts to commercialize RRPs and to communicate with the public. The outcomes of these matters may affect our RRP commercialization and public communication activities and performance in one or more markets.

In April 2020, affiliates of British American Tobacco plc ("BAT") filed a complaint against PMI, Philip Morris Products S.A., Altria Group, Inc., and its subsidiaries before the International Trade Commission ("ITC"). On September 29, 2021, the ITC issued its Final Determination ("FD"), Limited Exclusion Order ("LEO") and Cease and Desist Order ("CDO"). The ITC upheld the finding of infringement in the FD and found a subsequent violation. The ITC issued a LEO against Philip Morris Products S.A., prohibiting the importation of infringing tobacco heating articles and components thereof, and CDOs against Altria Client Services, LLC, and certain of its affiliates, which went into effect at the end of the 60-day Presidential review period on November 28, 2021. We have appealed the patent issues. Furthermore, lawsuits based on the same patent families have been repeatedly and universally rejected in European courts and the European Patent Office. The decision has no bearing outside the United States. For further details, see Note 10. Contingencies to our condensed consolidated financial statements.

Our RRP Business Development Initiatives: In December 2013, we established a strategic framework with Altria Group, Inc. (“Altria”) setting out terms on how the parties would collaborate to develop and commercialize e-vapor products and commercialize two of our RRPs in the U.S. In late 2018, Altria announced that it will participate in the e-vapor category only through another e-vapor company in which Altria acquired a minority interest. In September 2019, Altria's subsidiary, Philip Morris USA Inc. (“PM USA”), began commercialization of a version of our Platform 1 product in the U.S. Under the agreement, PM USA was required to achieve certain milestones in order to maintain its exclusive distribution right and additional milestones in order to extend the agreement after the initial 5-year term. On October 20, 2022, PMI announced that it had reached an agreement with Altria to terminate the companies' commercial relationship covering IQOS in the U.S., as of April 30, 2024. Thereafter, PMI will hold the full rights to commercialize IQOS in the U.S. For more details, see Note 2. Acquisitions and Note 10. Contingencies to our condensed consolidated financial statements.

In January 2020, we announced an agreement with KT&G, a leading tobacco and nicotine company in South Korea, for the commercialization of KT&G’s smoke-free products outside of South Korea on an exclusive basis. On January 30, 2023, we announced a renewal and extension of this arrangement. For more information, see Acquisitions and Other Business Arrangements below.

Other Developments: In September 2017, we announced our support of the Foundation for a Smoke-Free World (the "Foundation"). The Foundation is an independent, nonprofit organization dedicated to reducing the health impacts of smoking as set out in its Articles of Incorporation and its Bylaws. In September 2020, our pledge agreement with the Foundation was amended. We contributed $45 million in 2020, $40 million in 2021, $17.5 million in 2022, and had expected to contribute up to $35 million annually from 2023 through 2029, as specified in the amended pledge agreement. The Foundation and PMI have now agreed to terminate the existing pledge agreement and PMI has made final grant payments totaling $140 million, commensurate with the early termination of the pledge agreement.

Governmental Investigations

From time to time, we are subject to governmental investigations on a range of matters, including tax, customs, antitrust, advertising, and labor practices. We describe certain matters pending in Russia, South Korea and Thailand in Note 10. Contingencies to our condensed consolidated financial statements.

In November 2010, a World Trade Organization ("WTO") panel issued its decision in a dispute between the Philippines and Thailand, concerning a series of Thai customs and tax measures affecting cigarettes imported by Philip Morris (Thailand) Limited ("PM Thailand") into Thailand (see Note 10. Contingencies for additional information). The decision concluded that Thailand had no basis to find that PM Thailand's declared customs values and taxes paid were too low, as alleged by the Thai government, and created obligations for Thailand to revise its laws, regulations, or practices affecting the customs valuation and tax treatment of future cigarette imports. Thailand agreed to fully comply with the decision, but the Philippines asserts that to date, Thailand has not fully complied with the WTO panel decision and commenced challenges at the WTO Appellate Body. The WTO Appellate Body is not operational, and the appeals by Thailand are suspended indefinitely. In December 2020, the
87
Philippines and Thailand agreed to pursue facilitator-assisted discussions aimed at progressing and resolving outstanding issues and the countries have since agreed to seek the establishment of a bilateral consultative mechanism, with the goal of reaching a comprehensive settlement of their dispute, consistent with their rights and obligations under the WTO Agreements, as well as the recommendations and rulings of the WTO Dispute Settlement Body.

In July 2020, the Public Prosecutor’s office of Rome, Italy, notified our Italian subsidiary, Philip Morris Italia S.r.l. (“PM Italia”), as well as three former or current employees and a former external consultant of PM Italia in March 2020, that it concluded a preliminary investigation against them for alleged contravention of anti-corruption laws and related disruption of trade freedom. The Public Prosecutor alleges that the individuals involved promised certain personal favors to government officials from January to July of 2018 in exchange for favorable treatment for PM Italia, and that PM Italia lacked appropriate organizational controls to prevent the alleged actions by the individuals. In September 2020, the Prosecutor issued his indictment and referred the matter to the court. At the preliminary hearing held on May 11, 2021, the judge decided to refer all charges/defendants (including our affiliate) to trial. The first trial hearing took place on September 22, 2021. BAT has filed a civil claim against PM Italia claiming vicarious liability for any wrongdoing of its former or current employees and seeking EUR 50 million (approximately $55.2 million) in damages. The court admitted the claim and issued summons for PM Italia to appear in the case. After a series of postponements, on September 25, 2023, the court proceeded with the examination of the first witness, i.e., the former external consultant of PM Italia. The court also set the calendar for the next hearings (11 in total), that began in October 2023 and will continue until May 2024, for the examination of the defendants, all remaining witnesses and experts. PM Italia believes the charges brought against it by the Public Prosecutor are without merit and will defend them vigorously.


Impact of Inflation on Our Business and Mitigation Efforts

Like many other global companies, we have experienced inflationary pressures in 2022 and the first nine months of 2023, including: growing pressures on the cost of certain direct materials, wages, energy, transportation, and logistics as well as an increased cost of capital due to interest rate increases driven by the response to increased inflation. For the nine months ended September 30, 2023, this impact was approximately $500 million and we expect it to continue at least through the fourth quarter of 2023. This impact has been, and we expect it to continue to be, significantly offset by the positive elements of pricing, productivities and the mitigating factors as we progress through the year. The net result of the inflationary impacts and our efforts to mitigate these impacts were not material to PMI during these periods.

Inflationary impacts driven by higher wages have resulted from merit increases that reflect local inflation as we continuously evaluate our compensation and benefit offerings to be competitive with the current market. Increased transportation costs resulted from increased shipping rates for all modes of transportation (air, ocean and inland) due to ocean and air capacity constraints. Increases in cost of sales resulted from higher cost of direct materials due to the pass on of energy, transportation, labor and commodity price increases from suppliers as well as increases in utility costs, including gas and electricity prices, primarily in Europe resulting from the war in Ukraine. Raw materials such as tobacco leaf have longer inventory durations which resulted in insignificant inflationary impacts to our cost of sales in 2022; however tobacco leaf purchases in both 2022 and 2023 have been at higher prices due to inflationary impacts on fertilizer prices and labor costs, thus resulting in increases in the cost of inventory with corresponding impacts on our financial results expected in 2023. In addition, our cash flow from operations was impacted by the net working capital investment related to the procurement of tobacco leaf inventory and higher cost of direct materials, which is expected to continue in 2023.

We have taken several actions to mitigate these inflationary pressures. Mitigation efforts have included (i) indexation clauses related to commodity costs and energy pricing within contracts, (ii) tactical inventory purchases, (iii) identification of new suppliers in different geographical locations for incremental sourcing, (iv) increasing tobacco leaf inventory durations to secure additional volumes at favorable prices, (v) optimizing the mix of tobacco leaf origins and suppliers, (vi) continuous evaluation of shipping routes and methods of shipment, (vii) supplier negotiations, (viii) variable contract durations for energy costs, (ix) hedging strategies, and (x) other pricing, productivity and procurement initiatives.


Asset Impairment and Exit Costs

We discuss asset impairment and exit costs related to restructuring activities in Note 17. Asset Impairment and Exit Costs to our condensed consolidated financial statements.


88
Climate Change Laws and Regulations

While, to date, the effect of climate-related laws and regulations on PMI has not been material to our business, results of operations or financial conditions, consideration of environmental and climate-related laws and regulations is an integral aspect of PMI’s climate-related risk assessment process. To this end, we actively monitor the existing and potential impact on PMI of significant pending or existing climate change-related legislation, regulations, international accords, reporting frameworks, standards, principles, and other forms of guidance. Examples include, but are not limited to, the EU Emissions Trading System, the 2015 Paris Climate Agreement, recommendations of the Task Force on Climate-related Financial Disclosures, the SEC’s proposed rules regarding climate-related disclosures, the Task Force on Nature-related Financial Disclosures, the EU Corporate Sustainability Reporting Directive, the EU Taxonomy Regulation, the EU Deforestation Regulation, the EU Proposal for a Corporate Sustainability Due Diligence Directive, the International Sustainability Standards Board proposed standards, CDP, the GHG Protocol, and carbon tax programs in Europe and Canada.


Acquisitions and Other Business Arrangements

We discuss our acquisitions in Note 2. Acquisitions to our condensed consolidated financial statements.

KT&G

On January 30, 2023, PMI announced a long-term collaboration with KT&G, South Korea’s leading tobacco and nicotine manufacturer, to continue to commercialize KT&G’s innovative smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea).

The agreement covers fifteen years, to January 29, 2038, with performance-review cycles and associated commitments, based on volume, to be confirmed for each three-year period, to allow flexibility for evolving market conditions.

The agreement gives PMI continued exclusive access to KT&G’s smoke-free brands and product-innovation pipeline, including offerings for low- and middle-income markets, that will enhance PMI’s existing portfolio of smoke-free products.

Products sold under the agreement will be subject to assessment to ensure they meet the regulatory requirements in the markets where they are launched, as well as PMI’s high standards of quality and scientific substantiation. PMI and KT&G will seek any necessary regulatory approvals that may be required on a market-by-market basis.

Equity Investments

We discuss our equity investments in Note 14. Related Parties - Equity Investments and Other to our condensed consolidated financial statements.

Trade Policy

PMI complies with all applicable trade restrictions and requirements, including sanctions, in the markets in which it operates. We have taken appropriate actions in response to the latest sanctions to ensure full compliance with the relevant restrictions.

We are subject to various trade restrictions imposed by the U.S., the EU, Switzerland, the U.K., and other jurisdictions in which we do business (“Trade Sanctions”), including the trade and economic sanctions administered by the U.S. Department of the Treasury's Office of Foreign Assets Control (“OFAC”) and the U.S. Department of State. It is our policy to comply fully with these Trade Sanctions.

Pursuant to specific exemptions or licenses, or where sanctions do not apply to our business, PMI may make sales in countries subject to Trade Sanctions.

We do not do business or sell products in Iran, North Korea or Syria.

We sell cigarettes in Cuba under a distribution agreement. These sales are permitted by U.S. law under a License Exception for Agricultural Commodities, issued by the U.S. Department of Commerce (Bureau of Industry and Security), and specifically granted to our distributor.
89

Certain states within the U.S. have enacted legislation permitting or requiring state pension funds to divest or abstain from future investment in stocks of companies that do business with certain countries that are sanctioned by the U.S. Because we do business in certain of these countries, consistent with our policy to fully comply with Trade Sanctions and as described above, these state pension funds may have divested of our stock or may not invest in our stock. We do not believe such legislation has had a material effect on the price of our shares.

On June 24, 2021, the EU introduced sanctions regarding Belarus aimed at specific sectors of the Belarus economy, including the tobacco sector. Subsequently, seven non-EU countries (Norway, Iceland, Liechtenstein, North Macedonia, Bosnia and Herzegovina, Montenegro, and Albania) announced that they “aligned themselves” with the majority of the EU sanctions. Switzerland and the U.K. have also imposed sanctions similar in scope to the EU sanctions.

On August 9, 2021, the U.S. imposed blocking sanctions on certain Belarusian individuals and entities pursuant to an Executive Order, which expanded the bases for the imposition of sanctions, including, among others, by authorizing the imposition by OFAC of blocking sanctions on persons operating in the tobacco sector of the Belarus economy. In 2021-2023, the U.S., the EU, the U.K., Switzerland and several other jurisdictions supplemented their respective sanctions lists by including additional Belarusian sanctions targets.

Following the start of the conflict in Ukraine on February 24, 2022, the U.S., the EU, the U.K., Switzerland, Canada, Australia, New Zealand, Singapore, South Korea, Japan and other countries introduced extensive economic sanctions and export controls regarding Russia. While the introduced sanctions slightly vary from jurisdiction to jurisdiction, they are largely aligned. The restrictions are primarily targeted at the Russian financial, banking, oil, military, aviation and marine sectors. The U.S. has also introduced a prohibition on new investment in the Russian Federation by a U.S. person, wherever located, and authorized the imposition of blocking sanctions on anyone operating in the Russian manufacturing sector. The potential application of the latter for goods other than military goods remains unclear. Among sanctions targets are Russian political figures and military personnel, certain oligarchs and journalists, and companies operating in the above-mentioned sectors. Export to Russia of certain luxury goods, and goods and technology which might contribute to Russia’s technological enhancement was banned. Seven non-EU countries (Norway, Iceland, Liechtenstein, North Macedonia, Bosnia and Herzegovina, Montenegro, and Albania) announced that they “aligned themselves” with the majority of the EU sanctions. The U.S., the EU, Switzerland and Japan introduced additional trade restrictions banning, among many other goods, the export of certain non-tobacco materials used to produce cigarettes and heated tobacco consumables in Russia. The EU, Switzerland and the U.K. also prohibited technical assistance and other services related to restricted goods. The EU, Switzerland and the U.K. prohibited import into their territories of certain goods, including cigarettes, among others, which might generate significant revenues for Russia if they originate in Russia or are exported from Russia. The EU and Switzerland prohibited transfer and licensing of intellectual property rights in relation to restricted goods. Additionally, the EU, the U.S., the U.K., Switzerland, Canada, Australia, New Zealand and Ukraine sanctioned Mr. Igor Kesaev, a non-majority shareholder of Megapolis Distribution B.V.

The U.S. and the U.K. banned the export of electronic cigarettes and similar personal electric vaporizing devices to Russia. Certain countries also banned the delivery of services to Russia, such as information technology consultancy services, accounting and business and management consulting services, most with exceptions for subsidiaries of U.S., E.U., or Swiss owned companies.

Russia introduced certain countermeasures aimed at reducing the effect of Western sanctions. Countermeasures include restrictions on export of certain goods from Russia, including tobacco-related production equipment, restrictions on lending to foreign borrowers, repatriation of dividends and transactions with securities and real estate involving companies from “hostile” countries (i.e., those which introduced sanctions regarding Russia).

PMI continues to monitor the development of new sanctions and ensure full compliance.


Segment Operating Results – Three Months and Nine Months Ended September 30, 2023

The following discussion compares operating results within each of our segments for the three months and nine months ended September 30, 2023, with the three months and nine months ended September 30, 2022.

Unless otherwise stated, references to total industry, total market, our shipment volume and our market share performance reflect cigarettes and heated tobacco units.

90

Europe:
Financial Summary
Quarters Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues$ 3,672 $ 3,272 12.2 %6.1 %$400 $202 $— $176 $22 $— 
Operating Income$ 1,708 $ 1,415 20.7 %11.9 %$293 $124 $— $176 $11 $(18)

During the quarter, net revenues, excluding currency and acquisitions, increased by 6.1%, reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, primarily driven by higher HTU volume, partly offset by lower cigarette volume, as well as unfavorable cigarette and HTU mix.

Operating income, excluding currency and acquisitions, increased by 11.9%, primarily reflecting: a favorable comparison to 2022 of $100 million related to costs associated with the Swedish Match AB offer, and a favorable pricing variance; partly offset by higher marketing, administration and research costs (primarily due to inflationary impacts), as well as the 2023 charge related to the termination of a pledge agreement with the Foundation for a Smoke-Free World of $62 million. Volume/mix was slightly favorable, mainly reflecting higher HTU volume and favorable device mix, largely offset by lower cigarette volume, as well as unfavorable HTU and cigarette mix.
Financial Summary
Nine Months Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues$ 9,984 $ 9,805 1.8 %1.9 %$179 $(6)$— $353 $(168)$— 
Operating Income$ 4,446 $ 4,447 — %(1.5)%$(1)$64 $— $353 $(225)$(193)

For the nine months ended September 30, 2023, net revenues, excluding currency and acquisitions, increased by 1.9%, reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing, partly offset by lower HTU (net) pricing (primarily in the first-half of 2023 related to the supplemental tax surcharge in Germany) and lower device pricing; partially offset by unfavorable volume/mix, mainly due to lower cigarette volume, as well as unfavorable HTU and cigarette mix, partly offset by higher HTU volume and favorable device mix.

The pricing variance for the full year 2022 and the first nine months of 2023 was negatively impacted by the supplemental tax surcharge on heated tobacco units in Germany, which went into effect in 2022. The negative impact will continue until a ruling on the legality of the surcharge is issued. It is currently being assessed in court and the obligation to pay the surcharge is temporarily suspended. PMI currently accounts for the surcharge as a reduction in net revenues and in accrued liabilities in its results. The accrued liability balance will continue to increase with the continuation of the HTU selling activities and in the case of an unfavorable ruling would negatively impact PMI’s future cash provided by operating activities. A favorable ruling would positively impact future PMI’s operating results.

Operating income, excluding currency and acquisitions, decreased by 1.5%, primarily reflecting: unfavorable volume/mix, mainly due to the same factors as for net revenues; higher marketing, administration and research costs (mainly due to inflationary impacts and lower commercial investments in the prior year period); higher manufacturing costs (primarily due to inflationary impacts); the 2023 charge related to the termination of a pledge agreement with the Foundation for a Smoke-Free World ($62 million) and the 2023 charges for asset impairment and exit costs ($49 million), partly offset by the favorable pricing variance, lower charges in 2023 related to the war in Ukraine ($109 million) and a favorable comparison to 2022 costs associated with the Swedish Match AB offer ($124 million).
91

Europe - Total Market, PMI Shipment Volume and Market Share Commentaries

In the third quarter, the estimated total market for cigarettes and HTUs in the Region decreased by 2.9% to 146.3 billion units, reflecting a 4.5% decline for cigarettes, partly offset by a 13.9% increase for HTUs. The decrease in the estimated total market was notably due to France (down by 10.6%), Germany (down by 4.7%) and the UK (down by 17.6%).

For the nine months year-to-date, the estimated total market for cigarettes and HTUs in the Region decreased by 1.4% to 411.6 billion units, reflecting a 3.2% decline for cigarettes, partly offset by a 16.6% increase for HTUs. The decrease in the estimated total market was notably due to the Czech Republic (down by 9.0%), France (down by 8.4%), Germany (down by 2.3%) and the UK (down by 15.1%).

Europe Key DataThird-QuarterNine Months Year-to-Date
ChangeChange
20232022% / pp20232022% / pp
PMI Market Share
Cigarettes30.4 %30.8 %(0.4)30.4 %31.3 %(0.9)
Heated Tobacco Units8.6 %7.5 %1.1 8.8 %7.5 %1.3 
Total Europe39.0 %38.2 %0.8 39.1 %38.8 %0.3 
Note: Sum may not foot to total due to roundings

3977
In the third quarter, our total cigarette and HTU shipment volume in the Region decreased by 0.8% to 56.5 billion units, mainly due to France (down by 22.5%; or by 12.9% excluding the net unfavorable impact of estimated distributor inventory movements) and Germany (down by 5.4%), partly offset by Italy (up by 4.0%; or down by 0.5% excluding the net favorable impact of estimated distributor inventory movements) and Ukraine (up by 16.4%).

Our estimated HTU adjusted in-market sales volume in the Region increased by 16.1% in the quarter, reflecting the strong continued growth momentum for IQOS (including in Poland, where adjusted in-market sales volume for HTUs increased by 11.7%).

Our HTU share of the total cigarette and HTU market in the Region increased by 1.1 points, or by 1.3 points on an adjusted basis.
92

For the nine months year-to-date, our total cigarette and HTU shipment volume in the Region decreased by 1.6% to 161.2 billion units, mainly due to Germany (down by 6.0%, or by 1.5% excluding the net unfavorable impact of estimated wholesaler inventory movements) and Italy (down by 5.1%; or by 0.5% excluding the net unfavorable impact of estimated distributor inventory movements), partly offset by Poland (up by 9.0%).

Our estimated HTU adjusted in-market sales volume in the Region increased by 19.3% in the first nine months, including growth in Germany and Italy of 33.6% and 16.3%, respectively.

Our HTU share of the total cigarette and HTU market in the Region increased by 1.3 points, or by 1.5 points on an adjusted basis.


SSEA, CIS & MEA:
Financial Summary
Quarters Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues$ 2,777 $ 2,822 (1.6)%12.6 %$(45)$(401)$— $265 $118 $(27)
Operating Income$ 801 $ 1,086 (26.2)%1.9 %$(285)$(306)$— $265 $(74)$(170)
During the quarter, net revenues, excluding currency and acquisitions, increased by 12.6%, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, primarily driven by favorable cigarette mix.

Operating income, excluding currency and acquisitions, increased by 1.9%, primarily reflecting: the favorable pricing variance and a favorable comparison to 2022 costs associated with the Swedish Match AB offer of $61 million, largely offset by higher marketing, administration and research costs; higher manufacturing costs (primarily due to inflationary impacts); and unfavorable volume/mix, mainly due to an unfavorable cigarette volume impact and unfavorable cigarette mix; as well as the 2023 charge related to the termination of a pledge agreement with the Foundation for a Smoke-Free World of $44 million.

Financial Summary
Nine Months Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues $ 7,922 $ 7,781 1.8 %11.2 %$141 $(733)$— $751 $303 $(180)
Operating Income$ 2,371 $ 3,009 (21.2)%(6.3)%$(638)$(448)$— $751 $(188)$(753)

For the nine months ended September 30, 2023, net revenues, excluding currency and acquisitions, increased by 11.2%, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing, with HTU pricing also higher; and favorable volume/mix, primarily driven by favorable cigarette mix, as well as higher volume for HTUs and devices, partly offset by an unfavorable cigarette volume impact; partially offset by the 2023 termination of a distribution arrangement in the Middle East of $80 million and lower fees for certain distribution rights billed to customers in certain markets, both included in "Cost/Other" in the table above.

Operating income, excluding currency and acquisitions, decreased by 6.3%, primarily reflecting: the termination of a distribution arrangement, as noted for net revenues, higher marketing, administration and research costs; higher manufacturing costs (primarily due to inflationary impacts); unfavorable volume/mix, mainly due to an unfavorable cigarette volume impact
93
and unfavorable cigarette mix, partly offset by higher HTU volume; and the impact of lower fees for certain distribution rights, as noted for net revenues; as well as the 2023 charge related to the termination of a pledge agreement with the Foundation for a Smoke-Free World of $44 million and the 2023 charges for asset impairment and exit costs ($34 million); partially offset by the favorable pricing variance and a favorable comparison to 2022 costs associated with the Swedish Match AB offer of $76 million.

SSEA, CIS & MEA - Total Market, PMI Shipment Volume and Market Share Commentaries

In the third quarter, the estimated total market for cigarettes and HTUs in the Region decreased by around 3%, primarily reflecting a decline for cigarettes. The decrease in the estimated total market was mainly due to Bangladesh (down by 7.3%), Egypt (down by 29.3%), Indonesia (down by 3.9%), Pakistan (down by 28.5%) and the Philippines (down by 19.4%), partly offset by Turkey (up by 24.3%).

For the nine months year-to-date, the estimated total market for cigarettes and HTUs in the Region decreased by around 2%, primarily reflecting a decline for cigarettes. The decrease in the estimated total market was mainly due to Egypt (down by 20.6%), Indonesia (down by 5.0%), Pakistan (down by 37.8%) and the Philippines (down by 20.4%), partly offset by Turkey (up by 18.0%).

8083
In the third quarter, our total cigarette and HTU shipment volume in the Region increased by 3.4% to 95.5 billion units, mainly driven by Egypt (up by 28.0%) and Turkey (up by 27.6%), partly offset by the Philippines (down by 26.6%).

For the nine months year-to-date, our total cigarette and HTU shipment volume in the Region increased by 1.6% to 267.7 billion units, mainly driven by Algeria (up by 24.1%), Egypt (up by 19.3%) and Turkey (up by 24.5%), partly offset by Indonesia (down by 3.9%), Pakistan (down by 44.3%) and the Philippines (down by 26.4%).


94
EA, AU & PMI DF:

Financial Summary
Quarters Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues$ 1,571$ 1,40711.7 %15.3 %$164 $(51)$— $36 $179 $— 
Operating Income$ 753$ 53341.3 %54.0 %$220 $(68)$— $36 $170 $82 

During the quarter, net revenues, excluding currency and acquisitions, increased by 15.3%, reflecting: favorable volume/mix, mainly driven by higher HTU volume, partly offset by lower cigarette volume; and a favorable pricing variance, driven by higher combustible tobacco pricing.

Operating income, excluding currency and acquisitions, increased by 54.0%, mainly reflecting: favorable volume/mix, primarily driven by the same factors as for net revenues; lower supply chain costs (primarily related to Japan); and a favorable comparison to 2022 costs associated with the Swedish Match AB offer ($45 million); partly offset by the 2023 charge related to the termination of a pledge agreement with the Foundation for a Smoke-Free World ($27 million).


Financial Summary
Nine Months Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues$ 4,771 $ 4,458 7.0 %15.0 %$313 $(354)$— $73 $594 $— 
Operating Income$ 1,920 $ 1,746 10.0 %27.9 %$174 $(313)$— $73 $459 $(45)

For the nine months ended September 30, 2023, net revenues, excluding currency and acquisitions, increased by 15.0%, reflecting: favorable volume/mix, mainly driven by higher HTU volume, partly offset by lower cigarette volume and unfavorable smoke-free product mix (for HTUs and devices); and a favorable pricing variance, driven by higher combustible tobacco and device pricing, partly offset by lower HTU (net) pricing (primarily related to Japan).

Operating income, excluding currency and acquisitions, increased by 27.9%, mainly reflecting favorable volume/mix, primarily driven by higher HTU volume and the favorable impact on profitability of lower device volume, partly offset by lower cigarette volume and unfavorable HTU mix; the favorable pricing variance; lower supply chain costs (primarily related to Japan); a favorable comparison to 2022 costs associated with the Swedish Match AB offer ($56 million); partly offset by the 2023 charge related to the South Korea indirect tax ($204 million), the 2023 charge related to the termination of a pledge agreement with the Foundation for a Smoke-Free World ($27 million) and the 2023 charges for asset impairment and exit costs ($21 million).

EA, AU & PMI DF - Total Market, PMI Shipment Volume and Market Share Commentaries

In the third quarter, the estimated total market for cigarettes and HTUs in the Region, excluding China, increased by around 1%, reflecting growth for HTUs, largely offset by a decline for cigarettes. The increase in the estimated total market was mainly driven by International Duty Free (up by 35.7%), partly offset by Japan (down by 1.0%) and South Korea (down by 3.0%).

For the nine months year-to-date, the estimated total market for cigarettes and HTUs in the Region, excluding China, increased by around 2%, reflecting growth for HTUs, partly offset by a decline for cigarettes. The increase in the estimated total market was mainly driven by International Duty Free (up by 40.0%), partly offset by Australia (down by 14.9%), South Korea (down by 1.3%) and Taiwan (down by 4.2%).
95
10595
In the third quarter, our total cigarette and HTU shipment volume in the Region increased by 11.4% to 26.0 billion units, mainly driven by Japan (up by 17.6%).

PMI's estimated HTU adjusted in-market sales volume in the Region increased by 14.1% in the quarter, including growth in Japan of 11.7%.

For the nine months year-to-date, our total cigarette and HTU shipment volume in the Region increased by 11.8% to 78.0 billion units, mainly driven by Japan (up by 19.0%) and International Duty Free (up by 12.0%).

PMI's estimated HTU adjusted in-market sales volume in the Region increased by 16.0% in the first nine months, including growth in Japan of 14.9%.

Americas:

Financial Summary
Quarters Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues$ 478 $ 474 0.8 %(7.2)%$4 $38 $— $21 $(54)$(1)
Operating Income$ 5 $ 85 (94.1)%(49.4)%$(80)$(38)$— $21 $(41)$(22)

During the quarter, net revenues, excluding currency and acquisitions, decreased by 7.2%, primarily reflecting: unfavorable volume/mix, mainly due to lower cigarette volume and unfavorable cigarette mix; partly offset by a favorable pricing variance, driven by higher combustible tobacco pricing.

Operating income, excluding currency and acquisitions, decreased by 49.4%, mainly reflecting: unfavorable volume/mix, mainly due to the same factors as for net revenues; and higher marketing, administration and research costs (including incremental investments in the U.S. in preparation for smoke-free product commercialization); partly offset by the favorable pricing variance.

96
Financial Summary
Nine Months Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues$ 1,399 $ 1,367 2.3 %(2.1)%$32 $61 $— $94 $(115)$(8)
Operating Income$ 141 $ 336 (58.0)%(36.0)%$(195)$(74)$— $94 $(84)$(131)

For the nine months ended September 30, 2023, net revenues, excluding currency and acquisitions, decreased by 2.1%, primarily reflecting: unfavorable volume/mix, mainly due to lower cigarette volume and unfavorable cigarette mix; partly offset by a favorable pricing variance, driven by higher combustible tobacco pricing.

Operating income, excluding currency and acquisitions, decreased by 36.0%, mainly reflecting: higher marketing, administration and research costs (notably reflecting the same factors as in the quarter); unfavorable volume/mix, mainly due to the same factors as for net revenues and higher manufacturing costs; partly offset by the favorable pricing variance.

Americas - Total Market, PMI Shipment Volume and Market Share Commentaries

In the third quarter, the estimated total market for cigarettes and HTUs in the Region, excluding the U.S., decreased by around 2%, primarily reflecting a decline for cigarettes. The decrease in the estimated total market was mainly due to Argentina (down by 13.1%), Canada (down by 13.9%) and Mexico (down by 4.7%), partly offset by Brazil (up by 11.3%).

For the nine months year-to-date, the estimated total market for cigarettes and HTUs in the Region, excluding the U.S., decreased by around 1%, primarily reflecting a decline for cigarettes. The decrease in the estimated total market was mainly due to Argentina (down by 3.9%), Canada (down by 12.9%) and Mexico (down by 6.0%), partly offset by Brazil (up by 9.6%).

13800
In the third quarter, our total cigarette and HTU shipment volume in the Region decreased by 7.3% to 15.6 billion units, mainly due to Argentina (down by 15.8%) and Mexico (down by 7.8%), partly offset by Brazil (up by 7.5%).

For the nine months year-to-date, our total cigarette and HTU shipment volume in the Region decreased by 3.4% to 46.2 billion units, mainly due to Argentina (down by 6.9%) and Mexico (down by 9.1%), partly offset by Brazil (up by 12.7%).
97


Swedish Match:

As of November 11, 2022, PMI became the owner of a majority position in Swedish Match and started consolidating Swedish Match operating results. The business operations of our Swedish Match segment are evaluated separately from the geographical segments.

The third quarter 2023 results of PMI's Swedish Match segment include the impact of financial statement presentation reclassifications recorded on a year-to-date basis primarily associated with the alignment of accounting policies related to the company's post-acquisition evaluation of sales incentives, excise taxes and acquired contracts. Net revenues were unfavorably impacted by these reclassifications, some of which are associated with the first and second quarter of 2023. These reclassifications were not material to the condensed consolidated results of the current period or the period in which they relate.

Financial Summary
Quarters Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues$ 568 $ — — %— %$568 $— $568 $— $— $— 
Operating Income$ 140 $ — — %— %$140 $— $140 $— $— $— 

We recorded net revenues of $568 million in the Swedish Match segment for the quarter.

We recorded operating income of $140 million in the third quarter. This included $175 million related to the amortization of acquired intangibles.


Financial Summary
Nine Months Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues$ 1,814 $ — — %— %$1,814 $— $1,814 $— $— $— 
Operating Income$ 597 $ — — %— %$597 $— $597 $— $— $— 

For the nine months ended September 30, 2023, we recorded net revenues of $1.8 billion in the Swedish Match segment, with smoke-free products accounting for over 80% of the segment's total net revenues.

We recorded operating income of $597 million for the nine months ended September 30, 2023. This included $274 million related to the amortization of acquired intangibles and $18 million of charges related to an acquisition accounting-related item.

98
Swedish Match - PMI Shipment Volume Commentary
Swedish Match Oral Product Shipment Volume (1) (million cans)
Third-QuarterNine Months Year-to-Date
Nicotine Pouches20232022Change20232022Change
U.S.105.4 — — %268.5 — — %
Scandinavia7.5 — — %21.6 — — %
Other1.3 — — %3.6 — — %
Total Nicotine Pouches114.2 — — %293.8 — — %
Snus
Scandinavia55.2 — — %162.6 — — %
Other1.4 — — %5.2 — — %
Total Snus56.6 — — %167.8 — — %
Moist Snuff33.2 — — %102.5 — — %
Other0.9 — — %3.3 — — %
Total Oral Products204.9 — — %567.4 — — %
(1) Excluding U.S. chew


Swedish Match Combustible Tobacco Shipment Volume (million units)Third-QuarterNine Months Year-to-Date
20232022Change20232022Change
Cigars334.3 — — %1,241.4 — — %

For comparison purposes, the following commentaries assumed the inclusion of Swedish Match's third quarter and first nine months of 2022 shipment volume prior to our acquisition, thereby providing the comparability of Swedish Match's volume performance between periods. Volume comparisons versus Swedish Match's 2022 results reflect data sourced from its disclosures, available at www.swedishmatch.com/investors.

Third-Quarter

Swedish Match's total shipment volume for oral products increased by 20.5% versus its corresponding shipments of 170.0 million cans in the third quarter of 2022.

Nicotine pouch shipment volume increased by 58.8% compared to Swedish Match's third-quarter 2022 shipment volume of 71.9 million cans, mainly driven by 65.7% growth for ZYN in the U.S. In Scandinavia, shipment volume for nicotine pouches grew by 2.8%.

Shipment volume for snus declined by 11.6% compared to Swedish Match's third-quarter 2022 shipment volume of 64.0 million cans. The decrease was primarily due to Scandinavia, mainly reflecting the comparison versus a strong total market in the prior year period.

Cigar shipment volume declined by 21.3% compared to Swedish Match's third-quarter 2022 cigar shipment volume of 424.6 million units, primarily due to the impact of industry pricing effects.

Nine Months Year-to-Date

Swedish Match's total shipment volume for oral products increased by 15.4% versus its corresponding shipments of 491.9 million cans in the first nine months of 2022.
99

Nicotine pouch shipment volume increased by 50.3% compared to Swedish Match's September year-to-date 2022 shipment volume of 195.4 million cans, reflecting 55.9% growth for ZYN in the U.S. In Scandinavia, shipment volume for nicotine pouches grew by 7.1%.

Shipment volume for snus declined by 12.4% compared to Swedish Match's September year-to-date 2022 shipment volume of 191.7 million cans.

Swedish Match's performance in the September year-to-date period primarily reflected the same factors as in the quarter, coupled with the impact of excise tax and price increases on snus in Scandinavia in the first quarter (including related inventory movements).

Cigar shipment volume declined by 7.3% compared to Swedish Match's September year-to-date 2022 cigar shipment volume of 1,339.7 million units, mainly due to the same factor as in the quarter.


Wellness and Healthcare:

The operating results of PMI’s Vectura Fertin Pharma business are reported in the Wellness and Healthcare segment. The business operations of our Wellness and Healthcare segment are evaluated separately from the geographical segments.
Financial Summary
Quarters Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues$ 75 $ 57 31.6 %26.3 %$18 $3 $— $15 $— $— 
Operating Income / (Loss)$ (37)$ (151)75.5 %74.8 %$114 $1 $— $15 $— $98 

During the quarter, net revenues, excluding currency and acquisitions, increased by 26.3%, notably reflecting higher net revenues for smoking cessation products and select inhalation products.

The operating loss of $37 million in 2023 was primarily due to investments in research and development, as well as the amortization of acquired intangibles. The operating loss of $151 million in 2022 included a charge for impairment of other intangible assets of $112 million.

Financial Summary
Nine Months Ended September 30,Change
Fav./(Unfav.)		Variance
Fav./(Unfav.)
20232022TotalExcl.
Curr. & Acquis.		TotalCur-
rency		Acqui-sitionsPriceVol/
Mix		Cost/
Other
(in millions)
Net Revenues$ 237 $ 199 19.1 %20.1 %$38 $(2)$— $38 $— $2 
Operating Income / (Loss)$ (808)$ (216)-(100)%-(100)%$(592)$(1)$— $38 $— $(629)

For the nine months ended September 30, 2023, net revenues, excluding currency and acquisitions, increased by 20.1%, notably reflecting the same factors as in the quarter.

The operating loss of $808 million in 2023 was primarily due to an impairment charge for goodwill and other intangibles of $680 million in the second quarter, as well as investments in research and development and the amortization of acquired intangibles. The operating loss of $216 million in 2022 included a charge for impairment of other intangible assets of $112 million.
100

Financial Review

Cash Flow Highlights
515253
For the Nine Months Ended September 30,
(in millions)20232022
Net cash provided by operating activities$5,902 $7,710 
Net cash used in investing activities(3,030)(151)
Net cash used in financing activities(2,685)(6,071)

Net Cash Provided by Operating Activities
During the first nine months of 2023, net cash provided by operating activities was $5.9 billion as compared to $7.7 billion in the first nine months of 2022. Excluding unfavorable currency movements of $0.7 billion, the unfavorable variance of $1.1 billion was due primarily to higher working capital requirements.

The higher working capital requirements in the first nine months of 2023 as compared with the first nine months of 2022 were primarily due to more cash used in accrued liabilities and other current assets and more cash used for inventories mainly reflecting the timing of excise tax-paid inventory movements primarily related to excise tax increases and timing of the corresponding excise tax payments. Higher cash used for inventories is also impacted by the higher cost of tobacco leaf and other direct materials due to inflationary pressures (for further details, see “Impact of Inflation on Our Business and Mitigation Efforts” section of this MD&A), as well as tactical stock increases for certain direct materials. More cash used in accounts payable primarily reflects the 2023 payment for higher IQOS ILUMA device purchases in the fourth quarter of 2022 to meet the needs of ILUMA launches. These increases in the working capital requirements were partly offset by less cash used in accounts receivable mainly reflecting the timing of sales and cash collections.

For the full year 2023, we currently expect net cash provided by operating activities of around $10 billion at prevailing exchange rates, subject to year-end working capital requirements.

Net Cash Used in Investing Activities

During the first nine months of 2023, net cash used in investing activities increased by $2.9 billion as compared with the first nine months of 2022. This increase in cash used was primarily due to the remaining cash payment (including interest) to Altria Group, Inc. in July 2023 of $1.8 billion for PMI to reacquire the IQOS commercialization rights in the U.S., the unfavorable movements of $744 million in net investment hedges of Euro assets, which was principally related to changes in exchange rates between the Euro and the U.S. dollar, and higher capital expenditures. For further detail on our cash payment to Altria Group, Inc. and derivatives designated as net investment hedges, see Note 2. Acquisitions and Note 7. Financial Instruments.
101

Capital expenditures of $1.0 billion during the first nine months of 2023 increased by $280 million as compared with the first nine months of 2022. The 2023 capital expenditures were primarily related to our ongoing investments in smoke-free product manufacturing capacity. We expect total capital expenditures in 2023 to be approximately $1.3 billion, partly reflecting increased investments behind smoke-free product manufacturing capacity, including for ILUMA consumables and Swedish Match's portfolio.

Net Cash Used in Financing Activities

During the first nine months of 2023, net cash used in financing activities was $2.7 billion as compared to $6.1 billion in the first nine months of 2022. The decrease in net cash used was primarily due to higher net borrowings in 2023 reflecting proceeds from long-term debt issuances in 2023 of $10.0 billion, partly offset by repayment on the bridge facility related to the Swedish Match acquisition and lower net short-term borrowings (primarily commercial paper). The decrease was also due to a favorable comparison resulting from transactions with noncontrolling interests related to our Turkish subsidiaries (sale of noncontrolling stakes in 2023 compared to purchase of such stakes in 2022) and the suspension of share repurchases. The decrease was partially offset by payments to acquire remaining issued and outstanding shares in Swedish Match. For further details on the transactions with noncontrolling interests in our Turkish subsidiaries and our purchase of remaining Swedish Match shares, see Note 2. Acquisitions.

Debt and Liquidity

We define cash and cash equivalents as short-term, highly liquid investments, readily convertible to known amounts of cash that mature within a maximum of three months and have an insignificant risk of change in value due to interest rate or credit risk changes. As a policy, we do not hold any investments in structured or equity-linked products. Our cash and cash equivalents are predominantly held with institutions that have investment-grade long-term credit rating. As part of our cash management strategy and in order to manage counterparty exposure, we also enter into reverse repurchase agreements. Such agreements are collateralized with government or corporate securities held by a custodial bank and, at maturity, cash is paid back to PMI, and the collateral is returned to the bank. For the full-year 2022, the activities for such reverse repurchase agreements were not material. For the nine months ended September 30, 2023, we did not enter into such reverse repurchase agreements.

In a number of jurisdictions, including Argentina, Egypt and Russia, we are impacted by various capital controls and/or foreign currency exchange constraints that affect the ability of our subsidiaries in these jurisdictions to settle foreign currency denominated imports of goods and services and/or to pay dividends. These factors increase foreign currency devaluation risks, which may have a negative impact on our financial condition, net assets and results of operations in these jurisdictions.

We utilize long-term and short-term debt financing, including a commercial paper program that is regularly used to finance ongoing liquidity requirements, as part of our overall cash management strategy. Our ability to access the capital and credit markets as well as overall dynamics of these markets may impact borrowing costs. We expect that the combination of our long-term and short-term debt financing, the commercial paper program and the committed credit facilities, coupled with our operating cash flows, will enable us to meet our liquidity requirements.

In August 2021, we published a business transformation-linked financing framework (“Framework”), which integrates PMI's smoke-free transformation into its financing strategy. The Framework outlines the guidelines that we will follow in issuing business transformation-linked financing instruments in the debt capital and loan markets, which may include public notes offerings, private placements, loans, and other relevant financing instruments.

Credit Ratings – The cost and terms of our financing arrangements as well as our access to commercial paper markets may be affected by applicable credit ratings. At September 30, 2023, our credit ratings and outlook by major credit rating agencies were as follows:
   Short-term  Long-term  Outlook
Moody’s  P-1  A2  Stable
Standard & Poor’s  A-2  A-  Stable
Fitch  F1  A  Stable
102

Revolving Credit Facilities

At September 30, 2023, our committed revolving credit facilities were as follows:
Type (in billions)Committed
Revolving Credit
Facilities
364-day revolving credit, expiring January 30, 2024
$1.8 
Multi-year revolving credit, expiring February 10, 2026 (1)
2.0 
Multi-year revolving credit, expiring September 29, 2026 (2) (3)
2.5 
 
Total facilities 
$6.3 
(1) On January 28, 2022, we entered into an agreement, effective February 10, 2022, to amend and extend the term of our $2.0 billion multi-year revolving credit facility, for an additional year covering the period February 11, 2026 to February 10, 2027, in the amount of $1.9 billion.
(2) Includes business transformation-linked pricing adjustments that may result in the reduction or increase in both the interest rate and commitment fee under the credit agreement if PMI achieves, or fails to achieve, certain specified targets based on its business transformation goals.
(3) On September 20, 2022, we entered into an agreement, effective September 29, 2022, to amend and extend the term of our $2.5 billion multi-year revolving credit facility, for an additional year covering the period September 30, 2026 to September 29, 2027, in the amount of $2.3 billion. On September 20, 2023, we entered into an agreement, effective September 29, 2023, to amend and further extend the term to September 29, 2028.

At September 30, 2023, there were no borrowings under the committed revolving credit facilities, and the entire committed amounts were available for borrowing. Subject to market conditions, we currently expect to request a further extension of the terms of our 364-day revolving credit facility for an additional one-year period, in accordance with and subject to the terms and conditions of the relevant revolving credit facility agreement.

All banks participating in our committed revolving credit facilities have an investment-grade long-term credit rating from the credit rating agencies. We continuously monitor the credit quality of our banking group, and at this time we are not aware of any potential non-performing credit provider.

These committed revolving credit facilities do not include any credit rating triggers, material adverse change clauses or any provisions that could require us to post collateral. We expect to continue to meet our covenants.

In addition to the committed revolving credit facilities discussed above, PMI maintains certain short-term credit arrangements, including uncommitted credit lines, to primarily meet working capital needs. These credit arrangements amounted to approximately $2.6 billion at September 30, 2023, and approximately $1.9 billion at December 31, 2022. Borrowings under these arrangements and other bank loans amounted to $221 million at September 30, 2023, and $295 million at December 31, 2022.

Credit Facilities related to the Financing of the Swedish Match Acquisition

In connection with PMI's all-cash recommended public offer to the shareholders of Swedish Match, on May 11, 2022, PMI entered into a credit agreement relating to a 364-day senior unsecured bridge facility. The facility provided for borrowings up to an aggregate principal amount of $17 billion, expiring 364 days after the occurrence of certain events unless extended. On June 23, 2022, PMI entered into a €5.5 billion (approximately $5.8 billion at the date of signing) senior unsecured term loan credit agreement consisting of a €3.0 billion (approximately $3.2 billion at the date of signing) tranche expiring three years after the occurrence of certain events and a €2.5 billion (approximately $2.6 billion at the date of signing) tranche expiring on June 23, 2027. In connection with the term loan facility, the aggregate principal amount of commitments under the 364-day senior unsecured bridge facility was reduced from $17 billion to $11 billion. On November 11, 2022, PMI acquired a controlling interest of 85.87% of the total issued shares in Swedish Match and acquired 94.81% of its outstanding shares as of December 31, 2022. In accordance with the Swedish Companies Act, PMI subsequently exercised its right to compulsorily redeem the remaining shares for which acceptances were not received and obtained legal title to 100% of the shares in Swedish Match on February 17, 2023.

103
PMI borrowed $8.4 billion under the bridge facility by delivering notices of borrowing for advances of $7.9 billion and $0.5 billion on November 7, 2022 and November 10, 2022, respectively. All amounts borrowed under the bridge facility would become due on November 8, 2023 unless prepaid or such maturity date is extended pursuant to the terms of the bridge facility. On November 7, 2022, PMI also delivered notices of borrowing for advances totaling €5.5 billion under the term loan facility, of which €3.0 billion will become due on November 9, 2025 and €2.5 billion will become due on June 23, 2027 unless prepaid pursuant to the terms of the credit agreement. On November 21, 2022 and February 17, 2023, PMI repaid $4.0 billion and $4.4 billion, respectively, under the bridge facility. Effective February 20, 2023, the remaining outstanding commitments under the bridge facility were fully canceled and the bridge facility agreement was terminated in accordance with its terms. As of September 30, 2023 and December 31, 2022, the €5.5 billion (approximately $6 billion) term loan facility was fully drawn and remained outstanding. The proceeds under the bridge facility and the term loan facility were used, directly or indirectly, to finance the acquisition, including, the payment of related fees and expenses. For further details on this acquisition, see Note 2. Acquisitions.

Commercial Paper Program – We continue to have access to liquidity in the commercial paper market through programs in place in the U.S. and in Europe having an aggregate issuance capacity of $8.0 billion. At September 30, 2023, we had $1.9 billion of commercial paper outstanding. At December 31, 2022, we had $0.9 billion commercial paper outstanding. The average commercial paper balance outstanding during the first nine months of 2023 was $3.8 billion. The average commercial paper balance outstanding during 2022 was $3.1 billion.

Sale of Accounts Receivable – To mitigate credit risk and enhance cash and liquidity management, we sell trade receivables to unaffiliated financial institutions. For further details, see Note 15. Sale of Accounts Receivable to our condensed consolidated financial statements.

Supply Chain Financing – We engage with unaffiliated global financial institutions that offer a voluntary supply chain financing program to some of our suppliers. For further details, see Note 19. Supply Chain Financing to our condensed consolidated financial statements.

Debt – Our total debt was $47.7 billion at September 30, 2023 and $43.1 billion at December 31, 2022.

On February 10, 2023, we filed a shelf registration statement with the U.S. Securities and Exchange Commission, under which we may from time to time sell debt securities and/or warrants to purchase debt securities over a three-year period.
104

PMI's debt issuances in the first nine months of 2023 were as follows:
(in millions)
TypeFace Value Interest RateIssuanceMaturity
U.S. dollar notes(a)$1,2504.875%February 2023February 2026
U.S. dollar notes(a)$1,0004.875%February 2023February 2028
U.S. dollar notes(a)$1,5005.125%February 2023February 2030
U.S. dollar notes(a)$1,5005.375%February 2023February 2033
U.S. dollar notes(a) (b)$4504.875%May 2023February 2026
U.S. dollar notes(a) (c)$5504.875%May 2023February 2028
U.S. dollar notes(a) (d)$7005.125%May 2023February 2030
U.S. dollar notes(a) (e)$7505.375%May 2023February 2033
U.S. dollar notes(f)$6505.250%September 2023September 2028
U.S. dollar notes(f)$7005.500%September 2023September 2030
U.S. dollar notes(f)$1,0005.625%September 2023September 2033
(a) Interest is payable semi-annually, commencing in August 2023
(b) These notes are a further issuance of the 4.875% notes issued in February 2023
(c) These notes are a further issuance of the 4.875% notes issued in February 2023
(d) These notes are a further issuance of the 5.125% notes issued in February 2023
(e) These notes are a further issuance of the 5.375% notes issued in February 2023
(f) Interest is payable semi-annually, commencing in March 2024

On February 17, 2023, PMI applied a portion of the net proceeds of the debt issuances to prepay $4.4 billion under its bridge facility, which represented all borrowings outstanding under the bridge facility. PMI used a portion of the May 2023 net proceeds to pay the remaining cash consideration due in accordance with the terms of its agreement with Altria. For further details on our agreement with Altria, see Note 2. Acquisitions. The remaining net proceeds of the February and May 2023 offerings, as well as the September 2023 offering have been or will be used for general corporate purposes.

Guarantees – At September 30, 2023, we have guarantees of our own performance, which are primarily related to excise taxes on the shipment of our products. There is no liability in the condensed consolidated financial statements associated with these guarantees. These guarantees have not had, and are not expected to have, a significant impact on PMI’s liquidity. In October 2020, we guaranteed an obligation for a then equity method investee that was subsequently divested in 2022. For further details, see Note 10. Contingencies to our condensed consolidated financial statements.

Swedish Match Notes Consent Solicitation and PMI Guarantee

On June 15, 2023, our wholly owned subsidiary, Swedish Match AB ("Swedish Match"), initiated a public consent solicitation of eligible holders of certain outstanding series of its notes to amend certain terms and conditions of these respective notes. The eligible noteholders provided the requisite irrevocable consent instructions voting in favor of the amendments, which were subsequently passed by way of extraordinary resolution at the noteholders’ meeting held on July 28, 2023. As a result of the passage of the extraordinary resolution, Philip Morris International Inc. entered into a guarantee, which guarantees unconditionally and irrevocably to the noteholders the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the principal, premium, if any, and interest on the notes.

Equity and Dividends

We discuss our stock awards as of September 30, 2023 in Note 4. Stock Plans to our condensed consolidated financial statements.

On June 11, 2021, our Board of Directors authorized a new share repurchase program of up to $7 billion, with target spending of $5 billion to $7 billion over a three-year period. On July 22, 2021, we began repurchasing shares under this new share repurchase program. From July 22, 2021 through March 31, 2022, we repurchased 10.5 million shares of our common stock at a cost of approximately $1.0 billion. During the first three months of 2022, we repurchased 2.0 million shares of our common stock at a cost of $199 million.

105
On May 11, 2022, we announced the suspension of our three-year share repurchase program following the recommended public offer to acquire the outstanding shares of Swedish Match from its shareholders. Prior to the suspension of the program, we made no share repurchases during the second quarter of 2022. We do not currently anticipate restarting our share repurchase program during 2023.

Dividends paid in the first nine months of 2023 were $5.9 billion. During the third quarter of 2023, our Board of Directors approved a 2.4% increase in the quarterly dividend to $1.30 per common share. As a result, the present annualized dividend rate is $5.20 per common share.

Market Risk
Counterparty Risk - We predominantly work with financial institutions with strong short- and long-term credit ratings as assigned by Standard & Poor’s and Moody’s. These banks are also part of a defined group of relationship banks. Non-investment grade institutions are only used in certain emerging markets to the extent required by local business needs. We have a conservative approach when it comes to choosing financial counterparties and financial instruments. As such, we do not invest or hold investments in any structured or equity-linked products. The majority of our cash and cash equivalents is currently invested with maturities of less than 30 days.
We continuously monitor and assess the credit worthiness of all our counterparties.
Derivative Financial Instruments - We operate in markets primarily outside of the United States of America, with manufacturing and sales facilities in various locations around the world. Consequently, we use certain financial instruments to manage our foreign currency and interest rate exposure. We use derivative financial instruments principally to reduce our exposure to market risks resulting from fluctuations in foreign exchange and interest rates by creating offsetting exposures. We are not a party to leveraged derivatives and, by policy, do not use derivative financial instruments for speculative purposes.
See Note 7. Financial Instruments to our condensed consolidated financial statements for further details on our derivative financial instruments and the related collateral arrangements.

Contingencies
See Note 10. Contingencies to our condensed consolidated financial statements for a discussion of contingencies.


Cautionary Factors That May Affect Future Results

Forward-Looking and Cautionary Statements
We may from time to time make written or oral forward-looking statements, including statements contained in filings with the SEC, in reports to stockholders and in press releases and investor webcasts. You can identify these forward-looking statements by use of words such as "strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "aspires," "estimates," "intends," "projects," "aims," "goals," "targets," "forecasts" and other words of similar meaning. You can also identify them by the fact that they do not relate strictly to historical or current facts.
We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Our RRPs constitute a relatively new product category that is less predictable than our mature cigarette business. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements and whether to invest in or remain invested in our securities. In connection with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, we are identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by us; any such statement is qualified by reference to the following cautionary statements. We elaborate on these and other risks we face throughout this document, particularly in the "Business Environment" section. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider the following to be a complete discussion of all potential risks or uncertainties. We do not undertake to update any forward-looking statement that we may make from time to time, except in the normal course of our public disclosure obligations.
106

Overall Business Risks
We may be unsuccessful in our attempts to introduce reduced-risk products, and regulators may not permit the commercialization of these products or the communication of scientifically substantiated information and claims.
Our key strategic priorities are to: (i) develop and commercialize products that present less risk of harm to adult smokers who switch to reduced-risk products versus continued cigarette smoking; and (ii) encourage and educate current adult smokers who would otherwise continue to smoke cigarettes to switch to those products. For our efforts to be successful, we must:
•develop RRPs that adult smokers who would otherwise continue to smoke cigarettes find to be satisfying alternatives to smoking;
•for those adult smokers, our goal is to offer RRPs with a scientifically substantiated risk-reduction profile that approaches as closely as possible the risk-reduction profile associated with smoking cessation;
•substantiate the reduction of risk for the individual adult smoker and the reduction of harm to the population as a whole, based on scientific evidence of the highest standard that is made available for scrutiny and review by external independent scientists and relevant regulatory bodies; and
•advocate for the development of science-based regulatory frameworks for the development and commercialization of RRPs, including the communication of scientifically substantiated information to enable adult smokers to make better choices.

We might not succeed in our efforts. If we do not succeed, but others do, or if heat-not-burn products are inequitably regulated compared to other RRP categories without regard to the totality of the scientific evidence available for such products, we may be at a competitive disadvantage. In addition, actions of some market entrants, such as the inappropriate marketing of e-vapor products to youth, as well as alleged health consequences associated with the use of certain e-vapor products, may unfavorably impact public opinion and/or mischaracterize all e-vapor products or other RRPs to consumers, regulators and policy makers without regard to the totality of scientific evidence available for specific products. This may impede our efforts to advocate for the development of science-based regulatory frameworks for the development and commercialization of RRPs. We cannot predict whether regulators will permit the sale and/or marketing of RRPs with scientifically substantiated information and claims. Such restrictions could limit the success of our RRPs.

The WHO study group on tobacco product regulation published their eighth report on the scientific basis of tobacco product regulation in May 2021. The report is based on a review of scientific evidence related to novel and emerging nicotine and tobacco products, such as electronic nicotine delivery systems ("ENDS"), electronic non-nicotine delivery systems and HTPs on a number of scientific topics. The report concludes by making a number of policy recommendations on HTPs and ENDS that, if implemented, could restrict both the availability of these products and the access to accurate information about them. In August 2021, the FCTC Secretariat published two reports on novel and emerging tobacco products to the Ninth Session of the CoP of the FCTC, which are not materially different from the WHO study group report. Substantive decisions based on these reports were deferred to the Tenth Session of the CoP ("CoP 10"), currently scheduled to take place in November of 2023. In May 2023, the WHO’s Executive Board noted the report summarizing the eleventh meeting of the WHO Study Group on Tobacco Products Regulation ("TobReg"). The full report from this meeting is not yet published. In June 2023, during the virtual press conference on global health issues, the WHO Director General called on governments to strictly regulate nicotine-containing products, like e-cigarettes. In August 2023, TobReg issued its ninth report, including recommendations on nicotine pouches, which were in line with previous policy recommendations on regulating flavors in tobacco and nicotine products. It is not possible to predict whether or to what extent these developments will be reflected in decisions adopted at CoP 10, following deliberations. The WHO’s reports are not binding on the WHO Member States nor on parties to the FCTC.

Additionally, any claims, regardless of merit, challenging our research and clinical data available to date, may impact the development of science-based regulatory frameworks for the commercialization of the RRP category and the commercialization of the RRP category in general.

Our RRPs and commercial activities for these products are designed for, and directed toward, current adult smokers and users of nicotine-containing products, and not for non-smokers or youth. We put significant effort to restrict access of our products from non-smokers or youth. Nevertheless, technological, operational, regulatory and/or commercial setbacks might impact the implementation or effectiveness of youth access prevention mechanisms and surrounding infrastructure. If nonetheless there is a significant usage of our products or competitive products among youth or non-smokers, even in situations over which we have no control, our reputation and credibility may suffer, the regulatory approach to our products may become more restrictive, and our efforts to advocate for the development of science-based regulatory frameworks for the development and commercialization
107
of RRPs may be significantly impacted.

Moreover, the FDA’s premarket tobacco product and modified risk tobacco product authorizations of two versions of our Platform 1 product are subject to strict marketing, reporting and other requirements. Although we have received these authorizations from the FDA, there is no guarantee that the product will remain authorized for sale in the U.S., or that new versions of the product (Platform 1 or other smoke-free platforms) will receive necessary authorizations, particularly if there is a significant uptake in youth or non-smoker initiation.

Premarket tobacco applications for certain ZYN products, which are currently marketed in the U.S., were submitted in March 2020. The FDA has not completed its review of such applications but concluded that such ZYN products can continue to be marketed in the U.S., subject to the FDA’s enforcement discretion, because the applications were submitted prior to a September 9, 2020 deadline. We also submitted additional premarket tobacco applications for other ZYN products after the deadline, and we are unable to market these products until the FDA authorizes such applications. There is no guarantee that the ZYN products will receive the necessary authorizations from the FDA or that the FDA will allow us to continue to sell the ZYN products currently in the market, pending its review of the applications.

The financial and business performance of our reduced-risk products is less predictable than our cigarette business.

Our RRPs are novel products in a new category, and the pace at which adult smokers adopt them may vary, depending on the competitive, regulatory, fiscal and cultural environment, and other factors in a specific market. There may be periods of accelerated growth and periods of slower growth for these products, the timing and drivers of which may be more difficult for us to predict versus our mature cigarette business. The impact of this lower predictability on our projected results for a specific period may be significant, particularly during the early stages of this new product category, due to geopolitical or macroeconomic events that negatively impact RRP availability or adoption, which in turn may have a material adverse effect on our results of operation.

We may be unsuccessful in our efforts to differentiate reduced-risk products and cigarettes with respect to taxation.

To date, we have been largely successful in demonstrating to regulators that our RRPs are not cigarettes due to the absence of combustion, and accordingly they are generally taxed either as a separate category or as other tobacco products, which typically yields more favorable tax rates than cigarettes. Nevertheless, we are unable to predict whether regulators will be issuing new regulations under which RRPs will be equally taxed in line with other tobacco products such as ordinary cigarettes. However, if we cease to be successful in these efforts, RRP unit margins may be materially adversely affected, which in turn may have a material adverse effect on our results of operation.

Consumption of tax-paid cigarettes continues to decline in many of our markets.

This decline is due to multiple factors, including increased taxes and pricing, governmental actions, the diminishing social acceptance of smoking, health concerns, competition, continuing economic and geopolitical uncertainty, and the continuing prevalence of illicit products. These factors and their potential consequences are discussed more fully below and in the "Business Environment" section in this Form 10-Q. A continuous decline in the consumption of cigarettes could have a material adverse effect on our revenue and profitability, which in turn may have a material adverse effect on our ability to fund our smoke-free transformation.
Cigarettes are subject to substantial taxes. Significant increases in cigarette-related taxes have been proposed or enacted and are likely to continue to be proposed or enacted in numerous jurisdictions. These tax increases may disproportionately affect our profitability and make us less competitive versus certain of our competitors.
Tax regimes, including excise taxes, sales taxes and import duties, can disproportionately affect the retail price of cigarettes versus other combustible tobacco products, or disproportionately affect the relative retail price of our cigarette brands versus cigarette brands manufactured by certain of our competitors. Because our portfolio is weighted toward the premium-price cigarette category, tax regimes based on sales price can place us at a competitive disadvantage in certain markets. Furthermore, our volume and profitability may be adversely affected in these markets.
In addition, increases in cigarette taxes are expected to continue to have an adverse impact on our sales of cigarettes, due to resulting lower consumption levels, a shift in sales from manufactured cigarettes to other combustible tobacco products and from the premium-price to the mid-price or low-price cigarette categories, where we may be under-represented, from local sales to cross-border purchases of lower price products, or to illicit products such as contraband, counterfeit and "illicit whites."
108
Each of these risks could have a material adverse effect on our business, operations, results of operations, revenues, cash flow and profitability.
Our business faces significant governmental action aimed at increasing regulatory requirements with the goal of reducing or preventing the use of tobacco or nicotine-containing products.
Governmental actions, combined with the diminishing social acceptance of smoking and private actions to restrict smoking, have resulted in reduced industry volumes for our products in many of our markets, and we expect that such factors will continue to reduce consumption levels and will increase down-trading and the risk of counterfeiting, contraband, "illicit whites" and cross-border purchases. Significant regulatory developments will continue to take place over the next few years in most of our markets, driven principally by the FCTC. Since it came into force in 2005, the FCTC has led to increased efforts by tobacco control advocates and public health organizations to promote increasingly restrictive regulatory measures on the marketing and sale of tobacco products to adult smokers. Regulatory initiatives that have been proposed, introduced or enacted by governmental authorities in various jurisdictions include:

•restrictions on or licensing of outlets permitted to sell cigarettes;
•the levying of substantial and increasing tax and duty charges;
•restrictions or bans on advertising, marketing and sponsorship;
•the display of larger health warnings, graphic health warnings and other labeling requirements;
•restrictions on packaging design, including the use of colors, and mandating plain packaging;
•restrictions on packaging and cigarette formats and dimensions;
•restrictions or bans on the display of tobacco product packaging at the point of sale and restrictions or bans on vending machines;
•generation sales bans, under which the sale of certain tobacco or nicotine products to people born after a certain year would be prohibited;
•requirements regarding testing, disclosure and performance standards for tar, nicotine, carbon monoxide and other smoke constituents;
•disclosure, restrictions, or bans of tobacco product ingredients, including bans on the flavors of certain tobacco products;
•increased restrictions on smoking and use of tobacco and nicotine-containing products in public and work places and, in some instances, in private places and outdoors;
•restrictions or prohibitions of novel tobacco or nicotine-containing products or related devices;
•elimination of duty free sales and duty free allowances for travelers;
•restrictions in terms of importing or exporting our products impacting our logistics activities and ability to ship our products;
•encouraging litigation against tobacco companies; and
•excluding tobacco companies from transparent public dialogue regarding public health and other policy matters.
Our financial results could be materially affected by regulatory initiatives resulting in a significant decrease in demand for our brands. More specifically, requirements that lead to a commoditization of tobacco products or impede adult consumers' ability to convert to our RRPs, as well as any significant increase in the cost of complying with new regulatory requirements, could have a material adverse effect on our financial results.

Changes in the earnings mix and changes in tax laws may result in significant variability in our effective tax rates. Our ability to receive payments from foreign subsidiaries or to repatriate royalties and dividends could be restricted by local country currency exchange controls and other regulations.

We are subject to income tax laws in the United States and numerous foreign jurisdictions. Changes in the U.S. tax system, including significant increases in the U.S. corporate income tax rate and the minimum tax rate on certain earnings of foreign subsidiaries could be enacted. Such changes could have a material adverse impact on our effective tax rate thereby reducing our net earnings. Further changes in the tax laws of foreign jurisdictions could arise as a result of the base erosion and profit shifting project undertaken by the Organisation for Economic Co-operation and Development, which recommended changes to numerous long-standing tax principles. If implemented, such changes, as well as changes in taxing jurisdictions’ administrative
109
interpretations, decisions, policies, or positions, could also have a material adverse impact on our effective tax rate thereby reducing our net earnings. In future periods, our ability to recover deferred tax assets could be subject to additional uncertainty as a result of such developments. Furthermore, changes in the earnings mix or applicable foreign tax laws may result in significant variability in our effective tax rates. 

As a result of Russia’s invasion of Ukraine, certain taxing jurisdictions, including the U.S., have proposed punitive tax legislation applicable to companies doing business in Russia, which could also have a material adverse impact on our effective tax rate if enacted, thereby reducing our net earnings.

Because we are a U.S. holding company, our most significant source of funds is distributions from our non-U.S. subsidiaries. Certain countries in which we operate have adopted or could institute currency exchange controls and other regulations or policies that limit or prohibit our local subsidiaries' ability to convert local currency into U.S. dollars or to make payments outside the country. This could subject us to the risks of local currency devaluation and business disruption.

Disruptions in the credit markets or changes to our credit ratings may adversely affect our business.

We currently generate significant cash flows from ongoing operations and have access to global credit markets through our various short- and long term financing activities. Our financial performance, credit ratings, interest rates, the stability of financial institutions with which we partner, geopolitical or national developments, the stability and liquidity of the credit markets and the state of the global economy could affect the availability and cost of financing.

Disruption in the credit markets, limitations on our ability to borrow or a downgrade of our current credit rating could increase our future borrowing costs which could materially and adversely affect our financial condition and results of operations. In addition, tighter or more volatile credit markets may lead to business disruptions for certain of our suppliers, contract manufacturers or trade customers which could, in turn, adversely impact our business, results of operations, cash flow and financial condition.

Risks Related to the Impact of the War in Ukraine on our Business

Our business, results of operations, cash flows and financial position may be adversely impacted by the continuation and consequences of the war in Ukraine.

In 2022, Russia accounted for around 9% of our total cigarette and heated tobacco unit shipment volume, and around 7% of our total net revenues. Ukraine accounted for around 2% of our total cigarette and heated tobacco unit shipment volume, and around 1% of our total net revenues. Historically, we also produced finished goods in Ukraine for export and manufactured products in Russia. In 2022, as a result of Russia’s invasion of Ukraine, we suspended planned investments and scaled down our manufacturing operations in Russia.

The short and long-term implications of the Russian invasion of Ukraine for our operations in those countries are impossible to predict at this time. The likelihood of retaliatory action by the Russian government against companies, including PMI, as a result of actions and statements made in response to the Russian invasion or otherwise, including the possibility of legal action against us or our employees; the deprivation of rights in, or access to, our Russian assets; or nationalization of foreign businesses or assets (including cash reserves held in Russia and intangible assets such as trademarks), is impossible to predict. We are continuously assessing the evolving situation in Russia, including regulatory constraints in the market entailing very complex terms and conditions that must be met for any divestment transaction to be granted approval by the authorities, and restrictions resulting from international regulations. In the event of a divestment, our ability to fully realize the value of the business would likely be subject to material impairment. In Ukraine, there is no way to know when and to what extent we will be able to fully normalize our operations or to what extent our workforce, facilities, inventory, and other assets will remain intact. These developments have and will continue to have a material adverse impact on our business, results of operations, cash flows and financial position, and may result in impairment charges.

The conflict also continues to elevate the likelihood of supply chain disruptions, both in the region and globally, and may inhibit our ability to timely source materials and services needed to make and sell our products. For example, historically we sourced certain finished goods, production materials and components from both Russia and Ukraine, including printed materials and filters, and the invasion has, and may continue to, disrupt the availability of and impact our supply chain for these materials. These disruptions, to the extent we are unable to find alternative sources or otherwise address these supply constraints, may impact the availability and cost of our products in other markets, which would adversely impact our business, results of operations, cash flows and financial position, and may result in impairment charges. Furthermore, the imposition of various restrictions on transactions with parties from certain jurisdictions, the ban on exports of various products, and other
110
economic and financial restrictions may adversely affect certain third parties with which we do business in Russia, such as customers, suppliers, intermediaries, service providers and banks.

The broader consequences of the invasion are also impossible to predict, but could include reputational consequences, further sanctions, financial or currency restrictions, punitive tax law changes, embargoes, regional instability, and geopolitical shifts, as well as adverse effects on macroeconomic conditions, security conditions, currency exchange rates, and financial markets. Given the nature of our business and global operations, such geopolitical instability and uncertainty could increase the costs of our materials and operations; reduce demand for our products; have a negative impact on our supply chains, manufacturing capabilities, or distribution capabilities; increase our exposure to currency fluctuations; constrain our liquidity or our ability to access capital markets; create staffing or operations difficulties; or subject us to increased cyber-attacks. While we will continue to monitor this fluid situation and develop contingency plans as necessary to address any disruptions to our business operations as they develop, the extent of the conflict’s effect on our business and results of operations as well as the global economy, cannot be predicted.

The conflict may also have the effect of heightening many other risks disclosed in this Form 10-Q, any of which could adversely affect our business, results of operations, cash flows or financial position. Such risks could affect, without limitation, the achievement of our strategic priorities, including achievement of our RRP growth targets; the availability of third-party manufacturing resources; the availability of attractive acquisition and strategic business opportunities and our ability to fully realize the benefits of these transactions; our ability to attract, motivate, and retain the best global talent; and our loss of revenue from counterfeiting and similar illicit activities.

Risks Related to Sourcing and Distribution of Products, Services and Materials

Use of third-parties may negatively impact the distribution, quality, and availability of our products and services, and we may be required to replace third-party contract distributors, manufacturers or service providers.

We increasingly rely on third-parties and their subcontractors/suppliers, sometimes concentrated in a specific geographic area, for product distribution and to manufacture some of our products and product parts (particularly, the electronic devices and accessories), as well as to provide services, including to support our finance, commercialization and information technology processes. While many of these arrangements improve efficiencies and decrease our operating costs, they also diminish our direct control. Such diminished control may lead to disruption in the distribution of our products and may have a material adverse effect on the quality and availability of products or services, our supply chain, and the speed and flexibility in our response to changing market conditions and adult consumer preferences, all of which may place us at a competitive disadvantage. In addition, we may be unable to renew these agreements on satisfactory terms for numerous reasons, including government regulations, and the distribution of our products may be disrupted in certain markets or our costs may increase significantly if we must replace such third parties with other partners or our own resources.

The effects of climate change and legal or regulatory responses related to climate change may have a negative impact on our business and results of operations.

While we seek to mitigate our business risks associated with climate change by establishing environmental goals and standards and seeking business partners, including within our supply chain, that are committed to operating in ways that protect the environment or mitigate environmental impacts, we recognize that there are inherent climate-related risks wherever business is conducted. Among other potential impacts, climate change could influence the quality and volume of the agricultural products we rely on, including tobacco, due to a number of factors beyond our control, including more frequent variations in weather patterns, extreme weather events causing unexpected downtime and inventory losses, other adverse weather conditions, and governmental restrictions on trade, all of which may lead to disruption of operations at factories, warehouses and other premises.

Furthermore, risks related to natural ecosystems degradation, decreased agricultural productivity in certain regions of the world, biodiversity loss, water resource depletion and deforestation, which are partially driven or exacerbated by climate change, may disrupt our business operations or those of our suppliers and business partners.

There is an increased focus by foreign, federal, state and local regulatory and legislative bodies regarding environmental policies relating to climate change. New climate-related legal or regulatory requirements may lead to additional carbon taxation, energy price increases, new compliance costs, increased distribution and supply chain costs, and other expenses impacting our cost of operation. Even if we make changes to align ourselves with legal or regulatory requirements, we may still be subject to significant penalties if such laws or regulations are interpreted and applied in a manner inconsistent with our practices.

111
Government mandated prices, production control programs, and shifts in crops driven by economic conditions may increase the cost or reduce the quality of the tobacco and other agricultural products used to manufacture our products.

As with other agricultural commodities, the price of tobacco leaf and cloves can be influenced by imbalances in supply and demand and the impacts of natural disasters and pandemics such as COVID-19. Tobacco production in certain countries is subject to a variety of controls, including government mandated prices and production control programs. Changes in the patterns of demand for agricultural products could cause farmers to produce less tobacco or cloves. Any significant change in tobacco leaf and clove prices, quality and quantity could affect our profitability and our business.

Risks Related to our International Operations

Because we have operations in numerous countries, our results may be adversely impacted by economic, regulatory and political developments, natural disasters, pandemics or conflicts.

Some of the countries in which we operate face the threat of civil unrest and can be subject to regime changes. In others, nationalization, terrorism, conflict and the threats of war or acts of war may have a significant impact on the business environment. Factors beyond our control, such as, without limitation, natural disasters, extreme weather events, pandemics (including COVID-19), economic, political, regulatory, acts of war or threats of war, or other developments could disrupt or increase the expenses related to our supply chain, manufacturing capabilities, distribution capabilities, or the energy and other utility services required to operate our factories, warehouses, and other premises. Our business continuity plans and other safeguards might not always be effective to fully mitigate their impact. For example, the global pandemic outbreak of the COVID-19 virus in 2020 created significant societal and economic disruption and the closure of stores, factories and offices, restrictions on manufacturing, distribution and travel, and supply chain disruptions, among other impacts. Such developments – including the impact on energy prices and availability in the EU and elsewhere resulting from the invasion of Ukraine by Russia – could cause significant volume declines in our duty-free business and certain other key markets; disrupt or delay our distribution, manufacturing or supply chain; increase currency volatility; increase costs of our materials and operations and lead to loss of property or equipment that are critical to our business in certain markets and difficulty in staffing and managing our operations, all of which could have a material adverse effect on our business, operations, volumes, revenue, cash flows, financial position, net earnings and profitability. We discuss additional risks associated with Russia's invasion of Ukraine and climate change, above.

In certain markets, we are dependent on governmental approvals of various actions such as price changes, and failure to obtain such approvals could impair growth of our profitability.

In addition, despite our high ethical standards and rigorous controls and compliance policies aimed at preventing and detecting unlawful conduct, given the breadth and scope of our international operations, we may not be able to detect all potential improper or unlawful conduct by our employees and partners. Such improper or unlawful conduct (actual or alleged) could lead to litigation and regulatory action, cause damage to our reputation and that of our brands, and result in substantial costs.

Our reported results could be adversely affected by unfavorable currency exchange rates and currency fluctuations could impair our competitiveness. Our results could also be adversely affected by capital controls or by foreign currency exchange constraints or devaluations.

We conduct our business primarily in local currency and, for purposes of financial reporting, the local currency results are translated into U.S. dollars based on average exchange rates prevailing during a reporting period. Foreign currencies may fluctuate significantly against the U.S. dollar reducing our net revenues, operating income and EPS. Our primary local currency cost bases may be different from our primary currency revenue markets, and U.S. dollar fluctuations against various currencies may have disproportionate negative impact on net revenues as compared to our gross profit and operating income margins.

Capital controls and/or foreign currency exchange constraints may affect the ability of our subsidiaries in impacted jurisdictions to settle foreign currency denominated imports of goods and services and/or to pay dividends. These factors may also increase foreign currency devaluation risks, which may have a negative impact on our net assets and results of operations in these jurisdictions. All of which could have a material adverse effect on our financial condition, cash flows, net earnings, and profitability.

112
A sustained period of elevated inflation across the markets in which we operate could result in higher operating and financing costs and lead to reduced demand for our products.

Increasing inflationary pressures may result in significant increases to our expenses, including direct materials, wages, energy, and transportation costs. While we take actions, wherever possible, to reduce the impact of the effects of inflation, in cases of sustained and elevated inflation across several of our major markets, it may be difficult to effectively control the increases to our costs. In recent periods, increased inflation has and may continue to lead to growing pressures on the cost of certain direct materials, wages, energy, transportation, and logistics as well as an increased cost of capital due to interest rate increases driven by the response to increased inflation. Increasing inflationary pressures may also negatively impact consumer purchasing power, which could result in reduced demand for our products. We expect inflation to remain elevated through 2023. If we are unable to increase our prices sufficiently or take other actions to mitigate the effect of increasing inflationary pressures, our profitability and financial position could be negatively impacted.

Risks Related to Legal Challenges and Investigations

Litigation related to tobacco use and exposure to environmental tobacco smoke could substantially reduce our profitability and could severely impair our liquidity.

There is litigation related to tobacco products pending in certain jurisdictions in which we operate. Damages claimed in some tobacco-related litigation are significant and, in certain cases in Brazil, Canada, and Nigeria, range into the billions of U.S. dollars. We anticipate that new cases will continue to be filed. The FCTC encourages litigation against tobacco product manufacturers. It is possible that our consolidated results of operations, cash flows or financial position could be materially adversely affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. We face various administrative and legal challenges related to certain RRP activities, including allegations concerning product classification, advertising restrictions, corporate communications, product coach activities, scientific substantiation, product liability, antitrust, and unfair competition.  While we design our programs to comply with relevant regulations, we expect these or similar challenges to continue as we expand our efforts to commercialize RRPs and to communicate with the public. The outcomes of these matters may affect our RRP commercialization and public communication activities and performance in one or more markets. Also, see Note 10. Contingencies to our condensed consolidated financial statements for a discussion of pending litigation.
From time to time, we are subject to governmental investigations on a range of matters.
Investigations include allegations of contraband shipments of cigarettes, allegations of unlawful pricing activities within certain markets, allegations of underpayment of income taxes, customs duties and/or excise taxes, allegations of false and misleading usage of descriptors, allegations of unlawful advertising, and allegations of unlawful labor practices. We cannot predict the outcome of those investigations or whether additional investigations may be commenced, and it is possible that our business could be materially adversely affected by an unfavorable outcome of pending or future investigations. See Note 10. Contingencies—Other Litigation to our condensed consolidated financial statements and the “Management's Discussion and Analysis of Financial Condition and Results of Operations—Operating Results by Business Segment—Business Environment—Governmental Investigations” in this Form 10-Q for a description of certain governmental investigations to which we are subject.
We may be unable to adequately protect our intellectual property rights, and disputes relating to intellectual property rights could harm our business.
Our intellectual property rights are valuable assets, their protection is important to our business, and that protection may not be equally available in every country in which we operate or in which our products are sold.  If the steps we take to protect our intellectual property rights globally, including through applying for, prosecuting, maintaining and enforcing, where relevant, a combination of trademark, design, copyright, patent, trade secrets and other intellectual property rights, are inadequate, or if others infringe or misappropriate our intellectual property rights, notwithstanding legal protection, our business, financial condition, and results of operations could be adversely impacted. Moreover, failing to manage our existing and/or future intellectual property may place us at a competitive disadvantage. Intellectual property rights of third parties may limit our ability to develop, manufacture and/or commercialize our products in one or more markets. Competitors or other third parties may claim that we infringe on their intellectual property rights. Any such claims, regardless of merit, could divert management’s attention; be costly, disruptive, time-consuming and unpredictable and expose us to significant litigation costs and damages; and may impede our ability to develop, manufacture and/or commercialize new RRPs and improve our products, and thus have a material adverse effect on our revenue and our profitability. In addition, if, as a result, we are unable to manufacture or sell our RRPs or improve their quality in one or more markets, our ability to convert adult smokers to our RRPs
113
in such markets would be adversely affected. See Note 10. Contingencies— Other Litigation to our condensed consolidated financial statements for a description of certain intellectual property proceedings.

Risks Related to our Competitive Environment

We face intense competition, and our failure to compete effectively could have a material adverse effect on our profitability and results of operations.

We are subject to highly competitive conditions in all aspects of our business. We compete primarily on the basis of product quality, brand recognition, brand loyalty, taste, R&D, innovation, packaging, customer service, marketing, advertising and retail price and, increasingly, adult smoker willingness to convert to our RRPs. The competitive environment and our competitive position can be significantly influenced by weak economic conditions, erosion of consumer confidence, competitors' introduction of lower-price products or innovative products, novel products which given their taste characteristics may be more commercially successful, higher tobacco product taxes, higher absolute prices and larger gaps between retail price categories, and product regulation that diminishes the ability to differentiate tobacco products and restricts adult consumer access to truthful and non-misleading information about our RRPs.

Competitors in our industry include British American Tobacco plc, Japan Tobacco Inc., Imperial Brands plc, new market entrants, particularly with respect to innovative products, several regional and local tobacco companies and, in some instances, state-owned tobacco enterprises, principally in Algeria, Egypt, China, Taiwan, Thailand and Vietnam. Some competitors have different profit, volume and regulatory objectives, and some international competitors may be less susceptible than PMI to changes in currency exchange rates. Certain new market entrants in the non-combustible product category may alienate consumers from innovative products through inappropriate marketing campaigns, messaging and inferior product satisfaction, and without scientific substantiation based on appropriate R&D protocols and standards. The growing use of digital media could increase the speed and extent of the dissemination of inaccurate and misleading information about our RRPs, all of which could have a material adverse effect on our profitability and results of operations.
We may be unable to anticipate changes in adult consumer preferences.
Our business is subject to changes in adult consumer preferences, which may be influenced by local economic conditions, accessibility to our products and availability of accurate information related to our products.
To be successful, we must: 
•promote brand equity successfully;
•anticipate and respond to new adult consumer trends;
•ensure that our products meet our quality standards;
•develop new products and markets and broaden brand portfolios;
•improve productivity;
•educate and encourage adult smokers to convert to our RRPs;
•ensure effective adult consumer engagement, including communication about product characteristics and usage of RRPs;
•provide excellent customer care;
•ensure adequate production capacity to meet demand for our products; and
•be able to protect or enhance margins through price increases.
In periods of economic uncertainty, adult consumers may tend to purchase low-price brands, and the volume of our premium-price and mid-price brands and our profitability could be materially adversely impacted as a result. Such down-trading trends may be reinforced by regulation that limits branding, communication and product differentiation. In addition to economic uncertainty (including recessions and inflation) unusual weather events and global or local epidemics, endemics or pandemics (such as COVID-19) could result in changes to the preferences of our adult consumers and lower demand for our products, particularly for our mid-price or premium-price brands.

114
Our ability to grow profitability may be limited by our inability to introduce new products, enter new markets or improve our margins through higher pricing and improvements in our brand and geographic mix.
Our profit growth may be materially adversely impacted if we are unable to introduce new products or enter new markets successfully, to raise prices or to improve the proportion of our sales of higher margin products and in higher margin geographies.

We may be unable to expand our brand portfolio through successful acquisitions or the development of strategic business relationships, and the intended benefits from our investments may not materialize.
One element of our growth strategy is to expand our brand portfolio and market positions through selective acquisitions and the development of strategic business relationships. Acquisition and strategic business development opportunities are limited and present risks of failing to achieve efficient and effective integration, strategic objectives and/or anticipated revenue improvements and cost savings. There is no assurance that we will be able to acquire attractive businesses or enter into strategic business relationships on favorable terms ahead of our competitors, or that such acquisitions or strategic business development relationships will be accretive to earnings or improve our competitive position. In addition, we may not have a controlling position in certain strategic investments or relationships, which could impact the extent to which the intended financial growth and other benefits from these investments or relationships may ultimately materialize.
Our ability to achieve our strategic goals may be impaired if we fail to attract, motivate and retain the best global talent and effectively align our organizational design with the goals of our transformation.
To be successful, we must continue transforming our culture and ways of working, align our talent and organizational design with our increasingly complex business needs, and innovate and transform to a consumer-centric business. We compete for talent, including in areas that are new to us such as digital, information technology, and life sciences, with companies in the consumer products, technology, pharmaceutical and other sectors that enjoy greater societal acceptance. As a result, we may be unable to attract, motivate and retain the best global talent with the right degree of diversity, experience and skills to achieve our strategic goals.

Risks Related to Illicit Trade

We lose revenues as a result of counterfeiting, contraband, cross-border purchases, "illicit whites," non-tax-paid volume produced by local manufacturers, and counterfeiting of our smoke-free products' devices and consumables.

Large quantities of counterfeit cigarettes are sold in the international market. We believe that Marlboro is the most heavily counterfeited international cigarette brand, although we cannot quantify the revenues we lose as a result of this activity. In addition, our revenues are reduced by contraband, cross-border purchases, "illicit whites" and non-tax-paid volume produced by local manufacturers. Our revenues and consumer satisfaction with our smoke-free products' devices and consumables may be materially adversely affected by counterfeit products that do not meet our product quality standards and scientific validation procedures.

115
Risks Related to Cybersecurity and Data Governance

We are significantly dependent on our and third party information technology networks and systems, and a cybersecurity incident or attack against those networks or systems may adversely impact our business and operations.

We and our business partners heavily rely on information technology networks and systems, including those connected to the Internet, to help manage business processes and operations, including the collection, storage, interpretation, and processing of confidential, sensitive, personal and other data; internal and external communications; marketing and e-commerce activities; the manufacture, sale, and distribution of our products; management of third-party business relationships; engagement with governmental authorities; innovation through research and development; and other activities necessary for business operations. Some of these information systems and networks are developed, supplied, or managed by third-party service providers that may make us vulnerable to “supply chain” style cyberattacks. The failure or disruption of our information technology networks and systems, or those managed by third-party service providers or owned by our business partners and used in furtherance of PMI’s business, due to cybersecurity attacks; unauthorized attempts to corrupt or extract data; security vulnerabilities; misconfigurations; human error; or failure or inability by us, third-parties, or our business partners to adhere to cybersecurity industry best practices, could place us at a competitive disadvantage, cause reputational damage, impact our operations, result in data breaches, significant business disruption, litigation, regulatory action including significant fines or penalties, financial impact, loss of revenue or assets including our intellectual property, personal, confidential, or sensitive data.

Cyberattacks, security incidents and vulnerabilities impacting PMI, newly acquired companies, our business partners, or our third-party providers, continue to dynamically evolve in sophistication and volume, making it difficult for us to predict probability, frequency, and impact severity of security incidents. Further, it may be inherently difficult to detect vulnerabilities during due diligence, for long periods of time, or soon enough to mitigate exploitation. There can be no assurance that such security incidents or vulnerabilities will not have a material adverse effect on us in the future.

We continue to make investments in administrative, technical, and physical safeguards to maintain information security protections in line with industry standards and best practices. We evaluate the adequacy of preventative actions to reduce security incidents on an ongoing basis.

Our safeguards may not, however, be effective in mitigating the impact of service disruptions or other failures of these information technology networks and systems. Failure to timely respond and mitigate security incidents could result in wide-ranging business interruptions. Such security incidents could place us at a competitive disadvantage; result in financial impacts, a loss of revenue, assets, including our intellectual property, personal or other sensitive data; result in litigation and regulatory action including significant fines or penalties; impact our operations; cause damage to our reputation and that of our brands; and result in significant remediation and other costs.

Our or our business partners’ failure or inability to adhere to privacy, data, artificial intelligence and information security laws could result in business disruption, loss of reputation and consumer trust, litigation, regulatory action including significant fines or penalties, financial impact, and loss of revenue, assets or personal, confidential, or sensitive data.

An actual or alleged failure to comply with complex and changing privacy, data, artificial intelligence and information security laws and regulations under the EU General Data Protection Regulation, various U.S. state and federal laws, and other similar privacy and information security laws across the jurisdictions in which PMI operates, such as the failure to protect personal data; implement appropriate technological and reasonable security measures; implement and maintain appropriate safeguards for personal data being transferred internationally; respect the privacy rights of data subjects; provide sufficient detailed notices of personal data processing; retrieve consent and provide opt-outs; meet stringent timeframe requirements for incident reporting to regulatory authorities; comply with artificial intelligence regulations; and others, could have a material adverse effect on us, subject us to substantial fines and/or legal challenges, and/or harm our business, reputation, financial condition, or operating results. Such laws and regulations across the jurisdictions in which PMI operates may vary, resulting in inconsistent or conflicting legal obligations.

Risks Related to the Acquisitions of Swedish Match, OtiTopic, Inc. ("OtiTopic"), Fertin Pharma A/G ("Fertin Pharma") and Vectura Group Ltd. ("Vectura") (collectively, the "Acquisitions")

As previously disclosed in this Form 10-Q, since 2021, we acquired Swedish Match, OtiTopic, Fertin Pharma and Vectura, and subsequently launched Vectura Fertin Pharma, our new Wellness and Healthcare business consolidating OtiTopic, Fertin Pharma and Vectura.

116
We may be unable to successfully integrate and realize the expected benefits from the Acquisitions.

The successful integration of the acquired businesses and their operations into those of our own and our ability to realize the benefits of the Acquisitions are subject to a number of risks and uncertainties, many of which are not in our control. The risks and uncertainties relating to integrating the businesses acquired include, among other things: (i) the challenge of integrating complex organizations, systems, operating procedures, industry specific compliance programs, technology, networks and other assets of the businesses that we acquire, and the costs related to such integration efforts; (ii) the possibility that we are unable to gain access to differentiated intellectual property, proprietary technology, and pharmaceutical development expertise as anticipated by these Acquisitions, and thus fail to realize our desired entry into additional smoke-free, wellness, therapeutic and healthcare platforms; (iii) the challenge of integrating the cultures and business practices of each of Swedish Match, Fertin Pharma and Vectura to our culture and business practices, which if not managed correctly, could lead to difficulties in retaining key management and other key employees; and (iv) the challenge of achieving a successful integration as a result of our affiliation to our combustible product portfolio. In addition, even if we are able to successfully integrate, the anticipated benefits of the Acquisitions may not be realized fully, or at all, or may take longer to realize than expected. Furthermore, the success of the Acquisitions also depends on Swedish Match's continued growth in highly competitive markets and on the success of the research and development efforts of Vectura Fertin Pharma, including the ability to obtain regulatory approval for new products, and the ability to commercialize or license these new products developed by them. Moreover, our combustible product portfolio may stand in the way of introducing and growing new product categories and may prevent our business from developing a long-term sustainable ecosystem of products in the wellness, therapeutic, and healthcare categories.

The businesses that we acquired in the Acquisitions may have liabilities that are not known to us.

The businesses that we have acquired may have liabilities that we were unable to identify, or were unable to discover, in the course of performing our due diligence investigations during the Acquisitions thereof. There is no assurance that the indemnification available to us under the respective acquisition agreements, will be sufficient in amount, scope or duration to fully offset the possible liabilities associated with the respective business or property that we will assume upon consummation of each Acquisition. Furthermore, the acquisition of Swedish Match was structured as a direct purchase of shares from Swedish Match shareholders and therefore did not include an acquisition agreement or indemnification rights. Any such liabilities, individually or in the aggregate, could have a material adverse effect on our business, financial condition and results of operations.

Accounting adjustments related to the Acquisitions could adversely affect our financial results.

We have accounted for the completion of the Acquisitions using the acquisition method of accounting. Differences between preliminary estimates and the final acquisition accounting may occur, and these differences could have a material impact on the consolidated financial statements and our future results of operations and financial position in combination with the businesses acquired. Furthermore, given the nature of the assets being acquired in the Acquisitions, we may not be able to avoid future impairments of those assets, which may also have a material impact on our future results of operation and financial position.

PMI, Swedish Match and Vectura Fertin Pharma may be subject to uncertainties that could adversely affect our respective businesses, and adversely affect the financial results of our combined businesses.

Our success following these Acquisitions will depend in part upon our ability and the ability of each of Swedish Match and Vectura Fertin Pharma to maintain business relationships. Uncertainty about the effect of the Acquisitions on customers, suppliers, employees and other constituencies of each of Swedish Match, Fertin Pharma and Vectura, may have a material adverse effect on us and/or the businesses that we have acquired through the Acquisitions. Customers, suppliers and others who do business with Swedish Match or Vectura Fertin Pharma may delay or defer business decisions, decide to terminate, modify or renegotiate their relationships, or take other actions as a result of the Acquisitions, which could negatively affect the revenues, earnings and cash flows of our company or the businesses that we have acquired. Regulatory changes may have an impact on the development and/or commercialization of products which originate from the Swedish Match or Vectura Fertin Pharma value chains, as well as our revenues, earnings and cash flow. If we are unable to maintain the business and operational relationships of Swedish Match, or of Vectura Fertin Pharma, our financial position, results of operations or cash flows upon combining with these companies could be adversely affected.

117
Item 4. Controls and Procedures.

PMI carried out an evaluation, with the participation of PMI’s management, including PMI’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of PMI’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based upon that evaluation, PMI’s Chief Executive Officer and Chief Financial Officer concluded that PMI’s disclosure controls and procedures are effective. There have been no changes in PMI’s internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, PMI’s internal control over financial reporting.



118

Part II - OTHER INFORMATION
 
Item 1.Legal Proceedings.
See Note 10. Contingencies of the Notes to the Condensed Consolidated Financial Statements included in Part I – Item 1 of this report for a discussion of legal proceedings pending against Philip Morris International Inc. and its subsidiaries.

Item 1A. Risk Factors.
Information regarding Risk Factors appears in “MD&A – Cautionary Factors That May Affect Future Results,” in Part I – Item 2 of this Form 10-Q and in Part I – Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2022.
119

Item 2.Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
Our share repurchase activity for each of the three months in the quarter ended September 30, 2023, was as follows:
 
PeriodTotal Number
of Shares
Repurchased		Average
Price Paid
Per Share		Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs		Approximate Dollar
Value of Shares that
May Yet be Purchased
Under the Plans or
Programs
July 1, 2023 –
July 31, 2023 (1)		— $— 10,481,359 $6,016,847,275 
August 1, 2023 –
August 31, 2023 (1)		— $— 10,481,359 $6,016,847,275 
September 1, 2023 –
September 30, 2023 (1)		— $— 10,481,359 $6,016,847,275 
Pursuant to Publicly
  Announced Plans
  or Programs		— $— 
July 1, 2023 –
July 31, 2023 (2)		4,513 $97.69 
August 1, 2023 –
August 31, 2023 (2)		2,410 $99.68 
September 1, 2023 –
September 30, 2023 (2)		7,049 $96.37 
For the Quarter Ended September 30, 202313,972 $97.37 
 

(1)On June 11, 2021, our Board of Directors authorized a new share repurchase program of up to $7 billion, with target spending of $5 billion to $7 billion over a three-year period that commenced in July 2021. These share repurchases have been made pursuant to the $7 billion program. On May 11, 2022, we announced the suspension of our three-year share repurchase program following the recommended public offer to acquire the outstanding shares of Swedish Match from its shareholders. For further details on the Swedish Match acquisition, see Note 2. Acquisitions of Part I, Item 1 of this Form 10-Q.

(2)Shares repurchased represent shares tendered to us by employees who vested in restricted and performance share unit awards and used shares to pay all, or a portion of, the related taxes.

120

Item 5.    Other Information.

During the three months ended September 30, 2023, no director or officer of PMI adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as such terms are defined in Item 408(a) of Regulation S-K.
121

Item 6.Exhibits.     
10.1
31.1
31.2
32.1
32.2
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema.
101.CALXBRL Taxonomy Extension Calculation Linkbase.
101.DEFXBRL Taxonomy Extension Definition Linkbase.
101.LABXBRL Taxonomy Extension Label Linkbase.
101.PREXBRL Taxonomy Extension Presentation Linkbase.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)


122
Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

PHILIP MORRIS INTERNATIONAL INC.
/s/ EMMANUEL BABEAU
Emmanuel Babeau
Chief Financial Officer
October 26, 2023
123
 EX-31.1 2 pm-ex311_093023xq3.htm EX-31.1 Document

Exhibit 31.1
Certifications
I, Jacek Olczak, certify that:
 
1.I have reviewed this quarterly report on Form 10-Q of Philip Morris International Inc.;
 
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: October 26, 2023
/s/ JACEK OLCZAK
Jacek Olczak
Chief Executive Officer
-1-
 EX-31.2 3 pm-ex312_093023xq3.htm EX-31.2 Document

Exhibit 31.2
Certifications
I, Emmanuel Babeau, certify that:
 
1.I have reviewed this quarterly report on Form 10-Q of Philip Morris International Inc.;
 
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: October 26, 2023
/s/ EMMANUEL BABEAU
Emmanuel Babeau
Chief Financial Officer
- 1 -

 EX-32.1 4 pm-ex321_093023xq3.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Philip Morris International Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jacek Olczak, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1)        the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)        the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ JACEK OLCZAK
Jacek Olczak
Chief Executive Officer
October 26, 2023


-1-
 EX-32.2 5 pm-ex322_093023xq3.htm EX-32.2 Document

Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Philip Morris International Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Emmanuel Babeau, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1)        the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)        the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ EMMANUEL BABEAU
Emmanuel Babeau
Chief Financial Officer
October 26, 2023

 

-1-
 EX-101.SCH 6 pm-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed Consolidated Statements of Earnings link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed Consolidated Statements of Comprehensive Earnings link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity link:presentationLink link:calculationLink link:definitionLink 0000010 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000011 - Statement - Condensed Consolidated Statements of Earnings (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Background and Basis of Presentation: link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Acquisitions: link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - War in Ukraine: link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Stock Plans: link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Benefit Plans: link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Goodwill and Other Intangible Assets, net: link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Financial Instruments: link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Earnings Per Share: link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Segment Reporting: link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Contingencies: link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Income Taxes: link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Indebtedness: link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Accumulated Other Comprehensive Losses: link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Related Parties - Equity Investments and Other: link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Sale of Accounts Receivable: link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Product Warranty: link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Asset Impairment and Exit Costs: link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Leases: link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Supply Chain Financing: link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Background and Basis of Presentation: (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Acquisitions: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - War in Ukraine: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Stock Plans: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Benefit Plans: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Goodwill and Other Intangible Assets, net: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Financial Instruments: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Earnings Per Share: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Segment Reporting: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Contingencies: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Indebtedness: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Accumulated Other Comprehensive Losses: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Related Parties - Equity Investments and Other: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Receivables, Loans, Notes Receivable, and Others (Tables) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Product Warranty: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Asset Impairment and Exit Costs: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Leases: (Tables) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Background and Basis of Presentation: (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Acquisitions: (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Acquisitions: (Swedish Match AB) (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Acquisitions: (Pro Forma) (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - War in Ukraine: Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - War in Ukraine: Pretax Charges (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Stock Plans: (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Stock Plans: (RSU Awards) (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Stock Plans: (PSU Awards) (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Benefit Plans: (Components of Pension and Other Employee Benefits Costs) (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Benefit Plans: (Components of Net Periodic Benefit Cost) (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Benefit Plans: (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Goodwill and Other Intangible Assets, net: (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Goodwill and Other Intangible Assets, net: (Movement in Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Goodwill and Other Intangible Assets, net: (Other Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Goodwill and Other Intangible Assets, net: (Other Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Financial Instruments: (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Financial Instruments: (Notional Amounts of Outstanding Derivative Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Financial Instruments: (Fair Value of Derivative Contracts) (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Financial Instruments: (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Financial Instruments: (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Earnings Per Share: (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Segment Reporting: (Segment Data) (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Segment Reporting: (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Contingencies: (Tobacco-Related Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Contingencies: (Number of Tobacco Related Cases Pertaining to Combustible Products Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Contingencies: (Verdicts and Post-Trial Developments) (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Contingencies: (Smoking and Health Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Contingencies: (Health Care Cost Recovery Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - Contingencies: (Label-Related Cases) (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - Contingencies: (Public Civil Actions) (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - Contingencies: (Other Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - Contingencies: (Third-Party Guarantees) (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - Income Taxes: (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - Indebtedness: (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954522 - Disclosure - Indebtedness: (Short-Term Borrowings) (Details) link:presentationLink link:calculationLink link:definitionLink 9954523 - Disclosure - Indebtedness: (Schedule of Long-Term Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - Indebtedness: (Schedule of Fair Value) (Details) link:presentationLink link:calculationLink link:definitionLink 9954525 - Disclosure - Indebtedness: (Debt Issuances Outstanding) (Details) link:presentationLink link:calculationLink link:definitionLink 9954526 - Disclosure - Indebtedness: (Schedule of Credit Facilities) (Details) link:presentationLink link:calculationLink link:definitionLink 9954527 - Disclosure - Accumulated Other Comprehensive Losses: (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) link:presentationLink link:calculationLink link:definitionLink 9954528 - Disclosure - Related Parties - Equity Investments and Other: (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954529 - Disclosure - Related Parties - Equity Investments and Other: (Balance Sheet and Earnings Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 9954530 - Disclosure - Sale of Accounts Receivable: (Details) link:presentationLink link:calculationLink link:definitionLink 9954531 - Disclosure - Product Warranty: (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954532 - Disclosure - Product Warranty: (Movement in Product Warranty Obligations) (Details) link:presentationLink link:calculationLink link:definitionLink 9954533 - Disclosure - Asset Impairment and Exit Costs: (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954534 - Disclosure - Asset Impairment and Exit Costs: (Asset Impairment and Exit Costs by Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 9954535 - Disclosure - Asset Impairment and Exit Costs: (Movement in Exit Cost Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 9954536 - Disclosure - Leases: (Details) link:presentationLink link:calculationLink link:definitionLink 9954537 - Disclosure - Supply Chain Financing: (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 pm-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 pm-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 pm-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Principal amount Committed credit facilities Line of Credit Facility, Maximum Borrowing Capacity Damages awarded Loss Contingency, Damages Awarded, Value Cash effects of changes, net of the effects from acquired companies: Increase (Decrease) in Operating Capital [Abstract] Trade receivables sold and derecognized that remain uncollected Trade Receivables Sold and Derecognized that Remained Uncollected Trade accounts receivable sold and derecognized from the consolidated balance sheets that remain uncollected by unaffiliated financial institutions. Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Investment, Name [Domain] Investment, Name [Domain] Derivative contracts impact on the condensed consolidated statements of earnings and other comprehensive earnings Schedule Of Derivative Instruments Recognized In Statement Of Earnings And Other Comprehensive Income [Table Text Block] Schedule Of Derivative Instruments Recognized In Statement Of Earnings And Other Comprehensive Income [Table Text Block] Pre-tax impairment charge Impairment of Intangible Assets (Excluding Goodwill) Payments to acquire noncontrolling interests Payments to Acquire Businesses, Gross Pension plan contributions, net of refunds (Note 5) Payment for Pension Benefits Compensatory damages awarded Loss Contingency, Damages Awarded, Compensatory Damages, Value Loss Contingency, Damages Awarded, Compensatory Damages, Value Deferred income taxes Deferred Income Tax Liabilities, Net Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Wellness & Healthcare Wellness and Healthcare Segment [Member] Wellness and Healthcare Segment Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Net assets acquired based on fair values: Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract] 4.375% Notes due 2041 4.375% Notes due 2041 [Member] 4.375% Notes due 2041 [Member] Unusual or Infrequent Item, or Both [Line Items] Unusual or Infrequent Item, or Both [Line Items] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Total Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), Before Reclassification And Tax Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), Before Reclassification And Tax Accrued liabilities: Accrued Liabilities, Current [Abstract] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Background and Basis of Presentation: Business Description and Basis of Presentation [Text Block] Ownership [Axis] Ownership [Axis] Reporting Unit [Domain] Reporting Unit [Domain] Case Decided In Favor Of Plaintiff Case Decided In Favor Of Plaintiff [Member] Case Decided in Favor of Plaintiff Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Diluted earnings per share (in dollars per share) Earnings Per Share, Diluted Less: cost of repurchased stock (556,942,754 and 559,098,620 shares in 2023 and 2022, respectively) Treasury Stock, Value Trade receivables (less allowances of $80 in 2023 and $42 in 2022) Trade receivables, related parties Accounts Receivable, after Allowance for Credit Loss, Current 1.875% Notes due 2037 1.875% Notes due 2037 [Member] 1.875% Notes due 2037 [Member] Scotland Scotland [Member] Scotland (Gains) losses transferred to earnings, net of income taxes Derivative (gains)/losses transferred to earnings Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax EIH EIH [Member] EIH Issuances - maturities longer than 90 days Proceeds from Short-Term Debt, Maturing in More than Three Months Accrued liabilities and other current assets Increase Decrease In Accrued Liabilities And Other Current Assets The net change during the reporting period in the aggregate amount of expenses incurred but not yet paid, as well as the net change during the reporting period in the aggregate value of other current assets, associated with transactions that are classified as operating activities Components of net periodic benefit cost Schedule of Net Benefit Costs [Table Text Block] Multi-year Revolving Credit Facility, Expiring February 10, 2026 Multi-year Revolving Credit Facility, Expiring February 10, 2026 [Member] Multi-year Revolving Credit Facility, Expiring February 10, 2026 Excise taxes on products Excise and Sales Taxes Litigation Case [Axis] Litigation Case [Axis] Trading Symbol Trading Symbol Restructuring Plan [Domain] Restructuring Plan [Domain] Equity investments Payments to Acquire Equity Method Investments Guarantor Obligations, Nature [Domain] Guarantor Obligations, Nature [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Total other intangible assets, gross Intangible Assets, Gross (Excluding Goodwill) 4.250% Notes due 2044 4.250% Notes due 2044 [Member] 4.250% Notes due 2044 [Member] Aggregate weighted performance factor Share-Based Compensation By Share-Based Payment Awards, The Aggregate Weighted Performance Factor That Results in The Vesting of the Targeted Number Of Performance Share Units Share-Based Compensation by Share-Based Payment Awards, the Aggregate Weighted Performance Factor that Results in the Vesting of the Targeted Number of Performance Share Units Other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Other Litigation Other Litigation [Member] Other Litigation [Member] Amount assessed by taxing authorities Income Tax Examination, Amount Assessed By Taxing Authorities Income Tax Examination, Amount Assessed By Taxing Authorities Public Civil Actions Public Civil Actions [Member] Public Civil Actions 0.800% Notes due 2031 0.800% Notes due 2031 [Member] 0.800% Notes due 2031 [Member] Other Other Intangible Assets [Member] Calculation of basic and diluted EPS Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Service cost Defined Benefit Plan, Service Cost Executive Category: Executive Category [Axis] Definite-Lived Intangibles And Other Assets Definite-Lived Intangibles And Other Assets [Member] Definite-Lived Intangibles And Other Assets Total Fair Value Fair Value [Member] Fair value [Member]. Currency/other Restructuring Reserve, Translation and Other Adjustment Level 1 Fair Value, Inputs, Level 1 [Member] Guarantees and Product Warranties [Abstract] Guarantees and Product Warranties [Abstract] Individual Action Smoking And Health Individual Actions [Member] Smoking And Health Individual Actions [Member] Equity Components [Axis] Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Hedging Relationship [Domain] Hedging Relationship [Domain] Investment Type [Axis] Investment Type [Axis] Shares available for grant under the plan (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Amount of alleged underpayments not underpaid as ruled by court Loss Contingency, Amount Of Alleged Underpayments Not Underpaid As Ruled By Court Loss Contingency, Amount Of Alleged Underpayments Not Underpaid As Ruled By Court 1.450% Notes due 2039 1.450% Notes due 2039 [Member] Swedish Match AB Swedish Match AB [Member] Swedish Match AB Entity Small Business Entity Small Business Investments [Domain] Investments [Domain] Estimated amortization expense, year four, assuming no additional transactions occur that require the amortization of intangible assets Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Notional amount Derivative, Notional Amount The Attorney General Of Oyo State The Attorney General Of Oyo State [Member] The Attorney General Of Oyo State [Member] Long-term debt Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Long-Term Debt Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Long-Term Debt Retirement Plan Type [Domain] Retirement Plan Type [Domain] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Commercial agreement, total cash consideration Commercial Agreement, Total Cash Consideration Commercial Agreement, Total Cash Consideration Trademarks Trademarks [Member] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Supplier Finance Program [Table] Supplier Finance Program [Table] EA, AU & PMI DF EA, AU & PMI DF Segment [Member] EA, AU & PMI DF Segment Geographical Segment Geographical Segment [Member] Geographical Segment Line of Credit Facility [Table] Line of Credit Facility [Table] Long-term debt Schedule of Long-Term Debt Instruments [Table Text Block] Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] Hugo Lespada Hugo Lespada [Member] Hugo Lespada [Member] Final redemption price (in usd per share) Business Combination, Final Redemption Price Per Share Business Combination, Final Redemption Price Per Share PMI and Swedish Match PMI and Swedish Match [Member] PMI and Swedish Match Schedule of business acquisitions, by acquisition Schedule of Business Acquisitions, by Acquisition [Table Text Block] Income taxes Accrued Income Taxes, Current Other receivables, allowances Allowance for Credit Loss, Receivable, Other, Current Short-term Debt [Line Items] Short-Term Debt [Line Items] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Amount of security ordered, funded by defendant Loss Contingency, Motion for Security Ordered by an Appeals Court to be Funded by Defendant Loss Contingency, Motion for Security Ordered by an Appeals Court to be Funded by Defendant Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Liability balance, January 1, 2023 Liability balance, September 30, 2023 Restructuring Reserve Acquisition related costs Business Combination, Acquisition Related Costs Antidilutive stock awards (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Amount of Gain/(Loss) Recognized in Earnings Derivative, Excluded Component, Gain (Loss), Recognized in Earnings Award Type [Axis] Award Type [Axis] Number of shares granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Document Quarterly Report Document Quarterly Report Product sustainability weight (as a percent) Product Sustainability Weight, Percentage Product Sustainability Weight, Percentage Contract Termination Contract Termination [Member] Dividends declared Dividends, Common Stock Income taxes and other liabilities Income Taxes And Other Liabilities, Noncurrent Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer and amount of liabilities classified as other, due after one year or the normal operating cycle. Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Goodwill [Line Items] Goodwill [Line Items] Net investment hedges Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Leases: Lessee, Finance Leases [Text Block] US Dollar Notes, 5.625%, Due September 2033 US Dollar Notes, 5.625%, Due September 2033 [Member] US Dollar Notes, 5.625%, Due September 2033 Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Currency-neutral compound annual adjusted diluted earnings per share growth rate (as a percent) Currency-Neutral Compound Annual Adjusted Diluted Earnings Growth Rate Percent Currency-Neutral Compound Annual Adjusted Diluted Earnings Growth Rate Percent Punitive damages, value Loss Contingency, Damages Awarded Including Interest, Punitive Damages, Value Loss Contingency, Damages Awarded Including Interest, Punitive Damages, Value Interest on lease liabilities Finance Lease, Interest Expense 3.250% Notes due 2024 3.250% Notes due 2024 [Member] 3.250% Notes due 2024 [Member] Argentina ARGENTINA Supplier Finance Program [Axis] Supplier Finance Program [Axis] 2.875% Notes due 2024 2.875% Notes due 2024 - 2 [Member] 2.875% Notes due 2024 - 2 [Member] Amortizable intangible assets, net Amortizable intangible assets, net Finite-Lived Intangible Assets, Net Australia AUSTRALIA Number of defendants Loss Contingency, Number of Defendants Counterparty Name [Domain] Counterparty Name [Domain] Amortizable intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization 4.875% Notes due 2043 4.875% Notes due 2043 [Member] 4.875% Notes due 2043 [Member] 2.875% Notes due 2029 2.875% Notes due 2029 [Member] 2.875% Notes due 2029 [Member] Fair value of outstanding long-term debt Debt Instrument, Fair Value Disclosure Other non-current liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Other Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Other Noncontrolling interest Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncontrolling Interest, Fair Value Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncontrolling Interest, Fair Value Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Gross profit Gross Profit Schedule of assumptions used to determine the grant date fair value of the PSU awards subject to the TSR performance metric Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Servicing liability Servicing Liability Accumulated other comprehensive losses (Note 13) Accumulated Other Comprehensive Income (Loss), Net of Tax Euro Notes Euro Notes Payable Member Euro Notes Payable Award vesting rights, percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Employee Stock Option Employee Stock Option [Member] Financial Instruments: Derivative Instruments and Hedging Activities Disclosure [Text Block] Gross amounts not offset in the condensed consolidated balance sheets - financial instruments Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset Employment costs Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent Income taxes Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Income Taxes Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Income Taxes Maximum Maximum [Member] Pre-tax asset impairment and exit costs by segment Restructuring and Related Costs [Table Text Block] Unrecognized compensation cost related to non-vested stock awards Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Motion for security ordered by appeals court, paid by defendant Loss Contingency, Motion for Security Ordered by Appeals Court, to be Furnished by Defendants and Paid Loss Contingency, Motion for Security Ordered by an Appeals Court and Paid Other Comprehensive Income Location [Domain] Other Comprehensive Income Location [Domain] Damages sought, period of future reimbursements Loss Contingency, Damages Sought, Future Reimbursements, Period Loss Contingency, Damages Sought, Future Reimbursements, Period Earnings and balance sheet activities with related parties - equity investments and other Schedule of Related Party Transactions [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Tabular List, Table Tabular List [Table Text Block] Unusual Risk or Uncertainty, Nature [Axis] Unusual Risk or Uncertainty, Nature [Axis] Preliminary purchase price allocation Finite-Lived Intangible Assets, Purchase Accounting Adjustments Common stock repurchased Treasury Stock, Value, Acquired, Cost Method Finance Lease Termination Finance Lease Termination [Member] Finance Lease Termination Other Other Related Party [Member] Other Related Party [Member] Stock Plans: Share-Based Payment Arrangement [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Supply Chain Financing: Supplier Finance Program [Text Block] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Business Acquisition [Axis] Business Acquisition [Axis] Trade receivables, allowances Accounts Receivable, Allowance for Credit Loss, Current Schedule of committed credit facilities Schedule of Line of Credit Facilities [Table Text Block] Derivative [Table] Derivative [Table] Purchase price allocation adjustments Indefinite-Lived Intangible Assets, Purchase Accounting Adjustments Other raw materials Inventory, Raw Materials, Net of Reserves Sale of Accounts Receivable: Sale of Trade Accounts Receivable Disclosure [Text Block] Sale of Trade Accounts Receivable Disclosure [Text Block] Title of 12(b) Security Title of 12(b) Security Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Other non-current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Acquisitions: Business Combination Disclosure [Text Block] Related Party, Type [Domain] Related Party, Type [Domain] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Non-amortizable intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Noncontrolling ownership percentage Subsidiary, Ownership Percentage, Noncontrolling Owner Operating Segments Operating Segments [Member] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Amortization: Amortization [Abstract] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Total lease cost Lease, Cost Other Comprehensive Income (Loss) Other Comprehensive Income (Loss) [Member] Deferred income taxes Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities Statistical Measurement [Axis] Statistical Measurement [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Share-based Compensation Components [Axis] Share-based Compensation Components [Axis] Share-based Compensation Components [Axis] Entity Interactive Data Current Entity Interactive Data Current Total consideration transferred Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Other assets Other Assets [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Pre tax charge on termination Gain (Loss) on Contract Termination Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Gross amounts not offset in the condensed consolidated balance sheets - financial instruments Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Bank loans Bank Loan Obligations [Member] Counterparty Name [Axis] Counterparty Name [Axis] Derivatives Derivatives, Policy [Policy Text Block] Estimated amortization expense, year one, assuming no additional transactions occur that require the amortization of intangible assets Finite-Lived Intangible Asset, Expected Amortization, Year One Interest cost Defined Benefit Plan, Interest Cost Label-Related Class Actions Label Related Class Action [Member] Label Related Class Action [Member] PEO PEO [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Postretirement Benefit Costs Postretirement Benefit Costs [Member] Benefit Plans: Retirement Benefits [Text Block] Long-term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities 2.750% Notes due 2026 2.750% Notes due 2026 [Member] 2.750% Notes due 2026 [Member] Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Accounts payable Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Accounts Payable Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Accounts Payable 3.375% Notes due 2025 3.375% Notes due 2025 [Member] 3.375% Notes due 2025 [Member] Amount of litigation charge Amount Of Litigation Charge Amount of Litigation Charge Debt Instrument [Axis] Debt Instrument [Axis] Anticipated additional employer contributions during the remainder of the current fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year Net revenues Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Grant Date Fair Value Grant Date Fair Value [Member] Grant date fair value [Member]. Total liabilities Liabilities Expected volatility (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Damages returned to subsidiary Loss Contingency, Damages Returned Loss Contingency, Damages Returned 2.000% Notes due 2036 2.000% Notes due 2036 [Member] 2.000% Notes due 2036 [Member] Brazil BRAZIL TTI TTI [Member] TTI [Member] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Amounts paid Payments For Fines, Demanded Notices Or Other Legal Issues The amount of cash paid for the fines, demanded notices or for other legal issues during the period. Canada CANADA Cases brought against PM Cases Brought Against Company Cases Brought Against Company Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Chile CHILE Average Rate Short-Term Debt, Weighted Average Interest Rate, at Point in Time Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Senem Yilmazel Senem Yilmazel [Member] Senem Yilmazel Total current assets Assets, Current Total smoke-free products excluding Wellness and Healthcare Smoke-Free Products Excluding Wellness And Healthcare [Member] Smoke-Free Products Excluding Wellness And Healthcare Schedule of short-term debt Schedule of Short-Term Debt [Table Text Block] STAEM STAEM [Member] STAEM [Member] Net periodic pension cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Restructuring Type [Axis] Restructuring Type [Axis] Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Long-term debt, including current maturities Long-term debt, including current maturities Long-Term Debt and Lease Obligation, Including Current Maturities Goodwill and Other Intangible Assets, net: Goodwill and Intangible Assets Disclosure [Text Block] PMM PMM [Member] PMM [Member] Other accrued liabilities Other Accrued Liabilities [Member] Other Accrued Liabilities [Member] Components of accumulated other comprehensive earnings (losses), net of taxes Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Estimated amortization expense, year five, assuming no additional transactions occur that require the amortization of intangible assets Finite-Lived Intangible Asset, Expected Amortization, Year Five Performance Share Units, TSR Performance Metric Performance Share Units, TSR Performance Metric [Member] Performance Share Units, TSR Performance Metric Weighted-average grant date fair value per RSU award granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Measurement Period Adjustments Measurement Period Adjustments [Abstract] Measurement Period Adjustments Number of cases decided in favor of plaintiff Loss Contingency Claims Resolved in Favor of Plaintiffs Loss Contingency Claims Resolved in Favor of Plaintiffs Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Class of Stock [Axis] Class of Stock [Axis] Currency/Other Standard Product Warranty Accrual, Foreign Currency Translation Gain (Loss) Derivative instruments, gains (losses) to be reclassified to earnings Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Italy ITALY Prior service cost (credit) Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Less distributed and undistributed earnings attributable to share-based payment awards Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] Non Employee Directors Plan 2017 Non Employee Directors Plan [Member] 2017 Non Employee Directors Plan [Member] Europe Europe Segment [Member] Europe Segment Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Business Combination and Asset Acquisition [Abstract] Asset Impairment Asset Impairment [Member] Asset Impairment Consolidation Items [Axis] Consolidation Items [Axis] Commercial paper Commercial Paper [Member] Net revenues Business Acquisition, Pro Forma Revenue Impairment Impairment Goodwill, Impairment Loss Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Derivatives accounted for as hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Combustible Tobacco Products Combustible Tobacco Products [Member] Combustible Tobacco Products Long-term debt (Note 12) Long-term debt Long-Term Debt and Lease Obligation Deferred income taxes Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Equity securities Equity Securities without Readily Determinable Fair Value, Amount Amortization of net losses, prior service costs and net transition costs, tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax 3.375% Notes due 2029 3.375% Notes due 2029 [Member] 3.375% Notes due 2029 [Member] 0.125% Notes due 2026 0.125% Notes due 2026 [Member] 0.125% Notes due 2026 [Member] Entity Emerging Growth Company Entity Emerging Growth Company Other intangible assets, net (Note 6) Total other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Standard product warranty term Standard Product Warranty, Term Standard Product Warranty, Term Net investment hedges and other derivatives (Note 7) Payments for (Proceeds from) Hedge, Investing Activities Swedish Match Swedish Match AB Segment [Member] Swedish Match AB Segment RBH Rothmans, Benson, And Hedges Inc. (RBH) [Member] Rothmans, Benson, And Hedges Inc. (RBH) [Member] Settlements Standard Product Warranty Accrual, Decrease for Payments Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Title Trading Arrangement, Individual Title EITA EITA [Member] EITA [Member] Nigeria NIGERIA Common Stock Common Stock [Member] Individual: Individual [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Income Statement Location [Domain] Income Statement Location [Domain] Adams Adams [Member] Adams [Member] Aggregate fair values of PMI's debt, excluding finance leases Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Total stockholders’ deficit Beginning balance Ending balance Total accumulated other comprehensive losses Equity, Including Portion Attributable to Noncontrolling Interest Dividends paid to noncontrolling interests Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] Cecilia Letourneau &Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] Management Et Developpement Des Actifs Et Des Ressources Holding (MADAR Holding) Management Et Developpement Des Actifs Et Des Ressources Holding (MADAR Holding) [Member] Management Et Developpement Des Actifs Et Des Ressources Holding (MADAR Holding) [Member] Minimum Minimum [Member] Property, plant and equipment Property, Plant and Equipment, Net Dividends from unconsolidated subsidiaries Proceeds from Equity Method Investment, Distribution Receivables Receivables, Net, Current Cash Cash Other comprehensive earnings (losses), net of income taxes Other comprehensive earnings (losses), net of income taxes Other Comprehensive Income (Loss), Net of Tax Supply chain financing, obligation, current Supplier Finance Program, Obligation, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Commodity contracts Commodity Contract [Member] Long-term debt proceeds Proceeds from Issuance of Long-Term Debt Change in currency translation adjustments, transferred to earnings, tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax LIABILITIES Liabilities [Abstract] Other current assets Other Current Assets [Member] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Deferred income taxes Deferred Income Tax Assets, Net Retirement Plan Type [Axis] Retirement Plan Type [Axis] Other current assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Assets, Other Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Assets, Other Contingencies: Commitments and Contingencies Disclosure [Text Block] Other Payments for (Proceeds from) Other Investing Activities Interest acquired (as a percent) Business Acquisition, Percentage of Voting Interests Acquired Earnings Reinvested in the Business Retained Earnings [Member] Warranties issued Standard Product Warranty Accrual, Increase for Warranties Issued Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Basic earnings per share (in dollars per share) Earnings Per Share, Basic Short-term borrowing activity by original maturity: Proceeds from (Repayments of) Debt [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Inventories Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Leaf tobacco Inventory Leaf Tobacco Carrying amount as of the balance sheet date of leaf tobacco inventory to be consumed in the manufacturing and production process. Amortization of net losses, prior service costs and net transition costs, net of income taxes Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax Commercial agreement, initial payment Commercial Agreement, Initial Payment Commercial Agreement, Initial Payment Pending Litigation Pending Litigation [Member] Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Appellate Ruling Appellate Ruling [Member] Appellate Ruling [Member] Goodwill Measurement period adjustments Goodwill, Purchase Accounting Adjustments Interest expense, net Interest Expense [Member] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Canadian Government Canadian Government [Member] Canadian Government Developed technology, including patents Technology-Based Intangible Assets [Member] Loss contingency, damages sought, value Loss Contingency, Fines Or Demanded Payments Sought The monetary value related to fines, demanded payments or other legal matters sought by government and other governmental authorities. Accounts payable Increase (Decrease) in Accounts Payable Medicago Inc. Medicago Inc. [Member] Medicago Inc. Change in fair value of derivatives accounted for as hedges, (gains) losses transferred to earnings, tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax Repayments under credit facilities related to Swedish Match AB acquisition Repayments under credit facilities related to acquisition Repayments of Lines of Credit Fair value hedge amount Hedged Liability, Fair Value Hedge Schedule of debt issuances during current period Schedule of Debt Issuances During Current Period [Table Text Block] Schedule of Debt Issuances During Current Period 2.875% Notes due 2024 2.875% Notes due 2024 - 1 [Member] 2.875% Notes due 2024 - 1 [Member] Korea KOREA, REPUBLIC OF Derivative Instrument [Axis] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] 4.125% Notes due 2043 4.125% Notes due 2043 [Member] 4.125% Notes due 2043 [Member] Schedule of verdicts and significant post trial developments where a verdict was returned in favor of the plaintiff(s) Schedule Of Verdicts And Post Trial Developments1 [Table Text Block] Schedule Of Verdicts And Post Trial Developments1 [Table Text Block] All Trading Arrangements All Trading Arrangements [Member] Unusual or Infrequent Item, or Both [Table] Unusual or Infrequent Item, or Both [Table] Less: accumulated depreciation Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization All Adjustments to Compensation All Adjustments to Compensation [Member] Movement in exit cost liabilities Restructuring Reserve [Roll Forward] Compensation Amount Outstanding Recovery Compensation Amount The South Korean Board Of Audit And Inspection The South Korean Board Of Audit And Inspection [Member] The South Korean Board Of Audit And Inspection [Member] Repayments - maturities longer than 90 days Repayments of Short-Term Debt, Maturing in More than Three Months Equity securities, unrealized gain (loss), net Equity Securities, FV-NI, Unrealized Gain (Loss), Net Of Tax Equity Securities, FV-NI, Unrealized Gain (Loss), Net Of Tax Russia RUSSIAN FEDERATION 3.125% Notes due 2033 3.125% Notes due 2033 [Member] 3.125% Notes due 2033 [Member] Multi-year Revolving Credit Facility, Expiring September 29, 2027 Multi-year Revolving Credit Facility, Expiring September 29, 2027 [Member] Multi-year Revolving Credit Facility, Expiring September 29, 2027 Schedule of pretax charges related to circumstances Schedule of Unusual or Infrequent Items, or Both [Table Text Block] Deferred income tax (benefit) provision Deferred Income Tax Expense (Benefit) Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Identifiable net assets acquired Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Finance lease, liability Finance Lease, Liability Damages, reduced amount Loss Contingency Damages, Reduced Amount Loss Contingencies, Damages awarded, reduced amount Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Payments to acquire Swedish Match AB noncontrolling interests (Note 2) Payments to acquire additional noncontrolling interests Payments to Acquire Additional Interest in Subsidiaries, Financing Activities Payments to Acquire Additional Interest in Subsidiaries, Financing Activities Three year tranche Debt Instrument, Redemption, Period One [Member] Movement in Standard Product Warranty Accrual [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] Plus contingently issuable performance stock units (PSUs), (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Equity securities, unrealized gain (loss) Equity Securities, FV-NI, Unrealized Gain (Loss) Multi-year Revolving Credit Facility, Expiring September 29, 2026 Multi-year Revolving Credit Facility, Expiring September 29, 2026 [Member] Multi-year Revolving Credit Facility, Expiring September 29, 2026 Absolute basis (as a percent) Total Shareholder Return (TSR) Relative to a Predetermined Peer Group, Absolute Basis Total Shareholder Return (TSR) Relative to a Predetermined Peer Group, Absolute Basis Future cash payments for exit costs expected to be paid Cash spent Payments for Restructuring Document Period End Date Document Period End Date UTC UTC [Member] UTC Philippines PHILIPPINES Adoption Date Trading Arrangement Adoption Date Net revenues Sales [Member] Performance metrics predefined at time of grant Performance Metrics Predefined At The Time Of Grant, Including Market And Non-Market Metrics, Used By The Company To Determine The Percentage Of PSU's That Will Vest Performance Metrics Predefined at Time of Grant, including Market and Non-Market Metrics, used by the Company to Determine the Percentage of PSU's that will Vest Changes due to: Goodwill Changes [Abstract] Goodwill Changes [Abstract] Cost of Repurchased Stock Treasury Stock, Common [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Provision for income taxes Income tax expense (benefit) Income Tax Expense (Benefit) Designated as Hedging Instrument Foreign exchange contracts Designated as Hedging Instrument [Member] Euro Bank Loan Euro Bank Loan [Member] Euro Bank Loan Lender Name [Axis] Lender Name [Axis] Other receivables (less allowances of $33 in 2023 and $32 in 2022) Other Receivables, Net, Current Suzanne Jacklin Suzanne Jacklin [Member] Suzanne Jacklin [Member] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Money Market Funds Money Market Funds [Member] Net loss Defined Benefit Plan, Amortization of Gain (Loss) Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Other acquisitions, net of acquired cash Payments to Acquire Businesses, Net of Cash Acquired Total comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Venezuela VENEZUELA Three Hundred Sixty-Four Day Revolving Credit Expiring January 31, 2023 Three Hundred Sixty-Four Day Revolving Credit Expiring January 30, 2024 [Member] Three Hundred Sixty-Four Day Revolving Credit Expiring January 30, 2023 US Dollar Notes, 5.250%, Due September 2028 US Dollar Notes, 5.250%, Due September 2028 [Member] US Dollar Notes, 5.250%, Due September 2028 e-Vapor Products Manufacturing Optimization e-Vapor Products Manufacturing Optimization [Member] e-Vapor Products Manufacturing Optimization SSEA, CIS & MEA SSEA, CIS & MEA Segment [Member] SSEA, CIS & MEA Segment Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Net amount Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Sale of Accounts Receivable [Abstract] Sale of Accounts Receivable [Abstract] Sale of Accounts Receivable [Abstract] Interest rate contracts Interest Rate Contract [Member] Other intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Ownership percentage Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage Ukraine UKRAINE Cecilia Letourneau Cecilia Letourneau [Member] Cecilia Letourneau [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid-in Capital Additional Paid-in Capital [Member] Gains (losses) recognized, net of income taxes Change in fair value Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Balance Sheet Location [Axis] Balance Sheet Location [Axis] Equity investments and securities (income)/loss, net Income (Loss) from Equity Method Investments Income taxes and other liabilities Other Liabilities [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cover [Abstract] Cover [Abstract] Gain/(loss) as of beginning of period, Gain/(loss) as of September 30, AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax Dividends paid Payments of Dividends Noncontrolling Interest Purchase Philip Morris Tütün Mamulleri Sanayi ve Ticaret A.Ş. Noncontrolling Interest Purchase Philip Morris Tütün Mamulleri Sanayi ve Ticaret A.Ş. [Member] Noncontrolling Interest Purchase Philip Morris Tütün Mamulleri Sanayi ve Ticaret A.Ş. U.S. dollar credit facility borrowings related to Swedish Match AB acquisition U.S. Dollar Notes US Dollar Notes [Member] U.S. Dollar Notes Amortization of right-of-use assets Finance Lease, Right-of-Use Asset, Amortization Segment Reporting: Segment Reporting Disclosure [Text Block] Increase (Decrease) Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cumulative fair value gain (loss) of hedged liability Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) Thailand THAILAND Equity Component [Domain] Equity Component [Domain] Derivative, Excluded Component, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Derivative, Excluded Component, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Turkey TÜRKIYE Entity Current Reporting Status Entity Current Reporting Status Cumulative trade receivables sold Accounts Receivable, Sale Awarded compensatory damages that are to be deposited into trust Loss Contingency, Damages Awarded, Compensatory Damages, Amount To Be Deposited Into Trust Loss Contingency, Damages Awarded, Compensatory Damages, Amount To Be Deposited Into Trust Operating income Operating income Operating Income (Loss) Other Comprehensive Income Location [Axis] Other Comprehensive Income Location [Axis] Segments [Axis] Segments [Axis] Other comprehensive earnings (losses), net of income taxes: Other Comprehensive Income (Loss), Net of Tax [Abstract] Scenario [Domain] Scenario [Domain] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Customer relationships Customer Relationships [Member] Type of Restructuring [Domain] Type of Restructuring [Domain] STOCKHOLDERS’ (DEFICIT) EQUITY Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Deferred income taxes and tax credits Deferred Income Taxes and Tax Credits Net earnings attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest 2.875% Notes due 2026 2.875% Notes due 2026 [Member] 2.875% Notes due 2026 [Member] Pay vs Performance Disclosure [Line Items] Statistical Measurement [Domain] Statistical Measurement [Domain] Business combination fair value adjustment to inventories Business Combination Fair Value Adjustment to Inventories Business Combination Fair Value Adjustment to Inventories Underlying Security Market Price Change Underlying Security Market Price Change, Percent Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Foreign Currency Obligations Foreign Currency Obligations [Member] Foreign Currency Obligations [Member] Indebtedness: Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations The Attorney General Of Ogun State The Attorney General Of Ogun State [Member] The Attorney General Of Ogun State [Member] Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Performance Shares Performance Shares [Member] Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable Payables Accounts Payable, Current Net earnings attributable to PMI Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Restatement Determination Date: Restatement Determination Date [Axis] Investment, Name [Axis] Investment, Name [Axis] Contingencies (Note 10) Commitments and Contingencies Pension plan contributions, net of refunds (Note 5) Defined Benefit Plan, Plan Assets, Pension Plan Contributions, Net Of Refunds Defined Benefit Plan, Plan Assets, Pension Plan Contributions, Net Of Refunds Schedule of Goodwill [Table] Schedule of Goodwill [Table] Geographical [Axis] Geographical [Axis] Award requisite service period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Smoke-Free Products Smoke-Free Products [Member] Smoke-Free Products Income Taxes: Income Tax Disclosure [Text Block] War in Ukraine: Unusual or Infrequent Items, or Both, Disclosure [Text Block] Property, plant and equipment, at cost Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Loss on sale of accounts receivable Gain (Loss) on Sale of Accounts Receivable Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Axis] US Dollar Notes, 5.500%, Due September 2030 US Dollar Notes, 5.500%, Due September 2030 [Member] US Dollar Notes, 5.500%, Due September 2030 Individual Smoking and Health Cases Individual Smoking And Health Cases [Member] Individual Smoking And Health Cases Business Acquisition [Line Items] Business Acquisition [Line Items] Supply Chain Financing Program Suppliers Using Supply Chain Financing Program [Member] Suppliers Using Supply Chain Financing Program Inventories: Inventory, Net [Abstract] Derivative liability fair value Derivative Liability, Subject to Master Netting Arrangement, before Offset PEO Total Compensation Amount PEO Total Compensation Amount Marketing, administration and research costs Marketing Administration And Research Costs [Member] Marketing, administration and research costs Hedging Relationship [Axis] Hedging Relationship [Axis] Schedule of tobacco related cases pertaining to combustible products pending against company Schedule Of Tobacco Related Cases Pending Against Company [Table Text Block] Schedule of tobacco related cases pertaining to combustible products pending against company and/or subsidiaries or indemnitees Goodwill [Roll Forward] Goodwill [Roll Forward] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Repurchased stock (in shares) Treasury Stock, Common, Shares Court-estimated number of members in class Loss Contingency, Court-Estimated Number Of Members In Class Loss Contingency, Court-Estimated Number Of Members In Class Payment period Loss Contingency, Damages Awarded to be Deposited into Trust, Payment Period Loss Contingency, Damages Awarded to be Deposited into Trust, Payment Period Current portion of long-term debt Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Long-Term Debt Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Long-Term Debt Depreciation, amortization and impairment of goodwill and other intangibles Depreciation, Amortization and Impairment The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets and amount of write-down of assets recognized in the income statement, includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. 3.875% Notes due 2042 3.875% Notes due 2042 [Member] 3.875% Notes due 2042 [Member] Amount of litigation charge net of tax Amount of Litigation Charge Net of Tax Amount of Litigation Charge Net of Tax Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Other investments Investments, Fair Value Disclosure Net earnings attributable to PMI Net earnings attributable to PMI Net Income (Loss) Attributable to Parent Net Income (Loss) Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Schedule of notional amounts of outstanding derivative positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Statute of limitations term Foreign and U.S. State Jurisdictions Statute of Limitations Foreign and U.S. State Jurisdictions Statute of Limitations Leases: Lessee, Operating Leases [Text Block] Total property, plant and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] (Gains)/losses transferred to earnings, net of income taxes of $0 in 2023 and 2022 Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax Unusual Risk or Uncertainty, Nature [Domain] Unusual Risk or Uncertainty, Nature [Domain] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] 4.500% Notes due 2042 4.500% Notes due 2042 [Member] 4.500% Notes due 2042 [Member] Swiss Franc Notes Swiss Franc Notes [Member] Swiss franc notes [Member] Foreign exchange contracts Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Receivables, net Increase (Decrease) in Receivables Share-based Compensation Component [Domain] Share-based Compensation Component [Domain] Share-based Compensation Component [Domain] Cost of sales Cost of Goods and Services Sold Litigation Status [Domain] Litigation Status [Domain] Acquired intangible assets, estimated useful life Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Schedule of non-amortizable intangible assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Disclosure of share-based compensation arrangements by payment award Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Foreign exchange contracts Foreign Exchange Contract [Member] Name Measure Name Name Forgone Recovery, Individual Name Altria Group Altria Group [Member] Altria Group Goodwill (Note 6) Goodwill Beginning balance Ending balance Goodwill Underlying Securities Award Underlying Securities Amount Contract termination charges: Restructuring and related cost, incurred cost Restructuring and Related Cost, Incurred Cost Accumulated Other Comprehensive Losses: Comprehensive Income (Loss) Note [Text Block] Marketing, administration and research costs (Notes 3 & 9) Marketing, Administration And Research Costs The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies. General and administrative expenses include costs such as salaries of nonsales personnel, rent, utilities, communication and realized and unrealized gains and losses on foreign currency transactions. Forecast Forecast [Member] Net issuances (repayments) - maturities of 90 days or less Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less Change in foreign currency translation adjustments, unrealized gains (losses), tax OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax Dividends declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Cash and cash equivalents Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash And Equivalents Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash And Equivalents Noncontrolling Interest Purchase Philip Morris Pazarlama ve Satış A.Ş. Noncontrolling Interest Purchase Philip Morris Pazarlama ve Satış A.Ş. [Member] Noncontrolling Interest Purchase Philip Morris Pazarlama ve Satış A.Ş. Debt instrument, term Debt Instrument, Term Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Damages allocated to subsidiary (percent) Loss Contingency, Damages Awarded, Percentage Allocated Loss Contingency, Damages Awarded, Compensatory Damages, Percentage Allocated Fair value of derivative contracts Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block] Income Statement Location [Axis] Income Statement Location [Axis] Foreign currency gain (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax Judicial Ruling Judicial Ruling [Member] Americas Americas Segment [Member] Americas Segment Change in accumulated amortization, currency movements Finite-Lived Intangible Assets, Accumulated Amortization, Foreign Currency Translation Increase (Decrease) Finite-Lived Intangible Assets, Accumulated Amortization, Foreign Currency Translation Increase (Decrease) Payables and Accruals [Abstract] Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Gross amounts not offset in the condensed consolidated balance sheets - cash collateral received / pledged Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset Lease cost components Lease, Cost [Table Text Block] Inventories Increase (Decrease) in Inventories CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities [Abstract] Litigation Status [Axis] Litigation Status [Axis] Change in currency translation adjustments: Change in currency translation adjustment [Abstract] Change in currency translation adjustment [Abstract] Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 2) Noncontrolling Interest, Increase from Sale of Parent Equity Interest Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Percentage of voting shares that PMI may own, used in determining non-employee director status Non Employee Director Ownership Limit Represents the lower limit of ownership in a company by PMI used in defining Non-employee directors under the stock compensation plan. Plan Name [Domain] Plan Name [Domain] Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Other Notes Payable, Other Payables [Member] Finite-lived intangible assets Finite-Lived Intangible Assets Acquired Trading Arrangement: Trading Arrangement [Axis] Other receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Claudia Milano Claudia Milano [Member] Claudia Milano Loss Contingencies [Table] Loss Contingencies [Table] Amortization of intangibles Amortization of Intangible Assets Entity Shell Company Entity Shell Company Noncontrolling interest Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Equity investments (Note 14) Long-Term Investments Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Restatement Determination Date Restatement Determination Date Net Revenues Net Revenues [Member] Net Revenues Income taxes Increase (Decrease) in Income Taxes Payable Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Balance at beginning of period Balance at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Asset Class [Axis] Asset Class [Axis] Senior Unsecured Term Loan Senior Unsecured Term Loan [Member] Senior Unsecured Term Loan Variable lease cost Variable Lease, Cost Operating lease cost Operating Lease, Cost Common stock, issued (in shares) Common Stock, Shares, Issued Stock awards vested during period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Current portion of long-term debt (Note 12) Less current portion of long-term debt Long-Term Debt and Lease Obligation, Current Supplier Finance Program [Line Items] Supplier Finance Program [Line Items] Currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Pre-tax charge Other Nonrecurring Expense Commercial agreement, remaining payment Commercial Agreement, Remaining Payment Commercial Agreement, Remaining Payment Payment period for awarded punitive damages to be deposited into trust Loss Contingency, Damages Awarded, Punitive Damages, Payment Period Loss Contingency, Damages Awarded, Punitive Damages, Payment Period Noncontrolling interests activity and Other (Note 2) Proceeds from (Payments for) Other Financing Activities Comprehensive earnings attributable to PMI Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2.750% Notes due 2025 2.750% Notes due 2025 [Member] 2.750% Notes due 2025 [Member] Loss Contingencies by Name of Plaintiff [Axis] Loss Contingencies by Name of Plaintiff [Axis] Loss Contingencies by Name of Plaintiff [Axis] Short-term lease cost Short-Term Lease, Cost Entity Address, Address Line One Entity Address, Address Line One US Dollar Notes, 4.875%, Due February 2026 US Dollar Notes, 4.875% Due February 2026 [Member] US Dollar Notes, 4.875% Due February 2026 Non-amortizable intangible assets, currency movements increase (decrease) Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Trade receivables Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Assets, Receivables Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Assets, Receivables Parent ownership percentage Subsidiary, Ownership Percentage, Parent Loss on sale of trade receivables Schedule Of Gain (Loss) On Sale Of Trade Receivables [Table Text Block] Schedule Of Gain (Loss) On Sale Of Trade Receivables Schedule of amortizable intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Income Statement [Abstract] Income Statement [Abstract] Other intangible assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Movement in exit cost liabilities Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Net earnings attributable to PMI Business Acquisition, Pro Forma Net Income (Loss) Issuance of stock awards Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Dividends payable Dividends Payable, Current Other current assets Other Assets, Current 6.375% Notes due 2038 6.375% Notes due 2038 [Member] 6.375% Notes due 2038 [Member] Health Care Cost Recovery Actions Health Care Cost Recovery Actions [Member] Health Care Cost Recovery Actions Equity method investments Equity Method Investments Total inventory, net Inventories Inventory, Net Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Length of performance cycle period Share-Based Compensation Arrangement By Share-Based Payment Awards, Length Of The Performance Cycle Period, Which Requires That Certain Predetermined Performance Metrics Be Achieved Share-Based Compensation Arrangement by Share-Based Payment Award, Duration of the Performance Cycle that Requires the Achievement of Predefined Performance Metrics Total consideration transferred Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred Other non-current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Total Shareholder Return Amount Total Shareholder Return Amount Cash, cash equivalents and restricted cash: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Repurchases of common stock Payments for Repurchase of Common Stock Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Pro Forma Pro Forma [Member] Asset impairment and exit costs, net of cash paid (Note 17) Restructuring Costs and Asset Impairment Charges Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Damages sought, period of past reimbursements Loss Contingency, Damages Sought, Past Reimbursements, Period Loss Contingency, Damages Sought, Past Reimbursements, Period Segments [Domain] Segments [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Non-cash pre-tax charge Non-cash pre-tax charge Amount Of Pre-Tax Charge Related To Alleged Underpayment Of Excise Taxes Amount Of Pre-Tax Charge Related To Alleged Underpayment Of Excise Taxes Earnings reinvested in the business Retained Earnings (Accumulated Deficit) Face Value Debt Instrument, Face Amount Reduction of guarantee obligation Reduction of Guarantee Obligation Reduction of Guarantee Obligation IPM India IPM India [Member] IPM India [Member] Leases [Abstract] Leases [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Number of shares of common stock issued for each vested PSU (in shares) The Number Of Shares Of Common Stock Issued For Each Vested Performance Share Unit The Number of shares of Common Stock Issued for each Vested Performance Share Unit CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities [Abstract] The Department of Special Investigations of the Government of Thailand The Department of Special Investigations of the Government of Thailand [Member] The Department of Special Investigations of the Government of Thailand [Member] Number of cases decided in favor of PM Loss Contingency Claims Resolved in Favor of the Company Loss Contingency Claims Resolved in Favor of the Company Borrowings under credit facilities Proceeds from Unsecured Lines of Credit Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Asset Class [Domain] Asset Class [Domain] Derivative asset fair value Derivative Asset, Subject to Master Netting Arrangement, before Offset Short Term Credit Arrangement Short Term Credit Arrangement [Member] Short Term Credit Arrangement [Member] Class of Stock [Domain] Class of Stock [Domain] Net earnings for basic EPS Net Income (Loss) Available to Common Stockholders, Basic Effective tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Accumulated Other Comprehensive Losses AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount All Executive Categories All Executive Categories [Member] Net amount Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction Less comprehensive earnings (losses) attributable to: Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest [Abstract] Financial Guarantee Financial Guarantee [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Pension and other benefits Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Plan Name [Axis] Plan Name [Axis] Income taxes Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Income Taxes Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Income Taxes Debt Disclosure [Abstract] Debt Disclosure [Abstract] Imperial Tobacco Ltd. Imperial Tobacco Ltd. [Member] Imperial Tobacco Ltd. [Member] Number of reportable segments Number of Reportable Segments Per share data (Note 8): Earnings Per Share [Abstract] Common stock, no par value (2,109,316,331 shares issued in 2023 and 2022) Common Stock, Value, Issued Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Property, plant and equipment Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Megapolis Group Megapolis [Member] Megapolis [Member] Restricted cash Restricted Cash All Individuals All Individuals [Member] Noncontrolling interest purchase Noncontrolling interest purchase [Member] Noncontrolling interest purchase Litigation Case [Domain] Litigation Case [Domain] Entity Filer Category Entity Filer Category Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Taxes, except income taxes Sales and Excise Tax Payable, Current Qualifying hedging activity reported in accumulated other comprehensive earnings (losses), net of income taxes Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] PEO Name PEO Name Schedule of Product Information [Table] Schedule of Product Information [Table] Schedule of movements in goodwill Schedule of Goodwill [Table Text Block] Cases on appeal Loss Contingency Claims On Appeal, Subject To An Appeal Or With The Possibility To Be Appealed By A Subsidiary Of The Company Loss Contingency Claims On Appeal, Subject To An Appeal Or With The Possibility To Be Appealed By A Subsidiary Of The Company Currency Goodwill, Translation and Purchase Accounting Adjustments Other Other Accrued Liabilities, Current Issuance of debt costs Debt Issuance Costs, Line of Credit Arrangements, Gross Payments to acquire noncontrolling interests Payments to Acquire Additional Interest in Subsidiaries Other Increase (Decrease) in Other Operating Assets and Liabilities, Net The Attorney General Of Kano State The Attorney General Of Kano State [Member] The Attorney General Of Kano State [Member] Interest rate, stated percentage Interest Rate Debt Instrument, Interest Rate, Stated Percentage Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total PMI stockholders’ deficit Equity, Attributable to Parent Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Reporting Unit [Axis] Reporting Unit [Axis] Supply chain payment terms Supplier Finance Program, Payment Timing, Period Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Components of pension and other employee benefit costs Schedule of Defined Benefit Plans Disclosures [Table Text Block] Other non-current assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets US Dollar Notes, 4.875%, Due February 2028 US Dollar Notes, 4.875%, Due February 2028 [Member] US Dollar Notes, 4.875%, Due February 2028 Postemployment Benefit Plans Postemployment Benefit Plans [Member] Postemployment Benefit Plans [Member] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Asset Impairment and Exit Costs: Restructuring and Related Activities Disclosure [Text Block] Cases Remaining On Appeal Cases On Appeal, Subject To An Appeal, Or With The Possibility To Be Appealed By A Subsidiary Of The Company [Member] Cases Remaining on Appeal Hedging Designation [Domain] Hedging Designation [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Difference between equity method investment carrying value and book value Equity Method Investment, Difference Between Carrying Amount and Underlying Equity Minimum number of cigarettes smoked Loss Contingency, Plaintiff Requirement, Minimum Number Of Cigarettes Smoked Loss Contingency, Plaintiff Requirement, Minimum Number Of Cigarettes Smoked Net Investment Hedging Net Investment Hedging [Member] Other tax expense (benefit) Other Tax Expense (Benefit) Schedule of accrued product warranties Schedule of Product Warranty Liability [Table Text Block] The Attorney General Of Lagos State The Attorney General Of Lagos State [Member] The Attorney General Of Lagos State [Member] Identifiable net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Weighted-average remaining useful life Finite-Lived Intangible Asset, Useful Life City Area Code City Area Code Product and Service [Axis] Product and Service [Axis] Earnings Per Share: Earnings Per Share [Text Block] Ownership percentage Equity Method Investment, Ownership Percentage Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Amount of Gain/(Loss) Recognized in Earnings Gain (Loss) on Fair Value Hedges Recognized in Earnings Marketing and selling Accrued Marketing Costs, Current Amount of taxes not underpaid as ruled by trial court Loss Contingency, Amount Of Taxes Not Underpaid As Ruled By Trial Court Loss Contingency, Amount Of Taxes Not Underpaid As Ruled By Trial Court Change in fair value of derivatives accounted for as hedges, gains (losses) recognized, tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax Receivables [Abstract] Net gains (losses) and prior service costs, net of income taxes Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] 3.600% Notes due 2023 3.600% Notes due 2023 [Member] 3.600% Notes due 2023 [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Equity securities, noncurrent Equity Securities, FV-NI, Noncurrent Loss Contingencies by Name of Plaintiff [Domain] Loss Contingencies By Name Of Plaintiff [Domain] Loss Contingencies by Name of Plaintiff [Domain] Net earnings Net earnings Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Balance at beginning of period Balance at end of period Standard Product Warranty Accrual Combustible Products Combustible Products [Member] Combustible Products [Member] Unrealized gains (losses), net of income taxes Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Developed technology, including patents Developed Technology Rights [Member] US Dollar Notes, 5.125%, Due February 2030 US Dollar Notes, 5.125%, Due February 2030 [Member] US Dollar Notes, 5.125%, Due February 2030 Change in fair value of derivatives accounted for as hedges: Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract] TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY Liabilities and Equity Other assets (less allowances of $24 in 2023 and $20 in 2022) (Note 2) Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Ownership [Domain] Ownership [Domain] Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Line Items] Risk-free interest rate (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Senior Unsecured Bridge Facility Senior Unsecured Bridge Facility [Member] Senior Unsecured Bridge Facility Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Product Warranty: Product Warranty Disclosure [Text Block] Net earnings for diluted EPS Net Income (Loss) Available to Common Stockholders, Diluted Arrangement Duration Trading Arrangement Duration In Process Research and Development In Process Research and Development [Member] Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Segment data Schedule of Segment Reporting Information, by Segment [Table Text Block] Related Party Related Party [Member] Expenses Costs and Expenses, Related Party Business combination fair value adjustment to debt Business Combination Fair Value Adjustment to Debt Business Combination Fair Value Adjustment to Debt Charges, net Restructuring Charges Changes due to: Changes In Standard Product Warranty Accrual [Abstract] Changes In Standard Product Warranty Accrual [Abstract] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Purchase of subsidiary shares from noncontrolling interests (Note 2) Purchase of subsidiary shares from noncontrolling interests (Note 2) Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Termination Date Trading Arrangement Termination Date Performance Share Units, Other Performance Metrics Performance Share Units, Other Performance Metrics [Member] Performance Share Units, Other Performance Metrics Cumulative foreign currency translation losses Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Swedish Krona Notes Swedish Krona Notes [Member] Swedish Krona Notes Document Information [Table] Document Information [Table] Proceeds from sale of holdings Proceeds from Noncontrolling Interests Unusual or Infrequent Items, or Both [Abstract] Foreign Debt Foreign Debt [Member] Foreign Debt Short-term borrowings (Note 12) Amount Outstanding Short-Term Debt Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Adjustments to reconcile net earnings to operating cash flows: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Motion for security ordered by appeals court Loss Contingency, Motion for Security Ordered by Appeals Court Loss Contingency, Motion for Security Ordered by Appeals Court Trade receivable, arrangement Accounts Receivable, Arrangement Accounts Receivable, Arrangement Derivative [Line Items] Derivative [Line Items] Award Timing Disclosures [Line Items] Smoking and Health Class Actions Smoking And Health Class Actions [Member] Smoking And Health Class Actions Noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Fair value of vested stock awards Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Gross amounts not offset in the condensed consolidated balance sheets - cash collateral received / pledged Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset Document Information [Line Items] Document Information [Line Items] Restructuring Plan [Axis] Restructuring Plan [Axis] Related Parties - Equity Investments and Other: Related Parties, Equity Investments and Other [Text Block] Related Parties, Equity Investments and Other Finite lived intangible asset, currency movements increase (decrease) Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Estimated amortization expense, year three, assuming no additional transactions occur that require the amortization of intangible assets Finite-Lived Intangible Asset, Expected Amortization, Year Three Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Insider Trading Arrangements [Line Items] Related Party, Type [Axis] Related Party, Type [Axis] Number of additional manufacturers found liable Loss Contingency, Number Of Additional Manufacturers Found Liable Loss Contingency, Number Of Additional Manufacturers Found Liable Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Supplier Finance Program [Domain] Supplier Finance Program [Domain] Estimated amortization expense, year two, assuming no additional transactions occur that require the amortization of intangible assets Finite-Lived Intangible Asset, Expected Amortization, Year Two Multi-year Revolving Credit Facility, Expiring February 10, 2027 Multi-year Revolving Credit Facility, Expiring February 10, 2027 [Member] Multi-year Revolving Credit Facility, Expiring February 10, 2027 Adjustment to Compensation, Amount Adjustment to Compensation Amount War In Ukraine War In Ukraine [Member] War In Ukraine Individual Label-Related Cases Individual Label Related Cases [Member] Individual Label Related Cases [Member] Cost of sales Cost of Sales [Member] Noncontrolling interests Equity, Attributable to Noncontrolling Interest Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Borrowings under credit facilities related to acquisition Proceeds from Lines of Credit Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Payment period for compensatory damages to be deposited into trust Loss Contingency, Damages Awarded, Compensatory Damages, Payment Period Loss Contingency, Damages Awarded, Compensatory Damages, Payment Period Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Long-term debt repaid Repayments of Long-Term Debt Entity Central Index Key Entity Central Index Key US Dollar Notes, 5.375%, Due February 2033 US Dollar Notes, 5.375%, Due February 2033 [Member] US Dollar Notes, 5.375%, Due February 2033 Amount of Gain/(Loss) Recognized in Earnings Derivative, Gain (Loss) on Derivative, Net Minimum retirement age Minimum Retirement Age Minimum Retirement Age The Attorney General Of Gombe State The Attorney General Of Gombe State [Member] The Attorney General Of Gombe State [Member] 2022 Performance Incentive Plan 2022 Performance Incentive Plan [Member] 2022 Performance Incentive Plan Compensation Expense Related to RSU Awards Compensation Expense Related to PSU Awards Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Amortizable intangible assets, gross carrying amount Finite-Lived Intangible Assets, Gross Finished product Inventory, Finished Goods, Net of Reserves Trade receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Pension and other employee benefit costs (Note 5) Total pension and other employee benefit costs Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Employment costs Employee-related Liabilities, Current Name Trading Arrangement, Individual Name Other current liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Other Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Other Total stockholders' equity before treasury stock Stockholders' Equity before Treasury Stock Net gains (losses) and prior service costs, tax Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax Total PMI net revenues Net revenues, related parties Revenue from Contract with Customer, Excluding Assessed Tax Entity [Domain] Entity [Domain] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Legal Entity [Axis] Legal Entity [Axis] Fair Value Hedging Fair Value Hedging [Member] Project contribution from government Project Contribution From Government Project Contribution From Government Interest expense, net Interest Income (Expense), Net Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 2) Noncontrolling Interest, Increase (Decrease) From Redemptions Or Purchase Of Interests Noncontrolling Interest, Increase (Decrease) From Redemptions Or Purchase Of Interests Received a cash refund Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Weighted-average shares for diluted EPS (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Trademark acquired Indefinite-Lived Intangible Assets Acquired Capital expenditures Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Number of cases that reached final resolution in favor of PM Loss Contingency Claims Resolved in Favor of Plaintiffs that have Subsequently Reached Final Resolution in Favor of the Company Loss Contingency Claims Resolved in Favor of Plaintiffs that have Subsequently Reached Final Resolution in Favor of the Company TOTAL ASSETS Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Amount to be deposited into trust Loss Contingency, Damages Awarded, Amount To Be Deposited Into Trust Loss Contingency, Damages Awarded, Amount To Be Deposited Into Trust Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] 0.625% Notes due 2024 0.625% Notes due 2024 [Member] 0.625% Notes due 2024 [Member] Damages sought, number of patients Loss Contingency, Damages Sought, Number Of Patients Loss Contingency, Damages Sought, Number Of Patients Average interest rate Debt Instrument, Interest Rate During Period Non-NEOs Non-NEOs [Member] Altria Group, Inc. agreement (Note 2) Payments to Acquire Projects Change in net loss and prior service cost: Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract] Operational sustainability weight (as a percentage) Operational Sustainability Weight, Percentage Operational Sustainability Weight, Percentage Pension Plan Pension Plan [Member] 3.125% Notes due 2028 3.125% Notes due 2028 [Member] 3.125% Notes due 2028 [Member] CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities [Abstract] Earnings before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Current portion of long-term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt Non-PEO NEO Non-PEO NEO [Member] Goodwill and non-amortizable intangible assets impairment charge Goodwill and Intangible Asset Impairment Adjustment to Compensation: Adjustment to Compensation [Axis] Other assets, allowances Accounts Receivable, Allowance for Credit Loss, Noncurrent Debt Instrument [Line Items] Debt Instrument [Line Items] Weighted-average shares for basic EPS (in shares) Weighted Average Number of Shares Outstanding, Basic Scenario [Axis] Scenario [Axis] Capitalized at acquisition date Unamortized Debt Issuance Expense Schedule of Short-term Debt [Table] Schedule of Short-Term Debt [Table] Five year tranche Debt Instrument, Redemption, Period Two [Member] 3.125% Notes due 2027 3.125% Notes due 2027 [Member] 3.125% Notes due 2027 [Member] Product Information [Line Items] Product Information [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Punitive damages awarded Loss Contingency, Damages Awarded, Punitive Damages, Value Loss Contingency, Damages Awarded, Punitive Damages, Value Other receivables Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Receivables Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Receivables Commercial agreement, interest rate Commercial Agreement, Interest Rate Commercial Agreement, Interest Rate Noncontrolling Interests Noncontrolling Interest [Member] EX-101.PRE 10 pm-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 pm-20230930_g1.jpg begin 644 pm-20230930_g1.jpg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pm-20230930_g10.jpg begin 644 pm-20230930_g10.jpg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pm-20230930_g11.jpg begin 644 pm-20230930_g11.jpg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end GRAPHIC 14 pm-20230930_g12.jpg begin 644 pm-20230930_g12.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" M5 &@ P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHKR7]OGXO>*_P!G[]ACXS?';P)QKG@SX5^(-;T9M@8+=6NG3SQ,0>H#HI/L M#0!PFM?\%(_#GC3X^>)/V8OV/O@OK_QA\5^")E@\?:CHE_:V&@>&+ELXM+O4 MKIPKW7!S;VT<\B8;S A4@+-_P43N?!'[1?PT_97^/7[+?C?P7XH^*&LWEAX> MU-Y;/4-#F^S:==WTCI?VTK?,!;"/R9HX9B90ZHR*S5X+_P &M'@/0_#'_!&# MX<^.;1C/K'CS6_$/B#Q1J4CEY;^_;5[JU\V1SDNXAM8$)))/EU]X>./AGX*^ M(USH5[XOT5+J?PSKT6LZ%.3A[.]CCDB$J$="8IIHSZI*X[T ;U%?GK^U)^TU M^WEX!^'_ .T7\<_BI\=M(^ %KX#U34[/]GKPU?V6C7D/CV&PL?M*75R;H2W$ M_P!KDS&D-LUN\*YR)&4D\/\ MA_\%8OVU?#O_!'?X%_\%%O@0O@S1M8^(=WX M9M?%^AW7AZ2[D\W4'\N4V$LMRL4 \Q"%6>.;Y9/O@IE@#]0J\J\>_''XV^%_ MVL? 7P)\,?LKZOKO@?Q3HNIWGB;XK6^N016?ABXMX]T%M+;,IDF:=L(&#+M+ M@@.%D*?!W[=G[:?_ 5L_P""6WQ5^'O[6O[2OQ%^&OC3X#>,O'5IX=\<^ _" M_A22UN/!*7>[RI;>_D"I-;MAJ\]A)?1:;YP\YK9'2-Y=G78'D1<],MBK]?EE^S[X8 M_:P\0_\ !Q3\?O#=_P#MB7LD7A_X7^&;F**?PC:R0)I,US]H_LJWB9\6\:L[ MYF!:1V=F8DFN\_:I_:C_ &]?AQ\*_P!HSX__ !6^.NC_ "'@'6=8M/V>O"& MH6.C7D'CZTTZR%S'=W)N1+TLDMA+<16\;SR3L9 AEF1-?VNOVL;_XQ_"GX2>*_P#@G_XC\*>$O'GC2?1O M%WB3Q%XET+4;6"T&DW]PMNT%E=7$A,TD")O950#*ELNJD ^KJ*^#?^"R_P"T M/^WW^PKIOAC]LCX&_$(:G\&-&\3V$7QM\*6_A&TNM6T?1'EBCFU'3YF7Y@HW M;TE#E&D5P1&&V>L?L=?$O]H[]J+Q%XQ_:@T7XQP#X->(7*? W1;_ ,)Q)-?V M@A53K%S(/+F:UEN/,:VAS'(]N$D=_P!Z%0 ^FJ*_+/\ 96_:2_X+6?\ !0"W M_:,^&?PR_:*^$G@'6OA#\>==\(67C)OA[)=0WJV"Q1PV=O92SR&VC=P\TMS. M]S(HF1(T.UB+?[+_ /P78^+-[_P38^('Q6_:;^%NG0?'CX5?%E/A3K?AK3+: M=K34_$DUY#:6LZPP"27R]TKM+%%N=OLDWE ;XT !^H-%?F[\4OVU?V_?@%^T M5\(=7^%L/Q8^._@;Q?XHAT3XM>&KW]ES6]";PQ!,5']L:?<_V="4MXB6+07, MEPVU0#+EC(EKP_\ M2_\%0?BS_P5A^.?_!/CPI\:/AGHFB>$O &CZQX>\5CP M!-(VCQWA5S(;-[QFOKOY_*!>YB@ 7S3$3^Y8 _1BO'_V\?VK[K]B']E7QA^U M%'\&=;\.VB1GDFDDN9$Q&JK\WEK+)R-L;3 M[&K%([EA&Z!$.TEXUY(+MYY^V_K7[>/[2W_!"/XB_MG>)?CKIOA^7QW\&+WQ M'-\)K?PS:3:-9>&KVR,JVANF07SZBME*)#<>>&/#6MQ?#'1?%$%O/:0:K#;S2_Z7-$%D%NLY MRWEKOV9(C7^)M:MK"*[O[>RMGNI@@EN9Y%BAA7/WG=V M50!R2:_+K]I?]K_]K7]A7_@WM_9O_:+_ &5O&/A;3)[3X7_#O2]9CU[PP]_< MO#>:?8P"2VD-PL4+*6Y$L,P8,<;",G<_X+?:?^T3=?M[_L5Z#X#_ &EKWPYH M/B+XR&"U\/VV@P36]MJ,%J6349M[9NW5971(VVQH&) +'=0!^G%%?"GQ$_:7 M_:Z_9\_X*Y?LV?L7ZY\=;;Q;X-^+'@_Q->>*EO\ PG:6MPMYI>GR3));R0!3 M'&[^6QC;>058;B& 70\#_M6?M1P_\%P/'/\ P3^U+XFZ=JG@:/\ 9U;Q]X:& MH^&X1_P#!/AS4 MO!_[/FJ^+QJVLV,<8O+J^GCT^ZMUMEN9&@2UA:*?$#2M*!,B( ??5%?EZ?\ M@L?^UOX%_P""6_@+]I3]L_X#Z_\ !#Q?J/QJT_X?_$WQ%K?@"^@B\/Z9*'DD M\2V]A>QB1H7C$<*%UDC2XE;Y91'Y3?7G[(7B+XT^+OB5K/B^R_:LTCXR?!36 M?".G7?P_\7V=MI?VK^T?M%TM[#-<::D<%ROEBU9&2*,#?\$\ M?#/[7?\ P0VL==_87^+7[-'Q!^+?P+A\2WFI_"+XI?"S1/[:O=,M+J4RR:=J MFFP$7,961FD\Z*-U9Y7QE2-GV[\/_CE\6_VAO$VF3?#SX/>+/ _@VTN%N=;\ M1?$#0AIU]J:J,K8V6GSDW$09L>=<7,<6V,%(5D>0RV_LU% 'Y*_##P;^WU!X M@_;+^$/QQ_8)\:^-_BW\1]3\3V?P\^,MU>6,?AY?"%S9/#INF07LTWF6L47S M.+2WA=GDN 90C"21?$OVQ=*_:"^&?_!LW\%_AC\8/V;/$'@OQ+X&^(7@W28= M \375O#>:G/!>R?O!&CN+>)VVJAF9)#\Q:-%",_[KU\J_P#!6C_@GY\4?^"D MGP(T;X"^!_CAH?@6RT[Q?IOB&ZU'4O"T*\^(VD:]\7-?\=^#[K1H- T MBP32>7#&;,W$*YD=I0H!:G^USX/^+VL?\%X/V;OC_X;^ ?C MG5? /P[\%^)=*\8>,--\,SRV=C=:C:R);J,+OG4-LWO$KJOF#)^5POWYX:C\ M2PZ#:Q>,+RQN-36("]FTRV>&!W]41W=E'L68^]7J /SQM_AY^U'^SU_P7L^( MWQ_T3]E#Q5XS\%?&'X4Z!H^B>+="NK2/3='O;*54F&I2S2JUO&J*TF4261AM M$<-?#3P1^W\;+]L[X)_'#]@;QMXS^,?Q)O/%=EX)^,MW>6,?A^3PG=6 M+P:;IUO?32F2WBB^9DLK>%RTDX,HC/FR)^N=% 'X^_$GX._M@>/O^#7>W_8E M;]BWX@Z?\2V\%Z)X9TCPC-81RWMY)9ZA:2W%W(L3LEG;^7$Y3[0\0>&K*VOM)U[3);2ZM+B.!$DB>.0 Y5U(W+ ME&QE68$$]W10!^9?_!>3P'\>?C-^T'^RG>_ /]F/XA>.[?X/?'K2O&GCFZ\. M>'',-OI]M-:S,D,LQCCN960-A8F8 J59E;BOHWXQ_P#!0[XC:)\.]2U7X0?\ M$X?CMXM\5PP,?#NB7_@Z&PMY;PJ5B,US-<8@B#$;W4,P7.U6/%?4]% 'R=\: M['XS_'GQAX%_X)^_%3P=XJU#P?J?A1;CXX_$VT\//;Z7XC>*"+=H,,D0 @2] M-[56\RXS%XI_P2D\-?M-?\$^/VDOB1_P $W]<^"GQ#UW]G?3?$ MDEY\!_B;=Z+-)#H\-P1+/HMPS?O&MXII)!%=;=AV2,6V2)L_1RH-474VTVX7 M198$O# XM'NHV:)9<':752"5SC(!!([B@#\I_P#@C3^TK:_!/X\_MSZ%XG^# M?Q"U:PN/VQ_&%SI>L>#?!5YKD5U=^<%>Q=+&.5[:0*L3B2=8X&$V!+E' J^* M/^",G[3_ ,6O^":_QVU6RCMO"'Q]^,'Q]N/C3X:T"?4(630+V*^6XT_2)IT+ M1-,(%D5I0QC6>XY9D3VNE^#I],ETO4;YU:2!'>]G$D "@*"H<8R6.:^L: /@7]DG_@H-_P4_\ MVK3H?P.^(G_!,'QG\&O%5M<6\?Q%^)/BFX@7P_96\3J;J72T<-)?3SJKI#& M\<+3*[R2)$0^9^SQX:^+'AS_ (+U_'K]I'Q)\ O'UA\//&'PPT/0?#7C&?PE M=&UOKVQ$1G0*J&6-?]8%=T5',9P3N3=^AM% 'Y+?!?\ 8E^,_P"TU>_\%$O@ M+\0/A'XR\!Z?^T5XA>\^&'BGQ-X;G@L[U([:6.*>0@%H%$RP.8Y0DC1R8"[@ MRKG:1\5_V_-?_P""*/CO_@F/\7_^"9OQ@C^+?A/X*7_@>#5]*TFVG\/ZQ:V] M@UI;7=M?"?\ TF5H4C'D0I+(\I&T;69H_P!>J* /R*_;S^"/[7?Q3_X-X?A# M^QWH/[&?Q"/Q2TC1?!.F7WA""SM;J2-=&CL_M-TT]M/)!#&_DGRXY9$G);!B M7:V/;_\ @KUX#^.GQ)\=_LD?MD_ ?]G7QIX[TSX5?&%=:\7>$M%TM8-=AL)[ M?RFD2TNWA)9&3!4L.64Y"$N/T&HH _-__@HGX=_:A\+?MV_LA_\ !3K0?V.O M''BW1O 5IXHTCXA^ ? Z6^J:_HL>KV(@M9?*CD$<[(68S>6[1HR%5D=2LC9W MPFT[]L'4?^"^^H?MN>-/V%_'FB?#K7OV7[?PR-0:6RFFT=VUE;Q#>JLX5[@) M;N7M;)[N6,2PC#,S!?TQHH _/;_@BOX/^,WPQ_:%_:S;XP?L]^.?!]E\3/V@ M=7\:>!M4\1>'I(;?4]+N#M1MXW""3"*WER[&(D& 2&"^4^"=7_X*(?\ !&;] MM3XU^%_"7[!_C;X^? ?XW?$J_P#'_A35?AGY#_&/[0?[&$_C73_B%\23:_$SX-Z' MIUIK\OA?PA/I%XJ12Y CU"2.Z@LY[@*'RUS+!%YBK&6\>_X)B_L#Z;^R_P#\ M%+_B5\7_ -BCP)XV^'_[-/BGX:VZ:CX+\7Z7J&EV]SXT-\&,^GZ?J*QW4,$- MFA5I)(U3?O//C7^VYI/[/'AG MP%I_Q-^%VK3?$3XGZX^D^!OA;X;O[:\U+4+H(\[(TTCPVT2PVZ^;_$W4OC3_ ,'"'[,O[&6H3E_#'P[^'NM?%/4]-/,5YJDD=YIM MA)(.[6Q222,]C.3Z5Z!_P6+_ & _VC?VJ],^&/[37[$/Q)L?#OQP^ ?B*[US MX?Q:T!_9^L1W,4<=YITY/">='#&H8_+C(K*ZM-1T*]GTXW3S6C3PSF:VN!!;2.%FB5)-C MF-VVD#ZKK\T/^"(7_!3GX&?M2:#H?[%7[1'@.;P!^T)\-M4U355\'Z_$4COI MGDODGO=)EW$7"+#=W,97)8(793(@,E?I7>+=O:2II\L<"?%":;X-\3:CKD%U M%XSLVBWF_@CC4-;J#@;&+_>'S!@Z)ZK7PG_P3@_:V_;C_:<^+_[6_P %/BI\ M2? K:_\ "/XE0^&_ VJ67@:>/2[>(PR.)9;,7WVB7<%5F0W>0VA^':ZBWB7^RY;A_L7[R5 M(].MPD/DJP2XF=OG:1,;6 /UTHKQW_@GS^TSJ?[9?[$/PL_:FUW0K?3-1\<^ M";'5=3T^T+&&"ZDB'GK'N);RQ('VY).W&237SI_P4L_;#_;E_9O_ &]OV8?@ MA\!/$7@67PC\9?%.J:7J6DZQH$R7BRVEG'*/-O?.E4P,TN_;%;QR#R=OF-YG MR@'W;17YMZI^TQ_P56_9_P#^"IF@_L >+?C[\-_B-8_&+X;:AKW@[Q)?_#Y] M&C\&WMI*?/S:VUS))?P+$K,D,DZR2.\:F>(*\C]G^Q/^U'^VOX3_ ."GWQ5_ MX)E_M9?&;P_\2FTGX86/CWP-XZL/!L>BRPV\URMK+97%K!*R.%ED4JP;<51B M6.\! #Z3^#_[0'QW\>_$?XN^$_B!^Q]X@\*Z1X U>*U\#:[)K]I#Y/$%A<:CJ5W806KRMO9XK6!_,N&CV>>Z#RMPE.X <9_P2W_; _:M M_:%_:P_:M^!O[3?BWPSJL?P=^(.FZ'X7?PKX;;3+<6TMO/*7,')K?7]9TNQ\(76MPW%U-?$/P2US0M.\4:=\1/&UWI%UXET::_LA+ M%>22!98(;BW=@VW;D2KMSNPV-IZ#X*?\%E?BCX(_X("^"_\ @I;\>=-T[Q7\ M2_%\MQIFAZ-;0+86NJ:S<:Y=V-E!B,8CA2.-7'[<.A?\%.?V9?V??V8/'7PZO_ (_\ !,K]L'XS^'OB;:'X.VWQ)\%^,M'\%QZ#+:6Y MU&.PGL)+>*:56422$HS.SXCR6._"\+^S5_P4&^/7[?/@#QKK7[/'[8NE>&OC MGX3\;ZI9:O\ LX:SX>TQ?[,TVRU22#R0EQ&M[-=/91B3[6)VMQ/)L,* %5 / MM_Q!^TQH/P__ &@M(^ ?Q4T&306\8[U^'?B)[D26.O7,4'FSZ>6VJ;:^15ED M6!LB:&,O%([)-'#Z;7Q7_P '"?AW5;O_ ().?$OXD>$-2DTWQ3\-Y-*\:>#] M;MSB?2]2TW4K>X2XB/\ "_EK*F?21AWKZ3_9+^-T?[3'[+'PU_:,BLTMAX]\ M!:1XA-M'G$)O;**X,8S_ '3(5_"@#T&BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\Z/V MN_AGJ7P7_P"#A[]F3]L74(&C\,_$?X=:W\+[_42,0VFJPQWFI64. M,?Q& CM7U)^U#\>OCY\ _C9\.];\+? +Q7XX^&&I:5KEI\0KCP5IT-]?Z'?[ M].?2[LV@87-Q"4748W6W5R#(C,IPH/H'Q\^ GPU_:3^&US\+OBEI4L]C)=6] M[8WEG<-!>:9?V\JS6M]:S+\T%S#,B21R+RK*.H)!W/ >D^+M!\)66C>.O%\> MOZI;1F.XUE--6T-V Q"2/$C%%D*;=Y3:C/N94C4B-0#\N/@?^SMXF_;P^/W[ M*'QM^'/P4U_PUHGP&\3^*=<\5_%'Q-H,FD3:C%/>W0MM#LH;A4N;I7D8O,[1 MK#"N]0[2.R5^K=S.EK;R74JN5C0LPCC9V( SPJ@EC[ $GM4>G:;IVD6BZ?I. MGP6L"%BD%O$$1226)"J !DDD^I)-3T ?G1_P2QTOXL?!+]KW]L[XJ_%[]G3X MC:!H/Q%^*$?B3P)>W7@R[D.M6$44L),<<2,\$G\*3RSW\FJK=M9^5)$& MA(8RA69G41D9?:"I;]6J* /E;_@BAX1^(/PP_P""8GPB^#'Q<^&VO^$O%?@O MPK%H_B#0_$.EO;RP7$3-RC$;)D92K!XV8?-@D,&4>0_\%5_!GQ?\:_\ !1O] MCGXB?#?X"^-_$WAWX4>.M7U;X@:[H/AN:XM]*M;NT@@B8$#-PV0[,D D90AR M-Q53^@]% 'YY?M(^&_BOKO\ P7F^ O[2'A[X!>/]0^'O@KX9Z]H?B?QC:>$K MIK6SO;Y9# FTJ)95^X&>-&5?,&3\K[3P#X6^+5A_P<1>-?VG[_X!>/8/AMJG M[/=OX*L/&LGA2Y^QS:O#JD-TT84+YHB**X$Q01EDX;:RL?T-HH _/#_@E;X9 M^+7PP_;U_;-^*7Q6^ 'C[PUX;^)GCVQU_P ":QJOA.Z$>KV-I:W$4K*B(TD< MA^1EBD5)'$@"J6!4,_X(C>'_ (M_L\67[4\_QZ_9Z^(/A,^-/VD_%7Q#\+1Z MCX2N9&U+1;XVRPF,0J^9\Q\P'$F#D*0KE?T2HH _,W_@B_X*^.'[,_\ P2D^ M(?PA^.W[-?Q"\.^,(?$?BC4;+PS<>%IYKC48M1D9[46[0AXY&9I C#>/+*EG MVI\]>/?#7_@ES^TO^U'_ ,&U/@_]@O4? .N?#_XW?"[5I=>T+2/%EBUI%+JD M&KW]U;QK.)?2$0:E'BWD6W2T>620 MRQ%EC .M \(W6DPSWL%U$AU&YUB!?L'V1H TVV M>474('EQH2H63]BZ* /B3_@O-K'BW0_^".?Q&^'48.O>-/'&EZ1X,T.QL80L MNM:QJ5]:V8C@C_O,9)'"]E4^E?3'[(OP1/[-'[*7PR_9T:[2X;P%\/\ 1_#S MW,?W9FLK*&W:09_O&,G\:9XI_9VT?XD?&[0_C!\4M8&LV_@N=KKP%X<^R".T MTJ^> PR:C*"S&YO DDT<4AVK#',X5-[-*?1J "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HJO9:OI.I7-W9Z=J=O<3:?<"WOXH)U=K:4QI*(Y # ME&,&&;Y7^5L;>2P! /S MV_9)_9Q^"'[1D?Q$_:5_X)V_'SQ1#_9WQ]\+W_ASQ7HGQ+U2YM_$&BIX?\)S M:E8ZDEU<2+?&2-[Y'^TJT\4W&Y60I7TY_P %;[#XA)_P3A^-7C3X8?'#Q;X# MUGPI\+?$&O:?JO@^\AMKF2>STZ>YBC:9XGDB0O$N3"T4F"<.*_,+X^? _P") MO_!#SXU_&7_@H9_P3E\6/I'PH\)?'/0_#7Q)_9VF>272M5T_4-$\/W'VFP#, MS0W8N]5E5 H^160*1%&T+_JA_P %5?\ E%[^TC_V03QA_P"F2[H SO\ @D'K M^N^*O^"6?[/?B7Q1K5WJ6I7_ ,(- N+[4+^Y::>YE>QB9I))')9V)))8DDD\ MUWG[;'[3&B?L:_LC?$?]J?Q!IXO(/ ?A"^U>.P+[?MD\43&&WW?P^9+Y<>>V M_->"[+4I;OP[);M=:5/(B_:8(GN89H\I*) M8MY0G R-K8(^8(?C3X,'_!K@/BA:ZE!]B3]B_P"P*0XVB]'AO[#Y&?470\KZ MU[%_P0]^#_BWX$?\$E/@)\-?'5C-::M!\/[:]O+2X4K);F\9[P1.IY5D6X"E M3R"I':@#R?\ X-KO'/Q.^(/_ 3SUC7/C!\4?$'C+78OC#XHM+KQ#XGU22\O M+H172QJ7DD))X' & .@ '%4_@+\0Q_P5/_X*;_M&^ OBAJVJS_"+]G.YTWP= MX8\'6&LW-E::KX@F%PVI:G>"VD0SRP/;_9X5=F2-6,BJLC%JC_X-C/\ E'9X MA_[+EXP_]+ZPO^"(7A+4/@Q_P4:_X*"_!#Q?"UOK4_QU@\8VT4PPT^F:R;V[ MMI4S]]0C $C."<'!H ]-_P""27[4'Q"U?X[_ +1__!.7XO\ C+4?$6J_L]>/ MH(?"GB'7+QKB_OO"^IQR7.G174SDO#K*\49CN-0T^Q*7L8/3="4A##MYPK]+Z M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKQS]I']L[P;\ /B/X+^ F MB^"M8\:_$GXB&]?PEX)\/R6\YECAM;6(,@9W8LS.$C21OEK M@/V(O^"B_B#]I&3X>^ OC1^S9XF\!>*_B!\)[?QUH.H%[6\T'6;+RK(W/V2Y MAG>2.2-[^#,%Q''(%D4_,.: /J*BOA#XO?\ !=?0?A_\8/%GPL^%_P#P3-_: MM^+%AX1\07&BW?C?X6_"9M5T2[O;9O+N8H+E9UWF*820OP,/$PZ8)](_8\_X M*O\ PH_:U_9[^(/[2&I? CXG?#32/AMXHG\/:]I'Q$\-);ZM)J4,<+26L-E; MRS323[[B&!8=HD>:01JK-Q0!]3T5\/>#_P#@MAI>G?M:^"?V5/VJOV&_BW\% M'^*=Z]G\,/%'CFVL9++6;H$;+64VD\OV6=RT:B(EV5I$#[0P-?0W[6?[8WPX M_9)TSPO9>(M&U3Q%XL\?>(XM ^'W@?P\L3:CK^HNI8I'YSI'%#&@,DUQ*ZQQ M1J2QR55@#UNBO$O@3^VIH7Q.^.^O_LG?%#X>:AX!^*7A[0+?7Y/"FJ7\%U'J MFC3R-$FI6-S Q6X@696@D!5'CE7#)M9'?VV@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ KSC]J+]E?X3_M>_#FV^&OQ;&M0V^G:[::WH MNJ>'-?N=,O\ 2]2M6+V]W;W%NZNDD;$D9RO/*FO1Z* /DWX=_P#!*7P3%\6] M<^)'[2/QK\9_%>T'Q(LO&'A'0O%VH6PLK6_M=%TW3X+V\@L[:WCO;N)K%O+> M8.B((F"><'E;W+]IW]G;PS^U;\%M>^ /CSQ=X@TOPWXITRXTSQ)!X;4 M+&>)HIK5I7B=DC='(8QE&(XW8)!] HH \V_90_9A\&_L>?!/1?V>_AIXL\1: MCX7\-645CXO^"3?_!/;PW^P MSXO^,FM?"2;QU9_#SQ_KUC?^']$^(6JR7%_+?1_:WO\ 5/*D5)+9+@W-O L< MRBCGX9&?Q0WPL/BAO$7_ I-M:7_ (14 M:@;G[66^S"/SC;_:O](^PF8V?F?-Y':OH?Q=X?O/$WAJZ\/:;XKU+0I;F,(F MJ:/Y/VFW&028_/CD0$@%JW&J3Z)XDUE+^-+Z=E,URDC1"96?:,KYFPDD[=QS6M\9/V*OAK M\5_B_:?M$:!XO\4>!/B#;>'WT&?QGX&OX;>[OM):3S?L-REQ#-!/&LF7C9XC M)"S,8GC+-GV&B@#A_P!G?]G+X/\ [*WPQMOA'\$O"O\ 9>D0W<]Y._C#\,O^"C__ 3?\4:4/C1\&;2_LX_! M?B-@NG^+]'N@#/8,[,JQR??"[F0'S,^9&\:-7/?\$&?^"DG[*?[:_P"S[\._ M@1%HEYX7^,_P:^&&FZ-J?A#Q3;F"^.GBRLXCJ-F3C[1:7 BMI,@;DW1[E :- MY/I7XW_M'?'/X!?M/Z;:ZK^SYXT\5_"'6_!RK<>)? ^AKJL^@:Y%=2EA/96Y M:]EAFMY(_GBBE"- H"C>Y'Q-_P $^?V8?%W[3W[3'['7[<7A3X-:MX,\+?!# M]F2UT37O&6OZ;]@N?'5]>:)!:P64%N^)Y;.T5YYQ=2JL;O*HB\Q?G !^AW[1 M/QA^'?[&/[*_C/XYZII5I8^'?AWX.OM6.G6D:PQF.V@>1;>-5 +LH15 Y9P M!UK@/^"7/[/'B+]GK]A'P'X+^*=N)O&FM6LGBOXA37$7SR^(M4N7U.^9\\ED MN;AT4GD").F!6)_P4R^&WQ _:.3X0_LE>'/!6J7_ (5\;_%?3[_XHZK!8R/8 MV7AW1\ZK+;W,RC;$;NZM;*U5207$T@' ->P?M2_&;QO^S[\"]<^+OP[^ 'B; MXGZMI"PO!X*\'M"-1OT:9$D,(F958HC-(5&68(0H)(H _/C_ (*??MC:)X(_ MX*6_LW:3^W1^Q?XZ\-?!3PK\0C=^#?BI-?:?.=V"2&+9;NKZ'[3>MZKXS_X.I?V;_AWKB02'*)?WSZ MG97#J.FXPV\()Z_*/2O3/VJ]!\4?\%C/@?X4_9RM/V5/B/X!\,WWC?1-=\>Z M[\5?#B://HUEI]W'=O:6L#2O+<7DYC%NKQJT$<^(?A/2E5K[5O"^HP21//:JS+YTUG+*UP( M0TJLX7+JJ. >._\ !2?Q#J/PZ_X.$?V#_$_A21DO?$FD^,]!UQ(C_P ?.GFS M1E1P/O*DDKR@'@,@/:OTTKX<\/?LX^./VT?^"M7A'_@H;XQ^'>O>%_AU\$_A M_>Z+\-K7Q=I4FGZEKNNZB9$O=0^Q3 36UK%:N(5%PDJ_:/"7A/A_B>GC'F='VGLW#E]Z<;7Y[_ RC>]EO<_(/%+BC/>'* MF$675O9\ZGS>[&5[ZORQHH_XA3P#_ - ?_E2K_P#) MA_Q$[CC_ *"__*=+_P"0/U._XB7?^K*O_,C_ /WNH_XB7?\ JRK_ ,R/_P#> MZORQHH_XA3P#_P! ?_E2K_\ )A_Q$[CC_H+_ /*=+_Y _4[_ (B7?^K*O_,C M_P#WNH_XB7?^K*O_ #(__P![J_+&BC_B%/ /_0'_ .5*O_R8?\1.XX_Z"_\ MRG2_^0/U._XB7?\ JRK_ ,R/_P#>ZC_B)=_ZLJ_\R/\ _>ZORQHH_P"(4\ _ M] ?_ )4J_P#R8?\ $3N./^@O_P ITO\ Y _4[_B)=_ZLJ_\ ,C__ 'NH_P"( MEW_JRK_S(_\ ][J_+&BC_B%/ /\ T!_^5*O_ ,F'_$3N./\ H+_\ITO_ ) _ M4[_B)=_ZLJ_\R/\ _>ZOIO\ X)K_ /!43_AX9K_BS0_^%&_\(A_PB]G:3^;_ M ,)-_:'VGSWE7;C[-#LV^7G.6SGMCG\%J_3?_@VO_P"1^^+'_8'TG_T;\(9+PEB<;@\-R58*-GSU':\XIZ2FULWNCZK@CCSBO-^*,-@\7B.:G-RN MN2FKVA)K513W2V9^LM%%%?S*?T:%%%% !1110 4444 %%%% !1110 5!INFZ M=HNG6^CZ/I\%I:6D"0VMK;1"..&-0%5$50 J@ < #%3T4 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D?$'_ )$'7/\ ML#W/_HIJ_EZK^H7X@_\ (@ZY_P!@>Y_]%-7\O5?T7X#_ ,',/6E_[D/P'QN_ MBX'TJ?\ M@4445_0)^$A1110 4444 %%%% !1110 4444 %?IO\ \&U__(_? M%C_L#Z3_ .C;FOS(K]-_^#:__D?OBQ_V!])_]&W-? ^*/_)!XWTA_P"G('W' MAM_R6V#]9?\ IN1^LM%%%?QB?UX%%%% !1110 4444 ?,?\ P4#_ .0UX8_Z M];K_ -"CKYWKZ(_X*!_\AKPQ_P!>MU_Z%'7SO0 4444 %%%% !1110 4444 M%%%% !1110 5^C6A_P#(%L_^O6/_ -!%?G+7Z-:'_P @6S_Z]8__ $$4 6J* M** "BBB@ HHHH **** "BN9^)GQE^%WP;L;74_BAXULM$M[V8Q6LMZY D<#) M48!YQS7'?\-S_LC_ /1>M!_[_/\ _$T >KT5Y1_PW/\ LC_]%ZT'_O\ /_\ M$T?\-S_LC_\ 1>M!_P"_S_\ Q- 'H'Q!_P"1!US_ + ]S_Z*:OY>J_HS\8_M MK_LI:KX1U72[#XZ:#)/845Z?_ ,,<_'S_ * 6@_\ A<:1_P#)5'_#'/Q\_P"@%H/_ (7& MD?\ R51_K=PG_P!#"A_X-I__ "0?ZJ\4?] -;_P5/_Y$\PHKT_\ X8Y^/G_0 M"T'_ ,+C2/\ Y*H_X8Y^/G_0"T'_ ,+C2/\ Y*H_UNX3_P"AA0_\&T__ )(/ M]5>*/^@&M_X*G_\ (GF%%>G_ /#'/Q\_Z 6@_P#A<:1_\E4?\,<_'S_H!:#_ M .%QI'_R51_K=PG_ -#"A_X-I_\ R0?ZJ\4?] -;_P %3_\ D3S"BO3_ /AC MGX^?] +0?_"XTC_Y*H_X8Y^/G_0"T'_PN-(_^2J/];N$_P#H84/_ ;3_P#D M@_U5XH_Z :W_ (*G_P#(GF%%>G_\,<_'S_H!:#_X7&D?_)5'_#'/Q\_Z 6@_ M^%QI'_R51_K=PG_T,*'_ (-I_P#R0?ZJ\4?] -;_ ,%3_P#D3S"OTW_X-K_^ M1^^+'_8'TG_T; M+H8;&4ISDHVC&I"3?OQ>B3;>FI]EX?\ #V?X+B_"UL1A*L()RO*5.:2]R2U; M22UT/UDHKRC_ (;G_9'_ .B]:#_W^?\ ^)H_X;G_ &1_^B]:#_W^?_XFOY+/ MZD/5Z*\H_P"&Y_V1_P#HO6@_]_G_ /B:/^&Y_P!D?_HO6@_]_G_^)H ]7HKR MC_AN?]D?_HO6@_\ ?Y__ (FC_AN?]D?_ *+UH/\ W^?_ .)H ]7HKRC_ (;G M_9'_ .B]:#_W^?\ ^)H_X;G_ &1_^B]:#_W^?_XF@#SK_@H'_P AKPQ_UZW7 M_H4=?.]>L?MA?M!_ _XIZIH5QX#^*^@WZ6=O.MRW]I)%L+,A'^L*YZ'I7C/_ M E?@[_H>-!_\'EM_P#%T 7J*H_\)7X._P"AXT'_ ,'EM_\ %T?\)7X._P"A MXT'_ ,'EM_\ %T 7J*H_\)7X._Z'C0?_ >6W_Q='_"5^#O^AXT'_P 'EM_\ M70!>HJC_ ,)7X._Z'C0?_!Y;?_%T?\)7X._Z'C0?_!Y;?_%T 7J*H_\ "5^# MO^AXT'_P>6W_ ,71_P )7X._Z'C0?_!Y;?\ Q= %ZBJ/_"5^#O\ H>-!_P#! MY;?_ !='_"5^#O\ H>-!_P#!Y;?_ != %ZBJ/_"5^#O^AXT'_P 'EM_\71_P ME?@[_H>-!_\ !Y;?_%T 7J_1K0_^0+9_]>L?_H(K\U_^$K\'?]#QH/\ X/+; M_P"+K[3TK]N#]DNVTNVMYOCOH*O';HKKY['!"@'^&@#U^BO*/^&Y_P!D?_HO M6@_]_G_^)H_X;G_9'_Z+UH/_ '^?_P")H ]7HKRC_AN?]D?_ *+UH/\ W^?_ M .)KIOAG^T%\%_C+?76F?"_XB:=K=Q91"6ZBLG),:$X#'('&>* .QHHHH ** M** *6L^'/#WB.)(/$.@V5^D;;HTO;5)0A]0&!P:S_P#A5WPS_P"B=Z%_X*(? M_B:W:* ,+_A5WPS_ .B=Z%_X*(?_ (FC_A5WPS_Z)WH7_@HA_P#B:W:* ,+_ M (5=\,_^B=Z%_P""B'_XFC_A5WPS_P"B=Z%_X*(?_B:W:* ,+_A5WPS_ .B= MZ%_X*(?_ (FC_A5WPS_Z)WH7_@HA_P#B:W:* ,+_ (5=\,_^B=Z%_P""B'_X MFC_A5WPS_P"B=Z%_X*(?_B:W:* ,+_A5WPS_ .B=Z%_X*(?_ (FC_A5WPS_Z M)WH7_@HA_P#B:W:* ,+_ (5=\,_^B=Z%_P""B'_XFC_A5WPS_P"B=Z%_X*(? M_B:W:* ,+_A5WPS_ .B=Z%_X*(?_ (FC_A5WPS_Z)WH7_@HA_P#B:W:* ,+_ M (5=\,_^B=Z%_P""B'_XFC_A5WPS_P"B=Z%_X*(?_B:W:* ,+_A5WPS_ .B= MZ%_X*(?_ (FC_A5WPS_Z)WH7_@HA_P#B:W:* ,+_ (5=\,_^B=Z%_P""B'_X MFC_A5WPS_P"B=Z%_X*(?_B:W:* ,+_A5WPS_ .B=Z%_X*(?_ (FC_A5WPS_Z M)WH7_@HA_P#B:W:* ,+_ (5=\,_^B=Z%_P""B'_XFC_A5WPS_P"B=Z%_X*(? M_B:W:* ,+_A5WPS_ .B=Z%_X*(?_ (FC_A5WPS_Z)WH7_@HA_P#B:W:* ,+_ M (5=\,_^B=Z%_P""B'_XFC_A5WPS_P"B=Z%_X*(?_B:W:* ,+_A5WPS_ .B= MZ%_X*(?_ (FC_A5WPS_Z)WH7_@HA_P#B:W:* ,+_ (5=\,_^B=Z%_P""B'_X MFC_A5WPS_P"B=Z%_X*(?_B:W:* ,+_A5WPS_ .B=Z%_X*(?_ (FC_A5WPS_Z M)WH7_@HA_P#B:W:* ,+_ (5=\,_^B=Z%_P""B'_XFC_A5WPS_P"B=Z%_X*(? M_B:W:* ,+_A5WPS_ .B=Z%_X*(?_ (FC_A5WPS_Z)WH7_@HA_P#B:W:* ,+_ M (5=\,_^B=Z%_P""B'_XFC_A5WPS_P"B=Z%_X*(?_B:W:* ,+_A5WPS_ .B= MZ%_X*(?_ (FC_A5WPS_Z)WH7_@HA_P#B:W:* ,+_ (5=\,_^B=Z%_P""B'_X MFC_A5WPS_P"B=Z%_X*(?_B:W:* ,+_A5WPS_ .B=Z%_X*(?_ (FKNC>$O"GA MR5Y_#WAG3[!Y%VR/964<1<>A*@9%:%% !1110 4444 %%%% !1110 4444 > M.?M'_M=V/P2^*'@3]GKP1\/[GQC\1OB1_:$OAGPY#J,=E;Q65C'&]Y?WEU(& M$%O'YL*?*DLCO,BI&WSLD7P$_:P\7_%/XY^*_P!G+XF_LX>(O ?B7PAX=TW6 M+J[OM1M;W2]5M[V:ZBB>PN8'W3(K6DH?S8X)%. 8\$,?+?\ @IS^P!I/[<'B M;P'X@^#W[2^K?"+X_?#6'4-:^%OC?0U\UX;>0P0WD%U;G"W-G(QMT=2>-PX9 M'DCD\'^!7_!3S]L[X&ZU\;_V;O\ @HY^SOX8B^//PB^ &J_$/PQXU\&%FT?Q M_H.GB0!U4@/ _P!I*J8_ER7D(CAV@, ?IE17YU?!WX7?\% /BQX<_9R_;,^% M/[16D:3;:G+HNK?%'4=>^.>M:MIGC31-2@C-S%!HTVG)I]A>,\R-;?9_+6-\ M1992*\V^#7P'_:@_;*^&/[8<%]_P4C^.?A_6/A=^T=XMTOX8WNA^-VLEL'M- M+TV:VCNO)1?M%F&=5^R?)" TSA?,E+@ _4?Q#X]\'>$]=T'PQXC\0VUIJ'BC M49;#P_9RM\]]<1VL]V\: =2L%O-(2> (SSD@'7K\=/ASXCU;]O7]H7_@F5^T ME\>M2\56OBGXC_#+QX?%:XTJPL98-12:4FYD^U-+YL-) M"(WBSQY)X5\+_'OQC^P;^VLVL_MU_'(7/[,GQ'\>6/PFU6T^(]W!J$,>FZ1; MZI:#4+Q"+C55628Q&.ZDD0Q+C;D[@ ??OQ/_ &V[_P"&?[?OPL_8>O/@O=S0 M?%#P]KVJ6'C5];A2& Z7#%+-"MLJM)(3Y\2[F:,#<2-V.?>Z_+/XJOXU_; _ M;#_X)UZ_XJ^*.O\ AG5_'O[/7C'5?$.O^#YX[._\RYT30I[@6\I1A;%V=E\R M-0Z*Q\MHWVNO)>*OVM?VJO\ @FK;_M>?LR?\-&>)_'VA?#G4/AYHZ2VL6(%I<($<2 M)&XC:(,_E[DS7GW_ 0?^&WQ@^./[)7PG_;A^.7[:?QC\6>(DC\7:7<>'M7\ M8F31-0@_M^_MXI+NU9";BXB$.8IBX9%81#]U''&H!^B-%%% !1110 4444 % M%%% !1110 4444 ?->A?M]>-_BQ?^.-=_9D_96UCX@^$?AYXJOO#>M:U:>)[ M*RO-6U.Q.R]ATJUN"%NA#+F'?/-;*\B.(RZ@.?7/V:?CCI/[3'[/_@[]H/0? M#.IZ+9>,O#UMJ]II.M1!+RSCGC#K%.JDA95!PR@G# C)QFOS]^*W[$G[=O[& MWQ6\+9M9\-7?C&Y M\.SP7&@0%)]&CU&RMI)X ;MI) \"1R2I9A+M=_;#U#2--L!H_B'X-VOAKXH:CK?B3PO!/%O$-O?7/AG5QI>O16[9-E>&V@NO(?MN\FY@? S@2#OD#7K\=/V>_'C? M\$_?V"?VZ_VJ?A+K_B)/$'@_]J3QCX.-5U&SL89]3TJSCOIK>[GGA MGN(/.$S7"_V8_P!N3P;^USX#^*7ACXZV?AWX8ZKX>U/1 MOB-X9U?X[:WXNN-9_; MF^,LGQ(^$_Q(\1R^$M1/CNX2VDCLO%;VH@OK="(]1A>$>68K@/&BA5B2, AO MKCQI:_%7]F#_ (*Z?LT:!H/[2WQ'\1Z3\=?#WCB#XA>'_%GBJ6\TJ2?3=.M; MZUN;*Q.+?3G61W0BV2,,A ()W%@#Z"_8!_;4N?VXOA[XU\:W_P (Y_!=UX*^ M*FN^";W2+G6H[YWGTN9899B\<:*NYRPV+O "YWMGCW:OQR^ O[+GQ0^*W['G M[77QN^%W[:GQ6^&?B7P'^TO\5M8\'0^"?% T_2DO;2_DN0U_;HG_ !,(Y618 MY$G9XUC V(C%V?UKX#?MF?M(_P#!07XC_"KX+Z_ID=I-JW[(WAOXF:]HEC\4 M]6\%3:IJ6JW$MM/=Q7.DVTMT\$ @39$KQQ@W^7$C)$4 /TSHK\IOVB?#7_!1 MW]FO]F;]GWX9?&/]NW4W\8G]M'PQX1;7_ _BB2\FN?#.HW7FP6FKS3VL$E[= M1QLBN)%\N:,1F19/-?/Z+?LS_L^+^S3\/;GX>1_&SXA>/4GUR\U*/6/B7XG. MKZA;BX??]D2X9%;[/']V-&W%5.-QXP >AT444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% 'C_Q[_8X\-_'3XP>$OCY:?&#QUX)\7^"='U+3-!UGP7JE MO%BVOI+62YCG@NK>>WNE8V<&$FB=%*A@H<*RU?A5^PW\./ WQ/\ $OQT^)7C M3Q#\3?'/BOPPGAK5/$_CQ;%GCT-7>3^RX+:RM;:U@MFD=Y'58M\K$&1WVKAW MQ[_X*#_LE?LQ?%OPO\"OCE\2+_0_%7C>Z2U\':7_ ,(AJMS_ &W<,Z((;66W MM7CGD#2(&1&++O7D_:'_:L^!G[*?@[3O'_QW\47^C:3JVJV^F6-U;^& MM0OB]Y<.$@@*6D$KI)([*B*P!9V"C+'% '@O[+W_ 1H_9L_8Z\8V^M_#OXY M?&*[\#:'JLFK>&/A#XE^(KW7A'P[=>894FM[,QJ["*0F6-9Y94CDQ*!YBJZ^ M#?\ !-/X"0?M ^,OVS/#>J_'3XD^$M(\<_M*>)+B3P]HT5M96^O^'[BTL85O MK>6[L7G1)\7$)N;26-BJ*5966-Q]??$?_@I=^QU\)M6\1:+X\\=^(K2?PAI4 M.I>+C!\-M?N8]"M9;47:R7LD%BZ6G^CD2L)2I1OB[??!W4]'U'Q/X#G^!2W%M\/)?A[K(TUK/3[BS2RN-. M)\M_]'DMXXXSLV2J$!21#S7#?%7_ ((U_L\^/_VG-;_:J\ _''XR_"W6_&$- MO'\0](^%'Q#DT;3O%WDJ(T>^C6-I/,\L;#+!)#)@LVX.S.>I\)?\%:/V$O'M MGKFJ>"_B;XDU2R\,:K<:9XFU"Q^%GB.2VT>]@QY]O=S#3_+MI(\C>DC*5R,@ M9KV3X+_'3X,_M&_#^S^*WP#^*>@>,?#5^66TUOPWJL5Y;.R\,F^-B ZGAD.& M4\$ T >:W'_!/_X4Q_M4>#OVLO#GC?Q3HFK> O [^$/#/AS29+!-(M=&K_M+_M5_L_?L>_#H?%;] MHWXD6WAO19+Y+*TD>TGNKB]NG#,MO;VUM')/QU![#4GM[>>VN;"Z4 F"XM;F..>WDP0=LD:D M@Y&10!YW?_\ !+WX3-H_P5;PS\:?B+H/B7X Z%/HGPY\<:7J&G-J-OI*+E7U'Q%+Y20Q22RP)$L/D1Q1+ END4<'E*8U0Y)V? O[6*Q$G53<-'N7YAQS0!F?LC_P#!+;X??L@QAM!_:C^-OCB?3=)D MTSP7-\3/',>L)X0MG4*5TV![98$8(%C$DT*=8\,:5>W=SI,7BN[MKB>S-U>63Y]Q!? (4 M #=^,/[5O[/GP'^$=G\=?B3\3+2#PMJ8@_L;4=*MYM3?5C-&985LH;))9KQG MC#2*L".2BLX&U216_94_;#_9L_;=^&#?&/\ 9<^*EIXK\/Q:E-IUWWE4,I,.%4$D\ $T ?.WAG_ ()V-\-; M'Q)H/P3_ &S_ (R^"M'\6>)=6UW6-&TG4M'NX8[S4KN:[NGM'U'3;F6Q#2SN M0MNZ*I)<*)"9*R_C/_P1_P#V+OC%^R=X(_9 M?#VO^#M$^&5]%J'PX\2>"=? MDLM=\-:@C,QOK:]8.QGD>21Y'D#^8[EV!<*P[W]FO_@H#^R;^U[XU\4_#K]G MCXE7FOZUX(N_LGC"Q?PGJED=&N=SK]GN6NK:)8IMT<@\IB'_ ';?+P:EUW]O M+]ESPS\4O%_P9U[QYJ5MXA\ ^''U_P 96TG@[5O)TG2UBDE^V2W(M?($3)#+ ML8.1(8V5-S*10!\9_P#!77]D70OV;/\ @BK\<_A?X1\??$GXH^.?'.EZ?:C7 MO'&KS:_XDU^6*_MVAME\J)0(H8_.=888DC3?-(5W22.WUG\(?V5/AIXF\5^ M_P!H_P 1?&OQA\3+CPAH\Z?#N?Q=-8^3HWVJ$03W,:6EG;-+=-"# 9;DRR(A MD4%3+*7Q;G_@K?\ L(V7B#PSX3O/B)XLBU7QK#<2^#=,E^$?B=;C7HX(A-.] ME&=.W72QQ,LCF(,%1@QP#FK?BC_@JS^PAX(^#FJ_M >,?C'J&E^$-!\3-X=U M_6=0\"ZW"NE:H$@?[+=QM9B2VZBD:7US;P(B/'+-Y,;;VD#8I(FASIMN;= M(D=86,*/,LS)$SQJ0DDBOV$'_!2K]BR'Q%HWA7Q=\89?!][XBN5MO#Z?$3PM MJGAJ/4YV^[%;R:K;6Z32-_"B,68\ $U[K0!\D_\ #G3X R?L0^+?^"?EU\9? MB5/\/O&NN76J:ZLNI:9]N>2YO#>W,:3BP&R.2Y/F$ ;A]U6525/H'CG]@KPA M\1_C]\)/VD_%OQN\>W'B;X+VVHP^$G2;2T@F%_;I;7K74:V(\UIH8T0X*!,; MHPC$L<7]HS_@KI_P3G_9+^+'_"DOVA/VG-,\/>(8Y;>+4(7TB_N;72Y)PK0I M?7=O;R6U@SJRN!<21G8ZM]U@3[!\4_C[\(/@OX#M?B7\1?'%M9Z/J%W:VFDS M6L4EY+JEST@MU>6\FE)&R*%'=_X5.#0!XC9_\ !*KX,Z3%\1?!WA[X MR_$G3OA_\6/%.H>(/B!\,+36;+^R=4O-0??J \][-M1MXKHY$L,-Y&A4LJA5 M9@9?VP/^"4_[.O[7/BCP-\2[;QCXZ^%7C;X;V+:=X/\ '?P<\01Z+JECIK ! MM.W&&6)[4@<1-&0H+!=H=PWK_P ._P!I;X'_ !2\%Z]X_P#"GC^"/3/"EU<6 MWBMM;M9M+GT*:",32I?6]ZD4UF5B9)<3(G[MTD&496/E_P"S9_P5E_X)Z_M= M?&";X!? ']I&QUCQ@E@]];:'>Z+J&FRZA:KG=/9F]MX5OHP 6WVYD7:"V=HS M0!G_ !%_X)8?!3XC_"GX??"?4/B[\2;6+X=_$&R\=6.O)XAM[O5=7\26CF2' M4M0N[VVG>YD5V)V?+%M"($$<<:+]+6L,EO:QV\UU).Z1A6GE"AI"!@L=H"Y/ M4X 'H!7SG^T9_P %=/\ @G/^R7\6/^%)?M"?M.:9X>\0QRV\6H0OI%_WDMK!G5E<"XDC.QU;[K GZ+L+^QU6QAU32[V*YMKF)9;>XMY \< ML; %75APRD$$$<$&@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M ^=?^"H'[!6C?\%"/V6[[X56&OGP[XYT&_A\1?"OQK 2D_ASQ':$R6=VCJ-R MJ6_=R8Y\N1B/F"D>)_\ !,']H/XN?\%4?#WAGXY_M)_#Y/#C? [5;KP_X@\. M>=%)%JGQ#M UM?:B%C9E%K;0N/LZDG]]?3,03:P2M]W:M)JL6F3R:%:6\]XL M1-K#=W#11.^. SJCE1GJ0K'V-?+W_!+#]B#XU_L'>"/B'X!^*GCOPOXEA\;_ M !3UKQQ#J&@6UQ;-:3ZE)&\EFT4NX.B%"5E#@X(!3^*@#H/^"HGAS0M$_P"" M9/[4FIZ1I4-O<:Q\$/%]YJDT28:ZG7P[-;B1SW8100IG^[&H[5!_P2J\.:%K MG_!+S]EC4]7TJ&XN-'^"'A&\TN:5,M:SMX>AMS(A[,8IYDS_ '9&'>NZ_;C^ M"GC_ /:6_9%^(O[-WPWU;1]-O_B'X,U3PS+J^M^:T.G07UG-;27 CB!,SJLF M50L@)Y+<;6J?L2_!'XI?LN?L8> ?V;?%]_H&MZS\.O!&G>&]/U'3IY[>UU.* MQLXK>&:0/&SV[.(QN4>:!U!.=H /F'_@W[X\(?M:8_Z/F^(G_HRRKB_V0=/@ M_9W_ .#E#]H']G'X+VZV/@/Q_P#!'3OB%XI\/V*[;.Q\2K>VMJ;A8Q\L4D\4 MTLLF,&1I QSM&/5?V(?V$_V]?V)M ^+&@^$/B_\ "+4I/BG\8==^(+W^I>&] M4D&DW>J-$9(!"ES']HBC\I=O[R)CDY(XQZM^Q#_P3W\.?LE>,O'_ ,>O''Q. MU'XC?%[XK:E#=_$#XB:O81VAN4@3R[:QL[6,LME90IA4A#NW W2/M3: >X:M MX&\':KXOTOXB:SHD$VKZ#:7<&DW\Q)-G'<^5Y^P$[06$$8+XW!0R@@.X;\V/ MBGX4\1?"KX _\%#_ /@J1\"[>31++XJ^ A'\/Y]/4Q->PZ-HES:OXC0+@8GN M;BXDAE_Y:PVT5P"5G!/UO_P4.^ G[9O[1_@32/AM^RO\9O GA#2I;TR^-HO& MGAN[U)=#OA_X$GT>TD@N08[IKEI[F=W/D@11JC(JK++D$E2 M#XT_;TMH?@1_P;O_ +-?C?X7H(-:^'LOPFUCP?/:C#C4%DL4,BXZM(D\X;^\ M)7!R&-?=?[9NC_"CX7_LF?$S0K?X76NNWOQ'MK^P@\)I$)9_%^NZC ;>&U/F M$F1I,1H68[(+>$L3'# 2GE7AK_@F+\1-9^$_P:_9)^-_Q5TC7?A1\"O$VFZM MH+6]G*-6\41:2&&BV6H*W[F&.V'DF9HS)]K:VC.VW5G0L^-O[+O_ 5J\6_M M5:I\>OA'^U/\$=-T6U@>Q\":#XJ^&VI:E)H5HW^MD#QW\2&YG 7S9=F0JK&A M5-V\ ];_ &-/V9-0_8O_ &'/A?\ ZXTB/QGXI^&/P[M='ANH7B22YNE@C$Z M6\TY7R87D0 9(PB(#G:!7@'_ 1>^)^C^)?B]^U%X&^(_P"SUK'PN^-B?%Q? M$GQ3\):AJ$%W:I!J-L$TJ:RN+?$<\3VMGEY ,O,97) D55]M_P"$$_X*:^$? MACX"M/#'QR^%/BKQ=:ZC>S?%"Y\5^%KZSL]5AFD+P1Z;]DF)L1 I$8$J3F15 M5F;=N+]9^SS^S/=_"_XF^/?VA_B)KUAJWQ ^);Z:GB&[TFP:VLK2QT^&2*RL M+='=W9(_.N':61BTDEQ(V(TV11@'K=%%% !1110 4444 %%%% !1110 4444 M ?FG_P %++;7?^"2_P"V9I'_ 6)^"_ABYU+P1X^FL?!G[27@72I(XY=4,C> M5I.MVZR,J&[AE98&R1N211\N^60?9?[.O[.EUH/PO\17G[0.GZ=K'C3XHRRZ MA\3PG[VU=YH! NEQ,0"UG:VP2TCX&]8VE8>9-(3Y[_P5P_8@^+O_ 4/_98/ M[,?PN\=^'?"RW?B32]6OM>UZVGN2GV&[CNHX4@BV[M[QJ"YD&T @*2V5^EO# M6 /W*,Z(Q!Z\J",XYQD@'P;_P %$O\ E.A_ MP3K_ .NGQ:_]1FVJE_P&]!T3_ ((U?&'4](TF"WN-8\4^$[S5)HDPUU.N MN:1;B1SW80P0QY_NQJ.U>N?M:_L1_'_X\?\ !0?]GW]L_P #^+_"%AI?P!/B M0VGA_5?M37&O?VUI\=E<;YHTVVGEHF4PLV3\S==HT/\ @KO^Q!\5/^"C/[&N ML?LA?#;QQX?\,1>(]2TZZU/Q!K<$]PT"65]!>)'%!%MWEW@4%F<;1G"L3E0# MN_\ @H9\"/A-^TI^Q%\4?@]\;-%LKSP]J?@G46N'O8U(LI8[=Y(KM"?N20R* MLJN.59 :\6_X-ZOC/\4_C]_P1O\ @=\2?C+J5U?:\^@WNG27]\Y::ZMK'4KN MRM979OF=FM[>$ESDL?F).[-=-^TM^R5^VM^VI\*;S]G?XQ?M*>$_ ?@;Q%:F MS\=CX9>&[I]9UJQ<;9[*"\O;@QV$4J%D=O(GA:5;9V6UM"@1%R22QP,EF)9B222230!X=_P4,\"? M#C0?V%_B7\"/"?PPL=9UGXO6FK:)X;\)E-[:]XCU=)BKN7R0J2,US+-TM[>U M>0;4@&WY@\:_"S7/@3_P4@_X)N?L-:UXFFU;P]\-?AAXHD%Q<9\O5]5TSPW! MIT-TRM_'$CRR)W3SS[5ZW\2?V6?^"O\ K'[3OB'X^?#;]K#X%V5G.CZ?X.TK MQ)\,M3U"3P]I196,$4BZA$OFS,B23RA TK(BY$<44:=S\0OV&OB]\2?#GP1^ M,'C#XS:7JGQX^"FNW.LV'C&31C;Z;JC7\,EOJNEM!&Q>"SGMY?*C8%Y(3;V\ MA\THZ2 'B_@?1M'\3?\ !?W]H#X!:YHR:CX.\;_LZ>%-?\8:1-DVUYJ-GJ,E MI!YR@X<-;'8Z-E9(TV.&3Y:])_:E^!^D?M4_\%+O@!>^$M-B\_\ 9]O=4\5> M-/$\$8#V*WM@UI8Z*)1_RTN7D^U21?PP6BLX7[1"7Z#PG^QE\<_ NO\ QL_: ME\)_$'PG#\>?B]::?9:=JM_I4]UH?A:PL8?)L[.*/THLK&"*1=0B7S9F1))Y0@:5D1 M%_BOX-^$.A^'?CG\1K?Q;XPAM2_B/Q!9::+.WNKJ1VD<00 G MRH4+>7&I+,$1=S,V20#KJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB 0B@ HHHH **** "BBB@#_V0$! end GRAPHIC 15 pm-20230930_g13.jpg begin 644 pm-20230930_g13.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" M5 &B P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ JMK%W?6&EW%[INDR7]Q%$6ALXI41IF X4,Y"@GU) JS1 M0!\4? 3_ (+*:A^U!\5OB=\&_@3_ ,$ZOC/KVL_"#Q/)X?\ '8_M?PI:165^ MDDL?EH]UK4?G!C!(0\89<+DD9&>V^"/_ 5J_9L^*7[2H_8P^)OA#QQ\(/BW M/;&YTGP%\5]#AL;C680&)DL+FVGN+.]7Y'QY,[$['P#L?;\Q?\$%_P#E(1_P M43_[.+'_ *.U*N;_ .#O+P?I?A[]@KP%^UOX6NO[(^(?PL^+NE7?@OQ+:X6[ MM#,LIDBC?J 9(;>;']ZV4^N0#]#?CK\'_&^M MWEGXT\8Z?KD%K#X*MXH5DBNIXI%+7"RL64*I3'EGDLR(_JM?!'[5_P"W)^V- M\*?VU/V,OA[X:\0^%;'P'\?-5N(/%VB'PNYU2WD@TV&Y:+[7)?@)!& MZ>5S(X+RE7R8Y=QQ&=V-OWVY Y'0/%W[0?Q)_;@ M^(?AKX>_&.&W^'_@+PM865SI5_X;M[B+_A++RWDG\@RIY:4$DLC[I53>0!0!]3_ +=W[5EU^Q)^RMXP_:BB M^#6M^.;;P;H\^IZCH^AW]I;21VT,;223R27,B 1JJG=Y:RRG[:VN_MX?M.?\$)/B/^VAXB^.FF^'I/'GP6O_$GV$&/C)XU_9\U7P]_PA MVNPQSN+'4F^R6%O=6[K &5E$+L\\<8?.2> _8C_:._X+&_\ !07X1_M!:5X> M_:;^&7@3Q%\+/CYXF\'Z9XHL_AJ;T7QTZWM!%8PV<]SLM+RLB-,7+SDA4=@$@9"0%,B%A7SO\)/\ @N'XQU#_ ((;_#G_ (*)^-?A M]I6H?%'X@ZHG@WPWX7@D>WL=5\4OJ=QIL))R6B@;[,]VZ@Y"*Z*<[37F'_!? MOX5_M=>!/V;?@;K?Q._:EA\=:9=_M#>#XO%^C77A"RL(;6_,\KQ7&F/;*LL4 M 8/&8+I[IRKJWF@H0P!^N=%?#O[5'_!0S2O _P#P4NTW]@GXE_M3+\"-(U#X M96OB#PCXJGTW3_\ BJ]6GO;BW>Q^U:G!-:PQPI!&?*"I-,\Y"R)L4/\ 2_[( ML/[1]K\"K&R_:R\0:9J_CFVUO6H+[5]&T]+2VO[--5NTT^YCA1G$0DL1:OLW M,5+$,2V30!YC_P %-?\ @IOX&_X);?":P^.?QB^!OC7Q/X5OM:MM);4?!S:? M(]M=SB4QI)%=74#;3Y1&]=P!8 XS7,>//^"Q?PR_9U^*'@[X:?MR?LQ_%'X& M0^/=06P\+^+_ !M'HU[H,UXP&VUFO=(U&\6UE)/28(N 7+!%9A\__P#!W*VS M_@DW"X0MCXL^'CM7J>9^*K?\%R?@Q^T[_P %@_A+X%_8,_9R_90\9:)9W/Q! MLM<\:?$OXA:9#INF>&[2WAN(6$2O+YMY.?M!.(%92JD!CO)0 _4FH-5NKNQT MNYO;#37O)X;=W@LXY%1IW"DB,,Q"@L<#)( SR:^4?C;XR_:Q\.?M,Q_"F?XD M)\'/V>?!OPEBU/4OC=TFJ++!;Q1P*9I&: L[, )$R,\) M_P $M/V[_P!JC]N7]AGXN^)I_&O@J?XB_"WXK>(_ ^D^-9O#$TFE:Z-.2VF@ MU"6QANH67S8KD*5CF0 @,!CY* /J+]COXT?&+]H/]GG0?BU\>_V:=4^$/BK5 M&NAJ7@#6-8BO[C3A'(KW3=.LT501 M'&%CA#O\S".*1SO;KY3_ ,'&/PN_;:\+_P#!)Q?&'Q@_:@T_Q/\ ;?%OAL?$ M7PG%X1M+33;*9[^%T;2)8E%U&L=P(XR+N6Y,D;LV8V % '[ T444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %5-=UFT\.Z/%V6>-@K#@$@D$8KL_VLOV-_VN?^"UWQ^^'OAG]I+X'7GP?_9@ M^&WB:/Q)?^&O%>JV=QXC\?ZC&K)$DEM933Q6%HJ/+&1)+YI6:0[W_!5CP3\7_&?_ 48_8W^(?PT^ ?C?Q-X<^$_CK5]5\?ZWH'AN:>VTJTN M[6W@B8$#-P*_B0VF6TD^[6[YVN[N&%$#R2QP%Q:P* S>3;0H < 5^??[& M/[#_ ,:_C[^RI^WO^R1\7?A)XO\ AQ>?'WXT^-/%?P_U;Q5H,L-M-8ZEY/V& M9W0,JLLL<9D@8B383M4X8K^LM% 'Y"^'_BM^WYJ__!%/QY_P3#^,'_!,[XOI M\6O"7P2U'P/;:QI.E6T_A[6;2WT][2UN[:^$_P#I$K0I&/(A221Y<;1M=FCF M^+?[*'_!1O0OV)?V(_VPOV$ M/CU\ ?BLWC[P_P"%O%EB;2+5[F/4M2GAABN'(@DWV]\Y'S_++&JN8PX>O5O^ M"F_QJ_;0_P""DW[%7PR\/?#/_@E=\<-#\9:!\9_#&N>+-"\1Z/:V<5O+9O,\ ML5K++.K7$);.VZ9(H%3!D>-F5&_7.B@#X9_;)TKX6?M8?$#6_P!G'_@HE_P3 MF\:^)?A3>>$--U/P?XIL/ LVN76AZO-]H2^L3)HAN;FUN%5+5EGMRT1WNK2 M!0W3_P#!#W]FS]H3]D_]A>#X-?'[5M>D@LO&>L2_#O2_%=VDVJZ1X5:X_P") M9:7C(659Q$#(8E8B(3"+Y=FQ?K^B@#\VO^#G'X2?'G]J/]A73OV;/V8O@!XQ M\>^+9_'NDZS+:Z!HDC6UM9VXN"[R7+A8=Q;:HC5FD^8$J%YK]"OAYXYLOB-X M3M/%MCH&MZ6MR@+Z=XAT::PN[=\##M=WK]MN+F.\N((+.XE M.]?MSGS%A*1H64NJX_\ P2#\)?M9?LJ^"_VM_!_[1O['?B[0QKO[0'C#QMI. MJ:65U&WUI=26SBM;73$B N+P$PRLUP\,,2(T1)!,JP_IC10!^*_PD_X)=_M6 M_M$_\&R&A_\ !/>\^&6O>!?C;\-M>N]?T?0_%5D;.*]O%UV^U""..X;]RXEM MKED#;\1R[/,V+\QZ;_@IY\:_V[?^"FG_ 29N_@+H7_!+/XT:#\53K_AUO%> MF:OH=O;Z:EW;ZA \K6,S3[[N%V4L)%C$<<>YI9$VJ)/V"HH R? WB'6/%GA' M3_$?B#P+J?AF]O+<27.@:S-:R75BQ_Y9R-:330,P]8Y'7GK6M110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 17U]9:993:EJ5Y%;V]O$TMQ<3R!$B11EF9CPH !))X M %>(Q_M]?!K3OV;/%7[;/CB8Z!\&] TMM2TKQKJ#MOUVR0L#>6]JJ%_L\K>6 MMLQ/F7/F!EC5&B>7YM_X.5/CAXO^&W_!//3O@EX$UN?3=1^.OQ/T/X;RZA:N M5E@LK]I9+O:?22"VD@;_ &9SWKZ0_;I_82^'G[:G[!7C']@R346\,:%XB\,P M:7I%UI]N'72GM9(9K)A'D;XXY;>$F/*[D4KN7.0 >/S?\%:/B+X-OO%_CWXO M?L&_$/1OASX8T[1=0OM6LKK2[O5]%LK^.1UN]1L([PLL2A59Q;M-)"NXR(-K M%?M6OQE_8N_X*#_$#]BG]J+QC_P3G_X+M:-86>J^-M"T;PMHWQ:LP9/#7B:S MBM9[:%+Z?(^SS7$,OS.ZQ]"94ASN;]FNO2@#RKQ=\ ]?\ "]]J6N?%R'7(([/0KR%L16$EJ5,DK2C!#AAC>,*X$AC]5KXD^)'[ M7_[6W@7_ (+C_"_]B6^\8^%IOA7XW^&.M>(TT_3_ P\.HI/;>8BQSW4MQ*) M0K(KAHD@!WE65MNX^??#[]J#_@J7\"[SQ?H6DK80Z_:Q!6@NVME)6"1@7! M1/E "=3N)VO^"W7[37[3_P"QE_P3F\??M2_LJ^*?#&FZ[X.M+>>X7Q+X;DU# MSH9KRWMCY!6XC2&5/.,@:2.=&V;2@SN !]:T5^8G[>O[9/\ P5)_8M^"?PD_ M;_?XQ^ M9\(ZYXG\-Z3XM^#$/@P1^;::DBJ9UUAI#*UUO.?D@BA0R#]VXB/F M]9^TM^TY_P %(OV'/VTOV>M3^-'QU\#>+_AW\=OB?%X&UKX=Z'X&-C_PC%S= MH3:S6FHO,\][L;B1Y4C60(2(8_,"Q 'UUXV^./QM\-_M;>"/@-X<_97U?6O MOB7P_J-]XB^+$&N01V?ARZMQF&SEM64R2M,< ,&7&\$!PLA3S?PE_P %'KGQ M+_P5/U;_ ()C:I^SGK>AW.F?"F?QS!XSU77+1HM1M4U&"QC%O;6YE/ER-)*P M>62.1?)PT(W9' _%[]K_ /:U^'?_ 6]^#?[%LOC'PM)\*_B%X!U_7'TZR\, M/%J2SV<$FV.>ZEN)1(H=4=3%'!U*L&QN/#)_RM8O_P!F*_\ NV"@#W?]G;_@ MH]<_'K_@H/\ %K]@?4_V<];\(WOPI\-Z9JUQKFMZY:3-J:WN&C\N"U,J)'L9 M6#F8MR5:-"#7I'P2^./QM^)/QT^*?PR^(W[+&K^"?#?@?4["V\%^.+_7(+F# MQK#/ TDT\$,:AK<0L$0AF?=Y@Y5E=%^/_P!E$2G_ (.0OVM1 RJY^#O@O877 M(!\A,9 (R*ZK]@#]N[]H_P ;?M9_ME_"[]L;X@^%;GP[^S[JNB+H]]X9\,OI MMM;V$UC>WEQ.Z23W$S,8XHBP:5P#&VT*#B@#[KHKX-_9^^-G_!0O_@H9^PV_ M[?'[.WQNTOP!JGB:/4M2^$_PPNO"=G?:;<6-M6UFM MTA$Z@)(8R7\'_:8_X+B?M-_$?_@A'IO_ 5*_9 E\+>#/$EEK5OH7C_PWK_A MR34IK'4&OXK*5;.5ITCB :19E\Z&?=%,JD(RDD _6JBOSO\ VO?VI/\ @I/^ MP]^UC^SU\0?BI\8O FN_#7XV_&73?AUK?PLT7P886\-RZEN6UN(=6DF,]])& M48R.T4$;[/EA0.-G3?&3_@H1;W/_ 4X\4?\$_?'7[6\7P%ETKP7HNI_#6YN M](TYAXYO;S[1]H)N-2ADB:*!HX(5M8?)GE&K; MXI_$'PM!+60KXQ\464V]O#<)9 E]<6^W<]DI+>?,C%H%"R-&T0EDA]#LK MVSU*SBU'3KN*>WGB62">&0.DB,,JRL.""""".#FO,_@%X4^,7C7]EJR\ _MJ MP:3K/BO4M-O],\<+862PV.HHTT\),<2LVV&6 J54DMMYB@7_ &8!0!^@ MU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110!^>G_!S!\$_%OQ#_X)XZ9\=O18&/:OJ[]JGXJ?&G1OV6Y?C+^Q MSX%?X@:]'>:#JNEZ!I=W:QR:YHYU.SDU".WDNG2(22::;KRRS [BNWYMHKU? M4M-T[6-.GTC5["&ZM+J%H;JUN8@\$ M7^$O@CQ1/<>!].V)X+\/WT1>7P];?-FPCN"Y,MI'\BP1NN^% 8_,=!&L8!^< M7[=UEK7_ 4U\*?M!?LB_"']DCQUJ'BWXC6?@RWTU_B!X)N-&L_!DT/G/)JE MY=7:*B&!/,*"U::2"9/AI\+_#?PXEUR?4V\/Z!9Z:VI70_ M>W9@@2+SGY/S-LW'D\FM>#3=.MKV?4K;3X([FZ""YN$B >4*"%#,!EL G&>F M34] 'YZ_M%>#_B]J?_!P!\$OVA]$^ ?CG4/A[X.^%FM>'/$GC2R\,SR65GJ% MZTS0H,+YDJ?ZL-+&C1KYHRV%L_%?X#^-?"6G?$SXXW?BOP+J7B'P]+!!JFF.&C$@?!$+\* MWE2['(D&%)5PO=_\%]OA]\4?C;_P2N^*'[/_ ,#_ (5^(O&7C#QI8V5EH.B^ M'=+>=G=-0M9I'DDXCA18XW;+LN[&%W'BOLJB@#\Q/^"O/@GXX_M&_P#!*7X4 M?!OX)_LT_$77_&-OXF\(ZAJOAJ#PE/#<:;%II1KOSFF"1*59-B@.?,)#)N3+ MCI_^"P^B_%?X]?%;]D'Q;\$?V>?B)XGL? '[0.B^-_&DECX.NHSI.D0,4D:1 M9T0M,,L?)0-)A"<#[?N[_(V?+]HV^5GG=L^>OT+HH _ M//\ 9?\ "7Q=T'_@O7^T)^T+XD^ 7CO3?A_X[^'_ (>T3PIXRO/"]PEG>WEA M#$)U(V^9$N=X621%1O+.&^9-W/\ [#?P ^(?CG]N;]O/3_C7\"/'OA?P)^T3 M+I=KX.\1ZKX;FMXM2L8=*O;"[?++FV?$RLBSB,L& QN!6OTLHH _-O\ X)4> M*OVJ?^"9O[(\O_!//]I3]DCXC>*O$_PPU#4K7X;>)/ ?AJ2_T;QOIDUS+"_NE\\@1QQPPI%;J68&5HRR*1NV_L[10!^= M'_!9O3/BQ^TA+^R9K_P)_9R^(_B1? _[2WA?XA>+K:V\&W,,NE:/823K<>:) ME0&?+'$*%F(7=C:\;/O?MK>"/@#^VIXV\>_L[?\ !0W]@'QUXK^'UO!87OPC M^)7ASX:ZC?WD(N=.MVN;6)["%[VPN8[H.Q:5$A;=YI7$LOB/4$N+O2-$6YGEL[>[F1F1I(; M3RPP5F6/;Y:DKE7_!M/\ !3Q9\.O^">&I?&WQMHT^G7OQT^*6N_$>WL+I M"LL-E?/%%:%AZ206LE_";_ (*?_L&?&KXBWOPK\"?M->%9-9AUN/2]*@O-6BMUUZ9[.UNU M.G/(P%\ICNXP#$6)(; *X8^N_%#XJ?#/X)> M2^*?QC^(&C>%O#6CQ++JNO^ M(-2BL[.S1G5%:2:5E1 795&2,E@.IK\[?^";7[5'[)'_ 6-TCXR>'M=TX>% M?&:?''PYXUF^&?B>.-==\.W6CZ1X:A\Y8FPQ1;_2KF#S5"G8V)%C,GEUW7_! M;>P_;>\2GX:Z9\ ?^"=NE_M$_#'P_JUSX@^*7@?6/$EA;0ZV\4+16-FUK1[HQB&0&6&U(5MC+0!]2? /]N+]C7]JG7K[PO^S1^U/\/_'^I:9:"ZU& MQ\'^++349;6 L$$DBP2,44L0,G R<5ZG7Q+_ ,$6?VC?^"U ':0?M\_L87/Q)M?A+!^TIX3;7+_6GT:P@_M1?(NM30E7T^*Y M_P!1)=JRLIMEO5^:'Q&\(?L]_&[_@U88^%HM._X1S2OV58=9?,R22<^O?LA?MZ?$#4/^"1?P+_:#\8:/ M+XK^*OQ#\%Z3I7AC0))_+F\4>(I(&16=\'RXF$,MY<38(A@CGEP0F" ?45A\ M?O@OJOQQO_V:M,^)6E7'CW2O#T6NZGX5AN0UW:Z=)+Y4=Q(@^XK/@#."<@XP M0:;\#="CE6(:GXBU6*UCDE;[L2;R#)(W0(N6 M8] :_-K_ ()Y_ _4_@+_ ,'$7QF\->+/&UQXG\4ZK^S7I&L>-?$]R"IU75[C M4X6N)HXR3Y$"D+%# #B*"**,$[,GJ/\ @ZJ^&7PZUO\ X)<:M\3-7\"Z1<^( M]&\:>&H]*UZ?38FO+2-]5B1XXYBN]$*RR J" =QXYH _2ZBBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHKQS]I']L[P;\ /B/X+^ FB^"M8\:_$GXB&] M?PEX)\/R6\YECAM;6(,@9W8LS.$C21OEH ]CHKY=_8B_P"" MB_B#]I&3X>^ OC1^S9XF\!>*_B!\)[?QUH.H%[6\T'6;+RK(W/V2YAG>2.2- M[^#,%Q''(%D4_,.:M?MV_P#!3'PW^Q#XKT#X>Z1^RE\9_C-XEUS3YM1N/#OP M3\$-KEWH]BD@B2ZO$61/(BED\R.-CG>T$H'W#0!],45Y=^QY^TKJ_P"UI\$; M/XU:O^SA\1OA6U]?7$$/A/XJZ$FF:RB1/L\Z2U$CM$CL&V;R&90&QM929_VK M?VJ?AE^Q[\*!\5OB;%J-XMYK5CHGA[0=$MUFU#7=7O9U@L]/M(W=%>>:5@HW M.B*-S.RJK, #TJBOGV7]N?4_AM\7_ ?P?_:F^ ^H_#V;XH:E)I?@;6UUZUU3 M3[C54A:<:9&_\$_/^"@7P)_X*/?LS6?[3WP0.IV&F&^N=.US1_$5LMO>Z+J%OM\^U MN5#,JNH9'R&(*2*>,D#S;7?^"M&B1_ O5_VR_ /[,/C7Q5\"=!N;G^T/B1H] MU9>;'O$6EP:EH>KV,F^&\M)HQ)%*A[JR,"/K6S0 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 5Y9^U;^UQ\*OV./#WA3QS\: MM8M=)\.>(_'%EX:O=?O[U8+;2I+N.?R)YG8;1&9HXHF9BJH)MY8!"#ZG537M M T+Q3H]QX>\3Z+::CI]Y$8[NQO[99H9T/571P58>Q&* /Q9_X*S? 3X;ZO\ M&KQQ^V)^R3KZ:;^UC9_M1^%]+^"MWX4U#_3/$]M-X4\+-RZ!'K4&@>)=3 M%@9[)WD19(YI]L,C%HI/W:N9 $+%<I6SCY;F"& V-J MMRFY)'CG"L?+)/M/[)O[>O[%W_!0[0/%O_#+?QBTKQW8^%M5?1?%ELFGSQ"" M5@XVO'Y YK8H _%K]E_]E[_@H3H?_!Q7XQ\*^+O^"HUUKGB+0/@] MX>UCQIXJ;X,Z+;'Q5H0U2$MH1MHSY=D& (^UP_OANR.E?1/_ =4:YHVC?\ M!(3Q%%JVJV]L]SXZ\,K;)/,JF5EU2"1@H)^8A$=CCH%)Z"OT+@\(>$K;Q//X MVMO"^G1ZUR \A2< ]JS/&_P;^$'Q,O(-0^)'PJ M\-^(+BVC,=M/KFAV]V\2$Y*JTJ,5&><"@#?L;ZRU2RBU+3;R*XM[B-9(+B"0 M.DB$9#*PX((Y!%2UG^%?"/A3P+H4/A?P3X8T[1M,MBQM].TJRCMX(MS%FVQQ M@*N68L<#DDGO6A0 4444 %%%% !1110 4444 %%%% !1110 5\'_ /!7/]AC M]L;QW\8?AE_P4?\ ^";_ (HTH?&CX,VE_9Q^"_$;!=/\7Z/= &>P9V95CD^^ M%W,@/F9\R-XT:OO"O _C?^T=\<_@%^T_IMKJO[/GC3Q7\(=;\'*MQXE\#Z&N MJSZ!KD5U*6$]E;EKV6&:WDC^>**4(T"@*-[D 'S5_P $&?\ @I)^RG^VO^S[ M\._@1%HEYX7^,_P:^&&FZ-J?A#Q3;F"^.GBRLXCJ-F3C[1:7 BMI,@;DW1[E M :-Y,[]M+]@K_@L3\-/VFOB!_P %"O\ @G3^W9H>K:OX@AL3=? WQ?X'A33M M1T_3XG6WTZ*]:5WW?O)V&/L^9;F5O-CWG'&?\$^?V8?%W[3W[3'['7[<7A3X M-:MX,\+?!#]F2UT37O&6OZ;]@N?'5]>:)!:P64%N^)Y;.T5YYQ=2JL;O*HB\ MQ?G'U'X1_P""C?[16L?$KQC\&_$O_!*GXVZ?KVA:]=67AC4[9=/F\/\ B"T1 MRL%Z-5EGABME=0)'0AVC5L+YK@I0!V/_ 3"_;NTC_@HW^QQX;_::M_!-QX7 MU>ZFNM+\6^%;LL9-&UBTF:"ZMB6 )4.N]<@-L==P#9 XG_@MQ^S5X*_:2_8" MU\^*?C];?"S4OA_J]CXT\&_$*^=A!HFMZ?(6M))%0,[AVD,(6-6DW3*421PJ M,_P+\._BI_P2]_X)W^,_&7P\^!MS\7?B=/KFL>-]>\$^"YVA&M:]J^I-=7-O M9LT;.+>#S]B'RC(T-J#Y>]MM>3?M4W'QW_X*K?\ !.3X+_M0?!?X&ZKI?B'P M-\+_@IJ^I0K=:M_P ([J]U::GH/G2>7#(XN()'C:38DAMX\A2P /" M_P!B/]M'X@?\%"_V[OA5^S1_P5U\(2?"/XN_!.V3Q9X'^'$^CRVEO\0M:>UF M1-<6:4_)]FMFD9+!!GS6FD,C")K>'].OVH?BE\5O@A\'=;^('P&_9DUGXJ>* M(H'EL?">@ZMI^GO=S"/Y6EFO)HP$PJJ3&)9> %C;I7RG^VI\#K#_ (*5_&O] MFWQA\*/@EXR\/^(/A-\8M+\8Z[X_\8>#+S09-#T>TW376DHUY'&]Y)=RI;Q; M+<2PC89'D"JHD]D\:_M_>-?AU^TUKW[/WB7]@/XY7ND6,%O)X?\ B-X6\*Q: MKHNLF2%7=/,AFW6K*[&/]Z ,HQ8H-NX ^2/^"0WB7X<_M9_\$B/CQ^S[^SOX M4UWP1\9[ZX\8V'Q8T/Q3$+6\L/'&K6T_F7&!CRK?S66.($*T:6NQ\O&SMRW_ M 38_P""CO[+/PT_X(QWW['7[5&K2^#_ (H_"+X;:[X:^('PHUK2+C^V!%;0 MW/[]+18VDFMWMBKO,JF./+[V 7/VP?BGX._X1OQ) M\=?&\7B"\\'V3K>2Z+IME9+:VD$QMC(DUZX6:XF$#2)YESY:-)L\Q^/_ &YO M OQ__P""HWA _L7_ F\,>)_AY\(=?N8E^+OQ.\3:1+I6H:EI:.KR:-H]A=* MMUYMP5"2W=Q%' D18)]H+E5 ,#_@V2M_'-O_ ,$0_@BGCTS^>UGK+Z>+G.\6 M)UJ^-MU_A\HJ4_V"F.*^\ZQ/AK\./!'P>^'>A?"?X:>';?2/#OAG2+;2]"TJ MU4B.TM((UBBB7/.%15'//'-;= !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%0ZA+)!83S1-ADA9E..A -?@A_P^L_X*:_]'+?^6;HO_R'7V?" M7 V;<9JL\%.$?9FE^*/1RGQ4X>SC,J6"HTJJG4=DW&%K^=IM_@S]/Z***_+3]+"BBB@ HH MHH **** "BBB@ HHHH @TW3=.T73K?1]'T^"TM+2!(;6UMHA''#&H"JB*H 5 M0 . !BIZ** ,OQGX;N/%_AB[\-6WBG5-%:\0(VI:++''=1)N!81O(CA"R@ MH6 WJ&)1D<*RP_#OX>>"_A-X'TOX;?#OP_#I>B:-9K;:=8P%F$4:^K,2SL3E MF=B6=B68EB2=JB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** (-5_Y!=S_U[O\ ^@FOY:J_J5U7_D%W/_7N_P#Z":_EJK^B M/ ;X?\ P;M_\GQ:]_V3._\ _2[3Z^#*^\_^#=O_ )/BU[_LF=__ .EV MGU\=X@_\D7CO^O;_ $/K.!?^2OP7^-'[4T445_$A_9 4444 %%%% !1110!X M=^WO_P DITK_ +&&/_T1/7R97UG^WO\ \DITK_L88_\ T1/7R90 4444 %%% M% !1110 4444 %%%% !1110 5]L?L??\F^:'_P!=+O\ ]*9:^)Z^V/V/O^3? M-#_ZZ7?_ *4RT >F4444 %%%% !1110 4444 %%%% !1110 4444 0:K_P @ MNY_Z]W_]!-?RU5_4KJO_ ""[G_KW?_T$U_+57]$> WPYC_W"_P# MODROK/\ ;W_Y)3I7_8PQ_P#HB>ODR@ HHHH **** "BBB@ HHHH **** "BB MB@ K[8_8^_Y-\T/_ *Z7?_I3+7Q/7VQ^Q]_R;YH?_72[_P#2F6@#TRBBB@ H MHHH **** "BBB@ HHHH **** "BBB@"#5?\ D%W/_7N__H)K^6JOZE=5_P"0 M7<_]>[_^@FOY:J_HCP&^',?^X7_N0_ _&[XL!_W%_P#<84445_0A^#A1110 M4444 %%%% !1110 4444 %?>?_!NW_R?%KW_ &3._P#_ $NT^O@ROO/_ (-V M_P#D^+7O^R9W_P#Z7:?7QWB#_P D7CO^O;_0^LX%_P"2OP7^-'[4T445_$A_ M9 4444 %%%% !1110!X=^WO_ ,DITK_L88__ $1/7R97UG^WO_R2G2O^QAC_ M /1$]?)E !1110 4444 %%%% !1110 4444 %%%% !7VQ^Q]_P F^:'_ -=+ MO_TIEKXGK[8_8^_Y-\T/_KI=_P#I3+0!Z91110 4444 %%%% !1110 4444 M%%%% !1110!!JO\ R"[G_KW?_P!!-?RU5_4KJO\ R"[G_KW?_P!!-?RU5_1' M@-\.8_\ <+_W(?@?C=\6 _[B_P#N,****_H0_!PHHHH **** "BBB@ HHHH M**** "OO/_@W;_Y/BU[_ +)G?_\ I=I]?!E?>?\ P;M_\GQ:]_V3._\ _2[3 MZ^.\0?\ DB\=_P!>W^A]9P+_ ,E?@O\ &C]J:***_B0_L@**** "BBB@ HHH MH \._;W_ .24Z5_V,,?_ *(GKY,KZS_;W_Y)3I7_ &,,?_HB>ODR@ HHHH * M*** "BBB@ HHHH **** "BBB@ K[8_8^_P"3?-#_ .NEW_Z4RU\3U]L?L??\ MF^:'_P!=+O\ ]*9: /3**** "BBB@ HHHH **** "BBB@ HHHH **** (-5_ MY!=S_P!>[_\ H)K^6JOZE=5_Y!=S_P!>[_\ H)K^6JOZ(\!OAS'_ +A?^Y#\ M#\;OBP'_ '%_]QA1117]"'X.%%%% !1110 4444 %%%% !1110 5]Y_\&[?_ M "?%KW_9,[__ -+M/KX,K[S_ .#=O_D^+7O^R9W_ /Z7:?7QWB#_ ,D7CO\ MKV_T/K.!?^2OP7^-'[4T445_$A_9 4444 %%%% !1110!X=^WO\ \DITK_L8 M8_\ T1/7R97UG^WO_P DITK_ +&&/_T1/7R90 4444 %%%% !1110 4444 % M%%% !1110 5]L?L??\F^:'_UTN__ $IEKXGK[8_8^_Y-\T/_ *Z7?_I3+0!Z M91110 4444 %%%% !1110 4444 %%%% !1110!!JO_(+N?\ KW?_ -!-?RU5 M_4KJO_(+N?\ KW?_ -!-?RU5_1'@-\.8_P#<+_W(?@?C=\6 _P"XO_N,**** M_H0_!PHHHH **** "BBB@ HHHH **** "OO/_@W;_P"3XM>_[)G?_P#I=I]? M!E?>?_!NW_R?%KW_ &3._P#_ $NT^OCO$'_DB\=_U[?Z'UG O_)7X+_&C]J: M***_B0_L@**** "BBB@ HHHH \._;W_Y)3I7_8PQ_P#HB>ODROK/]O?_ ))3 MI7_8PQ_^B)Z^3* "BBB@ HHHH **** "BBB@ HHHH **** "OMC]C[_DWS0_ M^NEW_P"E,M?$]?;'['W_ ";YH?\ UTN__2F6@#TRBBB@ HHHH **** "BBB@ M HHHH **** "BBB@"#5?^07<_P#7N_\ Z":_EJK^I75?^07<_P#7N_\ Z":_ MEJK^B/ ;X_P"R9W__ M *7:?7QWB#_R1>._Z]O]#ZS@7_DK\%_C1^U-%%%?Q(?V0%%%% !1110 4444 M >'?M[_\DITK_L88_P#T1/7R97UG^WO_ ,DITK_L88__ $1/7R90 4444 %% M%% !1110 4444 %%%% !1110 5]L?L??\F^:'_UTN_\ TIEKXGK[8_8^_P"3 M?-#_ .NEW_Z4RT >F4444 %%%% !1110 4444 %%%% !1110 4444 0:K_R" M[G_KW?\ ]!-?RU5_4KJO_(+N?^O=_P#T$U_+57]$> WPYC_W"_\ W^A]9P M+_R5^"_QH_:FBBBOXD/[("BBB@ HHHH **** /#OV]_^24Z5_P!C#'_Z(GKY M,KZS_;W_ .24Z5_V,,?_ *(GKY,H **** "BBB@ HHHH **** "BBB@ HHHH M *^V/V/O^3?-#_ZZ7?\ Z4RU\3U]L?L??\F^:'_UTN__ $IEH ],HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH @U7_D%W/_7N_P#Z":_EJK^I75?^07<_ M]>[_ /H)K^6JOZ(\!OAS'_N%_P"Y#\#\;OBP'_<7_P!QA1117]"'X.%%%% ! M1110 4444 %%%% !1110 5]Y_P#!NW_R?%KW_9,[_P#]+M/KX,K[S_X-V_\ MD^+7O^R9W_\ Z7:?7QWB#_R1>._Z]O\ 0^LX%_Y*_!?XT?M31117\2']D!11 M10 4444 %%%% 'AW[>__ "2G2O\ L88__1$]?)E?6?[>_P#R2G2O^QAC_P#1 M$]?)E !1110 4444 %%%% !1110 4444 %%%% !7VQ^Q]_R;YH?_ %TN_P#T MIEKXGK[8_8^_Y-\T/_KI=_\ I3+0!Z91110 4444 %%%% !1110 4444 %%% M% !1110!!JO_ ""[G_KW?_T$U_+57]2NJ_\ (+N?^O=__037\M5?T1X#?#F/ M_<+_ -R'X'XW?%@/^XO_ +C"BBBOZ$/P<**** "BBB@ HHHH **** "BBB@ MK[S_ .#=O_D^+7O^R9W_ /Z7:?7P97WG_P &[?\ R?%KW_9,[_\ ]+M/KX[Q M!_Y(O'?]>W^A]9P+_P E?@O\:/VIHHHK^)#^R HHHH **** "BBB@#P[]O?_ M ))3I7_8PQ_^B)Z^3*^L_P!O?_DE.E?]C#'_ .B)Z^3* "BBB@ HHHH **** M "BBB@ HHHH **** "OMC]C[_DWS0_\ KI=_^E,M?$]?;'['W_)OFA_]=+O_ M -*9: /3**** "BBB@ HHHH **** "BBB@ HHHH **** (-5_P"07<_]>[_^ M@FOY:J_J5U7_ )!=S_U[O_Z":_EJK^B/ ;X_[)G?_ /I=I]?'>(/_ "1>._Z]O]#ZS@7_ )*_ M!?XT?M31117\2']D!1110 4444 %%%% 'AW[>_\ R2G2O^QAC_\ 1$]?)E?6 M?[>__)*=*_[&&/\ ]$3U\F4 %%%% !1110 4444 %%%% !1110 4444 %?;' M['W_ ";YH?\ UTN__2F6OB>OMC]C[_DWS0_^NEW_ .E,M 'IE%%% !1110 4 M444 %%%% !1110 4444 %%%% $&J_P#(+N?^O=__ $$U_+57]2NJ_P#(+N?^ MO=__ $$U_+57]$> WPYC_P!PO_ODROK/]O?_DE.E?\ 8PQ_ M^B)Z^3* "BBB@ HHHH **** "BBB@ HHHH **** "OMC]C[_ )-\T/\ ZZ7? M_I3+7Q/7VQ^Q]_R;YH?_ %TN_P#TIEH ],HHHH **** "BBB@ HHHH **** M"BBB@ HHHH @U7_D%W/_ %[O_P"@FOY:J_J5U7_D%W/_ %[O_P"@FOY:J_HC MP&^',?\ N%_[D/P/QN^+ ?\ <7_W&%%%%?T(?@X4444 %%%% !1110 4444 M%%%% !7WG_P;M_\ )\6O?]DSO_\ TNT^O@ROO/\ X-V_^3XM>_[)G?\ _I=I M]?'>(/\ R1>._P"O;_0^LX%_Y*_!?XT?M31117\2']D!1110 4444 %%%% ' MAW[>_P#R2G2O^QAC_P#1$]?)E?6?[>__ "2G2O\ L88__1$]?)E !1110 44 M44 %%%% !1110 4444 %%%% !7VQ^Q]_R;YH?_72[_\ 2F6OB>OMC]C[_DWS M0_\ KI=_^E,M 'IE%%% !1110 4444 %%%% !1110 4444 %%%% $&J_\@NY M_P"O=_\ T$U_+57]2NJ_\@NY_P"O=_\ T$U_+57]$> WPYC_ -PO_[_P#H)K^6JOZE=5_Y M!=S_ ->[_P#H)K^6JOZ(\!OAS'_N%_[D/P/QN^+ ?]Q?_<84445_0A^#A111 M0 4444 %%%% !1110 4444 %?>?_ ;M_P#)\6O?]DSO_P#TNT^O@ROO/_@W M;_Y/BU[_ +)G?_\ I=I]?'>(/_)%X[_KV_T/K.!?^2OP7^-'[4T445_$A_9 M4444 %%%% !1110!X=^WO_R2G2O^QAC_ /1$]?)E?6?[>_\ R2G2O^QAC_\ M1$]?)E !1110 4444 %%%% !1110 4444 %%%% !7VQ^Q]_R;YH?_72[_P#2 MF6OB>OMC]C[_ )-\T/\ ZZ7?_I3+0!Z91110 4444 %%%% !1110 4444 %% MBO*/^&Y_V1_^B]:#_P!_G_\ B:/^&Y_V1_\ HO6@_P#?Y_\ MXF@#U#5?^07<_P#7N_\ Z":_EJK^C_4/VXOV2I[">&+X\:"6>%E4>RMSSC&]O:7MS M-7M=7MM='XGXP95FF9RP7U.A.KR^TOR1E*U^2U[)VO9VOV9YA17I_P#PQS\? M/^@%H/\ X7&D?_)5'_#'/Q\_Z 6@_P#A<:1_\E5^Z?ZW<)_]#"A_X-I__)'X MK_JKQ1_T UO_ 5/_P"1/,**]/\ ^&.?CY_T M!_\+C2/_DJC_ACGX^?] +0 M?_"XTC_Y*H_UNX3_ .AA0_\ !M/_ .2#_57BC_H!K?\ @J?_ ,B>845Z?_PQ MS\?/^@%H/_A<:1_\E4?\,<_'S_H!:#_X7&D?_)5'^MW"?_0PH?\ @VG_ /)! M_JKQ1_T UO\ P5/_ .1/,**]/_X8Y^/G_0"T'_PN-(_^2J/^&.?CY_T M!_\ M+C2/_DJC_6[A/_H84/\ P;3_ /D@_P!5>*/^@&M_X*G_ /(GF%%>G_\ #'/Q M\_Z 6@_^%QI'_P E4?\ #'/Q\_Z 6@_^%QI'_P E4?ZW<)_]#"A_X-I__)!_ MJKQ1_P! -;_P5/\ ^1/,**]/_P"&.?CY_P! +0?_ N-(_\ DJC_ (8Y^/G_ M $ M!_\ "XTC_P"2J/\ 6[A/_H84/_!M/_Y(/]5>*/\ H!K?^"I__(GF%?>? M_!NW_P GQ:]_V3.__P#2[3Z^6_\ ACGX^?\ 0"T'_P +C2/_ )*KZW_X(R>% M;S]E#]JK5_B3\?\ 6M!T#1;KP-=Z?!>_\)-8W6ZY>[LY%39;32.,K%(+X1QE&AC:4YR@THQJ0;;TT24KL^GX,XBO*/^&Y_P!D?_HO6@_]_G_^)H_X;G_9'_Z+UH/_ '^?_P")H ]7 MHKRC_AN?]D?_ *+UH/\ W^?_ .)H_P"&Y_V1_P#HO6@_]_G_ /B: ,7]O?\ MY)3I7_8PQ_\ HB>ODRO>/VN?VGOV>_B?\/K#0_ WQ@T&^NH-92>6+[6W_Q= %ZBJ/_ E?@[_H>-!_\'EM M_P#%T?\ "5^#O^AXT'_P>6W_ ,70!>HJC_PE?@[_ *'C0?\ P>6W_P 71_PE M?@[_ *'C0?\ P>6W_P 70!>HJC_PE?@[_H>-!_\ !Y;?_%T?\)7X._Z'C0?_ M >6W_Q= %ZBJ/\ PE?@[_H>-!_\'EM_\71_PE?@[_H>-!_\'EM_\70!>HJC M_P )7X._Z'C0?_!Y;?\ Q='_ E?@[_H>-!_\'EM_P#%T 7J*H_\)7X._P"A MXT'_ ,'EM_\ %T?\)7X._P"AXT'_ ,'EM_\ %T 7J^V/V/O^3?-#_P"NEW_Z M4RU\,_\ "5^#O^AXT'_P>6W_ ,77U#^S?^UM^S5X!^#NE>%?%OQHT&TO[9[@ MS0?;/,V[IY'7YD!4Y5@>#WH ^D:*\H_X;G_9'_Z+UH/_ '^?_P")H_X;G_9' M_P"B]:#_ -_G_P#B: /5Z*\H_P"&Y_V1_P#HO6@_]_G_ /B:T/"G[7?[-/CG MQ':>$?"/QCT>_P!2OY?*L[."5B\KXSM&5Z\4 >CT444 %%%% !1110!2UGPY MX>\1Q)!XAT&ROTC;=&E[:I*$/J P.#6?_P *N^&?_1.]"_\ !1#_ /$UNT4 M87_"KOAG_P!$[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__ !-;M% &%_PJ[X9_ M]$[T+_P40_\ Q-'_ J[X9_]$[T+_P %$/\ \36[10!A?\*N^&?_ $3O0O\ MP40__$T?\*N^&?\ T3O0O_!1#_\ $UNT4 87_"KOAG_T3O0O_!1#_P#$T?\ M"KOAG_T3O0O_ 40_P#Q-;M% &%_PJ[X9_\ 1.]"_P#!1#_\31_PJ[X9_P#1 M.]"_\%$/_P 36[10!A?\*N^&?_1.]"_\%$/_ ,31_P *N^&?_1.]"_\ !1#_ M /$UNT4 87_"KOAG_P!$[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__ !-;M% & M%_PJ[X9_]$[T+_P40_\ Q-'_ J[X9_]$[T+_P %$/\ \36[10!A?\*N^&?_ M $3O0O\ P40__$T?\*N^&?\ T3O0O_!1#_\ $UNT4 87_"KOAG_T3O0O_!1# M_P#$T?\ "KOAG_T3O0O_ 40_P#Q-;M% &%_PJ[X9_\ 1.]"_P#!1#_\31_P MJ[X9_P#1.]"_\%$/_P 36[10!A?\*N^&?_1.]"_\%$/_ ,31_P *N^&?_1.] M"_\ !1#_ /$UNT4 87_"KOAG_P!$[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__ M !-;M% &%_PJ[X9_]$[T+_P40_\ Q-'_ J[X9_]$[T+_P %$/\ \36[10!A M?\*N^&?_ $3O0O\ P40__$T?\*N^&?\ T3O0O_!1#_\ $UNT4 87_"KOAG_T M3O0O_!1#_P#$T?\ "KOAG_T3O0O_ 40_P#Q-;M% &%_PJ[X9_\ 1.]"_P#! M1#_\31_PJ[X9_P#1.]"_\%$/_P 36[10!A?\*N^&?_1.]"_\%$/_ ,31_P * MN^&?_1.]"_\ !1#_ /$UNT4 87_"KOAG_P!$[T+_ ,%$/_Q-'_"KOAG_ -$[ MT+_P40__ !-;M% &%_PJ[X9_]$[T+_P40_\ Q-'_ J[X9_]$[T+_P %$/\ M\36[10!A?\*N^&?_ $3O0O\ P40__$T?\*N^&?\ T3O0O_!1#_\ $UNT4 87 M_"KOAG_T3O0O_!1#_P#$T?\ "KOAG_T3O0O_ 40_P#Q-;M% &%_PJ[X9_\ M1.]"_P#!1#_\34MC\/O .EWD>H:9X(T>WN(FW13P:9$CH?4,%R#6Q10 4444 M %%%% !1110 4444 %%%% !1110!XY^T?^UW8_!+XH>!/V>O!'P_N?&/Q&^) M']H2^&?#D.HQV5O%96,<;WE_>74@806\?FPI\J2R.\R*D;?.R1? 3]K#Q?\ M%/XY^*_V&WD,$-Y!=6YPMS9R,;='4GC<.&1Y(Y/!_@5_P %//VSO@;K7QO_ &;O^"CG M[._AB+X\_"+X :K\0_#'C7P86;1_'^@Z>) '52 \#_:2JF/Y--$ MU*",W,4&C3:$]=T'PQXC\0VUIJ'BC49;#P_9RM\]]<1VL]V\: =2L%O-(2> M (SSD@'7K\=/ASXCU;]O7]H7_@F5^TE\>M2\56OBGXC_ R\>'Q7-H/C?5M( M6>:ST: +=6\=E[_;'_ ."DUI^TE:? SXCO MX5\2^ OBWK?@;X?:S8_'#6_#Z^%KC2XX%MYKC2K"QE@U%)I2;F3[4TOFQSF) M0BHN #]):*_.+4HOVHO''_!3SX'? ;XM?M?^*$M/%W[*^I:E\0M/^&?B=[31 M;_6+:YTV&>[T]DCC>)97DE9)^)XTD(C>+/'DGA7PO\>_&/[!O[:S:S^W7\O/@O=S0?%#P]KVJ6'C5];A2& Z7#%+-"MLJM)(3Y\ M2[F:,#<2-V.?>Z_+/XJOXU_; _;#_P""=>O^*OBCK_AG5_'O[/7C'5?$.O\ M@^>.SO\ S+G1-"GN!;RE&%L79V7S(U#HK'RVC?:Z\EXJ_:U_:J_X)JV_[7G[ M,G_#1GB?Q]H7PYU#X>7'PX^('Q+ULW^I^&+;Q5?K9745[J$TB^-K7XZ0^%_A1XC\)7VA^,/!VH?'' M7/%M_=:IY4DUGJ.DMK%B!:7"!'$B1N(VB#/Y>Y,UY]_P0?\ AM\8/CC^R5\) M_P!N'XY?MI_&/Q9XB2/Q=I=QX>U?QB9-$U"#^W[^WBDN[5D)N+B(0YBF+AD5 MA$/W4<<:@'Z(T444 %%%% !1110 4444 %%%% !1110!\UZ%^WUXW^+%_P". M-=_9D_96UCX@^$?AYXJOO#>M:U:>)[*RO-6U.Q.R]ATJUN"%NA#+F'?/-;*\ MB.(RZ@.?7/V:?CCI/[3'[/\ X._:#T'PSJ>BV7C+P];:O::3K402\LXYXPZQ M3JI(650<,H)PP(R<9K\_?BM^Q)^W;^QM\5O''[=?_!$SXS:5XP\*^-/%.HZ[ M\1OV;O&I9M,U75A+9M9\-7?C&Y\.SP7&@0%)]&CU&RMI)X ;MI) \"1R M2I9A/;CP/\4? ?B[Q&UQI3-<6$US#J&F6B!4TH MP-!(Q$&/E1 6YD+@'Z#^&?'O@[QGJ>NZ-X6\0V]]<^&=7&EZ]%;MDV5X;:"Z M\A^V[R;F!\#.!(.^0->OQT_9[\>-_P $_?V"?VZ_VJ?A+K_B)/$'@_\ :D\8 M^'-$NO$'CC5=1L[&&?4]*LX[Z:WNYYX9[B#SA,UW-%).XB*N[J64_6W@O]F/ M]N3P;^USX#^*7ACXZV?AWX8ZKX>U/1OB-X9U?X[:WXNN-D_ M'7P]XX@^(7A_Q9XJEO-*DGTW3K6^M;FRL3BWTYUD=T(MDC#(0""=Q8 ^@OV M?VU+G]N+X>^-?&M_\(Y_!=UX*^*FN^";W2+G6H[YWGTN9899B\<:*NYRPV+O M "YWMGCW:OQR^ O[+GQ0^*W['G[77QN^%W[:GQ6^&?B7P'^TO\5M8\'0^"?% M T_2DO;2_DN0U_;HG_$PCE9%CD2=GC6,#8B,79_6O@-^V9^TC_P4%^(_PJ^" M^OZ9':3:M^R-X;^)FO:)8_%/5O!4VJ:EJMQ+;3W<5SI-M+=/! ($V1*\<8-_ MEQ(R1% #],Z*_*;]HGPU_P %'?V:_P!F;]GWX9?&/]NW4W\8G]M'PQX1;7_ M_BB2\FN?#.HW7FP6FKS3VL$E[=1QLBN)%\N:,1F19/-?/Z+?LS_L^+^S3\/; MGX>1_&SXA>/4GUR\U*/6/B7XG.KZA;BX??\ 9$N&16^SQ_=C1MQ53C<>, 'H M=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >/\ Q[_8X\-_ M'3XP>$OCY:?&#QUX)\7^"='U+3-!UGP7JEO%BVOI+62YCG@NK>>WNE8V<&$F MB=%*A@H<*RU?A5^PW\./ WQ/\2_'3XE>-/$/Q-\<^*_#">&M4\3^/%L6>/0U M=Y/[+@MK*UMK6"V:1WD=5BWRL09'?:N'?'O_ (*#_LE?LQ?%OPO\"OCE\2+_ M $/Q5XWNDM?!VE_\(AJMS_;=PSH@AM9;>U>.>0-(@9$8LN]=P&X9Z3]H?]JS MX&?LI^#M.\?_ !W\47^C:3JVJV^F6-U;^&M0OB]Y<.$@@*6D$KI)([*B*P!9 MV"C+'% '@O[+W_!&C]FS]CKQC;ZW\._CE\8KOP-H>JR:MX8^$/B7XBO=>$?# MMUYAE2:WLS&KL(I"98UGEE2.3$H'F*KKX-_P33^ D'[0/C+]LSPWJOQT^)/A M+2/'/[2GB2XD\/:-%;65OK_A^XM+&%;ZWEN[%YT2?%Q";FTEC8JBE65ECR06+I M:?Z.1*PE*E%R6"X--^&__!3/]C7XM:WX7\/^ _B!X@NKCQQI\U[X+:X^'&O6 ML.OP16;WK/92SV*1W6;:-Y5$;,7494-D9 (_C/\ \$V_V>OB[??!W4]'U'Q/ MX#G^!2W%M\/)?A[K(TUK/3[BS2RN-.)\M_\ 1Y+>..,[-DJA 4D0\UPWQ5_X M(U_L\^/_ -IS6_VJO /QQ^,OPMUOQA#;Q_$/2/A1\0Y-&T[Q=Y*B-'OHUC:3 MS/+&PRP20R8+-N#LSGJ?"7_!6C]A+Q[9ZYJG@OXF^)-4LO#&JW&F>)M0L?A9 MXCDMM'O8,>?;WJQ7EL[+PR;XV(#J>&0X93P0#0!YK#OVLO M#GC?Q3HFK> O [^$/#/AS29+!-(M=&K_ +2_[5?[/W['OPZ'Q6_:-^)%MX;T62^2RM)'M)[JXO;I MPS+;V]M;1R3W,I5';RXD=MJ,V,*2,[]DK]MC]EG]NGX>W/Q1_92^,6G^+]'L M=0>PU)[>WGMKFPNE )@N+6YCCGMY,$';)&I(.1D4 >=W_P#P2]^$S:/\%6\, M_&GXBZ#XE^ .A3Z)\.?'&EZAIS:C;Z7-;06LUG<13V,EG=1O!;0(6DMC(/+# M!PQ9CTL__!/#]F?Q%\&?B/\ !;XJ>';SQO;?&"1I?B?KGBBY5]1\12^4D,4D MLL"1+#Y$<42P);I%'!Y2F-4.2=GP+^W+^RU\2?'.G_#[P9\4?M=YK.H7MAX? MOWT2^ATS6[NTW_:;>PU&6%;._EC$4Q:.WFD8""8XQ$^WCOVH_P#@K)_P3V_8 MO^(:?"O]I3]I"Q\.ZX([>2\M8]$U"^CTU)SB%KV:SMY8K$2=5-PT>Y?F''- M&9^R/_P2V^'W[(,8;0?VH_C;XXGTW29-,\%S?$SQS'K">$+9U"E=-@>V6!&" M!8Q)-'-(L:^6&",Z-WW[#W[&'P^_8&^ =C^S;\)?''BG6/#&E7MW;4WU8S1F6%;*&R26:\9XPTBK CDHK.!M4D5OV5/VP_V;/VW? MA@WQC_9<^*EIXK\/Q:E-IUWWE4,I,.%4$D\ $T ?.WAG_@G8WPUL?$F@_!/]L_XR^"M'\6>)=6UW6-&TG4M M'NX8[S4KN:[NGM'U'3;F6Q#2SN0MNZ*I)<*)"9*R_C/_ ,$?_P!B[XQ?LG>" M/V0+7P]K_@[1/AE?1:A\./$G@G7Y++7?#6H(S,;ZVO6#L9Y'DD>1Y _F.Y=@ M7"L.]_9K_P""@/[)O[7OC7Q3\.OV>/B5>:_K7@B[^R>,+%_">J61T:YW.OV> MY:ZMHEBFW1R#RF(?]VWR\&I==_;R_9<\,_%+Q?\ !G7O'FI6WB'P#X\<:O-K_ (DU^6*_MVAME\J)0(H8_.=888DC M3?-(5W22.WUG\(?V5/AIXF\5^ _VC_$7QK\8?$RX\(:/.GP[G\736/DZ-]JA M$$]S&EI9VS2W30@P&6Y,LB(9%!4RRE\6Y_X*W_L(V7B#PSX3O/B)XLBU7QK# M<2^#=,E^$?B=;C7HX(A-.]E&=.W72QQ,LCF(,%1@QP#FK?BC_@JS^PAX(^#F MJ_M >,?C'J&E^$-!\3-X=U_6=0\"ZW"NE:H$@?[+=QM9B2V^(KE;;P^GQ$\+:IX:CU.=ONQ6\FJVUNDTC?PHC%F/ !->ZT ?) M/_#G3X R?L0^+?\ @GY=?&7XE3_#[QKKEUJFNK+J6F?;GDN;PWMS&DXL!LCD MN3YA &X?=5E4E3Z!XY_8*\(?$?X_?"3]I/Q;\;O'MQXF^"]MJ,/A)TFTM()A M?VZ6UZUU&MB/-::&-$."@3&Z,(Q+'%_:,_X*Z?\ !.?]DOXL?\*2_:$_:^,OQ)T[X?_ !8\4ZAX@^('PPM-9LO[)U2\U!]^ MH#SWLVU&WBNCD2PPWD:%2RJ%5F!E_; _X)3_ +.O[7/BCP-\2[;QCXZ^%7C; MX;V+:=X/\=_!SQ!'HNJ6.FL &T[<898GM2!Q$T9"@L%VAW#>O_#O]I;X'_%+ MP7KWC_PIX_@CTSPI=7%MXK;6[6;2Y]"F@C$TJ7UO>I%-9E8F27$R)^[=)!E& M5CY?^S9_P5E_X)Z_M=?&";X!? ']I&QUCQ@E@]];:'>Z+J&FRZA:KG=/9F]M MX5OHP 6WVYD7:"V=HS0!G_$7_@EA\%/B/\*?A]\)]0^+OQ)M8OAW\0;+QU8Z M\GB&WN]5U?Q):.9(=2U"[O;:=[F178G9\L6T(@01QQHOTM:PR6]K';S74D[I M&%:>4*&D(&"QV@+D]3@ >@%?.?[1G_!73_@G/^R7\6/^%)?M"?M.:9X>\0QR MV\6H0OI%_WDMK!G5E<"XDC.QU;[K GZ+L+^QU6QAU32[V* MYMKF)9;>XMY \+$3:PW=PT43OC@,ZHY49ZD*Q]C7R]_P2P_8@^-?[!W M@CXA^ ?BIX[\+^)8?&_Q3UKQQ#J&@6UQ;-:3ZE)&\EFT4NX.B%"5E#@X(!3^ M*@#H/^"HGAS0M$_X)D_M2:GI&E0V]QK'P0\7WFJ31)AKJ=?#LUN)'/=A%!"F M?[L:CM4'_!*KPYH6N?\ !+S]EC4]7TJ&XN-'^"'A&\TN:5,M:SMX>AMS(A[, M8IYDS_=D8=Z[K]N/X*>/_P!I;]D7XB_LW?#?5M'TV_\ B'X,U3PS+J^M^:T. MG07UG-;27 CB!,SJLF50L@)Y+<;6J?L2_!'XI?LN?L8> ?V;?%]_H&MZS\.O M!&G>&]/U'3IY[>UU.*QLXK>&:0/&SV[.(QN4>:!U!.=H /F'_@W[X\(?M:8_ MZ/F^(G_HRRKB_P!D'3X/V=_^#E#]H']G'X+VZV/@/Q_\$=.^(7BGP_8KML[' MQ*M[:VIN%C'RQ23Q32RR8P9&D#'.T8]5_8A_83_;U_8FT#XL:#X0^+_PBU*3 MXI_&'7?B"]_J7AO5)!I-WJC1&2 0IK?L0_\ !/?P MY^R5XR\?_'KQQ\3M1^(WQ>^*VI0W?Q ^(FKV$=H;E($\NVL;.UC++964*85( M0[MP-TC[4V@'N&K>!O!VJ^+]+^(FLZ)!-J^@VEW!I-_,239QW/E>?L!.T%A! M&"^-P4,H(#N&_-CXI^%/$7PJ^ /_ 4/_P""I'P+MY-$LOBKX"$?P_GT]3$U M[#HVB7-J_B- N!B>YN+B2&7_ ):PVT5P"5G!/UO_ ,%#O@)^V;^T?X$TCX;? MLK_&;P)X0TJ6],OC:+QIX;N]277+5<;-/*V]Q 5MG.?.7=F90(C^[:5),_X$ M?LV_MM^)]/\ %W@C_@H=\=_ASXY\&:_X/G\/6W@[X?\ @2?1[22"Y!CNFN6G MN9W<^2!%&J,BJLLN025( /C3]O2VA^!'_!N_^S7XW^%Z"#6OA[+\)M8\'SVH MPXU!9+%#(N.K2)/.&_O"5P_$>VO[ M"#PFD0EG\7Z[J,!MX;4^829&DQ&A9CL@MX2Q,<,!*>5>&O\ @F+\1-9^$_P: M_9)^-_Q5TC7?A1\"O$VFZMH+6]G*-6\41:2&&BV6H*W[F&.V'DF9HS)]K:VC M.VW5G0L^-O[+O_!6KQ;^U5JGQZ^$?[4_P1TW1;6!['P)H/BKX;:EJ4FA6C?Z MV0/'?Q(;F&ZA>))+FZ6",3I;S3E?)A>1 !DC"(@.=H%> ?\$7OB?H_B7XO?M1>!OB/ M^SUK'PN^-B?%Q?$GQ3\):AJ$%W:I!J-L$TJ:RN+?$<\3VMGEY ,O,97) D55 M]M_X03_@IKX1^&/@*T\,?'+X4^*O%UKJ-[-\4+GQ7X6OK.SU6&:0O!'IOV28 MFQ$"D1@2I.9%569MVXOUG[//[,]W\+_B;X]_:'^(FO6&K?$#XEOIJ>(;O2;! MK:RM+'3X9(K*PMT=W=DC\ZX=I9&+227$C8C39%& >MT444 %%%% !1110 44 M44 %%%% !1110!^:?_!2RVUW_@DO^V9I'_!8GX+^&+G4O!'CZ:Q\&?M)>!=* MDCCEU0R-Y6DZW;K(RH;N&5E@;)&Y)%'R[Y9!]E_LZ_LZ76@_"_Q%>?M Z?IV ML>-/BC++J'Q/"?O;5WF@$"Z7$Q +6=K;!+2/@;UC:5AYDTA/GO\ P5P_8@^+ MO_!0_P#98/[,?PN\=^'?"RW?B32]6OM>UZVGN2GV&[CNHX4@BV[M[QJ"YD&T M @*2V5^EO#6 /W*,Z(Q!Z\J",XYQD@'P;_P M42_Y3H?\$Z_^NGQ:_P#49MJI?\'-'AO0=$_X(U?&'4](TF"WN-8\4^$[S5)H MDPUU.NN:1;B1SW80P0QY_NQJ.U>N?M:_L1_'_P"/'_!0?]GW]L_P/XO\(6&E M_ $^)#:>']5^U-<:]_;6GQV5QOFC3;:>6B93"S9/S-UVC0_X*[_L0?%3_@HS M^QKK'[(7PV\<>'_#$7B/4M.NM3\0:W!/<- EE?07B1Q01;=Y=X%!9G&T9PK$ MY4 [O_@H9\"/A-^TI^Q%\4?@]\;-%LKSP]J?@G46N'O8U(LI8[=Y(KM"?N20 MR*LJN.59 :\6_P"#>KXS_%/X_?\ !&_X'?$GXRZE=7VO/H-[ITE_?.6FNK:Q MU*[LK65V;YG9K>WA)R@O+VX,=A%*A9';R)W*$J&4$Y^A/@[\(OAU\ ? MA5X=^"?PB\+V^B^&/"NCP:7H6E6V=EM;0H$1'?\%# M/ GPXT']A?XE_ CPG\,+'6=9^+UIJVB>&_"93>VO>(]728J[E\D*DC-WM7D&U(!M^8/&OPLUSX$_\ !2#_ ()N?L-:UXFFU;P]\-?AAXHD%Q<9\O5] M5TSPW!IT-TRM_'$CRR)W3SS[5ZW\2?V6?^"O^L?M.^(?CY\-OVL/@796,/C-I>J?'CX*:[,9-&-OINJ-?PR6^JZ6T$;%X+.>WE\J-@7D MA-O;R'S2CI( >+^!]&T?Q-_P7]_: ^ 6N:,FH^#O&_[.GA37_&&D39-M>:C9 MZC):0>?B]::?9:=JM_I4]UH?A:PL8?)L[.*/Q:[K^9 MEENF>\N;Z5!-<[2CRF,E$&_"93>VO>(]728J[E\D*DC-WM7D&U(!M]5_9.^"#?LS?L MM_#?]G*3Q#)J[> ? >D>'7U67.Z\-E9Q6YFP>1N,>[';.*^9OB3^RS_P5_UC M]IWQ#\?/AM^UA\"[*SG1]/\ !VE>)/AEJ>H2>'M*+*Q@BD74(E\V9D22>4(& ME9$7(CBBC3ZK^ WA?XK^#?A#H?AWXY_$:W\6^,(;4OXC\066FBSM[JZD=I'$ M$ )\J%"WEQJ2S!$7 GRAPHIC 16 pm-20230930_g2.jpg begin 644 pm-20230930_g2.jpg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end GRAPHIC 17 pm-20230930_g3.jpg begin 644 pm-20230930_g3.jpg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end GRAPHIC 18 pm-20230930_g4.jpg begin 644 pm-20230930_g4.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@! MX 54 P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "N8^-'QG^%O[._PIU[XW_&OQM9>'/"GAC3I+[7-:U"0K%;0)U) MP"68DA5106=F55!8@'IZ_'?_ (.D?C!K7C3XY_L@_P#!.F.[=?#/Q6^+]E=^ M-[0-A;Z"+4;"TMH'Q]^/==W#E3QNBB/51@ ^ZO'7_!47X7_!3]E?1?VL?V@O MAIXC\*:?XYU^STSX7>"BL=SXD\3R7H4V,(LP5CMKJ?YW$#S$11A3,\3EXH^ M\.?\%C]9\-^.]0T']I;]B'QYX*\.P_%^W^'4/C/2-3T_7++3]7N8K%[:+4UM MIA+:>8]]%&)(TG@WE5\W+ 5F?\%_O^"5?Q+_ ."H?[*.A:)^SYX\C\/_ !(^ M&WB0>(O!1N;IK>"]E$3(]L9DYMY#\CQ3=%>, [56OC#QE\5;:]U/QIK4<0$'B!8]/AMH]0AB 1$+V-I*EY$ M2F]E=AL)E4 _H)KXY_9H_P""MK?M%_\ !4?XN?\ !-0_LH^+?#P^%FDM>_\ M"?ZA<;K74MLD$>&@\E?LZ2^?O@?S9/.2-FPG2OL8C(QFOR'_ ."8?[?'[;_Q M._X."OVB/V /C%^TWK/BSX:^ ?#&NS>%]+U31=+AFMI8=3TN*"0SVMI$\C)% M)+JWCCN;FRGMEE2.;RU59&1UD MQ(1N*LH.=N2 ?J/17S-_P6,^*/Q=^!?_ 32^+GQS^ _Q0U'PAXM\&>%9=8T M76=-M+6=EEA(/EO'=0RQO&P)##;GN""*_(3Q+^WC_P %>_%7_!OYH_\ P5>U M#_@H_K.G>)M#\<&PM=&T/P9I,$>J6S:L]F9+]_LY\R56(")&J0^5& Z2.[. M#^A2OD'_ (+!_P#!5UO^"3OPL\%?$I?V7O$OQ._X3#Q@FA_9-!O/LR6.4+;F MD\F7=,_W8H=H\U@PWKMY_,K_ (*4_P#!2#_@JU\'/^":G[-G_!6SPQ^VJ=%U M7XA:MIUO?_#'P]X2LX] $_MO_!R? M_P %)OVUOV/OV5_@)^U#^QW^T+JO@*Z^(7[K6]&M](TV]M9$DL4NT?\ TRUE M=9%+E,JP4KC*Y&: /IG_ (*:_P#!;?3O^"97QC^$?PU^('[+^J:_I_QCD\KP M]JMGXDCMI[*5);6.>.ZMI(#L9#>0D;9&W?,/E(JQ^V=_P6HT[]BC_@H]\)O^ M">WCK]FR\U63XQ:IH]KX9\8:7XIC$5O'?:@+ O<6[P!E:.4,Q178,FTAP6*K M\"?\':-Y2[YI]>U225\ ;F:[\/DGCCJ:O\ _!?K_E8]_8._ M[&#PG_ZE9H _0OXR_P#!6U_A'_P5K^'O_!+0?LH^+=6'COPX=4/Q%M;C%K9_ M)<-\MOY)\Z!/(Q+-YJ>67QL;'/V-7Y%?M'?M]_MN_![_ (.;OA9^P=X9_:6U M>;X2>-=.MM3U7P;>Z+ICQH9;2_9H8[@6HN%C#VT;C,A8'(W$<5M?#;_@H'\> M_P#@IO\ \%SOBM_P3U\ _'+Q+\-?A%\$/"6I_;9/ S6UOJNOZY:7MG8RO-=3 M0RM'#'-E0WFI$0V;R6 M]Q.D"A+<)*2@B19#([%Y&0+'0!_1/5'Q+<^(;+P[?WGA+2+74-5BLY'TVPOK MYK6&YG"DQQR3+'(8E9L N(W*@YVMC!_'WXA?\%BOV\I_^#7KPQ_P42\!RQ2_ M%?4[K^PO$GB^TT>%UTV*+5[G3WU;R-AA61U@A4Y3RTENMP4 !:]Y_P""-W[8 M>E?MP?$33_C!^SM^W=XO^('PVMOAM>6WC3X7?$YM./B+PCXG>\T]K>:22WMH M9;JWF@2^"R$R1(R.$;]X8X@#Z^_9-_;&^%W[7.A^(5\(VU]HOBCP1KTNA?$' MP-KJHFI^&]3CZP3K&S(Z.HWQ3QL\4R$,C'Y@/6:_'GXH?%[5OV0_^#O7POX6 M\+7#6^A_M$?""RMO&MG&<)(/[#4 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %?D7_ ,'27P&\1>'O$W[,7_!3 M/1=+GN='^ _Q7LI/'9MHB[6NFS:A8W$5TP'2..:T,1/]Z[3\/UTK+\<>!_!W MQ+\':I\//B%X7L-;T+6["6QUC2-4M5GM[RVE4I)%)&X*NC*2"",$&@#P[]M_ MQ[^U[X'/PM^,?[''PBN/B=I.F^+FE^(?A'1?$5E97.J>'Y]/N(_.M7NYHH)I M8IWMYTC+CS-FT$;MP_+OX_?\$\/B-_P69^,>J^%] _98UWP#;:#^UE>>(/&G MQ1\;_8+2[T?0SH6D)-HD,,%Q+/<74LB)* %^SQF.,F7+L!^QG[-W[/\ HG[, M7PPM?@SX,\9:]JGAK1W\GPM9>(;U;J71=/5%6+3HIRHEF@B"D1F=I)54A3(P M5<=[0 'ITK\@/^"=/[!/_!0#X(?\'!?QT_X* ?%C]CK7M&^&7Q.TK7-/T+5G M\7>'9YX#/?6%Q#)/;P:D\BJR6;C"AV4NF0!N(_7^B@#\;O\ @E?^P3_P40_9 M9_X*P?M9_MC_ !B_8E\16/@[XP+XIOO!AM_&7AJ>YEDN=9:_M;:6./5#Y4DD M9V9)\M7X9U7YAV'_ :Q?\$]/VXO^")=>L-4T M/4?^$GT?4;>Y6.%XI(O]!O)I$D!(;YD"D9^;(Q7ZPT4 ?-7_ 6"^$?QD_:! M_P"";'Q;^ O[/_POO?%_B[QIX4FT?1M'LM3L;/,DQ \UY;VX@B6-!DGYRW]U M6-?F*_\ P2Y_X*7M_P &T"?\$QQ^Q=K/_"UU\?\ VDZ9_P )MX;^R_8_[7.H M_:?M']I^7MV'R]F?,W_P[?FK]SZ* /PP_P""B/\ P2]_X*8?M*_\$+_V8_V# M?AG^Q3K4GQ"^&^JVLWC"RO/&WAJ*WLTM+"[M05F.I[9?-:Y5TV9(5&W[#@'L M_P#@O?\ \$Z/^"B/_!0']A#]FOX$?LY?L(_!.G17/C&VU#QCX=M4TJ9 M-/CM#;&234@LTA=&<-$7CV%?GW$J/VO[0/_ 3/_P""Y/Q9_P""@OPZ^!?B'XE_"7XX>%-3-[%X M)ELY-5\/ZY=7EI?2I-;7-Q"9899K>?9)&6"_:$#[=A9OU6HH _)W_@CI_P $ MF?VG/V*/@5^TM^T]\>?AF\WQ:^/"7\FE?#31M9L9;C3+5S=R16TEU)/':^?+ M-=DO^]\M$AC^?<64?/?[!/\ P2C_ ."GO[/'_!#G]J#]A3XB?L5:O'\0?B7K M,4_@ZRM?''AN6WNXY8;6%V:8:GLB\K[,S,'()#KLWG('[S44 ?EQ_P $YOV> M/^"BG[$?_!%GX>?LP>(/V(/[>\;^'/'EW:>./ACK'B#0+FT\3^&[_4;V:[1+ M@7,F6$(P,;'=R/_!,/_@C]K'[//\ P6<\5?MO?L\_L]^,?@G\ M$6\ 36"^#?&FH6ANM0UF[9#/;6T%M=7!2PB,<:H6+<@!3]=:I>)--U M/6?#U]I&C>(KC2+RZLY(;75;2&*26SD92%F1)E>-F0D, ZLI(&Y2,@@'Y)^) M?@AK'[9W_!VQ:_%;PY:O/X6_9F^%5A%XLU*,9A35+FVO9+.SWCCS2=3\[;_= MM9 <$5^O->=_LU_LN?"']E+P7>^$/A3I%QYVM:Q<:SXHU_5;HW.I^(-5G;=/ M?WMPWS33N<<\*BA4141%1?1* "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH ***I^(?$.@>$M"O/%/BO7+/3-,TZV>XU#4=0N4A@MH44L\DDCD*B* 26 M) &30!")=<6Z@MK&&[U=;:'599H4F MC6QGFVQ7VZ.1&'V=Y,YKI?VQ/V_/V.OV /!5GX__ &P?CYHO@C3M2G:'2UOQ M+/'A@ ^S\T ?9M%-@F2XA2>,,%=0RAT*G!& M>0<$'V/-.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH *_/?_ (.5@EQ;$*&;:I_0BO#/V]?VV M_!O[ WP]\)?&GXI0>7X-O_B!8:%XPUC[/)(-%LKN*X5;YO+!VQQSK;^8Q! C M9\#=MH _);_@FE_P43_8C_X+40?&[]D7]N2QT+X>?$/XQ7N@R>&_#\T?^CKJ MFFZ/;6"76F2RJ%BN4N+82QVK-OVOY0,PWD_J]\?/^"8?[#_[5OQ-U;XM_M5? M K2/B/JFH:%%HUB/&,*W4.B6";R8K!, 6K/)))*\Z?OBS >8%CC5/PQ_X+W_@ME\._V(/AOX7_X)\:]X[UO4O'WBS0K M2'XR:UX"DA_M+0M&>!18K'#?7HW)$S9,$,K3[=WDAP#R_P#X-'_V;-8^ M%/Q7_:G^/?@75KV'X)3^+3X<\"7U[.3#K,=A>7CB[#'AQ#;21*9>A-PX!RK M>*_LI_\ !49/VL?V]OC7_P %F?VJOV8_BA\5OAC\"8TM/A3X?\&Z597>G^!+ M*:64_P!JS07=W !:1]I2026I14W,_P!H"@;@0 #] /\ @HY_P5)\%_M(_P#!#3Q3^T]^ MP'X<\4?$'_A9<(\(V&D:#HMR^I6#7+F+4HKJ.W5Y+22*T%R/,&5#O"R,RNC- M^9/_ 37_;9_X-_O&G[4/AGX5?M9_P#!(#3_ ('>,8/$=HN@^)Y/&&JZCIMK MJ:S(UN+V&Y>-[1?,V#+K-'SF38FXCZC_ ."*GQ>N/^""G_!"[_AJ']NCX2_$ M$:5\1/C"VI6&@>'- 6>_TNQO+*VMK>[NHIY81;Q/]@=]SL,B:W !:0 ]W_P5 MI\-_\$\/^#@']COPU!^PUXT\)>._C9?^(=(C\%7^CQ@:QX?LI+R)=1;6(P!< M65C%:-['&3[FK= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7RC_P68_X* M::=_P2B_8LN_VE1X+B\0:WJ/B"U\/>%-+O)WBM'U&X2:19+ET!<0QQ6\\C!! MN?RP@*E]R_5U>)?\%!?V*/V&/^%T?'3X-?'3X9_'+0 MOAI=>';^Z\&6O@E[*UUG1[O0[+4+J?1+RUNY)(V19I)(TG^U^:H.&#%5.U^U M[_P5'^+GB7_@M!\+?^",?[-WB\>"_P"W-)N-7^)/Q$M=-M;S4[-4TR[U"&QL M(KR*:V1VBMHR\LT,PQ<+M4;&W?D_X ^*G_!0;_@UB_;$\8^!=$OO^%I? "W\ M::=I?B^7^SO)MKV:XT^*]@",2SZ?J LY25&YH9#&X_>"/*?HO^W3_P $N_VM M/$W_ 5?^$O_ 7(_P""<-EX<\93KIEA)XH\"^)-=_LF6^MFL7M#+!<.C(JR MZ?/Y1##=&Z*X64,50 [/_@EE_P %:?CQXW_X*2?&?_@D/^VOK.GZ]XR^'6HW MT_@7X@6>E16$OB+38)4(2[MX (4N3;S0S@PJB%1*"H* O^E&JW-[9Z7:_!+_@CAX;^)G[;'_!SA\?OVY+[P59 M:-H_P_34K+7#HNLG4K"/4VACTB&UCN_)A%QO2WNI@X15(A)&059OWUH _)70 MO^"R/_!0?Q'_ ,'$_@C_ ()6_$[X<^"/ G@R%]1FUVP\.7K:S1/O?K+?7UEIEE-J6I7D5O;6\32W%Q/($2)%&69F M/"@ $DG@ 5^$/C;_ )7B_"O_ &!&_P#4"NZ^N/\ @NC_ ,%5OV9/V3/BO\/O MV-?VK[SQ+I_P^\:Z1-X@^(4OAO2OM4^NZ;#/Y4.A "1#'!W.EV5WHT*7'B2 M[5K26+6?-DC\^."2*YS BLJO"R2,I9\+TO\ P<4?\%8?VZ_^"6WP/TKQ[^SM M\%O!2:-XE\0KH%KXZ\0ZS)>7=K>/:RW ,>F)&B ;89MLLD[C=&0T."I;\U_^ M"!8SHJQSK?7J:79VZS1!\0 MQ"2!P6!.U<'':OLS_@]>_P"4:OPV_P"RY67_ *9M6H _4O\ 9*\<^*/B?^RI M\,OB5XXU/[;K7B'X?:+J>L7@@2+S[J>QAEEDV1A43<[L=J@*,X XKT&O*/V M#/\ DQKX,?\ 9)_#O_ILMZ]7H **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH ***XC]ICPE\2O'W[.'Q \"_!CQ*-%\8ZUX M(U:P\)ZP93']@U.:SECM9]PY79,R/DTTR:W\KSH;VZ3,%E(OGQ92=T;YAQ7KFK?&?X3:)\(K M[X^WWQ&T<^"=.T*?6KSQ3;WZ36*:?#$TLET)HRRM&L:LVY21@<5_.9_P2>_X M*=Z'^P[^T%\*?^"=?_!5?X10_#.R^#UOXUT&_P!:U[3'9+O^WYK:81ZE#L96 MB+QRC[6"T4D,T9;"*TK??_\ P5WM] _X)[_\$9O#'[+/[&_P0USXK>"_%WCM M5BT#PK;75S;/X2N-5GURYM6NK)9#':21/'IZR@[GAN-RG=D@ ^G/"/\ P7P_ MX) >/?%FE^!?!G[?%+X\_%/0/!WARP&;O6O$FJQ6=LAP2%WRL 6.#A1EF/ !- M?@;_ ,$7?VS?^"!7Q?\ VQ_!GP^\3$3<2(UK8'* _6__ =\? 3X.:U_P3 U/X]ZM\.],N?& M>B^+]%MM)\2S0;KRS@DF:.2&.0\I&ZL=R#"L0&(+ $ 'Z>_!;XS?#/\ :(^% M.@_&_P"#7BF/6_"OB?3DO]!U>*WEB6[MG^[($E574'MN4&OGSXI_\%P/^"3_ M ,%?CX_[,GQ._;?\(:7XR@O_ +%>V#?:9;:QN=VUH;F]BB:UMG5N&665"A!# M8P:H_P#!%?18_$O_ 1@^ GAV74;RS6_^$%C;-=Z=)-%\"S0#0?# M[0N+FXNKF"#?J '_@_P#$E?&7A73/A[HUEX=\6)*'_MBRALHHH;LG M)^:1$#GN"Q!YKTJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;+%%/ M$T,T:NCJ5=&&0P/4$=Q3J* .-^''[//P3^$/C'Q/X_\ AC\-M,T/5_&5U;W' MB2[T^(I]LD@@2"([,[4Q'&HP@4$C<06))[*BB@ K.UKP?X2\27MGJ7B+POIU M_<:?)YEA<7ME'*]L_'S1LP)0\#D8Z"M&B@"*]LK+4K.73]1M(KBWGC*303QA MTD4C!5E/!!'8U2\,>#O"'@FQ;3/!OA73=(MGDWO;Z98QVZ,W]XJ@ )]ZTJ* M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ+]N[]EKXE_M5?#'P M_HGP7_:"F^&/C#PAXWL/%'AKQ7'H*ZG'' M')H)O&+:;HUO:+#%+<7\TFEVPD1A*K)),[+^[E12"?L/]ICX"_M+_&OPO)\& M/@S^T/I_PA\&W%@EC?:QX7\/&[\1&U*!'BL9Y94M],;;E%E\FY90 R>6V"OM M]% 'BO[(_P"P'^S?^PI^S6W[+_[*WAB?PKHTL,[7>KV]SYFIWE[+'L?4)[AP M3+B>&='MO M#WAO1[73["RA6&SL;&W6*&"-1A41% 55 X % 'YQZS_P $)?C]K'_!8*S_ M ."Q#_MY>%X_%EA.JV_A)?@K.=.%J-);2FA+_P!N^86-N[MOS_K&SMVC97Z, MOH=CJ$$+>(=/LKVY2)5DF-F I;')56+%5)R0-QQZGK5VB@#X4^!W_!$_3?@O M_P %C?'W_!61/V@H-0B\;:/+8P_#H>"1"NG,\-E&)1>_:V$A!M-V! G^LZC; MDR_\%J/^"0?Q-_X+"_#+P]\$;K]K/1OA[X4\/>)TUZ""+X9RZI?3W26DMLH> M+KKPAX= ML=%M-UMHX$>2"2\NOWC"/ M_P#!8OXL?\$H_P#@KG\-?A7\6==^.GA73T'P?\<:E'?V^KV\6N:!KD%OIDMA MIEW!GSFE^TM-"+-U_>F1_*&YED'HO_!._P#;JE_X(8?\$2_@)>?\%,/AY\28 MAXI\1ZA9:7;Z7X>^U3^&=/GN)KFU6_$TL9@4QDNL0W2A7V+'F-E7]2=9_9U^ M!_B#XO:)\?-7^&6E2^,?#MO>0Z/KX@V3PI="(3@[2!(6$,>"X8KM.TKN;/5Z MOHVD>(--FT77M*MKZSN$V7%I>0++%*OHRL"&'L10!^3G_!2;X$_L)_\ !;+Q MC^S_ /%?_@G_ ..O"GBWXF6/Q2T?4?$'CGP2Z/=:-X4A$DUV^KE 'MF0QPBW MAN@DQF/EQJ TV-;_ (.]OBO\,M(_X)1:M\*M2^(&C0^)]5\::')IWAZ34XA? M7$:3/(TBP;MY0+&Q+8P,=:_4CP]X8\-^$=,71?"GAZQTNS1BR6FG6B01*3U( M5 "?I5Z@#\^O^"47[:7P,^"7_! GX>_']M;D\66'PK^#L%SXOT3P4T6H:G; M/;(XD@,"R#9+F-QB0H %9B0JDCR+_@H?^VK_ ,$OO^"VW_!(GQ?IGP>\9:;X MK\?7^F^9\-/AU/#%_P )G8^* 1]EMX=/1GGW._[N22'?"T!F;S#&K,/UBZ]: MQ_#GP[^'_@^_N-4\)>!=&TNZNQBZN=.TR*"2;G/SLB@MSSSWH \/_P""3/[* MWCC]B;_@G%\(OV7_ (FWD;45^/ M_P"MG%7_ $'UO_!L_P#Y(\+Z[C/^?DOO?^9Z3_PUW^T/_P!%"_\ *3:?_&J/ M^&N_VA_^BA?^4FT_^-5YM11_K9Q5_P!!];_P;/\ ^2#Z[C/^?DOO?^9Z3_PU MW^T/_P!%"_\ *3:?_&J/^&N_VA_^BA?^4FT_^-5YM11_K9Q5_P!!];_P;/\ M^2#Z[C/^?DOO?^9Z3_PUW^T/_P!%"_\ *3:?_&J/^&N_VA_^BA?^4FT_^-5Y MM11_K9Q5_P!!];_P;/\ ^2#Z[C/^?DOO?^9Z3_PUW^T/_P!%"_\ *3:?_&J/ M^&N_VA_^BA?^4FT_^-5YM11_K9Q5_P!!];_P;/\ ^2#Z[C/^?DOO?^9Z3_PU MW^T/_P!%"_\ *3:?_&J/^&N_VA_^BA?^4FT_^-5YM11_K9Q5_P!!];_P;/\ M^2#Z[C/^?DOO?^9Z3_PUW^T/_P!%"_\ *3:?_&J/^&N_VA_^BA?^4FT_^-5Y MM11_K9Q5_P!!];_P;/\ ^2#Z[C/^?DOO?^9ZQX5_:N^/VI>)]-TZ]\>[X;B_ MACE3^R[4;E9P",B+(X/:OLROSO\ _\ R.FC_P#84M__ $8M?HA7[QX.9KF> M:87&/&5YU7&4+<\I2M=2O;F;L?29#6K5H5/:2;M;=W[A1117[0>^%%%% !11 M10!Y+^U%\'_VIOBL=#/[-/[8G_"IQ8"Y_MH?\*^L==_M3?Y7D_\ 'TZ^1Y>R M7[N=_G<_=%>3?\,@_P#!4O\ Z3"_^:^Z)_\ ':^LZ*\^OEF&Q%5U)RFF^U2I M%?=&:2^2\]S[#*^.,ZR? 0PE"EA90C>SJ8+!UIZMMWJ5:$ZDM7IS2=E:*M%) M+Y,_X9!_X*E_])A?_-?=$_\ CM'_ R#_P %2_\ I,+_ .:^Z)_\=KZSHK'^ MQL'_ #5/_!U;_P"3/0_XB7Q%_P ^,%_X;BBO0P]"&&I*G!MK^]*4G]\FW^)\CFV:XK.L;+%XB-.,G96ITJ5&&B MMI3HPA37FU%-O5W84445L>:%%%% !1110!\W_$#_ (*X?\$]OA;XYUCX;>._ MV@?L.M:!J4VGZM9?\(IJTOD7,+E)$WQVK(V&4C*D@XX)%9'_ ^L_P""97_1 MRW_EFZU_\AU^,_[?_P#R?+\7_P#LI6M?^ELM>15_3F7>"_"V+R^C7G6K7G&, MG:4+7:3T_=G\XX_Q?XEPN.JT84:-HRDE>,[V3:U_>'[Z_P##ZS_@F5_TE=)7S=_P2'_ .4<7PN_[!-U_P"EUQ7TC7\TYS@Z679Q MB<)3;<:=2<5?>T9-*]K*]EKHC^B,HQ=3'Y3A\5424JD(2=MKRBF[7OIKIJPH MHHKS3T0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***^4_CS^TG\:O!?Q2>IKYGBGBK+N$L%#%8R,Y1E+E7(DW M>S?64=-.YR8S&TL#34ZB;3=M/^'1]645\2?\-=_M#_\ 10O_ "DVG_QJC_AK MO]H?_HH7_E)M/_C5?"_\1KX5_P"?-;_P&'_RP\W_ %@P?\LON7^9]MT5\2?\ M-=_M#_\ 10O_ "DVG_QJC_AKO]H?_HH7_E)M/_C5'_$:^%?^?-;_ ,!A_P#+ M _U@P?\ ++[E_F?;=%?$G_#7?[0__10O_*3:?_&J/^&N_P!H?_HH7_E)M/\ MXU1_Q&OA7_GS6_\ 8?_ "P/]8,'_++[E_F?;=%?$G_#7?[0_P#T4+_RDVG_ M ,:H_P"&N_VA_P#HH7_E)M/_ (U1_P 1KX5_Y\UO_ 8?_+ _U@P?\LON7^9] MMT5\2?\ #7?[0_\ T4+_ ,I-I_\ &J/^&N_VA_\ HH7_ )2;3_XU1_Q&OA7_ M )\UO_ 8?_+ _P!8,'_++[E_F?;=%?$G_#7?[0__ $4+_P I-I_\:H_X:[_: M'_Z*%_Y2;3_XU1_Q&OA7_GS6_P# 8?\ RP/]8,'_ "R^Y?YGVW17Q)_PUW^T M/_T4+_RDVG_QJC_AKO\ :'_Z*%_Y2;3_ .-4?\1KX5_Y\UO_ &'_P L#_6# M!_RR^Y?YGVW17Q)_PUW^T/\ ]%"_\I-I_P#&J^G/V9O&WB?XA?".R\3^+]3^ MV7TUQ.LD_DI'D+(0!M10.@]*^BX8\1:BE9-+I.3OJNA MUX/-D%%%% !1110!ROQS_P"2,^*?^P!=?^BF MKX%K]&==T32_$NC77A[6[7S[.]MW@NH=[+OC88894@C(/4$&N!_X9$_9X_Z) M[_Y5KO\ ^.U^1^(O 6<<78^A7P=2G%0BXOG)FN6U\=4C*FTK+K M?_)GQ)17VW_PR)^SQ_T3W_RK7?\ \=H_X9$_9X_Z)[_Y5KO_ ..U^=_\04XJ M_P"?U'_P*?\ \K/*_P!7\9_-'[W_ )'Q)17VW_PR)^SQ_P!$]_\ *M=__':/ M^&1/V>/^B>_^5:[_ /CM'_$%.*O^?U'_ ,"G_P#*P_U?QG\T?O?^1\245]M_ M\,B?L\?]$]_\JUW_ /':/^&1/V>/^B>_^5:[_P#CM'_$%.*O^?U'_P "G_\ M*P_U?QG\T?O?^1\245]M_P##(G[/'_1/?_*M=_\ QVC_ (9$_9X_Z)[_ .5: M[_\ CM'_ !!3BK_G]1_\"G_\K#_5_&?S1^]_Y'Q)17VW_P ,B?L\?]$]_P#* MM=__ !VC_AD3]GC_ *)[_P"5:[_^.T?\04XJ_P"?U'_P*?\ \K#_ %?QG\T? MO?\ D?$E%?;?_#(G[/'_ $3W_P JUW_\=H_X9$_9X_Z)[_Y5KO\ ^.T?\04X MJ_Y_4?\ P*?_ ,K#_5_&?S1^]_Y'Q)17VW_PR)^SQ_T3W_RK7?\ \=H_X9$_ M9X_Z)[_Y5KO_ ..T?\04XJ_Y_4?_ *?_P K#_5_&?S1^]_Y'QQX'_Y'31_^ MPI;_ /HQ:_1"O.[']E'X Z;>PZC9> MDUO*LD3_VI=':RG(.#+@\CO7HE?JW MAQP;F?!]#$0QDX2=1Q:Y')[)WOS1CW\SVLJP%; QFJC3O;;_ (9!1117Z4>L M%%%% !1110 4444 %%%% %37M=T7PMH=[XF\2:M;V&G:=:275_?7TK_@MA>_%?5_!?B?\ 95_8<\?_ !(^'_C:S\2W7A[Q M+8ZIIMA?Z];Z++!%=7&F:?=3H\\9>9E47#VTLACPD;9&?L#X]?"'P_\ M!_ MSQI\!/%EY-_">HZ!J=Q9L%FBM[RUDMI&0GHP60D'U K^;G0?B+_ ,%% M/^#7K]L/X=^#OVN?#$_Q-^".A3>((?AS/IE\D=M-::BUL;^6QD96>VN 8H)7 MLIB$\QG*G$IG8 _H>_9Y_;(^!O[27[*FF?MF>$=^++;^S MI=,AM)9HKK[4LAQ"87@F#DDJ/+)!(P:\WLO^"HGPH'[(_B#]O3Q!\/\ Q%8_ M"N+R1\/;Q;5I=:\<>;+Y$#V6F!0Z+=3-$EJ)'$DRR>8\<$85F_-3_@XL_P"" MAWP>\;?\$1/AO+^P1K*VO@K]HGQ[<2WC6D1MY#;B>YO]2M94SF*9M3=1,H)4 MD2KRK#/[/^!_@_X!\#?#_P (?#JP\,6$MCX&T^TMO#:S6B-]@^SVIM8Y(<@^ M4XA9X]RX.UV7.&((!^9'[+W_ =2?#3XH_MM:3^Q7^U7^P[X]^!>I^)=6M], M\.ZAXOO2THN;E@MJM[:2VT$EFLK,JJZF50SKDA,NOUE^VW_P58^'?[*'[3GP MR_88\!_#VX\>_&?XLS!O#?A1-733;.QLMTBF^O[QTE,$.89]HCAFD;R),)PH M;XP_X*)?LCV?_!53_@X&^#G@KX>:3%+X;_9KT.QUKXU>+H(QLAG:]^W6.A&0 M?>GD$:/LSE(KN5^JD'S?_@Z,_93UG5OVTO@1^U3^QA\;I+;]IY$@TWP?\,-& M@>?5]9M[*XN+R+4K545DB\AGN!)]HVQ2QJ5#%HS'( ?H3\%?^"J0\&]/3Q6=0T'Q19-$KH]MJ M(IHR"X#K):!E"R,J MR;"*]>_95_;*^&_[4\OBSP?I>FWOAWQU\.]:&C_$;P!K;1_VAH-XR;XBWELR M36T\?[V"YC)CFC.1A@Z+^/\ _P &]W[8GPY_X*%?\%:?'_[2?[K_MB_%[5O MV.?^#LCX'ZUX,N&M])^.WPGLO#OCNRC.%U"5[K4;:VE8="TF><%%%% !1110 4444 %%%% !1110 4444 ?T%_\ !(?_ M )1Q?"[_ +!-U_Z77%?2-?-W_!(?_E'%\+O^P3=?^EUQ7TC7\(<4?\E-CO\ MK]5_]+D?VSPU_P DY@_^O5/_ -(04445X1[84444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 >0_M-?MZ_L@_L>+'#^T3\>-#\/WTT4,T.B&9KG4 M9();A+=9ULX \YA\V1%,NS8I/+"NK^!_[1?P#_:8\)MX[_9Z^,WACQMI"3&& M;4/#&MPWL<$HZQ2&)CY4@[H^&'<"OYX_^"A'[3'[5O\ P2H_X*7?M'>'OVL_ MA%=Z[\/OVD?B#X>UWP]\0BC-);Z3I&M07]I#:2X*S""U#6DMH2C*R1."%QYO MZ[?#WXK_ +'7A3X#_'K_ (+ ?\$]9H/'P^(W@FTU"]T/P;IVC7SH[R8WEO%-&Z*Z^4LC#+LQ .G^)__!=+_@DG\&?B-KOPD^)G[<7A+2O$ M7AK5I],UW2Y8KMWL[N"0QRPL8X676SC*2H)%5MK#D$@9!!'!%?RW?LS?MN_\ !(SP MEXTT?X8?\%9_^"+^JZ?XANXXF\7?%"7Q5K+:G?WLG^OU.[TR5H#^]E,DS^2W MRY(2-L 5^F__ <=?\%,Y/V.?^"=WPB_9R_X)W>)H=.D^.&F1:?X)USPE.1] MB\*V]M;*HL74YC:9;FTACD'(C,NW#A64 _2>R_;>_9%/#NH:_K/V-?O73V.F6]Q<1P\']ZZ*AP<'BOBG_@E[^W MU^PG^Q9\1/!7_!$^Z_9V^(WP5\>0:);RZ5+\1M L;:/QI?RQ%I+W[19W=P'N M+EXY67S"!E/(4AT6(?"W[4_[1_[17_! 7_@X;\>_MN_M#?#+4_&/PL^.T-S; MVVLV;JTTVD.UI(8K5W(5;FQ>"&+[.Y4/$J\J)$D4 _=_]G#]J3]GK]KOX=CX MK_LU_%K1_&&@_;)+2>]TF^K\L_P#@ MV5^$[>([']H[_@H[HWC[1Y?#O[2'Q=O-<\.>"-'U-+A_#5O%>ZA.(KT1DK!> M,M^@:$#Q!_ND?\ M7Z,X&BBBOYD/D0HHHH **** "BBB@ HHHH **** "BBB@ K[0_8R_P"2":;_ M -?=S_Z-:OB^OM#]C+_D@FF_]?=S_P"C6K];\&/^2MG_ ->I?^E0/;R#_?7_ M (7^:/5****_J4^Q"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#DOCYHWQ \1? KQKX?^ M$VHO9^*K_P ):E;^&;N.Y\EH-0>UD6W<2?\ +,B4H=W;&>U?EU^V-XZ_:H_: M^N?A;\"/VG/^"6WC&X^).I?!OQ]H&K^$Y]2T*;1-4U6XM=)CCO[74/MYBCMH MYHUN"[[)X?E\M)'4$_KE10!^ G_!3_\ X(=_&']EW_@W$\ ?#FQU./Q+XY^" M'C"X\:^-CHP>6!+6^\Y;Y;8, S1VWF6KLY REM-)M4' _6?]I+]IS]J#Q?\ M\$\[']H/_@FO\#(_B;X]\>>%;"]\"V1US3K*SLEOK83)J%P]]<0I)%"K!O*5 MF>1RBX"EW3Z/OK&RU.RFTW4K.*XMKB)HKBWGC#I*C##*RGA@02"#P0:\W_9C M_96\ ?LC>&]0^&WP:U;5;7P5+>M=>'O!=U.DMEX:,CO)-!8L4\V.V>1RZP.[ MI$"_!>@^*=:EE\:?$&T\0^'9 M]=DN;Z4?;];FN3JTDD]Z0S2>9L9AL58U 1$'U?\ MI?L#?M2?#+_ (+K?"#_ M (*[?"'X7:E\4/ NC>%)/#7C/PQHNH6_]LZ&&LKZT6[MH[N:,7,7^F)(RHYD MRLWR_.#7Z>T4 ?EI^S#_ ,$N?BO\3?\ @OKXO_X+#^*O@U>?"OP-8Z0;;PIX M?UN:U&K>)=4ETL:=<:A-;6LLJVL)1IVQ(XE=Q&Y0%GQR'[2_P0UC]MW_ (.O M/AA=>$K5KCPY^S;\)]/U;Q_J$8REE?R3:C=6-L6Z"61KNR<(>3&DK $*:_7' M6;.^U#1[NPTS5I+"YGMI([>^BB1VMI&4A9 K@JQ4D$!@0<<@BN _9L_95^$W M[+.A:Q8_#NTO+O5O%&LR:QXS\6:Y<"XU7Q%J4@ >[O)@JAFP JQHJ11( D4< M:*% !Z11110 4444 %%%% !1110 4444 %%%% '\X'[?_P#R?+\7_P#LI6M? M^ELM>15Z[^W_ /\ )\OQ?_[*5K7_ *6RUY%7]\Y+_P B;#?]>X?^DH_AS./^ M1MB/\<__ $IA1117IGG!1110 4444 %%%% !1110 4444 %%%% ']!?_ 2' M_P"4<7PN_P"P3=?^EUQ7TC7S=_P2'_Y1Q?"[_L$W7_I=<5](U_"'%'_)38[_ M *_5?_2Y']L\-?\ ).8/_KU3_P#2$%%%%>$>V%%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% 'Y<_\ !2G]N3]B[]L;]DWXY?L7_M':YX1TKQIX M#^,&EZ'?^#_$M\EE=7>ECQ)8I%JMCY[+(R/82N'G@.8R)CE%9<_._P#P0F\( MV_\ P2YO/VW?VJO Y\:>-/V6_">HJ/ %_HMC]MG\5K8SW.^YT\92*Z6&%UB> M[4I#(,/NVQML_9SXU?L]_!3]HOPP/!WQL^&^F>(M/6ZMKB.*^B(>.2"XCN(F M61"'3$L2,0& ;&U@5)!["&&&WA2WMXECC10J(BX"@< #H* /RW_ &FOVZ_^ M"0/_ 73_P"";OC/P;X6\0Z;XE\;W?AN^'@/X=ZK81Q^-M.\1>0QLQ96:L\K MR&81!I+=I(#&7$LGEB3'Q7_P6^_X)7_M,_LQ_P#!,[]CCXM6.@W?BJ^_9OT/ M^S_BA;:4#<_V?Y\EK>"92N$;VYU+PIX* MTC3+F\.;NXT_38H7G.<_.R*"W///>M9E5E*LH((P01UH _#S_@HEX.T+_@J) M_P %^_V./B#^Q+XELO%^E^$_#>A>,/&WBOPY<+<6^BZ/;:S)J,(NIHR5@ED5 M9%CB*_#LMG\*X?B5=QV M]A/X.&H/)$-,FG94C*0+8R[H&$B2Q3/D2)(P_:_PYX1\*>#K1]/\(^&-.TJ" M64R20:;91P([GJQ" D^O6H_%'@?P5XX@BM?&O@_2]8BMW+P1ZII\=PL;$8+ M*)%.#[B@#\:/^#1K]F'XH?!+QE^TQXV\+W^J77P-U;QC%I7PPUW4%98?$ZV- MU?(-3M@0 Z&W> -,@"NSA028B%_:NFPPPVT*6]O$L<<:A41%P% X '04Z@ MHHHH **** "BBB@ HHHH **** "OAG]J'_DO?B3_ *^T_P#125]S5\,_M0_\ ME[\2?]?:?^BDK\:\;?\ DG,/_P!?5_Z1,\'B#_=(_P"+]&<#1117\R'R(444 M4 %%%% !1110 4444 %%%% !1110 5]H?L9?\D$TW_K[N?\ T:U?%]?:'[&7 M_)!--_Z^[G_T:U?K?@Q_R5L_^O4O_2H'MY!_OK_PO\T>J4445_4I]B%%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110!_.!^W__ ,GR_%__ +*5K7_I;+7D5>N_M_\ _)\OQ?\ ^RE: MU_Z6RUY%7]\Y+_R)L-_U[A_Z2C^',X_Y&V(_QS_]*84445Z9YP4444 %%%% M!1110 4444 %%%% !1110!_07_P2'_Y1Q?"[_L$W7_I=<5](U\W?\$A_^4<7 MPN_[!-U_Z77%?2-?PAQ1_P E-CO^OU7_ -+D?VSPU_R3F#_Z]4__ $A!1117 MA'MA1110 4444 %%%% !1110 4444 %%%% !117P'_PXCT&S^T:?KD-W<2+?QS7,4\#S7"RJ'!>-V M1<-S/_!?+]N/7/@-_P %L_V?_AE^VK#JTW[*=KHUOJNM^&8(Y7TO7;F62[@F MNKV%.+];67[([6KAP(TXC/V@AP#]R**_)#_@EWXNUK4?^"[GQPT3]@'7UU+] MD9_ >G7VH1^'+GS?"=AXCGM+&9%TO83!#,_F3-)%!A0#*'4&.,+^AW_!03]I MW_AC#]B/XI_M30V<-S=^"/!-_J>EVMP#Y<]ZL1%K$^"#L:=HE..<,: /8:*_ MF_N/%7Q 3_@W-@_X+ CQSJ0_:3;XXG5_^%Q>?_Q.RO\ :K6'V'[1][[!Y0Q] MA_X]N/\ 5U^N'A+0->_X+3_\$\?@]X\\0?'#Q/\ #_P?\0/!%OJWQ%T_X<:A M_9^I:K?-%&CZ>EX5=H+%9Q=>8J 23;85WJ@D60 ^T**_"S_@A-^R[\8_V/O^ M"[_[07[,'[+/QUUWQ?\ L[?#_3FMO%-WK&K+/"^I7$-O-;VS*F$>_@G:YA>: M-%^6WF#;"X2O=O\ @M)_P1$^*?[=OP]^*7[5_P 8_P!N/Q7INN>#])U/4_AA MX T:=5\+:1I]C$\L*3QL@EDN[A(O,FN@R^5)-L42QP)N /U=HK\QO^#33]H? M]IG]HK_@EM)JG[2'B?5->3PW\0+_ $3P9KNMW#S75UI45M:2!&E.=_LL4NY0F0,2*P'/I7E9WF^&R'*ZN/Q";A32;4;-ZM+2[2Z M]T8XBO##475ELNQZ]17Q)_PUW^T/_P!%"_\ *3:?_&J/^&N_VA_^BA?^4FT_ M^-5^:?\ $:^%?^?-;_P&'_RP\C_6#!_RR^Y?YGVW17Q)_P -=_M#_P#10O\ MRDVG_P :H_X:[_:'_P"BA?\ E)M/_C5'_$:^%?\ GS6_\!A_\L#_ %@P?\LO MN7^9]MT5\2?\-=_M#_\ 10O_ "DVG_QJC_AKO]H?_HH7_E)M/_C5'_$:^%?^ M?-;_ ,!A_P#+ _U@P?\ ++[E_F?;=%?$G_#7?[0__10O_*3:?_&J/^&N_P!H M?_HH7_E)M/\ XU1_Q&OA7_GS6_\ 8?_ "P/]8,'_++[E_F?;=%?$G_#7?[0 M_P#T4+_RDVG_ ,:H_P"&N_VA_P#HH7_E)M/_ (U1_P 1KX5_Y\UO_ 8?_+ _ MU@P?\LON7^9]MT5\2?\ #7?[0_\ T4+_ ,I-I_\ &J/^&N_VA_\ HH7_ )2; M3_XU1_Q&OA7_ )\UO_ 8?_+ _P!8,'_++[E_F?;=%?$G_#7?[0__ $4+_P I M-I_\:H_X:[_:'_Z*%_Y2;3_XU1_Q&OA7_GS6_P# 8?\ RP/]8,'_ "R^Y?YG MVW17Q)_PUW^T/_T4+_RDVG_QJO3OV3_CS\5_B7\3)_#WC;Q5]MLTTB6=8?L, M$>)!)& ,XYKTU1O\&;4,ZPN(K1 MIQC*[\E_F?1M%%%?IYZX4444 %%%% !7PS^U#_R7OQ)_U]I_Z*2ON:N&\4?L MV?!7QIK]SXG\2^"_M-]>.&N)_P"T;E-Y !VI( . .@KX#Q$X5S'BW*:6%P< MH1E&:D^=M*W+)=(RUU['F9I@JN.H*%-I-.^OH_)GPI17VW_PR)^SQ_T3W_RK M7?\ \=H_X9$_9X_Z)[_Y5KO_ ..U^/?\04XJ_P"?U'_P*?\ \K/"_P!7\9_- M'[W_ )'Q)17VW_PR)^SQ_P!$]_\ *M=__':/^&1/V>/^B>_^5:[_ /CM'_$% M.*O^?U'_ ,"G_P#*P_U?QG\T?O?^1\245]M_\,B?L\?]$]_\JUW_ /':/^&1 M/V>/^B>_^5:[_P#CM'_$%.*O^?U'_P "G_\ *P_U?QG\T?O?^1\245]M_P## M(G[/'_1/?_*M=_\ QVC_ (9$_9X_Z)[_ .5:[_\ CM'_ !!3BK_G]1_\"G_\ MK#_5_&?S1^]_Y'Q)17VW_P ,B?L\?]$]_P#*M=__ !VC_AD3]GC_ *)[_P"5 M:[_^.T?\04XJ_P"?U'_P*?\ \K#_ %?QG\T?O?\ D?$E%?;?_#(G[/'_ $3W M_P JUW_\=H_X9$_9X_Z)[_Y5KO\ ^.T?\04XJ_Y_4?\ P*?_ ,K#_5_&?S1^ M]_Y'Q)17VW_PR)^SQ_T3W_RK7?\ \=H_X9$_9X_Z)[_Y5KO_ ..T?\04XJ_Y M_4?_ *?_P K#_5_&?S1^]_Y'Q)7VA^QE_R033?^ONY_]&M5O_AD3]GC_HGO M_E6N_P#X[7:>#/!/ACX>Z!'X8\(:9]CL879HX/.>3!8Y)W.Q/4^M?<^'WAUG M?"F>2QF+J4Y1<'&T')N[<7UA%6T?4]'+,JQ&"Q#J3::M;2_EY(U:***_9SWP MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** /YP/V__P#D^7XO_P#92M:_]+9:\BKUW]O_ /Y/E^+_ M /V4K6O_ $MEKR*O[YR7_D38;_KW#_TE'\.9Q_R-L1_CG_Z4PHHHKTSS@HHH MH **** "BBB@ HHHH **** "BBB@#^@O_@D/_P HXOA=_P!@FZ_]+KBOI&OF M[_@D/_RCB^%W_8)NO_2ZXKZ1K^$.*/\ DIL=_P!?JO\ Z7(_MGAK_DG,'_UZ MI_\ I""BBBO"/;"BBB@ HHHH **** "BBB@ HHHH **** "O//VC_%?P'L/# M&C_"K]HO1].U+P]\3M?3P@NF:U91SV5]<75O/)';3I)\I67R&B48.9)(UQ\V M1Z'7FW[5/[(W[/W[:WPK/P7_ &D_ C>(/#ZZG;ZE;V\6JW5C-:WL!)AN89[6 M6.6*1"2597!&: /YR_\ @I5^P;\2?^",W[7OQ%_;Y_X)>?$>\\%>&_A?\2M! MT&3PNVHRS2PC5-(MM1$1,C'[98O*SPO;R[F"F,Y?DI]N?\%!O'-S_P %;O\ M@L-\)O\ @CA^TOX!C\,_#"U^'P\:^)(X+.)=;O=6ET::Y6.UO98V>UC@=D1A M$ 9#!.LA=<*OW'\,O^",'[,7A7XXZQ\:?BUXE\8?%(R>)M,U[PKI'Q'\6ZCJ ML&C7UEI\5G%=2I<7+QZC-Q]/_:6_X)X?LL_M5_%+PE\> M_B1X-O[#XA^!"P\(_$'PIKMSI.LZ;&V_="+BV=#+"PDE!AE#QXED^7YVR ?C MI_P0W\*_M)?\$H/^"[GQ2_X)(R?%.[\3?"B'P]>:Y>O=OMM;*$6=O>V>K%2= MMK,8IHK:?!",SC.[9$1]X_MW?M2?LK?\%?O^"2_[3?PV_8(^.>E_$35?#_@R MY_M"PT6&=+A;FW/VR*-8YHT>19OLDB1R(&CD((5FP:^H?@'_ ,$_?V6/V<_$ M'C/QSX*^'\VI>*OB,-OC[QEXLU6XU?5M>C">6(9[F[=V\@( H@39$H4 (,"O MGG_@E#_P2H^"G[#O[1'Q9_:%_9^^"5_\-/!?C73-+T;PGX/U75KJYO)X;62X MGN-4N4N9I7MC/)<1QPVQ8/'#:JTB1R2O&@!^3MYJUG)_P94VMG'.F^/XI&"1 M=W(?_A(WEQ]=I!^E?KG_ ,$HO"'P=^#?_!+_ . '[ O[1WCCP[9>,O%OPE6[ M?X=ZOK\5KJU_;70>ZN(X[;S%G<1"=DO M#X=_X3;_ (3'_A6Y\2WO_"*_V_MV_P!H?V1YOV7?C_EGL\G/S>7GFKO[<'_! M([]A[_@H1\0?"_Q@_:(^'NK'QGX,B6+PWXO\,^*+W2=1LHEE,R(LMM(N0LK- M(A(+(S,5*[FR ?EIX/\ ^"7=S_P3#_X.>O@QX:_8*U/6+/P#\0_"NIZ]XC\/ M-?RW"Z1I:17,5[;3N[%I;4RI;/"TQ9A,\:Y+(K'[._X+@?M\? 73K2#_ ()< M:E^U?X2^&.L?%31W'Q+\9Z_JL<0\*^$I#LN1&A/[V_O4+V\$..$>69RBJA;[ M)^!'[)'P5_9YU2^\5^"]-U?4_$VJV$%EJ_C/QAXDO=;UJ^MH23%!)>WTLLPA M5F=Q"K+$K.[! S,3\Z_&[_@W>_X(_?M(?%K7_CK\!/A!H^FV!U+03YM@);G[0_E"X.#<77[IIYVQRUTC%BS.%^G:\8_8E M_P"">O['O_!.CP!JWPO_ &-?@ZG@W0]15Z[^W_\ M\GR_%_\ [*5K7_I;+7D5?WSDO_(FPW_7N'_I*/XF><%%%% !1110 4444 %%%% !1110 4444 ?T%_\$A_^4<7PN_[!-U_Z77% M?2-?-W_!(?\ Y1Q?"[_L$W7_ *77%?2-?PAQ1_R4V._Z_5?_ $N1_;/#7_). M8/\ Z]4__2$%%%%>$>V%%%% !1110 4444 %%%% !1110 45\(?MS_\ !;+_ M (8M_:.U;]G[_AF?_A)?[+M+2?\ M?\ X3/['YOGP)+CROL&O&N8X.GBL/A>:G-*47STU=-73LYIK3NKG MQ>,\0^#\!BYX:OB>6<&XR7)4=FG9JZ@T]>SL?J=17Y8_\1+O_5E7_F1__O=1 M_P 1+O\ U95_YD?_ .]U=/\ Q"GC[_H#_P#*E+_Y,YO^(G<#_P#07_Y3J_\ MR!^IU%?EC_Q$N_\ 5E7_ )D?_P"]U'_$2[_U95_YD?\ ^]U'_$*>/O\ H#_\ MJ4O_ ),/^(G<#_\ 07_Y3J__ "!^IU%?EC_Q$N_]65?^9'_^]U'_ !$N_P#5 ME7_F1_\ [W4?\0IX^_Z _P#RI2_^3#_B)W __07_ .4ZO_R!^IU%?EC_ ,1+ MO_5E7_F1_P#[W4?\1+O_ %95_P"9'_\ O=1_Q"GC[_H#_P#*E+_Y,/\ B)W M_P#T%_\ E.K_ /('ZG45^6/_ !$N_P#5E7_F1_\ [W4?\1+O_5E7_F1__O=1 M_P 0IX^_Z __ "I2_P#DP_XB=P/_ -!?_E.K_P#('ZG45^6/_$2[_P!65?\ MF1__ +W4?\1+O_5E7_F1_P#[W4?\0IX^_P"@/_RI2_\ DP_XB=P/_P!!?_E. MK_\ ('ZG45^6/_$2[_U95_YD?_[W4?\ $2[_ -65?^9'_P#O=1_Q"GC[_H#_ M /*E+_Y,/^(G<#_]!?\ Y3J__('ZG45X/_P3O_;:_P"&]O@9>_&C_A67_"*? M8_$L^D_V;_;7V[?Y4,$OF^9Y,6,^?C;MXVYRH?9/.\OS_)A:39NP=N=N,X.,YP>E3*481< MGLC6A1J8BM&E35Y2:27=MV6YMT5^3/\ Q%$_]6-_^9,_^]M'_$43_P!6-_\ MF3/_ +VU\M_KOPO_ -!'_DD__D3]Z_XE<\=?^A1_Y<87_P"7'ZS45^3/_$43 M_P!6-_\ F3/_ +VT?\11/_5C?_F3/_O;1_KOPO\ ]!'_ ))/_P"1#_B5SQU_ MZ%'_ )<87_Y _M_?\ (EZ!_P!A23_T77OU> _M_?\ (EZ!_P!A23_T77P_B1_R1&,_ MPQ_]+B>=FO\ R+ZGI^J/EFBBBOXW/A HHHH **** "BBB@ HHHH **** "BB MB@ KVC]A3_DLUU_V )__ $;#7B]>T?L*?\EFNO\ L 3_ /HV&OK> _\ DL<# M_P!?$=N6_P"_T_4^O****_M,^_"BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _G _;__ .3Y M?B__ -E*UK_TMEKR*O7?V_\ _D^7XO\ _92M:_\ 2V6O(J_OG)?^1-AO^O&O^2:?_I*/XMXO_P"2JQW_ %]J?^E,****^F/G0HHH MH **** "BBB@ HHHH **** "BBB@#]K/^#=__DQK6_\ LI5__P"D5A7WA7P? M_P &[_\ R8UK?_92K_\ ](K"OO"OXD\0/^2TQW_7Q_H?V1P+_P DA@O\""BB MBOCCZP**** "N*_:5_Y-S\?_ /8DZK_Z1RUVM<5^TK_R;GX__P"Q)U7_ -(Y M:PQ/^[3]'^1Z>2_\CG#?]?(?^E(_EHHHHK^6C_>D**** "BBB@ HHHH **** M "BBB@ HHHH **** /ZRH?\ 5+_NBG4V'_5+_NBG5_5:V/\ 1[A1113$%%% M% !7@/[?W_(EZ!_V%)/_ $77OU> _M_?\B7H'_84D_\ 1=?#^)'_ "1&,_PQ M_P#2XGG9K_R+ZGI^J/EFBBBOXW/A HHHH **** "BBB@ HHHH **** "BBB@ M KVC]A3_ )+-=?\ 8 G_ /1L->+U[1^PI_R6:Z_[ $__ *-AKZW@/_DL<#_U M\1VY;_O]/U/KRBBBO[3/OPHHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /YP/V_\ _D^7XO\ M_92M:_\ 2V6O(J]=_;__ .3Y?B__ -E*UK_TMEKR*O[YR7_D38;_ *]P_P#2 M4?PYG'_(VQ'^.?\ Z4PHHHKTSS@HHHH **** "BBB@ HHHH **** "BBB@#^ M@O\ X)#_ /*.+X7?]@FZ_P#2ZXKZ1KYN_P""0_\ RCB^%W_8)NO_ $NN*^D: M_A#BC_DIL=_U^J_^ER/[9X:_Y)S!_P#7JG_Z0@HHHKPCVPHHHH **** "BBB M@ HHHH **** /P@_X+G_ /*1WQ;_ -@G2?\ TAAKY"KZ]_X+G_\ *1WQ;_V" M=)_](8:^0J_N;@O_ ))' ?\ 7FG_ .DH_BWB_P#Y*K'?]?:G_I3"BBBOICYT M**** "BBB@ HHHH **** "BBB@ HHHH _:S_ (-W_P#DQK6_^RE7_P#Z16%? M>%?!_P#P;O\ _)C6M_\ 92K_ /\ 2*PK[PK^)/$#_DM,=_U\?Z']D<"_\DA@ MO\""BBBOCCZP**** "BBB@ HHHH **** "BFPS0W$2SV\JR(PRKHV01[$4Z@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** / MYP/V_P#_ )/E^+__ &4K6O\ TMEKR*O7?V__ /D^7XO_ /92M:_]+9:\BK^^ M&O^2:?_I*/XMXO_Y*K'?]?:G_ *4PHHHK MZ8^="BBB@ HHHH **** "BBB@ HHHH **** /VL_X-W_ /DQK6_^RE7_ /Z1 M6%?>%?!__!N__P F-:W_ -E*O_\ TBL*^\*_B3Q _P"2TQW_ %\?Z']D<"_\ MDA@O\""BBBOCCZP**** "BBB@ HHHH *_)'_ (+K_P#!3'4?V1O^"F?[.WP$ M_:2U[Q?X<_9GUW1+K6/B#J/@V\NK.?6;TO-6#K(RT ?*_\ P1Y_94UJQ^#O[,/[6_[*?[0' MB.+P5J?AF_M/B_X!/C&XO=#U1&LKL6M]!:SR2):7<-XEO&ZP"/W)E$B;5'YD?\$3_"W[9'_!+C_@I[^S]\%?!/Q-N?$?PG_:A\+3 MZU=>&(I&,<4*0W0>:6$Y6*ZM9+96-P@ DAX.-S(GU!_P:?VVLZ7^V'^WQHWC M;>OB.#XHZ8FL+/\ ZPS+J'B)9,YYSYF[/N: /:_^"Q/_ 1"^*'_ 48\.?$ M3X_?&+]N'Q5HE]X8TR\NOA/\/]"F5?#&DVUK"SQM>1N@DGNKAHS)+<*4,/FB M-?-2!2_C_P#P;S_\%$_VDO!7_!!WXS_M-_M'ZYJ/BK3_ (+W&M-X!U#Q#$?AIXK^+^CS0>+_&7B35$BC\(>%),Q7EV$)#2WEPADM[6%<$LTDK,B0ECR M.K#]@S]I3_@CG\=?^";?_!)GQ-:^+M(^'7P4DAL[CPY_I%O=:A<17D\-N;@; M?M%]<36_\ !8+Q+XVU*7]I*U^. M$.K:=\8$N"NM62?VM8V L8+@?-#8"*:0?8EQ;_-_J^!CTW_@K=_P6-^-WQY_ M80_8BT?PKXQOO">G_M&E+KXP:GX>NWLI+E+*YLK*]L8I8R'BMY+B:Y9U5@2L M<:DE2X/D/PVU6S?_ (,JOB#9),OF1_%*&WD7/(?_ (2/39=OUVD'Z5]T?LX_ M\$(_@[^WI_P05_9N_9M_:@N-;\+>*_"WAR7Q'X8\2Z0$%]HLFJW$M\\#QR@A MXWCGA$D1VMNA3#*4H \B_;*^+E[_ ,$9O^#B3X)^$/V5[2/PM\(?CKHVAV'C MSX9Z*GV?16NKK4I],>^BLTQ%#-&%M9]\:JS,LH8D2ON^L/VFOVI+[_@DM_P5 M ^$/@VYU65?@+^T[>76C7NA3SEK?P=XMCF@6.^L]QQ;6MV;N%9K==L0=9;@! M6WA_A#X?_LD_&?\ X*0_\'"G@JPU/]I;7OC;\/?V2;?28?&?Q9U;0[&SMIM3 MT^=[R/3(C91HD\C7C1QR>8TDC>3=.6*A%KU?_@\_AUF]^#G[.6E^#0Y\17'Q M1NUT-8#^\,WV>(+MQSGS&B_'% '[6T4#..>O?%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110!_.!^W_ /\ )\OQ?_[*5K7_ *6RUY%7KO[?_P#R?+\7 M_P#LI6M?^ELM>15_?.2_\B;#?]>X?^DH_AS./^1MB/\ '/\ ]*84445Z9YP4 M444 %%%% !1110 4444 %%%% !1110!_07_P2'_Y1Q?"[_L$W7_I=<5](U\W M?\$A_P#E'%\+O^P3=?\ I=<5](U_"'%'_)38[_K]5_\ 2Y']L\-?\DY@_P#K MU3_](04445X1[84444 %%%% !1110 4444 %%%% 'X0?\%S_ /E([XM_[!.D M_P#I##7R%7U[_P %S_\ E([XM_[!.D_^D,-?(5?W-P7_ ,DC@/\ KS3_ /24 M?Q;Q?_R56._Z^U/_ $IA1117TQ\Z%%%% !1110 4444 %%%% !1110 4444 M?M9_P;O_ /)C6M_]E*O_ /TBL*^\*^#_ /@W?_Y,:UO_ +*5?_\ I%85]X5_ M$GB!_P EICO^OC_0_LC@7_DD,%_@04445\'?CUX[T[Q+I'C_PGI\EAX<\<>"O&NI:)J5E:2.7DM_,LYXU MEB8D[HY5=3D\E^%H_#\GQ&\ M37MU1-^QYXH_X)^?\%6_%?_!0 M?X/>#M1UKX5_'?0XM/\ C)HGA^PDNKSPYKL+JUMKB6T0:2YM)/WJ3K$K2127 M#SD&/>8_O>B@#XP^/W_!OA_P2+_:E^,6O_'_ /: _98O?$_C#Q/?&[UO6[_X MF>) \\A 4 (FHJD:*H5$C151$555550![#^Q#_P3D_8Q_P"" JL%Y)QDDGVZB@#YU?QHOB_6/AS'XEOD\+7^OJ !J,VDK*+5Y#M4L MFSRG*JS1L0#7M'QQ_9Z\%_M#>'%\$?$/Q!XHAT!XVCOM&\.>*;O1TOT; *33 M6,D4[1X!4QB41LK$.K XKNZ* .3^"?P)^#'[-OPZL?A'\ OA=H7@_P ,Z:#] MBT3P]IL=K;H3]YRJ ;G8\L[99CRQ)YKXV^-?['?B7_@II_P4U^%_[0'Q-\&Z MCI/P4_9HENK[PK%KMC):S^-/%DTL+?:(K>0+(-.M#:V[)/(JB>53Y0DA8R'[ MUHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^<#]O_P#Y/E^+ M_P#V4K6O_2V6O(J]=_;_ /\ D^7XO_\ 92M:_P#2V6O(J_OG)?\ D38;_KW# M_P!)1_#F:?_ *2C^+>+_P#DJL=_U]J?^E,****^ MF/G0HHHH **** "BBB@ HHHH **** "BBB@#]K/^#=__ ),:UO\ [*5?_P#I M%85]X5\'_P#!N_\ \F-:W_V4J_\ _2*PK[PK^)/$#_DM,=_U\?Z']D<"_P#) M(8+_ (****^./K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _G _;__ .3Y?B__ -E* MUK_TMEKR*O7?V_\ _D^7XO\ _92M:_\ 2V6O(J_OG)?^1-AO^O&O^2:?_I*/XMXO_P"2JQW_ %]J?^E,****^F/G0HHHH **** " MBBB@ HHHH **** "BBB@#]K/^#=__DQK6_\ LI5__P"D5A7WA7P?_P &[_\ MR8UK?_92K_\ ](K"OO"OXD\0/^2TQW_7Q_H?V1P+_P DA@O\""BBBOCCZP** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** /YP/V_P#_ )/E^+__ &4K6O\ TMEKR*O7?V__ M /D^7XO_ /92M:_]+9:\BK^^&O^2
XML 25 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Earnings - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Total PMI net revenues $ 9,141 [1],[2] $ 8,032 [1],[2] $ 26,127 [3],[4] $ 23,610 [3],[4]
Cost of sales 3,165 [5] 2,935 [5] 9,431 [6] 8,191 [6]
Gross profit 5,976 5,097 16,696 15,419
Marketing, administration and research costs (Notes 3 & 9) 2,606 2,129 8,029 [7] 6,097 [7]
Operating income 3,370 2,968 8,667 9,322
Interest expense, net 261 138 788 418
Pension and other employee benefit costs (Note 5) 8 7 36 16
Earnings before income taxes 3,101 2,823 7,843 8,888
Provision for income taxes 1,031 622 2,019 1,835
Equity investments and securities (income)/loss, net (101) (21) (131) 20
Net earnings 2,171 2,222 5,955 7,033
Net earnings attributable to noncontrolling interests 117 135 338 382
Net earnings attributable to PMI $ 2,054 $ 2,087 $ 5,617 $ 6,651
Per share data (Note 8):        
Basic earnings per share (in dollars per share) $ 1.32 $ 1.34 $ 3.61 $ 4.28
Diluted earnings per share (in dollars per share) $ 1.32 $ 1.34 $ 3.61 $ 4.27
[1] Includes net revenues from related parties of $857 million and $1,087 million for the three months ended September 30, 2023 and 2022, respectively
[2] Net of excise taxes of $13,092 million and $12,856 million for the three months ended September 30, 2023 and 2022, respectively
[3] Includes net revenues from related parties of $2,631 million and $2,634 million for the nine months ended September 30, 2023 and 2022, respectively
[4] Net of excise tax on products of $37,140 million and $37,028 million for the nine months ended September 30, 2023 and 2022, respectively
[5] Includes an impairment charge for other intangibles of $112 million for the three months ended September 30, 2022. For further details, see Note 6. Goodwill and Other Intangible Assets, net
[6] Includes an impairment charge for other intangibles of $112 million for the nine months ended September 30, 2022. For further details, see Note 6. Goodwill and Other Intangible Assets, net
[7] Includes an impairment charge for goodwill and other intangibles of $680 million and a charge of $204 million for the South Korea indirect tax charge for the nine months ended September 30, 2023, respectively. For further details, see Note 6. Goodwill and Other Intangible Assets, net and Note 10. Contingencies
XML 26 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Comprehensive Earnings - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net earnings $ 2,171 $ 2,222 $ 5,955 $ 7,033
Change in currency translation adjustments:        
Unrealized gains (losses), net of income taxes 158 (571) (669) (352)
(Gains)/losses transferred to earnings, net of income taxes of $0 in 2023 and 2022 2 0 4 0
Change in net loss and prior service cost:        
Net gains (losses) and prior service costs, net of income taxes 0 27 0 63
Amortization of net losses, prior service costs and net transition costs, net of income taxes 18 54 59 164
Change in fair value of derivatives accounted for as hedges:        
Gains (losses) recognized, net of income taxes 58 222 304 523
(Gains) losses transferred to earnings, net of income taxes (51) (51) (155) (106)
Other comprehensive earnings (losses), net of income taxes 185 (319) (457) 292
Total comprehensive earnings 2,356 1,903 5,498 7,325
Less comprehensive earnings (losses) attributable to:        
Noncontrolling interests 74 61 139 385
Comprehensive earnings attributable to PMI $ 2,282 $ 1,842 $ 5,359 $ 6,940
XML 27 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Change in foreign currency translation adjustments, unrealized gains (losses), tax $ (95) $ (158) $ (12) $ (340)
Change in currency translation adjustments, transferred to earnings, tax 0 0 0 0
Net gains (losses) and prior service costs, tax 0 (7) 0 29
Amortization of net losses, prior service costs and net transition costs, tax (6) (15) (20) (37)
Change in fair value of derivatives accounted for as hedges, gains (losses) recognized, tax (8) (52) (56) (106)
Change in fair value of derivatives accounted for as hedges, (gains) losses transferred to earnings, tax $ 8 $ 9 $ 30 $ 18
XML 28 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
ASSETS    
Cash and cash equivalents $ 3,017 $ 3,207
Trade receivables (less allowances of $80 in 2023 and $42 in 2022) [1] 3,891 3,850
Other receivables (less allowances of $33 in 2023 and $32 in 2022) 898 906
Inventories:    
Leaf tobacco 1,972 1,674
Other raw materials 2,198 2,028
Finished product 5,475 6,184
Total inventory, net 9,645 9,886
Other current assets 1,742 1,770
Total current assets 19,193 19,619
Property, plant and equipment, at cost 15,893 15,443
Less: accumulated depreciation 9,010 8,733
Total property, plant and equipment, net 6,883 6,710
Goodwill (Note 6) 16,509 19,655
Other intangible assets, net (Note 6) 9,579 6,732
Equity investments (Note 14) 4,691 4,431
Deferred income taxes 577 603
Other assets (less allowances of $24 in 2023 and $20 in 2022) (Note 2) 5,495 3,931
TOTAL ASSETS 62,927 61,681
LIABILITIES    
Short-term borrowings (Note 12) 2,149 5,637
Current portion of long-term debt (Note 12) 2,652 2,611
Accounts payable 3,533 4,076
Accrued liabilities:    
Marketing and selling 857 695
Taxes, except income taxes 5,853 7,440
Employment costs 1,131 1,168
Dividends payable 2,040 1,990
Other 2,250 2,679
Income taxes 1,082 1,040
Total current liabilities 21,547 27,336
Long-term debt (Note 12) 42,914 34,875
Deferred income taxes 2,903 1,956
Employment costs 1,915 1,984
Income taxes and other liabilities 1,354 1,841
Total liabilities 70,633 67,992
Contingencies (Note 10)
STOCKHOLDERS’ (DEFICIT) EQUITY    
Common stock, no par value (2,109,316,331 shares issued in 2023 and 2022) 0 0
Additional paid-in capital 2,253 2,230
Earnings reinvested in the business 33,919 34,289
Accumulated other comprehensive losses (Note 13) (9,817) (9,559)
Total stockholders' equity before treasury stock 26,355 26,960
Less: cost of repurchased stock (556,942,754 and 559,098,620 shares in 2023 and 2022, respectively) 35,788 35,917
Total PMI stockholders’ deficit (9,433) (8,957)
Noncontrolling interests 1,727 2,646
Total stockholders’ deficit (7,706) (6,311)
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY $ 62,927 $ 61,681
[1] Includes trade receivables from related parties of $655 million and $688 million as of September 30, 2023, and December 31, 2022, respectively (less allowances of $43 million as of September 30, 2023 and $7 million as of December 31, 2022). For further details, see Note 14. Related Parties - Equity Investments and Other.
XML 29 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Trade receivables, allowances $ 80 $ 42
Other receivables, allowances 33 32
Other assets, allowances $ 24 $ 20
Common stock, issued (in shares) 2,109,316,331 2,109,316,331
Repurchased stock (in shares) 556,942,754 559,098,620
Trade receivables, related parties [1] $ 3,891 $ 3,850
Related Party    
Trade receivables, allowances 43 7
Trade receivables, related parties $ 655 $ 688
[1] Includes trade receivables from related parties of $655 million and $688 million as of September 30, 2023, and December 31, 2022, respectively (less allowances of $43 million as of September 30, 2023 and $7 million as of December 31, 2022). For further details, see Note 14. Related Parties - Equity Investments and Other.
XML 30 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES    
Net earnings $ 5,955 $ 7,033
Adjustments to reconcile net earnings to operating cash flows:    
Depreciation, amortization and impairment of goodwill and other intangibles 1,709 898
Deferred income tax (benefit) provision 34 (146)
Asset impairment and exit costs, net of cash paid (Note 17) 35 (79)
Cash effects of changes, net of the effects from acquired companies:    
Receivables, net [1] (267) (963)
Inventories (181) 793
Accounts payable (623) 275
Accrued liabilities and other current assets (922) (326)
Income taxes (201) (190)
Pension plan contributions, net of refunds (Note 5) (96)  
Pension plan contributions, net of refunds (Note 5)   38
Other 459 377
Net cash provided by operating activities 5,902 7,710
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES    
Capital expenditures (1,010) (730)
Altria Group, Inc. agreement (Note 2) (1,775) 0
Equity investments (111) (20)
Net investment hedges and other derivatives (Note 7) (110) 634
Other (24) (35)
Net cash used in investing activities (3,030) (151)
Short-term borrowing activity by original maturity:    
Net issuances (repayments) - maturities of 90 days or less 356 2,619
Issuances - maturities longer than 90 days 1,109 795
Repayments - maturities longer than 90 days (554) (795)
Repayments under credit facilities related to Swedish Match AB acquisition (4,430) 0
Long-term debt proceeds 9,959 0
Long-term debt repaid (2,034) (1,979)
Repurchases of common stock 0 (209)
Dividends paid (5,941) (5,839)
Noncontrolling interests activity and Other (Note 2) (267) (663)
Net cash used in financing activities (2,685) (6,071)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (370) (614)
Cash, cash equivalents and restricted cash:    
Increase (Decrease) [2] (183) 874
Balance at beginning of period [2] 3,217 4,500
Balance at end of period [2] 3,034 5,374
Swedish Match AB    
Short-term borrowing activity by original maturity:    
Payments to acquire Swedish Match AB noncontrolling interests (Note 2) $ (883) $ 0
[1] Includes amounts from related parties of $(130) million and $(226) million for September 30, 2023 and 2022, respectively
[2] The amounts for cash, cash equivalents and restricted cash shown above include restricted cash of $17 million and $6 million as of September 30, 2023 and 2022, respectively, and $10 million and $4 million as of December 31, 2022 and 2021, respectively, which were included in other current assets in the condensed consolidated balance sheets.
XML 31 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Receivables, net [1] $ (267) $ (963)    
Restricted cash 17 6 $ 10 $ 4
Related Party        
Receivables, net $ (130) $ (226)    
[1] Includes amounts from related parties of $(130) million and $(226) million for September 30, 2023 and 2022, respectively
XML 32 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' (Deficit) Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Earnings Reinvested in the Business
Accumulated Other Comprehensive Losses
Cost of Repurchased Stock
Noncontrolling Interests
Beginning balance at Dec. 31, 2021 $ (8,208) $ 0 $ 2,225 $ 33,082 $ (9,577) $ (35,836) $ 1,898
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 7,033     6,651     382
Other comprehensive earnings (losses), net of income taxes 292       460   (168)
Issuance of stock awards 126   9     117  
Dividends declared (5,868)     (5,868)      
Dividends paid to noncontrolling interests (368)           (368)
Common stock repurchased (199)         (199)  
Purchase of subsidiary shares from noncontrolling interests (Note 2) (211)   (30)   (171)   (10)
Ending balance at Sep. 30, 2022 (7,403) 0 2,204 33,865 (9,288) (35,918) 1,734
Beginning balance at Jun. 30, 2022 (7,260) 0 2,165 33,755 (9,043) (35,921) 1,784
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 2,222     2,087     135
Other comprehensive earnings (losses), net of income taxes (319)       (245)   (74)
Issuance of stock awards 42   39     3  
Dividends declared (1,977)     (1,977)      
Dividends paid to noncontrolling interests (111)           (111)
Ending balance at Sep. 30, 2022 (7,403) 0 2,204 33,865 (9,288) (35,918) 1,734
Beginning balance at Dec. 31, 2022 (6,311) 0 2,230 34,289 (9,559) (35,917) 2,646
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 5,955     5,617     338
Other comprehensive earnings (losses), net of income taxes (457)       (438)   (19)
Issuance of stock awards 158   29     129  
Dividends declared (5,987)     (5,987)      
Dividends paid to noncontrolling interests (407)           (407)
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 2) (657)   (6)   180   (831)
Ending balance at Sep. 30, 2023 (7,706) 0 2,253 33,919 (9,817) (35,788) 1,727
Beginning balance at Jun. 30, 2023 (7,960) 0 2,240 33,893 (10,045) (35,791) 1,743
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 2,171     2,054     117
Other comprehensive earnings (losses), net of income taxes 185       227   (42)
Issuance of stock awards 43   40     3  
Dividends declared (2,028)     (2,028)      
Dividends paid to noncontrolling interests (89)           (89)
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 2) (28)   (27)   1   (2)
Ending balance at Sep. 30, 2023 $ (7,706) $ 0 $ 2,253 $ 33,919 $ (9,817) $ (35,788) $ 1,727
XML 33 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) - $ / shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Stockholders' Equity [Abstract]        
Dividends declared (in dollars per share) $ 1.30 $ 1.27 $ 3.84 $ 3.77
XML 34 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Earnings (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Net revenues, related parties $ 9,141 [1],[2] $ 8,032 [1],[2] $ 26,127 [3],[4] $ 23,610 [3],[4]
Excise taxes on products 13,092 12,856 37,140 37,028
Pre-tax impairment charge   112   112
Goodwill and non-amortizable intangible assets impairment charge     680  
EA, AU & PMI DF        
Net revenues, related parties 1,571 1,407 4,771 4,458
EA, AU & PMI DF | Korea        
Non-cash pre-tax charge     204  
Related Party        
Net revenues, related parties $ 857 $ 1,087 $ 2,631 $ 2,634
[1] Includes net revenues from related parties of $857 million and $1,087 million for the three months ended September 30, 2023 and 2022, respectively
[2] Net of excise taxes of $13,092 million and $12,856 million for the three months ended September 30, 2023 and 2022, respectively
[3] Includes net revenues from related parties of $2,631 million and $2,634 million for the nine months ended September 30, 2023 and 2022, respectively
[4] Net of excise tax on products of $37,140 million and $37,028 million for the nine months ended September 30, 2023 and 2022, respectively
XML 35 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Background and Basis of Presentation:
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Background and Basis of Presentation: Background and Basis of Presentation:
Background

Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A. (also referred to herein as the U.S., the United States or the United States of America), whose subsidiaries and affiliates and their licensees are primarily engaged in the manufacture and sale of cigarettes and smoke-free products. Throughout these financial statements, the term "PMI" refers to Philip Morris International Inc. and its subsidiaries.

Smoke-free products (also referred to herein as "SFPs") is the term PMI primarily uses to refer to all of its products that are not combustible tobacco products, such as heat-not-burn, e-vapor, and oral nicotine. In addition, SFPs include wellness and healthcare products, as well as consumer accessories such as lighters and matches.

Reduced-risk products ("RRPs") is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. PMI's RRPs are smoke-free products that contain and/or generate far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.

"Platform 1" is the term PMI uses to refer to PMI’s reduced-risk product that uses a precisely controlled heating device into which a specially designed and proprietary tobacco unit is inserted and heated to generate an aerosol.

Basis of Presentation

The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") and such principles are applied on a consistent basis. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S.GAAP have been omitted. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year.

In the fourth quarter of 2022, PMI acquired a controlling interest of the total issued shares in Swedish Match AB (“Swedish Match”). The operating results of Swedish Match are included in a separate segment. For further details, see Note 2. Acquisitions and Note 9. Segment Reporting.

In the third quarter of 2021, PMI acquired Fertin Pharma A/S, Vectura Group plc. and OtiTopic, Inc. On March 31, 2022, PMI launched a Wellness and Healthcare business consolidating these entities, Vectura Fertin Pharma. The operating results of this business are reported in the Wellness and Healthcare segment. For further details, see Note 9. Segment Reporting.

To further support the growth of PMI's smoke-free business, reinforce consumer centricity, and increase the speed of innovation and deployment, in January 2023, PMI began managing its business in four geographical segments, down from six previously, in addition to its continuing Swedish Match and Wellness and Healthcare segments. The four geographical segments are as follows: Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region ("SSEA, CIS & MEA"); East Asia, Australia, and PMI Duty Free Region ("EA, AU & PMI DF"); and Americas Region.

Certain prior years' amounts have been reclassified to conform with the current year's presentation. As a result of the new regional structure discussed above, certain goodwill amounts under the former six geographical segments were reallocated to the four geographical segments under the new structure. For further details, see Note 6. Goodwill and Other Intangible Assets, net. Following the Swedish Match acquisition and a review of PMI and Swedish Match’s combined product portfolio, PMI reclassified certain of its own products previously reported under its combustible tobacco product category to the newly created smoke-free product category to better reflect the characteristics of these products. For further details, see Note 9. Segment Reporting. These reclassifications did not impact PMI’s consolidated financial position, results of operations or cash flows in any of the periods presented.

These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended December 31, 2022.
XML 36 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions:
 9 Months Ended
Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Acquisitions: Acquisitions:
Transactions With Noncontrolling Interests

Turkey – In the first quarter of 2022, PMI acquired the remaining 25% stake of its holding in Philip Morris Tütün Mamulleri Sanayi ve Ticaret A.Ş. ("PMTM") (formerly Philsa Philip Morris Sabanci Sigara ve Tütüncülük Sanayi ve Ticaret A.Ş.) and 24.75% stake in Philip Morris Pazarlama ve Satiş A.Ş. ("PMPS") (formerly Philip Morris SA, Philip Morris Sabanci Pazarlama ve Satiş A.Ş.) from its Turkish partners, Sabanci Holding for a total acquisition price including transaction costs and remaining dividend entitlements of approximately $223 million. As a result of this acquisition, PMI owned 100% of these Turkish subsidiaries as of December 31, 2022. The purchase of the remaining stakes in these holdings resulted in a decrease to PMI's additional paid-in capital of $30 million and an increase to accumulated other comprehensive losses of $171 million primarily following the reclassification of accumulated currency translation losses from noncontrolling interests to PMI’s accumulated other comprehensive losses during the first quarter of 2022.

In January 2023, PMI sold the acquired stakes of its holdings in PMTM and PMPS to Pioneers Tutun Yatirim Anonim Sirketi (“Pioneers”) for a consideration of approximately $258 million, including transaction costs and dividend entitlements. The sale resulted in an increase to PMI's additional paid-in capital of $36 million and a decrease to accumulated other comprehensive losses of $179 million, following the reclassification of accumulated other comprehensive losses from PMI’s accumulated other comprehensive losses to noncontrolling interests.

Business Combinations

Swedish Match AB – On November 11, 2022 (the acquisition date), Philip Morris Holland Holdings B.V. (“PMHH”), a wholly owned subsidiary of PMI, acquired a controlling interest of 85.87% of the total issued shares in Swedish Match AB (“Swedish Match”) and acquired 94.81% of its outstanding shares as of December 31, 2022. The shares were acquired through acceptances of the tender offer and a series of open market and over-the-counter purchases. PMI funded the acquisition through cash on-hand and debt proceeds, as described in Note 12. Indebtedness. The aggregate cash paid as of the acquisition date was $14,460 million (or $13,976 million net of cash acquired), which was included in investing activities in the consolidated statements of cash flows for the year ended December 31, 2022. The cash paid in connection with the additional purchases of the noncontrolling interests after the acquisition date and through December 31, 2022 amounted to $1,495 million and was included in financing activities in the consolidated statements of cash flows for the year ended December 31, 2022.

In accordance with the Swedish Companies Act, PMI subsequently exercised its right to initiate arbitral proceedings to compulsorily redeem the remaining shares for which acceptances were not received and obtained legal title to 100% of the shares in Swedish Match on February 17, 2023. Cash paid in connection with such legal title, together with an immaterial amount attributable to open market purchases that were executed in December 2022 but settled in January 2023, amounted to $883 million and was included in financing activities in the condensed consolidated statements of cash flows for the nine months ended September 30, 2023. While PMI has paid the referenced amounts and has acquired legal title to the shares, the redemption process will not be complete under the Swedish Companies Act until a final redemption price is determined by an arbitral tribunal. On September 12, 2023, the arbitral tribunal determined the final redemption price to be Swedish krona (SEK) 115.07, which is unchanged from the SEK 115.07 that PMI paid per share in connection with obtaining legal title to the shares. This final redemption price is subject to appeal by the remaining minority shareholders within 60 days. Pending appeal, PMI expects this process to be completed in the fourth quarter of 2023 and believes that the likelihood of additional payments to be made is remote.

Swedish Match is a market leader in oral nicotine delivery with a significant presence in the United States market. The acquisition will accelerate PMI’s transformation to become a smoke-free company with a comprehensive global smoke-free portfolio with leadership positions in heat-not-burn, and the fastest growing category of oral nicotine, with the potential for accelerated international expansion.
The table below summarizes the preliminary purchase price allocation for the fair value of assets acquired and liabilities assumed as of the acquisition date, including the measurement period adjustments made for the first nine months of 2023. PMI is still assessing information received as of the acquisition date and expects to complete the allocation by the end of the measurement period in November 2023.
(in millions)
Recognized as of the acquisition dateMeasurement Period AdjustmentsRecognized as of September 30, 2023
Cash and cash equivalents$484 $— $484 
Trade receivables135 — 135 
Other receivables53 — 53 
Inventories444 (7)437 
Other current assets524 (109)415 
Property, plant and equipment627 50 677 
Other intangible assets 4,512 3,289 7,801 
Other non-current assets214 4 218 
Current portion of long-term debt224 — 224 
Accounts payable120 — 120 
Other current liabilities531 1 532 
Income taxes 14 — 14 
Long-term debt1,126 (5)1,121 
Deferred income taxes 1,253 836 2,089 
Other non-current liabilities187 9 196 
Identifiable net assets acquired3,538 2,386 5,924 
Noncontrolling interest2,379 — 2,379 
Goodwill 13,301 (2,386)10,915 
Total consideration transferred$14,460 $— $14,460 

The total fair value step-up adjustment for inventories was $146 million, of which $125 million was recognized in cost of sales in the fourth quarter of 2022 and the remaining balance in the first quarter of 2023.

The fair value of long-term debt was primarily determined using readily available market prices as of the acquisition date and the total purchase price adjustment of $(107) million is being amortized as an increase to interest expense, net over the lives of the related debt.

Goodwill is primarily attributable to future growth opportunities, anticipated synergies in the U.S. and intangible assets that did not qualify for separate recognition. The goodwill is not deductible for income tax purposes.

Identifiable intangible assets of Swedish Match consist of:
Type Useful LifeEstimated Fair Value (in millions)
TrademarksNon-amortizable$3,133 
TrademarksAmortizable
20 - 30 years
1,067 
Developed technology, including patents10 years113 
Customer relationships
6 - 15 years
3,488 
Total identifiable intangible assets$7,801 
The significant assumptions used in determining the preliminary fair values of the identifiable intangible assets included royalty rates, revenue growth rates, profit margins, customer attrition rates and discount rates.

Trademarks primarily relate to $3,133 million for the ZYN trademark, which has been determined to have an indefinite life due to the fast growth and the leading position of the brand in the U.S. market. All other trademarks have been determined to have a useful life ranging between 20 - 30 years. The trademarks have been valued using the relief from royalty method supported by revenue growth rate assumptions and royalty rates disaggregated at the individual trademark level.

Developed technology, including patents, relates to the nicotine pouch technology of $113 million. These patents have been assigned a useful life of 10 years, which is in line with their protection period and have been valued using the comparable transactions and income methods.

Customer relationships have been valued by categories of customers and geographic locations, namely the U.S. market, Scandinavia, and other markets using the multiple periods excess earnings method. The significant assumptions included customer attrition rates disaggregated at the customer category level, the revenue growth rates, as well as profit margins.

PMI consolidated statements of earnings for the year ended December 31, 2022, include $316 million of net revenues and $(26) million of net losses associated with the results of operations of Swedish Match from the acquisition date to December 31, 2022. The operating results of Swedish Match are included in a separate segment.

Acquisition related transaction costs, which were comprised primarily of regulatory, financial advisory and legal fees, totaled $59 million for the year ended December 31, 2022, and were included in marketing, administration and research costs in the consolidated statements of earnings. Bridge and term loan credit agreement related fees associated with the issuance of debt amounted to $54 million, of which $37 million were capitalized at the acquisition date. The fair value of the noncontrolling interest was based on the tender offer as of the acquisition date.

Under the EU Merger Regulation, approval by the European Commission of PMI's acquisition of Swedish Match was conditional on PMHH's divestiture of Swedish Match's subsidiary, SMD Logistics AB ("SMDL"), following the completion of the offer to tender all shares in Swedish Match to PMHH. As a result, these assets were accounted for as assets held for sale and included within other current assets and other accrued liabilities in PMI’s condensed consolidated balance sheets at March 31, 2023 and December 31, 2022. PMI subsequently sold SMDL on June 30, 2023 and the transaction did not have a material impact on the condensed consolidated statements of earnings for the nine months ended September 30, 2023.

The unaudited pro forma combined financial information was prepared using the acquisition method of accounting and was based on the historical financial information of PMI and Swedish Match. In order to reflect the occurrence of the acquisition on January 1, 2021, as required, the unaudited pro forma financial information includes adjustments to reflect the following:

•incremental amortization expense to be incurred based on the current preliminary fair values of the identifiable intangible assets acquired;
•incremental cost of products sold related to the fair value adjustments associated with acquisition date inventory;
•additional interest expense associated with the issuance of debt to finance the acquisition, including the effects of the related derivative financial instruments designated to hedge interest rate risks as well as economic hedges;
•reclassification of non-recurring acquisition-related costs incurred during the year ended December 31, 2022, to the year ended December 31, 2021;
•impact of a deferred tax cost of $430 million in 2022 and $321 million in 2021 related to the theoretical unrealized foreign currency gains on intercompany loans related to the acquisition financing. These theoretical unrealized pre-tax foreign currency movements were fully offset in the consolidated statements of earnings and were reflected as currency translation adjustments in PMI's consolidated statements of stockholders' (deficit) equity, while the corresponding deferred tax impacts were reflected in PMI's consolidated statements of earnings; and
•other immaterial items (i.e., the alignment of accounting policies from IFRS to US GAAP.)
The unaudited pro forma financial information is not necessarily indicative of what the consolidated results of operations would have been had the acquisition been completed on January 1, 2021. In addition, the unaudited pro forma financial information is not a projection of future results of operations of the combined company, nor does it reflect the expected realization of any synergies or cost savings associated with the acquisition.

The unaudited pro forma financial information is as follows:
For the Years Ended December 31,
(in millions)20222021
Net revenues$33,579 $33,488 
Net earnings attributable to PMI$8,788 $8,495 

Altria Group, Inc. Agreement
On October 20, 2022, PMI announced that it had reached an agreement with Altria Group, Inc. ("Altria") to end the companies' relationship regarding the IQOS commercialization rights in the U.S. as of April 30, 2024. As a result of PMI reacquiring these rights, effective May 1, 2024, PMI will hold the full rights to commercialize IQOS in the U.S. As part of the agreement, PMI agreed to pay a total cash consideration of $2.7 billion, with $1.0 billion paid at the inception of the agreement and the remaining $1.7 billion (plus interest, at a per annum rate equal to six percent (6%)), to be paid by July 2023 at the latest. The cash consideration paid at the inception of the agreement of $1.0 billion has been accounted for within other assets in PMI’s condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022. The remaining consideration of $1.7 billion plus interest was paid to Altria on July 14, 2023 and has been accounted for within other assets in PMI's condensed consolidated balance sheets as of September 30, 2023. PMI will finalize the accounting for this transaction by assigning the consideration to the respective assets in May 2024, when PMI can exercise its ability to commercialize IQOS in the U.S.
XML 37 R14.htm IDEA: XBRL DOCUMENT v3.23.3
War in Ukraine:
 9 Months Ended
Sep. 30, 2023
Unusual or Infrequent Items, or Both [Abstract]  
War in Ukraine: War in Ukraine:
Since the onset of the war in Ukraine in February 2022, PMI's main priority has been the safety and security of its employees and their families in the country.

Ukraine

PMI temporarily suspended its commercial and manufacturing operations in Ukraine, including the closing of its factory in Kharkiv at the end of February 2022, in order to preserve the safety of its employees. PMI subsequently resumed some retail activities where safety allowed, in order to provide product availability and service to adult consumers, and began to supply the market from production centers outside Ukraine, as well as through a contract manufacturing arrangement. Production at the factory in Kharkiv remains suspended. While the effects of the war are unpredictable and could trigger impairment reviews for long-lived assets, as of September 30, 2023, PMI is unable to estimate the information required to perform impairment analyses (i.e., forecast of revenues, manufacturing and commercial plans). PMI is not aware of any major damage to its production facilities, inventories or other assets in Ukraine. As a result, PMI has not recorded an impairment of long-lived assets. As of September 30, 2023, PMI’s Ukrainian operations had approximately $500 million in total assets, excluding intercompany balances. These total assets included $82 million, $350 million and $28 million in receivables, inventories and property, plant and equipment, respectively.

Russia

PMI has suspended its planned investments in the Russian Federation including all new product launches and commercial, innovation, and manufacturing investments. PMI has also taken steps to scale down its manufacturing operations in Russia amid ongoing supply chain disruptions and the evolving regulatory environment. PMI is continuously assessing the evolving situation in Russia, including recent regulatory constraints in the market that entail very complex terms and conditions that must be met for any divestment transaction to be granted approval by the authorities, and restrictions resulting from international regulations. As a result of PMI continuing operations within Russia as of September 30, 2023, it has not recorded an impairment of long-lived and other assets. However, PMI recorded specific asset write downs in 2022 as referred to in the table below. PMI’s Russian operations as of September 30, 2023 had approximately $2.4 billion in total assets, excluding
intercompany balances. These total assets included $677 million, $411 million, $838 million, $242 million and $158 million in cash (primarily held in local currency), receivables, inventories, property, plant and equipment and goodwill, respectively. In addition, there was approximately $1,343 million of cumulative foreign currency translation losses reflected in accumulated other comprehensive losses in the condensed consolidated statement of stockholders’ equity as of September 30, 2023.

During the nine months and three months ended September 30, 2023 and 2022, PMI recorded in its condensed consolidated statements of earnings pre-tax charges related to circumstances driven by the war as follows:

(in millions)For the Nine Months Ended September 30, 2023For the Nine Months Ended September 30, 2022
Cost of salesMarketing, administration and research costsTotalCost of salesMarketing, administration and research costsTotal
Ukraine 1
$11 $8 $19 $28 $31 $59 
Russia 2
— — — 18 51 69 
Total$11 $8 $19 $46 $82 $128 
1 The 2023 pre-tax charges were primarily due to the cost of PMI’s humanitarian efforts, which includes salary continuation for its employees. The 2022 pre-tax charges were primarily due to an inventory write-down, additional allowance for receivables and the cost of PMI’s humanitarian efforts, which includes salary continuation for its employees.
2 The pre-tax charges were primarily due to machinery and inventory write downs related to the commercial decisions noted above.

(in millions)For the Three Months Ended September 30, 2023For the Three Months Ended September 30, 2022
Cost of salesMarketing, administration and research costsTotalCost of salesMarketing, administration and research costsTotal
Ukraine 1
$11 $8 $19 $3 $5 $8 
Russia — — — (3)1 (2)
Total$11 $8 $19 $— $6 $6 
1 The pre-tax charges were primarily due to PMI’s humanitarian efforts, which includes salary continuation for its employees.

PMI will continue to monitor the situation as it evolves and will determine if further charges are needed.
XML 38 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Plans:
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock Plans: Stock Plans:
In May 2022, PMI’s shareholders approved the Philip Morris International Inc. 2022 Performance Incentive Plan (the “2022 Plan”). Under the 2022 Plan, PMI may grant to eligible employees restricted shares and restricted share units, performance-based cash incentive awards and performance-based equity awards. Up to 25 million shares of PMI’s common stock may be issued under the 2022 Plan. At September 30, 2023, shares available for grant under the 2022 Plan were 22,165,030.

In May 2017, PMI’s shareholders approved the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors (the “2017 Non-Employee Directors Plan”). A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least 50% of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to 1 million shares of PMI common stock may be awarded under the 2017 Non-Employee Directors Plan. At September 30, 2023, shares available for grant under the plan were 876,226.
Restricted share unit (RSU) awards

During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the weighted-average grant date fair value per share related to RSU awards were as follows:
Number of
Shares
Granted		Weighted-Average Grant Date Fair Value Per RSU Award Granted
20231,756,750 $ 101.96 
20221,579,680 $  104.96 

Compensation expense related to RSU awards was as follows:
Compensation Expense Related to RSU Awards
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023$ 124 $ 38 
2022$ 109 $ 35 

As of September 30, 2023, PMI had $199 million of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically three years after the date of the award, or upon death, disability or reaching the age of 58.

During the nine months ended September 30, 2023, 1,421,086 RSU awards vested. The grant date fair value of all the vested awards was approximately $124 million. The total fair value of RSU awards that vested during the nine months ended September 30, 2023 was approximately $143 million.

Performance share unit (PSU) awards

During the nine months ended September 30, 2023 and 2022, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance metrics, which are predetermined at the time of grant, typically over a three-year performance cycle. The performance metrics for such PSU's granted during the nine months ended September 30, 2023 and 2022 consisted of PMI's Total Shareholder Return ("TSR") relative to a predetermined peer group and on an absolute basis (40% weight), PMI’s currency-neutral compound annual adjusted diluted earnings per share growth rate (30% weight), and a Sustainability Index, which consists of two drivers:

•Product Sustainability (20% weight) measuring progress on PMI's efforts to maximize the benefits of smoke-free products, purposefully phase out cigarettes, seek net positive impact in wellness and healthcare, and reduce post-consumer waste; and

•Operational Sustainability (10% weight) measuring progress on PMI's efforts to tackle climate change, preserve nature, improve the quality of life of people in its supply chain, and foster an empowered, and inclusive workplace.

The aggregate of the weighted performance factors for the three metrics in each such PSU award determines the percentage of PSUs that will vest at the end of the three-year performance cycle. The minimum percentage of such PSUs that can vest is zero, with a target percentage of 100 and a maximum percentage of 200. Each such vested PSU entitles the participant to one share of common stock. An aggregate weighted PSU performance factor of 100 will result in the targeted number of PSUs being vested. At the end of the performance cycle, participants are entitled to an amount equivalent to the accumulated dividends paid on common stock during the performance cycle for the number of shares earned.
During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the grant date fair value per share related to PSU awards were as follows:
Number of Shares GrantedWeighted-
Average PSU Grant Date 
Fair Value Subject to Other Performance Factors 		Weighted-
Average PSU Grant Date 
Fair Value Subject to TSR Performance Factors
(Per Share)(Per Share)
2023482,360 $ 102.02 $ 133.54 
2022451,790 $  105.07 $ 143.94 

The grant date fair value of the PSU awards subject to the other performance factors was determined by using the market price of PMI’s stock on the date of the grant. The grant date fair value of the PSU market-based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model. The following assumptions were used to determine the grant date fair value of the PSU awards subject to the TSR performance factor:
20232022
Average risk-free interest rate (a)
4.1 %1.6 %
Average expected volatility (b)
24.3 %28.6 %
(a) Based on the U.S. Treasury yield curve.
(b) Determined using the observed historical volatility.

Compensation expense related to PSU awards was as follows:
Compensation Expense Related to PSU Awards
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023$ 51 $ 6 
2022$  44 $  13 

As of September 30, 2023, PMI had $49 million of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the performance cycle of the awards, or upon death, disability or reaching the age of 58.

During the nine months ended September 30, 2023, 902,232 PSU awards vested. The grant date fair value of all the vested awards was approximately $83 million. The total fair value of PSU awards that vested during the nine months ended September 30, 2023 was approximately $91 million.
XML 39 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Benefit Plans:
 9 Months Ended
Sep. 30, 2023
Retirement Benefits [Abstract]  
Benefit Plans: Benefit Plans:Pension coverage for employees of PMI’s subsidiaries is provided, to the extent deemed appropriate, through separate plans, many of which are governed by local statutory requirements. In addition, PMI provides health care and other benefits to certain U.S. retired employees and certain non-U.S. retired employees. In general, health care benefits for non-U.S. retired employees are covered through local government plans.
Pension and other employee benefit costs per the condensed consolidated statements of earnings consisted of the following:
 For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Net pension costs (income)$(61)$(71)$(24)$(22)
Net postemployment costs88 81 29 27 
Net postretirement costs9 6 3 2 
Total pension and other employee benefit costs$36 $16 $8 $7 

Pension Plans

Components of Net Periodic Benefit Cost

Net periodic pension cost consisted of the following:
 
Pension (1)
 For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Service cost$130 $176 $45 $57 
Interest cost193 58 64 20 
Expected return on plan assets(273)(267)(92)(87)
Amortization:
Net loss21 139 5 45 
Prior service cost (credit)(2)(1)(1)— 
Net periodic pension cost$69 $105 $21 $35 
(1) Primarily non-U.S. based defined benefit retirement plans.

Employer Contributions

PMI makes, and plans to make, contributions, to the extent that they are tax deductible and meet specific funding requirements of its funded pension plans.

Employer contributions of $96 million were made to the pension plans during the nine months ended September 30, 2023. Currently, PMI anticipates making additional contributions during the remainder of 2023 of approximately $39 million to its pension plans, based on current tax and benefit laws. However, this estimate is subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on pension assets, or changes in interest and currency rates.
Employer contributions of $85 million were made to the pension plans during the nine months ended September 30, 2022. During the second quarter of 2022, PMI received a cash refund of $123 million from one of its pension plans due to a change in discount rate and value of assets that resulted in the overfunding of the plan.
XML 40 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets, net:
 9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets, net: Goodwill and Other Intangible Assets, net:
Annual impairment review of goodwill and non-amortizable intangible assets

During the second quarter of 2023, PMI completed its annual review of goodwill and non-amortizable intangible assets for potential impairment. Based on this review, it was determined that the estimated fair value of the Wellness and Healthcare reporting unit was lower than its carrying value. Consequently, PMI recorded a goodwill impairment charge of $665 million, reflecting the impact of reduced estimated future cash flows, which were primarily attributable to clinical trial results that became available in June 2023 for an inhalable aspirin product being developed by the Wellness and Healthcare business. While it was observed that the experimental product had a rapid onset of effect, which is the key medical advantage sought, there was significant variability in inhaled dose among subjects. The study was therefore deemed unsuccessful and, as a result, product design improvements are required. PMI had planned to file a new drug application for this product with the U.S. Food and Drug Administration later this year. However, additional time is now required to evaluate design improvements and the corresponding less certain outcome. The cash flow estimates were also adversely impacted by slower-than-anticipated development of the contract development and manufacturing organization ("CDMO") business, including challenges associated with increased cost related to certain key products. Additionally, as a result of the impairment test of non-amortizable intangible assets, PMI recorded a pre-tax impairment charge of $15 million for an in-process research and development project related to one of PMI's 2021 acquisitions. These impairment charges were recorded within marketing, administration and research costs in the consolidated statements of earnings for the nine months ended September 30, 2023. The goodwill impairment charge is not deductible for income tax purposes.

The Wellness and Healthcare reporting unit's fair value was determined using the discounted cash flow model. PMI will continue to monitor this reporting unit as any changes in assumptions and estimates, unfavorable clinical trial results, failure to obtain regulatory approvals or other market factors could result in additional future goodwill and other intangible asset impairments. Certain Wellness and Healthcare products include components or gases which may be subject to enhanced climate change regulations that could impact the related product development and market strategies. This may also lead to supply disruptions that could result in additional future impairments.

While PMI’s remaining reporting units have fair values substantially in excess of their carrying values, there are still risks related to PMI’s Russian reporting unit’s assets as the fair value of these assets is difficult to predict due to the volatility in foreign currency and commodity markets, supply chain, and current economic, political and social conditions. For more information see Note 3. War in Ukraine. PMI has performed a quantitative impairment assessment for all of its reporting units and non-amortizable intangible assets with the exception of the Swedish Match segment. As the purchase price allocation for the acquisition of Swedish Match is preliminary, PMI has performed a qualitative impairment assessment and concluded that it was not more likely than not that the fair value of the Swedish Match reporting units and its non-amortizable intangible assets were less than the respective carrying amounts.

Goodwill

The movements in goodwill were as follows:
(in millions)Europe
SSEA, CIS & MEA
EA, AU & PMI DF
AmericasSwedish MatchWellness & HealthcareTotal
Balances at December 31, 2022$1,370 $2,869 $493 $615 $13,296 $1,012 $19,655 
Changes due to:
Impairment— — — — — (665)(665)
Currency(13)(34)(9)57 (121)25 (95)
Measurement period adjustments— — — — (2,386)— (2,386)
Balances, September 30, 2023$1,357 $2,835 $484 $672 $10,789 $372 $16,509 

As discussed in Note 1. Background and Basis of Presentation, in January 2023, PMI began managing its business in four geographical segments, Swedish Match segment and Wellness and Healthcare segment. As a result, the December 31, 2022 goodwill balance in the table above included the reclassifications from the former six geographical segments to the four geographical segments under the new structure.
The decrease in goodwill was primarily due to the measurement period adjustments to the Swedish Match preliminary purchase price allocation (see Note 2, Acquisitions), coupled with the impairment discussed above and currency movements.

At September 30, 2023, goodwill primarily reflects PMI’s business combinations in Greece, Indonesia, Mexico, the Philippines and Serbia, as well as the goodwill from the 2021 acquisitions of Fertin Pharma A/S and Vectura Group plc. and the preliminary purchase price allocation of Swedish Match AB, which was acquired in the fourth quarter of 2022.

Other Intangible Assets

Details of other intangible assets were as follows:
September 30, 2023December 31, 2022
(in millions)Weighted-Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationNetGross Carrying AmountAccumulated AmortizationNet
Non-amortizable intangible assets$4,416 $4,416 $3,346 $3,346 
Amortizable intangible assets:
Trademarks16 years2,158 $740 1,418 2,050 $674 1,376 
Developed technology, including patents7 years718 290 428 975 243 732 
Customer relationships and other12 years3,667 350 3,317 1,390 112 1,278 
Total other intangible assets$10,959 $1,380 $9,579 $7,761 $1,029 $6,732 

Non-amortizable intangible assets substantially consist of trademarks from PMI’s acquisitions in Indonesia and Mexico, as well as the preliminary purchase price allocation associated with the Swedish Match acquisition in 2022, and PMI's business combinations in 2021 (primarily in-process research and development). The increase since December 31, 2022 was due to the measurement period adjustments to the Swedish Match preliminary purchase price allocation in the amount of $1,056 million (see Note 2, Acquisitions), coupled with currency movements of $29 million, partially offset by an impairment for an in-process research and development project related to one of PMI's 2021 acquisitions discussed above.

The increase in the gross carrying amount of amortizable intangible assets from December 31, 2022, was due to the measurement period adjustments to the Swedish Match preliminary purchase price allocation in the amount of $2,233 million (see Note 2, Acquisitions), partially offset by currency movements of $105 million.

The change in the accumulated amortization from December 31, 2022, was mainly due to the 2023 amortization of $368 million, partially offset by currency movements of $17 million. The amortization of intangibles for the nine months ended September 30, 2023 was recorded in cost of sales ($43 million) and in marketing, administration and research costs ($325 million) on PMI's condensed consolidated statements of earnings.
Amortization expense for each of the next five years is estimated to be approximately $460 million or less, assuming no additional transactions occur that require the amortization of intangible assets. This estimate is subject to change based on the finalization of the preliminary purchase price allocation of the Swedish Match acquisition. Additionally, the estimated future amortization expense could significantly increase following the reacquisition of IQOS commercialization rights in the U.S. from Altria Group, Inc (see Note 2, Acquisitions), the accounting for which will depend on the facts and circumstances effective May 1, 2024, when PMI will hold the full rights.

2022 Impairment of Other Intangibles In the third quarter of 2022, PMI recorded a pre-tax impairment charge of $112 million, reflecting the impact of general economic and market conditions resulting in a reduction in future estimated cash flows on certain products within the Wellness and Healthcare segment. The impairment reduced the carrying values of developed technology definite-lived intangible assets in the Wellness and Healthcare segment to $308 million as of September 30, 2022. The fair value of these intangible assets was primarily determined using the multi-period excess earnings method. This impairment charge was recorded within cost of sales in the condensed consolidated statements of earnings for the three months and nine months ended September 30, 2022.
XML 41 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Instruments:
 9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments: Financial Instruments:
Overview

PMI operates in markets primarily outside of the United States of America, with manufacturing and sales facilities in various locations around the world and is exposed to risks such as changes in foreign currency exchange rates and interest rates. As a result, PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options (collectively referred to as "foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in foreign currency exchange and interest rates related to net investments in foreign operations, third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Euro, Egyptian pound, Indonesian rupiah, Japanese yen, Mexican peso, Philippine peso, Russian ruble and Swiss franc.

Additionally, certain materials that PMI uses in the manufacturing of its products are exposed to market price risks. PMI uses commodity derivative contracts (“commodity contracts") to manage its exposure to the market price volatility of certain commodity components of these materials.

These foreign exchange contracts, interest rate contracts and commodity contracts are collectively referred to as "derivative contracts". PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Substantially all of PMI's derivative financial instruments are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. While these contracts contain the enforceable right to offset through close-out netting rights, PMI elects to present them on a gross basis in the consolidated balance sheets. Collateral associated with these arrangements is in the form of cash and is unrestricted. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings.

The gross notional amounts for outstanding derivatives at the end of each period were as follows:
(in millions)At September 30, 2023At December 31, 2022
Derivative contracts designated as hedging instruments:
Foreign exchange contracts$18,256 $17,627 
Interest rate contracts1,000 1,019 
Commodity contracts27 — 
Derivative contracts not designated as hedging instruments:
Foreign exchange contracts17,818 21,755 
Total$37,101 $40,401 
The fair value of PMI’s derivative contracts included in the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022, were as follows:
 Derivative AssetsDerivative Liabilities
 Fair ValueFair Value
AtAtAtAt
(in millions)Balance Sheet ClassificationSeptember 30, 2023December 31, 2022Balance Sheet ClassificationSeptember 30, 2023December 31, 2022
Derivative contracts designated as hedging instruments:
Foreign exchange contractsOther current assets$472 $376 Other accrued liabilities$126 $126 
Other assets386 341 Income taxes and other liabilities56 147 
Interest rate contractsOther current assets— — Other accrued liabilities40 27 
Other assets— — Income taxes and other liabilities50 56 
Commodity contractsOther current assets— — Other accrued liabilities2 — 
Derivative contracts not designated as hedging instruments:
Foreign exchange contracts
Other current assets 
241 156 Other accrued liabilities87 165 
Other assets— — Income taxes and other liabilities42 16 
Total gross amount derivatives contracts presented in the condensed consolidated balance sheets $1,099 $873  $403 $537 
Gross amounts not offset in the condensed consolidated balance sheets
Financial instruments(292)(346)(292)(346)
Cash collateral received/pledged(566)(341)(60)(48)
Net amount$241 $186 $51 $143 

PMI assesses the fair value of its derivative contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts, foreign currency swaps and interest rate contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates. The fair value of PMI’s commodity contracts is determined by using the prevailing market spot and futures prices and the respective maturity dates of the instruments. PMI’s derivative contracts have been classified within Level 2 at September 30, 2023 and December 31, 2022.
For the nine months ended September 30, 2023 and 2022, PMI's derivative contracts impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:
(pre-tax, in millions)For the Nine Months Ended September 30,
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on DerivativesStatement of Earnings
Classification of Gain/(Loss)
on Derivatives		Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into EarningsAmount of Gain/(Loss) Recognized in Earnings
202320222023202220232022
Derivative contracts designated as hedging instruments:
Cash flow hedges:
Foreign exchange contracts$290 $325 Net revenues$112 $151 
Cost of sales— — 
Marketing, administration and research costs52 (17)
Interest expense, net(13)(5)
Interest rate contracts72 304 Interest expense, net34 (5)
Commodity contracts(2)— Cost of sales— — 
Fair value hedges:
Interest rate contracts
Interest expense, net (a)
$(24)$(81)
Net investment hedges (b):
Foreign exchange contracts14 1,088 
Interest expense, net (c)
200 116 
Derivative contracts not designated as hedging instruments:
Foreign exchange contractsInterest expense, net212 56 
Marketing, administration and research costs (d)
154 (160)
Total$374 $1,717 $185 $124 $542 $(69)
(a) The gains (losses) from these contracts are offset by the changes in the fair value of the hedged item
(b) Amount of gains (losses) on hedges of net investments principally related to changes in exchange and interest rates between the Euro and U.S. dollar
(c) Represent the gains for amounts excluded from the effectiveness testing
(d) The gains (losses) from these contracts attributable to changes in foreign currency exchange rates are partially offset by the (losses) and gains generated by the underlying intercompany and third-party loans being hedged
For the three months ended September 30, 2023 and 2022, PMI's derivative contracts impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:
(pre-tax, in millions)For the Three Months Ended September 30,
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on DerivativesStatement of Earnings
Classification of Gain/(Loss)
on Derivatives		Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into EarningsAmount of Gain/(Loss) Recognized in Earnings
202320222023202220232022
Derivative contracts designated as hedging instruments:
Cash flow hedges:
Foreign exchange contracts$67 $77 Net revenues$73 $70 
Cost of sales— — 
Marketing, administration and research costs(19)(7)
Interest expense, net(7)(2)
Interest rate contracts— 197 Interest expense, net12 (1)
Commodity contracts(1)— Cost of sales— — 
Fair value hedges:
Interest rate contracts
Interest expense, net (a)
$(10)$(24)
Net investment hedges (b):
Foreign exchange contracts453 558 
Interest expense, net (c)
73 48 
Derivative contracts not designated as hedging instruments:
Foreign exchange contractsInterest expense, net60 13 
Marketing, administration and research costs (d)
258 (225)
Total$519 $832 $59 $60 $381 $(188)
(a) The gains (losses) from these contracts are offset by the changes in the fair value of the hedged item
(b) Amount of gains (losses) on hedges of net investments principally related to changes in exchange and interest rates between the Euro and U.S. dollar
(c) Represent the gains for amounts excluded from the effectiveness testing
(d) The gains (losses) from these contracts attributable to changes in foreign currency exchange rates are partially offset by the (losses) and gains generated by the underlying intercompany and third-party loans being hedged


Cash Flow Hedges

PMI has entered into derivative contracts to hedge the foreign currency exchange, interest rate and commodity price risks related to certain forecasted transactions. Gains and losses associated with qualifying cash flow hedge contracts are deferred as components of accumulated other comprehensive losses until the underlying hedged transactions are reported in PMI’s condensed consolidated statements of earnings. As of September 30, 2023, PMI has hedged forecasted transactions with derivative contracts expiring at various dates through May 2028. The impact of these hedges is primarily included in operating cash flows on PMI’s condensed consolidated statements of cash flows.
Fair Value Hedges

PMI has entered into fixed-to-floating interest rate contracts, designated as fair value hedges to minimize exposure to changes in the fair value of fixed rate U.S. dollar-denominated debt that results from fluctuations in benchmark interest rates. For derivative contracts that are designated and qualify as fair value hedges, the gain or loss on the derivative, as well as the offsetting gain or loss on the hedged items attributable to the hedged risk, is recognized in current earnings. The carrying amount of the debt hedged, which includes the cumulative adjustment for fair value gains/losses, as of September 30, 2023 was $906 million, and is recorded in long-term debt in the condensed consolidated balance sheets. The cumulative amount of fair value gains/(losses) included in the carrying amount of the debt hedged was $90 million as of September 30, 2023.

Hedges of Net Investments in Foreign Operations

PMI designates derivative contracts and certain foreign currency denominated debt and other financial instruments as net investment hedges, primarily of its Euro net assets. For the nine months ended September 30, 2023 and 2022, the amount of pre-tax gain/(loss) related to the non-derivative financial instruments, that was reported as a component of accumulated other comprehensive losses within currency translation adjustments, was $51 million and $525 million, respectively. For the three months ended September 30, 2023 and 2022, the amount of pre-tax gain/(loss) related to the non-derivative financial instruments, that was reported as a component of accumulated other comprehensive losses within currency translation adjustments, was $27 million and $267 million, respectively. The premiums paid for, and settlements of, net investment hedges are included in investing cash flows on PMI’s condensed consolidated statements of cash flows.

Other Derivatives

PMI has entered into derivative contracts to hedge the foreign currency exchange and interest rate risks related to intercompany loans between certain subsidiaries, third-party loans and acquisition related transactions. While effective as economic hedges, no hedge accounting is applied for these contracts; therefore, the gains (losses) relating to these contracts are reported in PMI’s condensed consolidated statements of earnings. Acquisition related transactions are included in investing cash flows on PMI’s condensed consolidated statements of cash flows.

Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses

Derivative gains or losses reported in accumulated other comprehensive losses are a result of qualifying hedging activity. Transfers of these gains or losses to earnings are offset by the corresponding gains or losses on the underlying hedged item. Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
 2023202220232022
Gain/(loss) as of beginning of period,$266 $4 $408 $250 
Derivative (gains)/losses transferred to earnings(155)(106)(51)(51)
Change in fair value304 523 58 222 
Gain/(loss) as of September 30,$415 $421 $415 $421 

At September 30, 2023, PMI expects $176 million of derivative gains that are included in accumulated other comprehensive losses to be reclassified to the condensed consolidated statement of earnings within the next 12 months. These gains are expected to be substantially offset by the statement of earnings impact of the respective hedged transactions.
Contingent Features
PMI’s derivative instruments do not contain contingent features.
Credit Exposure and Credit Risk
PMI is exposed to credit loss in the event of non-performance by counterparties. While PMI does not anticipate non-performance, its risk is limited to the fair value of the financial instruments less any cash collateral received or pledged. PMI
actively monitors its exposure to credit risk through the use of credit approvals and credit limits and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.
Other Investments
A certain PMI investment, which is comprised primarily of money market funds, has been classified within Level 1 and had a fair value of $216 million at September 30, 2023. For the nine months and three months ended September 30, 2023, the unrealized pre-tax gains (losses) on these investments were immaterial.
XML 42 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share:
 9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Earnings Per Share: Earnings Per Share:
Basic and diluted earnings per share (“EPS”) were calculated using the following:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
 2023202220232022
Net earnings attributable to PMI$5,617 $6,651 $2,054 $2,087 
Less distributed and undistributed earnings attributable to share-based payment awards
17 18 6 5 
Net earnings for basic and diluted EPS$5,600 $6,633 $2,048 $2,082 
Weighted-average shares for basic EPS1,552 1,550 1,552 1,550 
Plus contingently issuable performance stock units (PSUs)(1)
1 2 2 2 
Weighted-average shares for diluted EPS1,553 1,552 1,554 1,552 
(1) Including rounding adjustment

Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and therefore are included in PMI’s earnings per share calculation pursuant to the two-class method.

For the 2023 and 2022 computations, there were no antidilutive stock awards.
XML 43 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Reporting:
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Segment Reporting: Segment Reporting:
PMI’s subsidiaries and affiliates are primarily engaged in the manufacture and sale of cigarettes and smoke-free products, including heat-not-burn, e-vapor and oral nicotine products. Excluding the Wellness and Healthcare segment and the 2022 acquisition of Swedish Match, PMI's segments are generally organized by geographic region and managed by segment managers who are responsible for the operating and financial results of the regions inclusive of combustible tobacco and smoke-free product categories sold in the region. Effective in January 2023, PMI began managing its business in four geographical segments, down from six previously, in addition to its continuing Swedish Match and Wellness and Healthcare segments. The four geographical segments are as follows: Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region ("SSEA, CIS & MEA"); East Asia, Australia, and PMI Duty Free Region ("EA, AU & PMI DF"); and Americas Region. PMI records net revenues and operating income to its geographical segments based upon the geographic area in which the customer resides.

PMI’s chief operating decision maker evaluates geographical segment performance and allocates resources based on regional operating income, which includes results from all product categories sold in each region, excluding Swedish Match and Wellness and Healthcare products. Business operations in the Swedish Match segment and the Wellness and Healthcare segment are evaluated separately.

PMI disaggregates its net revenues from contracts with customers by product category for each of PMI's four geographical segments and for the Swedish Match segment. For the Wellness and Healthcare business, Vectura Fertin Pharma, net revenues from contracts with customers are included in the Wellness and Healthcare segment. PMI believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors.
Segment data were as follows:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023202220232022
Net revenues:
Europe$9,984 $9,805 $3,672 $3,272 
SSEA, CIS & MEA
7,922 7,781 2,777 2,822 
EA, AU & PMI DF
4,771 4,458 1,571 1,407 
Americas1,399 1,367 478 474 
Swedish Match1,814 — 568 — 
Wellness and Healthcare237 199 75 57 
Net revenues$26,127 $23,610 $9,141 $8,032 
Operating income (loss):
Europe$4,446 $4,447 $1,708 $1,415 
SSEA, CIS & MEA
2,371 3,009 801 1,086 
EA, AU & PMI DF
1,920 1,746 753 533 
Americas141 336 5 85 
Swedish Match597 — 140 — 
Wellness and Healthcare(808)(216)(37)(151)
Operating income$8,667 $9,322 $3,370 $2,968 
PMI's net revenues by product category were as follows:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023202220232022
Net revenues:
Combustible tobacco products:
Europe$6,084 $5,996 $2,160 $1,996 
SSEA, CIS & MEA
6,988 6,852 2,485 2,454 
EA, AU & PMI DF
2,091 2,214 678 692 
Americas1,349 1,296 460 450 
Swedish Match333 — 49 — 
Total combustible tobacco products16,845 16,358 5,832 5,591 
Smoke-free products:
Smoke-free products excluding Wellness and Healthcare:
Europe3,900 3,809 1,512 1,276 
SSEA, CIS & MEA
934 929 292 368 
EA, AU & PMI DF
2,680 2,244 893 715 
Americas50 71 18 24 
Swedish Match1,481 — 519 — 
Total smoke-free products excluding Wellness and Healthcare9,045 7,053 3,234 2,384 
Wellness and Healthcare237 199 75 57 
Total smoke-free products9,282 7,252 3,309 2,441 
Total PMI net revenues$26,127 $23,610 $9,141 $8,032 
Note: Sum of product categories or Regions might not foot to total PMI due to roundings.

Items affecting the comparability of results from operations were as follows:

•Impairment of goodwill and other intangibles – See Note 6. Goodwill and Other Intangible Assets, net for the details of the $680 million goodwill and non-amortizable intangible assets impairment charges included in the Wellness and Healthcare segment for the nine months ended September 30, 2023. For the nine months and three months ended September 30, 2022, PMI recorded an impairment charge related to definite-lived intangible assets of $112 million. This charge was included in the Wellness and Healthcare segment. For further details, see Note 6. Goodwill and Other Intangible Assets, net.
•South Korea indirect tax charge – See Note 10. Contingencies for details of the $204 million pre-tax charge included in the EA, AU & PMI DF segment results for the nine months ended September 30, 2023.
•Termination of distribution arrangement in the Middle East – In the first quarter of 2023, PMI recorded a pre-tax charge of $80 million following the termination of a distribution arrangement in the Middle East. This pre-tax charge was recorded as a reduction of net revenues in the condensed consolidated statements of earnings, and was included in the SSEA, CIS & MEA segment results for the nine months ended September 30, 2023.
•Charges related to the war in Ukraine – In the third quarter of 2023, PMI recorded a pre-tax charge of $19 million related to the war in Ukraine. This charge was included in the condensed consolidated statements of earnings and was included in the Europe segment for the nine months and three months ended September 30, 2023. For the nine months and three months ended September 30, 2022, PMI recorded a pre-tax charge of $128 million and $6 million, respectively. These charges were included in the condensed consolidated statements of earnings and were included in the Europe segment for the nine months and three months ended September 30, 2022. For further details, see Note 3. War in Ukraine.
•Swedish Match AB acquisition accounting related item – See Note 2. Acquisitions for details of the $18 million pre-tax purchase accounting adjustments related to the sale of acquired inventories stepped up to fair value included in the Swedish Match segment for the nine months ended September 30, 2023.
•Asset impairment and exit costs – See Note 17. Asset Impairment and Exit Costs for details of the $109 million pre-tax charge for the nine months ended September 30, 2023, as well as a breakdown of these costs by segment.
•Termination of agreement with Foundation for a Smoke-Free World – On September 29, 2023, PMI and the Foundation for a Smoke-Free World (the "Foundation") entered into the Final Grant Agreement and Termination of the Second Amended and Restated Pledge Agreement ("Agreement"). Under the terms of the agreement, PMI paid $140 million in the third quarter of 2023 in return for the termination of the pledge agreement between the parties. As a result, in the third quarter of 2023, PMI recorded a pre-tax charge of $140 million commensurate with the early termination of the pledge agreement. The pre-tax charge was recorded in marketing, administration and research costs in the condensed consolidated statements of earnings during the nine months and three months ended September 30, 2023 and was included in the operating results of the following segments for both of these periods: Europe ($62 million); SSEA, CIS & MEA ($44 million); EA, AU & PMI DF ($27 million); and Americas ($7 million).

The third quarter 2023 results of PMI's Swedish Match segment include the impact of financial statement presentation reclassifications recorded on a year-to-date basis primarily associated with the alignment of accounting policies related to the company's post-acquisition evaluation of sales incentives, excise taxes and acquired contracts. Net revenues were unfavorably impacted by these reclassifications, some of which are associated with the first and second quarter of 2023. These reclassifications were not material to the condensed consolidated results of the current period or the period in which they relate.
Following the Swedish Match acquisition and a review of PMI and Swedish Match’s combined product portfolio, PMI reclassified certain of its own products previously reported under its combustible tobacco product category to the newly created smoke-free product category to better reflect the characteristics of these products. This reclassification did not impact PMI’s consolidated financial position, results of operations or cash flows in any of the periods presented.
Net revenues related to combustible tobacco products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of PMI's cigarettes and other tobacco products that are combusted. Other tobacco products primarily include roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos, and do not include smoke-free products.

Net revenues related to smoke-free products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes, if applicable. These net revenue amounts consist of the sale of all of PMI's products that are not combustible tobacco products, such as heat-not-burn, e-vapor, and oral nicotine, also including wellness and healthcare products, as well as consumer accessories such as lighters and matches.

Net revenues related to wellness and healthcare products primarily consist of operating revenues generated from the sale of products primarily associated with inhaled therapeutics, and oral and intra-oral delivery systems that are included in the operating results of PMI's Wellness and Healthcare business, Vectura Fertin Pharma.
XML 44 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies:
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Contingencies: Contingencies:
Tobacco-Related Litigation
Legal proceedings covering a wide range of matters are pending or threatened against us, and/or our subsidiaries, and/or our indemnitees in various jurisdictions. Our indemnitees include distributors, licensees, and others that have been named as parties in certain cases and that we have agreed to defend, as well as to pay costs and some or all of judgments, if any, that may be entered against them. Pursuant to the terms of the Distribution Agreement between Altria Group, Inc. (“Altria”) and PMI, PMI will indemnify Altria and Philip Morris USA Inc. (“PM USA”), a U.S. tobacco subsidiary of Altria, for tobacco product claims based in substantial part on products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for tobacco product claims based in substantial part on products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.
It is possible that there could be adverse developments in pending cases against us and our subsidiaries. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation.
Damages claimed in some of the tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. Much of the tobacco-related litigation is in its early stages, and litigation is subject to uncertainty. However, as discussed below, we have to date been largely successful in defending tobacco-related litigation.
We and our subsidiaries record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, except as stated otherwise in this Note 10. Contingencies, while it is reasonably possible that an unfavorable outcome in a case may occur, after assessing the information available to it (i) management has not concluded that it is probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss for any of the pending tobacco-related cases; and (iii) accordingly, no estimated loss has been accrued in the consolidated financial statements for unfavorable outcomes in these cases, if any. Legal defense costs are expensed as incurred.
It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Nevertheless, although litigation is subject to uncertainty, we and each of our subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended. However, we and our subsidiaries may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.    
CCAA Proceedings and Stay of Tobacco-Related Cases Pending in Canada
As a result of the Court of Appeal of Quebec’s decision in both the Létourneau and Blais cases described below, our subsidiary, Rothmans, Benson & Hedges Inc. (“RBH”), and the other defendants, JTI Macdonald Corp., and Imperial Tobacco Canada Limited, sought protection in the Ontario Superior Court of Justice under the Companies’ Creditors Arrangement Act (“CCAA”) on March 22, March 8, and March 12, 2019, respectively. CCAA is a Canadian federal law that permits a Canadian business to restructure its affairs while carrying on its business in the ordinary course. The initial CCAA order made by the Ontario Superior Court on March 22, 2019 authorizes RBH to pay all expenses incurred in carrying on its business in the ordinary course after the CCAA filing, including obligations to employees, vendors, and suppliers. RBH's financial results have been deconsolidated from our consolidated financial statements since March 22, 2019. As part of the CCAA proceedings, there is currently a comprehensive stay up to and including March 29, 2024 of all tobacco-related litigation pending in Canada against RBH and the other defendants, including PMI and our indemnitees (PM USA and Altria), namely, the smoking and health class actions filed in various Canadian provinces and health care cost recovery actions. These proceedings are presented below under the caption “Stayed Litigation — Canada.” Ernst & Young Inc. has been appointed as monitor of RBH in the CCAA proceedings. In accordance with the CCAA process, as the parties work towards a plan of arrangement or compromise in a confidential mediation, it is anticipated that the court will set additional hearings and further extend the stay of proceedings. On April 17, 2019, the Ontario Superior Court ruled that RBH and the other defendants will not be allowed to file an application to the Supreme Court of Canada for leave to appeal the Court of Appeal’s decision in the Létourneau and the Blais cases so long as the comprehensive stay of all tobacco-related litigation in Canada remains in effect and that the time period to file the application would be extended by the stay period. While RBH believes that the findings of liability and damages in both Létourneau and the Blais cases were incorrect, the CCAA proceedings will provide a forum for RBH to seek resolution through a plan of arrangement or compromise of all tobacco-related litigation pending in Canada. It is not possible to predict the resolution of the underlying legal proceedings or the length of the CCAA process.
Stayed Litigation — Canada

Smoking and Health Litigation — Canada

In the first class action pending in Canada, Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais v. Imperial Tobacco Canada Ltd., Rothmans, Benson & Hedges Inc. and JTI-Macdonald Corp., Quebec Superior Court, Canada, filed in November 1998, RBH and other Canadian cigarette manufacturers (Imperial Tobacco Canada Ltd. and JTI-Macdonald Corp.) are defendants. The plaintiffs, an anti-smoking organization and an individual smoker, sought compensatory and punitive damages for each member of the class who suffers allegedly from certain smoking-related diseases. The class was certified in 2005. The trial court issued its judgment on May 27, 2015. The trial court found RBH and two other Canadian manufacturers liable and found that the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.3 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion (approximately $2.26 billion), including pre-judgment interest). In addition, the trial court awarded CAD 90,000 (approximately $66,000) in punitive damages, allocating CAD 30,000 (approximately $22,000) to RBH. The trial court estimated the disease class at 99,957 members. RBH appealed to the Court of Appeal of Quebec. In October 2015, the Court of Appeal ordered RBH to furnish security totaling CAD 226 million (approximately $165 million) to cover both the Létourneau and Blais cases, which RBH has paid in installments through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD 758 million (approximately $553 million) in installments through June 2017. JTI Macdonald Corp. was not required to furnish security in accordance with plaintiffs’ motion. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court’s judgment or upon further order of the Court of Appeal.

On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court’s findings of liability and the compensatory and punitive damages award while reducing the total amount of compensatory damages to approximately CAD 13.5 billion (approximately $9.8 billion), including interest due to the trial court’s error in the calculation of interest. The compensatory damages award is on a joint and several basis with an allocation of 20% to RBH (approximately CAD 2.7 billion (approximately $2.0 billion), including pre-judgment interest). The Court of Appeal upheld the trial court’s findings that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking and by conspiring to prevent consumers from learning of the dangers of smoking. The Court of Appeal further held that the plaintiffs either need not prove, or had adequately proven, that these faults were a cause of the class members’ injuries. In accordance with the judgment, defendants were required to deposit their respective portions of the damages awarded in both the Létourneau case described below and the Blais case, approximately CAD 1.1 billion (approximately $802 million), into trust accounts within 60 days. RBH’s share of the deposit was approximately CAD 257 million (approximately $194 million). PMI recorded a pre-tax charge of $194 million in its consolidated results, representing $142 million net of tax, as tobacco litigation-related expense, in the first quarter of 2019. The charge reflects PMI’s assessment of the portion of the judgment that represents probable and estimable loss prior to the deconsolidation of RBH and corresponds to the trust account deposit required by the judgment.

In the second class action pending in Canada, Cecilia Létourneau v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI-Macdonald Corp., Quebec Superior Court, Canada, filed in September 1998, RBH and other Canadian cigarette manufacturers (Imperial Tobacco Canada Ltd. and JTI-Macdonald Corp.) are defendants.  The plaintiff, an individual smoker, sought compensatory and punitive damages for each member of the class who is deemed addicted to smoking. The class was certified in 2005. The trial court issued its judgment on May 27, 2015. The trial court found RBH and two other Canadian manufacturers liable and awarded a total of CAD 131 million (approximately $96 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to RBH. The trial court estimated the size of the addiction class at 918,000 members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court found that a claims process to allocate the awarded punitive damages to individual class members would be too expensive and difficult to administer. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court’s findings of liability and the total amount of punitive damages awarded allocating CAD 57 million (approximately $42 million), including interest to RBH. See the Blais description above for further detail concerning the security order pertaining to both Létourneau and Blais cases and the impact of the decision on PMI’s financial statements.

RBH and PMI believe the findings of liability and damages in both Létourneau and the Blais cases were incorrect and in contravention of applicable law on several grounds, including the following: (i) defendants had no obligation to warn class members who knew, or should have known, of the risks of smoking; (ii) defendants cannot be liable to class members who
would have smoked regardless of what warnings were given; and (iii) defendants cannot be liable to all class members given the individual differences among class members.
In the third class action pending in Canada, Kunta v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Winnipeg, Canada, filed June 12, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic obstructive pulmonary disease (“COPD”), severe asthma, and mild reversible lung disease resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products.
In the fourth class action pending in Canada, Adams v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Saskatchewan, Canada, filed July 10, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, emphysema, heart disease, or cancer, as well as restitution of profits.
In the fifth class action pending in Canada, Semple v. Canadian Tobacco Manufacturers' Council, et al., The Supreme Court (trial court), Nova Scotia, Canada, filed June 18, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and COPD resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products.
In the sixth class action pending in Canada, Dorion v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Alberta, Canada, filed June 15, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic bronchitis and severe sinus infections resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. To date, we, our subsidiaries, and our indemnitees have not been properly served with the complaint.
In the seventh class action pending in Canada, McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and heart disease resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from heart disease allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed.

In the eighth class action pending in Canada, Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, the heir to a deceased smoker, alleges that the decedent was addicted to tobacco products and suffered from emphysema resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from chronic respiratory diseases allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. In December 2014, plaintiff filed an amended statement of claim.

In the ninth class action pending in Canada, Suzanne Jacklin v. Canadian Tobacco Manufacturers' Council, et al., Ontario Superior Court of Justice, filed June 20, 2012, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, heart disease, or cancer, as well as restitution of profits.
Health Care Cost Recovery Litigation — Canada
In the first health care cost recovery case pending in Canada, Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001, we, RBH, our indemnitee (PM USA), and other members of the industry are defendants. The plaintiff, the government of the province of British Columbia, brought a claim based upon legislation enacted by the province authorizing the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, resulting from a “tobacco related wrong.”
In the second health care cost recovery case filed in Canada, Her Majesty the Queen in Right of New Brunswick v. Rothmans Inc., et al., Court of Queen's Bench of New Brunswick, Trial Court, New Brunswick, Fredericton, Canada, filed March 13, 2008, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of New Brunswick based on legislation enacted in the province. This legislation is similar to the law introduced in British Columbia that authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the third health care cost recovery case filed in Canada, Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Ontario Superior Court of Justice, Toronto, Canada, filed September 29, 2009, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Ontario based on legislation enacted in the province. This legislation is similar to the laws introduced in British Columbia and New Brunswick that authorize the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the fourth health care cost recovery case filed in Canada, Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, St. Johns, Canada, filed February 8, 2011, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Newfoundland and Labrador based on legislation enacted in the province that is similar to the laws introduced in British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the fifth health care cost recovery case filed in Canada, Attorney General of Quebec v. Imperial Tobacco Limited, et al., Superior Court of Quebec, Canada, filed June 8, 2012, we, RBH, our indemnitee (PM USA), and other members of the industry are defendants. The claim was filed by the government of the province of Quebec based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the sixth health care cost recovery case filed in Canada, Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Supreme Court of Queen's Bench Alberta, Canada, filed June 8, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Alberta based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the seventh health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Manitoba v. Rothmans, Benson & Hedges, Inc., et al., The Queen's Bench, Winnipeg Judicial Centre, Canada, filed May 31, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Manitoba based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the eighth health care cost recovery case filed in Canada, The Government of Saskatchewan v. Rothmans, Benson & Hedges Inc., et al., Queen's Bench, Judicial Centre of Saskatchewan, Canada, filed June 8, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Saskatchewan based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
In the ninth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Prince Edward Island v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Prince Edward Island (General Section), Canada, filed September 10, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Prince Edward Island based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”

In the tenth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Nova Scotia v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Nova Scotia, Canada, filed January 2, 2015, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Nova Scotia based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.”
__________
The table below lists the number of tobacco-related cases pertaining to combustible products pending against us and/or our subsidiaries or indemnitees as of September 30, 2023, and September 30, 2022:

Type of Case1
Number of Cases Pending as of September 30, 2023Number of Cases Pending as of September 30, 2022
Individual Smoking and Health Cases4838
Smoking and Health Class Actions99
Health Care Cost Recovery Actions1717
Label-Related Class Actions——
Individual Label-Related Cases56
Public Civil Actions11
______
¹ Includes cases pending in Canada.

Since 1995, when the first tobacco-related litigation was filed against a PMI entity, 538 Smoking and Health, Label-Related, Health Care Cost Recovery, and Public Civil Actions in which we and/or one of our subsidiaries and/or indemnitees were a defendant have been terminated in our favor. Fifteen cases have had decisions in favor of plaintiffs. Ten of these cases have subsequently reached final resolution in our favor and five remain on appeal, or are subject to an appeal, or our subsidiary may file an appeal.
The table below lists the verdict and significant post-trial developments in the five pending cases where a verdict was returned in favor of the plaintiff:
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
May 27, 2015  Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais
  Class Action  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.3 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.26 billion)). The trial court awarded CAD 90,000 (approximately $66,000) in punitive damages, allocating CAD 30,000 (approximately $22,000) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $729 million) of the compensatory damage award, CAD 200 million (approximately $146 million) of which is our subsidiary’s portion, into a trust within 60 days.
  
In June 2015, RBH commenced the appellate process with the Court of Appeal of Quebec. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court's decision. (See “Stayed Litigation — Canada” for further detail.)
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
May 27, 2015  Canada/Cecilia Létourneau
  Class Action  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $96 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to RBH. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.
  
In June 2015, RBH commenced the appellate process with the Court of Appeal of Quebec. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court's decision. (See “Stayed Litigation — Canada” for further detail.)
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
August 5, 2016Argentina/Hugo LespadaIndividual Action
On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $314), plus interest, in compensatory and moral damages. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.
On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On May 17, 2021, plaintiff filed a federal extraordinary appeal. On November 1, 2021, the Supreme Court of the Province of Buenos Aires dismissed plaintiff's federal extraordinary appeal. On November 10, 2021, plaintiff filed a direct appeal before the Federal Supreme Court.
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
June 17, 2021Argentina/Claudia MilanoIndividual Action
On June 17, 2021, the Civil Court No. 9 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded her smoking cessation treatments, ARS 150,000 (approximately $429), in compensatory and moral damages, and ARS 4,000,000 (approximately $11,435) in punitive damages, plus interest and costs. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.
On July 2, 2021, our subsidiary filed its notice of appeal. In addition, plaintiff filed an appeal challenging the dismissal of the claim for psychological damages. As required by local law, our subsidiary deposited the damages awarded, plus interest and costs, in total ARS 6,114,428 (approximately $17,479), into a court escrow account. Our subsidiary challenged the amount determined by the court. The Civil and Commercial Court of Appeals of Mar del Plata granted our subsidiary's challenge to the escrow amount determined by the trial court. As a result, on December 16, 2021, ARS 893,428 (approximately $2,554) was returned to our subsidiary. If our subsidiary ultimately prevails, the remaining deposited amounts will be returned to our subsidiary. On May 31, 2022, the Civil and Commercial Court of Appeals of Mar del Plata ruled that the statute of limitations barred plaintiff's claim and reversed the trial court's decision. On June 15, 2022, plaintiff filed an extraordinary appeal.

Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
June 23, 2023Turkey/ Senem YilmazelIndividual Action
On June 23, 2023, the Ankara Consumer Court published its decision in favor of plaintiff, the daughter of an individual smoker, against our subsidiary and a BAT subsidiary, awarding her TRY 10,000 (approximately $357) in damages. The trial court found that the plaintiff’s father died as a result of lung cancer and COPD caused by his cigarette consumption.
On September 8, 2023, our subsidiary filed its appeal. On September 25, 2023, the plaintiff filed an appeal challenging the damages amount determined by the court.
Pending claims related to tobacco products generally fall within the following categories:
Smoking and Health Litigation: These cases primarily allege personal injury and are brought by individual plaintiffs or on behalf of a class or purported class of individual plaintiffs. Plaintiffs' allegations of liability in these cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of express and implied warranties, violations of deceptive trade practice laws and consumer protection statutes. Plaintiffs in these cases seek various forms of relief, including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include licit activity, failure to state a claim, lack of defect, lack of proximate cause, assumption of the risk, contributory negligence, and statute of limitations.
As of September 30, 2023, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:

•48 cases brought by individual plaintiffs in Argentina (32), Australia (1), Canada (2), Chile (10), the Philippines (1), Turkey (1) and Scotland (1), compared with 38 such cases on September 30, 2022; and
•9 cases brought on behalf of classes of individual plaintiffs, compared with 9 such cases on September 30, 2022.

The class actions pending in Canada are described above under the caption “Smoking and Health Litigation — Canada.”

Health Care Cost Recovery Litigation: These cases, brought by governmental and non-governmental plaintiffs, seek reimbursement of health care cost expenditures allegedly caused by tobacco products. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including unjust enrichment, negligence, negligent design, strict liability, breach of express and implied warranties, violation of a voluntary undertaking or special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, defective product, failure to warn, sale of cigarettes to minors, and claims under statutes governing competition and deceptive trade practices. Plaintiffs in these cases seek various forms of relief including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, remoteness of injury, failure to state a claim, adequate remedy at law, “unclean hands” (namely, that plaintiffs cannot obtain equitable relief because they participated in, and benefited from, the sale of cigarettes), and statute of limitations.
As of September 30, 2023, there were 17 health care cost recovery cases pending against us, our subsidiaries or indemnitees in Brazil (1), Canada (10), Korea (1) and Nigeria (5), compared with 17 such cases on September 30, 2022.

The health care cost recovery actions pending in Canada are described above under the caption “Health Care Cost Recovery Litigation — Canada.”
In the health care cost recovery case in Brazil, The Attorney General of Brazil v. Souza Cruz Ltda., et al., Federal Trial Court, Porto Alegre, Rio Grande do Sul, Brazil, filed May 21, 2019, we, our subsidiaries, and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases in certain prior years, payment of anticipated costs of treating future alleged smoking-related diseases, and moral damages. Defendants filed answers to the complaint in May 2020.
In the first health care cost recovery case in Nigeria, The Attorney General of Lagos State v. British American Tobacco (Nigeria) Limited, et al., High Court of Lagos State, Lagos, Nigeria, filed March 13, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.
In the second health care cost recovery case in Nigeria, The Attorney General of Kano State v. British American Tobacco (Nigeria) Limited, et al., High Court of Kano State, Kano, Nigeria, filed May 9, 2007, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of challenging the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.
In the third health care cost recovery case in Nigeria, The Attorney General of Gombe State v. British American Tobacco (Nigeria) Limited, et al., High Court of Gombe State, Gombe, Nigeria, filed October 17, 2008, we and other members of the
industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In February 2011, the court ruled that the plaintiff had not complied with the procedural steps necessary to serve us. As a result of this ruling, plaintiff must re-serve its claim. We have not yet been re-served.
In the fourth health care cost recovery case in Nigeria, The Attorney General of Oyo State, et al., v. British American Tobacco (Nigeria) Limited, et al., High Court of Oyo State, Ibadan, Nigeria, filed May 25, 2007, we and other members of the industry are defendants. Plaintiffs seek reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We challenged service as improper. In June 2010, the court ruled that plaintiffs did not have leave to serve the writ of summons on the defendants and that they must re-serve the writ. We have not yet been re-served.
In the fifth health care cost recovery case in Nigeria, The Attorney General of Ogun State v. British American Tobacco (Nigeria) Limited, et al., High Court of Ogun State, Abeokuta, Nigeria, filed February 26, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In May 2010, the trial court rejected our objections to the court's jurisdiction. We have appealed. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.

In the health care cost recovery case in Korea, the National Health Insurance Service v. KT&G, et. al., filed April 14, 2014, our subsidiary and other Korean manufacturers are defendants. Plaintiff alleges that defendants concealed the health hazards of smoking, marketed to youth, added ingredients to make their products more harmful and addictive, and misled consumers into believing that Lights cigarettes are safer than regular cigarettes. The National Health Insurance Service seeks to recover damages allegedly incurred in treating 3,484 patients with small cell lung cancer, squamous cell lung cancer, and squamous cell laryngeal cancer from 2003 to 2012. The trial court dismissed the case in its entirety on November 20, 2020. The Appellate court granted the Plaintiff a de novo appeal in 2021 and determined that the appellate proceedings will take place in stages: wrongful conduct/product defect allegations first, then causation and finally issues such as standing/direct action.

Label-Related Cases: These cases, now brought only by individual plaintiffs, allege that the use of the descriptor “Lights” or other alleged misrepresentations or omissions of labeling information constitute fraudulent and misleading conduct. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including misrepresentation, deception, and breach of consumer protection laws. Plaintiffs seek various forms of relief including restitution, injunctive relief, and compensatory and other damages. Defenses raised include lack of causation, lack of reliance, assumption of the risk, and statute of limitations.

As of September 30, 2023, there were 5 label-related cases brought by individual plaintiffs in Italy (1) and Chile (4) pending against our subsidiaries, compared with 6 such cases on September 30, 2022.

Public Civil Actions: Claims have been filed either by an individual, or a public or private entity, seeking to protect collective or individual rights, such as the right to health, the right to information or the right to safety. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including product defect, concealment, and misrepresentation. Plaintiffs in these cases seek various forms of relief including injunctive relief such as banning cigarettes, descriptors, smoking in certain places and advertising, as well as implementing communication campaigns and reimbursement of medical expenses incurred by public or private institutions.

As of September 30, 2023, there was 1 public civil action pending against our subsidiary in Venezuela (1), compared with 1 such case on September 30, 2022.

In a public civil action in Venezuela, Federation of Consumers and Users Associations (“FEVACU”), et al. v. National Assembly of Venezuela and the Venezuelan Ministry of Health, Constitutional Chamber of the Venezuelan Supreme Court, filed April 29, 2008, we were not named as a defendant, but the plaintiffs published a notice pursuant to court order, notifying all interested parties to appear in the case. In January 2009, our subsidiary appeared in the case in response to this notice. The plaintiffs purport to represent the right to health of the citizens of Venezuela and claim that the government failed to protect adequately its citizens' right to health. The claim asks the court to order the government to enact stricter regulations on the manufacture and sale of tobacco products. In addition, the plaintiffs ask the court to order companies involved in the tobacco
industry to allocate a percentage of their “sales or benefits” to establish a fund to pay for the health care costs of treating smoking-related diseases. In October 2008, the court ruled that plaintiffs have standing to file the claim and that the claim meets the threshold admissibility requirements. In December 2012, the court admitted our subsidiary and a subsidiary of British American Tobacco plc as interested third parties. In February 2013, our subsidiary answered the complaint.

Other Litigation

The Department of Special Investigations of the government of Thailand ("DSI") conducted an investigation into alleged underpayment by our subsidiary, Philip Morris (Thailand) Limited ("PM Thailand"), of customs duties and excise taxes relating to imports from the Philippines covering the period 2003-2007. On January 18, 2016, the Public Prosecutor filed charges against our subsidiary and seven former and current employees in the Bangkok Criminal Court alleging that PM Thailand and the individual defendants jointly and with the intention to defraud the Thai government, under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries of cigarettes from the Philippines during the period of July 2003 to June 2006. The government sought a fine of approximately THB 80.8 billion (approximately $2.2 billion). In May 2017, Thailand enacted a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies. Trial in the case began in November 2017 and concluded in September 2019. In November 2019, the trial court found our subsidiary guilty of under-declaration of the prices and imposed a fine of approximately THB 1.2 billion (approximately $32.8 million). The trial court dismissed all charges against the individual defendants. In December 2019, as required by the Thai law, our subsidiary paid the fine. This payment is included in other assets on the condensed consolidated balance sheets and negatively impacted net cash provided by operating activities in the condensed consolidated statements of cash flows in the period of payment. Both our subsidiary and the Public Prosecutor filed an appeal of the trial court's decision. The appellate court issued its decision on the appeals on June 1, 2022. The appellate court affirmed the findings of under-declaration of import prices of cigarettes but reduced the fine to approximately THB 122 million (approximately $3.3 million) finding the trial court erred in its calculation of the under-declaration and fine. The appellate court affirmed the acquittals of the individual defendants. Our subsidiary has appealed the decision to the Supreme Court of Thailand. The Public Prosecutor has also filed an appeal challenging the dismissal of charges against the individual defendants and the amount of the fine imposed. Thailand is required to refund any payment made by our subsidiary in excess of any fine asserted by the courts.

The DSI also conducted an investigation into alleged underpayment by PM Thailand of customs duties and excise taxes relating to imports from Indonesia covering the period 2000-2003. On January 26, 2017, the Public Prosecutor filed charges against PM Thailand and its former Thai employee in the Bangkok Criminal Court alleging that PM Thailand and its former employee jointly and with the intention to defraud the Thai government under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries during the period from January 2002 to July 2003. The government is seeking a fine of approximately THB 19.8 billion (approximately $541 million). In May 2017, Thailand enacted a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law, and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and a Thai court. Trial in the case began in November 2018 and concluded in December 2019. In March 2020, the trial court found our subsidiary guilty of under-declaration of the prices and imposed a fine of approximately THB 130 million (approximately $3.6 million). The trial court dismissed all charges against the individual defendant. In April 2020, as required by Thai law, our subsidiary paid the fine. This payment is included in other assets on the condensed consolidated balance sheets and negatively impacted net cash provided by operating activities in the condensed consolidated statements of cash flows in the period of payment. Our subsidiary filed an appeal of the trial court's decision. In addition, the Public Prosecutor filed an appeal of the trial court's decision challenging the dismissal of charges against the individual defendant and the amount of the fine imposed. The appellate court issued its decision on the appeals on January 31, 2023. The appellate court affirmed the findings of under-declaration of import prices of cigarettes but reduced the fine imposed by the trial court. The appellate court directed the Public Prosecutor to coordinate with customs officials to calculate such reduced fine in accordance with the appellate court’s decision. The appellate court affirmed the acquittal of the individual defendant. Our subsidiary has appealed the decision to the Supreme Court of Thailand. The Public Prosecutor has filed an appeal to the Supreme Court of Thailand challenging the dismissal of charges against the individual defendant and the amount of the fine. Thailand is required to refund any payment made by our subsidiary in excess of any fine assessed by the courts.
The South Korean Board of Audit and Inspection (“BAI”) conducted an audit of certain Korean government agencies and the tobacco industry into whether inventory movements ahead of the January 1, 2015 increase of cigarette-related taxes by tobacco companies, including Philip Morris Korea Inc. ("PM Korea"), our South Korean subsidiary, were in compliance with South Korean tax laws.  In November 2016, the tax authorities completed their audit and assessed allegedly underpaid taxes and penalties.  In order to avoid nonpayment financial costs, PM Korea paid approximately KRW 272 billion (approximately $204 million), of which KRW 100 billion (approximately $75 million) was paid in 2016 and KRW 172 billion (approximately $129 million) was paid in the first quarter of 2017.  These paid amounts negatively impacted net cash provided by operating activities in the condensed consolidated statements of cash flows in the period of payment.  PM Korea appealed the assessments. In January 2020, a trial court ruled that PM Korea did not underpay taxes in the amount of approximately KRW 218 billion (approximately $164 million). The tax authorities appealed this decision to the appellate court. In September 2020, the appellate court upheld the trial court's decision. The tax authorities have appealed to the Supreme Court of South Korea. On July 13, 2023, the Supreme Court reversed the appellate court's decision and remanded the appeals back to the appellate court. Based on the decision issued by the Supreme Court of South Korea on July 13, 2023, management has concluded that an adverse outcome is probable. In June 2020, another trial court ruled that PM Korea did not underpay approximately KRW 54 billion (approximately $40 million) of alleged underpayments. The government agencies appealed this decision. In January 2021, the appellate court upheld the trial court's decision. The government agencies appealed to the Supreme Court of South Korea. Based on the decision issued by the Supreme Court of South Korea on July 13, 2023, management has concluded that an adverse outcome is probable. Consequently, in the second quarter of 2023, PMI recorded a non-cash pre-tax charge of $204 million in marketing, administration and research costs, reflecting the full amount previously paid by PM Korea.

A putative shareholder class action lawsuit, In re Philip Morris International Inc. Securities Litigation, is pending in the United States District Court for the Southern District of New York, purportedly on behalf of purchasers of Philip Morris International Inc. stock between July 26, 2016 and April 18, 2018. The lawsuit names Philip Morris International Inc. and certain officers and employees as defendants and includes allegations that the defendants made false and/or misleading statements and/or failed to disclose information about PMI’s business, operations, financial condition, and prospects, related to product sales of, and alleged irregularities in clinical studies of, PMI’s Platform 1 product. The lawsuit seeks various forms of relief, including damages. In November 2018, the court consolidated three putative shareholder class action lawsuits with similar allegations previously filed in the Southern District of New York (namely, City of Westland Police and Fire Retirement System v. Philip Morris International Inc., et al., Greater Pennsylvania Carpenters’ Pension Fund v. Philip Morris International Inc., et al., and Gilchrist v. Philip Morris International Inc., et al.) into these proceedings. A putative shareholder class action lawsuit, Rubenstahl v. Philip Morris International Inc., et al., that had been previously filed in December 2017 in the United States District Court for the District of New Jersey, was voluntarily dismissed by the plaintiff due to similar allegations in these proceedings. On February 4, 2020, the court granted defendants’ motion in its entirety, dismissing all but one of the plaintiffs’ claims with prejudice.  The court noted that one of plaintiffs’ claims (allegations relating to four non-clinical studies of PMI’s Platform 1 product) did not state a viable claim but allowed plaintiffs to replead that claim by March 3, 2020. On February 18, 2020, the plaintiffs filed a motion for reconsideration of the court's February 4th decision; this motion was denied on September 21, 2020. On September 28, 2020, plaintiffs filed an amended complaint seeking to replead allegations relating to four non-clinical studies of PMI's Platform 1 product. On September 10, 2021, the court granted defendant's motion to dismiss plaintiffs' amended complaint in its entirety. Plaintiffs have filed an appeal with the U.S. Court of Appeal for the Second Circuit. We believe that this lawsuit is without merit and will continue to defend it vigorously.

In April 2020, affiliates of British American Tobacco plc (“BAT”) commenced patent infringement proceedings, RAI Strategic Holdings, Inc., et al. v. Altria Client Services LLC, et al.,  in the federal court in the Eastern District of Virginia, where PMI's subsidiary, Philip Morris Products S.A. ("PMPSA"), as well as Altria Group, Inc.'s subsidiaries, are defendants. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade products in the United States.  In April 2020, BAT affiliates filed a complaint against PMI, PMPSA, Altria Group, Inc., and its subsidiaries before the International Trade Commission ("ITC"). Plaintiffs seek an order to prevent the importation of Platform 1 products into the United States. The ITC evidentiary hearing closed on February 1, 2021. On May 14, 2021, the administrative law judge issued an Initial and Recommended Determination ("ID/RD") finding that the Platform 1 blade products infringe two of the three patents asserted by Plaintiffs, recommending that the ITC issue a Limited Exclusion order against infringing products, and recommending against a cease-and-desist, as well as recommending against a bond pending Presidential review of the ITC's Final Determination ("FD"). Defendants and Plaintiffs filed separate Petitions for Review with the ITC of the ID/RD on May 28, 2021; on July 27, 2021, the ITC granted each of the petitions in part, deciding to review certain issues in the ID/RD. Plaintiffs and Defendants also submitted brief statements of the public interest factors in issue to the ITC on June 15, 2021. On September 29, 2021, the ITC issued its FD finding a violation of section 337 of the U.S. Tariff Act and issued (a) a limited exclusion order against PMPSA, prohibiting, inter alia, the importation of Platform 1 product and infringing components; and (b) a cease-and-desist order
against Altria Client Services, LLC and its affiliate prohibiting, inter alia, sales of imported Platform 1 products. The ITC predicated the orders on its finding that Platform 1 blade products infringe two patents owned by a BAT affiliate. The ITC also found that Platform 1 blade products do not infringe a third patent owned by a BAT affiliate. The ITC further held that there were insufficient concerns over public interest to prevent the issuance of remedial orders. Following the Presidential Review period, the orders became effective and Defendants filed a petition for review of the FD with the U.S. Court of Appeals for the Federal Circuit. Defendants also filed motions in the ITC and Federal Circuit for a stay of the orders pending disposition of the appeal; the ITC denied the motion on January 20, 2022 and the Federal Circuit denied the motion on January 25, 2022. The Federal Circuit heard oral argument on defendants' appeal of the FD on October 3, 2022 and, on March 31, 2023, the Federal Circuit affirmed the FD. This adverse ruling impacts our ability to import the products and components impacted by the ITC's FD but has an immaterial financial impact. In the Eastern District of Virginia case, the defendants also counterclaimed that BAT infringed their patents relating to certain e-vapor products, seeking damages for, and injunctive relief against, the commercialization of these products by BAT. The trial of Defendant PMPSA’s counterclaims took place from June 8-14, 2022 and, on June 15, 2022, the jury returned a verdict for PMPSA awarding approximately $10.8 million in damages for infringement up to December 31, 2021 of two PMPSA patents by BAT’s affiliate and two of BAT’s e-vapor products; the jury also found BAT’s affiliate did not infringe one of the two PMPSA patents and that the BAT affiliates had failed to prove one of the two PMPSA patents was invalid. PMPSA filed a motion for an injunction or, in the alternative, an ongoing royalty on August 12, 2022. On March 30, 2023, the court denied PMPSA's motion for an injunction and granted PMPSA an ongoing royalty against two of BAT's U.S. e-vapor products. On May 1, 2023, the court entered partial final judgment under Rule 54(b) on PMPSA's claim against BAT's affiliate. That same day, BAT's affiliate filed a notice of appeal to the U.S. Court of Appeals for the Federal Circuit. On May 10, 2023, PMPSA filed a notice of cross-appeal. Upon petition of PMPSA, the Patent Trial and Appeal Board ("PTAB") of the United States Patent and Trademark Office has instituted review of certain claims pertaining to four of the six patents asserted by BAT affiliates in both proceedings. On January 11, 2022, PTAB issued its final decision on one of the two patents underlying the ITC's FD, invalidating all challenged claims of BAT's patent. On March 30, 2022, PTAB issued its final decision on the second of the two patents underlying the ITC's FD, finding the challenged claims patentable. The parties have filed appeals of these PTAB results to the U.S. Court of Appeals for the Federal Circuit. Oral argument was held on July 13, 2023. On July 17, 2023, the Federal Circuit issued a decision summarily affirming PTAB’s decision to invalidate all challenged claims in one of the two patents underlying the ITC’s FD. The Federal Circuit issued the mandate notifying the USPTO to record the invalidity of the challenged claims on August 23, 2023. On September 14, 2023, the Federal Circuit issued a decision affirming the PTAB's decision finding certain claims in the second of the two patents underlying the ITC’s FD patentable.  PMPSA’s counterclaim in the Eastern District of Virginia challenging the validity of the remaining claims in the second of the two patents underlying the ITC’s FD is currently stayed. On July 21, 2022, PMPSA filed a Request for Rehearing of PTAB's November 2020 decision not to institute review of certain claims in the second of the two patents underlying the ITC's FD; PTAB denied the Request on October 13, 2022.

In April 2020, BAT’s affiliate commenced patent infringement proceedings, Nicoventures Trading Limited v. PM GmbH, et al., against PMI’s German subsidiary, Philip Morris GmbH, and PMPSA, in the Regional Court in Munich, Germany. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade products in Germany. In June 2021, the court stayed the proceeding in respect of one of the two patents asserted by BAT’s Affiliate. Following the December 2022 confirmation of the revocation of the other BAT patent by the European Patent Office Board of Appeal, BAT withdrew its initial claim based on that patent; the stayed action based on the second patent remains pending and is stayed pending a possible appeal by BAT of the revocation of that second patent by the European Patent Office.

In September 2020, BAT’s affiliates commenced patent infringement and unfair competition proceedings, RAI Strategic Holdings, Inc., et al. v. Philip Morris Products S.A., et al., against PMPSA. and PMI’s Italian subsidiaries, Philip Morris Manufacturing & Technology Bologna S.p.A. and Philip Morris Italia S.r.l., in the Court of Milan, Italy. Plaintiffs seek damages, as well as injunctive relief against the manufacture in Italy of the Platform 1 blade heated tobacco units allegedly infringing the asserted patents and the commercialization of the Platform 1 blade products in Italy. As part of this proceeding, in October 2020, BAT’s affiliates filed a request based on one of the two asserted patents seeking preliminary injunctive relief against the manufacture and commercialization of the Platform 1 blade products in Italy. In July 2022, the court dismissed plaintiffs’ request for preliminary injunction in its entirety and plaintiffs did not appeal this ruling. The merits proceeding remains pending; the next hearing is currently scheduled to occur in the first quarter of 2024.

In October 2020, BAT’s affiliates commenced patent infringement proceedings, RAI Strategic Holdings, Inc., et al. v. Philip Morris Japan, Limited, et al., against PMI’s Japanese subsidiary, Philip Morris Japan Limited, and a third-party distributor in the Tokyo District Court. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade products in Japan. On December 23, 2022, the Court dismissed BAT’s claims with respect to one of the two patents that it
asserted, finding no infringement; BAT filed an appeal of this dismissal. On September 21, 2023, the court issued its judgment dismissing BAT's appeal regarding the Beard patent. BAT's claim with respect to the second patent remains pending; the final procedural hearing was held on September 6, 2023, during which the Court closed the proceedings and announced that the judgment would be rendered in the fourth quarter of 2023.

In November 2020, BAT’s affiliates commenced patent infringement proceedings, RAI Strategic Holdings, Inc., et al. v. Philip Morris Romania SRL, et al., against PMI’s Romanian subsidiaries, Philip Morris Romania S.R.L. and Philip Morris Trading S.R.L., and a third-party distributor in the Court of Law of Bucharest, Civil Registry. Plaintiffs seek damages and preliminary and permanent injunctive relief against the manufacture and commercialization of the Platform 1 blade products in Romania. In February 2021, the court dismissed plaintiffs’ request for a preliminary injunction. In April 2021, the appellate court denied plaintiffs' appeal, confirming the dismissal of plaintiffs' request for preliminary injunction. Plaintiffs' proceeding requesting damages and a permanent injunction remains pending before the Court of Law of Bucharest, Civil Registry. In an October 14, 2021 hearing, the court stayed the proceeding.

In March 2021, BAT’s affiliates commenced patent infringement proceedings, RAI Strategic Holdings, Inc., et al. v. Philip Morris Korea, Co., Ltd., against PM Korea in the Seoul Central District Court. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade heated tobacco units in South Korea. On May 30, 2022, the Korean Patent Office issued a decision that all of the challenged claims in the patent asserted by Plaintiffs are invalid; Plaintiffs filed an appeal of this decision. Following BAT’s unsuccessful correction action at the Korean Patent Office, the court held the first hearing in the appeal of the infringement proceeding on September 12, 2023. An additional hearing in the appeal is currently scheduled to occur in the fourth quarter of 2024.

In July, 2021, PMPSA filed a claim at the High Court of Justice of England and Wales against BAT affiliates Nicoventures Trading Limited and British American Tobacco (Investments) Limited seeking revocation of the UK parts of two BAT European patents. In March, the BAT affiliates stated that they would consent to revocation of one of the patents and filed a counterclaim against PMPSA and Philip Morris Limited seeking from the court a declaration that the remaining BAT affiliate patent is infringed by Platform 1 induction products, as well as damages and injunctive relief against the commercialization of the Platform 1 induction products in the U.K. The trial took place from September 21-28, 2022. On October 25, 2023, the Court issued its decision finding that the remaining BAT patent was invalid and not infringed.

Other patent challenges by both parties are pending in various jurisdictions.

We believe that the foregoing proceedings by the affiliates of BAT are without merit and will defend them vigorously.

We are also involved in additional litigation arising in the ordinary course of our business. While the outcomes of these proceedings are uncertain, management does not expect that the ultimate outcomes of other litigation, including any reasonably possible losses in excess of current accruals, will have a material adverse effect on our consolidated results of operations, cash flows or financial position.

Third-Party Guarantees

Until November 1, 2022, Medicago Inc. ("Medicago") was an equity method investee of Philip Morris Investments B.V. (“PMIBV”), a PMI subsidiary. On October 17, 2020, Medicago had entered into a contribution agreement with the Canadian government (the “Contribution Agreement”) whereby the Canadian government agreed to contribute up to CAD 173 million (approximately $131 million on the date of signing) to Medicago, to support its on-going COVID-19 vaccine development and clinical trials ("First Stage"), and for the construction of its Quebec City manufacturing facility ("Second Stage", and together with the First Stage, the “Project”). On March 31, 2022, the Contribution Agreement was amended (the “Contribution Agreement Amendment”) to reflect an additional contribution from the Canadian government up to CAD 27 million (approximately $22 million on the date of signing) to Medicago for the Second Stage. In August 2022, Medicago received the final tranche of the contribution from the Canadian government in relation to the First Stage, confirming thereby the completion of such first stage and consequently reducing by approximately CAD 123 million (approximately $93 million on the date of signing) the Repayment Obligations (as defined below).

PMIBV and Mitsubishi Tanabe Pharma Corporation (“MTPC”) are also parties to the Contribution Agreement and the Contribution Agreement Amendment as guarantors of Medicago’s obligations thereunder on a joint and several basis (“Co-Guarantors”). The Co-Guarantors agreed to repay amounts contributed by the Canadian government plus interest, if Medicago
fails to do so (the "Repayment Obligations"), and could be responsible for the costs of Medicago’s other obligations (such as the achievement of specific milestones of the Project). The guarantees are in effect through March 31, 2026. Prior to the release of PMIBV from its obligations as guarantor described below, it was reasonably possible that PMI could have been responsible for a portion of those costs and obligations.

On November 1, 2022, PMIBV transferred all of the shares it owned in Medicago to MTPC Holdings Canada Inc., the majority shareholder of Medicago. MTPC assumed and agreed to perform all of PMIBV's obligations under the guarantees and to indemnify and save PMIBV harmless in respect of any and all claims related to the guaranteed obligations. On February 3, 2023, PMI learned through a public announcement that a decision had been taken to cease all operations at Medicago and to proceed with an orderly wind up of Medicago’s business and operations.
On September 27, 2023, the Canadian government released PMIBV from all its obligations as guarantor under the Contribution Agreement and the Contribution Agreement Amendment.
XML 45 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes:
 9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes: Income Taxes:
Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis, and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets.

PMI’s effective tax rates for the nine months and three months ended September 30, 2023 were 25.7% and 33.2%, respectively.

The effective tax rate for the nine months ended September 30, 2023, was unfavorably impacted by: (i) an increase in deferred tax liabilities related to the unremitted earnings of PMI's Russian subsidiaries ($173 million) due to the unilateral suspension of certain Russian double tax treaties by the Russian authorities on August 8, 2023, with respect to certain payments including dividends; (ii) the non-deductible Wellness and Healthcare goodwill impairment charge and (iii) a deferred tax cost for unrealized foreign currency gains on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings ($41 million), while the underlying pre-tax foreign currency movements fully offset in the condensed consolidated statements of earnings and were reflected as currency translation adjustments in its condensed consolidated statements of stockholders' (deficit) equity.

The effective tax rate for the three months ended September 30, 2023 was unfavorably impacted by an increase in deferred tax liabilities related to the unremitted earnings of PMI's Russian subsidiaries ($173 million) and a deferred tax cost for unrealized foreign currency gains on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings ($138 million).

PMI’s effective tax rates for the nine months and three months ended September 30, 2022 were 20.6% and 22.0%, respectively.

The effective tax rate for the nine months ended September 30, 2022, was favorably impacted by changes in earnings mix by taxing jurisdiction and by a reduction in deferred tax liabilities related to pension plan assets ($40 million), as well as a decrease in deferred tax liabilities related to the fair value adjustment of equity securities held by PMI ($13 million). For further details, see Note 14. Related Parties - Equity Investments and Other.

PMI estimates that its full-year 2023 effective tax rate will be approximately 20.5% to 21.5%, excluding discrete tax events. Changes in currency exchange rates, earnings mix by taxing jurisdiction or future legislative or regulatory developments may have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions.

PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years 2019 and onward. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from 3 to 5 years. In October 2021, a subsidiary of PMI in Indonesia, PT Hanjaya Mandala Sampoerna Tbk ("HMS"), received a tax assessment in the amount of 3.8 trillion Indonesian rupiah (approximately $260 million in the period of payment) primarily relating to corporate income taxes on domestic and other intercompany transactions for the years 2017 to 2019. HMS paid the assessment in the fourth quarter of 2021 in order to avoid potential penalties and filed an objection letter with the tax office in January 2022. The amount paid was included in other assets in
PMI’s condensed consolidated balance sheets at September 30, 2023 and December 31, 2022, and negatively impacted net cash provided by operating activities in the consolidated statements of cash flows in the period of payment.

It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in unrecognized tax benefits along with related interest and penalties. An estimate of any possible change cannot be made at this time.
XML 46 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Indebtedness:
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Indebtedness: Indebtedness:
Short-term Borrowings:

At September 30, 2023 and December 31, 2022, PMI’s short-term borrowings and related average interest rates consisted of the following:
September 30, 2023December 31, 2022
(in millions)Amount OutstandingAverage RateAmount OutstandingAverage Rate
Commercial paper
$1,928 5.5 %$912 4.4 %
Bank loans
221 9.0 295 7.5 
U.S. dollar credit facility borrowings related to Swedish Match AB acquisition— — 4,430 4.9 
$2,149 $5,637 

Given the mix of PMI's legal entities and their respective local economic environments, the average interest rate for bank loans above can vary significantly from day to day and country to country.

The fair values of PMI’s short-term borrowings, based on current market interest rates, approximate carrying value.

Long-term Debt:

At September 30, 2023 and December 31, 2022, PMI’s long-term debt consisted of the following:

(in millions)September 30, 2023December 31, 2022
U.S. dollar notes, 0.875% to 6.375% (average interest rate 4.433%), due through 2044
$30,733 $22,596 
Foreign currency obligations:
Euro notes, 0.125% to 3.125% (average interest rate 1.877%), due through 2039
8,069 8,116 
Swiss franc note, 1.625%, due 2024
272 378 
Euro credit facility borrowings related to Swedish Match AB acquisition, (average interest rate 4.265%), due through 2027
5,797 5,850 
Swedish krona notes, 1.395% to 5.762% (average interest rate 2.357%), due through 2029
234 343
Other (average interest rate 6.156%), due through 2031 (a)
461 203 
Carrying value of long-term debt45,566 37,486 
Less current portion of long-term debt2,652 2,611 
 $42,914 $34,875 
(a) Includes long-term bank loans at subsidiaries, as well as $40 million and $54 million in finance leases at September 30, 2023 and December 31, 2022, respectively.
The fair value of PMI’s outstanding long-term debt, which is utilized solely for disclosure purposes, is determined using quotes and market interest rates currently available to PMI for issuances of debt with similar terms and remaining maturities. At September 30, 2023, the fair value of PMI's outstanding long-term debt, excluding the aforementioned finance leases, was as follows:

(in millions)
September 30, 2023
Level 1$36,217 
Level 26,356 
For a description of the fair value hierarchy and the three levels of inputs used to measure fair values, see Item 8, Note 2. Summary of Significant Accounting Policies of PMI's Annual Report on Form 10-K for the year ended December 31, 2022.

Credit Facilities related to the Financing of the Swedish Match Acquisition

In connection with PMI's all-cash recommended public offer to the shareholders of Swedish Match, on May 11, 2022, PMI entered into a credit agreement relating to a 364-day senior unsecured bridge facility. The facility provided for borrowings up to an aggregate principal amount of $17 billion, expiring 364 days after the occurrence of certain events unless extended. On June 23, 2022, PMI entered into a €5.5 billion (approximately $5.8 billion at the date of signing) senior unsecured term loan credit agreement consisting of a €3.0 billion (approximately $3.2 billion at the date of signing) tranche expiring three years after the occurrence of certain events and a €2.5 billion (approximately $2.6 billion at the date of signing) tranche expiring on June 23, 2027. In connection with the term loan facility, the aggregate principal amount of commitments under the 364-day senior unsecured bridge facility was reduced from $17 billion to $11 billion. On November 11, 2022, PMI acquired a controlling interest of 85.87% of the total issued shares in Swedish Match and acquired 94.81% of its outstanding shares as of December 31, 2022. In accordance with the Swedish Companies Act, PMI subsequently exercised its right to compulsorily redeem the remaining shares for which acceptances were not received and obtained legal title to 100% of the shares in Swedish Match on February 17, 2023.

PMI borrowed $8.4 billion under the bridge facility by delivering notices of borrowing for advances of $7.9 billion and $0.5 billion on November 7, 2022 and November 10, 2022, respectively. All amounts borrowed under the bridge facility would become due on November 8, 2023 unless prepaid or such maturity date is extended pursuant to the terms of the bridge facility.
On November 7, 2022, PMI also delivered notices of borrowing for advances totaling €5.5 billion under the term loan facility, of which €3.0 billion will become due on November 9, 2025 and €2.5 billion will become due on June 23, 2027 unless prepaid pursuant to the terms of the credit agreement. On November 21, 2022 and February 17, 2023, PMI repaid $4.0 billion and $4.4 billion, respectively, under the bridge facility. Effective February 20, 2023, the remaining outstanding commitments under the bridge facility were fully canceled and the bridge facility agreement was terminated in accordance with its terms. As of September 30, 2023 and December 31, 2022, the €5.5 billion (approximately $6 billion) term loan facility was fully drawn and remained outstanding. The proceeds under the bridge facility and the term loan facility were used, directly or indirectly, to finance the acquisition, including, the payment of related fees and expenses. For further details on this acquisition, see Note 2. Acquisitions.
Debt Issuances
PMI's debt issuances in the first nine months of 2023 were as follows:
(in millions)
TypeFace Value Interest RateIssuanceMaturity
U.S. dollar notes
(a)
$1,2504.875%February 2023February 2026
U.S. dollar notes
(a)
$1,0004.875%February 2023February 2028
U.S. dollar notes
(a)
$1,5005.125%February 2023February 2030
U.S. dollar notes
(a)
$1,5005.375%February 2023February 2033
U.S. dollar notes(a) (b)$4504.875%May 2023February 2026
U.S. dollar notes(a) (c)$5504.875%May 2023February 2028
U.S. dollar notes(a) (d)$7005.125%May 2023February 2030
U.S. dollar notes(a) (e)$7505.375%May 2023February 2033
U.S. dollar notes(f)$6505.250%September 2023September 2028
U.S. dollar notes(f)$7005.500%September 2023September 2030
U.S. dollar notes(f)$1,0005.625%September 2023September 2033
(a) Interest is payable semi-annually, commencing in August 2023
(b) These notes are a further issuance of the 4.875% notes issued in February 2023
(c) These notes are a further issuance of the 4.875% notes issued in February 2023
(d) These notes are a further issuance of the 5.125% notes issued in February 2023
(e) These notes are a further issuance of the 5.375% notes issued in February 2023
(f) Interest is payable semi-annually, commencing in March 2024

On February 17, 2023, PMI applied a portion of the net proceeds of the debt issuances to prepay $4.4 billion under its bridge facility, which represented all borrowings outstanding under the bridge facility. PMI used a portion of the May 2023 net proceeds to pay the remaining cash consideration due in accordance with the terms of its agreement with Altria. For further details on PMI's agreement with Altria, see Note 2. Acquisitions. The remaining net proceeds of the February and May 2023 offerings, as well as the September 2023 offering have been or will be used for general corporate purposes.

Revolving Credit Facilities:

At September 30, 2023, PMI's total committed revolving credit facilities were as follows:

(in billions)


Type
Committed
Revolving Credit
Facilities
364-day revolving credit, expiring January 30, 2024
$1.8 
Multi-year revolving credit, expiring February 10, 2026 (1)
2.0 
Multi-year revolving credit, expiring September 29, 2026 (2) (3)
2.5 
Total facilities
$6.3 
(1) On January 28, 2022, PMI entered into an agreement, effective February 10, 2022, to amend and extend the term of its $2.0 billion multi-year revolving credit facility, for an additional year covering the period February 11, 2026 to February 10, 2027, in the amount of $1.9 billion.
(2) Includes pricing adjustments that may result in the reduction or increase in both the interest rate and commitment fee under the credit agreement if PMI achieves, or fails to achieve, certain specified targets.
(3) On September 20, 2022, PMI entered into an agreement, effective September 29, 2022, to amend and extend the term of its $2.5 billion multi-year revolving credit facility, for an additional year covering the period September 30, 2026 to September 29, 2027, in the amount of $2.3 billion. On September 20, 2023, PMI entered into an agreement, effective September 29, 2023, to amend and further extend the term to September 29, 2028.
At September 30, 2023, there were no borrowings under these committed revolving credit facilities, and the entire committed amounts were available for borrowing.In addition to the committed revolving credit facilities discussed above, PMI maintains certain short-term credit arrangements, including uncommitted credit lines, to primarily meet working capital needs. These credit arrangements amounted to approximately $2.6 billion at September 30, 2023, and approximately $1.9 billion at December 31, 2022. Borrowings under these arrangements and other bank loans amounted to $221 million at September 30, 2023, and $295 million at December 31, 2022.
XML 47 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Accumulated Other Comprehensive Losses:
 9 Months Ended
Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Accumulated Other Comprehensive Losses: Accumulated Other Comprehensive Losses:
PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:
(Losses) EarningsAtAtAt
(in millions)September 30, 2023December 31, 2022September 30, 2022
Currency translation adjustments$(8,475)$(8,003)$(7,055)
Pension and other benefits(1,757)(1,822)(2,654)
Derivatives accounted for as hedges415 266 421 
Total accumulated other comprehensive losses$(9,817)$(9,559)$(9,288)

Reclassifications from Other Comprehensive Earnings

The movements in accumulated other comprehensive losses and the related tax impact, for each of the components above, that are due to current period activity and reclassifications to the income statement, are shown on the condensed consolidated statements of comprehensive earnings for the nine months and three months ended September 30, 2023 and 2022. For additional information, see Note 2. Acquisitions (Transactions With Noncontrolling Interests) for disclosures related to currency translation adjustments, Note 5. Benefit Plans for disclosures related to PMI's pension and other benefits and Note 7. Financial Instruments for disclosures related to derivative financial instruments.
XML 48 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Related Parties - Equity Investments and Other:
 9 Months Ended
Sep. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Related Parties - Equity Investments and Other: Related Parties - Equity Investments and Other:
Equity Method Investments:

At September 30, 2023 and December 31, 2022, PMI had total equity method investments of $1,238 million and $1,000 million, respectively. Equity method investments are initially recorded at cost. Under the equity method of accounting, the investment is adjusted for PMI's proportionate share of earnings or losses, dividends, capital contributions, changes in ownership interests and movements in currency translation adjustments. The carrying value of our equity method investments at September 30, 2023 and December 31, 2022, exceeded our share of the investees' book value by $881 million and $750 million, respectively. The difference between the investment carrying value and the amount of underlying equity in net assets is mainly attributable to equity method goodwill, convertible debt instruments, and definite-lived intangible assets and other assets. The difference related to the definite-lived intangibles and other assets at September 30, 2023 and December 31, 2022 of $33 million and $35 million, respectively, is amortized on a straight-line basis and is included in Equity investments and securities (income)/loss, net on the condensed consolidated statements of earnings. At September 30, 2023 and December 31, 2022, PMI received year-to-date dividends from equity method investees of $57 million and $9 million, respectively.

PMI holds a 23% equity interest in Megapolis Distribution BV, the holding company of CJSC TK Megapolis, PMI's distributor in Russia (SSEA, CIS & MEA segment), which as of September 30, 2023 had a carrying value of $351 million. While as of September 30, 2023, there have been no impairment indicators based on the business’ performance, there are still risks related to this investment as the fair value of these assets is difficult to predict due to the volatility in foreign currency and commodity markets, supply chain, and current economic, political and social conditions. For more information, see Note 3. War in Ukraine. Additionally, there was approximately $588 million of cumulative foreign currency translation losses associated with Megapolis Distribution BV reflected in accumulated other comprehensive losses in the condensed consolidated statement of stockholders’ equity as of September 30, 2023.
PMI holds a 49% equity interest in United Arab Emirates-based Emirati Investors-TA (FZC) (“EITA”). PMI holds an approximate 25% economic interest in Société des Tabacs Algéro-Emiratie (“STAEM”), an Algerian joint venture that is 51% owned by EITA and 49% by the Algerian state-owned enterprise Management et Développement des Actifs et des Ressources Holding ("MADAR Holding"), which manufactures and distributes under license some of PMI’s brands (SSEA, CIS & MEA segment).

In April 2023, PMI increased its equity ownership and acquired 66.73% of Egyptian Investment Holding (“EIH”), a United Arab Emirates based company and as a result, acquired an approximate economic interest of 25% in United Tobacco Company ("UTC"). UTC is an entity incorporated in Egypt, which is 38% owned by EIH and manufactures products under license for Philip Morris Misr LCC (“PMM”), an entity incorporated in Egypt which is consolidated in PMI’s financial statements in the SSEA, CIS & MEA segment.

The initial investments in Megapolis Distribution BV, EITA and UTC have been recorded at cost and are included in equity investments on the consolidated balance sheets. Transactions between these equity method investees and PMI subsidiaries are considered to be related-party transactions and are included in the tables below.

Equity securities:

Following the deconsolidation of RBH on March 22, 2019, PMI recorded the continuing investment in RBH, PMI's wholly owned subsidiary in Canada, at fair value of $3,280 million at the date of deconsolidation, within equity investments. Transactions between PMI and RBH are considered to be related party transactions from the date of deconsolidation and are included in the tables below.

The fair value of PMI’s other equity securities, which have been classified within Level 1, was $378 million at September 30, 2023. Unrealized pre-tax gain (loss) of $52 million ($41 million net of tax) on these equity securities was recorded in equity investments and securities (income)/loss, net on the condensed consolidated statements of earnings for the nine months ended September 30, 2023.

Other related parties:

United Arab Emirates-based Trans-Emirates Trading and Investments (FZC) ("TTI") holds a 33% non-controlling interest in Philip Morris Misr LLC ("PMM"), an entity incorporated in Egypt which is consolidated in PMI’s financial statements in the SSEA, CIS & MEA segment. PMM sells, under license, PMI brands in Egypt through an exclusive distribution agreement with a local entity that is also controlled by TTI.

Godfrey Phillips India Ltd ("GPI") is one of the non-controlling interest holders in IPM India, which is a 56.3% owned PMI consolidated subsidiary in the SSEA, CIS & MEA segment. GPI also acts as contract manufacturer and distributor for IPM India.
Financial activity with the above related parties:

PMI’s net revenues and expenses with the above related parties were as follows:
For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Net revenues:
Megapolis Group$1,714 $1,770 $530 $777 
Other917 864 327 310 
Net revenues (a)
$2,631 $2,634 $857 $1,087 
Expenses:
Other$180 $62 $67 $33 
Expenses$180 $62 $67 $33 
(a) Net revenues exclude excise taxes and VAT billed to customers.

PMI’s balance sheet activity with the above related parties was as follows:
(in millions)At September 30, 2023
At December 31, 2022
Receivables:
Megapolis Group$394 $478 
Other261 210 
Receivables$655 $688 
Payables:
Other$33 $31 
Payables$33 $31 
The activities with the above related parties are in the ordinary course of business, and are primarily for distribution, service fees, contract manufacturing and license agreements. PMI eliminated its respective share of all significant intercompany transactions with the equity method investees.
XML 49 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Sale of Accounts Receivable:
 9 Months Ended
Sep. 30, 2023
Sale of Accounts Receivable [Abstract]  
Sale of Accounts Receivable: Sale of Accounts Receivable:
To mitigate risk and enhance cash and liquidity management, PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of September 30, 2023 and September 30, 2022. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions.

Cumulative trade receivables sold, including excise taxes, for the nine months ended September 30, 2023 and 2022, were $9.4 billion and $8.4 billion, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of September 30, 2023 and September 30, 2022, were $670 million, and $512 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference
between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the condensed consolidated statements of earnings.

The loss on sale of trade receivables was as follows:

(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023$37 $13 
2022$15 $7 
XML 50 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Product Warranty:
 9 Months Ended
Sep. 30, 2023
Guarantees and Product Warranties [Abstract]  
Product Warranty: Product Warranty:
PMI's heat-not-burn devices and e-vapor products are subject to standard product warranties generally for a period of 12 months from the date of purchase or such other periods as required by law. PMI generally provides in cost of sales for the estimated cost of warranty in the period the related revenue is recognized. PMI assesses the adequacy of its accrued product warranties and adjusts the amounts as necessary based on actual experience and changes in future estimates. Factors that affect product warranties may vary across markets but typically include device version mix, product failure rates, logistics and service delivery costs, and warranty policies. PMI accounts for its product warranties within other accrued liabilities. At September 30, 2023 and December 31, 2022, these amounts were as follows:
(in millions)As of and For the Nine Months Ended September 30, 2023As of and For the Year Ended December 31, 2022
Balance at beginning of period$104 $113 
Changes due to:
   Warranties issued55 107 
    Settlements (62)(114)
    Currency/Other(2)(2)
Balance at end of period$95 $104 
XML 51 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Asset Impairment and Exit Costs:
 9 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Asset Impairment and Exit Costs: Asset Impairment and Exit Costs:
For the nine months ended September 30, 2023, PMI recorded total pre-tax asset impairment and exit costs of $109 million related to restructuring activities. These pre-tax charges were included in marketing, administration and research costs in the condensed consolidated statements of earnings for the nine months ended September 30, 2023. For the three months ended September 30, 2023, PMI did not record such charges related to restructuring activities. For the nine months and three months ended September 30, 2022, PMI did not record any charges for asset impairment and exit costs related to restructuring activities.

For the nine months ended September 30, 2023, PMI recorded a pre-tax impairment charge on goodwill and other intangibles of $680 million within the Wellness and Healthcare segment. For the nine months and three months ended September 30, 2022, PMI recorded a pre-tax impairment charge on other intangibles of $112 million within the Wellness and Healthcare segment. For further details, see Note 6. Goodwill and Other Intangible Assets, net.

e-Vapor Products Manufacturing Optimization

In the first quarter of 2023, PMI initiated a project to fully outsource and restructure the manufacturing of e-vapor devices and consumables. As a result, PMI recorded pre-tax asset impairment and exit costs of $109 million. This amount included contract termination costs for suppliers of $78 million, including $21 million of embedded finance lease terminations, payable in cash. This amount also included asset impairment costs of $31 million, primarily related to machinery and equipment, which were non-cash charges.
Asset Impairment and Exit Costs by Segment

PMI recorded the following pre-tax asset impairment and exit costs by segment:

(in millions)For the Nine Months Ended September 30,
 2023
Contract termination charges:
Europe$35 
SSEA, CIS & MEA25 
EA, AU & PMI DF15 
Americas3 
Total contract termination charges78 
Asset impairment charges:
Europe14 
SSEA, CIS & MEA9 
EA, AU & PMI DF6 
Americas2 
Total asset impairment charges31 
Asset impairment and exit costs$109 

Movement in Exit Cost Liabilities

The movement in exit cost liabilities for the nine months ended September 30, 2023 was as follows:
(in millions) 
Liability balance, January 1, 2023$40 
Charges, net78 
Cash spent(74)
Currency/other(8)
Liability balance, September 30, 2023$36 
Future cash payments for exit costs incurred to date are anticipated to be substantially paid by the end of 2024, with approximately $6 million expected to be paid in the remainder of 2023.
XML 52 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Leases:
 9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Leases: Leases:
The components of PMI’s lease cost were as follows for the nine months and three months ended September 30, 2023 and 2022:
For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Operating lease cost$199 $187 $66 $61 
Finance lease cost:
Amortization of right-of-use assets37 60 9 13 
Interest on lease liabilities
1 — 1 — 
Short-term lease cost44 45 15 15 
Variable lease cost20 17 6 6 
Total lease cost$301 $309 $97 $95 
Leases: Leases:
The components of PMI’s lease cost were as follows for the nine months and three months ended September 30, 2023 and 2022:
For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Operating lease cost$199 $187 $66 $61 
Finance lease cost:
Amortization of right-of-use assets37 60 9 13 
Interest on lease liabilities
1 — 1 — 
Short-term lease cost44 45 15 15 
Variable lease cost20 17 6 6 
Total lease cost$301 $309 $97 $95 
XML 53 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Supply Chain Financing:
 9 Months Ended
Sep. 30, 2023
Payables and Accruals [Abstract]  
Supply Chain Financing: Supply Chain Financing: PMI has engaged with unaffiliated global financial institutions that offer a voluntary supply chain financing ("SCF") program to some of our suppliers. Under the SCF program, the suppliers may elect, at their sole discretion, to sell PMI's payment obligations to these financial institutions. The suppliers independently negotiate the sale arrangements directly with these financial institutions. PMI does not participate in these negotiations, nor does it have any economic interest in these agreements, or in the designated suppliers’ voluntary decision to sell PMI's payment obligations to these financial institutions. No guarantees or securities are provided by PMI or any of its subsidiaries under the SCF programs. PMI's obligations to its suppliers, including amounts due and scheduled payment terms are not impacted by the suppliers’ decision to sell amounts under the SCF program. The payment terms of PMI’s suppliers generally do not exceed 120 days. All outstanding payable amounts related to suppliers that are participating in the SCF program are recorded in accounts payable in PMI's condensed consolidated balance sheets. The associated payments are included in cash flows from operating activities within PMI's condensed consolidated statement of cash flows. As of September 30, 2023 and December 31, 2022, the total amount due to suppliers participating in the SCF program was approximately $0.8 billion and $1.1 billion, respectively.
XML 54 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Pay vs Performance Disclosure        
Net Income (Loss) Attributable to Parent $ 2,054 $ 2,087 $ 5,617 $ 6,651
XML 55 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 56 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Background and Basis of Presentation: (Policies)
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") and such principles are applied on a consistent basis. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S.GAAP have been omitted. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year.
Derivatives
PMI operates in markets primarily outside of the United States of America, with manufacturing and sales facilities in various locations around the world and is exposed to risks such as changes in foreign currency exchange rates and interest rates. As a result, PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options (collectively referred to as "foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in foreign currency exchange and interest rates related to net investments in foreign operations, third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Euro, Egyptian pound, Indonesian rupiah, Japanese yen, Mexican peso, Philippine peso, Russian ruble and Swiss franc.

Additionally, certain materials that PMI uses in the manufacturing of its products are exposed to market price risks. PMI uses commodity derivative contracts (“commodity contracts") to manage its exposure to the market price volatility of certain commodity components of these materials.
These foreign exchange contracts, interest rate contracts and commodity contracts are collectively referred to as "derivative contracts". PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Substantially all of PMI's derivative financial instruments are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. While these contracts contain the enforceable right to offset through close-out netting rights, PMI elects to present them on a gross basis in the consolidated balance sheets. Collateral associated with these arrangements is in the form of cash and is unrestricted. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings.
Fair Value of Financial Instruments PMI assesses the fair value of its derivative contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts, foreign currency swaps and interest rate contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates.
XML 57 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions: (Tables)
 9 Months Ended
Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule of business acquisitions, by acquisition
(in millions)
Recognized as of the acquisition dateMeasurement Period AdjustmentsRecognized as of September 30, 2023
Cash and cash equivalents$484 $— $484 
Trade receivables135 — 135 
Other receivables53 — 53 
Inventories444 (7)437 
Other current assets524 (109)415 
Property, plant and equipment627 50 677 
Other intangible assets 4,512 3,289 7,801 
Other non-current assets214 4 218 
Current portion of long-term debt224 — 224 
Accounts payable120 — 120 
Other current liabilities531 1 532 
Income taxes 14 — 14 
Long-term debt1,126 (5)1,121 
Deferred income taxes 1,253 836 2,089 
Other non-current liabilities187 9 196 
Identifiable net assets acquired3,538 2,386 5,924 
Noncontrolling interest2,379 — 2,379 
Goodwill 13,301 (2,386)10,915 
Total consideration transferred$14,460 $— $14,460 
Identifiable intangible assets of Swedish Match consist of:
Type Useful LifeEstimated Fair Value (in millions)
TrademarksNon-amortizable$3,133 
TrademarksAmortizable
20 - 30 years
1,067 
Developed technology, including patents10 years113 
Customer relationships
6 - 15 years
3,488 
Total identifiable intangible assets$7,801 
The unaudited pro forma financial information is as follows:
For the Years Ended December 31,
(in millions)20222021
Net revenues$33,579 $33,488 
Net earnings attributable to PMI$8,788 $8,495 
XML 58 R35.htm IDEA: XBRL DOCUMENT v3.23.3
War in Ukraine: (Tables)
 9 Months Ended
Sep. 30, 2023
Unusual or Infrequent Items, or Both [Abstract]  
Schedule of pretax charges related to circumstances PMI recorded in its condensed consolidated statements of earnings pre-tax charges related to circumstances driven by the war as follows:
(in millions)For the Nine Months Ended September 30, 2023For the Nine Months Ended September 30, 2022
Cost of salesMarketing, administration and research costsTotalCost of salesMarketing, administration and research costsTotal
Ukraine 1
$11 $8 $19 $28 $31 $59 
Russia 2
— — — 18 51 69 
Total$11 $8 $19 $46 $82 $128 
1 The 2023 pre-tax charges were primarily due to the cost of PMI’s humanitarian efforts, which includes salary continuation for its employees. The 2022 pre-tax charges were primarily due to an inventory write-down, additional allowance for receivables and the cost of PMI’s humanitarian efforts, which includes salary continuation for its employees.
2 The pre-tax charges were primarily due to machinery and inventory write downs related to the commercial decisions noted above.

(in millions)For the Three Months Ended September 30, 2023For the Three Months Ended September 30, 2022
Cost of salesMarketing, administration and research costsTotalCost of salesMarketing, administration and research costsTotal
Ukraine 1
$11 $8 $19 $3 $5 $8 
Russia — — — (3)1 (2)
Total$11 $8 $19 $— $6 $6 
1 The pre-tax charges were primarily due to PMI’s humanitarian efforts, which includes salary continuation for its employees.
XML 59 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Plans: (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Disclosure of share-based compensation arrangements by payment award
During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the weighted-average grant date fair value per share related to RSU awards were as follows:
Number of
Shares
Granted		Weighted-Average Grant Date Fair Value Per RSU Award Granted
20231,756,750 $ 101.96 
20221,579,680 $  104.96 

Compensation expense related to RSU awards was as follows:
Compensation Expense Related to RSU Awards
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023$ 124 $ 38 
2022$ 109 $ 35 
During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the grant date fair value per share related to PSU awards were as follows:
Number of Shares GrantedWeighted-
Average PSU Grant Date 
Fair Value Subject to Other Performance Factors 		Weighted-
Average PSU Grant Date 
Fair Value Subject to TSR Performance Factors
(Per Share)(Per Share)
2023482,360 $ 102.02 $ 133.54 
2022451,790 $  105.07 $ 143.94 
Compensation expense related to PSU awards was as follows:
Compensation Expense Related to PSU Awards
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023$ 51 $ 6 
2022$  44 $  13 
Schedule of assumptions used to determine the grant date fair value of the PSU awards subject to the TSR performance metric The following assumptions were used to determine the grant date fair value of the PSU awards subject to the TSR performance factor:
20232022
Average risk-free interest rate (a)
4.1 %1.6 %
Average expected volatility (b)
24.3 %28.6 %
(a) Based on the U.S. Treasury yield curve.
(b) Determined using the observed historical volatility.
XML 60 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Benefit Plans: (Tables)
 9 Months Ended
Sep. 30, 2023
Retirement Benefits [Abstract]  
Components of pension and other employee benefit costs
Pension and other employee benefit costs per the condensed consolidated statements of earnings consisted of the following:
 For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Net pension costs (income)$(61)$(71)$(24)$(22)
Net postemployment costs88 81 29 27 
Net postretirement costs9 6 3 2 
Total pension and other employee benefit costs$36 $16 $8 $7 
Components of net periodic benefit cost
Net periodic pension cost consisted of the following:
 
Pension (1)
 For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Service cost$130 $176 $45 $57 
Interest cost193 58 64 20 
Expected return on plan assets(273)(267)(92)(87)
Amortization:
Net loss21 139 5 45 
Prior service cost (credit)(2)(1)(1)— 
Net periodic pension cost$69 $105 $21 $35 
(1) Primarily non-U.S. based defined benefit retirement plans.
XML 61 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets, net: (Tables)
 9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of movements in goodwill
The movements in goodwill were as follows:
(in millions)Europe
SSEA, CIS & MEA
EA, AU & PMI DF
AmericasSwedish MatchWellness & HealthcareTotal
Balances at December 31, 2022$1,370 $2,869 $493 $615 $13,296 $1,012 $19,655 
Changes due to:
Impairment— — — — — (665)(665)
Currency(13)(34)(9)57 (121)25 (95)
Measurement period adjustments— — — — (2,386)— (2,386)
Balances, September 30, 2023$1,357 $2,835 $484 $672 $10,789 $372 $16,509 
Schedule of amortizable intangible assets
Details of other intangible assets were as follows:
September 30, 2023December 31, 2022
(in millions)Weighted-Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationNetGross Carrying AmountAccumulated AmortizationNet
Non-amortizable intangible assets$4,416 $4,416 $3,346 $3,346 
Amortizable intangible assets:
Trademarks16 years2,158 $740 1,418 2,050 $674 1,376 
Developed technology, including patents7 years718 290 428 975 243 732 
Customer relationships and other12 years3,667 350 3,317 1,390 112 1,278 
Total other intangible assets$10,959 $1,380 $9,579 $7,761 $1,029 $6,732 
Schedule of non-amortizable intangible assets
Details of other intangible assets were as follows:
September 30, 2023December 31, 2022
(in millions)Weighted-Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationNetGross Carrying AmountAccumulated AmortizationNet
Non-amortizable intangible assets$4,416 $4,416 $3,346 $3,346 
Amortizable intangible assets:
Trademarks16 years2,158 $740 1,418 2,050 $674 1,376 
Developed technology, including patents7 years718 290 428 975 243 732 
Customer relationships and other12 years3,667 350 3,317 1,390 112 1,278 
Total other intangible assets$10,959 $1,380 $9,579 $7,761 $1,029 $6,732 
XML 62 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Instruments: (Tables)
 9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of notional amounts of outstanding derivative positions
The gross notional amounts for outstanding derivatives at the end of each period were as follows:
(in millions)At September 30, 2023At December 31, 2022
Derivative contracts designated as hedging instruments:
Foreign exchange contracts$18,256 $17,627 
Interest rate contracts1,000 1,019 
Commodity contracts27 — 
Derivative contracts not designated as hedging instruments:
Foreign exchange contracts17,818 21,755 
Total$37,101 $40,401 
Fair value of derivative contracts
The fair value of PMI’s derivative contracts included in the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022, were as follows:
 Derivative AssetsDerivative Liabilities
 Fair ValueFair Value
AtAtAtAt
(in millions)Balance Sheet ClassificationSeptember 30, 2023December 31, 2022Balance Sheet ClassificationSeptember 30, 2023December 31, 2022
Derivative contracts designated as hedging instruments:
Foreign exchange contractsOther current assets$472 $376 Other accrued liabilities$126 $126 
Other assets386 341 Income taxes and other liabilities56 147 
Interest rate contractsOther current assets— — Other accrued liabilities40 27 
Other assets— — Income taxes and other liabilities50 56 
Commodity contractsOther current assets— — Other accrued liabilities2 — 
Derivative contracts not designated as hedging instruments:
Foreign exchange contracts
Other current assets 
241 156 Other accrued liabilities87 165 
Other assets— — Income taxes and other liabilities42 16 
Total gross amount derivatives contracts presented in the condensed consolidated balance sheets $1,099 $873  $403 $537 
Gross amounts not offset in the condensed consolidated balance sheets
Financial instruments(292)(346)(292)(346)
Cash collateral received/pledged(566)(341)(60)(48)
Net amount$241 $186 $51 $143 
Derivative contracts impact on the condensed consolidated statements of earnings and other comprehensive earnings
For the nine months ended September 30, 2023 and 2022, PMI's derivative contracts impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:
(pre-tax, in millions)For the Nine Months Ended September 30,
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on DerivativesStatement of Earnings
Classification of Gain/(Loss)
on Derivatives		Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into EarningsAmount of Gain/(Loss) Recognized in Earnings
202320222023202220232022
Derivative contracts designated as hedging instruments:
Cash flow hedges:
Foreign exchange contracts$290 $325 Net revenues$112 $151 
Cost of sales— — 
Marketing, administration and research costs52 (17)
Interest expense, net(13)(5)
Interest rate contracts72 304 Interest expense, net34 (5)
Commodity contracts(2)— Cost of sales— — 
Fair value hedges:
Interest rate contracts
Interest expense, net (a)
$(24)$(81)
Net investment hedges (b):
Foreign exchange contracts14 1,088 
Interest expense, net (c)
200 116 
Derivative contracts not designated as hedging instruments:
Foreign exchange contractsInterest expense, net212 56 
Marketing, administration and research costs (d)
154 (160)
Total$374 $1,717 $185 $124 $542 $(69)
(a) The gains (losses) from these contracts are offset by the changes in the fair value of the hedged item
(b) Amount of gains (losses) on hedges of net investments principally related to changes in exchange and interest rates between the Euro and U.S. dollar
(c) Represent the gains for amounts excluded from the effectiveness testing
(d) The gains (losses) from these contracts attributable to changes in foreign currency exchange rates are partially offset by the (losses) and gains generated by the underlying intercompany and third-party loans being hedged
For the three months ended September 30, 2023 and 2022, PMI's derivative contracts impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:
(pre-tax, in millions)For the Three Months Ended September 30,
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on DerivativesStatement of Earnings
Classification of Gain/(Loss)
on Derivatives		Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into EarningsAmount of Gain/(Loss) Recognized in Earnings
202320222023202220232022
Derivative contracts designated as hedging instruments:
Cash flow hedges:
Foreign exchange contracts$67 $77 Net revenues$73 $70 
Cost of sales— — 
Marketing, administration and research costs(19)(7)
Interest expense, net(7)(2)
Interest rate contracts— 197 Interest expense, net12 (1)
Commodity contracts(1)— Cost of sales— — 
Fair value hedges:
Interest rate contracts
Interest expense, net (a)
$(10)$(24)
Net investment hedges (b):
Foreign exchange contracts453 558 
Interest expense, net (c)
73 48 
Derivative contracts not designated as hedging instruments:
Foreign exchange contractsInterest expense, net60 13 
Marketing, administration and research costs (d)
258 (225)
Total$519 $832 $59 $60 $381 $(188)
(a) The gains (losses) from these contracts are offset by the changes in the fair value of the hedged item
(b) Amount of gains (losses) on hedges of net investments principally related to changes in exchange and interest rates between the Euro and U.S. dollar
(c) Represent the gains for amounts excluded from the effectiveness testing
(d) The gains (losses) from these contracts attributable to changes in foreign currency exchange rates are partially offset by the (losses) and gains generated by the underlying intercompany and third-party loans being hedged
Qualifying hedging activity reported in accumulated other comprehensive earnings (losses), net of income taxes Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
 2023202220232022
Gain/(loss) as of beginning of period,$266 $4 $408 $250 
Derivative (gains)/losses transferred to earnings(155)(106)(51)(51)
Change in fair value304 523 58 222 
Gain/(loss) as of September 30,$415 $421 $415 $421 
XML 63 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share: (Tables)
 9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Calculation of basic and diluted EPS
Basic and diluted earnings per share (“EPS”) were calculated using the following:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
 2023202220232022
Net earnings attributable to PMI$5,617 $6,651 $2,054 $2,087 
Less distributed and undistributed earnings attributable to share-based payment awards
17 18 6 5 
Net earnings for basic and diluted EPS$5,600 $6,633 $2,048 $2,082 
Weighted-average shares for basic EPS1,552 1,550 1,552 1,550 
Plus contingently issuable performance stock units (PSUs)(1)
1 2 2 2 
Weighted-average shares for diluted EPS1,553 1,552 1,554 1,552 
(1) Including rounding adjustment
XML 64 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Reporting: (Tables)
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Segment data
Segment data were as follows:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023202220232022
Net revenues:
Europe$9,984 $9,805 $3,672 $3,272 
SSEA, CIS & MEA
7,922 7,781 2,777 2,822 
EA, AU & PMI DF
4,771 4,458 1,571 1,407 
Americas1,399 1,367 478 474 
Swedish Match1,814 — 568 — 
Wellness and Healthcare237 199 75 57 
Net revenues$26,127 $23,610 $9,141 $8,032 
Operating income (loss):
Europe$4,446 $4,447 $1,708 $1,415 
SSEA, CIS & MEA
2,371 3,009 801 1,086 
EA, AU & PMI DF
1,920 1,746 753 533 
Americas141 336 5 85 
Swedish Match597 — 140 — 
Wellness and Healthcare(808)(216)(37)(151)
Operating income$8,667 $9,322 $3,370 $2,968 
PMI's net revenues by product category were as follows:
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023202220232022
Net revenues:
Combustible tobacco products:
Europe$6,084 $5,996 $2,160 $1,996 
SSEA, CIS & MEA
6,988 6,852 2,485 2,454 
EA, AU & PMI DF
2,091 2,214 678 692 
Americas1,349 1,296 460 450 
Swedish Match333 — 49 — 
Total combustible tobacco products16,845 16,358 5,832 5,591 
Smoke-free products:
Smoke-free products excluding Wellness and Healthcare:
Europe3,900 3,809 1,512 1,276 
SSEA, CIS & MEA
934 929 292 368 
EA, AU & PMI DF
2,680 2,244 893 715 
Americas50 71 18 24 
Swedish Match1,481 — 519 — 
Total smoke-free products excluding Wellness and Healthcare9,045 7,053 3,234 2,384 
Wellness and Healthcare237 199 75 57 
Total smoke-free products9,282 7,252 3,309 2,441 
Total PMI net revenues$26,127 $23,610 $9,141 $8,032 
Note: Sum of product categories or Regions might not foot to total PMI due to roundings.
XML 65 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies: (Tables)
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Schedule of tobacco related cases pertaining to combustible products pending against company
The table below lists the number of tobacco-related cases pertaining to combustible products pending against us and/or our subsidiaries or indemnitees as of September 30, 2023, and September 30, 2022:

Type of Case1
Number of Cases Pending as of September 30, 2023Number of Cases Pending as of September 30, 2022
Individual Smoking and Health Cases4838
Smoking and Health Class Actions99
Health Care Cost Recovery Actions1717
Label-Related Class Actions——
Individual Label-Related Cases56
Public Civil Actions11
______
¹ Includes cases pending in Canada.
Schedule of verdicts and significant post trial developments where a verdict was returned in favor of the plaintiff(s)
The table below lists the verdict and significant post-trial developments in the five pending cases where a verdict was returned in favor of the plaintiff:
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
May 27, 2015  Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais
  Class Action  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.3 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.26 billion)). The trial court awarded CAD 90,000 (approximately $66,000) in punitive damages, allocating CAD 30,000 (approximately $22,000) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $729 million) of the compensatory damage award, CAD 200 million (approximately $146 million) of which is our subsidiary’s portion, into a trust within 60 days.
  
In June 2015, RBH commenced the appellate process with the Court of Appeal of Quebec. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court's decision. (See “Stayed Litigation — Canada” for further detail.)
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
May 27, 2015  Canada/Cecilia Létourneau
  Class Action  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $96 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to RBH. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.
  
In June 2015, RBH commenced the appellate process with the Court of Appeal of Quebec. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court's decision. (See “Stayed Litigation — Canada” for further detail.)
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
August 5, 2016Argentina/Hugo LespadaIndividual Action
On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $314), plus interest, in compensatory and moral damages. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.
On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On May 17, 2021, plaintiff filed a federal extraordinary appeal. On November 1, 2021, the Supreme Court of the Province of Buenos Aires dismissed plaintiff's federal extraordinary appeal. On November 10, 2021, plaintiff filed a direct appeal before the Federal Supreme Court.
Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
June 17, 2021Argentina/Claudia MilanoIndividual Action
On June 17, 2021, the Civil Court No. 9 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded her smoking cessation treatments, ARS 150,000 (approximately $429), in compensatory and moral damages, and ARS 4,000,000 (approximately $11,435) in punitive damages, plus interest and costs. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.
On July 2, 2021, our subsidiary filed its notice of appeal. In addition, plaintiff filed an appeal challenging the dismissal of the claim for psychological damages. As required by local law, our subsidiary deposited the damages awarded, plus interest and costs, in total ARS 6,114,428 (approximately $17,479), into a court escrow account. Our subsidiary challenged the amount determined by the court. The Civil and Commercial Court of Appeals of Mar del Plata granted our subsidiary's challenge to the escrow amount determined by the trial court. As a result, on December 16, 2021, ARS 893,428 (approximately $2,554) was returned to our subsidiary. If our subsidiary ultimately prevails, the remaining deposited amounts will be returned to our subsidiary. On May 31, 2022, the Civil and Commercial Court of Appeals of Mar del Plata ruled that the statute of limitations barred plaintiff's claim and reversed the trial court's decision. On June 15, 2022, plaintiff filed an extraordinary appeal.

Date  Location of
Court/Name of
Plaintiff		  Type of
Case		  Verdict  Post-Trial
Developments
June 23, 2023Turkey/ Senem YilmazelIndividual Action
On June 23, 2023, the Ankara Consumer Court published its decision in favor of plaintiff, the daughter of an individual smoker, against our subsidiary and a BAT subsidiary, awarding her TRY 10,000 (approximately $357) in damages. The trial court found that the plaintiff’s father died as a result of lung cancer and COPD caused by his cigarette consumption.
On September 8, 2023, our subsidiary filed its appeal. On September 25, 2023, the plaintiff filed an appeal challenging the damages amount determined by the court.
XML 66 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Indebtedness: (Tables)
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Schedule of short-term debt
At September 30, 2023 and December 31, 2022, PMI’s short-term borrowings and related average interest rates consisted of the following:
September 30, 2023December 31, 2022
(in millions)Amount OutstandingAverage RateAmount OutstandingAverage Rate
Commercial paper
$1,928 5.5 %$912 4.4 %
Bank loans
221 9.0 295 7.5 
U.S. dollar credit facility borrowings related to Swedish Match AB acquisition— — 4,430 4.9 
$2,149 $5,637 
Long-term debt
At September 30, 2023 and December 31, 2022, PMI’s long-term debt consisted of the following:

(in millions)September 30, 2023December 31, 2022
U.S. dollar notes, 0.875% to 6.375% (average interest rate 4.433%), due through 2044
$30,733 $22,596 
Foreign currency obligations:
Euro notes, 0.125% to 3.125% (average interest rate 1.877%), due through 2039
8,069 8,116 
Swiss franc note, 1.625%, due 2024
272 378 
Euro credit facility borrowings related to Swedish Match AB acquisition, (average interest rate 4.265%), due through 2027
5,797 5,850 
Swedish krona notes, 1.395% to 5.762% (average interest rate 2.357%), due through 2029
234 343
Other (average interest rate 6.156%), due through 2031 (a)
461 203 
Carrying value of long-term debt45,566 37,486 
Less current portion of long-term debt2,652 2,611 
 $42,914 $34,875 
(a) Includes long-term bank loans at subsidiaries, as well as $40 million and $54 million in finance leases at September 30, 2023 and December 31, 2022, respectively.
Aggregate fair values of PMI's debt, excluding finance leases At September 30, 2023, the fair value of PMI's outstanding long-term debt, excluding the aforementioned finance leases, was as follows:
(in millions)
September 30, 2023
Level 1$36,217 
Level 26,356 
Schedule of debt issuances during current period
PMI's debt issuances in the first nine months of 2023 were as follows:
(in millions)
TypeFace Value Interest RateIssuanceMaturity
U.S. dollar notes
(a)
$1,2504.875%February 2023February 2026
U.S. dollar notes
(a)
$1,0004.875%February 2023February 2028
U.S. dollar notes
(a)
$1,5005.125%February 2023February 2030
U.S. dollar notes
(a)
$1,5005.375%February 2023February 2033
U.S. dollar notes(a) (b)$4504.875%May 2023February 2026
U.S. dollar notes(a) (c)$5504.875%May 2023February 2028
U.S. dollar notes(a) (d)$7005.125%May 2023February 2030
U.S. dollar notes(a) (e)$7505.375%May 2023February 2033
U.S. dollar notes(f)$6505.250%September 2023September 2028
U.S. dollar notes(f)$7005.500%September 2023September 2030
U.S. dollar notes(f)$1,0005.625%September 2023September 2033
(a) Interest is payable semi-annually, commencing in August 2023
(b) These notes are a further issuance of the 4.875% notes issued in February 2023
(c) These notes are a further issuance of the 4.875% notes issued in February 2023
(d) These notes are a further issuance of the 5.125% notes issued in February 2023
(e) These notes are a further issuance of the 5.375% notes issued in February 2023
(f) Interest is payable semi-annually, commencing in March 2024
Schedule of committed credit facilities
At September 30, 2023, PMI's total committed revolving credit facilities were as follows:

(in billions)


Type
Committed
Revolving Credit
Facilities
364-day revolving credit, expiring January 30, 2024
$1.8 
Multi-year revolving credit, expiring February 10, 2026 (1)
2.0 
Multi-year revolving credit, expiring September 29, 2026 (2) (3)
2.5 
Total facilities
$6.3 
(1) On January 28, 2022, PMI entered into an agreement, effective February 10, 2022, to amend and extend the term of its $2.0 billion multi-year revolving credit facility, for an additional year covering the period February 11, 2026 to February 10, 2027, in the amount of $1.9 billion.
(2) Includes pricing adjustments that may result in the reduction or increase in both the interest rate and commitment fee under the credit agreement if PMI achieves, or fails to achieve, certain specified targets.
(3) On September 20, 2022, PMI entered into an agreement, effective September 29, 2022, to amend and extend the term of its $2.5 billion multi-year revolving credit facility, for an additional year covering the period September 30, 2026 to September 29, 2027, in the amount of $2.3 billion. On September 20, 2023, PMI entered into an agreement, effective September 29, 2023, to amend and further extend the term to September 29, 2028.
XML 67 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Accumulated Other Comprehensive Losses: (Tables)
 9 Months Ended
Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Components of accumulated other comprehensive earnings (losses), net of taxes
PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:
(Losses) EarningsAtAtAt
(in millions)September 30, 2023December 31, 2022September 30, 2022
Currency translation adjustments$(8,475)$(8,003)$(7,055)
Pension and other benefits(1,757)(1,822)(2,654)
Derivatives accounted for as hedges415 266 421 
Total accumulated other comprehensive losses$(9,817)$(9,559)$(9,288)
XML 68 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Related Parties - Equity Investments and Other: (Tables)
 9 Months Ended
Sep. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Earnings and balance sheet activities with related parties - equity investments and other
PMI’s net revenues and expenses with the above related parties were as follows:
For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Net revenues:
Megapolis Group$1,714 $1,770 $530 $777 
Other917 864 327 310 
Net revenues (a)
$2,631 $2,634 $857 $1,087 
Expenses:
Other$180 $62 $67 $33 
Expenses$180 $62 $67 $33 
(a) Net revenues exclude excise taxes and VAT billed to customers.

PMI’s balance sheet activity with the above related parties was as follows:
(in millions)At September 30, 2023
At December 31, 2022
Receivables:
Megapolis Group$394 $478 
Other261 210 
Receivables$655 $688 
Payables:
Other$33 $31 
Payables$33 $31 
XML 69 R46.htm IDEA: XBRL DOCUMENT v3.23.3
Receivables, Loans, Notes Receivable, and Others (Tables)
 9 Months Ended
Sep. 30, 2023
Receivables [Abstract]  
Loss on sale of trade receivables
The loss on sale of trade receivables was as follows:

(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023$37 $13 
2022$15 $7 
XML 70 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Product Warranty: (Tables)
 9 Months Ended
Sep. 30, 2023
Guarantees and Product Warranties [Abstract]  
Schedule of accrued product warranties At September 30, 2023 and December 31, 2022, these amounts were as follows:
(in millions)As of and For the Nine Months Ended September 30, 2023As of and For the Year Ended December 31, 2022
Balance at beginning of period$104 $113 
Changes due to:
   Warranties issued55 107 
    Settlements (62)(114)
    Currency/Other(2)(2)
Balance at end of period$95 $104 
XML 71 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Asset Impairment and Exit Costs: (Tables)
 9 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Pre-tax asset impairment and exit costs by segment
PMI recorded the following pre-tax asset impairment and exit costs by segment:

(in millions)For the Nine Months Ended September 30,
 2023
Contract termination charges:
Europe$35 
SSEA, CIS & MEA25 
EA, AU & PMI DF15 
Americas3 
Total contract termination charges78 
Asset impairment charges:
Europe14 
SSEA, CIS & MEA9 
EA, AU & PMI DF6 
Americas2 
Total asset impairment charges31 
Asset impairment and exit costs$109 
Movement in exit cost liabilities
The movement in exit cost liabilities for the nine months ended September 30, 2023 was as follows:
(in millions) 
Liability balance, January 1, 2023$40 
Charges, net78 
Cash spent(74)
Currency/other(8)
Liability balance, September 30, 2023$36 
XML 72 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Leases: (Tables)
 9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Lease cost components
The components of PMI’s lease cost were as follows for the nine months and three months ended September 30, 2023 and 2022:
For the Nine Months Ended September 30,For the Three Months Ended September 30,
(in millions)2023202220232022
Operating lease cost$199 $187 $66 $61 
Finance lease cost:
Amortization of right-of-use assets37 60 9 13 
Interest on lease liabilities
1 — 1 — 
Short-term lease cost44 45 15 15 
Variable lease cost20 17 6 6 
Total lease cost$301 $309 $97 $95 
XML 73 R50.htm IDEA: XBRL DOCUMENT v3.23.3
Background and Basis of Presentation: (Narrative) (Details) - segment
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Geographical Segment    
Product Information [Line Items]    
Number of reportable segments 4 6
XML 74 R51.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions: (Details)
$ in Millions
 1 Months Ended 2 Months Ended 3 Months Ended 5 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
Sep. 12, 2023
kr / shares
Nov. 11, 2022
USD ($)
Jan. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2023
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Jul. 14, 2023
USD ($)
Feb. 17, 2023
Oct. 20, 2022
USD ($)
Business Acquisition [Line Items]                              
Purchase of subsidiary shares from noncontrolling interests (Note 2)                   $ 211          
Proceeds from sale of holdings       $ 258                      
Additional Paid-in Capital                              
Business Acquisition [Line Items]                              
Purchase of subsidiary shares from noncontrolling interests (Note 2)             $ 30     30          
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 2)       36                      
Accumulated Other Comprehensive Losses                              
Business Acquisition [Line Items]                              
Purchase of subsidiary shares from noncontrolling interests (Note 2)             $ 171     171          
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 2)       $ 179                      
Altria Group                              
Business Acquisition [Line Items]                              
Commercial agreement, initial payment                             $ 1,000
Commercial agreement, remaining payment                         $ 1,700   $ 1,700
Commercial agreement, interest rate                             6.00%
Commercial agreement, total cash consideration                             $ 2,700
Noncontrolling Interest Purchase Philip Morris Tütün Mamulleri Sanayi ve Ticaret A.Ş.                              
Business Acquisition [Line Items]                              
Interest acquired (as a percent)             25.00%                
Noncontrolling Interest Purchase Philip Morris Pazarlama ve Satış A.Ş.                              
Business Acquisition [Line Items]                              
Interest acquired (as a percent)             24.75%                
Noncontrolling interest purchase                              
Business Acquisition [Line Items]                              
Payments to acquire noncontrolling interests             $ 223                
Ownership percentage             100.00%                
Swedish Match AB                              
Business Acquisition [Line Items]                              
Interest acquired (as a percent)     85.87%   94.81% 94.81%         94.81%     100.00%  
Payments to acquire noncontrolling interests     $ 14,460                        
Other acquisitions, net of acquired cash     13,976                        
Payments to acquire additional noncontrolling interests         $ 1,495       $ 883 $ 0          
Final redemption price (in usd per share) | kr / shares   kr 115.07                          
Business combination fair value adjustment to inventories           $ 125   $ 146 $ 18            
Business combination fair value adjustment to debt     (107)                        
Net revenues         316                    
Net earnings attributable to PMI         (26)                    
Acquisition related costs                     $ 59        
Issuance of debt costs         $ 54 $ 54         54        
Capitalized at acquisition date     $ 37                        
Swedish Match AB | Developed technology, including patents                              
Business Acquisition [Line Items]                              
Acquired intangible assets, estimated useful life 10 years                            
Finite-lived intangible assets $ 113                            
Swedish Match AB | Trademarks                              
Business Acquisition [Line Items]                              
Trademark acquired $ 3,133                            
PMI and Swedish Match | Pro Forma                              
Business Acquisition [Line Items]                              
Deferred income taxes and tax credits                     $ 430 $ 321      
XML 75 R52.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions: (Swedish Match AB) (Details) - USD ($)
$ in Millions
 9 Months Ended 11 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Sep. 30, 2023
Dec. 31, 2022
Nov. 11, 2022
Net assets acquired based on fair values:          
Goodwill $ 16,509 $ 16,509 $ 16,509 $ 19,655  
Measurement Period Adjustments          
Goodwill   (2,386)      
Swedish Match AB          
Net assets acquired based on fair values:          
Cash and cash equivalents 484 484 484   $ 484
Trade receivables 135 135 135   135
Other receivables 53 53 53   53
Inventories 437 437 437   444
Other current assets 415 415 415   524
Property, plant and equipment 677 677 677   627
Other intangible assets 7,801 7,801 7,801   4,512
Other non-current assets 218 218 218   214
Current portion of long-term debt 224 224 224   224
Accounts payable 120 120 120   120
Other current liabilities 532 532 532   531
Income taxes 14 14 14   14
Long-term debt 1,121 1,121 1,121   1,126
Deferred income taxes 2,089 2,089 2,089   1,253
Other non-current liabilities 196 196 196   187
Identifiable net assets acquired 5,924 5,924 5,924   3,538
Noncontrolling interest 2,379 2,379 2,379   2,379
Goodwill 10,915 10,915 10,915   13,301
Total consideration transferred 14,460 $ 14,460 14,460   $ 14,460
Measurement Period Adjustments          
Cash and cash equivalents     0    
Trade receivables     0    
Other receivables     0    
Inventories     (7)    
Other current assets     (109)    
Property, plant and equipment     50    
Other intangible assets     3,289    
Other non-current assets     4    
Current portion of long-term debt     0    
Accounts payable     0    
Other current liabilities     1    
Income taxes     0    
Long-term debt     (5)    
Deferred income taxes     836    
Other non-current liabilities     9    
Identifiable net assets acquired     2,386    
Noncontrolling interest     0    
Goodwill     (2,386)    
Total consideration transferred     $ 0    
Swedish Match AB | Trademarks          
Measurement Period Adjustments          
Trademark acquired 3,133        
Swedish Match AB | Trademarks          
Measurement Period Adjustments          
Finite-lived intangible assets $ 1,067        
Swedish Match AB | Trademarks | Minimum          
Measurement Period Adjustments          
Acquired intangible assets, estimated useful life 20 years        
Swedish Match AB | Trademarks | Maximum          
Measurement Period Adjustments          
Acquired intangible assets, estimated useful life 30 years        
Swedish Match AB | Developed technology, including patents          
Measurement Period Adjustments          
Acquired intangible assets, estimated useful life 10 years        
Finite-lived intangible assets $ 113        
Swedish Match AB | Customer relationships          
Measurement Period Adjustments          
Finite-lived intangible assets $ 3,488        
Swedish Match AB | Customer relationships | Minimum          
Measurement Period Adjustments          
Acquired intangible assets, estimated useful life 6 years        
Swedish Match AB | Customer relationships | Maximum          
Measurement Period Adjustments          
Acquired intangible assets, estimated useful life 15 years        
XML 76 R53.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions: (Pro Forma) (Details) - PMI and Swedish Match - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]    
Net revenues $ 33,579 $ 33,488
Net earnings attributable to PMI $ 8,788 $ 8,495
XML 77 R54.htm IDEA: XBRL DOCUMENT v3.23.3
War in Ukraine: Narrative (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Unusual or Infrequent Item, or Both [Line Items]    
Total assets $ 62,927 $ 61,681
Inventories 9,645 9,886
Goodwill 16,509 $ 19,655
Ukraine | War In Ukraine    
Unusual or Infrequent Item, or Both [Line Items]    
Total assets 500  
Receivables 82  
Inventories 350  
Property, plant and equipment 28  
Russia | War In Ukraine    
Unusual or Infrequent Item, or Both [Line Items]    
Total assets 2,400  
Receivables 411  
Inventories 838  
Property, plant and equipment 242  
Cash 677  
Goodwill 158  
Cumulative foreign currency translation losses $ 1,343  
XML 78 R55.htm IDEA: XBRL DOCUMENT v3.23.3
War in Ukraine: Pretax Charges (Details) - War In Ukraine - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Unusual or Infrequent Item, or Both [Line Items]        
Pre-tax charge $ 19 $ 6 $ 19 $ 128
Cost of sales        
Unusual or Infrequent Item, or Both [Line Items]        
Pre-tax charge 11 0 11 46
Marketing, administration and research costs        
Unusual or Infrequent Item, or Both [Line Items]        
Pre-tax charge 8 6 8 82
Ukraine        
Unusual or Infrequent Item, or Both [Line Items]        
Pre-tax charge 19 8 19 59
Ukraine | Cost of sales        
Unusual or Infrequent Item, or Both [Line Items]        
Pre-tax charge 11 3 11 28
Ukraine | Marketing, administration and research costs        
Unusual or Infrequent Item, or Both [Line Items]        
Pre-tax charge 8 5 8 31
Russia        
Unusual or Infrequent Item, or Both [Line Items]        
Pre-tax charge 0 (2) 0 69
Russia | Cost of sales        
Unusual or Infrequent Item, or Both [Line Items]        
Pre-tax charge 0 (3) 0 18
Russia | Marketing, administration and research costs        
Unusual or Infrequent Item, or Both [Line Items]        
Pre-tax charge $ 0 $ 1 $ 0 $ 51
XML 79 R56.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Plans: (Additional Information) (Details) - shares
Sep. 30, 2023
May 31, 2022
May 31, 2017
Non Employee Directors Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares)     1,000,000
Shares available for grant under the plan (in shares) 876,226    
Percentage of voting shares that PMI may own, used in determining non-employee director status     50.00%
2022 Performance Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares)   25,000,000  
Shares available for grant under the plan (in shares) 22,165,030    
XML 80 R57.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Plans: (RSU Awards) (Details)
$ / shares in Units, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
year
$ / shares
shares
Sep. 30, 2022
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Compensation Expense Related to RSU Awards $ 6 $ 13 $ 51 $ 44
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares granted (in shares) | shares     1,756,750 1,579,680
Weighted-average grant date fair value per RSU award granted (in dollars per share) | $ / shares     $ 101.96 $ 104.96
Compensation Expense Related to RSU Awards 38 $ 35 $ 124 $ 109
Unrecognized compensation cost related to non-vested stock awards $ 199   $ 199  
Award requisite service period     3 years  
Minimum retirement age | year     58  
Stock awards vested during period (in shares) | shares     1,421,086  
Restricted Stock Units (RSUs) | Grant Date Fair Value        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Fair value of vested stock awards     $ 124  
Restricted Stock Units (RSUs) | Total Fair Value        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Fair value of vested stock awards     $ 143  
XML 81 R58.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Plans: (PSU Awards) (Details)
$ / shares in Units, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
year
performanceMetric
$ / shares
shares
Sep. 30, 2022
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Compensation Expense Related to PSU Awards $ 6 $ 13 $ 51 $ 44
Disclosure of share-based compensation arrangements by payment award    
During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the weighted-average grant date fair value per share related to RSU awards were as follows:
Number of
Shares
Granted		Weighted-Average Grant Date Fair Value Per RSU Award Granted
20231,756,750 $ 101.96 
20221,579,680 $  104.96 

Compensation expense related to RSU awards was as follows:
Compensation Expense Related to RSU Awards
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023$ 124 $ 38 
2022$ 109 $ 35 
During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the grant date fair value per share related to PSU awards were as follows:
Number of Shares GrantedWeighted-
Average PSU Grant Date 
Fair Value Subject to Other Performance Factors 		Weighted-
Average PSU Grant Date 
Fair Value Subject to TSR Performance Factors
(Per Share)(Per Share)
2023482,360 $ 102.02 $ 133.54 
2022451,790 $  105.07 $ 143.94 
Compensation expense related to PSU awards was as follows:
Compensation Expense Related to PSU Awards
(in millions)For the Nine Months Ended September 30,For the Three Months Ended September 30,
2023$ 51 $ 6 
2022$  44 $  13 
  
Performance Shares        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Length of performance cycle period     3 years  
Absolute basis (as a percent) 40.00%   40.00%  
Currency-neutral compound annual adjusted diluted earnings per share growth rate (as a percent) 30.00%   30.00%  
Product sustainability weight (as a percent) 20.00%   20.00%  
Operational sustainability weight (as a percentage) 10.00%   10.00%  
Performance metrics predefined at time of grant | performanceMetric     3  
Aggregate weighted performance factor     100.00%  
Number of shares of common stock issued for each vested PSU (in shares) | shares     1  
Number of shares granted (in shares) | shares     482,360 451,790
Risk-free interest rate (as a percent)     4.10% 1.60%
Expected volatility (as a percent)     24.30% 28.60%
Unrecognized compensation cost related to non-vested stock awards $ 49   $ 49  
Minimum retirement age | year     58  
Stock awards vested during period (in shares) | shares     902,232  
Performance Shares | Grant Date Fair Value        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Fair value of vested stock awards     $ 83  
Performance Shares | Total Fair Value        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Fair value of vested stock awards     $ 91  
Performance Shares | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting rights, percentage     0.00%  
Performance Shares | Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting rights, percentage     200.00%  
Performance Share Units, Other Performance Metrics        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted-average grant date fair value per RSU award granted (in dollars per share) | $ / shares     $ 102.02 $ 105.07
Performance Share Units, TSR Performance Metric        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted-average grant date fair value per RSU award granted (in dollars per share) | $ / shares     $ 133.54 $ 143.94
XML 82 R59.htm IDEA: XBRL DOCUMENT v3.23.3
Benefit Plans: (Components of Pension and Other Employee Benefits Costs) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]        
Total pension and other employee benefit costs $ 8 $ 7 $ 36 $ 16
Pension Plan        
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]        
Total pension and other employee benefit costs (24) (22) (61) (71)
Postemployment Benefit Plans        
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]        
Total pension and other employee benefit costs 29 27 88 81
Postretirement Benefit Costs        
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]        
Total pension and other employee benefit costs $ 3 $ 2 $ 9 $ 6
XML 83 R60.htm IDEA: XBRL DOCUMENT v3.23.3
Benefit Plans: (Components of Net Periodic Benefit Cost) (Details) - Pension Plan - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Defined Benefit Plan Disclosure [Line Items]        
Service cost $ 45 $ 57 $ 130 $ 176
Interest cost 64 20 193 58
Expected return on plan assets (92) (87) (273) (267)
Amortization:        
Net loss 5 45 21 139
Prior service cost (credit) (1) 0 (2) (1)
Net periodic pension cost $ 21 $ 35 $ 69 $ 105
XML 84 R61.htm IDEA: XBRL DOCUMENT v3.23.3
Benefit Plans: (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jun. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Retirement Benefits [Abstract]      
Employer contributions   $ 96 $ 85
Anticipated additional employer contributions during the remainder of the current fiscal year   $ 39  
Received a cash refund $ 123    
XML 85 R62.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets, net: (Additional Information) (Details)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
segment
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
segment
Nov. 11, 2022
USD ($)
Finite-Lived Intangible Assets [Line Items]          
Impairment   $ 665      
Pre-tax impairment charge $ 112   $ 112    
Purchase price allocation adjustments   1,056      
Non-amortizable intangible assets, currency movements increase (decrease)   29      
Preliminary purchase price allocation   2,233      
Finite lived intangible asset, currency movements increase (decrease)   (105)      
Amortization of intangibles   368      
Change in accumulated amortization, currency movements   17      
Estimated amortization expense, year one, assuming no additional transactions occur that require the amortization of intangible assets   460      
Estimated amortization expense, year two, assuming no additional transactions occur that require the amortization of intangible assets   460      
Estimated amortization expense, year three, assuming no additional transactions occur that require the amortization of intangible assets   460      
Estimated amortization expense, year four, assuming no additional transactions occur that require the amortization of intangible assets   460      
Estimated amortization expense, year five, assuming no additional transactions occur that require the amortization of intangible assets   460      
Goodwill (Note 6)   16,509   $ 19,655  
Swedish Match AB          
Finite-Lived Intangible Assets [Line Items]          
Cash and cash equivalents   484     $ 484
Trade receivables   135     135
Other receivables   53     53
Inventories   437     444
Other current assets   415     524
Property, plant and equipment   677     627
Other intangible assets   7,801     4,512
Other non-current assets   218     214
Current portion of long-term debt   224     224
Accounts payable   120     120
Other current liabilities   532     531
Income taxes   14     14
Long-term debt   1,121     1,126
Deferred income taxes   2,089     1,253
Other non-current liabilities   196     187
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net   5,924     3,538
Noncontrolling interest   2,379     2,379
Goodwill (Note 6)   10,915     13,301
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest   14,460     $ 14,460
In Process Research and Development          
Finite-Lived Intangible Assets [Line Items]          
Pre-tax impairment charge   $ 15      
Geographical Segment          
Finite-Lived Intangible Assets [Line Items]          
Number of reportable segments | segment   4   6  
Wellness & Healthcare          
Finite-Lived Intangible Assets [Line Items]          
Impairment   $ 665      
Goodwill (Note 6)   372   $ 1,012  
Developed technology, including patents          
Finite-Lived Intangible Assets [Line Items]          
Amortizable intangible assets, net   428   $ 732  
Developed technology, including patents | Wellness & Healthcare          
Finite-Lived Intangible Assets [Line Items]          
Amortizable intangible assets, net $ 308   $ 308    
Cost of sales          
Finite-Lived Intangible Assets [Line Items]          
Amortization of intangibles   43      
Marketing, administration and research costs          
Finite-Lived Intangible Assets [Line Items]          
Amortization of intangibles   $ 325      
XML 86 R63.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets, net: (Movement in Goodwill) (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2023
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 19,655
Changes due to:  
Impairment (665)
Currency (95)
Measurement period adjustments (2,386)
Ending balance 16,509
Europe  
Goodwill [Roll Forward]  
Beginning balance 1,370
Changes due to:  
Impairment 0
Currency (13)
Measurement period adjustments 0
Ending balance 1,357
SSEA, CIS & MEA  
Goodwill [Roll Forward]  
Beginning balance 2,869
Changes due to:  
Impairment 0
Currency (34)
Measurement period adjustments 0
Ending balance 2,835
EA, AU & PMI DF  
Goodwill [Roll Forward]  
Beginning balance 493
Changes due to:  
Impairment 0
Currency (9)
Measurement period adjustments 0
Ending balance 484
Americas  
Goodwill [Roll Forward]  
Beginning balance 615
Changes due to:  
Impairment 0
Currency 57
Measurement period adjustments 0
Ending balance 672
Swedish Match  
Goodwill [Roll Forward]  
Beginning balance 13,296
Changes due to:  
Impairment 0
Currency (121)
Measurement period adjustments (2,386)
Ending balance 10,789
Wellness & Healthcare  
Goodwill [Roll Forward]  
Beginning balance 1,012
Changes due to:  
Impairment (665)
Currency 25
Measurement period adjustments 0
Ending balance $ 372
XML 87 R64.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets, net: (Other Intangible Assets) (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Non-amortizable intangible assets $ 4,416 $ 3,346
Finite-Lived Intangible Assets [Line Items]    
Amortizable intangible assets, accumulated amortization 1,380 1,029
Total other intangible assets, gross 10,959 7,761
Total other intangible assets, net $ 9,579 6,732
Trademarks    
Finite-Lived Intangible Assets [Line Items]    
Weighted-average remaining useful life 16 years  
Amortizable intangible assets, gross carrying amount $ 2,158 2,050
Amortizable intangible assets, accumulated amortization 740 674
Amortizable intangible assets, net $ 1,418 1,376
Developed technology, including patents    
Finite-Lived Intangible Assets [Line Items]    
Weighted-average remaining useful life 7 years  
Amortizable intangible assets, gross carrying amount $ 718 975
Amortizable intangible assets, accumulated amortization 290 243
Amortizable intangible assets, net $ 428 732
Other    
Finite-Lived Intangible Assets [Line Items]    
Weighted-average remaining useful life 12 years  
Amortizable intangible assets, gross carrying amount $ 3,667 1,390
Amortizable intangible assets, accumulated amortization 350 112
Amortizable intangible assets, net $ 3,317 $ 1,278
XML 88 R65.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Instruments: (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Derivative [Line Items]          
Notional amount $ 37,101   $ 37,101   $ 40,401
Cumulative fair value gain (loss) of hedged liability 90   90    
Level 1 | Money Market Funds          
Derivative [Line Items]          
Other investments 216   216    
Net Investment Hedging | Foreign Debt          
Derivative [Line Items]          
Foreign currency gain (loss) 27 $ 267 51 $ 525  
Fair Value Hedging          
Derivative [Line Items]          
Fair value hedge amount 906   906    
Foreign exchange contracts          
Derivative [Line Items]          
Derivative instruments, gains (losses) to be reclassified to earnings 176   176    
Foreign exchange contracts | Not Designated as Hedging Instrument          
Derivative [Line Items]          
Notional amount $ 17,818   $ 17,818   $ 21,755
XML 89 R66.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Instruments: (Notional Amounts of Outstanding Derivative Instruments) (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Derivative [Line Items]    
Notional amount $ 37,101 $ 40,401
Designated as Hedging Instrument | Foreign exchange contracts    
Derivative [Line Items]    
Notional amount 18,256 17,627
Designated as Hedging Instrument | Interest rate contracts    
Derivative [Line Items]    
Notional amount 1,000 1,019
Designated as Hedging Instrument | Commodity contracts    
Derivative [Line Items]    
Notional amount 27 0
Not Designated as Hedging Instrument | Foreign exchange contracts    
Derivative [Line Items]    
Notional amount $ 17,818 $ 21,755
XML 90 R67.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Instruments: (Fair Value of Derivative Contracts) (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Derivatives, Fair Value [Line Items]    
Derivative asset fair value $ 1,099 $ 873
Gross amounts not offset in the condensed consolidated balance sheets - financial instruments (292) (346)
Gross amounts not offset in the condensed consolidated balance sheets - cash collateral received / pledged (566) (341)
Net amount 241 186
Derivative liability fair value 403 537
Gross amounts not offset in the condensed consolidated balance sheets - financial instruments (292) (346)
Gross amounts not offset in the condensed consolidated balance sheets - cash collateral received / pledged (60) (48)
Net amount 51 143
Foreign exchange contracts | Foreign exchange contracts | Other current assets    
Derivatives, Fair Value [Line Items]    
Derivative asset fair value 472 376
Foreign exchange contracts | Foreign exchange contracts | Other assets    
Derivatives, Fair Value [Line Items]    
Derivative asset fair value 386 341
Foreign exchange contracts | Foreign exchange contracts | Other accrued liabilities    
Derivatives, Fair Value [Line Items]    
Derivative liability fair value 126 126
Foreign exchange contracts | Foreign exchange contracts | Income taxes and other liabilities    
Derivatives, Fair Value [Line Items]    
Derivative liability fair value 56 147
Foreign exchange contracts | Not Designated as Hedging Instrument | Other current assets    
Derivatives, Fair Value [Line Items]    
Derivative asset fair value 241 156
Foreign exchange contracts | Not Designated as Hedging Instrument | Other assets    
Derivatives, Fair Value [Line Items]    
Derivative asset fair value 0 0
Foreign exchange contracts | Not Designated as Hedging Instrument | Other accrued liabilities    
Derivatives, Fair Value [Line Items]    
Derivative liability fair value 87 165
Foreign exchange contracts | Not Designated as Hedging Instrument | Income taxes and other liabilities    
Derivatives, Fair Value [Line Items]    
Derivative liability fair value 42 16
Interest rate contracts | Foreign exchange contracts | Other current assets    
Derivatives, Fair Value [Line Items]    
Derivative asset fair value 0 0
Interest rate contracts | Foreign exchange contracts | Other assets    
Derivatives, Fair Value [Line Items]    
Derivative asset fair value 0 0
Interest rate contracts | Foreign exchange contracts | Other accrued liabilities    
Derivatives, Fair Value [Line Items]    
Derivative liability fair value 40 27
Interest rate contracts | Foreign exchange contracts | Income taxes and other liabilities    
Derivatives, Fair Value [Line Items]    
Derivative liability fair value 50 56
Commodity contracts | Foreign exchange contracts | Other current assets    
Derivatives, Fair Value [Line Items]    
Derivative asset fair value 0 0
Commodity contracts | Foreign exchange contracts | Other accrued liabilities    
Derivatives, Fair Value [Line Items]    
Derivative liability fair value $ 2 $ 0
XML 91 R68.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Instruments: (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Derivative Instruments, Gain (Loss) [Line Items]        
Total $ 519 $ 832 $ 374 $ 1,717
Derivative, Excluded Component, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]   Interest Income (Expense), Net Interest Income (Expense), Net  
Foreign exchange contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Foreign exchange contracts 67 $ 77 $ 290 325
Net investment hedges 453 558 14 1,088
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings 59 60 185 124
Foreign exchange contracts | Foreign exchange contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings 73 48 200 116
Foreign exchange contracts | Not Designated as Hedging Instrument        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings 381 (188) 542 (69)
Foreign exchange contracts | Net revenues        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings 73 70 112 151
Foreign exchange contracts | Cost of sales        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings 0 0 0 0
Foreign exchange contracts | Marketing, administration and research costs        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings (19) (7) 52 (17)
Foreign exchange contracts | Marketing, administration and research costs | Not Designated as Hedging Instrument        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings 258 (225) 154 (160)
Foreign exchange contracts | Interest expense, net        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings (7) (2) (13) (5)
Foreign exchange contracts | Interest expense, net | Not Designated as Hedging Instrument        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings 60 13 212 56
Interest rate contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Foreign exchange contracts 0 197 72 304
Interest rate contracts | Interest expense, net        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings 12 (1) 34 (5)
Interest rate contracts | Interest expense, net | Foreign exchange contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings (10) (24) (24) (81)
Commodity contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Foreign exchange contracts (1) 0 (2) 0
Commodity contracts | Cost of sales        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings $ 0 $ 0 $ 0 $ 0
XML 92 R69.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Instruments: (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Derivative (gains)/losses transferred to earnings $ (51) $ (51) $ (155) $ (106)
Change in fair value 58 222 304 523
Other Comprehensive Income (Loss)        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Gain/(loss) as of beginning of period, 408 250 266 4
Derivative (gains)/losses transferred to earnings (51) (51) (155) (106)
Change in fair value 58 222 304 523
Gain/(loss) as of September 30, $ 415 $ 421 $ 415 $ 421
XML 93 R70.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share: (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share [Abstract]        
Net earnings attributable to PMI $ 2,054 $ 2,087 $ 5,617 $ 6,651
Less distributed and undistributed earnings attributable to share-based payment awards 6 5 17 18
Net earnings for basic EPS 2,048 2,082 5,600 6,633
Net earnings for diluted EPS $ 2,048 $ 2,082 $ 5,600 $ 6,633
Weighted-average shares for basic EPS (in shares) 1,552,000,000 1,550,000,000 1,552,000,000 1,550,000,000
Plus contingently issuable performance stock units (PSUs), (in shares) 2,000,000 2,000,000 1,000,000 2,000,000
Weighted-average shares for diluted EPS (in shares) 1,554,000,000 1,552,000,000 1,553,000,000 1,552,000,000
Antidilutive stock awards (in shares)     0 0
XML 94 R71.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Reporting: (Segment Data) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Total PMI net revenues $ 9,141 [1],[2] $ 8,032 [1],[2] $ 26,127 [3],[4] $ 23,610 [3],[4]
Operating income 3,370 2,968 8,667 9,322
Europe        
Segment Reporting Information [Line Items]        
Total PMI net revenues 3,672 3,272 9,984 9,805
Operating income 1,708 1,415 4,446 4,447
SSEA, CIS & MEA        
Segment Reporting Information [Line Items]        
Total PMI net revenues 2,777 2,822 7,922 7,781
Operating income 801 1,086 2,371 3,009
EA, AU & PMI DF        
Segment Reporting Information [Line Items]        
Total PMI net revenues 1,571 1,407 4,771 4,458
Operating income 753 533 1,920 1,746
Americas        
Segment Reporting Information [Line Items]        
Total PMI net revenues 478 474 1,399 1,367
Operating income 5 85 141 336
Swedish Match        
Segment Reporting Information [Line Items]        
Total PMI net revenues 568 0 1,814 0
Operating income 140 0 597 0
Wellness & Healthcare        
Segment Reporting Information [Line Items]        
Total PMI net revenues 75 57 237 199
Operating income (37) (151) (808) (216)
Combustible Tobacco Products        
Segment Reporting Information [Line Items]        
Total PMI net revenues 5,832 5,591 16,845 16,358
Combustible Tobacco Products | Europe        
Segment Reporting Information [Line Items]        
Total PMI net revenues 2,160 1,996 6,084 5,996
Combustible Tobacco Products | SSEA, CIS & MEA        
Segment Reporting Information [Line Items]        
Total PMI net revenues 2,485 2,454 6,988 6,852
Combustible Tobacco Products | EA, AU & PMI DF        
Segment Reporting Information [Line Items]        
Total PMI net revenues 678 692 2,091 2,214
Combustible Tobacco Products | Americas        
Segment Reporting Information [Line Items]        
Total PMI net revenues 460 450 1,349 1,296
Combustible Tobacco Products | Swedish Match        
Segment Reporting Information [Line Items]        
Total PMI net revenues 49 0 333 0
Smoke-Free Products        
Segment Reporting Information [Line Items]        
Total PMI net revenues 3,309 2,441 9,282 7,252
Smoke-Free Products | Total smoke-free products excluding Wellness and Healthcare        
Segment Reporting Information [Line Items]        
Total PMI net revenues 3,234 2,384 9,045 7,053
Smoke-Free Products | Europe        
Segment Reporting Information [Line Items]        
Total PMI net revenues 1,512 1,276 3,900 3,809
Smoke-Free Products | SSEA, CIS & MEA        
Segment Reporting Information [Line Items]        
Total PMI net revenues 292 368 934 929
Smoke-Free Products | EA, AU & PMI DF        
Segment Reporting Information [Line Items]        
Total PMI net revenues 893 715 2,680 2,244
Smoke-Free Products | Americas        
Segment Reporting Information [Line Items]        
Total PMI net revenues 18 24 50 71
Smoke-Free Products | Swedish Match        
Segment Reporting Information [Line Items]        
Total PMI net revenues 519 0 1,481 0
Smoke-Free Products | Wellness & Healthcare        
Segment Reporting Information [Line Items]        
Total PMI net revenues $ 75 $ 57 $ 237 $ 199
[1] Includes net revenues from related parties of $857 million and $1,087 million for the three months ended September 30, 2023 and 2022, respectively
[2] Net of excise taxes of $13,092 million and $12,856 million for the three months ended September 30, 2023 and 2022, respectively
[3] Includes net revenues from related parties of $2,631 million and $2,634 million for the nine months ended September 30, 2023 and 2022, respectively
[4] Net of excise tax on products of $37,140 million and $37,028 million for the nine months ended September 30, 2023 and 2022, respectively
XML 95 R72.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Reporting: (Additional Information) (Details)
$ in Millions
 3 Months Ended 5 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2022
USD ($)
Mar. 31, 2023
USD ($)
Sep. 30, 2023
USD ($)
segment
Sep. 30, 2022
USD ($)
Dec. 31, 2022
segment
Segment Reporting Information [Line Items]                  
Goodwill and non-amortizable intangible assets impairment charge             $ 680    
Pre-tax impairment charge         $ 112     $ 112  
Contract termination charges: $ 0       0   109 0  
Marketing, administration and research costs                  
Segment Reporting Information [Line Items]                  
Pre tax charge on termination 140           140    
War In Ukraine                  
Segment Reporting Information [Line Items]                  
Pre-tax charge 19       6   19 128  
War In Ukraine | Marketing, administration and research costs                  
Segment Reporting Information [Line Items]                  
Pre-tax charge 8       $ 6   8 $ 82  
Swedish Match AB                  
Segment Reporting Information [Line Items]                  
Business combination fair value adjustment to inventories       $ 125   $ 146 $ 18    
Geographical Segment                  
Segment Reporting Information [Line Items]                  
Number of reportable segments | segment             4   6
SSEA, CIS & MEA | Net Revenues                  
Segment Reporting Information [Line Items]                  
Pre tax charge on termination     $ 80            
SSEA, CIS & MEA | Marketing, administration and research costs                  
Segment Reporting Information [Line Items]                  
Pre tax charge on termination 44           $ 44    
EA, AU & PMI DF | Korea                  
Segment Reporting Information [Line Items]                  
Non-cash pre-tax charge   $ 204         204    
EA, AU & PMI DF | Marketing, administration and research costs                  
Segment Reporting Information [Line Items]                  
Pre tax charge on termination 27           27    
Europe | Marketing, administration and research costs                  
Segment Reporting Information [Line Items]                  
Pre tax charge on termination 62           62    
Americas | Marketing, administration and research costs                  
Segment Reporting Information [Line Items]                  
Pre tax charge on termination $ 7           $ 7    
XML 96 R73.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies: (Tobacco-Related Litigation) (Details)
$ in Thousands, $ in Thousands
 1 Months Ended 3 Months Ended
Mar. 01, 2019
CAD ($)
Mar. 01, 2019
USD ($)
May 27, 2015
CAD ($)
plaintiff
manufacturer
May 27, 2015
USD ($)
plaintiff
manufacturer
Jun. 20, 2012
cigarette
Jul. 10, 2009
cigarette
Oct. 30, 2015
CAD ($)
Oct. 30, 2015
USD ($)
Mar. 31, 2019
USD ($)
Sep. 30, 2023
litigationCase
Loss Contingencies [Line Items]                    
Number of cases decided in favor of PM                   538
Number of cases decided in favor of plaintiff                   15
Cases Remaining On Appeal                    
Loss Contingencies [Line Items]                    
Cases on appeal                   5
Case Decided In Favor Of Plaintiff                    
Loss Contingencies [Line Items]                    
Number of cases that reached final resolution in favor of PM                   10
Canada | Adams | Pending Litigation                    
Loss Contingencies [Line Items]                    
Minimum number of cigarettes smoked | cigarette           25,000        
Canada | Suzanne Jacklin | Pending Litigation                    
Loss Contingencies [Line Items]                    
Minimum number of cigarettes smoked | cigarette         25,000          
Canada | Smoking and Health Class Actions | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais                    
Loss Contingencies [Line Items]                    
Number of additional manufacturers found liable | manufacturer     2 2            
Court-estimated number of members in class | plaintiff     99,957 99,957            
Canada | Smoking and Health Class Actions | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais | Judicial Ruling | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp.                    
Loss Contingencies [Line Items]                    
Compensatory damages awarded     $ 15,500,000 $ 11,300,000            
Punitive damages awarded     90 66            
Damages, reduced amount $ 13,500,000 $ 9,800,000                
Canada | Smoking and Health Class Actions | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais | Judicial Ruling | RBH                    
Loss Contingencies [Line Items]                    
Compensatory damages awarded $ 2,700,000 $ 2,000,000 $ 3,100,000 $ 2,260,000            
Damages allocated to subsidiary (percent) 20.00% 20.00% 20.00% 20.00%            
Punitive damages awarded     $ 30 $ 22            
Canada | Smoking and Health Class Actions | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases | Judicial Ruling | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp.                    
Loss Contingencies [Line Items]                    
Amount to be deposited into trust $ 1,100,000 $ 802,000                
Payment period 60 days 60 days                
Canada | Smoking and Health Class Actions | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases | Appellate Ruling | RBH                    
Loss Contingencies [Line Items]                    
Motion for security ordered by appeals court, paid by defendant             $ 226,000 $ 165,000    
Amount of security ordered, funded by defendant $ 257,000 $ 194,000                
Amount of litigation charge | $                 $ 194,000  
Amount of litigation charge net of tax | $                 $ 142,000  
Canada | Smoking and Health Class Actions | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases | Appellate Ruling | Imperial Tobacco Ltd.                    
Loss Contingencies [Line Items]                    
Motion for security ordered by appeals court             $ 758,000 $ 553,000    
Canada | Smoking and Health Class Actions | Cecilia Letourneau                    
Loss Contingencies [Line Items]                    
Number of additional manufacturers found liable | manufacturer     2 2            
Court-estimated number of members in class | plaintiff     918,000 918,000            
Canada | Smoking and Health Class Actions | Cecilia Letourneau | Judicial Ruling | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp.                    
Loss Contingencies [Line Items]                    
Punitive damages awarded     $ 131,000 $ 96,000            
Canada | Smoking and Health Class Actions | Cecilia Letourneau | Judicial Ruling | RBH                    
Loss Contingencies [Line Items]                    
Punitive damages awarded     $ 46,000 $ 34,000            
Punitive damages, value $ 57,000 $ 42,000                
XML 97 R74.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies: (Number of Tobacco Related Cases Pertaining to Combustible Products Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) - Combustible Products - litigationCase
Sep. 30, 2023
Sep. 30, 2022
Individual Smoking and Health Cases    
Loss Contingencies [Line Items]    
Cases brought against PM 48 38
Smoking and Health Class Actions    
Loss Contingencies [Line Items]    
Cases brought against PM 9 9
Health Care Cost Recovery Actions    
Loss Contingencies [Line Items]    
Cases brought against PM 17 17
Label-Related Class Actions    
Loss Contingencies [Line Items]    
Cases brought against PM 0 0
Individual Label-Related Cases    
Loss Contingencies [Line Items]    
Cases brought against PM 5 6
Public Civil Actions    
Loss Contingencies [Line Items]    
Cases brought against PM 1 1
XML 98 R75.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies: (Verdicts and Post-Trial Developments) (Details) - Judicial Ruling
₺ in Thousands, $ in Thousands
Jun. 23, 2023
USD ($)
Jun. 23, 2023
TRY (₺)
Dec. 16, 2021
USD ($)
Dec. 16, 2021
ARS ($)
Jul. 02, 2021
USD ($)
Jul. 02, 2021
ARS ($)
Jun. 17, 2021
USD ($)
Jun. 17, 2021
ARS ($)
Mar. 01, 2019
CAD ($)
Mar. 01, 2019
USD ($)
Aug. 05, 2016
USD ($)
Aug. 05, 2016
ARS ($)
May 27, 2015
CAD ($)
May 27, 2015
USD ($)
Canada | Smoking and Health Class Actions | Cecilia Letourneau | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp.                            
Loss Contingencies [Line Items]                            
Punitive damages awarded                         $ 131,000 $ 96,000,000
Canada | Smoking and Health Class Actions | Cecilia Letourneau | RBH                            
Loss Contingencies [Line Items]                            
Punitive damages awarded                         $ 46,000 $ 34,000,000
Payment period for awarded punitive damages to be deposited into trust                         60 days 60 days
Canada | Smoking and Health Class Actions | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp.                            
Loss Contingencies [Line Items]                            
Compensatory damages awarded                         $ 15,500,000 $ 11,300,000,000
Punitive damages awarded                         90 66,000
Awarded compensatory damages that are to be deposited into trust                         1,000,000 729,000,000
Canada | Smoking and Health Class Actions | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais | RBH                            
Loss Contingencies [Line Items]                            
Compensatory damages awarded                 $ 2,700,000 $ 2,000,000,000     $ 3,100,000 $ 2,260,000,000
Damages allocated to subsidiary (percent)                 20.00% 20.00%     20.00% 20.00%
Punitive damages awarded                         $ 30 $ 22,000
Awarded compensatory damages that are to be deposited into trust                         $ 200,000 $ 146,000,000
Payment period for compensatory damages to be deposited into trust                         60 days 60 days
Argentina | Individual Action | Hugo Lespada                            
Loss Contingencies [Line Items]                            
Compensatory damages awarded                     $ 314 $ 110,000    
Argentina | Individual Action | Claudia Milano                            
Loss Contingencies [Line Items]                            
Compensatory damages awarded             $ 429 $ 150,000            
Punitive damages awarded             $ 11,435 $ 4,000,000            
Amount to be deposited into trust         $ 17,479 $ 6,114,428                
Damages returned to subsidiary     $ 2,554 $ 893,428                    
Turkey | Individual Action | Senem Yilmazel                            
Loss Contingencies [Line Items]                            
Compensatory damages awarded $ 357 ₺ 10                        
XML 99 R76.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies: (Smoking and Health Litigation) (Details) - Combustible Products - litigationCase
Sep. 30, 2023
Sep. 30, 2022
Individual Smoking and Health Cases    
Loss Contingencies [Line Items]    
Cases brought against PM 48 38
Individual Smoking and Health Cases | Argentina    
Loss Contingencies [Line Items]    
Cases brought against PM 32  
Individual Smoking and Health Cases | Canada    
Loss Contingencies [Line Items]    
Cases brought against PM 2  
Individual Smoking and Health Cases | Chile    
Loss Contingencies [Line Items]    
Cases brought against PM 10  
Individual Smoking and Health Cases | Philippines    
Loss Contingencies [Line Items]    
Cases brought against PM 1  
Individual Smoking and Health Cases | Turkey    
Loss Contingencies [Line Items]    
Cases brought against PM 1  
Individual Smoking and Health Cases | Scotland    
Loss Contingencies [Line Items]    
Cases brought against PM 1  
Individual Smoking and Health Cases | Australia    
Loss Contingencies [Line Items]    
Cases brought against PM 1  
Smoking and Health Class Actions    
Loss Contingencies [Line Items]    
Cases brought against PM 9 9
XML 100 R77.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies: (Health Care Cost Recovery Litigation) (Details) - Health Care Cost Recovery Actions
Apr. 14, 2014
patient
Oct. 17, 2008
Mar. 13, 2008
Feb. 26, 2008
May 25, 2007
May 09, 2007
Sep. 30, 2023
litigationCase
Sep. 30, 2022
litigationCase
Korea                
Loss Contingencies [Line Items]                
Damages sought, number of patients | patient 3,484              
Nigeria | Pending Litigation | The Attorney General Of Lagos State                
Loss Contingencies [Line Items]                
Damages sought, period of past reimbursements     20 years          
Damages sought, period of future reimbursements     20 years          
Nigeria | Pending Litigation | The Attorney General Of Kano State                
Loss Contingencies [Line Items]                
Damages sought, period of past reimbursements           20 years    
Damages sought, period of future reimbursements           20 years    
Nigeria | Pending Litigation | The Attorney General Of Gombe State                
Loss Contingencies [Line Items]                
Damages sought, period of past reimbursements   20 years            
Damages sought, period of future reimbursements   20 years            
Nigeria | Pending Litigation | The Attorney General Of Oyo State                
Loss Contingencies [Line Items]                
Damages sought, period of past reimbursements         20 years      
Damages sought, period of future reimbursements         20 years      
Nigeria | Pending Litigation | The Attorney General Of Ogun State                
Loss Contingencies [Line Items]                
Damages sought, period of past reimbursements       20 years        
Damages sought, period of future reimbursements       20 years        
Combustible Products                
Loss Contingencies [Line Items]                
Cases brought against PM             17 17
Combustible Products | Brazil                
Loss Contingencies [Line Items]                
Cases brought against PM             1  
Combustible Products | Canada                
Loss Contingencies [Line Items]                
Cases brought against PM             10  
Combustible Products | Korea                
Loss Contingencies [Line Items]                
Cases brought against PM             1  
Combustible Products | Nigeria                
Loss Contingencies [Line Items]                
Cases brought against PM             5  
XML 101 R78.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies: (Label-Related Cases) (Details) - Individual Label-Related Cases - Combustible Products - litigationCase
Sep. 30, 2023
Sep. 30, 2022
Loss Contingencies [Line Items]    
Cases brought against PM 5 6
Italy    
Loss Contingencies [Line Items]    
Cases brought against PM 1  
Chile    
Loss Contingencies [Line Items]    
Cases brought against PM 4  
XML 102 R79.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies: (Public Civil Actions) (Details) - Public Civil Actions - Combustible Products - litigationCase
Sep. 30, 2023
Sep. 30, 2022
Loss Contingencies [Line Items]    
Cases brought against PM 1 1
Venezuela    
Loss Contingencies [Line Items]    
Cases brought against PM 1  
XML 103 R80.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies: (Other Litigation) (Details) - Other Litigation
฿ in Millions, $ in Millions, ₩ in Billions
 1 Months Ended 3 Months Ended 5 Months Ended 12 Months Ended
Jun. 15, 2022
USD ($)
Jun. 01, 2022
USD ($)
Jun. 01, 2022
THB (฿)
Jan. 26, 2017
USD ($)
Jan. 26, 2017
THB (฿)
Jan. 18, 2016
USD ($)
defendant
Jan. 18, 2016
THB (฿)
defendant
Jun. 30, 2020
USD ($)
Jun. 30, 2020
KRW (₩)
Mar. 31, 2020
USD ($)
Mar. 31, 2020
THB (฿)
Jan. 31, 2020
USD ($)
Jan. 31, 2020
KRW (₩)
Nov. 30, 2019
USD ($)
Nov. 30, 2019
THB (฿)
Mar. 31, 2017
USD ($)
Mar. 31, 2017
KRW (₩)
Mar. 31, 2017
USD ($)
Mar. 31, 2017
KRW (₩)
Dec. 31, 2016
USD ($)
Dec. 31, 2016
KRW (₩)
Loss Contingencies [Line Items]                                          
Damages awarded | $ $ 10.8                                        
Thailand | The Department of Special Investigations of the Government of Thailand                                          
Loss Contingencies [Line Items]                                          
Loss contingency, damages sought, value   $ 3.3 ฿ 122 $ 541.0 ฿ 19,800 $ 2,200.0 ฿ 80,800     $ 3.6 ฿ 130     $ 32.8 ฿ 1,200            
Korea | The South Korean Board Of Audit And Inspection                                          
Loss Contingencies [Line Items]                                          
Amounts paid                               $ 129.0 ₩ 172 $ 204.0 ₩ 272 $ 75.0 ₩ 100
Amount of taxes not underpaid as ruled by trial court                       $ 164.0 ₩ 218                
Amount of alleged underpayments not underpaid as ruled by court               $ 40.0 ₩ 54                        
Pending Litigation | Thailand | The Department of Special Investigations of the Government of Thailand                                          
Loss Contingencies [Line Items]                                          
Number of defendants | defendant           7 7                            
XML 104 R81.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies: (Third-Party Guarantees) (Details)
$ in Millions, $ in Millions
Aug. 31, 2022
CAD ($)
Aug. 31, 2022
USD ($)
Mar. 31, 2022
CAD ($)
Mar. 31, 2022
USD ($)
Oct. 17, 2020
CAD ($)
Oct. 17, 2020
USD ($)
Canadian Government            
Loss Contingencies [Line Items]            
Project contribution from government     $ 27 $ 22 $ 173 $ 131
Medicago Inc. | Financial Guarantee            
Loss Contingencies [Line Items]            
Reduction of guarantee obligation $ 123 $ 93        
XML 105 R82.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes: (Details)
$ in Millions, Rp in Trillions
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Oct. 31, 2021
USD ($)
Oct. 31, 2021
IDR (Rp)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2023
Income Taxes [Line Items]              
Effective tax rate (as a percent)     33.20% 22.00% 25.70% 20.60%  
Other tax expense (benefit)           $ (13)  
Income tax expense (benefit)     $ (1,031) $ (622) $ (2,019) (1,835)  
Amount assessed by taxing authorities $ 260 Rp 3.8          
Russia              
Income Taxes [Line Items]              
Income tax expense (benefit)     (173)   (173)    
Pension Plan              
Income Taxes [Line Items]              
Other tax expense (benefit)           $ (40)  
Swedish Match AB              
Income Taxes [Line Items]              
Income tax expense (benefit)     $ (138)   $ (41)    
Minimum              
Income Taxes [Line Items]              
Statute of limitations term         3 years    
Maximum              
Income Taxes [Line Items]              
Statute of limitations term         5 years    
Forecast | Minimum              
Income Taxes [Line Items]              
Effective tax rate (as a percent)             20.50%
Forecast | Maximum              
Income Taxes [Line Items]              
Effective tax rate (as a percent)             21.50%
XML 106 R83.htm IDEA: XBRL DOCUMENT v3.23.3
Indebtedness: (Narrative) (Details)
 9 Months Ended
Feb. 17, 2023
USD ($)
Nov. 21, 2022
USD ($)
Nov. 10, 2022
USD ($)
Nov. 10, 2022
USD ($)
Nov. 07, 2022
USD ($)
Nov. 07, 2022
EUR (€)
Jun. 23, 2022
USD ($)
May 11, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
EUR (€)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
EUR (€)
Nov. 11, 2022
Jun. 23, 2022
EUR (€)
Debt Instrument [Line Items]                              
Principal amount                 $ 6,300,000,000            
Repayments under credit facilities related to acquisition                 4,430,000,000 $ 0          
Long-term debt, including current maturities                 45,566,000,000     $ 37,486,000,000      
Borrowings under credit facilities                 0            
Amount Outstanding                 2,149,000,000     5,637,000,000      
Bank loans                              
Debt Instrument [Line Items]                              
Amount Outstanding                 221,000,000     295,000,000      
Short Term Credit Arrangement                              
Debt Instrument [Line Items]                              
Principal amount                 2,600,000,000     $ 1,900,000,000      
Swedish Match AB                              
Debt Instrument [Line Items]                              
Interest acquired (as a percent) 100.00%                     94.81% 94.81% 85.87%  
Senior Unsecured Bridge Facility                              
Debt Instrument [Line Items]                              
Debt instrument, term               364 days              
Principal amount             $ 11,000,000,000 $ 17,000,000,000              
Repayments under credit facilities related to acquisition $ 4,400,000,000                            
Senior Unsecured Bridge Facility | Swedish Match AB                              
Debt Instrument [Line Items]                              
Borrowings under credit facilities related to acquisition     $ 500,000,000 $ 8,400,000,000 $ 7,900,000,000                    
Repayments under credit facilities related to acquisition $ 4,400,000,000 $ 4,000,000,000                          
Senior Unsecured Term Loan                              
Debt Instrument [Line Items]                              
Principal amount             $ 5,800,000,000               € 5,500,000,000
Senior Unsecured Term Loan | Swedish Match AB                              
Debt Instrument [Line Items]                              
Borrowings under credit facilities related to acquisition | €           € 5,500,000,000                  
Long-term debt, including current maturities                 $ 6,000,000,000   € 5,500,000,000 $ 6,000,000,000 € 5,500,000,000    
Senior Unsecured Term Loan | Three year tranche                              
Debt Instrument [Line Items]                              
Debt instrument, term             3 years                
Principal amount             $ 3,200,000,000               3,000,000,000
Senior Unsecured Term Loan | Three year tranche | Swedish Match AB                              
Debt Instrument [Line Items]                              
Borrowings under credit facilities related to acquisition | €           3,000,000,000                  
Senior Unsecured Term Loan | Five year tranche                              
Debt Instrument [Line Items]                              
Principal amount             $ 2,600,000,000               € 2,500,000,000
Senior Unsecured Term Loan | Five year tranche | Swedish Match AB                              
Debt Instrument [Line Items]                              
Borrowings under credit facilities related to acquisition | €           € 2,500,000,000                  
XML 107 R84.htm IDEA: XBRL DOCUMENT v3.23.3
Indebtedness: (Short-Term Borrowings) (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Short-term Debt [Line Items]    
Amount Outstanding $ 2,149 $ 5,637
Commercial paper    
Short-term Debt [Line Items]    
Amount Outstanding $ 1,928 $ 912
Average Rate 5.50% 4.40%
Bank loans    
Short-term Debt [Line Items]    
Amount Outstanding $ 221 $ 295
Average Rate 9.00% 7.50%
U.S. dollar credit facility borrowings related to Swedish Match AB acquisition    
Short-term Debt [Line Items]    
Amount Outstanding $ 0 $ 4,430
Average Rate 0.00% 4.90%
XML 108 R85.htm IDEA: XBRL DOCUMENT v3.23.3
Indebtedness: (Schedule of Long-Term Debt) (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Long-term debt, including current maturities $ 45,566 $ 37,486
Less current portion of long-term debt 2,652 2,611
Long-term debt 42,914 34,875
Finance lease, liability $ 40 54
U.S. Dollar Notes    
Debt Instrument [Line Items]    
Average interest rate 4.433%  
Long-term debt, including current maturities $ 30,733 22,596
U.S. Dollar Notes | Minimum    
Debt Instrument [Line Items]    
Interest rate, stated percentage 0.875%  
U.S. Dollar Notes | Maximum    
Debt Instrument [Line Items]    
Interest rate, stated percentage 6.375%  
Euro Notes | Foreign Currency Obligations    
Debt Instrument [Line Items]    
Average interest rate 1.877%  
Long-term debt, including current maturities $ 8,069 8,116
Euro Notes | Foreign Currency Obligations | Minimum    
Debt Instrument [Line Items]    
Interest rate, stated percentage 0.125%  
Euro Notes | Foreign Currency Obligations | Maximum    
Debt Instrument [Line Items]    
Interest rate, stated percentage 3.125%  
Swiss Franc Notes | Foreign Currency Obligations    
Debt Instrument [Line Items]    
Average interest rate 1.625%  
Long-term debt, including current maturities $ 272 378
Euro Bank Loan | Foreign Currency Obligations    
Debt Instrument [Line Items]    
Average interest rate 4.265%  
Long-term debt, including current maturities $ 5,797 5,850
Swedish Krona Notes | Foreign Currency Obligations    
Debt Instrument [Line Items]    
Average interest rate 2.357%  
Long-term debt, including current maturities $ 234 343
Swedish Krona Notes | Foreign Currency Obligations | Minimum    
Debt Instrument [Line Items]    
Interest rate, stated percentage 1.395%  
Swedish Krona Notes | Foreign Currency Obligations | Maximum    
Debt Instrument [Line Items]    
Interest rate, stated percentage 5.762%  
Other | Foreign Currency Obligations    
Debt Instrument [Line Items]    
Average interest rate 6.156%  
Long-term debt, including current maturities $ 461 $ 203
XML 109 R86.htm IDEA: XBRL DOCUMENT v3.23.3
Indebtedness: (Schedule of Fair Value) (Details)
$ in Millions
Sep. 30, 2023
USD ($)
Level 1  
Debt Instrument [Line Items]  
Fair value of outstanding long-term debt $ 36,217
Level 2  
Debt Instrument [Line Items]  
Fair value of outstanding long-term debt $ 6,356
XML 110 R87.htm IDEA: XBRL DOCUMENT v3.23.3
Indebtedness: (Debt Issuances Outstanding) (Details) - USD ($)
Sep. 30, 2023
May 30, 2023
Feb. 28, 2023
US Dollar Notes, 4.875%, Due February 2026      
Debt Instrument [Line Items]      
Face Value   $ 450,000,000 $ 1,250,000,000
Interest Rate   4.875% 4.875%
US Dollar Notes, 4.875%, Due February 2028      
Debt Instrument [Line Items]      
Face Value   $ 550,000,000 $ 1,000,000,000
Interest Rate   4.875% 4.875%
US Dollar Notes, 5.125%, Due February 2030      
Debt Instrument [Line Items]      
Face Value   $ 700,000,000 $ 1,500,000,000
Interest Rate   5.125% 5.125%
US Dollar Notes, 5.375%, Due February 2033      
Debt Instrument [Line Items]      
Face Value   $ 750,000,000 $ 1,500,000,000
Interest Rate   5.375% 5.375%
US Dollar Notes, 5.250%, Due September 2028      
Debt Instrument [Line Items]      
Face Value $ 650,000,000    
Interest Rate 5.25%    
US Dollar Notes, 5.500%, Due September 2030      
Debt Instrument [Line Items]      
Face Value $ 700,000,000    
Interest Rate 5.50%    
US Dollar Notes, 5.625%, Due September 2033      
Debt Instrument [Line Items]      
Face Value $ 1,000,000,000    
Interest Rate 5.625%    
XML 111 R88.htm IDEA: XBRL DOCUMENT v3.23.3
Indebtedness: (Schedule of Credit Facilities) (Details) - USD ($)
Sep. 30, 2023
Sep. 20, 2023
Jan. 28, 2022
Line of Credit Facility [Line Items]      
Committed credit facilities $ 6,300,000,000    
Three Hundred Sixty-Four Day Revolving Credit Expiring January 31, 2023      
Line of Credit Facility [Line Items]      
Committed credit facilities 1,800,000,000    
Multi-year Revolving Credit Facility, Expiring February 10, 2026      
Line of Credit Facility [Line Items]      
Committed credit facilities 2,000,000,000    
Multi-year Revolving Credit Facility, Expiring September 29, 2026      
Line of Credit Facility [Line Items]      
Committed credit facilities $ 2,500,000,000    
Multi-year Revolving Credit Facility, Expiring February 10, 2027      
Line of Credit Facility [Line Items]      
Committed credit facilities     $ 1,900,000,000
Multi-year Revolving Credit Facility, Expiring September 29, 2027      
Line of Credit Facility [Line Items]      
Committed credit facilities   $ 2,300,000,000  
XML 112 R89.htm IDEA: XBRL DOCUMENT v3.23.3
Accumulated Other Comprehensive Losses: (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]            
Total accumulated other comprehensive losses $ (7,706) $ (7,960) $ (6,311) $ (7,403) $ (7,260) $ (8,208)
Accumulated Other Comprehensive Losses            
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]            
Total accumulated other comprehensive losses (9,817) $ (10,045) (9,559) (9,288) $ (9,043) $ (9,577)
Currency translation adjustments            
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]            
Total accumulated other comprehensive losses (8,475)   (8,003) (7,055)    
Pension and other benefits            
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]            
Total accumulated other comprehensive losses (1,757)   (1,822) (2,654)    
Derivatives accounted for as hedges            
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]            
Total accumulated other comprehensive losses $ 415   $ 266 $ 421    
XML 113 R90.htm IDEA: XBRL DOCUMENT v3.23.3
Related Parties - Equity Investments and Other: (Narrative) (Details) - USD ($)
$ in Millions
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Apr. 30, 2023
Mar. 22, 2019
Schedule of Equity Method Investments [Line Items]        
Equity method investments $ 1,238 $ 1,000    
Difference between equity method investment carrying value and book value 881 750    
Dividends from unconsolidated subsidiaries 57 9    
Equity securities, unrealized gain (loss) 52      
Equity securities, unrealized gain (loss), net 41      
EIH        
Schedule of Equity Method Investments [Line Items]        
Ownership percentage     66.73%  
Definite-Lived Intangibles And Other Assets        
Schedule of Equity Method Investments [Line Items]        
Difference between equity method investment carrying value and book value 33 $ 35    
Level 1        
Schedule of Equity Method Investments [Line Items]        
Equity securities, noncurrent $ 378      
IPM India        
Schedule of Equity Method Investments [Line Items]        
Parent ownership percentage 56.30%      
TTI | PMM        
Schedule of Equity Method Investments [Line Items]        
Noncontrolling ownership percentage 33.00%      
Megapolis Group        
Schedule of Equity Method Investments [Line Items]        
Equity method investments $ 351      
Ownership percentage 23.00%      
Cumulative foreign currency translation losses $ 588      
EITA        
Schedule of Equity Method Investments [Line Items]        
Ownership percentage 49.00%      
STAEM        
Schedule of Equity Method Investments [Line Items]        
Ownership percentage 25.00%      
STAEM | EITA        
Schedule of Equity Method Investments [Line Items]        
Ownership percentage 51.00%      
STAEM | Management Et Developpement Des Actifs Et Des Ressources Holding (MADAR Holding)        
Schedule of Equity Method Investments [Line Items]        
Ownership percentage 49.00%      
RBH        
Schedule of Equity Method Investments [Line Items]        
Equity securities       $ 3,280
UTC        
Schedule of Equity Method Investments [Line Items]        
Ownership percentage     25.00%  
UTC | EIH        
Schedule of Equity Method Investments [Line Items]        
Ownership percentage     38.00%  
XML 114 R91.htm IDEA: XBRL DOCUMENT v3.23.3
Related Parties - Equity Investments and Other: (Balance Sheet and Earnings Activity) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]          
Total PMI net revenues $ 9,141 [1],[2] $ 8,032 [1],[2] $ 26,127 [3],[4] $ 23,610 [3],[4]  
Expenses 67 33 180 62  
Trade receivables, related parties [5] 3,891   3,891   $ 3,850
Payables 3,533   3,533   4,076
Related Party          
Schedule of Equity Method Investments [Line Items]          
Total PMI net revenues 857 1,087 2,631 2,634  
Trade receivables, related parties 655   655   688
Payables 33   33   31
Megapolis Group | Related Party          
Schedule of Equity Method Investments [Line Items]          
Total PMI net revenues 530 777 1,714 1,770  
Trade receivables, related parties 394   394   478
Other          
Schedule of Equity Method Investments [Line Items]          
Expenses 67 33 180 62  
Other | Related Party          
Schedule of Equity Method Investments [Line Items]          
Total PMI net revenues 327 $ 310 917 $ 864  
Trade receivables, related parties 261   261   210
Payables $ 33   $ 33   $ 31
[1] Includes net revenues from related parties of $857 million and $1,087 million for the three months ended September 30, 2023 and 2022, respectively
[2] Net of excise taxes of $13,092 million and $12,856 million for the three months ended September 30, 2023 and 2022, respectively
[3] Includes net revenues from related parties of $2,631 million and $2,634 million for the nine months ended September 30, 2023 and 2022, respectively
[4] Net of excise tax on products of $37,140 million and $37,028 million for the nine months ended September 30, 2023 and 2022, respectively
[5] Includes trade receivables from related parties of $655 million and $688 million as of September 30, 2023, and December 31, 2022, respectively (less allowances of $43 million as of September 30, 2023 and $7 million as of December 31, 2022). For further details, see Note 14. Related Parties - Equity Investments and Other.
XML 115 R92.htm IDEA: XBRL DOCUMENT v3.23.3
Sale of Accounts Receivable: (Details)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
arrangement
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
arrangement
Sep. 30, 2022
USD ($)
Sale of Accounts Receivable [Abstract]        
Trade receivable, arrangement | arrangement 2   2  
Servicing liability $ 0 $ 0 $ 0 $ 0
Cumulative trade receivables sold     9,400,000,000 8,400,000,000
Trade receivables sold and derecognized that remain uncollected 670,000,000 512,000,000 670,000,000 512,000,000
Loss on sale of accounts receivable $ 13,000,000 $ 7,000,000 $ 37,000,000 $ 15,000,000
XML 116 R93.htm IDEA: XBRL DOCUMENT v3.23.3
Product Warranty: (Narrative) (Details)
 9 Months Ended
Sep. 30, 2023
Guarantees and Product Warranties [Abstract]  
Standard product warranty term 12 months
XML 117 R94.htm IDEA: XBRL DOCUMENT v3.23.3
Product Warranty: (Movement in Product Warranty Obligations) (Details) - USD ($)
$ in Millions
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Movement in Standard Product Warranty Accrual [Roll Forward]    
Balance at beginning of period $ 104 $ 113
Changes due to:    
Warranties issued 55 107
Settlements (62) (114)
Currency/Other (2) (2)
Balance at end of period $ 95 $ 104
XML 118 R95.htm IDEA: XBRL DOCUMENT v3.23.3
Asset Impairment and Exit Costs: (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, incurred cost   $ 0   $ 0 $ 109 $ 0
Goodwill and non-amortizable intangible assets impairment charge         680  
Pre-tax impairment charge       $ 112   $ 112
Future cash payments for exit costs expected to be paid         74  
Forecast            
Restructuring Cost and Reserve [Line Items]            
Future cash payments for exit costs expected to be paid $ 6          
e-Vapor Products Manufacturing Optimization            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, incurred cost     $ 109      
Contract Termination            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, incurred cost         78  
Contract Termination | e-Vapor Products Manufacturing Optimization            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, incurred cost     78      
Finance Lease Termination | e-Vapor Products Manufacturing Optimization            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, incurred cost     21      
Asset Impairment            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, incurred cost         $ 31  
Asset Impairment | e-Vapor Products Manufacturing Optimization            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, incurred cost     $ 31      
XML 119 R96.htm IDEA: XBRL DOCUMENT v3.23.3
Asset Impairment and Exit Costs: (Asset Impairment and Exit Costs by Segment) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]        
Contract termination charges: $ 0 $ 0 $ 109 $ 0
Contract Termination        
Restructuring Cost and Reserve [Line Items]        
Contract termination charges:     78  
Asset Impairment        
Restructuring Cost and Reserve [Line Items]        
Contract termination charges:     31  
Europe | Operating Segments | Contract Termination        
Restructuring Cost and Reserve [Line Items]        
Contract termination charges:     35  
Europe | Operating Segments | Asset Impairment        
Restructuring Cost and Reserve [Line Items]        
Contract termination charges:     14  
SSEA, CIS & MEA | Operating Segments | Contract Termination        
Restructuring Cost and Reserve [Line Items]        
Contract termination charges:     25  
SSEA, CIS & MEA | Operating Segments | Asset Impairment        
Restructuring Cost and Reserve [Line Items]        
Contract termination charges:     9  
EA, AU & PMI DF | Operating Segments | Contract Termination        
Restructuring Cost and Reserve [Line Items]        
Contract termination charges:     15  
EA, AU & PMI DF | Operating Segments | Asset Impairment        
Restructuring Cost and Reserve [Line Items]        
Contract termination charges:     6  
Americas | Operating Segments | Contract Termination        
Restructuring Cost and Reserve [Line Items]        
Contract termination charges:     3  
Americas | Operating Segments | Asset Impairment        
Restructuring Cost and Reserve [Line Items]        
Contract termination charges:     $ 2  
XML 120 R97.htm IDEA: XBRL DOCUMENT v3.23.3
Asset Impairment and Exit Costs: (Movement in Exit Cost Liabilities) (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2023
USD ($)
Movement in exit cost liabilities  
Liability balance, January 1, 2023 $ 40
Charges, net 78
Cash spent (74)
Currency/other (8)
Liability balance, September 30, 2023 $ 36
XML 121 R98.htm IDEA: XBRL DOCUMENT v3.23.3
Leases: (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Leases [Abstract]        
Operating lease cost $ 66 $ 61 $ 199 $ 187
Amortization of right-of-use assets 9 13 37 60
Interest on lease liabilities 1 0 1 0
Short-term lease cost 15 15 44 45
Variable lease cost 6 6 20 17
Total lease cost $ 97 $ 95 $ 301 $ 309
XML 122 R99.htm IDEA: XBRL DOCUMENT v3.23.3
Supply Chain Financing: (Details) - USD ($)
$ in Billions
Sep. 30, 2023
Dec. 31, 2022
Supplier Finance Program [Line Items]    
Supply chain payment terms 120 days  
Supply Chain Financing Program    
Supplier Finance Program [Line Items]    
Supply chain financing, obligation, current $ 0.8 $ 1.1
XML 123 pm-20230930_htm.xml IDEA: XBRL DOCUMENT 0001413329 2023-01-01 2023-09-30 0001413329 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001413329 pm:A3.600Notesdue2023Member 2023-01-01 2023-09-30 0001413329 pm:A2.875Notesdue20241Member 2023-01-01 2023-09-30 0001413329 pm:A2.875Notesdue20242Member 2023-01-01 2023-09-30 0001413329 pm:A0.625Notesdue2024Member 2023-01-01 2023-09-30 0001413329 pm:A3.250Notesdue2024Member 2023-01-01 2023-09-30 0001413329 pm:A2.750Notesdue2025Member 2023-01-01 2023-09-30 0001413329 pm:A3.375Notesdue2025Member 2023-01-01 2023-09-30 0001413329 pm:A2.750Notesdue2026Member 2023-01-01 2023-09-30 0001413329 pm:A2.875Notesdue2026Member 2023-01-01 2023-09-30 0001413329 pm:A0.125Notesdue2026Member 2023-01-01 2023-09-30 0001413329 pm:A3.125Notesdue2027Member 2023-01-01 2023-09-30 0001413329 pm:A3.125Notesdue2028Member 2023-01-01 2023-09-30 0001413329 pm:A2.875Notesdue2029Member 2023-01-01 2023-09-30 0001413329 pm:A3.375Notesdue2029Member 2023-01-01 2023-09-30 0001413329 pm:A0.800Notesdue2031Member 2023-01-01 2023-09-30 0001413329 pm:A3.125Notesdue2033Member 2023-01-01 2023-09-30 0001413329 pm:A2.000Notesdue2036Member 2023-01-01 2023-09-30 0001413329 pm:A1.875Notesdue2037Member 2023-01-01 2023-09-30 0001413329 pm:A6.375Notesdue2038Member 2023-01-01 2023-09-30 0001413329 pm:A1.450Notesdue2039Member 2023-01-01 2023-09-30 0001413329 pm:A4.375Notesdue2041Member 2023-01-01 2023-09-30 0001413329 pm:A4.500Notesdue2042Member 2023-01-01 2023-09-30 0001413329 pm:A3.875Notesdue2042Member 2023-01-01 2023-09-30 0001413329 pm:A4.125Notesdue2043Member 2023-01-01 2023-09-30 0001413329 pm:A4.875Notesdue2043Member 2023-01-01 2023-09-30 0001413329 pm:A4.250Notesdue2044Member 2023-01-01 2023-09-30 0001413329 2023-10-20 0001413329 2022-01-01 2022-09-30 0001413329 us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001413329 us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001413329 country:KR pm:EAAUPMIDFSegmentMember 2023-01-01 2023-09-30 0001413329 2023-07-01 2023-09-30 0001413329 2022-07-01 2022-09-30 0001413329 us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001413329 us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0001413329 2023-09-30 0001413329 2022-12-31 0001413329 us-gaap:RelatedPartyMember 2023-09-30 0001413329 us-gaap:RelatedPartyMember 2022-12-31 0001413329 pm:SwedishMatchABMember 2023-01-01 2023-09-30 0001413329 pm:SwedishMatchABMember 2022-01-01 2022-09-30 0001413329 2021-12-31 0001413329 2022-09-30 0001413329 us-gaap:CommonStockMember 2021-12-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001413329 us-gaap:RetainedEarningsMember 2021-12-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001413329 us-gaap:TreasuryStockCommonMember 2021-12-31 0001413329 us-gaap:NoncontrollingInterestMember 2021-12-31 0001413329 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001413329 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-09-30 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001413329 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001413329 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-09-30 0001413329 us-gaap:CommonStockMember 2022-09-30 0001413329 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001413329 us-gaap:RetainedEarningsMember 2022-09-30 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001413329 us-gaap:TreasuryStockCommonMember 2022-09-30 0001413329 us-gaap:NoncontrollingInterestMember 2022-09-30 0001413329 us-gaap:CommonStockMember 2022-12-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001413329 us-gaap:RetainedEarningsMember 2022-12-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001413329 us-gaap:TreasuryStockCommonMember 2022-12-31 0001413329 us-gaap:NoncontrollingInterestMember 2022-12-31 0001413329 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001413329 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-09-30 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0001413329 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001413329 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-09-30 0001413329 us-gaap:CommonStockMember 2023-09-30 0001413329 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001413329 us-gaap:RetainedEarningsMember 2023-09-30 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001413329 us-gaap:TreasuryStockCommonMember 2023-09-30 0001413329 us-gaap:NoncontrollingInterestMember 2023-09-30 0001413329 us-gaap:CommonStockMember 2022-06-30 0001413329 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001413329 us-gaap:RetainedEarningsMember 2022-06-30 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001413329 us-gaap:TreasuryStockCommonMember 2022-06-30 0001413329 us-gaap:NoncontrollingInterestMember 2022-06-30 0001413329 2022-06-30 0001413329 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001413329 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001413329 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001413329 us-gaap:TreasuryStockCommonMember 2022-07-01 2022-09-30 0001413329 us-gaap:CommonStockMember 2023-06-30 0001413329 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001413329 us-gaap:RetainedEarningsMember 2023-06-30 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001413329 us-gaap:TreasuryStockCommonMember 2023-06-30 0001413329 us-gaap:NoncontrollingInterestMember 2023-06-30 0001413329 2023-06-30 0001413329 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001413329 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001413329 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001413329 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0001413329 pm:GeographicalSegmentMember 2023-01-01 2023-09-30 0001413329 pm:GeographicalSegmentMember 2022-01-01 2022-12-31 0001413329 pm:NoncontrollingInterestPurchasePhilipMorrisTtnMamulleriSanayiVeTicaretAMember 2022-03-31 0001413329 pm:NoncontrollingInterestPurchasePhilipMorrisPazarlamaVeSatAMember 2022-03-31 0001413329 pm:NoncontrollingInterestPurchaseMember 2022-01-01 2022-03-31 0001413329 pm:NoncontrollingInterestPurchaseMember 2022-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001413329 2023-01-01 2023-01-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-01-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-01-31 0001413329 pm:SwedishMatchABMember 2022-11-11 0001413329 pm:SwedishMatchABMember 2022-12-31 0001413329 pm:SwedishMatchABMember 2022-11-11 2022-11-11 0001413329 pm:SwedishMatchABMember 2022-11-11 2022-12-31 0001413329 pm:SwedishMatchABMember 2023-02-17 0001413329 pm:SwedishMatchABMember 2023-09-12 2023-09-12 0001413329 pm:SwedishMatchABMember 2022-11-11 2023-09-30 0001413329 pm:SwedishMatchABMember 2023-09-30 0001413329 pm:SwedishMatchABMember 2022-11-12 2023-03-31 0001413329 pm:SwedishMatchABMember 2022-10-01 2022-12-31 0001413329 pm:SwedishMatchABMember us-gaap:TrademarksMember 2023-09-30 2023-09-30 0001413329 srt:MinimumMember pm:SwedishMatchABMember us-gaap:TrademarksMember 2023-09-30 2023-09-30 0001413329 srt:MaximumMember pm:SwedishMatchABMember us-gaap:TrademarksMember 2023-09-30 2023-09-30 0001413329 pm:SwedishMatchABMember us-gaap:TrademarksMember 2023-09-30 2023-09-30 0001413329 pm:SwedishMatchABMember us-gaap:TechnologyBasedIntangibleAssetsMember 2023-09-30 2023-09-30 0001413329 srt:MinimumMember pm:SwedishMatchABMember us-gaap:CustomerRelationshipsMember 2023-09-30 2023-09-30 0001413329 srt:MaximumMember pm:SwedishMatchABMember us-gaap:CustomerRelationshipsMember 2023-09-30 2023-09-30 0001413329 pm:SwedishMatchABMember us-gaap:CustomerRelationshipsMember 2023-09-30 2023-09-30 0001413329 pm:SwedishMatchABMember 2022-01-01 2022-12-31 0001413329 srt:ProFormaMember pm:PMIAndSwedishMatchMember 2022-01-01 2022-12-31 0001413329 srt:ProFormaMember pm:PMIAndSwedishMatchMember 2021-01-01 2021-12-31 0001413329 pm:PMIAndSwedishMatchMember 2022-01-01 2022-12-31 0001413329 pm:PMIAndSwedishMatchMember 2021-01-01 2021-12-31 0001413329 pm:AltriaGroupMember 2022-10-20 0001413329 pm:AltriaGroupMember 2023-07-14 0001413329 country:UA pm:WarInUkraineMember 2023-09-30 0001413329 country:RU pm:WarInUkraineMember 2023-09-30 0001413329 country:UA us-gaap:CostOfSalesMember pm:WarInUkraineMember 2023-01-01 2023-09-30 0001413329 country:UA pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2023-01-01 2023-09-30 0001413329 country:UA pm:WarInUkraineMember 2023-01-01 2023-09-30 0001413329 country:UA us-gaap:CostOfSalesMember pm:WarInUkraineMember 2022-01-01 2022-09-30 0001413329 country:UA pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2022-01-01 2022-09-30 0001413329 country:UA pm:WarInUkraineMember 2022-01-01 2022-09-30 0001413329 country:RU us-gaap:CostOfSalesMember pm:WarInUkraineMember 2023-01-01 2023-09-30 0001413329 country:RU pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2023-01-01 2023-09-30 0001413329 country:RU pm:WarInUkraineMember 2023-01-01 2023-09-30 0001413329 country:RU us-gaap:CostOfSalesMember pm:WarInUkraineMember 2022-01-01 2022-09-30 0001413329 country:RU pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2022-01-01 2022-09-30 0001413329 country:RU pm:WarInUkraineMember 2022-01-01 2022-09-30 0001413329 us-gaap:CostOfSalesMember pm:WarInUkraineMember 2023-01-01 2023-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2023-01-01 2023-09-30 0001413329 pm:WarInUkraineMember 2023-01-01 2023-09-30 0001413329 us-gaap:CostOfSalesMember pm:WarInUkraineMember 2022-01-01 2022-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2022-01-01 2022-09-30 0001413329 pm:WarInUkraineMember 2022-01-01 2022-09-30 0001413329 country:UA us-gaap:CostOfSalesMember pm:WarInUkraineMember 2023-07-01 2023-09-30 0001413329 country:UA pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2023-07-01 2023-09-30 0001413329 country:UA pm:WarInUkraineMember 2023-07-01 2023-09-30 0001413329 country:UA us-gaap:CostOfSalesMember pm:WarInUkraineMember 2022-07-01 2022-09-30 0001413329 country:UA pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2022-07-01 2022-09-30 0001413329 country:UA pm:WarInUkraineMember 2022-07-01 2022-09-30 0001413329 country:RU us-gaap:CostOfSalesMember pm:WarInUkraineMember 2023-07-01 2023-09-30 0001413329 country:RU pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2023-07-01 2023-09-30 0001413329 country:RU pm:WarInUkraineMember 2023-07-01 2023-09-30 0001413329 country:RU us-gaap:CostOfSalesMember pm:WarInUkraineMember 2022-07-01 2022-09-30 0001413329 country:RU pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2022-07-01 2022-09-30 0001413329 country:RU pm:WarInUkraineMember 2022-07-01 2022-09-30 0001413329 us-gaap:CostOfSalesMember pm:WarInUkraineMember 2023-07-01 2023-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2023-07-01 2023-09-30 0001413329 pm:WarInUkraineMember 2023-07-01 2023-09-30 0001413329 us-gaap:CostOfSalesMember pm:WarInUkraineMember 2022-07-01 2022-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:WarInUkraineMember 2022-07-01 2022-09-30 0001413329 pm:WarInUkraineMember 2022-07-01 2022-09-30 0001413329 pm:A2022PerformanceIncentivePlanMember 2022-05-31 0001413329 pm:A2022PerformanceIncentivePlanMember 2023-09-30 0001413329 pm:A2017NonEmployeeDirectorsPlanMember 2017-05-31 0001413329 pm:A2017NonEmployeeDirectorsPlanMember 2023-09-30 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2022-09-30 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0001413329 us-gaap:RestrictedStockUnitsRSUMember pm:GrantDateFairValueMember 2023-01-01 2023-09-30 0001413329 us-gaap:RestrictedStockUnitsRSUMember pm:FairValueMember 2023-01-01 2023-09-30 0001413329 us-gaap:PerformanceSharesMember 2023-01-01 2023-09-30 0001413329 us-gaap:PerformanceSharesMember 2023-09-30 0001413329 srt:MinimumMember us-gaap:PerformanceSharesMember 2023-01-01 2023-09-30 0001413329 srt:MaximumMember us-gaap:PerformanceSharesMember 2023-01-01 2023-09-30 0001413329 pm:PerformanceShareUnitsOtherPerformanceMetricsMember 2023-01-01 2023-09-30 0001413329 pm:PerformanceShareUnitsTSRPerformanceMetricMember 2023-01-01 2023-09-30 0001413329 us-gaap:PerformanceSharesMember 2022-01-01 2022-09-30 0001413329 pm:PerformanceShareUnitsOtherPerformanceMetricsMember 2022-01-01 2022-09-30 0001413329 pm:PerformanceShareUnitsTSRPerformanceMetricMember 2022-01-01 2022-09-30 0001413329 us-gaap:PerformanceSharesMember pm:GrantDateFairValueMember 2023-01-01 2023-09-30 0001413329 us-gaap:PerformanceSharesMember pm:FairValueMember 2023-01-01 2023-09-30 0001413329 us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-09-30 0001413329 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-09-30 0001413329 us-gaap:PensionPlansDefinedBenefitMember 2023-07-01 2023-09-30 0001413329 us-gaap:PensionPlansDefinedBenefitMember 2022-07-01 2022-09-30 0001413329 pm:PostemploymentBenefitPlansMember 2023-01-01 2023-09-30 0001413329 pm:PostemploymentBenefitPlansMember 2022-01-01 2022-09-30 0001413329 pm:PostemploymentBenefitPlansMember 2023-07-01 2023-09-30 0001413329 pm:PostemploymentBenefitPlansMember 2022-07-01 2022-09-30 0001413329 us-gaap:PostretirementBenefitCostsMember 2023-01-01 2023-09-30 0001413329 us-gaap:PostretirementBenefitCostsMember 2022-01-01 2022-09-30 0001413329 us-gaap:PostretirementBenefitCostsMember 2023-07-01 2023-09-30 0001413329 us-gaap:PostretirementBenefitCostsMember 2022-07-01 2022-09-30 0001413329 2022-04-01 2022-06-30 0001413329 pm:WellnessAndHealthcareSegmentMember 2023-01-01 2023-09-30 0001413329 us-gaap:InProcessResearchAndDevelopmentMember 2023-01-01 2023-09-30 0001413329 pm:EuropeSegmentMember 2022-12-31 0001413329 pm:SSEACISMEASegmentMember 2022-12-31 0001413329 pm:EAAUPMIDFSegmentMember 2022-12-31 0001413329 pm:AmericasSegmentMember 2022-12-31 0001413329 pm:SwedishMatchABSegmentMember 2022-12-31 0001413329 pm:WellnessAndHealthcareSegmentMember 2022-12-31 0001413329 pm:EuropeSegmentMember 2023-01-01 2023-09-30 0001413329 pm:SSEACISMEASegmentMember 2023-01-01 2023-09-30 0001413329 pm:EAAUPMIDFSegmentMember 2023-01-01 2023-09-30 0001413329 pm:AmericasSegmentMember 2023-01-01 2023-09-30 0001413329 pm:SwedishMatchABSegmentMember 2023-01-01 2023-09-30 0001413329 pm:EuropeSegmentMember 2023-09-30 0001413329 pm:SSEACISMEASegmentMember 2023-09-30 0001413329 pm:EAAUPMIDFSegmentMember 2023-09-30 0001413329 pm:AmericasSegmentMember 2023-09-30 0001413329 pm:SwedishMatchABSegmentMember 2023-09-30 0001413329 pm:WellnessAndHealthcareSegmentMember 2023-09-30 0001413329 us-gaap:TrademarksMember 2023-09-30 0001413329 us-gaap:TrademarksMember 2022-12-31 0001413329 us-gaap:DevelopedTechnologyRightsMember 2023-09-30 0001413329 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001413329 us-gaap:OtherIntangibleAssetsMember 2023-09-30 0001413329 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0001413329 us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember 2023-01-01 2023-09-30 0001413329 us-gaap:DevelopedTechnologyRightsMember pm:WellnessAndHealthcareSegmentMember 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-12-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-09-30 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-12-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-09-30 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-12-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-09-30 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-09-30 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-12-31 0001413329 us-gaap:ForeignExchangeContractMember 2023-01-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember 2022-01-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:SalesMember 2023-01-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:SalesMember 2022-01-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember pm:MarketingAdministrationAndResearchCostsMember 2023-01-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember pm:MarketingAdministrationAndResearchCostsMember 2022-01-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:InterestExpenseMember 2023-01-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:InterestExpenseMember 2022-01-01 2022-09-30 0001413329 us-gaap:InterestRateContractMember 2023-01-01 2023-09-30 0001413329 us-gaap:InterestRateContractMember 2022-01-01 2022-09-30 0001413329 us-gaap:InterestRateContractMember us-gaap:InterestExpenseMember 2023-01-01 2023-09-30 0001413329 us-gaap:InterestRateContractMember us-gaap:InterestExpenseMember 2022-01-01 2022-09-30 0001413329 us-gaap:CommodityContractMember 2023-01-01 2023-09-30 0001413329 us-gaap:CommodityContractMember 2022-01-01 2022-09-30 0001413329 us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001413329 us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001413329 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2023-01-01 2023-09-30 0001413329 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2022-01-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2023-01-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2022-01-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember pm:MarketingAdministrationAndResearchCostsMember 2023-01-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember pm:MarketingAdministrationAndResearchCostsMember 2022-01-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-01-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember 2023-07-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember 2022-07-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:SalesMember 2023-07-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:SalesMember 2022-07-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember pm:MarketingAdministrationAndResearchCostsMember 2023-07-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember pm:MarketingAdministrationAndResearchCostsMember 2022-07-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:InterestExpenseMember 2023-07-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:InterestExpenseMember 2022-07-01 2022-09-30 0001413329 us-gaap:InterestRateContractMember 2023-07-01 2023-09-30 0001413329 us-gaap:InterestRateContractMember 2022-07-01 2022-09-30 0001413329 us-gaap:InterestRateContractMember us-gaap:InterestExpenseMember 2023-07-01 2023-09-30 0001413329 us-gaap:InterestRateContractMember us-gaap:InterestExpenseMember 2022-07-01 2022-09-30 0001413329 us-gaap:CommodityContractMember 2023-07-01 2023-09-30 0001413329 us-gaap:CommodityContractMember 2022-07-01 2022-09-30 0001413329 us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001413329 us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0001413329 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2023-07-01 2023-09-30 0001413329 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2022-07-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-07-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-07-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2023-07-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2022-07-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember pm:MarketingAdministrationAndResearchCostsMember 2023-07-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember pm:MarketingAdministrationAndResearchCostsMember 2022-07-01 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-07-01 2023-09-30 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-07-01 2022-09-30 0001413329 us-gaap:FairValueHedgingMember 2023-09-30 0001413329 pm:ForeignDebtMember us-gaap:NetInvestmentHedgingMember 2023-01-01 2023-09-30 0001413329 pm:ForeignDebtMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-09-30 0001413329 pm:ForeignDebtMember us-gaap:NetInvestmentHedgingMember 2023-07-01 2023-09-30 0001413329 pm:ForeignDebtMember us-gaap:NetInvestmentHedgingMember 2022-07-01 2022-09-30 0001413329 us-gaap:OtherComprehensiveIncomeMember 2022-12-31 0001413329 us-gaap:OtherComprehensiveIncomeMember 2021-12-31 0001413329 us-gaap:OtherComprehensiveIncomeMember 2023-06-30 0001413329 us-gaap:OtherComprehensiveIncomeMember 2022-06-30 0001413329 us-gaap:OtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0001413329 us-gaap:OtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001413329 us-gaap:OtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001413329 us-gaap:OtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001413329 us-gaap:OtherComprehensiveIncomeMember 2023-09-30 0001413329 us-gaap:OtherComprehensiveIncomeMember 2022-09-30 0001413329 us-gaap:ForeignExchangeContractMember 2023-09-30 0001413329 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2023-09-30 0001413329 pm:EuropeSegmentMember 2022-01-01 2022-09-30 0001413329 pm:EuropeSegmentMember 2023-07-01 2023-09-30 0001413329 pm:EuropeSegmentMember 2022-07-01 2022-09-30 0001413329 pm:SSEACISMEASegmentMember 2022-01-01 2022-09-30 0001413329 pm:SSEACISMEASegmentMember 2023-07-01 2023-09-30 0001413329 pm:SSEACISMEASegmentMember 2022-07-01 2022-09-30 0001413329 pm:EAAUPMIDFSegmentMember 2022-01-01 2022-09-30 0001413329 pm:EAAUPMIDFSegmentMember 2023-07-01 2023-09-30 0001413329 pm:EAAUPMIDFSegmentMember 2022-07-01 2022-09-30 0001413329 pm:AmericasSegmentMember 2022-01-01 2022-09-30 0001413329 pm:AmericasSegmentMember 2023-07-01 2023-09-30 0001413329 pm:AmericasSegmentMember 2022-07-01 2022-09-30 0001413329 pm:SwedishMatchABSegmentMember 2022-01-01 2022-09-30 0001413329 pm:SwedishMatchABSegmentMember 2023-07-01 2023-09-30 0001413329 pm:SwedishMatchABSegmentMember 2022-07-01 2022-09-30 0001413329 pm:WellnessAndHealthcareSegmentMember 2022-01-01 2022-09-30 0001413329 pm:WellnessAndHealthcareSegmentMember 2023-07-01 2023-09-30 0001413329 pm:WellnessAndHealthcareSegmentMember 2022-07-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:EuropeSegmentMember 2023-01-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:EuropeSegmentMember 2022-01-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:EuropeSegmentMember 2023-07-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:EuropeSegmentMember 2022-07-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:SSEACISMEASegmentMember 2023-01-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:SSEACISMEASegmentMember 2022-01-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:SSEACISMEASegmentMember 2023-07-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:SSEACISMEASegmentMember 2022-07-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:EAAUPMIDFSegmentMember 2023-01-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:EAAUPMIDFSegmentMember 2022-01-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:EAAUPMIDFSegmentMember 2023-07-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:EAAUPMIDFSegmentMember 2022-07-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:AmericasSegmentMember 2023-01-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:AmericasSegmentMember 2022-01-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:AmericasSegmentMember 2023-07-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:AmericasSegmentMember 2022-07-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:SwedishMatchABSegmentMember 2023-01-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:SwedishMatchABSegmentMember 2022-01-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:SwedishMatchABSegmentMember 2023-07-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember pm:SwedishMatchABSegmentMember 2022-07-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember 2023-01-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember 2022-01-01 2022-09-30 0001413329 pm:CombustibleTobaccoProductsMember 2023-07-01 2023-09-30 0001413329 pm:CombustibleTobaccoProductsMember 2022-07-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:EuropeSegmentMember 2023-01-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:EuropeSegmentMember 2022-01-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:EuropeSegmentMember 2023-07-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:EuropeSegmentMember 2022-07-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:SSEACISMEASegmentMember 2023-01-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:SSEACISMEASegmentMember 2022-01-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:SSEACISMEASegmentMember 2023-07-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:SSEACISMEASegmentMember 2022-07-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:EAAUPMIDFSegmentMember 2023-01-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:EAAUPMIDFSegmentMember 2022-01-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:EAAUPMIDFSegmentMember 2023-07-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:EAAUPMIDFSegmentMember 2022-07-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:AmericasSegmentMember 2023-01-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:AmericasSegmentMember 2022-01-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:AmericasSegmentMember 2023-07-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:AmericasSegmentMember 2022-07-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:SwedishMatchABSegmentMember 2023-01-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:SwedishMatchABSegmentMember 2022-01-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:SwedishMatchABSegmentMember 2023-07-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:SwedishMatchABSegmentMember 2022-07-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:SmokeFreeProductsExcludingWellnessAndHealthcareMember 2023-01-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:SmokeFreeProductsExcludingWellnessAndHealthcareMember 2022-01-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:SmokeFreeProductsExcludingWellnessAndHealthcareMember 2023-07-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:SmokeFreeProductsExcludingWellnessAndHealthcareMember 2022-07-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:WellnessAndHealthcareSegmentMember 2023-01-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:WellnessAndHealthcareSegmentMember 2022-01-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember pm:WellnessAndHealthcareSegmentMember 2023-07-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember pm:WellnessAndHealthcareSegmentMember 2022-07-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember 2023-01-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember 2022-01-01 2022-09-30 0001413329 pm:SmokeFreeProductsMember 2023-07-01 2023-09-30 0001413329 pm:SmokeFreeProductsMember 2022-07-01 2022-09-30 0001413329 pm:NetRevenuesMember pm:SSEACISMEASegmentMember 2023-01-01 2023-03-31 0001413329 pm:MarketingAdministrationAndResearchCostsMember 2023-07-01 2023-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:EuropeSegmentMember 2023-01-01 2023-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:EuropeSegmentMember 2023-07-01 2023-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:SSEACISMEASegmentMember 2023-01-01 2023-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:SSEACISMEASegmentMember 2023-07-01 2023-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:EAAUPMIDFSegmentMember 2023-01-01 2023-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:EAAUPMIDFSegmentMember 2023-07-01 2023-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:AmericasSegmentMember 2023-07-01 2023-09-30 0001413329 pm:MarketingAdministrationAndResearchCostsMember pm:AmericasSegmentMember 2023-01-01 2023-09-30 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember country:CA pm:SmokingAndHealthClassActionsMember 2015-05-27 2015-05-27 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember country:CA us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member 2015-05-27 2015-05-27 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember country:CA us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember pm:RothmansBensonAndHedgesInc.RBHMember 2015-05-27 2015-05-27 0001413329 pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember country:CA pm:AppellateRulingMember pm:SmokingAndHealthClassActionsMember pm:RothmansBensonAndHedgesInc.RBHMember 2015-10-01 2015-10-30 0001413329 pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember country:CA pm:AppellateRulingMember pm:SmokingAndHealthClassActionsMember pm:ImperialTobaccoLtd.Member 2015-10-01 2015-10-30 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember country:CA us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member 2019-03-01 2019-03-01 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember country:CA us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember pm:RothmansBensonAndHedgesInc.RBHMember 2019-03-01 2019-03-01 0001413329 pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember country:CA us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member 2019-03-01 2019-03-01 0001413329 pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember country:CA pm:AppellateRulingMember pm:SmokingAndHealthClassActionsMember pm:RothmansBensonAndHedgesInc.RBHMember 2019-03-01 2019-03-01 0001413329 pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember country:CA pm:AppellateRulingMember pm:SmokingAndHealthClassActionsMember pm:RothmansBensonAndHedgesInc.RBHMember 2019-01-01 2019-03-31 0001413329 pm:CeciliaLetourneauMember country:CA pm:SmokingAndHealthClassActionsMember 2015-05-27 2015-05-27 0001413329 pm:CeciliaLetourneauMember country:CA us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member 2015-05-27 2015-05-27 0001413329 pm:CeciliaLetourneauMember country:CA us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember pm:RothmansBensonAndHedgesInc.RBHMember 2015-05-27 2015-05-27 0001413329 pm:CeciliaLetourneauMember country:CA us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember pm:RothmansBensonAndHedgesInc.RBHMember 2019-03-01 2019-03-01 0001413329 pm:AdamsMember country:CA us-gaap:PendingLitigationMember 2009-07-10 2009-07-10 0001413329 pm:SuzanneJacklinMember country:CA us-gaap:PendingLitigationMember 2012-06-20 2012-06-20 0001413329 pm:CombustibleProductsMember pm:IndividualSmokingAndHealthCasesMember 2023-09-30 0001413329 pm:CombustibleProductsMember pm:IndividualSmokingAndHealthCasesMember 2022-09-30 0001413329 pm:CombustibleProductsMember pm:SmokingAndHealthClassActionsMember 2023-09-30 0001413329 pm:CombustibleProductsMember pm:SmokingAndHealthClassActionsMember 2022-09-30 0001413329 pm:CombustibleProductsMember pm:HealthCareCostRecoveryActionsMember 2023-09-30 0001413329 pm:CombustibleProductsMember pm:HealthCareCostRecoveryActionsMember 2022-09-30 0001413329 pm:CombustibleProductsMember pm:LabelRelatedClassActionMember 2023-09-30 0001413329 pm:CombustibleProductsMember pm:LabelRelatedClassActionMember 2022-09-30 0001413329 pm:CombustibleProductsMember pm:IndividualLabelRelatedCasesMember 2023-09-30 0001413329 pm:CombustibleProductsMember pm:IndividualLabelRelatedCasesMember 2022-09-30 0001413329 pm:CombustibleProductsMember pm:PublicCivilActionsMember 2023-09-30 0001413329 pm:CombustibleProductsMember pm:PublicCivilActionsMember 2022-09-30 0001413329 pm:CaseDecidedInFavorOfPlaintiffMember 2023-09-30 0001413329 pm:CasesOnAppealSubjectToAnAppealOrWithThePossibilityToBeAppealedByASubsidiaryOfTheCompanyMember 2023-09-30 0001413329 pm:HugoLespadaMember country:AR us-gaap:JudicialRulingMember pm:SmokingAndHealthIndividualActionsMember 2016-08-05 2016-08-05 0001413329 pm:ClaudiaMilanoMember country:AR us-gaap:JudicialRulingMember pm:SmokingAndHealthIndividualActionsMember 2021-06-17 2021-06-17 0001413329 pm:ClaudiaMilanoMember country:AR us-gaap:JudicialRulingMember pm:SmokingAndHealthIndividualActionsMember 2021-07-02 2021-07-02 0001413329 pm:ClaudiaMilanoMember country:AR us-gaap:JudicialRulingMember pm:SmokingAndHealthIndividualActionsMember 2021-12-16 2021-12-16 0001413329 pm:SenemYilmazelMember country:TR us-gaap:JudicialRulingMember pm:SmokingAndHealthIndividualActionsMember 2023-06-23 2023-06-23 0001413329 pm:CombustibleProductsMember country:AR pm:IndividualSmokingAndHealthCasesMember 2023-09-30 0001413329 pm:CombustibleProductsMember country:AU pm:IndividualSmokingAndHealthCasesMember 2023-09-30 0001413329 pm:CombustibleProductsMember country:CA pm:IndividualSmokingAndHealthCasesMember 2023-09-30 0001413329 pm:CombustibleProductsMember country:CL pm:IndividualSmokingAndHealthCasesMember 2023-09-30 0001413329 pm:CombustibleProductsMember country:PH pm:IndividualSmokingAndHealthCasesMember 2023-09-30 0001413329 pm:CombustibleProductsMember country:TR pm:IndividualSmokingAndHealthCasesMember 2023-09-30 0001413329 pm:CombustibleProductsMember pm:ScotlandMember pm:IndividualSmokingAndHealthCasesMember 2023-09-30 0001413329 pm:CombustibleProductsMember country:BR pm:HealthCareCostRecoveryActionsMember 2023-09-30 0001413329 pm:CombustibleProductsMember country:CA pm:HealthCareCostRecoveryActionsMember 2023-09-30 0001413329 pm:CombustibleProductsMember country:KR pm:HealthCareCostRecoveryActionsMember 2023-09-30 0001413329 pm:CombustibleProductsMember country:NG pm:HealthCareCostRecoveryActionsMember 2023-09-30 0001413329 pm:TheAttorneyGeneralOfLagosStateMember country:NG us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember 2008-03-13 2008-03-13 0001413329 pm:TheAttorneyGeneralOfKanoStateMember country:NG us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember 2007-05-09 2007-05-09 0001413329 pm:TheAttorneyGeneralOfGombeStateMember country:NG us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember 2008-10-17 2008-10-17 0001413329 pm:TheAttorneyGeneralOfOyoStateMember country:NG us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember 2007-05-25 2007-05-25 0001413329 pm:TheAttorneyGeneralOfOgunStateMember country:NG us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember 2008-02-26 2008-02-26 0001413329 country:KR pm:HealthCareCostRecoveryActionsMember 2014-04-14 2014-04-14 0001413329 pm:CombustibleProductsMember country:IT pm:IndividualLabelRelatedCasesMember 2023-09-30 0001413329 pm:CombustibleProductsMember country:CL pm:IndividualLabelRelatedCasesMember 2023-09-30 0001413329 pm:CombustibleProductsMember country:VE pm:PublicCivilActionsMember 2023-09-30 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember country:TH us-gaap:PendingLitigationMember pm:OtherLitigationMember 2016-01-18 2016-01-18 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember country:TH pm:OtherLitigationMember 2016-01-18 2016-01-18 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember country:TH pm:OtherLitigationMember 2019-11-01 2019-11-30 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember country:TH pm:OtherLitigationMember 2022-06-01 2022-06-01 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember country:TH pm:OtherLitigationMember 2017-01-26 2017-01-26 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember country:TH pm:OtherLitigationMember 2020-03-01 2020-03-31 0001413329 pm:TheSouthKoreanBoardOfAuditAndInspectionMember country:KR pm:OtherLitigationMember 2016-11-01 2017-03-31 0001413329 pm:TheSouthKoreanBoardOfAuditAndInspectionMember country:KR pm:OtherLitigationMember 2016-01-01 2016-12-31 0001413329 pm:TheSouthKoreanBoardOfAuditAndInspectionMember country:KR pm:OtherLitigationMember 2017-01-01 2017-03-31 0001413329 pm:TheSouthKoreanBoardOfAuditAndInspectionMember country:KR pm:OtherLitigationMember 2020-01-01 2020-01-31 0001413329 pm:TheSouthKoreanBoardOfAuditAndInspectionMember country:KR pm:OtherLitigationMember 2020-06-01 2020-06-30 0001413329 country:KR pm:EAAUPMIDFSegmentMember 2023-04-01 2023-06-30 0001413329 pm:OtherLitigationMember 2022-06-15 2022-06-15 0001413329 pm:CanadianGovernmentMember 2020-10-17 0001413329 pm:CanadianGovernmentMember 2022-03-31 0001413329 us-gaap:FinancialGuaranteeMember pm:MedicagoIncMember 2022-08-31 0001413329 country:RU 2023-01-01 2023-09-30 0001413329 country:RU 2023-07-01 2023-09-30 0001413329 pm:SwedishMatchABMember 2023-07-01 2023-09-30 0001413329 srt:MinimumMember srt:ScenarioForecastMember 2023-01-01 2023-12-31 0001413329 srt:MaximumMember srt:ScenarioForecastMember 2023-01-01 2023-12-31 0001413329 srt:MinimumMember 2023-01-01 2023-09-30 0001413329 srt:MaximumMember 2023-01-01 2023-09-30 0001413329 2021-10-01 2021-10-31 0001413329 us-gaap:CommercialPaperMember 2023-09-30 0001413329 us-gaap:CommercialPaperMember 2022-12-31 0001413329 us-gaap:BankLoanObligationsMember 2023-09-30 0001413329 us-gaap:BankLoanObligationsMember 2022-12-31 0001413329 pm:UsDollarNotesMember 2023-09-30 0001413329 pm:UsDollarNotesMember 2022-12-31 0001413329 srt:MinimumMember pm:UsDollarNotesMember 2023-09-30 0001413329 srt:MaximumMember pm:UsDollarNotesMember 2023-09-30 0001413329 pm:UsDollarNotesMember 2023-01-01 2023-09-30 0001413329 pm:UsDollarNotesMember 2023-09-30 0001413329 pm:UsDollarNotesMember 2022-12-31 0001413329 srt:MinimumMember pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2023-09-30 0001413329 srt:MaximumMember pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2023-09-30 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2023-01-01 2023-09-30 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2023-09-30 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2022-12-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2023-01-01 2023-09-30 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2023-09-30 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2022-12-31 0001413329 pm:EuroBankLoanMember pm:ForeignCurrencyObligationsMember 2023-01-01 2023-09-30 0001413329 pm:EuroBankLoanMember pm:ForeignCurrencyObligationsMember 2023-09-30 0001413329 pm:EuroBankLoanMember pm:ForeignCurrencyObligationsMember 2022-12-31 0001413329 srt:MinimumMember pm:SwedishKronaNotesMember pm:ForeignCurrencyObligationsMember 2023-09-30 0001413329 srt:MaximumMember pm:SwedishKronaNotesMember pm:ForeignCurrencyObligationsMember 2023-09-30 0001413329 pm:SwedishKronaNotesMember pm:ForeignCurrencyObligationsMember 2023-01-01 2023-09-30 0001413329 pm:SwedishKronaNotesMember pm:ForeignCurrencyObligationsMember 2023-09-30 0001413329 pm:SwedishKronaNotesMember pm:ForeignCurrencyObligationsMember 2022-12-31 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2023-01-01 2023-09-30 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2023-09-30 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2022-12-31 0001413329 us-gaap:FairValueInputsLevel1Member 2023-09-30 0001413329 us-gaap:FairValueInputsLevel2Member 2023-09-30 0001413329 pm:SeniorUnsecuredBridgeFacilityMember 2022-05-11 2022-05-11 0001413329 pm:SeniorUnsecuredBridgeFacilityMember 2022-05-11 0001413329 pm:SeniorUnsecuredTermLoanMember 2022-06-23 0001413329 pm:SeniorUnsecuredTermLoanMember us-gaap:DebtInstrumentRedemptionPeriodOneMember 2022-06-23 0001413329 pm:SeniorUnsecuredTermLoanMember us-gaap:DebtInstrumentRedemptionPeriodOneMember 2022-06-23 2022-06-23 0001413329 pm:SeniorUnsecuredTermLoanMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2022-06-23 0001413329 pm:SeniorUnsecuredBridgeFacilityMember 2022-06-23 0001413329 pm:SwedishMatchABMember pm:SeniorUnsecuredBridgeFacilityMember 2022-11-07 2022-11-10 0001413329 pm:SwedishMatchABMember pm:SeniorUnsecuredBridgeFacilityMember 2022-11-07 2022-11-07 0001413329 pm:SwedishMatchABMember pm:SeniorUnsecuredBridgeFacilityMember 2022-11-10 2022-11-10 0001413329 pm:SwedishMatchABMember pm:SeniorUnsecuredTermLoanMember 2022-11-07 2022-11-07 0001413329 pm:SwedishMatchABMember pm:SeniorUnsecuredTermLoanMember us-gaap:DebtInstrumentRedemptionPeriodOneMember 2022-11-07 2022-11-07 0001413329 pm:SwedishMatchABMember pm:SeniorUnsecuredTermLoanMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2022-11-07 2022-11-07 0001413329 pm:SwedishMatchABMember pm:SeniorUnsecuredBridgeFacilityMember 2022-11-21 2022-11-21 0001413329 pm:SwedishMatchABMember pm:SeniorUnsecuredBridgeFacilityMember 2023-02-17 2023-02-17 0001413329 pm:SwedishMatchABMember pm:SeniorUnsecuredTermLoanMember 2022-12-31 0001413329 pm:SwedishMatchABMember pm:SeniorUnsecuredTermLoanMember 2023-09-30 0001413329 pm:USDollarNotes4875DueFebruary2026Member 2023-02-28 0001413329 pm:USDollarNotes4875DueFebruary2028Member 2023-02-28 0001413329 pm:USDollarNotes5125DueFebruary2030Member 2023-02-28 0001413329 pm:USDollarNotes5375DueFebruary2033Member 2023-02-28 0001413329 pm:USDollarNotes4875DueFebruary2026Member 2023-05-30 0001413329 pm:USDollarNotes4875DueFebruary2028Member 2023-05-30 0001413329 pm:USDollarNotes5125DueFebruary2030Member 2023-05-30 0001413329 pm:USDollarNotes5375DueFebruary2033Member 2023-05-30 0001413329 pm:USDollarNotes5250DueSeptember2028Member 2023-09-30 0001413329 pm:USDollarNotes5500DueSeptember2030Member 2023-09-30 0001413329 pm:USDollarNotes5625DueSeptember2033Member 2023-09-30 0001413329 pm:SeniorUnsecuredBridgeFacilityMember 2023-02-17 2023-02-17 0001413329 pm:ThreeHundredSixtyFourDayRevolvingCreditExpiringJanuary302024Member 2023-09-30 0001413329 pm:MultiYearRevolvingCreditFacilityExpiringFebruary102026Member 2023-09-30 0001413329 pm:MultiYearRevolvingCreditFacilityExpiringSeptember292026Member 2023-09-30 0001413329 pm:MultiYearRevolvingCreditFacilityExpiringFebruary102027Member 2022-01-28 0001413329 pm:MultiYearRevolvingCreditFacilityExpiringSeptember292027Member 2023-09-20 0001413329 pm:ShortTermCreditArrangementMember 2023-09-30 0001413329 pm:ShortTermCreditArrangementMember 2022-12-31 0001413329 us-gaap:AccumulatedTranslationAdjustmentMember 2023-09-30 0001413329 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001413329 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0001413329 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-09-30 0001413329 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001413329 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-09-30 0001413329 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-09-30 0001413329 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001413329 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-09-30 0001413329 pm:DefiniteLivedIntangiblesAndOtherAssetsMember 2023-09-30 0001413329 pm:DefiniteLivedIntangiblesAndOtherAssetsMember 2022-12-31 0001413329 2022-01-01 2022-12-31 0001413329 pm:MegapolisMember 2023-09-30 0001413329 pm:EITAMember 2023-09-30 0001413329 pm:STAEMMember 2023-09-30 0001413329 pm:STAEMMember pm:EITAMember 2023-09-30 0001413329 pm:STAEMMember pm:ManagementEtDeveloppementDesActifsEtDesRessourcesHoldingMADARHoldingMember 2023-09-30 0001413329 pm:EIHMember 2023-04-30 0001413329 pm:UTCMember 2023-04-30 0001413329 pm:UTCMember pm:EIHMember 2023-04-30 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember 2019-03-22 0001413329 pm:PMMMember pm:TTIMember 2023-09-30 0001413329 pm:IPMIndiaMember 2023-09-30 0001413329 pm:MegapolisMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001413329 pm:MegapolisMember us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001413329 pm:MegapolisMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001413329 pm:MegapolisMember us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0001413329 pm:OtherRelatedPartyMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001413329 pm:OtherRelatedPartyMember us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001413329 pm:OtherRelatedPartyMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001413329 pm:OtherRelatedPartyMember us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0001413329 pm:OtherRelatedPartyMember 2023-01-01 2023-09-30 0001413329 pm:OtherRelatedPartyMember 2022-01-01 2022-09-30 0001413329 pm:OtherRelatedPartyMember 2023-07-01 2023-09-30 0001413329 pm:OtherRelatedPartyMember 2022-07-01 2022-09-30 0001413329 pm:MegapolisMember us-gaap:RelatedPartyMember 2023-09-30 0001413329 pm:MegapolisMember us-gaap:RelatedPartyMember 2022-12-31 0001413329 pm:OtherRelatedPartyMember us-gaap:RelatedPartyMember 2023-09-30 0001413329 pm:OtherRelatedPartyMember us-gaap:RelatedPartyMember 2022-12-31 0001413329 pm:EVaporProductsManufacturingOptimizationMember 2023-01-01 2023-03-31 0001413329 us-gaap:ContractTerminationMember pm:EVaporProductsManufacturingOptimizationMember 2023-01-01 2023-03-31 0001413329 pm:FinanceLeaseTerminationMember pm:EVaporProductsManufacturingOptimizationMember 2023-01-01 2023-03-31 0001413329 pm:AssetImpairmentMember pm:EVaporProductsManufacturingOptimizationMember 2023-01-01 2023-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:EuropeSegmentMember us-gaap:ContractTerminationMember 2023-01-01 2023-09-30 0001413329 us-gaap:OperatingSegmentsMember pm:SSEACISMEASegmentMember us-gaap:ContractTerminationMember 2023-01-01 2023-09-30 0001413329 us-gaap:OperatingSegmentsMember pm:EAAUPMIDFSegmentMember us-gaap:ContractTerminationMember 2023-01-01 2023-09-30 0001413329 us-gaap:OperatingSegmentsMember pm:AmericasSegmentMember us-gaap:ContractTerminationMember 2023-01-01 2023-09-30 0001413329 us-gaap:ContractTerminationMember 2023-01-01 2023-09-30 0001413329 us-gaap:OperatingSegmentsMember pm:EuropeSegmentMember pm:AssetImpairmentMember 2023-01-01 2023-09-30 0001413329 us-gaap:OperatingSegmentsMember pm:SSEACISMEASegmentMember pm:AssetImpairmentMember 2023-01-01 2023-09-30 0001413329 us-gaap:OperatingSegmentsMember pm:EAAUPMIDFSegmentMember pm:AssetImpairmentMember 2023-01-01 2023-09-30 0001413329 us-gaap:OperatingSegmentsMember pm:AmericasSegmentMember pm:AssetImpairmentMember 2023-01-01 2023-09-30 0001413329 pm:AssetImpairmentMember 2023-01-01 2023-09-30 0001413329 srt:ScenarioForecastMember 2023-10-01 2023-12-31 0001413329 pm:SuppliersUsingSupplyChainFinancingProgramMember 2023-09-30 0001413329 pm:SuppliersUsingSupplyChainFinancingProgramMember 2022-12-31 shares iso4217:USD iso4217:USD shares pm:segment pure iso4217:SEK shares pm:year pm:performanceMetric pm:manufacturer iso4217:CAD pm:plaintiff pm:cigarette pm:litigationCase iso4217:ARS iso4217:TRY pm:patient pm:defendant iso4217:THB iso4217:KRW iso4217:IDR iso4217:EUR pm:arrangement 0001413329 --12-31 2023 Q3 false http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet 10-Q true 2023-09-30 false 001-33708 Philip Morris International Inc. VA 13-3435103 677 Washington Blvd, Suite 1100 Stamford CT 06901 (203) 905-2410 Common Stock, no par value PM NYSE 3.600% Notes due 2023 PM23A NYSE 2.875% Notes due 2024 PM24 NYSE 2.875% Notes due 2024 PM24C NYSE 0.625% Notes due 2024 PM24B NYSE 3.250% Notes due 2024 PM24A NYSE 2.750% Notes due 2025 PM25 NYSE 3.375% Notes due 2025 PM25A NYSE 2.750% Notes due 2026 PM26A NYSE 2.875% Notes due 2026 PM26 NYSE 0.125% Notes due 2026 PM26B NYSE 3.125% Notes due 2027 PM27 NYSE 3.125% Notes due 2028 PM28 NYSE 2.875% Notes due 2029 PM29 NYSE 3.375% Notes due 2029 PM29A NYSE 0.800% Notes due 2031 PM31 NYSE 3.125% Notes due 2033 PM33 NYSE 2.000% Notes due 2036 PM36 NYSE 1.875% Notes due 2037 PM37A NYSE 6.375% Notes due 2038 PM38 NYSE 1.450% Notes due 2039 PM39 NYSE 4.375% Notes due 2041 PM41 NYSE 4.500% Notes due 2042 PM42 NYSE 3.875% Notes due 2042 PM42A NYSE 4.125% Notes due 2043 PM43 NYSE 4.875% Notes due 2043 PM43A NYSE 4.250% Notes due 2044 PM44 NYSE Yes Yes Large Accelerated Filer false false false 1552405991 26127000000 23610000000 9431000000 8191000000 16696000000 15419000000 8029000000 6097000000 8667000000 9322000000 -788000000 -418000000 36000000 16000000 7843000000 8888000000 2019000000 1835000000 131000000 -20000000 5955000000 7033000000 338000000 382000000 5617000000 6651000000 3.61 4.28 3.61 4.27 2631000000 2634000000 37140000000 37028000000 112000000 680000000 204000000 9141000000 8032000000 3165000000 2935000000 5976000000 5097000000 2606000000 2129000000 3370000000 2968000000 -261000000 -138000000 8000000 7000000 3101000000 2823000000 1031000000 622000000 101000000 21000000 2171000000 2222000000 117000000 135000000 2054000000 2087000000 1.32 1.34 1.32 1.34 857000000 1087000000 13092000000 12856000000 112000000 5955000000 7033000000 12000000 340000000 -669000000 -352000000 0 0 -4000000 0 0 29000000 0 -63000000 20000000 37000000 59000000 164000000 56000000 106000000 304000000 523000000 30000000 18000000 155000000 106000000 -457000000 292000000 5498000000 7325000000 139000000 385000000 5359000000 6940000000 2171000000 2222000000 95000000 158000000 158000000 -571000000 0 0 -2000000 0 0 -7000000 0 -27000000 6000000 15000000 18000000 54000000 8000000 52000000 58000000 222000000 8000000 9000000 51000000 51000000 185000000 -319000000 2356000000 1903000000 74000000 61000000 2282000000 1842000000 3017000000 3207000000 80000000 42000000 3891000000 3850000000 33000000 32000000 898000000 906000000 1972000000 1674000000 2198000000 2028000000 5475000000 6184000000 9645000000 9886000000 1742000000 1770000000 19193000000 19619000000 15893000000 15443000000 9010000000 8733000000 6883000000 6710000000 16509000000 19655000000 9579000000 6732000000 4691000000 4431000000 577000000 603000000 24000000 20000000 5495000000 3931000000 62927000000 61681000000 655000000 688000000 43000000 7000000 2149000000 5637000000 2652000000 2611000000 3533000000 4076000000 857000000 695000000 5853000000 7440000000 1131000000 1168000000 2040000000 1990000000 2250000000 2679000000 1082000000 1040000000 21547000000 27336000000 42914000000 34875000000 2903000000 1956000000 1915000000 1984000000 1354000000 1841000000 70633000000 67992000000 2109316331 2109316331 0 0 2253000000 2230000000 33919000000 34289000000 -9817000000 -9559000000 26355000000 26960000000 556942754 559098620 35788000000 35917000000 -9433000000 -8957000000 1727000000 2646000000 -7706000000 -6311000000 62927000000 61681000000 5955000000 7033000000 1709000000 898000000 34000000 -146000000 35000000 -79000000 267000000 963000000 181000000 -793000000 -623000000 275000000 922000000 326000000 -201000000 -190000000 96000000 38000000 -459000000 -377000000 5902000000 7710000000 1010000000 730000000 1775000000 0 111000000 20000000 110000000 -634000000 24000000 35000000 -3030000000 -151000000 130000000 226000000 356000000 2619000000 1109000000 795000000 554000000 795000000 4430000000 0 9959000000 0 2034000000 1979000000 0 209000000 5941000000 5839000000 883000000 0 -267000000 -663000000 -2685000000 -6071000000 -370000000 -614000000 -183000000 874000000 3217000000 4500000000 3034000000 5374000000 17000000 6000000 10000000 4000000 0 2225000000 33082000000 -9577000000 -35836000000 1898000000 -8208000000 6651000000 382000000 7033000000 460000000 -168000000 292000000 9000000 117000000 126000000 3.77 5868000000 5868000000 368000000 368000000 199000000 199000000 30000000 171000000 10000000 211000000 0 2204000000 33865000000 -9288000000 -35918000000 1734000000 -7403000000 0 2230000000 34289000000 -9559000000 -35917000000 2646000000 -6311000000 5617000000 338000000 5955000000 -438000000 -19000000 -457000000 29000000 129000000 158000000 3.84 5987000000 5987000000 407000000 407000000 -6000000 180000000 -831000000 -657000000 0 2253000000 33919000000 -9817000000 -35788000000 1727000000 -7706000000 0 2165000000 33755000000 -9043000000 -35921000000 1784000000 -7260000000 2087000000 135000000 2222000000 -245000000 -74000000 -319000000 39000000 3000000 42000000 1.27 1977000000 1977000000 111000000 111000000 0 2204000000 33865000000 -9288000000 -35918000000 1734000000 -7403000000 0 2240000000 33893000000 -10045000000 -35791000000 1743000000 -7960000000 2054000000 117000000 2171000000 227000000 -42000000 185000000 40000000 3000000 43000000 1.30 2028000000 2028000000 89000000 89000000 -27000000 1000000 -2000000 -28000000 0 2253000000 33919000000 -9817000000 -35788000000 1727000000 -7706000000 Background and Basis of Presentation: <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A. (also referred to herein as the U.S., the United States or the United States of America), whose subsidiaries and affiliates and their licensees are primarily engaged in the manufacture and sale of cigarettes and smoke-free products. Throughout these financial statements, the term "PMI" refers to Philip Morris International Inc. and its subsidiaries. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Smoke-free products (also referred to herein as "SFPs") is the term PMI primarily uses to refer to all of its products that are not combustible tobacco products, such as heat-not-burn, e-vapor, and oral nicotine. In addition, SFPs include wellness and healthcare products, as well as consumer accessories such as lighters and matches.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reduced-risk products ("RRPs") is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. PMI's RRPs are smoke-free products that contain and/or generate far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Platform 1" is the term PMI uses to refer to PMI’s reduced-risk product that uses a precisely controlled heating device into which a specially designed and proprietary tobacco unit is inserted and heated to generate an aerosol.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") and such principles are applied on a consistent basis. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S.GAAP have been omitted. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the fourth quarter of 2022, PMI acquired a controlling interest of the total issued shares in Swedish Match AB (“Swedish Match”). The operating results of Swedish Match are included in a separate segment. For further details, see Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and Note 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the third quarter of 2021, PMI acquired Fertin Pharma A/S, Vectura Group plc. and OtiTopic, Inc. On March 31, 2022, PMI launched a Wellness and Healthcare business consolidating these entities, Vectura Fertin Pharma. The operating results of this business are reported in the Wellness and Healthcare segment. For further details, see Note 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To further support the growth of PMI's smoke-free business, reinforce consumer centricity, and increase the speed of innovation and deployment, in January 2023, PMI began managing its business in four geographical segments, down from six previously, in addition to its continuing Swedish Match and Wellness and Healthcare segments. The four geographical segments are as follows: Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region ("SSEA, CIS &amp; MEA"); East Asia, Australia, and PMI Duty Free Region ("EA, AU &amp; PMI DF"); and Americas Region. </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain prior years' amounts have been reclassified to conform with the current year's presentation. As a result of the new regional structure discussed above, certain goodwill amounts under the former six geographical segments were reallocated to the four geographical segments under the new structure. For further details, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Goodwill and Other Intangible Assets, net. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following the Swedish Match acquisition and a review of PMI and Swedish Match’s combined product portfolio, PMI reclassified certain of its own products previously reported under its combustible tobacco product category to the newly created smoke-free product category to better reflect the characteristics of these products. For further details, see Note 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Segment Reporting. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These reclassifications did not impact PMI’s consolidated financial position, results of operations or cash flows in any of the periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended December 31, 2022.</span></div> The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") and such principles are applied on a consistent basis. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S.GAAP have been omitted. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year. 4 6 4 6 4 Acquisitions: <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transactions With Noncontrolling Interests </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Turkey</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – In the first quarter of 2022, PMI acquired the remaining 25% stake of its holding in Philip Morris Tütün Mamulleri Sanayi ve Ticaret A.Ş. ("PMTM") (formerly Philsa Philip Morris Sabanci Sigara ve Tütüncülük Sanayi ve Ticaret A.Ş.) and 24.75% stake in Philip Morris Pazarlama ve Satiş A.Ş. ("PMPS") (formerly Philip Morris SA, Philip Morris Sabanci Pazarlama ve Satiş A.Ş.) from its Turkish partners, Sabanci Holding for a total acquisition price including transaction costs and remaining dividend entitlements of approximately $223 million. As a result of this acquisition, PMI owned 100% of these Turkish subsidiaries as of December 31, 2022. The purchase of the remaining stakes in these holdings resulted in a decrease to PMI's additional paid-in capital of $30 million and an increase to accumulated other comprehensive losses of $171 million primarily following the reclassification of accumulated currency translation losses from noncontrolling interests to PMI’s accumulated other comprehensive losses during the first quarter of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, PMI sold the acquired stakes of its holdings in PMTM and PMPS to Pioneers Tutun Yatirim Anonim Sirketi (“Pioneers”) for a consideration of approximately $258 million, including transaction costs and dividend entitlements. The sale resulted in an increase to PMI's additional paid-in capital of $36 million and a decrease to accumulated other comprehensive losses of $179 million, following the reclassification of accumulated other comprehensive losses from PMI’s accumulated other comprehensive losses to noncontrolling interests. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Swedish Match AB </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">– On November 11, 2022 (the acquisition date), Philip Morris Holland Holdings B.V. (“PMHH”), a wholly owned subsidiary of PMI, acquired a controlling interest of 85.87% of the total issued shares in Swedish Match AB (“Swedish Match”) and acquired 94.81% of its outstanding shares as of December 31, 2022. The shares were acquired through acceptances of the tender offer and a series of open market and over-the-counter purchases. PMI funded the acquisition through cash on-hand and debt proceeds, as described in Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indebtedness. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate cash paid as of the acquisition date was $14,460 million (or $13,976 million net of cash acquired), which was included in investing activities in the consolidated statements of cash flows for the year ended December 31, 2022. The cash paid in connection with the additional purchases of the noncontrolling interests after the acquisition date and through December 31, 2022 amounted to $1,495 million and was included in financing activities in the consolidated statements of cash flows for the year ended December 31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with the Swedish Companies Act, PMI subsequently exercised its right to initiate arbitral proceedings to compulsorily redeem the remaining shares for which acceptances were not received and obtained legal title to 100% of the shares in Swedish Match on February 17, 2023. Cash paid in connection with such legal title, together with an immaterial amount attributable to open market purchases that were executed in December 2022 but settled in January 2023, amounted to $883 million and was included in financing activities in the condensed consolidated statements of cash flows for the nine months ended September 30, 2023. While PMI has paid the referenced amounts and has acquired legal title to the shares, the redemption process will not be complete under the Swedish Companies Act until a final redemption price is determined by an arbitral tribunal. On September 12, 2023, the arbitral tribunal determined the final redemption price to be Swedish krona (SEK) 115.07, which is unchanged from the SEK 115.07 that PMI paid per share in connection with obtaining legal title to the shares. This final redemption price is subject to appeal by the remaining minority shareholders within 60 days. Pending appeal, PMI expects this process to be completed in the fourth quarter of 2023 and believes that the likelihood of additional payments to be made is remote. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Swedish Match is a market leader in oral nicotine delivery with a significant presence in the United States market.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The acquisition will accelerate PMI’s transformation to become a smoke-free company with a comprehensive global smoke-free portfolio with leadership positions in heat-not-burn, and the fastest growing category of oral nicotine, with the potential for accelerated international expansion. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the preliminary purchase price allocation for the fair value of assets acquired and liabilities assumed as of the acquisition date, including the measurement period adjustments made for the first nine months of 2023. PMI is still assessing information received as of the acquisition date and expects to complete the allocation by the end of the measurement period in November 2023. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions) </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized as of the acquisition date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized as of September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,801 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable net assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,538 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,924 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,301 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,915 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,460 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,460 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value step-up adjustment for inventories was $146 million, of which $125 million was recognized in cost of sales in the fourth quarter of 2022 and the remaining balance in the first quarter of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of long-term debt was primarily determined using readily available market prices as of the acquisition date and the total purchase price adjustment of $(107) million is being amortized as an increase to interest expense, net over the lives of the related debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is primarily attributable to future growth opportunities, anticipated synergies in the U.S. and intangible assets that did not qualify for separate recognition. The goodwill is not deductible for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets of Swedish Match consist of: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Fair Value (in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-amortizable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 - 30 years</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 - 15 years</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,488 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,801 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant assumptions used in determining the preliminary fair values of the identifiable intangible assets included royalty rates, revenue growth rates, profit margins, customer attrition rates and discount rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks primarily relate to $3,133 million for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ZYN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark, which has been determined to have an indefinite life due to the fast growth and the leading position of the brand in the U.S. market. All other trademarks have been determined to have a useful life ranging between 20 - 30 years. The trademarks have been valued using the relief from royalty method supported by revenue growth rate assumptions and royalty rates disaggregated at the individual trademark level.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology, including patents, relates to the nicotine pouch technology of $113 million. These patents have been assigned a useful life of 10 years, which is in line with their protection period and have been valued using the comparable transactions and income methods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships have been valued by categories of customers and geographic locations, namely the U.S. market, Scandinavia, and other markets using the multiple periods excess earnings method. The significant assumptions included customer attrition rates disaggregated at the customer category level, the revenue growth rates, as well as profit margins. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI consolidated statements of earnings for the year ended December 31, 2022, include $316 million of net revenues and $(26) million of net losses associated with the results of operations of Swedish Match from the acquisition date to December 31, 2022. The operating results of Swedish Match are included in a separate segment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition related transaction costs, which were comprised primarily of regulatory, financial advisory and legal fees, totaled $59 million for the year ended December 31, 2022, and were included in marketing, administration and research costs in the consolidated statements of earnings. Bridge and term loan credit agreement related fees associated with the issuance of debt amounted to $54 million, of which $37 million were capitalized at the acquisition date. The fair value of the noncontrolling interest was based on the tender offer as of the acquisition date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the EU Merger Regulation, approval by the European Commission of PMI's acquisition of Swedish Match was conditional on PMHH's divestiture of Swedish Match's subsidiary, SMD Logistics AB ("SMDL"), following the completion of the offer to tender all shares in Swedish Match to PMHH. As a result, these assets were accounted for as assets held for sale and included within other current assets and other accrued liabilities in PMI’s condensed consolidated balance sheets at March 31, 2023 and December 31, 2022. PMI subsequently sold SMDL on June 30, 2023 and the transaction did not have a material impact on the condensed consolidated statements of earnings for the nine months ended September 30, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma combined financial information was prepared using the acquisition method of accounting and was based on the historical financial information of PMI and Swedish Match. In order to reflect the occurrence of the acquisition on January 1, 2021, as required, the unaudited pro forma financial information includes adjustments to reflect the following:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">incremental amortization expense to be incurred based on the current preliminary fair values of the identifiable intangible assets acquired;</span></div><div style="margin-bottom:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">incremental cost of products sold related to the fair value adjustments associated with acquisition date inventory; </span></div><div style="margin-bottom:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">additional interest expense associated with the issuance of debt to finance the acquisition, including the effects of the related derivative financial instruments designated to hedge interest rate risks as well as economic hedges;</span></div><div style="margin-bottom:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reclassification of non-recurring acquisition-related costs incurred during the year ended December 31, 2022, to the year ended December 31, 2021;</span></div><div style="margin-bottom:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">impact of a deferred tax cost of $430 million in 2022 and $321 million in 2021 related to the theoretical unrealized foreign currency gains on intercompany loans related to the acquisition financing. These theoretical unrealized pre-tax foreign currency movements were fully offset in the consolidated statements of earnings and were reflected as currency translation adjustments in PMI's consolidated statements of stockholders' (deficit) equity, while the corresponding deferred tax impacts were reflected in PMI's consolidated statements of earnings; and</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">other immaterial items (i.e., the alignment of accounting policies from IFRS to US GAAP.)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information is not necessarily indicative of what the consolidated results of operations would have been had the acquisition been completed on January 1, 2021. In addition, the unaudited pro forma financial information is not a projection of future results of operations of the combined company, nor does it reflect the expected realization of any synergies or cost savings associated with the acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.954%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,579 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,488 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to PMI</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,788 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,495 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altria Group, Inc. Agreement </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 20, 2022, PMI announced that it had reached an agreement with Altria Group, Inc. ("Altria") to end the companies' relationship regarding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> commercialization rights in the U.S. as of April 30, 2024. As a result of PMI reacquiring these rights, effective May 1, 2024, PMI will hold the full rights to commercialize </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. As part of the agreement, PMI agreed to pay a total cash consideration of $2.7 billion, with $1.0 billion paid at the inception of the agreement and the remaining $1.7 billion (plus interest, at a per annum rate equal to six percent (6%)), to be paid by July 2023 at the latest. The cash consideration paid at the inception of the agreement of $1.0 billion has been accounted for within other assets in PMI’s condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022. The remaining consideration of $1.7 billion plus interest was paid to Altria on July 14, 2023 and has been accounted for within other assets in PMI's condensed consolidated balance sheets as of September 30, 2023. PMI will finalize the accounting for this transaction by assigning the consideration to the respective assets in May 2024, when PMI can exercise its ability to commercialize </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span> in the U.S. 0.25 0.2475 223000000 1 30000000 171000000 258000000 36000000 179000000 0.8587 0.9481 14460000000 13976000000 1495000000 1 883000000 115.07 115.07 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions) </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized as of the acquisition date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized as of September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,801 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable net assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,538 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,924 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,301 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,915 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,460 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,460 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets of Swedish Match consist of: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Fair Value (in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-amortizable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 - 30 years</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 - 15 years</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,488 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,801 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.954%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,579 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,488 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to PMI</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,788 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,495 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 484000000 0 484000000 135000000 0 135000000 53000000 0 53000000 444000000 -7000000 437000000 524000000 -109000000 415000000 627000000 50000000 677000000 4512000000 3289000000 7801000000 214000000 4000000 218000000 224000000 0 224000000 120000000 0 120000000 531000000 1000000 532000000 14000000 0 14000000 1126000000 -5000000 1121000000 1253000000 836000000 2089000000 187000000 9000000 196000000 3538000000 2386000000 5924000000 2379000000 0 2379000000 13301000000 -2386000000 10915000000 14460000000 0 14460000000 146000000 125000000 -107000000 3133000000 P20Y P30Y 1067000000 P10Y 113000000 P6Y P15Y 3488000000 7801000000 3133000000 P20Y P30Y 113000000 P10Y 316000000 -26000000 59000000 54000000 37000000 430000000 321000000 33579000000 33488000000 8788000000 8495000000 2700000000 1000000000 1700000000 0.06 1000000000 1700000000 War in Ukraine: <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the onset of the war in Ukraine in February 2022, PMI's main priority has been the safety and security of its employees and their families in the country. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ukraine</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI temporarily suspended its commercial and manufacturing operations in Ukraine, including the closing of its factory in Kharkiv at the end of February 2022, in order to preserve the safety of its employees. PMI subsequently resumed some retail activities where safety allowed, in order to provide product availability and service to adult consumers, and began to supply the market from production centers outside Ukraine, as well as through a contract manufacturing arrangement. Production at the factory in Kharkiv remains suspended. While the effects of the war are unpredictable and could trigger impairment reviews for long-lived assets, as of September 30, 2023, PMI is unable to estimate the information required to perform impairment analyses (i.e., forecast of revenues, manufacturing and commercial plans). PMI is not aware of any major damage to its production facilities, inventories or other assets in Ukraine. As a result, PMI has not recorded an impairment of long-lived assets. As of September 30, 2023, PMI’s Ukrainian operations had approximately $500 million in total assets, excluding intercompany balances. These total assets included $82 million, $350 million and $28 million in receivables, inventories and property, plant and equipment, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Russia </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI has suspended its planned investments in the Russian Federation including all new product launches and commercial, innovation, and manufacturing investments. PMI has also taken steps to scale down its manufacturing operations in Russia amid ongoing supply chain disruptions and the evolving regulatory environment. PMI is continuously assessing the evolving situation in Russia, including recent regulatory constraints in the market that entail very complex terms and conditions that must be met for any divestment transaction to be granted approval by the authorities, and restrictions resulting from international regulations. As a result of PMI continuing operations within Russia as of September 30, 2023, it has not recorded an impairment of long-lived and other assets. However, PMI recorded specific asset write downs in 2022 as referred to in the table below. PMI’s Russian operations as of September 30, 2023 had approximately $2.4 billion in total assets, excluding </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intercompany balances. These total assets included $677 million, $411 million, $838 million, $242 million and $158 million in cash (primarily held in local currency), receivables, inventories, property, plant and equipment and goodwill, respectively. In addition, there was approximately $1,343 million of cumulative foreign currency translation losses reflected in accumulated other comprehensive losses in the condensed consolidated statement of stockholders’ equity as of September 30, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months and three months ended September 30, 2023 and 2022, PMI recorded in its condensed consolidated statements of earnings pre-tax charges related to circumstances driven by the war as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukraine </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The 2023 pre-tax charges were primarily due to the cost of PMI’s humanitarian efforts, which includes salary continuation for its employees. The 2022 pre-tax charges were primarily due to an inventory write-down, additional allowance for receivables and the cost of PMI’s humanitarian efforts, which includes salary continuation for its employees. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The pre-tax charges were primarily due to machinery and inventory write downs related to the commercial decisions noted above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukraine </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The pre-tax charges were primarily due to PMI’s humanitarian efforts, which includes salary continuation for its employees. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI will continue to monitor the situation as it evolves and will determine if further charges are needed.</span></div> 500000000 82000000 350000000 28000000 2400000000 677000000 411000000 838000000 242000000 158000000 -1343000000 PMI recorded in its condensed consolidated statements of earnings pre-tax charges related to circumstances driven by the war as follows: <div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukraine </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The 2023 pre-tax charges were primarily due to the cost of PMI’s humanitarian efforts, which includes salary continuation for its employees. The 2022 pre-tax charges were primarily due to an inventory write-down, additional allowance for receivables and the cost of PMI’s humanitarian efforts, which includes salary continuation for its employees. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The pre-tax charges were primarily due to machinery and inventory write downs related to the commercial decisions noted above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukraine </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>1 The pre-tax charges were primarily due to PMI’s humanitarian efforts, which includes salary continuation for its employees. 11000000 8000000 19000000 28000000 31000000 59000000 0 0 0 18000000 51000000 69000000 11000000 8000000 19000000 46000000 82000000 128000000 11000000 8000000 19000000 3000000 5000000 8000000 0 0 0 -3000000 1000000 -2000000 11000000 8000000 19000000 0 6000000 6000000 Stock Plans: <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, PMI’s shareholders approved the Philip Morris International Inc. 2022 Performance Incentive Plan (the “2022 Plan”). Under the 2022 Plan, PMI may grant to eligible employees restricted shares and restricted share units, performance-based cash incentive awards and performance-based equity awards. Up to 25 million shares of PMI’s common stock may be issued under the 2022 Plan. At September 30, 2023, shares available for grant under the 2022 Plan were 22,165,030. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, PMI’s shareholders approved the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors (the “2017 Non-Employee Directors Plan”). A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least 50% of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to 1 million shares of PMI common stock may be awarded under the 2017 Non-Employee Directors Plan. At September 30, 2023, shares available for grant under the plan were 876,226.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted share unit (RSU) awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the weighted-average grant date fair value per share related to RSU awards were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:60.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.928%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of <br/>Shares <br/>Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date Fair Value Per RSU Award Granted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756,750 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 101.96 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579,680 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$  104.96 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense related to RSU awards was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation Expense Related to RSU Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 124 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 38 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 109 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 35 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, PMI had $199 million of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically three years after the date of the award, or upon death, disability or reaching the age of 58.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023, 1,421,086 RSU awards vested. The grant date fair value of all the vested awards was approximately $124 million. The total fair value of RSU awards that vested during the nine months ended September 30, 2023 was approximately $143 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance share unit (PSU) awards </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023 and 2022, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance metrics, which are predetermined at the time of grant, typically over a three-year performance cycle. The performance metrics for such PSU's granted during the nine months ended September 30, 2023 and 2022 consisted of PMI's Total Shareholder Return ("TSR") relative to a predetermined peer group and on an absolute basis (40% weight), PMI’s currency-neutral compound annual adjusted diluted earnings per share growth rate (30% weight), and a Sustainability Index, which consists of two drivers: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Product Sustainability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (20% weight) measuring progress on PMI's efforts to maximize the benefits of smoke-free products, purposefully phase out cigarettes, seek net positive impact in wellness and healthcare, and reduce post-consumer waste; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Operational Sustainability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (10% weight) measuring progress on PMI's efforts to tackle climate change, preserve nature, improve the quality of life of people in its supply chain, and foster an empowered, and inclusive workplace. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate of the weighted performance factors for the three metrics in each such PSU award determines the percentage of PSUs that will vest at the end of the three-year performance cycle. The minimum percentage of such PSUs that can vest is zero, with a target percentage of 100 and a maximum percentage of 200. Each such vested PSU entitles the participant to one share of common stock. An aggregate weighted PSU performance factor of 100 will result in the targeted number of PSUs being vested. At the end of the performance cycle, participants are entitled to an amount equivalent to the accumulated dividends paid on common stock during the performance cycle for the number of shares earned. </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the grant date fair value per share related to PSU awards were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:46.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.153%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:63pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Shares Granted</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted- <br/>Average PSU Grant Date <br/>Fair Value Subject to Other Performance Factors </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted- <br/>Average PSU Grant Date <br/>Fair Value Subject to TSR Performance Factors </span></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Per Share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,360 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 102.02 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 133.54 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,790 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$  105.07 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 143.94 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant date fair value of the PSU awards subject to the other performance factors was determined by using the market price of PMI’s stock on the date of the grant. The grant date fair value of the PSU market-based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model. The following assumptions were used to determine the grant date fair value of the PSU awards subject to the TSR performance factor: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.391%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the U.S. Treasury yield curve.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Determined using the observed historical volatility.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense related to PSU awards was as follows:</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation Expense Related to PSU Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 51 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$  44 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$  13 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, PMI had $49 million of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the performance cycle of the awards, or upon death, disability or reaching the age of 58.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023, 902,232 PSU awards vested. The grant date fair value of all the vested awards was approximately $83 million. The total fair value of PSU awards that vested during the nine months ended September 30, 2023 was approximately $91 million.</span></div> 25000000 22165030 0.50 1000000 876226 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the weighted-average grant date fair value per share related to RSU awards were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:60.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.928%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of <br/>Shares <br/>Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date Fair Value Per RSU Award Granted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756,750 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 101.96 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579,680 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$  104.96 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense related to RSU awards was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation Expense Related to RSU Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 124 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 38 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 109 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 35 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023 and 2022, shares granted to eligible employees and the grant date fair value per share related to PSU awards were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:46.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.153%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:63pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Shares Granted</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted- <br/>Average PSU Grant Date <br/>Fair Value Subject to Other Performance Factors </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted- <br/>Average PSU Grant Date <br/>Fair Value Subject to TSR Performance Factors </span></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Per Share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,360 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 102.02 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 133.54 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,790 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$  105.07 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 143.94 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense related to PSU awards was as follows:</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation Expense Related to PSU Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 51 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$  44 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$  13 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div> 1756750 101.96 1579680 104.96 124000000 38000000 109000000 35000000 199000000 P3Y 58 1421086 124000000 143000000 P3Y 0.40 0.30 0.20 0.10 3 P3Y 0 1 2 1 1 482360 102.02 133.54 451790 105.07 143.94 The following assumptions were used to determine the grant date fair value of the PSU awards subject to the TSR performance factor: <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.391%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Based on the U.S. Treasury yield curve.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Determined using the observed historical volatility.</span></div> 0.041 0.016 0.243 0.286 51000000 6000000 44000000 13000000 49000000 58 902232 83000000 91000000 Benefit Plans:Pension coverage for employees of PMI’s subsidiaries is provided, to the extent deemed appropriate, through separate plans, many of which are governed by local statutory requirements. In addition, PMI provides health care and other benefits to certain U.S. retired employees and certain non-U.S. retired employees. In general, health care benefits for non-U.S. retired employees are covered through local government plans. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension and other employee benefit costs per the condensed consolidated statements of earnings consisted of the following: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:49.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension costs (income)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net postemployment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net postretirement costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension and other employee benefit costs</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Net Periodic Benefit Cost</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic pension cost consisted of the following: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Primarily non-U.S. based defined benefit retirement plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employer Contributions</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI makes, and plans to make, contributions, to the extent that they are tax deductible and meet specific funding requirements of its funded pension plans. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employer contributions of $96 million were made to the pension plans during the nine months ended September 30, 2023. Currently, PMI anticipates making additional contributions during the remainder of 2023 of approximately $39 million to its pension plans, based on current tax and benefit laws. However, this estimate is subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on pension assets, or changes in interest and currency rates.</span></div>Employer contributions of $85 million were made to the pension plans during the nine months ended September 30, 2022. During the second quarter of 2022, PMI received a cash refund of $123 million from one of its pension plans due to a change in discount rate and value of assets that resulted in the overfunding of the plan. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension and other employee benefit costs per the condensed consolidated statements of earnings consisted of the following: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:49.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension costs (income)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net postemployment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net postretirement costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension and other employee benefit costs</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -61000000 -71000000 -24000000 -22000000 88000000 81000000 29000000 27000000 9000000 6000000 3000000 2000000 36000000 16000000 8000000 7000000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic pension cost consisted of the following: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Primarily non-U.S. based defined benefit retirement plans.</span></div> 130000000 176000000 45000000 57000000 193000000 58000000 64000000 20000000 273000000 267000000 92000000 87000000 -21000000 -139000000 -5000000 -45000000 -2000000 -1000000 -1000000 0 69000000 105000000 21000000 35000000 96000000 39000000 85000000 -123000000 Goodwill and Other Intangible Assets, net: <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual impairment review of goodwill and non-amortizable intangible assets </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2023, PMI completed its annual review of goodwill and non-amortizable intangible assets for potential impairment. Based on this review, it was determined that the estimated fair value of the Wellness and Healthcare reporting unit was lower than its carrying value. Consequently, PMI recorded a goodwill impairment charge of $665 million, reflecting the impact of reduced estimated future cash flows, which were primarily attributable to clinical trial results that became available in June 2023 for an inhalable aspirin product being developed by the Wellness and Healthcare business. While it was observed that the experimental product had a rapid onset of effect, which is the key medical advantage sought, there was significant variability in inhaled dose among subjects. The study was therefore deemed unsuccessful and, as a result, product design improvements are required. PMI had planned to file a new drug application for this product with the U.S. Food and Drug Administration later this year. However, additional time is now required to evaluate design improvements and the corresponding less certain outcome. The cash flow estimates were also adversely impacted by slower-than-anticipated development of the contract development and manufacturing organization ("CDMO") business, including challenges associated with increased cost related to certain key products. Additionally, as a result of the impairment test of non-amortizable intangible assets, PMI recorded a pre-tax impairment charge of $15 million for an in-process research and development project related to one of PMI's 2021 acquisitions. These impairment charges were recorded within marketing, administration and research costs in the consolidated statements of earnings for the nine months ended September 30, 2023. The goodwill impairment charge is not deductible for income tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Wellness and Healthcare reporting unit's fair value was determined using the discounted cash flow model. PMI will continue to monitor this reporting unit as any changes in assumptions and estimates, unfavorable clinical trial results, failure to obtain regulatory approvals or other market factors could result in additional future goodwill and other intangible asset impairments. Certain Wellness and Healthcare products include components or gases which may be subject to enhanced climate change regulations that could impact the related product development and market strategies. This may also lead to supply disruptions that could result in additional future impairments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While PMI’s remaining reporting units have fair values substantially in excess of their carrying values, there are still risks related to PMI’s Russian reporting unit’s assets as the fair value of these assets is difficult to predict due to the volatility in foreign currency and commodity markets, supply chain, and current economic, political and social conditions. For more information see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">War in Ukraine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. PMI has performed a quantitative impairment assessment for all of its reporting units and non-amortizable intangible assets with the exception of the Swedish Match segment. As the purchase price allocation for the acquisition of Swedish Match is preliminary, PMI has performed a qualitative impairment assessment and concluded that it was not more likely than not that the fair value of the Swedish Match reporting units and its non-amortizable intangible assets were less than the respective carrying amounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in goodwill were as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.078%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SSEA, CIS &amp; MEA</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EA, AU &amp; PMI DF</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish Match</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wellness &amp; Healthcare</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,869 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,655 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes due to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,789 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,509 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in January 2023, PMI began managing its business in four geographical segments, Swedish Match segment and Wellness and Healthcare segment. As a result, the December 31, 2022 goodwill balance in the table above included the reclassifications from the former six geographical segments to the four geographical segments under the new structure. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in goodwill was primarily due to the measurement period adjustments to the Swedish Match preliminary purchase price allocation (see Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), coupled with the impairment discussed above and currency movements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2023, goodwill primarily reflects PMI’s business combinations in Greece, Indonesia, Mexico, the Philippines and Serbia, as well as the goodwill from the 2021 acquisitions of Fertin Pharma A/S and Vectura Group plc. and the preliminary purchase price allocation of Swedish Match AB, which was acquired in the fourth quarter of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of other intangible assets were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Remaining Useful Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-amortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,346 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,346 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,158 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships and other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,667 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,317 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,959 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,579 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,761 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-amortizable intangible assets substantially consist of trademarks from PMI’s acquisitions in Indonesia and Mexico, as well as the preliminary purchase price allocation associated with the Swedish Match acquisition in 2022, and PMI's business combinations in 2021 (primarily in-process research and development). The increase since December 31, 2022 was due to the measurement period adjustments to the Swedish Match preliminary purchase price allocation in the amount of $1,056 million (see Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), coupled with currency movements of $29 million, partially offset by an impairment for an in-process research and development project related to one of PMI's 2021 acquisitions discussed above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the gross carrying amount of amortizable intangible assets from December 31, 2022, was due to the measurement period adjustments to the Swedish Match preliminary purchase price allocation in the amount of $2,233 million (see Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), partially offset by currency movements of $105 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the accumulated amortization from December 31, 2022, was mainly due to the 2023 amortization of $368 million, partially offset by currency movements of $17 million. The amortization of intangibles for the nine months ended September 30, 2023 was recorded in cost of sales ($43 million) and in marketing, administration and research costs ($325 million) on PMI's condensed consolidated statements of earnings.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for each of the next five years is estimated to be approximately $460 million or less, assuming no additional transactions occur that require the amortization of intangible assets. This estimate is subject to change based on the finalization of the preliminary purchase price allocation of the Swedish Match acquisition. Additionally, the estimated future amortization expense could significantly increase following the reacquisition of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercialization rights in the U.S. from Altria Group, Inc (see Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the accounting for which will depend on the facts and circumstances effective May 1, 2024, when PMI will hold the full rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>2022 Impairment of Other Intangibles In the third quarter of 2022, PMI recorded a pre-tax impairment charge of $112 million, reflecting the impact of general economic and market conditions resulting in a reduction in future estimated cash flows on certain products within the Wellness and Healthcare segment. The impairment reduced the carrying values of developed technology definite-lived intangible assets in the Wellness and Healthcare segment to $308 million as of September 30, 2022. The fair value of these intangible assets was primarily determined using the multi-period excess earnings method. This impairment charge was recorded within cost of sales in the condensed consolidated statements of earnings for the three months and nine months ended September 30, 2022. 665000000 15000000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in goodwill were as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.078%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SSEA, CIS &amp; MEA</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EA, AU &amp; PMI DF</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish Match</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wellness &amp; Healthcare</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,869 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,655 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes due to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,789 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,509 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1370000000 2869000000 493000000 615000000 13296000000 1012000000 19655000000 0 0 0 0 0 665000000 665000000 -13000000 -34000000 -9000000 57000000 -121000000 25000000 -95000000 0 0 0 0 -2386000000 0 -2386000000 1357000000 2835000000 484000000 672000000 10789000000 372000000 16509000000 4 6 4 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of other intangible assets were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Remaining Useful Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-amortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,346 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,346 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,158 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships and other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,667 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,317 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,959 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,579 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,761 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of other intangible assets were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Remaining Useful Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-amortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,346 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,346 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,158 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships and other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,667 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,317 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,959 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,579 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,761 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 4416000000 4416000000 3346000000 3346000000 P16Y 2158000000 740000000 1418000000 2050000000 674000000 1376000000 P7Y 718000000 290000000 428000000 975000000 243000000 732000000 P12Y 3667000000 350000000 3317000000 1390000000 112000000 1278000000 10959000000 1380000000 9579000000 7761000000 1029000000 6732000000 1056000000 29000000 2233000000 -105000000 368000000 -17000000 43000000 325000000 460000000 460000000 460000000 460000000 460000000 112000000 308000000 Financial Instruments: <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI operates in markets primarily outside of the United States of America, with manufacturing and sales facilities in various locations around the world and is exposed to risks such as changes in foreign currency exchange rates and interest rates. As a result, PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options (collectively referred to as "foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in foreign currency exchange and interest rates related to net investments in foreign operations, third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Euro, Egyptian pound, Indonesian rupiah, Japanese yen, Mexican peso, Philippine peso, Russian ruble and Swiss franc. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain materials that PMI uses in the manufacturing of its products are exposed to market price risks. PMI uses commodity derivative contracts (“commodity contracts") to manage its exposure to the market price volatility of certain commodity components of these materials. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These foreign exchange contracts, interest rate contracts and commodity contracts are collectively referred to as "derivative contracts". PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Substantially all of PMI's derivative financial instruments are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. While these contracts contain the enforceable right to offset through close-out netting rights, PMI elects to present them on a gross basis in the consolidated balance sheets. Collateral associated with these arrangements is in the form of cash and is unrestricted. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross notional amounts for outstanding derivatives at the end of each period were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At September 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,627 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,818 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,755 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,101 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,401 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of PMI’s derivative contracts included in the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross amount derivatives contracts presented in the condensed consolidated balance sheets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amounts not offset in the condensed consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash collateral received/pledged</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(566)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI assesses the fair value of its derivative contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts, foreign currency swaps and interest rate contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates. The fair value of PMI’s commodity contracts is determined by using the prevailing market spot and futures prices and the respective maturity dates of the instruments. PMI’s derivative contracts have been classified within Level 2 at September 30, 2023 and December 31, 2022. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2023 and 2022, PMI's derivative contracts impacted the condensed consolidated statements of earnings and comprehensive earnings as follows: </span></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:22.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.692%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(pre-tax, in millions)</span></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statement of Earnings <br/>Classification of Gain/(Loss) <br/>on Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Recognized in Earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:f-988"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The gains (losses) from these contracts are offset by the changes in the fair value of the hedged item</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amount of gains (losses) on hedges of net investments principally related to changes in exchange and interest rates between the Euro and U.S. dollar</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(c)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Represent the gains for amounts excluded from the effectiveness testing </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(d) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The gains (losses) from these contracts attributable to changes in foreign currency exchange rates are partially offset by the (losses) and gains generated by the underlying intercompany and third-party loans being hedged</span></div><div style="margin-top:5pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2023 and 2022, PMI's derivative contracts impacted the condensed consolidated statements of earnings and comprehensive earnings as follows: </span></div><div style="margin-top:5pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:21.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.691%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.423%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.643%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(pre-tax, in millions)</span></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statement of Earnings <br/>Classification of Gain/(Loss) <br/>on Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Recognized in Earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:f-1023"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The gains (losses) from these contracts are offset by the changes in the fair value of the hedged item</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amount of gains (losses) on hedges of net investments principally related to changes in exchange and interest rates between the Euro and U.S. dollar</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(c)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Represent the gains for amounts excluded from the effectiveness testing </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(d) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The gains (losses) from these contracts attributable to changes in foreign currency exchange rates are partially offset by the (losses) and gains generated by the underlying intercompany and third-party loans being hedged</span></div><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI has entered into derivative contracts to hedge the foreign currency exchange, interest rate and commodity price risks related to certain forecasted transactions. Gains and losses associated with qualifying cash flow hedge contracts are deferred as components of accumulated other comprehensive losses until the underlying hedged transactions are reported in PMI’s condensed consolidated statements of earnings. As of September 30, 2023, PMI has hedged forecasted transactions with derivative contracts expiring at various dates through May 2028. The impact of these hedges is primarily included in operating cash flows on PMI’s condensed consolidated statements of cash flows.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PMI has entered into fixed-to-floating interest rate contracts, designated as fair value hedges to minimize exposure to changes in the fair value of fixed rate U.S. dollar-denominated debt that results from fluctuations in benchmark interest rates. For derivative contracts that are designated and qualify as fair value hedges, the gain or loss on the derivative, as well as the offsetting gain or loss on the hedged items attributable to the hedged risk, is recognized in current earnings. The carrying amount of the debt hedged, which includes the cumulative adjustment for fair value gains/losses, as of September 30, 2023 was $906 million, and is recorded in long-term debt in the condensed consolidated balance sheets. The cumulative amount of fair value gains/(losses) included in the carrying amount of the debt hedged was $90 million as of September 30, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedges of Net Investments in Foreign Operations </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI designates derivative contracts and certain foreign currency denominated debt and other financial instruments as net investment hedges, primarily of its Euro net assets. For the nine months ended September 30, 2023 and 2022, the amount of pre-tax gain/(loss) related to the non-derivative financial instruments, that was reported as a component of accumulated other comprehensive losses within currency translation adjustments, was $51 million and $525 million, respectively. For the three months ended September 30, 2023 and 2022, the amount of pre-tax gain/(loss) related to the non-derivative financial instruments, that was reported as a component of accumulated other comprehensive losses within currency translation adjustments, was $27 million and $267 million, respectively. The premiums paid for, and settlements of, net investment hedges are included in investing cash flows on PMI’s condensed consolidated statements of cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Derivatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI has entered into derivative contracts to hedge the foreign currency exchange and interest rate risks related to intercompany loans between certain subsidiaries, third-party loans and acquisition related transactions. While effective as economic hedges, no hedge accounting is applied for these contracts; therefore, the gains (losses) relating to these contracts are reported in PMI’s condensed consolidated statements of earnings. Acquisition related transactions are included in investing cash flows on PMI’s condensed consolidated statements of cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:22.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative gains or losses reported in accumulated other comprehensive losses are a result of qualifying hedging activity. Transfers of these gains or losses to earnings are offset by the corresponding gains or losses on the underlying hedged item. Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain/(loss) as of beginning of period,</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative (gains)/losses transferred to earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain/(loss) as of September 30,</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2023, PMI expects $176 million of derivative gains that are included in accumulated other comprehensive losses to be reclassified to the condensed consolidated statement of earnings within the next 12 months. These gains are expected to be substantially offset by the statement of earnings impact of the respective hedged transactions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Features</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI’s derivative instruments do not contain contingent features.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Exposure and Credit Risk</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI is exposed to credit loss in the event of non-performance by counterparties. While PMI does not anticipate non-performance, its risk is limited to the fair value of the financial instruments less any cash collateral received or pledged. PMI </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">actively monitors its exposure to credit risk through the use of credit approvals and credit limits and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments </span></div>A certain PMI investment, which is comprised primarily of money market funds, has been classified within Level 1 and had a fair value of $216 million at September 30, 2023. For the nine months and three months ended September 30, 2023, the unrealized pre-tax gains (losses) on these investments were immaterial. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI operates in markets primarily outside of the United States of America, with manufacturing and sales facilities in various locations around the world and is exposed to risks such as changes in foreign currency exchange rates and interest rates. As a result, PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options (collectively referred to as "foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in foreign currency exchange and interest rates related to net investments in foreign operations, third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Euro, Egyptian pound, Indonesian rupiah, Japanese yen, Mexican peso, Philippine peso, Russian ruble and Swiss franc. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain materials that PMI uses in the manufacturing of its products are exposed to market price risks. PMI uses commodity derivative contracts (“commodity contracts") to manage its exposure to the market price volatility of certain commodity components of these materials. </span></div>These foreign exchange contracts, interest rate contracts and commodity contracts are collectively referred to as "derivative contracts". PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Substantially all of PMI's derivative financial instruments are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. While these contracts contain the enforceable right to offset through close-out netting rights, PMI elects to present them on a gross basis in the consolidated balance sheets. Collateral associated with these arrangements is in the form of cash and is unrestricted. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross notional amounts for outstanding derivatives at the end of each period were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At September 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,627 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,818 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,755 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,101 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,401 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 18256000000 17627000000 1000000000 1019000000 27000000 0 17818000000 21755000000 37101000000 40401000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of PMI’s derivative contracts included in the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross amount derivatives contracts presented in the condensed consolidated balance sheets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amounts not offset in the condensed consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash collateral received/pledged</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(566)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 472000000 376000000 126000000 126000000 386000000 341000000 56000000 147000000 0 0 40000000 27000000 0 0 50000000 56000000 0 0 2000000 0 241000000 156000000 87000000 165000000 0 0 42000000 16000000 1099000000 873000000 403000000 537000000 292000000 346000000 292000000 346000000 566000000 341000000 60000000 48000000 241000000 186000000 51000000 143000000 PMI assesses the fair value of its derivative contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts, foreign currency swaps and interest rate contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2023 and 2022, PMI's derivative contracts impacted the condensed consolidated statements of earnings and comprehensive earnings as follows: </span></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:22.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.692%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(pre-tax, in millions)</span></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statement of Earnings <br/>Classification of Gain/(Loss) <br/>on Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Recognized in Earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:f-988"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The gains (losses) from these contracts are offset by the changes in the fair value of the hedged item</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amount of gains (losses) on hedges of net investments principally related to changes in exchange and interest rates between the Euro and U.S. dollar</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(c)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Represent the gains for amounts excluded from the effectiveness testing </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(d) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The gains (losses) from these contracts attributable to changes in foreign currency exchange rates are partially offset by the (losses) and gains generated by the underlying intercompany and third-party loans being hedged</span></div><div style="margin-top:5pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2023 and 2022, PMI's derivative contracts impacted the condensed consolidated statements of earnings and comprehensive earnings as follows: </span></div><div style="margin-top:5pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:21.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.691%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.423%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.643%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(pre-tax, in millions)</span></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statement of Earnings <br/>Classification of Gain/(Loss) <br/>on Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of Gain/(Loss) Recognized in Earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:f-1023"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative contracts not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The gains (losses) from these contracts are offset by the changes in the fair value of the hedged item</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amount of gains (losses) on hedges of net investments principally related to changes in exchange and interest rates between the Euro and U.S. dollar</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(c)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Represent the gains for amounts excluded from the effectiveness testing </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(d) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The gains (losses) from these contracts attributable to changes in foreign currency exchange rates are partially offset by the (losses) and gains generated by the underlying intercompany and third-party loans being hedged</span></div> 290000000 325000000 112000000 151000000 0 0 52000000 -17000000 -13000000 -5000000 72000000 304000000 34000000 -5000000 -2000000 0 0 0 -24000000 -81000000 14000000 1088000000 200000000 116000000 212000000 56000000 154000000 -160000000 374000000 1717000000 185000000 124000000 542000000 -69000000 67000000 77000000 73000000 70000000 0 0 -19000000 -7000000 -7000000 -2000000 0 197000000 12000000 -1000000 -1000000 0 0 0 -10000000 -24000000 453000000 558000000 73000000 48000000 60000000 13000000 258000000 -225000000 519000000 832000000 59000000 60000000 381000000 -188000000 906000000 90000000 51000000 525000000 27000000 267000000 Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain/(loss) as of beginning of period,</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative (gains)/losses transferred to earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain/(loss) as of September 30,</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 266000000 4000000 408000000 250000000 155000000 106000000 51000000 51000000 304000000 523000000 58000000 222000000 415000000 421000000 415000000 421000000 176000000 216000000 Earnings Per Share: <div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share (“EPS”) were calculated using the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to PMI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,617 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,651 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,087 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less distributed and undistributed earnings attributable to share-based payment awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings for basic and diluted EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,600 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,633 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,048 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,082 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic EPS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus contingently issuable performance stock units (PSUs)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for diluted EPS</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Including rounding adjustment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and therefore are included in PMI’s earnings per share calculation pursuant to the two-class method.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the 2023 and 2022 computations, there were no antidilutive stock awards.</span></div> <div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share (“EPS”) were calculated using the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to PMI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,617 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,651 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,087 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less distributed and undistributed earnings attributable to share-based payment awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings for basic and diluted EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,600 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,633 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,048 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,082 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic EPS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus contingently issuable performance stock units (PSUs)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for diluted EPS</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Including rounding adjustment</span></div> 5617000000 6651000000 2054000000 2087000000 17000000 18000000 6000000 5000000 5600000000 5600000000 6633000000 6633000000 2048000000 2048000000 2082000000 2082000000 1552000000 1550000000 1552000000 1550000000 1000000 2000000 2000000 2000000 1553000000 1552000000 1554000000 1552000000 0 0 Segment Reporting: <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">PMI’s subsidiaries and affiliates are primarily engaged in the manufacture and sale of cigarettes and smoke-free products, including heat-not-burn, e-vapor and oral nicotine products. Excluding the Wellness and Healthcare segment and the 2022 acquisition of Swedish Match, PMI's segments are generally organized by geographic region and managed by segment managers who are responsible for the operating and financial results of the regions inclusive of combustible tobacco and smoke-free product categories sold in the region. Effective in January 2023, PMI began managing its business in four geographical segments, down from six previously, in addition to its continuing Swedish Match and Wellness and Healthcare segments. The four geographical segments are as follows: Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region ("SSEA, CIS &amp; MEA"); East Asia, Australia, and PMI Duty Free Region ("EA, AU &amp; PMI DF"); and Americas Region. PMI records net revenues and operating income to its geographical segments based upon the geographic area in which the customer resides. </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI’s chief operating decision maker evaluates geographical segment performance and allocates resources based on regional operating income, which includes results from all product categories sold in each region, excluding Swedish Match and Wellness and Healthcare products. Business operations in the Swedish Match segment and the Wellness and Healthcare segment are evaluated separately. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PMI disaggregates its net revenues from contracts with customers by product category for each of PMI's four geographical segments and for the Swedish Match segment. For the Wellness and Healthcare business, Vectura Fertin Pharma, net revenues from contracts with customers are included in the Wellness and Healthcare segment. PMI believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.339%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,805 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SSEA, CIS &amp; MEA</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,822 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EA, AU &amp; PMI DF</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,771 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish Match</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,814 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wellness and Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,127 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,610 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,032 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,446 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,447 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,708 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SSEA, CIS &amp; MEA</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EA, AU &amp; PMI DF</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish Match</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wellness and Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,667 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,322 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI's net revenues by product category were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combustible tobacco products:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,084 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,996 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SSEA, CIS &amp; MEA</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,988 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,852 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,454 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EA, AU &amp; PMI DF</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,091 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,296 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish Match</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total combustible tobacco products</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,845 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,358 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,832 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smoke-free products:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smoke-free products excluding Wellness and Healthcare:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,900 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SSEA, CIS &amp; MEA</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EA, AU &amp; PMI DF</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish Match</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total smoke-free products excluding Wellness and Healthcare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,045 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,053 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,384 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wellness and Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total smoke-free products</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,282 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,252 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,309 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total PMI net revenues</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,127 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,610 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,141 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,032 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Sum of product categories or Regions might not foot to total PMI due to roundings. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Items affecting the comparability of results from operations were as follows: </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Impairment of goodwill and other intangibles </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">–</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the details of the $680 million goodwill and non-amortizable intangible assets impairment charges included in the Wellness and Healthcare segment for the nine months ended September 30, 2023. For the nine months and three months ended September 30, 2022, PMI recorded an impairment charge related to definite-lived intangible assets of $112 million. This charge was included in the Wellness and Healthcare segment. For further details, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.8pt">South Korea indirect tax charge </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">–</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 10. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details of the $204 million pre-tax charge included in the EA, AU &amp; PMI DF segment results for the nine months ended September 30, 2023. </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Termination of distribution arrangement in the Middle East </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">–</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023, PMI recorded a pre-tax charge of $80 million following the termination of a distribution arrangement in the Middle East. This pre-tax charge was recorded as a reduction of net revenues in the condensed consolidated statements of earnings, and was included in the SSEA, CIS &amp; MEA segment results for the nine months ended September 30, 2023. </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Charges related to the war in Ukraine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">–</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the third quarter of 2023, PMI recorded a pre-tax charge of $19 million related to the war in Ukraine. This charge was included in the condensed consolidated statements of earnings and was included in the Europe segment for the nine months and three months ended September 30, 2023. For the nine months and three months ended September 30, 2022, PMI recorded a pre-tax charge of $128 million and $6 million, respectively. These charges were included in the condensed consolidated statements of earnings and were included in the Europe segment for the nine months and three months ended September 30, 2022. For further details, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">War in Ukraine. </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Swedish Match AB acquisition accounting related item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">–</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details of the $18 million pre-tax purchase accounting adjustments related to the sale of acquired inventories stepped up to fair value included in the Swedish Match segment for the nine months ended September 30, 2023.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Asset impairment and exit costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">–</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Impairment and Exit Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details of the $109 million pre-tax charge for the nine months ended September 30, 2023, as well as a breakdown of these costs by segment. </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Termination of agreement with Foundation for a Smoke-Free World </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">– </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 29, 2023, PMI and the Foundation for a Smoke-Free World (the "Foundation") entered into the Final Grant Agreement and Termination of the Second Amended and Restated Pledge Agreement ("Agreement"). Under the terms of the agreement, PMI paid $140 million in the third quarter of 2023 in return for the termination of the pledge agreement between the parties. As a result, in the third quarter of 2023, PMI recorded a pre-tax charge of $140 million commensurate with the early termination of the pledge agreement. The pre-tax charge was recorded in marketing, administration and research costs in the condensed consolidated statements of earnings during the nine months and three months ended September 30, 2023 and was included in the operating results of the following segments for both of these periods: Europe ($62 million); SSEA, CIS &amp; MEA ($44 million); EA, AU &amp; PMI DF ($27 million); and Americas ($7 million). </span></div><div style="margin-bottom:3pt;padding-right:2.25pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The third quarter 2023 results of PMI's Swedish Match segment include the impact of financial statement presentation reclassifications recorded on a year-to-date basis primarily associated with the alignment of accounting policies related to the company's post-acquisition evaluation of sales incentives, excise taxes and acquired contracts. Net revenues were unfavorably impacted by these reclassifications, some of which are associated with the first and second quarter of 2023. These reclassifications were not material to the condensed consolidated results of the current period or the period in which they relate. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Swedish Match acquisition and a review of PMI and Swedish Match’s combined product portfolio, PMI reclassified certain of its own products previously reported under its combustible tobacco product category to the newly created smoke-free product category to better reflect the characteristics of these products. This reclassification did not impact PMI’s consolidated financial position, results of operations or cash flows in any of the periods presented. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues related to combustible tobacco products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of PMI's cigarettes and other tobacco products that are combusted. Other tobacco products primarily include roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos, and do not include smoke-free products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues related to smoke-free products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes, if applicable. These net revenue amounts consist of the sale of all of PMI's products that are not combustible tobacco products, such as heat-not-burn, e-vapor, and oral nicotine, also including wellness and healthcare products, as well as consumer accessories such as lighters and matches.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues related to wellness and healthcare products primarily consist of operating revenues generated from the sale of products primarily associated with inhaled therapeutics, and oral and intra-oral delivery systems that are included in the operating results of PMI's Wellness and Healthcare business, Vectura Fertin Pharma.</span></div> 4 6 4 4 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.339%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,805 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SSEA, CIS &amp; MEA</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,822 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EA, AU &amp; PMI DF</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,771 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish Match</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,814 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wellness and Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,127 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,610 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,032 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,446 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,447 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,708 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SSEA, CIS &amp; MEA</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EA, AU &amp; PMI DF</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish Match</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wellness and Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,667 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,322 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI's net revenues by product category were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combustible tobacco products:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,084 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,996 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SSEA, CIS &amp; MEA</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,988 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,852 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,454 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EA, AU &amp; PMI DF</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,091 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,296 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish Match</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total combustible tobacco products</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,845 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,358 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,832 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smoke-free products:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smoke-free products excluding Wellness and Healthcare:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,900 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SSEA, CIS &amp; MEA</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EA, AU &amp; PMI DF</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish Match</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total smoke-free products excluding Wellness and Healthcare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,045 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,053 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,384 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wellness and Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total smoke-free products</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,282 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,252 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,309 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total PMI net revenues</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,127 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,610 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,141 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,032 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Note: Sum of product categories or Regions might not foot to total PMI due to roundings. 9984000000 9805000000 3672000000 3272000000 7922000000 7781000000 2777000000 2822000000 4771000000 4458000000 1571000000 1407000000 1399000000 1367000000 478000000 474000000 1814000000 0 568000000 0 237000000 199000000 75000000 57000000 26127000000 23610000000 9141000000 8032000000 4446000000 4447000000 1708000000 1415000000 2371000000 3009000000 801000000 1086000000 1920000000 1746000000 753000000 533000000 141000000 336000000 5000000 85000000 597000000 0 140000000 0 -808000000 -216000000 -37000000 -151000000 8667000000 9322000000 3370000000 2968000000 6084000000 5996000000 2160000000 1996000000 6988000000 6852000000 2485000000 2454000000 2091000000 2214000000 678000000 692000000 1349000000 1296000000 460000000 450000000 333000000 0 49000000 0 16845000000 16358000000 5832000000 5591000000 3900000000 3809000000 1512000000 1276000000 934000000 929000000 292000000 368000000 2680000000 2244000000 893000000 715000000 50000000 71000000 18000000 24000000 1481000000 0 519000000 0 9045000000 7053000000 3234000000 2384000000 237000000 199000000 75000000 57000000 9282000000 7252000000 3309000000 2441000000 26127000000 23610000000 9141000000 8032000000 680000000 112000000 112000000 204000000 -80000000 19000000 128000000 6000000 18000000 109000000 -140000000 -140000000 -140000000 -140000000 -62000000 -62000000 -44000000 -44000000 -27000000 -27000000 -7000000 -7000000 Contingencies:<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tobacco-Related Litigation</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings covering a wide range of matters are pending or threatened against us, and/or our subsidiaries, and/or our indemnitees in various jurisdictions. Our indemnitees include distributors, licensees, and others that have been named as parties in certain cases and that we have agreed to defend, as well as to pay costs and some or all of judgments, if any, that may be entered against them. Pursuant to the terms of the Distribution Agreement between Altria Group, Inc. (“Altria”) and PMI, PMI will indemnify Altria and Philip Morris USA Inc. (“PM USA”), a U.S. tobacco subsidiary of Altria, for tobacco product claims based in substantial part on products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for tobacco product claims based in substantial part on products manufactured by PM USA, excluding tobacco products contract manufactured for PMI. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that there could be adverse developments in pending cases against us and our subsidiaries. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Damages claimed in some of the tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. Much of the tobacco-related litigation is in its early stages, and litigation is subject to uncertainty. However, as discussed below, we have to date been largely successful in defending tobacco-related litigation.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our subsidiaries record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, except as stated otherwise in this Note 10. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, while it is reasonably possible that an unfavorable outcome in a case may occur, after assessing the information available to it (i) management has not concluded that it is probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss for any of the pending tobacco-related cases; and (iii) accordingly, no estimated loss has been accrued in the consolidated financial statements for unfavorable outcomes in these cases, if any. Legal defense costs are expensed as incurred.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Nevertheless, although litigation is subject to uncertainty, we and each of our subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended. However, we and our subsidiaries may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.    </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:174%">CCAA Proceedings and Stay of Tobacco-Related Cases Pending in Canada</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of the Court of Appeal of Quebec’s decision in both the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Létourneau</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Blais</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> cases described below, our subsidiary, Rothmans, Benson &amp; Hedges Inc. (“RBH”), and the other defendants, JTI Macdonald Corp., and Imperial Tobacco Canada Limited, sought protection in the Ontario Superior Court of Justice under the Companies’ Creditors Arrangement Act (“CCAA”) on March 22, March 8, and March 12, 2019, respectively. CCAA is a Canadian federal law that permits a Canadian business to restructure its affairs while carrying on its business in the ordinary course. The initial CCAA order made by the Ontario Superior Court on March 22, 2019 authorizes RBH to pay all expenses incurred in carrying on its business in the ordinary course after the CCAA filing, including obligations to employees, vendors, and suppliers. RBH's financial results have been deconsolidated from our consolidated financial statements since March 22, 2019. As part of the CCAA proceedings, there is currently a comprehensive stay up to and including March 29, 2024 of all tobacco-related litigation pending in Canada against RBH and the other defendants, including PMI and our indemnitees (PM USA and Altria), namely, the smoking and health class actions filed in various Canadian provinces and health care cost recovery actions. These proceedings are presented below under the caption “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Stayed Litigation — Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.” Ernst &amp; Young Inc. has been appointed as monitor of RBH in the CCAA proceedings. In accordance with the CCAA process, as the parties work towards a plan of arrangement or compromise in a confidential mediation, it is anticipated that the court will set additional hearings and further extend the stay of proceedings. On April 17, 2019, the Ontario Superior Court ruled that RBH and the other defendants will not be allowed to file an application to the Supreme Court of Canada for leave to appeal the Court of Appeal’s decision in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Létourneau</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Blais</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> cases so long as the comprehensive stay of all tobacco-related litigation in Canada remains in effect and that the time period to file the application would be extended by the stay period. While RBH believes that the findings of liability and damages in both</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Létourneau</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Blais</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> cases were incorrect, the CCAA proceedings will provide a forum for RBH to seek resolution through a plan of arrangement or compromise of all tobacco-related litigation pending in Canada. It is not possible to predict the resolution of the underlying legal proceedings or the length of the CCAA process. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:174%">Stayed Litigation — Canada</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation — Canada</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first class action pending in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais v. Imperial Tobacco Canada Ltd.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rothmans, Benson &amp; Hedges Inc. and JTI-Macdonald Corp., Quebec Superior Court, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in November 1998, RBH and other Canadian cigarette manufacturers (Imperial Tobacco Canada Ltd. and JTI-Macdonald Corp.) are defendants. The plaintiffs, an anti-smoking organization and an individual smoker, sought compensatory and punitive damages for each member of the class who suffers allegedly from certain smoking-related diseases. The class was certified in 2005. The trial court issued its judgment on May 27, 2015. The trial court found RBH and two other Canadian manufacturers liable and found that the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.3 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion (approximately $2.26 billion), including pre-judgment interest). In addition, the trial court awarded CAD 90,000 (approximately $66,000) in punitive damages, allocating CAD 30,000 (approximately $22,000) to RBH. The trial court estimated the disease class at 99,957 members. RBH appealed to the Court of Appeal of Quebec. In October 2015, the Court of Appeal ordered RBH to furnish security totaling CAD 226 million (approximately $165 million) to cover both the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Létourneau </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Blais</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases, which RBH has paid in installments through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD 758 million (approximately $553 million) in installments through June 2017. JTI Macdonald Corp. was not required to furnish security in accordance with plaintiffs’ motion. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court’s judgment or upon further order of the Court of Appeal. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court’s findings of liability and the compensatory and punitive damages award while reducing the total amount of compensatory damages to approximately CAD 13.5 billion (approximately $9.8 billion), including interest due to the trial court’s error in the calculation of interest. The compensatory damages award is on a joint and several basis with an allocation of 20% to RBH (approximately CAD 2.7 billion (approximately $2.0 billion), including pre-judgment interest). The Court of Appeal upheld the trial court’s findings that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking and by conspiring to prevent consumers from learning of the dangers of smoking. The Court of Appeal further held that the plaintiffs either need not prove, or had adequately proven, that these faults were a cause of the class members’ injuries. In accordance with the judgment, defendants were required to deposit their respective portions of the damages awarded in both the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Létourneau</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case described below and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Blais</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case, approximately CAD 1.1 billion (approximately $802 million), into trust accounts within 60 days. RBH’s share of the deposit was approximately CAD 257 million (approximately $194 million). PMI recorded a pre-tax charge of $194 million in its consolidated results, representing $142 million net of tax, as tobacco litigation-related expense, in the first quarter of 2019. The charge reflects PMI’s assessment of the portion of the judgment that represents probable and estimable loss prior to the deconsolidation of RBH and corresponds to the trust account deposit required by the judgment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second class action pending in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cecilia Létourneau v. Imperial Tobacco Ltd., Rothmans, Benson &amp; Hedges Inc. and JTI-Macdonald Corp., Quebec Superior Court, Canada,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed in September 1998, RBH and other Canadian cigarette manufacturers (Imperial Tobacco Canada Ltd. and JTI-Macdonald Corp.) are defendants.  The plaintiff, an individual smoker, sought compensatory and punitive damages for each member of the class who is deemed addicted to smoking. The class was certified in 2005. The trial court issued its judgment on May 27, 2015. The trial court found RBH and two other Canadian manufacturers liable and awarded a total of CAD 131 million (approximately $96 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to RBH. The trial court estimated the size of the addiction class at 918,000 members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court found that a claims process to allocate the awarded punitive damages to individual class members would be too expensive and difficult to administer. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court’s findings of liability and the total amount of punitive damages awarded allocating CAD 57 million (approximately $42 million), including interest to RBH. See the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Blais </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">description above for further detail concerning the security order pertaining to both </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Létourneau</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Blais</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases and the impact of the decision on PMI’s financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RBH and PMI believe the findings of liability and damages in both </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Létourneau </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Blais</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases were incorrect and in contravention of applicable law on several grounds, including the following: (i) defendants had no obligation to warn class members who knew, or should have known, of the risks of smoking; (ii) defendants cannot be liable to class members who </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">would have smoked regardless of what warnings were given; and (iii) defendants cannot be liable to all class members given the individual differences among class members. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third class action pending in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kunta v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Winnipeg, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed June 12, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic obstructive pulmonary disease (“COPD”), severe asthma, and mild reversible lung disease resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth class action pending in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adams v. Canadian Tobacco Manufacturers' Council, et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Queen's Bench, Saskatchewan, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed July 10, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, emphysema, heart disease, or cancer, as well as restitution of profits. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fifth class action pending in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Semple v. Canadian Tobacco Manufacturers' Council, et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Supreme Court (trial court), Nova Scotia, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed June 18, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and COPD resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the sixth class action pending in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dorion v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Alberta, Canada,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed June 15, 2009, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic bronchitis and severe sinus infections resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. To date, we, our subsidiaries, and our indemnitees have not been properly served with the complaint. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the seventh class action pending in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McDermid v. Imperial Tobacco Canada Limited, et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supreme Court, British Columbia, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed June 25, 2010, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and heart disease resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from heart disease allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the eighth class action pending in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bourassa v. Imperial Tobacco Canada Limited, et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supreme Court, British Columbia, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed June 25, 2010, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, the heir to a deceased smoker, alleges that the decedent was addicted to tobacco products and suffered from emphysema resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from chronic respiratory diseases allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. In December 2014, plaintiff filed an amended statement of claim. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ninth class action pending in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Suzanne Jacklin v. Canadian Tobacco Manufacturers' Council, et al., Ontario Superior Court of Justice, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filed June 20, 2012, we, RBH, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, heart disease, or cancer, as well as restitution of profits. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation — Canada </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first health care cost recovery case pending in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed January 24, 2001, we, RBH, our indemnitee (PM USA), and other members of the industry are defendants. The plaintiff, the government of the province of British Columbia, brought a claim based upon legislation enacted by the province authorizing the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, resulting from a “tobacco related wrong.” </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second health care cost recovery case filed in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of New Brunswick v. Rothmans Inc., et al., Court of Queen's Bench of New Brunswick, Trial Court, New Brunswick, Fredericton, Canada,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed March 13, 2008, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of New Brunswick based on legislation enacted in the province. This legislation is similar to the law introduced in British Columbia that authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third health care cost recovery case filed in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Ontario Superior Court of Justice, Toronto, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed September 29, 2009, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Ontario based on legislation enacted in the province. This legislation is similar to the laws introduced in British Columbia and New Brunswick that authorize the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth health care cost recovery case filed in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, St. Johns, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed February 8, 2011, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Newfoundland and Labrador based on legislation enacted in the province that is similar to the laws introduced in British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fifth health care cost recovery case filed in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorney General of Quebec v. Imperial Tobacco Limited, et al., Superior Court of Quebec, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed June 8, 2012, we, RBH, our indemnitee (PM USA), and other members of the industry are defendants. The claim was filed by the government of the province of Quebec based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the sixth health care cost recovery case filed in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Supreme Court of Queen's Bench Alberta, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed June 8, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Alberta based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the seventh health care cost recovery case filed in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of the Province of Manitoba v. Rothmans, Benson &amp; Hedges, Inc., et al., The Queen's Bench, Winnipeg Judicial Centre, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed May 31, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Manitoba based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the eighth health care cost recovery case filed in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Government of Saskatchewan v. Rothmans, Benson &amp; Hedges Inc., et al., Queen's Bench, Judicial Centre of Saskatchewan, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed June 8, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Saskatchewan based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ninth health care cost recovery case filed in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of the Province of Prince Edward Island v. Rothmans, Benson &amp; Hedges Inc., et al., Supreme Court of Prince Edward Island (General Section), Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed September 10, 2012, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Prince Edward Island based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the tenth health care cost recovery case filed in Canada, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of the Province of Nova Scotia v. Rothmans, Benson &amp; Hedges Inc., et al., Supreme Court of Nova Scotia, Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed January 2, 2015, we, RBH, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Nova Scotia based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of tobacco-related cases pertaining to combustible products pending against us and/or our subsidiaries or indemnitees as of September 30, 2023, and September 30, 2022: </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of Case</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Cases Pending as of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Cases Pending as of September 30, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smoking and Health Class Actions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Label-Related Class Actions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Label-Related Cases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Civil Actions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">______</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">¹ Includes cases pending in Canada.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 1995, when the first tobacco-related litigation was filed against a PMI entity, 538 Smoking and Health, Label-Related, Health Care Cost Recovery, and Public Civil Actions in which we and/or one of our subsidiaries and/or indemnitees were a defendant have been terminated in our favor. Fifteen cases have had decisions in favor of plaintiffs. Ten of these cases have subsequently reached final resolution in our favor and five remain on appeal, or are subject to an appeal, or our subsidiary may file an appeal.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the verdict and significant post-trial developments in the five pending cases where a verdict was returned in favor of the plaintiff:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location of<br/>Court/Name of<br/>Plaintiff</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of<br/>Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verdict</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Trial<br/>Developments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 27, 2015</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class Action</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Blais</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.3 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.26 billion)). The trial court awarded CAD 90,000 (approximately $66,000) in punitive damages, allocating CAD 30,000 (approximately $22,000) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $729 million) of the compensatory damage award, CAD 200 million (approximately $146 million) of which is our subsidiary’s portion, into a trust within 60 days. </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In June 2015, RBH commenced the appellate process with the Court of Appeal of Quebec. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court's decision. (See “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Stayed Litigation — Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">” for further detail.)</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location of<br/>Court/Name of<br/>Plaintiff</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of<br/>Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verdict</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Trial<br/>Developments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 27, 2015</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada/Cecilia Létourneau<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class Action</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Létourneau</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> class on liability and awarded a total of CAD 131 million (approximately $96 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to RBH. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.<br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In June 2015, RBH commenced the appellate process with the Court of Appeal of Quebec. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court's decision. (See “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Stayed Litigation — Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">” for further detail.)</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location of<br/>Court/Name of<br/>Plaintiff</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of<br/>Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verdict</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Trial<br/>Developments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 5, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina/Hugo Lespada</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Action</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $314), plus interest, in compensatory and moral damages. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes. </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On May 17, 2021, plaintiff filed a federal extraordinary appeal. On November 1, 2021, the Supreme Court of the Province of Buenos Aires dismissed plaintiff's federal extraordinary appeal. On November 10, 2021, plaintiff filed a direct appeal before the Federal Supreme Court.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location of<br/>Court/Name of<br/>Plaintiff</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of<br/>Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verdict</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Trial<br/>Developments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 17, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina/Claudia Milano</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Action</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 17, 2021, the Civil Court No. 9 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded her smoking cessation treatments, ARS 150,000 (approximately $429), in compensatory and moral damages, and ARS 4,000,000 (approximately $11,435) in punitive damages, plus interest and costs. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 2, 2021, our subsidiary filed its notice of appeal. In addition, plaintiff filed an appeal challenging the dismissal of the claim for psychological damages.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As required by local law, our subsidiary deposited the damages awarded, plus interest and costs, in total ARS 6,114,428 (approximately $17,479), into a court escrow account. Our subsidiary challenged the amount determined by the court. The Civil and Commercial Court of Appeals of Mar del Plata granted our subsidiary's challenge to the escrow amount determined by the trial court. As a result, on December 16, 2021, ARS 893,428 (approximately $2,554) was returned to our subsidiary. If our subsidiary ultimately prevails, the remaining deposited amounts will be returned to our subsidiary.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 31, 2022, the Civil and Commercial Court of Appeals of Mar del Plata ruled that the statute of limitations barred plaintiff's claim and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">reversed the trial court's decision. On June 15, 2022, plaintiff filed an extraordinary appeal.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location of<br/>Court/Name of<br/>Plaintiff</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of<br/>Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verdict</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Trial<br/>Developments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 23, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey/ Senem Yilmazel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Action</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 23, 2023, the Ankara Consumer Court published its decision in favor of plaintiff, the daughter of an individual smoker, against our subsidiary and a BAT subsidiary, awarding her TRY 10,000 (approximately $357) in damages. The trial court found that the plaintiff’s father died as a result of lung cancer and COPD caused by his cigarette consumption.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 8, 2023, our subsidiary filed its appeal. On September 25, 2023, the plaintiff filed an appeal challenging the damages amount determined by the court. </span></div></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pending claims related to tobacco products generally fall within the following categories:</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Smoking and Health Litigation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These cases primarily allege personal injury and are brought by individual plaintiffs or on behalf of a class or purported class of individual plaintiffs. Plaintiffs' allegations of liability in these cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of express and implied warranties, violations of deceptive trade practice laws and consumer protection statutes. Plaintiffs in these cases seek various forms of relief, including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include licit activity, failure to state a claim, lack of defect, lack of proximate cause, assumption of the risk, contributory negligence, and statute of limitations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:</span></div><div><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">48 cases brought by individual plaintiffs in Argentina (32), Australia (1), Canada (2), Chile (10), the Philippines (1), Turkey (1) and Scotland (1), compared with 38 such cases on September 30, 2022; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">9 cases brought on behalf of classes of individual plaintiffs, compared with 9 such cases on September 30, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The class actions pending in Canada are described above under the caption “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation — Canada.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Health Care Cost Recovery Litigation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These cases, brought by governmental and non-governmental plaintiffs, seek reimbursement of health care cost expenditures allegedly caused by tobacco products. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including unjust enrichment, negligence, negligent design, strict liability, breach of express and implied warranties, violation of a voluntary undertaking or special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, defective product, failure to warn, sale of cigarettes to minors, and claims under statutes governing competition and deceptive trade practices. Plaintiffs in these cases seek various forms of relief including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, remoteness of injury, failure to state a claim, adequate remedy at law, “unclean hands” (namely, that plaintiffs cannot obtain equitable relief because they participated in, and benefited from, the sale of cigarettes), and statute of limitations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, there were 17 health care cost recovery cases pending against us, our subsidiaries or indemnitees in Brazil (1), Canada (10), Korea (1) and Nigeria (5), compared with 17 such cases on September 30, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health care cost recovery actions pending in Canada are described above under the caption “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation — Canada.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the health care cost recovery case in Brazil, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Attorney General of Brazil v. Souza Cruz Ltda., et al., Federal Trial Court, Porto Alegre, Rio Grande do Sul, Brazil</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed May 21, 2019, we, our subsidiaries, and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases in certain prior years, payment of anticipated costs of treating future alleged smoking-related diseases, and moral damages. Defendants filed answers to the complaint in May 2020. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first health care cost recovery case in Nigeria, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Attorney General of Lagos State v. British American Tobacco (Nigeria) Limited, et al., High Court of Lagos State, Lagos, Nigeria,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed March 13, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second health care cost recovery case in Nigeria, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Attorney General of Kano State v. British American Tobacco (Nigeria) Limited, et al., High Court of Kano State, Kano, Nigeria,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed May 9, 2007, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of challenging the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third health care cost recovery case in Nigeria, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Attorney General of Gombe State v. British American Tobacco (Nigeria) Limited, et al., High Court of Gombe State, Gombe, Nigeria,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed October 17, 2008, we and other members of the </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">industry are defendants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In February 2011, the court ruled that the plaintiff had not complied with the procedural steps necessary to serve us. As a result of this ruling, plaintiff must re-serve its claim. We have not yet been re-served.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth health care cost recovery case in Nigeria, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Attorney General of Oyo State, et al., v. British American Tobacco (Nigeria) Limited, et al., High Court of Oyo State, Ibadan, Nigeria,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed May 25, 2007, we and other members of the industry are defendants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Plaintiffs seek reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We challenged service as improper. In June 2010, the court ruled that plaintiffs did not have leave to serve the writ of summons on the defendants and that they must re-serve the writ. We have not yet been re-served.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fifth health care cost recovery case in Nigeria, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Attorney General of Ogun State v. British American Tobacco (Nigeria) Limited, et al., High Court of Ogun State, Abeokuta, Nigeria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed February 26, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In May 2010, the trial court rejected our objections to the court's jurisdiction. We have appealed. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the health care cost recovery case in Korea, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">National Health Insurance Service v. KT&amp;G, et. al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed April 14, 2014, our subsidiary and other Korean manufacturers are defendants. Plaintiff alleges that defendants concealed the health hazards of smoking, marketed to youth, added ingredients to make their products more harmful and addictive, and misled consumers into believing that </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Lights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> cigarettes are safer than regular cigarettes. The National Health Insurance Service seeks to recover damages allegedly incurred in treating 3,484 patients with small cell lung cancer, squamous cell lung cancer, and squamous cell laryngeal cancer from 2003 to 2012. The trial court dismissed the case in its entirety on November 20, 2020. The Appellate court granted the Plaintiff a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">de novo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> appeal in 2021 and determined that the appellate proceedings will take place in stages: wrongful conduct/product defect allegations first, then causation and finally issues such as standing/direct action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Label-Related Cases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These cases, now brought only by individual plaintiffs, allege that the use of the descriptor “Lights” or other alleged misrepresentations or omissions of labeling information constitute fraudulent and misleading conduct. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including misrepresentation, deception, and breach of consumer protection laws. Plaintiffs seek various forms of relief including restitution, injunctive relief, and compensatory and other damages. Defenses raised include lack of causation, lack of reliance, assumption of the risk, and statute of limitations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, there were 5 label-related cases brought by individual plaintiffs in Italy (1) and Chile (4) pending against our subsidiaries, compared with 6 such cases on September 30, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Public Civil Actions:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Claims have been filed either by an individual, or a public or private entity, seeking to protect collective or individual rights, such as the right to health, the right to information or the right to safety. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including product defect, concealment, and misrepresentation. Plaintiffs in these cases seek various forms of relief including injunctive relief such as banning cigarettes, descriptors, smoking in certain places and advertising, as well as implementing communication campaigns and reimbursement of medical expenses incurred by public or private institutions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, there was 1 public civil action pending against our subsidiary in Venezuela (1), compared with 1 such case on September 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a public civil action in Venezuela, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federation of Consumers and Users Associations (“FEVACU”), et al. v. National Assembly of Venezuela and the Venezuelan Ministry of Health, Constitutional Chamber of the Venezuelan Supreme Court</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed April 29, 2008, we were not named as a defendant, but the plaintiffs published a notice pursuant to court order, notifying all interested parties to appear in the case. In January 2009, our subsidiary appeared in the case in response to this notice. The plaintiffs purport to represent the right to health of the citizens of Venezuela and claim that the government failed to protect adequately its citizens' right to health. The claim asks the court to order the government to enact stricter regulations on the manufacture and sale of tobacco products. In addition, the plaintiffs ask the court to order companies involved in the tobacco </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">industry to allocate a percentage of their “sales or benefits” to establish a fund to pay for the health care costs of treating smoking-related diseases. In October 2008, the court ruled that plaintiffs have standing to file the claim and that the claim meets the threshold admissibility requirements. In December 2012, the court admitted our subsidiary and a subsidiary of British American Tobacco plc as interested third parties. In February 2013, our subsidiary answered the complaint.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Litigation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Department of Special Investigations of the government of Thailand ("DSI") conducted an investigation into alleged underpayment by our subsidiary, Philip Morris (Thailand) Limited ("PM Thailand"), of customs duties and excise taxes relating to imports from the Philippines covering the period 2003-2007. On January 18, 2016, the Public Prosecutor filed charges against our subsidiary and seven former and current employees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bangkok Criminal Court alleging that PM Thailand and the individual defendants jointly and with the intention to defraud the Thai government, under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries of cigarettes from the Philippines during the period of July 2003 to June 2006. The government sought a fine of approximately THB 80.8 billion (approximately $2.2 billion). In May 2017, Thailand enacted a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies. Trial in the case began in November 2017 and concluded in September 2019. In November 2019, the trial court found our subsidiary guilty of under-declaration of the prices and imposed a fine of approximately THB 1.2 billion (approximately $32.8 million). The trial court dismissed all charges against the individual defendants. In December 2019, as required by the Thai law, our subsidiary paid the fine. This payment is included in other assets on the condensed consolidated balance sheets and negatively impacted net cash provided by operating activities in the condensed consolidated statements of cash flows in the period of payment. Both our subsidiary and the Public Prosecutor filed an appeal of the trial court's decision. The appellate court issued its decision on the appeals on June 1, 2022. The appellate court affirmed the findings of under-declaration of import prices of cigarettes but reduced the fine to approximately THB 122 million (approximately $3.3 million) finding the trial court erred in its calculation of the under-declaration and fine. The appellate court affirmed the acquittals of the individual defendants. Our subsidiary has appealed the decision to the Supreme Court of Thailand. The Public Prosecutor has also filed an appeal challenging the dismissal of charges against the individual defendants and the amount of the fine imposed. Thailand is required to refund any payment made by our subsidiary in excess of any fine asserted by the courts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DSI also conducted an investigation into alleged underpayment by PM Thailand of customs duties and excise taxes relating to imports from Indonesia covering the period 2000-2003. On January 26, 2017, the Public Prosecutor filed charges against PM Thailand and its former Thai employee in the Bangkok Criminal Court alleging that PM Thailand and its former employee jointly and with the intention to defraud the Thai government under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries during the period from January 2002 to July 2003. The government is seeking a fine of approximately THB 19.8 billion (approximately $541 million). In May 2017, Thailand enacted a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law, and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and a Thai court. Trial in the case began in November 2018 and concluded in December 2019. In March 2020, the trial court found our subsidiary guilty of under-declaration of the prices and imposed a fine of approximately THB 130 million (approximately $3.6 million). The trial court dismissed all charges against the individual defendant. In April 2020, as required by Thai law, our subsidiary paid the fine. This payment is included in other assets on the condensed consolidated balance sheets and negatively impacted net cash provided by operating activities in the condensed consolidated statements of cash flows in the period of payment. Our subsidiary filed an appeal of the trial court's decision. In addition, the Public Prosecutor filed an appeal of the trial court's decision challenging the dismissal of charges against the individual defendant and the amount of the fine imposed. The appellate court issued its decision on the appeals on January 31, 2023. The appellate court affirmed the findings of under-declaration of import prices of cigarettes but reduced the fine imposed by the trial court. The appellate court directed the Public Prosecutor to coordinate with customs officials to calculate such reduced fine in accordance with the appellate court’s decision. The appellate court affirmed the acquittal of the individual defendant. Our subsidiary has appealed the decision to the Supreme Court of Thailand. The Public Prosecutor has filed an appeal to the Supreme Court of Thailand challenging the dismissal of charges against the individual defendant and the amount of the fine. Thailand is required to refund any payment made by our subsidiary in excess of any fine assessed by the courts.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The South Korean Board of Audit and Inspection (“BAI”) conducted an audit of certain Korean government agencies and the tobacco industry into whether inventory movements ahead of the January 1, 2015 increase of cigarette-related taxes by tobacco companies, including Philip Morris Korea Inc. ("PM Korea"), our South Korean subsidiary, were in compliance with South Korean tax laws.  In November 2016, the tax authorities completed their audit and assessed allegedly underpaid taxes and penalties.  In order to avoid nonpayment financial costs, PM Korea paid approximately KRW 272 billion (approximately $204 million), of which KRW 100 billion (approximately $75 million) was paid in 2016 and KRW 172 billion (approximately $129 million) was paid in the first quarter of 2017.  These paid amounts negatively impacted net cash provided by operating activities in the condensed consolidated statements of cash flows in the period of payment.  PM Korea appealed the assessments. In January 2020, a trial court ruled that PM Korea did not underpay taxes in the amount of approximately KRW 218 billion (approximately $164 million). The tax authorities appealed this decision to the appellate court. In September 2020, the appellate court upheld the trial court's decision. The tax authorities have appealed to the Supreme Court of South Korea. On July 13, 2023, the Supreme Court reversed the appellate court's decision and remanded the appeals back to the appellate court. Based on the decision issued by the Supreme Court of South Korea on July 13, 2023, management has concluded that an adverse outcome is probable. In June 2020, another trial court ruled that PM Korea did not underpay approximately KRW 54 billion (approximately $40 million) of alleged underpayments. The government agencies appealed this decision. In January 2021, the appellate court upheld the trial court's decision. The government agencies appealed to the Supreme Court of South Korea. Based on the decision issued by the Supreme Court of South Korea on July 13, 2023, management has concluded that an adverse outcome is probable. Consequently, in the second quarter of 2023, PMI recorded a non-cash pre-tax charge of $204 million in marketing, administration and research costs, reflecting the full amount previously paid by PM Korea.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A putative shareholder class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Philip Morris International Inc. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, is pending in the United States District Court for the Southern District of New York, purportedly on behalf of purchasers of Philip Morris International Inc. stock between July 26, 2016 and April 18, 2018. The lawsuit names Philip Morris International Inc. and certain officers and employees as defendants and includes allegations that the defendants made false and/or misleading statements and/or failed to disclose information about PMI’s business, operations, financial condition, and prospects, related to product sales of, and alleged irregularities in clinical studies of, PMI’s Platform 1 product. The lawsuit seeks various forms of relief, including damages. In November 2018, the court consolidated three putative shareholder class action lawsuits with similar allegations previously filed in the Southern District of New York (namely, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Westland Police and Fire Retirement System v. Philip Morris International Inc., et al., Greater Pennsylvania Carpenters’ Pension Fund v. Philip Morris International Inc., et al., and Gilchrist v. Philip Morris International Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) into these proceedings. A putative shareholder class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rubenstahl v. Philip Morris International Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that had been previously filed in December 2017 in the United States District Court for the District of New Jersey, was voluntarily dismissed by the plaintiff due to similar allegations in these proceedings. On February 4, 2020, the court granted defendants’ motion in its entirety, dismissing all but one of the plaintiffs’ claims with prejudice.  The court noted that one of plaintiffs’ claims (allegations relating to four non-clinical studies of PMI’s Platform 1 product) did not state a viable claim but allowed plaintiffs to replead that claim by March 3, 2020. On February 18, 2020, the plaintiffs filed a motion for reconsideration of the court's February 4th decision; this motion was denied on September 21, 2020. On September 28, 2020, plaintiffs filed an amended complaint seeking to replead allegations relating to four non-clinical studies of PMI's Platform 1 product. On September 10, 2021, the court granted defendant's motion to dismiss plaintiffs' amended complaint in its entirety. Plaintiffs have filed an appeal with the U.S. Court of Appeal for the Second Circuit. We believe that this lawsuit is without merit and will continue to defend it vigorously.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, affiliates of British American Tobacco plc (“BAT”) commenced patent infringement proceedings, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RAI Strategic Holdings, Inc., et al. v. Altria Client Services LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,  in the federal court in the Eastern District of Virginia, where PMI's subsidiary, Philip Morris Products S.A. ("PMPSA"), as well as Altria Group, Inc.'s subsidiaries, are defendants. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade products in the United States.  In April 2020, BAT affiliates filed a complaint against PMI, PMPSA, Altria Group, Inc., and its subsidiaries before the International Trade Commission ("ITC"). Plaintiffs seek an order to prevent the importation of Platform 1 products into the United States. The ITC evidentiary hearing closed on February 1, 2021. On May 14, 2021, the administrative law judge issued an Initial and Recommended Determination ("ID/RD") finding that the Platform 1 blade products infringe two of the three patents asserted by Plaintiffs, recommending that the ITC issue a Limited Exclusion order against infringing products, and recommending against a cease-and-desist, as well as recommending against a bond pending Presidential review of the ITC's Final Determination ("FD"). Defendants and Plaintiffs filed separate Petitions for Review with the ITC of the ID/RD on May 28, 2021; on July 27, 2021, the ITC granted each of the petitions in part, deciding to review certain issues in the ID/RD. Plaintiffs and Defendants also submitted brief statements of the public interest factors in issue to the ITC on June 15, 2021. On September 29, 2021, the ITC issued its FD finding a violation of section 337 of the U.S. Tariff Act and issued (a) a limited exclusion order against PMPSA, prohibiting, inter alia, the importation of Platform 1 product and infringing components; and (b) a cease-and-desist order </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">against Altria Client Services, LLC and its affiliate prohibiting, inter alia, sales of imported Platform 1 products. The ITC predicated the orders on its finding that Platform 1 blade products infringe two patents owned by a BAT affiliate. The ITC also found that Platform 1 blade products do not infringe a third patent owned by a BAT affiliate. The ITC further held that there were insufficient concerns over public interest to prevent the issuance of remedial orders. Following the Presidential Review period, the orders became effective and Defendants filed a petition for review of the FD with the U.S. Court of Appeals for the Federal Circuit. Defendants also filed motions in the ITC and Federal Circuit for a stay of the orders pending disposition of the appeal; the ITC denied the motion on January 20, 2022 and the Federal Circuit denied the motion on January 25, 2022. The Federal Circuit heard oral argument on defendants' appeal of the FD on October 3, 2022 and, on March 31, 2023, the Federal Circuit affirmed the FD. This adverse ruling impacts our ability to import the products and components impacted by the ITC's FD but has an immaterial financial impact. In the Eastern District of Virginia case, the defendants also counterclaimed that BAT infringed their patents relating to certain e-vapor products, seeking damages for, and injunctive relief against, the commercialization of these products by BAT. The trial of Defendant PMPSA’s counterclaims took place from June 8-14, 2022 and, on June 15, 2022, the jury returned a verdict for PMPSA awarding approximately $10.8 million in damages for infringement up to December 31, 2021 of two PMPSA patents by BAT’s affiliate and two of BAT’s e-vapor products; the jury also found BAT’s affiliate did not infringe one of the two PMPSA patents and that the BAT affiliates had failed to prove one of the two PMPSA patents was invalid. PMPSA filed a motion for an injunction or, in the alternative, an ongoing royalty on August 12, 2022. On March 30, 2023, the court denied PMPSA's motion for an injunction and granted PMPSA an ongoing royalty against two of BAT's U.S. e-vapor products. On May 1, 2023, the court entered partial final judgment under Rule 54(b) on PMPSA's claim against BAT's affiliate. That same day, BAT's affiliate filed a notice of appeal to the U.S. Court of Appeals for the Federal Circuit. On May 10, 2023, PMPSA filed a notice of cross-appeal. Upon petition of PMPSA, the Patent Trial and Appeal Board ("PTAB") of the United States Patent and Trademark Office has instituted review of certain claims pertaining to four of the six patents asserted by BAT affiliates in both proceedings. On January 11, 2022, PTAB issued its final decision on one of the two patents underlying the ITC's FD, invalidating all challenged claims of BAT's patent. On March 30, 2022, PTAB issued its final decision on the second of the two patents underlying the ITC's FD, finding the challenged claims patentable. The parties have filed appeals of these PTAB results to the U.S. Court of Appeals for the Federal Circuit. Oral argument was held on July 13, 2023. On July 17, 2023, the Federal Circuit issued a decision summarily affirming PTAB’s decision to invalidate all challenged claims in one of the two patents underlying the ITC’s FD. The Federal Circuit issued the mandate notifying the USPTO to record the invalidity of the challenged claims on August 23, 2023. On September 14, 2023, the Federal Circuit issued a decision affirming the PTAB's decision finding certain claims in the second of the two patents underlying the ITC’s FD patentable.  PMPSA’s counterclaim in the Eastern District of Virginia challenging the validity of the remaining claims in the second of the two patents underlying the ITC’s FD is currently stayed. On July 21, 2022, PMPSA filed a Request for Rehearing of PTAB's November 2020 decision not to institute review of certain claims in the second of the two patents underlying the ITC's FD; PTAB denied the Request on October 13, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, BAT’s affiliate commenced patent infringement proceedings, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nicoventures Trading Limited v. PM GmbH, et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> against PMI’s German subsidiary, Philip Morris GmbH, and PMPSA, in the Regional Court in Munich, Germany. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade products in Germany. In June 2021, the court stayed the proceeding in respect of one of the two patents asserted by BAT’s Affiliate. Following the December 2022 confirmation of the revocation of the other BAT patent by the European Patent Office Board of Appeal, BAT withdrew its initial claim based on that patent; the stayed action based on the second patent remains pending and is stayed pending a possible appeal by BAT of the revocation of that second patent by the European Patent Office.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, BAT’s affiliates commenced patent infringement and unfair competition proceedings, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RAI Strategic Holdings, Inc., et al. v. Philip Morris Products S.A., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, against PMPSA. and PMI’s Italian subsidiaries, Philip Morris Manufacturing &amp; Technology Bologna S.p.A. and Philip Morris Italia S.r.l., in the Court of Milan, Italy. Plaintiffs seek damages, as well as injunctive relief against the manufacture in Italy of the Platform 1 blade heated tobacco units allegedly infringing the asserted patents and the commercialization of the Platform 1 blade products in Italy. As part of this proceeding, in October 2020, BAT’s affiliates filed a request based on one of the two asserted patents seeking preliminary injunctive relief against the manufacture and commercialization of the Platform 1 blade products in Italy. In July 2022, the court dismissed plaintiffs’ request for preliminary injunction in its entirety and plaintiffs did not appeal this ruling. The merits proceeding remains pending; the next hearing is currently scheduled to occur in the first quarter of 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, BAT’s affiliates commenced patent infringement proceedings, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RAI Strategic Holdings, Inc., et al. v. Philip Morris Japan, Limited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., against PMI’s Japanese subsidiary, Philip Morris Japan Limited, and a third-party distributor in the Tokyo District Court. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade products in Japan. On December 23, 2022, the Court dismissed BAT’s claims with respect to one of the two patents that it </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">asserted, finding no infringement; BAT filed an appeal of this dismissal. On September 21, 2023, the court issued its judgment dismissing BAT's appeal regarding the Beard patent. BAT's claim with respect to the second patent remains pending; the final procedural hearing was held on September 6, 2023, during which the Court closed the proceedings and announced that the judgment would be rendered in the fourth quarter of 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, BAT’s affiliates commenced patent infringement proceedings, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RAI Strategic Holdings, Inc., et al. v. Philip Morris Romania SRL, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, against PMI’s Romanian subsidiaries, Philip Morris Romania S.R.L. and Philip Morris Trading S.R.L., and a third-party distributor in the Court of Law of Bucharest, Civil Registry. Plaintiffs seek damages and preliminary and permanent injunctive relief against the manufacture and commercialization of the Platform 1 blade products in Romania. In February 2021, the court dismissed plaintiffs’ request for a preliminary injunction. In April 2021, the appellate court denied plaintiffs' appeal, confirming the dismissal of plaintiffs' request for preliminary injunction. Plaintiffs' proceeding requesting damages and a permanent injunction remains pending before the Court of Law of Bucharest, Civil Registry. In an October 14, 2021 hearing, the court stayed the proceeding. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, BAT’s affiliates commenced patent infringement proceedings, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RAI Strategic Holdings, Inc., et al. v. Philip Morris Korea, Co., Ltd., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">against PM Korea in the Seoul Central District Court. Plaintiffs seek damages and injunctive relief against the commercialization of the Platform 1 blade heated tobacco units in South Korea.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 30, 2022, the Korean Patent Office issued a decision that all of the challenged claims in the patent asserted by Plaintiffs are invalid; Plaintiffs filed an appeal of this decision. Following BAT’s unsuccessful correction action at the Korean Patent Office, the court held the first hearing in the appeal of the infringement proceeding on September 12, 2023. An additional hearing in the appeal is currently scheduled to occur in the fourth quarter of 2024. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July, 2021, PMPSA filed a claim at the High Court of Justice of England and Wales against BAT affiliates Nicoventures Trading Limited and British American Tobacco (Investments) Limited seeking revocation of the UK parts of two BAT European patents. In March, the BAT affiliates stated that they would consent to revocation of one of the patents and filed a counterclaim against PMPSA and Philip Morris Limited seeking from the court a declaration that the remaining BAT affiliate patent is infringed by Platform 1 induction products, as well as damages and injunctive relief against the commercialization of the Platform 1 induction products in the U.K. The trial took place from September 21-28, 2022. On October 25, 2023, the Court issued its decision finding that the remaining BAT patent was invalid and not infringed.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other patent challenges by both parties are pending in various jurisdictions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the foregoing proceedings by the affiliates of BAT are without merit and will defend them vigorously.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also involved in additional litigation arising in the ordinary course of our business. While the outcomes of these proceedings are uncertain, management does not expect that the ultimate outcomes of other litigation, including any reasonably possible losses in excess of current accruals, will have a material adverse effect on our consolidated results of operations, cash flows or financial position.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third-Party Guarantees </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until November 1, 2022, Medicago Inc. ("Medicago") was an equity method investee of Philip Morris Investments B.V. (“PMIBV”), a PMI subsidiary. On October 17, 2020, Medicago had entered into a contribution agreement with the Canadian government (the “Contribution Agreement”) whereby the Canadian government agreed to contribute up to CAD 173 million (approximately $131 million on the date of signing) to Medicago, to support its on-going COVID-19 vaccine development and clinical trials ("First Stage"), and for the construction of its Quebec City manufacturing facility ("Second Stage", and together with the First Stage, the “Project”). On March 31, 2022, the Contribution Agreement was amended (the “Contribution Agreement Amendment”) to reflect an additional contribution from the Canadian government up to CAD 27 million (approximately $22 million on the date of signing) to Medicago for the Second Stage. In August 2022, Medicago received the final tranche of the contribution from the Canadian government in relation to the First Stage, confirming thereby the completion of such first stage and consequently reducing by approximately CAD 123 million (approximately $93 million on the date of signing) the Repayment Obligations (as defined below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMIBV and Mitsubishi Tanabe Pharma Corporation (“MTPC”) are also parties to the Contribution Agreement and the Contribution Agreement Amendment as guarantors of Medicago’s obligations thereunder on a joint and several basis (“Co-Guarantors”). The Co-Guarantors agreed to repay amounts contributed by the Canadian government plus interest, if Medicago </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fails to do so (the "Repayment Obligations"), and could be responsible for the costs of Medicago’s other obligations (such as the achievement of specific milestones of the Project). The guarantees are in effect through March 31, 2026. Prior to the release of PMIBV from its obligations as guarantor described below, it was reasonably possible that PMI could have been responsible for a portion of those costs and obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, PMIBV transferred all of the shares it owned in Medicago to MTPC Holdings Canada Inc., the majority shareholder of Medicago. MTPC assumed and agreed to perform all of PMIBV's obligations under the guarantees and to indemnify and save PMIBV harmless in respect of any and all claims related to the guaranteed obligations. On February 3, 2023, PMI learned through a public announcement that a decision had been taken to cease all operations at Medicago and to proceed with an orderly wind up of Medicago’s business and operations. </span></div>On September 27, 2023, the Canadian government released PMIBV from all its obligations as guarantor under the Contribution Agreement and the Contribution Agreement Amendment. 2 15500000000 11300000000 0.20 3100000000 2260000000 90000 66000 30000 22000 99957 226000000 165000000 758000000 553000000 13500000000 9800000000 0.20 2700000000 2000000000 1100000000 802000000 P60D 257000000 194000000 194000000 142000000 2 131000000 96000000 46000000 34000000 918000 57000000 42000000 25000 25000 <div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of tobacco-related cases pertaining to combustible products pending against us and/or our subsidiaries or indemnitees as of September 30, 2023, and September 30, 2022: </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of Case</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Cases Pending as of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Cases Pending as of September 30, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smoking and Health Class Actions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Label-Related Class Actions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Label-Related Cases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Civil Actions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">______</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">¹ Includes cases pending in Canada.</span></div> 48 38 9 9 17 17 0 0 5 6 1 1 538 15 10 5 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the verdict and significant post-trial developments in the five pending cases where a verdict was returned in favor of the plaintiff:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location of<br/>Court/Name of<br/>Plaintiff</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of<br/>Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verdict</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Trial<br/>Developments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 27, 2015</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class Action</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Blais</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.3 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.26 billion)). The trial court awarded CAD 90,000 (approximately $66,000) in punitive damages, allocating CAD 30,000 (approximately $22,000) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $729 million) of the compensatory damage award, CAD 200 million (approximately $146 million) of which is our subsidiary’s portion, into a trust within 60 days. </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In June 2015, RBH commenced the appellate process with the Court of Appeal of Quebec. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court's decision. (See “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Stayed Litigation — Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">” for further detail.)</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location of<br/>Court/Name of<br/>Plaintiff</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of<br/>Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verdict</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Trial<br/>Developments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 27, 2015</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada/Cecilia Létourneau<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class Action</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Létourneau</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> class on liability and awarded a total of CAD 131 million (approximately $96 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to RBH. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.<br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In June 2015, RBH commenced the appellate process with the Court of Appeal of Quebec. On March 1, 2019, the Court of Appeal issued a decision largely affirming the trial court's decision. (See “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Stayed Litigation — Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">” for further detail.)</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location of<br/>Court/Name of<br/>Plaintiff</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of<br/>Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verdict</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Trial<br/>Developments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 5, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina/Hugo Lespada</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Action</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $314), plus interest, in compensatory and moral damages. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes. </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On May 17, 2021, plaintiff filed a federal extraordinary appeal. On November 1, 2021, the Supreme Court of the Province of Buenos Aires dismissed plaintiff's federal extraordinary appeal. On November 10, 2021, plaintiff filed a direct appeal before the Federal Supreme Court.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location of<br/>Court/Name of<br/>Plaintiff</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of<br/>Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verdict</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Trial<br/>Developments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 17, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina/Claudia Milano</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Action</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 17, 2021, the Civil Court No. 9 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded her smoking cessation treatments, ARS 150,000 (approximately $429), in compensatory and moral damages, and ARS 4,000,000 (approximately $11,435) in punitive damages, plus interest and costs. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 2, 2021, our subsidiary filed its notice of appeal. In addition, plaintiff filed an appeal challenging the dismissal of the claim for psychological damages.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As required by local law, our subsidiary deposited the damages awarded, plus interest and costs, in total ARS 6,114,428 (approximately $17,479), into a court escrow account. Our subsidiary challenged the amount determined by the court. The Civil and Commercial Court of Appeals of Mar del Plata granted our subsidiary's challenge to the escrow amount determined by the trial court. As a result, on December 16, 2021, ARS 893,428 (approximately $2,554) was returned to our subsidiary. If our subsidiary ultimately prevails, the remaining deposited amounts will be returned to our subsidiary.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 31, 2022, the Civil and Commercial Court of Appeals of Mar del Plata ruled that the statute of limitations barred plaintiff's claim and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">reversed the trial court's decision. On June 15, 2022, plaintiff filed an extraordinary appeal.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location of<br/>Court/Name of<br/>Plaintiff</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type of<br/>Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verdict</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Trial<br/>Developments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 23, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey/ Senem Yilmazel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Action</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 23, 2023, the Ankara Consumer Court published its decision in favor of plaintiff, the daughter of an individual smoker, against our subsidiary and a BAT subsidiary, awarding her TRY 10,000 (approximately $357) in damages. The trial court found that the plaintiff’s father died as a result of lung cancer and COPD caused by his cigarette consumption.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 8, 2023, our subsidiary filed its appeal. On September 25, 2023, the plaintiff filed an appeal challenging the damages amount determined by the court. </span></div></td></tr></table></div> 5 15500000000 11300000000 0.20 3100000000 2260000000 90000 66000 30000 22000 1000000000 729000000 200000000 146000000 P60D 131000000 96000000 46000000 34000000 P60D 110000 314 150000 429 4000000 11435 6114428 17479 893428 2554 10000 357 48 32 1 2 10 1 1 1 38 9 9 17 1 10 1 5 17 P20Y P20Y P20Y P20Y P20Y P20Y P20Y P20Y P20Y P20Y 3484 5 1 4 6 1 1 1 7 80800000000 2200000000 1200000000 32800000 122000000 3300000 19800000000 541000000 130000000 3600000 272000000000 204000000 100000000000 75000000 172000000000 129000000 218000000000 164000000 54000000000 40000000 204000000 10800000 173000000 131000000 27000000 22000000 123000000 93000000 Income Taxes: <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis, and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI’s effective tax rates for the nine months and three months ended September 30, 2023 were 25.7% and 33.2%, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the nine months ended September 30, 2023, was unfavorably impacted by: (i) an increase in deferred tax liabilities related to the unremitted earnings of PMI's Russian subsidiaries ($173 million) due to the unilateral suspension of certain Russian double tax treaties by the Russian authorities on August 8, 2023, with respect to certain payments including dividends; (ii) the non-deductible Wellness and Healthcare goodwill impairment charge and (iii) a deferred tax cost for unrealized foreign currency gains on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings ($41 million), while the underlying pre-tax foreign currency movements fully offset in the condensed consolidated statements of earnings and were reflected as currency translation adjustments in its condensed consolidated statements of stockholders' (deficit) equity. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended September 30, 2023 was unfavorably impacted by an increase in deferred tax liabilities related to the unremitted earnings of PMI's Russian subsidiaries ($173 million) and a deferred tax cost for unrealized foreign currency gains on intercompany loans related to the Swedish Match acquisition financing reflected in the condensed consolidated statements of earnings ($138 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI’s effective tax rates for the nine months and three months ended September 30, 2022 were 20.6% and 22.0%, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the nine months ended September 30, 2022, was favorably impacted by changes in earnings mix by taxing jurisdiction and by a reduction in deferred tax liabilities related to pension plan assets ($40 million), as well as a decrease in deferred tax liabilities related to the fair value adjustment of equity securities held by PMI ($13 million). For further details, see Note 14. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Parties - Equity Investments and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI estimates that its full-year 2023 effective tax rate will be approximately 20.5% to 21.5%, excluding discrete tax events. Changes in currency exchange rates, earnings mix by taxing jurisdiction or future legislative or regulatory developments may have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions. </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years 2019 and onward. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from 3 to 5 years. In October 2021, a subsidiary of PMI in Indonesia, PT Hanjaya Mandala Sampoerna Tbk ("HMS"), received a tax assessment in the amount of 3.8 trillion Indonesian rupiah (approximately $260 million in the period of payment) primarily relating to corporate income taxes on domestic and other intercompany transactions for the years 2017 to 2019. HMS paid the assessment in the fourth quarter of 2021 in order to avoid potential penalties and filed an objection letter with the tax office in January 2022. The amount paid was included in other assets in </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PMI’s condensed consolidated balance sheets at September 30, 2023 and December 31, 2022, and negatively impacted net cash provided by operating activities in the consolidated statements of cash flows in the period of payment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in unrecognized tax benefits along with related interest and penalties. An estimate of any possible change cannot be made at this time.</span></div> 0.257 0.332 173000000 41000000 173000000 138000000 0.206 0.220 -40000000 -13000000 0.205 0.215 P3Y P5Y 3800000000000 260000000 Indebtedness:<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term Borrowings:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2023 and December 31, 2022, PMI’s short-term borrowings and related average interest rates consisted of the following:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank loans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar credit facility borrowings related to Swedish Match AB acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,430 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,637 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the mix of PMI's legal entities and their respective local economic environments, the average interest rate for bank loans above can vary significantly from day to day and country to country.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of PMI’s short-term borrowings, based on current market interest rates, approximate carrying value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2023 and December 31, 2022, PMI’s long-term debt consisted of the following: </span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes, 0.875% to 6.375% (average interest rate 4.433%), due through 2044</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,733 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,596 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes, 0.125% to 3.125% (average interest rate 1.877%), due through 2039</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,069 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swiss franc note, 1.625%, due 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro credit facility borrowings related to Swedish Match AB acquisition, (average interest rate 4.265%), due through 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish krona notes, 1.395% to 5.762% (average interest rate 2.357%), due through 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (average interest rate 6.156%), due through 2031 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,566 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,486 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,914 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,875 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> Includes long-term bank loans at subsidiaries, as well as $40 million and $54 million in finance leases at September 30, 2023 and December 31, 2022, respectively. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of PMI’s outstanding long-term debt, which is utilized solely for disclosure purposes, is determined using quotes and market interest rates currently available to PMI for issuances of debt with similar terms and remaining maturities. At September 30, 2023, the fair value of PMI's outstanding long-term debt, excluding the aforementioned finance leases, was as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.684%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:87%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:2.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:87%">Level 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">36,217 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;text-indent:2.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:87%">Level 2</span></td><td colspan="2" style="border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">6,356 </span></td><td style="border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:21.154%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.473%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For a description of the fair value hierarchy and the three levels of inputs used to measure fair values, see Item 8, Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of PMI's Annual Report on Form 10-K for the year ended December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Credit Facilities related to the Financing of the Swedish Match Acquisition </span></div><div style="padding-right:2.25pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with PMI's all-cash recommended public offer to the shareholders of Swedish Match, on May 11, 2022, PMI entered into a credit agreement relating to a 364-day senior unsecured bridge facility. The facility provided for borrowings up to an aggregate principal amount of $17 billion, expiring 364 days after the occurrence of certain events unless extended. On June 23, 2022, PMI entered into a €5.5 billion (approximately $5.8 billion at the date of signing) senior unsecured term loan credit agreement consisting of a €3.0 billion (approximately $3.2 billion at the date of signing) tranche expiring three years after the occurrence of certain events and a €2.5 billion (approximately $2.6 billion at the date of signing) tranche expiring on June 23, 2027. In connection with the term loan facility, the aggregate principal amount of commitments under the 364-day senior unsecured bridge facility was reduced from $17 billion to $11 billion. On November 11, 2022, PMI acquired a controlling interest of 85.87% of the total issued shares in Swedish Match and acquired 94.81% of its outstanding shares as of December 31, 2022. In accordance with the Swedish Companies Act, PMI subsequently exercised its right to compulsorily redeem the remaining shares for which acceptances were not received and obtained legal title to 100% of the shares in Swedish Match on February 17, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI borrowed $8.4 billion under the bridge facility by delivering notices of borrowing for advances of $7.9 billion and $0.5 billion on November 7, 2022 and November 10, 2022, respectively. All amounts borrowed under the bridge facility would become due on November 8, 2023 unless prepaid or such maturity date is extended pursuant to the terms of the bridge facility. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 7, 2022, PMI also delivered notices of borrowing for advances totaling €5.5 billion under the term loan facility, of which €3.0 billion will become due on November 9, 2025 and €2.5 billion will become due on June 23, 2027 unless prepaid pursuant to the terms of the credit agreement. On November 21, 2022 and February 17, 2023, PMI repaid $4.0 billion and $4.4 billion, respectively, under the bridge facility. Effective February 20, 2023, the remaining outstanding commitments under the bridge facility were fully canceled and the bridge facility agreement was terminated in accordance with its terms. As of September 30, 2023 and December 31, 2022, the €5.5 billion (approximately $6 billion) term loan facility was fully drawn and remained outstanding. The proceeds under the bridge facility and the term loan facility were used, directly or indirectly, to finance the acquisition, including, the payment of related fees and expenses. For further details on this acquisition, see Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt Issuances </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI's debt issuances in the first nine months of 2023 were as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.125%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2030</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2033</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$450</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$550</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (d)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$700</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.125%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2030</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (e)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2033</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$650</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.250%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2028</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$700</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.500%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2030</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.625%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2033</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(a) Interest is payable semi-annually, commencing in August 2023 </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(b) These notes are a further issuance of the 4.875% notes issued in February 2023</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(c) These notes are a further issuance of the 4.875% notes issued in February 2023</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(d) These notes are a further issuance of the 5.125% notes issued in February 2023</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(e) These notes are a further issuance of the 5.375% notes issued in February 2023</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(f) Interest is payable semi-annually, commencing in March 2024 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 17, 2023, PMI applied a portion of the net proceeds of the debt issuances to prepay $4.4 billion under its bridge facility, which represented all borrowings outstanding under the bridge facility. PMI used a portion of the May 2023 net proceeds to pay the remaining cash consideration due in accordance with the terms of its agreement with Altria. For further details on PMI's agreement with Altria, see Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The remaining net proceeds of the February and May 2023 offerings, as well as the September 2023 offering have been or will be used for general corporate purposes. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2023, PMI's total committed revolving credit facilities were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:15.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in billions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:15.75pt;text-align:justify"><span><br/></span></div><div style="padding-right:15.75pt;text-align:justify"><span><br/></span></div><div style="padding-right:15.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Committed<br/>Revolving Credit<br/>Facilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:13.5pt;padding-right:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364-day revolving credit, expiring January 30, 2024</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:13.5pt;padding-right:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-year revolving credit, expiring February 10, 2026 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:13.5pt;padding-right:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-year revolving credit, expiring September 29, 2026 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-right:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total facilities</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 28, 2022, PMI entered into an agreement, effective February 10, 2022, to amend and extend the term of its $2.0 billion multi-year revolving credit facility, for an additional year covering the period February 11, 2026 to February 10, 2027, in the amount of $1.9 billion.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes pricing adjustments that may result in the reduction or increase in both the interest rate and commitment fee under the credit agreement if PMI achieves, or fails to achieve, certain specified targets.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On September 20, 2022, PMI entered into an agreement, effective September 29, 2022, to amend and extend the term of its $2.5 billion multi-year revolving credit facility, for an additional year covering the period September 30, 2026 to September 29, 2027, in the amount of $2.3 billion. On September 20, 2023, PMI entered into an agreement, effective September 29, 2023, to amend and further extend the term to September 29, 2028. </span></div>At September 30, 2023, there were no borrowings under these committed revolving credit facilities, and the entire committed amounts were available for borrowing.In addition to the committed revolving credit facilities discussed above, PMI maintains certain short-term credit arrangements, including uncommitted credit lines, to primarily meet working capital needs. These credit arrangements amounted to approximately $2.6 billion at September 30, 2023, and approximately $1.9 billion at December 31, 2022. Borrowings under these arrangements and other bank loans amounted to $221 million at September 30, 2023, and $295 million at December 31, 2022. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2023 and December 31, 2022, PMI’s short-term borrowings and related average interest rates consisted of the following:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank loans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar credit facility borrowings related to Swedish Match AB acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,430 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,637 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div> 1928000000 0.055 912000000 0.044 221000000 0.090 295000000 0.075 0 0 4430000000 0.049 2149000000 5637000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2023 and December 31, 2022, PMI’s long-term debt consisted of the following: </span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes, 0.875% to 6.375% (average interest rate 4.433%), due through 2044</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,733 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,596 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes, 0.125% to 3.125% (average interest rate 1.877%), due through 2039</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,069 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swiss franc note, 1.625%, due 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro credit facility borrowings related to Swedish Match AB acquisition, (average interest rate 4.265%), due through 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swedish krona notes, 1.395% to 5.762% (average interest rate 2.357%), due through 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (average interest rate 6.156%), due through 2031 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,566 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,486 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,914 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,875 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>(a) Includes long-term bank loans at subsidiaries, as well as $40 million and $54 million in finance leases at September 30, 2023 and December 31, 2022, respectively. 0.00875 0.06375 0.04433 30733000000 22596000000 0.00125 0.03125 0.01877 8069000000 8116000000 0.01625 272000000 378000000 0.04265 5797000000 5850000000 0.01395 0.05762 0.02357 234000000 343000000 0.06156 461000000 203000000 45566000000 37486000000 2652000000 2611000000 42914000000 34875000000 40000000 54000000 At September 30, 2023, the fair value of PMI's outstanding long-term debt, excluding the aforementioned finance leases, was as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.684%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:87%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:2.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:87%">Level 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">36,217 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;text-indent:2.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:87%">Level 2</span></td><td colspan="2" style="border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">6,356 </span></td><td style="border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table> 36217000000 6356000000 P364D 17000000000 P364D 5500000000 5800000000 3000000000 3200000000 P3Y 2500000000 2600000000 P364D 17000000000 11000000000 0.8587 0.9481 1 8400000000 7900000000 500000000 5500000000 3000000000 2500000000 4000000000 4400000000 5500000000 5500000000 6000000000 6000000000 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI's debt issuances in the first nine months of 2023 were as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.125%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2030</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2033</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$450</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$550</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (d)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$700</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.125%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2030</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (e)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2033</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$650</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.250%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2028</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$700</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.500%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2030</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar notes</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.625%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2033</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(a) Interest is payable semi-annually, commencing in August 2023 </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(b) These notes are a further issuance of the 4.875% notes issued in February 2023</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(c) These notes are a further issuance of the 4.875% notes issued in February 2023</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(d) These notes are a further issuance of the 5.125% notes issued in February 2023</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(e) These notes are a further issuance of the 5.375% notes issued in February 2023</span></div>(f) Interest is payable semi-annually, commencing in March 2024 1250000000 0.04875 1000000000 0.04875 1500000000 0.05125 1500000000 0.05375 450000000 0.04875 550000000 0.04875 700000000 0.05125 750000000 0.05375 650000000 0.05250 700000000 0.05500 1000000000 0.05625 0.04875 0.04875 0.05125 0.05375 4400000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2023, PMI's total committed revolving credit facilities were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:15.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in billions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:15.75pt;text-align:justify"><span><br/></span></div><div style="padding-right:15.75pt;text-align:justify"><span><br/></span></div><div style="padding-right:15.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Type</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Committed<br/>Revolving Credit<br/>Facilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:13.5pt;padding-right:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364-day revolving credit, expiring January 30, 2024</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:13.5pt;padding-right:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-year revolving credit, expiring February 10, 2026 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:13.5pt;padding-right:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-year revolving credit, expiring September 29, 2026 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-right:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total facilities</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 28, 2022, PMI entered into an agreement, effective February 10, 2022, to amend and extend the term of its $2.0 billion multi-year revolving credit facility, for an additional year covering the period February 11, 2026 to February 10, 2027, in the amount of $1.9 billion.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes pricing adjustments that may result in the reduction or increase in both the interest rate and commitment fee under the credit agreement if PMI achieves, or fails to achieve, certain specified targets.</span></div>(3) On September 20, 2022, PMI entered into an agreement, effective September 29, 2022, to amend and extend the term of its $2.5 billion multi-year revolving credit facility, for an additional year covering the period September 30, 2026 to September 29, 2027, in the amount of $2.3 billion. On September 20, 2023, PMI entered into an agreement, effective September 29, 2023, to amend and further extend the term to September 29, 2028. 1800000000 2000000000.0 2500000000 6300000000 2000000000 1900000000 2500000000 2300000000 0 2600000000 1900000000 221000000 295000000 Accumulated Other Comprehensive Losses:<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Losses) Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,475)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,003)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,055)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,757)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives accounted for as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,817)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,559)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,288)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications from Other Comprehensive Earnings </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in accumulated other comprehensive losses and the related tax impact, for each of the components above, that are due to current period activity and reclassifications to the income statement, are shown on the condensed consolidated statements of comprehensive earnings for the nine months and three months ended September 30, 2023 and 2022. For additional information, see Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions (Transactions With Noncontrolling Interests) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for disclosures related to currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for disclosures related to PMI's pension and other benefits and Note 7. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for disclosures related to derivative financial instruments.</span></div> <div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Losses) Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,475)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,003)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,055)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,757)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives accounted for as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,817)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,559)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,288)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -8475000000 -8003000000 -7055000000 -1757000000 -1822000000 -2654000000 415000000 266000000 421000000 -9817000000 -9559000000 -9288000000 Related Parties - Equity Investments and Other: <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2023 and December 31, 2022, PMI had total equity method investments of $1,238 million and $1,000 million, respectively. Equity method investments are initially recorded at cost. Under the equity method of accounting, the investment is adjusted for PMI's proportionate share of earnings or losses, dividends, capital contributions, changes in ownership interests and movements in currency translation adjustments. The carrying value of our equity method investments at September 30, 2023 and December 31, 2022, exceeded our share of the investees' book value by $881 million and $750 million, respectively. The difference between the investment carrying value and the amount of underlying equity in net assets is mainly attributable to equity method goodwill, convertible debt instruments, and definite-lived intangible assets and other assets. The difference related to the definite-lived intangibles and other assets at September 30, 2023 and December 31, 2022 of $33 million and $35 million, respectively, is amortized on a straight-line basis and is included in Equity investments and securities (income)/loss, net on the condensed consolidated statements of earnings. At September 30, 2023 and December 31, 2022, PMI received year-to-date dividends from equity method investees of $57 million and $9 million, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PMI holds a 23% equity interest in Megapolis Distribution BV, the holding company of CJSC TK Megapolis, PMI's distributor in Russia (SSEA, CIS &amp; MEA segment), which as of September 30, 2023 had a carrying value of $351 million. While as of September 30, 2023, there have been no impairment indicators based on the business’ performance, there are still risks related to this investment as the fair value of these assets is difficult to predict due to the volatility in foreign currency and commodity markets, supply chain, and current economic, political and social conditions. For more information, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">War in Ukraine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Additionally, there was approximately $588 million of cumulative foreign currency translation losses associated with Megapolis Distribution BV reflected in accumulated other comprehensive losses in the condensed consolidated statement of stockholders’ equity as of September 30, 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI holds a 49% equity interest in United Arab Emirates-based Emirati Investors-TA (FZC) (“EITA”). PMI holds an approximate 25% economic interest in Société des Tabacs Algéro-Emiratie (“STAEM”), an Algerian joint venture that is 51% owned by EITA and 49% by the Algerian state-owned enterprise Management et Développement des Actifs et des Ressources Holding ("MADAR Holding"), which manufactures and distributes under license some of PMI’s brands (SSEA, CIS &amp; MEA segment).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2023, PMI increased its equity ownership and acquired 66.73% of Egyptian Investment Holding (“EIH”), a United Arab Emirates based company and as a result, acquired an approximate economic interest of 25% in United Tobacco Company ("UTC"). UTC is an entity incorporated in Egypt, which is 38% owned by EIH and manufactures products under license for Philip Morris Misr LCC (“PMM”), an entity incorporated in Egypt which is consolidated in PMI’s financial statements in the SSEA, CIS &amp; MEA segment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial investments in Megapolis Distribution BV, EITA and UTC have been recorded at cost and are included in equity investments on the consolidated balance sheets. Transactions between these equity method investees and PMI subsidiaries are considered to be related-party transactions and are included in the tables below. </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity securities:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the deconsolidation of RBH on March 22, 2019, PMI recorded the continuing investment in RBH, PMI's wholly owned subsidiary in Canada, at fair value of $3,280 million at the date of deconsolidation, within equity investments. Transactions between PMI and RBH are considered to be related party transactions from the date of deconsolidation and are included in the tables below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of PMI’s other equity securities, which have been classified within Level 1, was $378 million at September 30, 2023. Unrealized pre-tax gain (loss) of $52 million ($41 million net of tax) on these equity securities was recorded in equity investments and securities (income)/loss, net on the condensed consolidated statements of earnings for the nine months ended September 30, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other related parties:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United Arab Emirates-based Trans-Emirates Trading and Investments (FZC) ("TTI") holds a 33% non-controlling interest in Philip Morris Misr LLC ("PMM"), an entity incorporated in Egypt which is consolidated in PMI’s financial statements in the SSEA, CIS &amp; MEA segment. PMM sells, under license, PMI brands in Egypt through an exclusive distribution agreement with a local entity that is also controlled by TTI. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Godfrey Phillips India Ltd ("GPI") is one of the non-controlling interest holders in IPM India, which is a 56.3% owned PMI consolidated subsidiary in the SSEA, CIS &amp; MEA segment. GPI also acts as contract manufacturer and distributor for IPM India. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial activity with the above related parties:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI’s net revenues and expenses with the above related parties were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Megapolis Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net revenues exclude excise taxes and VAT billed to customers. </span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI’s balance sheet activity with the above related parties was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At September 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At December 31, 2022</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Receivables:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Megapolis Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Payables:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payables</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>The activities with the above related parties are in the ordinary course of business, and are primarily for distribution, service fees, contract manufacturing and license agreements. PMI eliminated its respective share of all significant intercompany transactions with the equity method investees. 1238000000 1000000000 881000000 750000000 33000000 35000000 57000000 9000000 0.23 351000000 -588000000 0.49 0.25 0.51 0.49 0.6673 0.25 0.38 3280000000 378000000 52000000 41000000 0.33 0.563 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI’s net revenues and expenses with the above related parties were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Megapolis Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net revenues exclude excise taxes and VAT billed to customers. </span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI’s balance sheet activity with the above related parties was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At September 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At December 31, 2022</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Receivables:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Megapolis Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Payables:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payables</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 1714000000 1770000000 530000000 777000000 917000000 864000000 327000000 310000000 2631000000 2634000000 857000000 1087000000 180000000 62000000 67000000 33000000 180000000 62000000 67000000 33000000 394000000 478000000 261000000 210000000 655000000 688000000 33000000 31000000 33000000 31000000 Sale of Accounts Receivable: <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To mitigate risk and enhance cash and liquidity management, PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of September 30, 2023 and September 30, 2022. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative trade receivables sold, including excise taxes, for the nine months ended September 30, 2023 and 2022, were $9.4 billion and $8.4 billion, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of September 30, 2023 and September 30, 2022, were $670 million, and $512 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the condensed consolidated statements of earnings. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss on sale of trade receivables was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2 0 0 9400000000 8400000000 670000000 512000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss on sale of trade receivables was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -37000000 -13000000 -15000000 -7000000 Product Warranty: <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI's heat-not-burn devices and e-vapor products are subject to standard product warranties generally for a period of 12 months from the date of purchase or such other periods as required by law. PMI generally provides in cost of sales for the estimated cost of warranty in the period the related revenue is recognized. PMI assesses the adequacy of its accrued product warranties and adjusts the amounts as necessary based on actual experience and changes in future estimates. Factors that affect product warranties may vary across markets but typically include device version mix, product failure rates, logistics and service delivery costs, and warranty policies. PMI accounts for its product warranties within other accrued liabilities. At September 30, 2023 and December 31, 2022, these amounts were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of and For the Nine Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of and For the Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes due to: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Warranties issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Settlements </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Currency/Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> P12M At September 30, 2023 and December 31, 2022, these amounts were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of and For the Nine Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of and For the Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes due to: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Warranties issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Settlements </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Currency/Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 104000000 113000000 55000000 107000000 62000000 114000000 2000000 2000000 95000000 104000000 Asset Impairment and Exit Costs: <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2023, PMI recorded total pre-tax asset impairment and exit costs of $109 million related to restructuring activities. These pre-tax charges were included in marketing, administration and research costs in the condensed consolidated statements of earnings for the nine months ended September 30, 2023. For the three months ended September 30, 2023, PMI did not record such charges related to restructuring activities. For the nine months and three months ended September 30, 2022, PMI did not record any charges for asset impairment and exit costs related to restructuring activities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2023, PMI recorded a pre-tax impairment charge on goodwill and other intangibles of $680 million within the Wellness and Healthcare segment. For the nine months and three months ended September 30, 2022, PMI recorded a pre-tax impairment charge on other intangibles of $112 million within the Wellness and Healthcare segment. For further details, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e-Vapor Products Manufacturing Optimization </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, PMI initiated a project to fully outsource and restructure the manufacturing of e-vapor devices and consumables. As a result, PMI recorded pre-tax asset impairment and exit costs of $109 million. This amount included contract termination costs for suppliers of $78 million, including $21 million of embedded finance lease terminations, payable in cash. This amount also included asset impairment costs of $31 million, primarily related to machinery and equipment, which were non-cash charges.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Asset Impairment and Exit Costs by Segment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">PMI recorded the following pre-tax asset impairment and exit costs by segment:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.155%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SSEA, CIS &amp; MEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EA, AU &amp; PMI DF</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contract termination charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment charges: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SSEA, CIS &amp; MEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EA, AU &amp; PMI DF</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment and exit costs</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Movement in Exit Cost Liabilities </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in exit cost liabilities for the nine months ended September 30, 2023 was as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance, January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash spent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency/other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance, September 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Future cash payments for exit costs incurred to date are anticipated to be substantially paid by the end of 2024, with approximately $6 million expected to be paid in the remainder of 2023. 109000000 0 0 0 680000000 112000000 112000000 109000000 78000000 21000000 31000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">PMI recorded the following pre-tax asset impairment and exit costs by segment:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.155%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SSEA, CIS &amp; MEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EA, AU &amp; PMI DF</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contract termination charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment charges: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SSEA, CIS &amp; MEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EA, AU &amp; PMI DF</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment and exit costs</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 35000000 25000000 15000000 3000000 78000000 14000000 9000000 6000000 2000000 31000000 109000000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in exit cost liabilities for the nine months ended September 30, 2023 was as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance, January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash spent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency/other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance, September 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 40000000 78000000 74000000 -8000000 36000000 6000000 Leases: <div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of PMI’s lease cost were as follows for the nine months and three months ended September 30, 2023 and 2022: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:50.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> Leases: <div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of PMI’s lease cost were as follows for the nine months and three months ended September 30, 2023 and 2022: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:50.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of PMI’s lease cost were as follows for the nine months and three months ended September 30, 2023 and 2022: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:50.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 199000000 187000000 66000000 61000000 37000000 60000000 9000000 13000000 1000000 0 1000000 0 44000000 45000000 15000000 15000000 20000000 17000000 6000000 6000000 301000000 309000000 97000000 95000000 Supply Chain Financing: PMI has engaged with unaffiliated global financial institutions that offer a voluntary supply chain financing ("SCF") program to some of our suppliers. Under the SCF program, the suppliers may elect, at their sole discretion, to sell PMI's payment obligations to these financial institutions. The suppliers independently negotiate the sale arrangements directly with these financial institutions. PMI does not participate in these negotiations, nor does it have any economic interest in these agreements, or in the designated suppliers’ voluntary decision to sell PMI's payment obligations to these financial institutions. No guarantees or securities are provided by PMI or any of its subsidiaries under the SCF programs. PMI's obligations to its suppliers, including amounts due and scheduled payment terms are not impacted by the suppliers’ decision to sell amounts under the SCF program. The payment terms of PMI’s suppliers generally do not exceed 120 days. All outstanding payable amounts related to suppliers that are participating in the SCF program are recorded in accounts payable in PMI's condensed consolidated balance sheets. The associated payments are included in cash flows from operating activities within PMI's condensed consolidated statement of cash flows. As of September 30, 2023 and December 31, 2022, the total amount due to suppliers participating in the SCF program was approximately $0.8 billion and $1.1 billion, respectively. P120D 800000000 1100000000 false false false false Net of excise tax on products of $37,140 million and $37,028 million for the nine months ended September 30, 2023 and 2022, respectively Includes net revenues from related parties of $2,631 million and $2,634 million for the nine months ended September 30, 2023 and 2022, respectively Includes net revenues from related parties of $857 million and $1,087 million for the three months ended September 30, 2023 and 2022, respectively Net of excise taxes of $13,092 million and $12,856 million for the three months ended September 30, 2023 and 2022, respectively Includes an impairment charge for other intangibles of $112 million for the three months ended September 30, 2022. For further details, see Note 6. Goodwill and Other Intangible Assets, net Includes trade receivables from related parties of $655 million and $688 million as of September 30, 2023, and December 31, 2022, respectively (less allowances of $43 million as of September 30, 2023 and $7 million as of December 31, 2022). For further details, see Note 14. Related Parties - Equity Investments and Other. Includes amounts from related parties of $(130) million and $(226) million for September 30, 2023 and 2022, respectively The amounts for cash, cash equivalents and restricted cash shown above include restricted cash of $17 million and $6 million as of September 30, 2023 and 2022, respectively, and $10 million and $4 million as of December 31, 2022 and 2021, respectively, which were included in other current assets in the condensed consolidated balance sheets. Includes an impairment charge for other intangibles of $112 million for the nine months ended September 30, 2022. For further details, see Note 6. Goodwill and Other Intangible Assets, net Includes an impairment charge for goodwill and other intangibles of $680 million and a charge of $204 million for the South Korea indirect tax charge for the nine months ended September 30, 2023, respectively. For further details, see Note 6. Goodwill and Other Intangible Assets, net and Note 10. Contingencies EXCEL 124 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 126 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 127 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 636 442 1 true 199 0 false 22 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.pmi.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Statements of Earnings Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings Condensed Consolidated Statements of Earnings Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Statements of Comprehensive Earnings Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings Condensed Consolidated Statements of Comprehensive Earnings Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsParenthetical Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.pmi.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 6 false false R7.htm 0000007 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 0000008 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical Condensed Consolidated Statements of Cash Flows (Parenthetical) Statements 8 false false R9.htm 0000009 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity Condensed Consolidated Statements of Stockholders' (Deficit) Equity Statements 9 false false R10.htm 0000010 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) Statements 10 false false R11.htm 0000011 - Statement - Condensed Consolidated Statements of Earnings (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical Condensed Consolidated Statements of Earnings (Parenthetical) Statements 11 false false R12.htm 0000012 - Disclosure - Background and Basis of Presentation: Sheet http://www.pmi.com/role/BackgroundandBasisofPresentation Background and Basis of Presentation: Notes 12 false false R13.htm 0000013 - Disclosure - Acquisitions: Sheet http://www.pmi.com/role/Acquisitions Acquisitions: Notes 13 false false R14.htm 0000014 - Disclosure - War in Ukraine: Sheet http://www.pmi.com/role/WarinUkraine War in Ukraine: Notes 14 false false R15.htm 0000015 - Disclosure - Stock Plans: Sheet http://www.pmi.com/role/StockPlans Stock Plans: Notes 15 false false R16.htm 0000016 - Disclosure - Benefit Plans: Sheet http://www.pmi.com/role/BenefitPlans Benefit Plans: Notes 16 false false R17.htm 0000017 - Disclosure - Goodwill and Other Intangible Assets, net: Sheet http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnet Goodwill and Other Intangible Assets, net: Notes 17 false false R18.htm 0000018 - Disclosure - Financial Instruments: Sheet http://www.pmi.com/role/FinancialInstruments Financial Instruments: Notes 18 false false R19.htm 0000019 - Disclosure - Earnings Per Share: Sheet http://www.pmi.com/role/EarningsPerShare Earnings Per Share: Notes 19 false false R20.htm 0000020 - Disclosure - Segment Reporting: Sheet http://www.pmi.com/role/SegmentReporting Segment Reporting: Notes 20 false false R21.htm 0000021 - Disclosure - Contingencies: Sheet http://www.pmi.com/role/Contingencies Contingencies: Notes 21 false false R22.htm 0000022 - Disclosure - Income Taxes: Sheet http://www.pmi.com/role/IncomeTaxes Income Taxes: Notes 22 false false R23.htm 0000023 - Disclosure - Indebtedness: Sheet http://www.pmi.com/role/Indebtedness Indebtedness: Notes 23 false false R24.htm 0000024 - Disclosure - Accumulated Other Comprehensive Losses: Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLosses Accumulated Other Comprehensive Losses: Notes 24 false false R25.htm 0000025 - Disclosure - Related Parties - Equity Investments and Other: Sheet http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOther Related Parties - Equity Investments and Other: Notes 25 false false R26.htm 0000026 - Disclosure - Sale of Accounts Receivable: Sheet http://www.pmi.com/role/SaleofAccountsReceivable Sale of Accounts Receivable: Notes 26 false false R27.htm 0000027 - Disclosure - Product Warranty: Sheet http://www.pmi.com/role/ProductWarranty Product Warranty: Notes 27 false false R28.htm 0000028 - Disclosure - Asset Impairment and Exit Costs: Sheet http://www.pmi.com/role/AssetImpairmentandExitCosts Asset Impairment and Exit Costs: Notes 28 false false R29.htm 0000029 - Disclosure - Leases: Sheet http://www.pmi.com/role/Leases Leases: Notes 29 false false R30.htm 0000030 - Disclosure - Supply Chain Financing: Sheet http://www.pmi.com/role/SupplyChainFinancing Supply Chain Financing: Notes 30 false false R31.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 31 false false R32.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 32 false false R33.htm 9954471 - Disclosure - Background and Basis of Presentation: (Policies) Sheet http://www.pmi.com/role/BackgroundandBasisofPresentationPolicies Background and Basis of Presentation: (Policies) Policies 33 false false R34.htm 9954472 - Disclosure - Acquisitions: (Tables) Sheet http://www.pmi.com/role/AcquisitionsTables Acquisitions: (Tables) Tables http://www.pmi.com/role/Acquisitions 34 false false R35.htm 9954473 - Disclosure - War in Ukraine: (Tables) Sheet http://www.pmi.com/role/WarinUkraineTables War in Ukraine: (Tables) Tables http://www.pmi.com/role/WarinUkraine 35 false false R36.htm 9954474 - Disclosure - Stock Plans: (Tables) Sheet http://www.pmi.com/role/StockPlansTables Stock Plans: (Tables) Tables http://www.pmi.com/role/StockPlans 36 false false R37.htm 9954475 - Disclosure - Benefit Plans: (Tables) Sheet http://www.pmi.com/role/BenefitPlansTables Benefit Plans: (Tables) Tables http://www.pmi.com/role/BenefitPlans 37 false false R38.htm 9954476 - Disclosure - Goodwill and Other Intangible Assets, net: (Tables) Sheet http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetTables Goodwill and Other Intangible Assets, net: (Tables) Tables http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnet 38 false false R39.htm 9954477 - Disclosure - Financial Instruments: (Tables) Sheet http://www.pmi.com/role/FinancialInstrumentsTables Financial Instruments: (Tables) Tables http://www.pmi.com/role/FinancialInstruments 39 false false R40.htm 9954478 - Disclosure - Earnings Per Share: (Tables) Sheet http://www.pmi.com/role/EarningsPerShareTables Earnings Per Share: (Tables) Tables http://www.pmi.com/role/EarningsPerShare 40 false false R41.htm 9954479 - Disclosure - Segment Reporting: (Tables) Sheet http://www.pmi.com/role/SegmentReportingTables Segment Reporting: (Tables) Tables http://www.pmi.com/role/SegmentReporting 41 false false R42.htm 9954480 - Disclosure - Contingencies: (Tables) Sheet http://www.pmi.com/role/ContingenciesTables Contingencies: (Tables) Tables http://www.pmi.com/role/Contingencies 42 false false R43.htm 9954481 - Disclosure - Indebtedness: (Tables) Sheet http://www.pmi.com/role/IndebtednessTables Indebtedness: (Tables) Tables http://www.pmi.com/role/Indebtedness 43 false false R44.htm 9954482 - Disclosure - Accumulated Other Comprehensive Losses: (Tables) Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesTables Accumulated Other Comprehensive Losses: (Tables) Tables http://www.pmi.com/role/AccumulatedOtherComprehensiveLosses 44 false false R45.htm 9954483 - Disclosure - Related Parties - Equity Investments and Other: (Tables) Sheet http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherTables Related Parties - Equity Investments and Other: (Tables) Tables http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOther 45 false false R46.htm 9954484 - Disclosure - Receivables, Loans, Notes Receivable, and Others (Tables) Notes http://www.pmi.com/role/ReceivablesLoansNotesReceivableandOthersTables Receivables, Loans, Notes Receivable, and Others (Tables) Tables 46 false false R47.htm 9954485 - Disclosure - Product Warranty: (Tables) Sheet http://www.pmi.com/role/ProductWarrantyTables Product Warranty: (Tables) Tables http://www.pmi.com/role/ProductWarranty 47 false false R48.htm 9954486 - Disclosure - Asset Impairment and Exit Costs: (Tables) Sheet http://www.pmi.com/role/AssetImpairmentandExitCostsTables Asset Impairment and Exit Costs: (Tables) Tables http://www.pmi.com/role/AssetImpairmentandExitCosts 48 false false R49.htm 9954487 - Disclosure - Leases: (Tables) Sheet http://www.pmi.com/role/LeasesTables Leases: (Tables) Tables http://www.pmi.com/role/Leases 49 false false R50.htm 9954488 - Disclosure - Background and Basis of Presentation: (Narrative) (Details) Sheet http://www.pmi.com/role/BackgroundandBasisofPresentationNarrativeDetails Background and Basis of Presentation: (Narrative) (Details) Details http://www.pmi.com/role/BackgroundandBasisofPresentationPolicies 50 false false R51.htm 9954489 - Disclosure - Acquisitions: (Details) Sheet http://www.pmi.com/role/AcquisitionsDetails Acquisitions: (Details) Details http://www.pmi.com/role/AcquisitionsTables 51 false false R52.htm 9954490 - Disclosure - Acquisitions: (Swedish Match AB) (Details) Sheet http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails Acquisitions: (Swedish Match AB) (Details) Details http://www.pmi.com/role/AcquisitionsTables 52 false false R53.htm 9954491 - Disclosure - Acquisitions: (Pro Forma) (Details) Sheet http://www.pmi.com/role/AcquisitionsProFormaDetails Acquisitions: (Pro Forma) (Details) Details http://www.pmi.com/role/AcquisitionsTables 53 false false R54.htm 9954492 - Disclosure - War in Ukraine: Narrative (Details) Sheet http://www.pmi.com/role/WarinUkraineNarrativeDetails War in Ukraine: Narrative (Details) Details 54 false false R55.htm 9954493 - Disclosure - War in Ukraine: Pretax Charges (Details) Sheet http://www.pmi.com/role/WarinUkrainePretaxChargesDetails War in Ukraine: Pretax Charges (Details) Details 55 false false R56.htm 9954494 - Disclosure - Stock Plans: (Additional Information) (Details) Sheet http://www.pmi.com/role/StockPlansAdditionalInformationDetails Stock Plans: (Additional Information) (Details) Details http://www.pmi.com/role/StockPlansTables 56 false false R57.htm 9954495 - Disclosure - Stock Plans: (RSU Awards) (Details) Sheet http://www.pmi.com/role/StockPlansRSUAwardsDetails Stock Plans: (RSU Awards) (Details) Details http://www.pmi.com/role/StockPlansTables 57 false false R58.htm 9954496 - Disclosure - Stock Plans: (PSU Awards) (Details) Sheet http://www.pmi.com/role/StockPlansPSUAwardsDetails Stock Plans: (PSU Awards) (Details) Details http://www.pmi.com/role/StockPlansTables 58 false false R59.htm 9954497 - Disclosure - Benefit Plans: (Components of Pension and Other Employee Benefits Costs) (Details) Sheet http://www.pmi.com/role/BenefitPlansComponentsofPensionandOtherEmployeeBenefitsCostsDetails Benefit Plans: (Components of Pension and Other Employee Benefits Costs) (Details) Details http://www.pmi.com/role/BenefitPlansTables 59 false false R60.htm 9954498 - Disclosure - Benefit Plans: (Components of Net Periodic Benefit Cost) (Details) Sheet http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails Benefit Plans: (Components of Net Periodic Benefit Cost) (Details) Details http://www.pmi.com/role/BenefitPlansTables 60 false false R61.htm 9954499 - Disclosure - Benefit Plans: (Narrative) (Details) Sheet http://www.pmi.com/role/BenefitPlansNarrativeDetails Benefit Plans: (Narrative) (Details) Details http://www.pmi.com/role/BenefitPlansTables 61 false false R62.htm 9954500 - Disclosure - Goodwill and Other Intangible Assets, net: (Additional Information) (Details) Sheet http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails Goodwill and Other Intangible Assets, net: (Additional Information) (Details) Details http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetTables 62 false false R63.htm 9954501 - Disclosure - Goodwill and Other Intangible Assets, net: (Movement in Goodwill) (Details) Sheet http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails Goodwill and Other Intangible Assets, net: (Movement in Goodwill) (Details) Details http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetTables 63 false false R64.htm 9954502 - Disclosure - Goodwill and Other Intangible Assets, net: (Other Intangible Assets) (Details) Sheet http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails Goodwill and Other Intangible Assets, net: (Other Intangible Assets) (Details) Details http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetTables 64 false false R65.htm 9954503 - Disclosure - Financial Instruments: (Narrative) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails Financial Instruments: (Narrative) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 65 false false R66.htm 9954504 - Disclosure - Financial Instruments: (Notional Amounts of Outstanding Derivative Instruments) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails Financial Instruments: (Notional Amounts of Outstanding Derivative Instruments) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 66 false false R67.htm 9954505 - Disclosure - Financial Instruments: (Fair Value of Derivative Contracts) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails Financial Instruments: (Fair Value of Derivative Contracts) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 67 false false R68.htm 9954506 - Disclosure - Financial Instruments: (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails Financial Instruments: (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 68 false false R69.htm 9954507 - Disclosure - Financial Instruments: (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedinAccumulatedOtherComprehensiveEarningsLossesNetofIncomeTaxesDetails Financial Instruments: (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 69 false false R70.htm 9954508 - Disclosure - Earnings Per Share: (Details) Sheet http://www.pmi.com/role/EarningsPerShareDetails Earnings Per Share: (Details) Details http://www.pmi.com/role/EarningsPerShareTables 70 false false R71.htm 9954509 - Disclosure - Segment Reporting: (Segment Data) (Details) Sheet http://www.pmi.com/role/SegmentReportingSegmentDataDetails Segment Reporting: (Segment Data) (Details) Details http://www.pmi.com/role/SegmentReportingTables 71 false false R72.htm 9954510 - Disclosure - Segment Reporting: (Additional Information) (Details) Sheet http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails Segment Reporting: (Additional Information) (Details) Details http://www.pmi.com/role/SegmentReportingTables 72 false false R73.htm 9954511 - Disclosure - Contingencies: (Tobacco-Related Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails Contingencies: (Tobacco-Related Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 73 false false R74.htm 9954512 - Disclosure - Contingencies: (Number of Tobacco Related Cases Pertaining to Combustible Products Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) Sheet http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails Contingencies: (Number of Tobacco Related Cases Pertaining to Combustible Products Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) Details http://www.pmi.com/role/ContingenciesTables 74 false false R75.htm 9954513 - Disclosure - Contingencies: (Verdicts and Post-Trial Developments) (Details) Sheet http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails Contingencies: (Verdicts and Post-Trial Developments) (Details) Details http://www.pmi.com/role/ContingenciesTables 75 false false R76.htm 9954514 - Disclosure - Contingencies: (Smoking and Health Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails Contingencies: (Smoking and Health Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 76 false false R77.htm 9954515 - Disclosure - Contingencies: (Health Care Cost Recovery Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails Contingencies: (Health Care Cost Recovery Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 77 false false R78.htm 9954516 - Disclosure - Contingencies: (Label-Related Cases) (Details) Sheet http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails Contingencies: (Label-Related Cases) (Details) Details http://www.pmi.com/role/ContingenciesTables 78 false false R79.htm 9954517 - Disclosure - Contingencies: (Public Civil Actions) (Details) Sheet http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails Contingencies: (Public Civil Actions) (Details) Details http://www.pmi.com/role/ContingenciesTables 79 false false R80.htm 9954518 - Disclosure - Contingencies: (Other Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesOtherLitigationDetails Contingencies: (Other Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 80 false false R81.htm 9954519 - Disclosure - Contingencies: (Third-Party Guarantees) (Details) Sheet http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails Contingencies: (Third-Party Guarantees) (Details) Details http://www.pmi.com/role/ContingenciesTables 81 false false R82.htm 9954520 - Disclosure - Income Taxes: (Details) Sheet http://www.pmi.com/role/IncomeTaxesDetails Income Taxes: (Details) Details http://www.pmi.com/role/IncomeTaxes 82 false false R83.htm 9954521 - Disclosure - Indebtedness: (Narrative) (Details) Sheet http://www.pmi.com/role/IndebtednessNarrativeDetails Indebtedness: (Narrative) (Details) Details http://www.pmi.com/role/IndebtednessTables 83 false false R84.htm 9954522 - Disclosure - Indebtedness: (Short-Term Borrowings) (Details) Sheet http://www.pmi.com/role/IndebtednessShortTermBorrowingsDetails Indebtedness: (Short-Term Borrowings) (Details) Details http://www.pmi.com/role/IndebtednessTables 84 false false R85.htm 9954523 - Disclosure - Indebtedness: (Schedule of Long-Term Debt) (Details) Sheet http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails Indebtedness: (Schedule of Long-Term Debt) (Details) Details http://www.pmi.com/role/IndebtednessTables 85 false false R86.htm 9954524 - Disclosure - Indebtedness: (Schedule of Fair Value) (Details) Sheet http://www.pmi.com/role/IndebtednessScheduleofFairValueDetails Indebtedness: (Schedule of Fair Value) (Details) Details http://www.pmi.com/role/IndebtednessTables 86 false false R87.htm 9954525 - Disclosure - Indebtedness: (Debt Issuances Outstanding) (Details) Sheet http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails Indebtedness: (Debt Issuances Outstanding) (Details) Details http://www.pmi.com/role/IndebtednessTables 87 false false R88.htm 9954526 - Disclosure - Indebtedness: (Schedule of Credit Facilities) (Details) Sheet http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails Indebtedness: (Schedule of Credit Facilities) (Details) Details http://www.pmi.com/role/IndebtednessTables 88 false false R89.htm 9954527 - Disclosure - Accumulated Other Comprehensive Losses: (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsofAccumulatedOtherComprehensiveEarningsLossesNetofTaxDetails Accumulated Other Comprehensive Losses: (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) Details http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesTables 89 false false R90.htm 9954528 - Disclosure - Related Parties - Equity Investments and Other: (Narrative) (Details) Sheet http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails Related Parties - Equity Investments and Other: (Narrative) (Details) Details http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherTables 90 false false R91.htm 9954529 - Disclosure - Related Parties - Equity Investments and Other: (Balance Sheet and Earnings Activity) (Details) Sheet http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails Related Parties - Equity Investments and Other: (Balance Sheet and Earnings Activity) (Details) Details http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherTables 91 false false R92.htm 9954530 - Disclosure - Sale of Accounts Receivable: (Details) Sheet http://www.pmi.com/role/SaleofAccountsReceivableDetails Sale of Accounts Receivable: (Details) Details http://www.pmi.com/role/SaleofAccountsReceivable 92 false false R93.htm 9954531 - Disclosure - Product Warranty: (Narrative) (Details) Sheet http://www.pmi.com/role/ProductWarrantyNarrativeDetails Product Warranty: (Narrative) (Details) Details http://www.pmi.com/role/ProductWarrantyTables 93 false false R94.htm 9954532 - Disclosure - Product Warranty: (Movement in Product Warranty Obligations) (Details) Sheet http://www.pmi.com/role/ProductWarrantyMovementinProductWarrantyObligationsDetails Product Warranty: (Movement in Product Warranty Obligations) (Details) Details http://www.pmi.com/role/ProductWarrantyTables 94 false false R95.htm 9954533 - Disclosure - Asset Impairment and Exit Costs: (Narrative) (Details) Sheet http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails Asset Impairment and Exit Costs: (Narrative) (Details) Details http://www.pmi.com/role/AssetImpairmentandExitCostsTables 95 false false R96.htm 9954534 - Disclosure - Asset Impairment and Exit Costs: (Asset Impairment and Exit Costs by Segment) (Details) Sheet http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails Asset Impairment and Exit Costs: (Asset Impairment and Exit Costs by Segment) (Details) Details http://www.pmi.com/role/AssetImpairmentandExitCostsTables 96 false false R97.htm 9954535 - Disclosure - Asset Impairment and Exit Costs: (Movement in Exit Cost Liabilities) (Details) Sheet http://www.pmi.com/role/AssetImpairmentandExitCostsMovementinExitCostLiabilitiesDetails Asset Impairment and Exit Costs: (Movement in Exit Cost Liabilities) (Details) Details http://www.pmi.com/role/AssetImpairmentandExitCostsTables 97 false false R98.htm 9954536 - Disclosure - Leases: (Details) Sheet http://www.pmi.com/role/LeasesDetails Leases: (Details) Details http://www.pmi.com/role/LeasesTables 98 false false R99.htm 9954537 - Disclosure - Supply Chain Financing: (Details) Sheet http://www.pmi.com/role/SupplyChainFinancingDetails Supply Chain Financing: (Details) Details http://www.pmi.com/role/SupplyChainFinancing 99 false false All Reports Book All Reports pm-20230930.htm pm-20230930.xsd pm-20230930_cal.xml pm-20230930_def.xml pm-20230930_lab.xml pm-20230930_pre.xml pm-20230930_g1.jpg pm-20230930_g10.jpg pm-20230930_g11.jpg pm-20230930_g12.jpg pm-20230930_g13.jpg pm-20230930_g2.jpg pm-20230930_g3.jpg pm-20230930_g4.jpg pm-20230930_g5.jpg pm-20230930_g6.jpg pm-20230930_g7.jpg pm-20230930_g8.jpg pm-20230930_g9.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 129 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "pm-20230930.htm": { "nsprefix": "pm", "nsuri": "http://www.pmi.com/20230930", "dts": { "inline": { "local": [ "pm-20230930.htm" ] }, "schema": { "local": [ "pm-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "pm-20230930_cal.xml" ] }, "definitionLink": { "local": [ "pm-20230930_def.xml" ] }, "labelLink": { "local": [ "pm-20230930_lab.xml" ] }, "presentationLink": { "local": [ "pm-20230930_pre.xml" ] } }, "keyStandard": 352, "keyCustom": 90, "axisStandard": 41, "axisCustom": 1, "memberStandard": 65, "memberCustom": 123, "hidden": { "total": 7, "http://xbrl.sec.gov/dei/2023": 5, "http://fasb.org/us-gaap/2023": 2 }, "contextCount": 636, "entityCount": 1, "segmentCount": 199, "elementCount": 906, "unitCount": 22, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1340, "http://xbrl.sec.gov/ecd/2023": 4, "http://xbrl.sec.gov/dei/2023": 107 }, "report": { "R1": { "role": "http://www.pmi.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings", "longName": "0000002 - Statement - Condensed Consolidated Statements of Earnings", "shortName": "Condensed Consolidated Statements of Earnings", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R3": { "role": "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings", "longName": "0000003 - Statement - Condensed Consolidated Statements of Comprehensive Earnings", "shortName": "Condensed Consolidated Statements of Comprehensive Earnings", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R4": { "role": "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsParenthetical", "longName": "0000004 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical)", "shortName": "Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets", "longName": "0000005 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-38", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "longName": "0000006 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-38", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows", "longName": "0000007 - Statement - Condensed Consolidated Statements of Cash Flows", "shortName": "Condensed Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pm:DepreciationAmortizationAndImpairment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R8": { "role": "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical", "longName": "0000008 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)", "shortName": "Condensed Consolidated Statements of Cash Flows (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncreaseDecreaseInReceivables", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-38", "name": "us-gaap:RestrictedCash", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "link:footnote", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R9": { "role": "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity", "longName": "0000009 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity", "shortName": "Condensed Consolidated Statements of Stockholders' (Deficit) Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "c-44", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-46", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R10": { "role": "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical", "longName": "0000010 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)", "shortName": "Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "10", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "longName": "0000011 - Statement - Condensed Consolidated Statements of Earnings (Parenthetical)", "shortName": "Condensed Consolidated Statements of Earnings (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "11", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "us-gaap:ExciseAndSalesTaxes", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "link:footnote", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R12": { "role": "http://www.pmi.com/role/BackgroundandBasisofPresentation", "longName": "0000012 - Disclosure - Background and Basis of Presentation:", "shortName": "Background and Basis of Presentation:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.pmi.com/role/Acquisitions", "longName": "0000013 - Disclosure - Acquisitions:", "shortName": "Acquisitions:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.pmi.com/role/WarinUkraine", "longName": "0000014 - Disclosure - War in Ukraine:", "shortName": "War in Ukraine:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.pmi.com/role/StockPlans", "longName": "0000015 - Disclosure - Stock Plans:", "shortName": "Stock Plans:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.pmi.com/role/BenefitPlans", "longName": "0000016 - Disclosure - Benefit Plans:", "shortName": "Benefit Plans:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnet", "longName": "0000017 - Disclosure - Goodwill and Other Intangible Assets, net:", "shortName": "Goodwill and Other Intangible Assets, net:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.pmi.com/role/FinancialInstruments", "longName": "0000018 - Disclosure - Financial Instruments:", "shortName": "Financial Instruments:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.pmi.com/role/EarningsPerShare", "longName": "0000019 - Disclosure - Earnings Per Share:", "shortName": "Earnings Per Share:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.pmi.com/role/SegmentReporting", "longName": "0000020 - Disclosure - Segment Reporting:", "shortName": "Segment Reporting:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.pmi.com/role/Contingencies", "longName": "0000021 - Disclosure - Contingencies:", "shortName": "Contingencies:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.pmi.com/role/IncomeTaxes", "longName": "0000022 - Disclosure - Income Taxes:", "shortName": "Income Taxes:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.pmi.com/role/Indebtedness", "longName": "0000023 - Disclosure - Indebtedness:", "shortName": "Indebtedness:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.pmi.com/role/AccumulatedOtherComprehensiveLosses", "longName": "0000024 - Disclosure - Accumulated Other Comprehensive Losses:", "shortName": "Accumulated Other Comprehensive Losses:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOther", "longName": "0000025 - Disclosure - Related Parties - Equity Investments and Other:", "shortName": "Related Parties - Equity Investments and Other:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "pm:RelatedPartiesEquityInvestmentsAndOtherTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pm:RelatedPartiesEquityInvestmentsAndOtherTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.pmi.com/role/SaleofAccountsReceivable", "longName": "0000026 - Disclosure - Sale of Accounts Receivable:", "shortName": "Sale of Accounts Receivable:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "pm:SaleofTradeAccountsReceivableDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pm:SaleofTradeAccountsReceivableDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.pmi.com/role/ProductWarranty", "longName": "0000027 - Disclosure - Product Warranty:", "shortName": "Product Warranty:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.pmi.com/role/AssetImpairmentandExitCosts", "longName": "0000028 - Disclosure - Asset Impairment and Exit Costs:", "shortName": "Asset Impairment and Exit Costs:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.pmi.com/role/Leases", "longName": "0000029 - Disclosure - Leases:", "shortName": "Leases:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.pmi.com/role/SupplyChainFinancing", "longName": "0000030 - Disclosure - Supply Chain Financing:", "shortName": "Supply Chain Financing:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplierFinanceProgramTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplierFinanceProgramTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R31": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": null }, "R32": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "32", "firstAnchor": { "contextRef": "c-34", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.pmi.com/role/BackgroundandBasisofPresentationPolicies", "longName": "9954471 - Disclosure - Background and Basis of Presentation: (Policies)", "shortName": "Background and Basis of Presentation: (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.pmi.com/role/AcquisitionsTables", "longName": "9954472 - Disclosure - Acquisitions: (Tables)", "shortName": "Acquisitions: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.pmi.com/role/WarinUkraineTables", "longName": "9954473 - Disclosure - War in Ukraine: (Tables)", "shortName": "War in Ukraine: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfUnusualOrInfrequentItemsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfUnusualOrInfrequentItemsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.pmi.com/role/StockPlansTables", "longName": "9954474 - Disclosure - Stock Plans: (Tables)", "shortName": "Stock Plans: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R37": { "role": "http://www.pmi.com/role/BenefitPlansTables", "longName": "9954475 - Disclosure - Benefit Plans: (Tables)", "shortName": "Benefit Plans: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetTables", "longName": "9954476 - Disclosure - Goodwill and Other Intangible Assets, net: (Tables)", "shortName": "Goodwill and Other Intangible Assets, net: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.pmi.com/role/FinancialInstrumentsTables", "longName": "9954477 - Disclosure - Financial Instruments: (Tables)", "shortName": "Financial Instruments: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.pmi.com/role/EarningsPerShareTables", "longName": "9954478 - Disclosure - Earnings Per Share: (Tables)", "shortName": "Earnings Per Share: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.pmi.com/role/SegmentReportingTables", "longName": "9954479 - Disclosure - Segment Reporting: (Tables)", "shortName": "Segment Reporting: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.pmi.com/role/ContingenciesTables", "longName": "9954480 - Disclosure - Contingencies: (Tables)", "shortName": "Contingencies: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "pm:ScheduleOfTobaccoRelatedCasesPendingAgainstCompanyTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pm:ScheduleOfTobaccoRelatedCasesPendingAgainstCompanyTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.pmi.com/role/IndebtednessTables", "longName": "9954481 - Disclosure - Indebtedness: (Tables)", "shortName": "Indebtedness: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesTables", "longName": "9954482 - Disclosure - Accumulated Other Comprehensive Losses: (Tables)", "shortName": "Accumulated Other Comprehensive Losses: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherTables", "longName": "9954483 - Disclosure - Related Parties - Equity Investments and Other: (Tables)", "shortName": "Related Parties - Equity Investments and Other: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.pmi.com/role/ReceivablesLoansNotesReceivableandOthersTables", "longName": "9954484 - Disclosure - Receivables, Loans, Notes Receivable, and Others (Tables)", "shortName": "Receivables, Loans, Notes Receivable, and Others (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "c-1", "name": "pm:ScheduleOfGainLossOnSaleOfTradeReceivablesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pm:ScheduleOfGainLossOnSaleOfTradeReceivablesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.pmi.com/role/ProductWarrantyTables", "longName": "9954485 - Disclosure - Product Warranty: (Tables)", "shortName": "Product Warranty: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.pmi.com/role/AssetImpairmentandExitCostsTables", "longName": "9954486 - Disclosure - Asset Impairment and Exit Costs: (Tables)", "shortName": "Asset Impairment and Exit Costs: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.pmi.com/role/LeasesTables", "longName": "9954487 - Disclosure - Leases: (Tables)", "shortName": "Leases: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.pmi.com/role/BackgroundandBasisofPresentationNarrativeDetails", "longName": "9954488 - Disclosure - Background and Basis of Presentation: (Narrative) (Details)", "shortName": "Background and Basis of Presentation: (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-104", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": null }, "R51": { "role": "http://www.pmi.com/role/AcquisitionsDetails", "longName": "9954489 - Disclosure - Acquisitions: (Details)", "shortName": "Acquisitions: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-30", "name": "us-gaap:MinorityInterestDecreaseFromRedemptions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-112", "name": "us-gaap:ProceedsFromMinorityShareholders", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R52": { "role": "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "longName": "9954490 - Disclosure - Acquisitions: (Swedish Match AB) (Details)", "shortName": "Acquisitions: (Swedish Match AB) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-121", "name": "pm:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R53": { "role": "http://www.pmi.com/role/AcquisitionsProFormaDetails", "longName": "9954491 - Disclosure - Acquisitions: (Pro Forma) (Details)", "shortName": "Acquisitions: (Pro Forma) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-136", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-136", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.pmi.com/role/WarinUkraineNarrativeDetails", "longName": "9954492 - Disclosure - War in Ukraine: Narrative (Details)", "shortName": "War in Ukraine: Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-140", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R55": { "role": "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails", "longName": "9954493 - Disclosure - War in Ukraine: Pretax Charges (Details)", "shortName": "War in Ukraine: Pretax Charges (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-174", "name": "us-gaap:OtherNonrecurringExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-172", "name": "us-gaap:OtherNonrecurringExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R56": { "role": "http://www.pmi.com/role/StockPlansAdditionalInformationDetails", "longName": "9954494 - Disclosure - Stock Plans: (Additional Information) (Details)", "shortName": "Stock Plans: (Additional Information) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-180", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-180", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.pmi.com/role/StockPlansRSUAwardsDetails", "longName": "9954495 - Disclosure - Stock Plans: (RSU Awards) (Details)", "shortName": "Stock Plans: (RSU Awards) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-182", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R58": { "role": "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "longName": "9954496 - Disclosure - Stock Plans: (PSU Awards) (Details)", "shortName": "Stock Plans: (PSU Awards) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-189", "name": "pm:ShareBasedCompensationArrangementByShareBasedPaymentAwardsLengthOfThePerformanceCyclePeriodWhichRequiresThatCertainPredeterminedPerformanceMetricsBeAchieved", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R59": { "role": "http://www.pmi.com/role/BenefitPlansComponentsofPensionandOtherEmployeeBenefitsCostsDetails", "longName": "9954497 - Disclosure - Benefit Plans: (Components of Pension and Other Employee Benefits Costs) (Details)", "shortName": "Benefit Plans: (Components of Pension and Other Employee Benefits Costs) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-202", "name": "us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R60": { "role": "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails", "longName": "9954498 - Disclosure - Benefit Plans: (Components of Net Periodic Benefit Cost) (Details)", "shortName": "Benefit Plans: (Components of Net Periodic Benefit Cost) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-202", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-202", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.pmi.com/role/BenefitPlansNarrativeDetails", "longName": "9954499 - Disclosure - Benefit Plans: (Narrative) (Details)", "shortName": "Benefit Plans: (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "longName": "9954500 - Disclosure - Goodwill and Other Intangible Assets, net: (Additional Information) (Details)", "shortName": "Goodwill and Other Intangible Assets, net: (Additional Information) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R63": { "role": "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails", "longName": "9954501 - Disclosure - Goodwill and Other Intangible Assets, net: (Movement in Goodwill) (Details)", "shortName": "Goodwill and Other Intangible Assets, net: (Movement in Goodwill) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-39", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R64": { "role": "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails", "longName": "9954502 - Disclosure - Goodwill and Other Intangible Assets, net: (Other Intangible Assets) (Details)", "shortName": "Goodwill and Other Intangible Assets, net: (Other Intangible Assets) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-38", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "longName": "9954503 - Disclosure - Financial Instruments: (Narrative) (Details)", "shortName": "Financial Instruments: (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-336", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R66": { "role": "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails", "longName": "9954504 - Disclosure - Financial Instruments: (Notional Amounts of Outstanding Derivative Instruments) (Details)", "shortName": "Financial Instruments: (Notional Amounts of Outstanding Derivative Instruments) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-241", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R67": { "role": "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails", "longName": "9954505 - Disclosure - Financial Instruments: (Fair Value of Derivative Contracts) (Details)", "shortName": "Financial Instruments: (Fair Value of Derivative Contracts) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-38", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "longName": "9954506 - Disclosure - Financial Instruments: (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details)", "shortName": "Financial Instruments: (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-34", "name": "pm:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "pm:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedinAccumulatedOtherComprehensiveEarningsLossesNetofIncomeTaxesDetails", "longName": "9954507 - Disclosure - Financial Instruments: (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details)", "shortName": "Financial Instruments: (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-340", "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R70": { "role": "http://www.pmi.com/role/EarningsPerShareDetails", "longName": "9954508 - Disclosure - Earnings Per Share: (Details)", "shortName": "Earnings Per Share: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R71": { "role": "http://www.pmi.com/role/SegmentReportingSegmentDataDetails", "longName": "9954509 - Disclosure - Segment Reporting: (Segment Data) (Details)", "shortName": "Segment Reporting: (Segment Data) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-351", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R72": { "role": "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "longName": "9954510 - Disclosure - Segment Reporting: (Additional Information) (Details)", "shortName": "Segment Reporting: (Additional Information) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetImpairment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "link:footnote", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-425", "name": "us-gaap:GainLossOnContractTermination", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "us-gaap:GainLossOnContractTermination", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R73": { "role": "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "longName": "9954511 - Disclosure - Contingencies: (Tobacco-Related Litigation) (Details)", "shortName": "Contingencies: (Tobacco-Related Litigation) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-38", "name": "pm:LossContingencyClaimsResolvedinFavoroftheCompany", "unitRef": "litigationcase", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-38", "name": "pm:LossContingencyClaimsResolvedinFavoroftheCompany", "unitRef": "litigationcase", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "longName": "9954512 - Disclosure - Contingencies: (Number of Tobacco Related Cases Pertaining to Combustible Products Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details)", "shortName": "Contingencies: (Number of Tobacco Related Cases Pertaining to Combustible Products Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-450", "name": "pm:CasesBroughtAgainstCompany", "unitRef": "litigationcase", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-456", "name": "pm:CasesBroughtAgainstCompany", "unitRef": "litigationcase", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "pm:ScheduleOfTobaccoRelatedCasesPendingAgainstCompanyTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R75": { "role": "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails", "longName": "9954513 - Disclosure - Contingencies: (Verdicts and Post-Trial Developments) (Details)", "shortName": "Contingencies: (Verdicts and Post-Trial Developments) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-445", "name": "pm:LossContingencyDamagesAwardedPunitiveDamagesValue", "unitRef": "cad", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-435", "name": "pm:LossContingencyDamagesAwardedCompensatoryDamagesAmountToBeDepositedIntoTrust", "unitRef": "cad", "xsiNil": "false", "lang": "en-US", "decimals": "-9", "ancestors": [ "span", "div", "td", "tr", "table", "div", "pm:ScheduleOfVerdictsAndPostTrialDevelopments1TableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R76": { "role": "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "longName": "9954514 - Disclosure - Contingencies: (Smoking and Health Litigation) (Details)", "shortName": "Contingencies: (Smoking and Health Litigation) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-450", "name": "pm:CasesBroughtAgainstCompany", "unitRef": "litigationcase", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-469", "name": "pm:CasesBroughtAgainstCompany", "unitRef": "litigationcase", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R77": { "role": "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "longName": "9954515 - Disclosure - Contingencies: (Health Care Cost Recovery Litigation) (Details)", "shortName": "Contingencies: (Health Care Cost Recovery Litigation) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c-485", "name": "pm:LossContingencyDamagesSoughtNumberOfPatients", "unitRef": "patient", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-485", "name": "pm:LossContingencyDamagesSoughtNumberOfPatients", "unitRef": "patient", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R78": { "role": "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "longName": "9954516 - Disclosure - Contingencies: (Label-Related Cases) (Details)", "shortName": "Contingencies: (Label-Related Cases) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c-458", "name": "pm:CasesBroughtAgainstCompany", "unitRef": "litigationcase", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "pm:ScheduleOfTobaccoRelatedCasesPendingAgainstCompanyTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-486", "name": "pm:CasesBroughtAgainstCompany", "unitRef": "litigationcase", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R79": { "role": "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails", "longName": "9954517 - Disclosure - Contingencies: (Public Civil Actions) (Details)", "shortName": "Contingencies: (Public Civil Actions) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c-460", "name": "pm:CasesBroughtAgainstCompany", "unitRef": "litigationcase", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-488", "name": "pm:CasesBroughtAgainstCompany", "unitRef": "litigationcase", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R80": { "role": "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "longName": "9954518 - Disclosure - Contingencies: (Other Litigation) (Details)", "shortName": "Contingencies: (Other Litigation) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c-501", "name": "us-gaap:LossContingencyDamagesAwardedValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-501", "name": "us-gaap:LossContingencyDamagesAwardedValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R81": { "role": "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails", "longName": "9954519 - Disclosure - Contingencies: (Third-Party Guarantees) (Details)", "shortName": "Contingencies: (Third-Party Guarantees) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c-503", "name": "pm:ProjectContributionFromGovernment", "unitRef": "cad", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-503", "name": "pm:ProjectContributionFromGovernment", "unitRef": "cad", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R82": { "role": "http://www.pmi.com/role/IncomeTaxesDetails", "longName": "9954520 - Disclosure - Income Taxes: (Details)", "shortName": "Income Taxes: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R83": { "role": "http://www.pmi.com/role/IndebtednessNarrativeDetails", "longName": "9954521 - Disclosure - Indebtedness: (Narrative) (Details)", "shortName": "Indebtedness: (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ProceedsFromUnsecuredLinesOfCredit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R84": { "role": "http://www.pmi.com/role/IndebtednessShortTermBorrowingsDetails", "longName": "9954522 - Disclosure - Indebtedness: (Short-Term Borrowings) (Details)", "shortName": "Indebtedness: (Short-Term Borrowings) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:ShortTermBorrowings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShortTermDebtTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-513", "name": "us-gaap:ShortTermBorrowings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShortTermDebtTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R85": { "role": "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails", "longName": "9954523 - Disclosure - Indebtedness: (Schedule of Long-Term Debt) (Details)", "shortName": "Indebtedness: (Schedule of Long-Term Debt) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-38", "name": "us-gaap:FinanceLeaseLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R86": { "role": "http://www.pmi.com/role/IndebtednessScheduleofFairValueDetails", "longName": "9954524 - Disclosure - Indebtedness: (Schedule of Fair Value) (Details)", "shortName": "Indebtedness: (Schedule of Fair Value) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "c-543", "name": "us-gaap:DebtInstrumentFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-543", "name": "us-gaap:DebtInstrumentFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R87": { "role": "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails", "longName": "9954525 - Disclosure - Indebtedness: (Debt Issuances Outstanding) (Details)", "shortName": "Indebtedness: (Debt Issuances Outstanding) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "c-566", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "pm:ScheduleOfDebtIssuancesDuringCurrentPeriodTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-566", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "pm:ScheduleOfDebtIssuancesDuringCurrentPeriodTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R88": { "role": "http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails", "longName": "9954526 - Disclosure - Indebtedness: (Schedule of Credit Facilities) (Details)", "shortName": "Indebtedness: (Schedule of Credit Facilities) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-574", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R89": { "role": "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsofAccumulatedOtherComprehensiveEarningsLossesNetofTaxDetails", "longName": "9954527 - Disclosure - Accumulated Other Comprehensive Losses: (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details)", "shortName": "Accumulated Other Comprehensive Losses: (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-581", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R90": { "role": "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails", "longName": "9954528 - Disclosure - Related Parties - Equity Investments and Other: (Narrative) (Details)", "shortName": "Related Parties - Equity Investments and Other: (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:EquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-38", "name": "us-gaap:EquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R91": { "role": "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails", "longName": "9954529 - Disclosure - Related Parties - Equity Investments and Other: (Balance Sheet and Earnings Activity) (Details)", "shortName": "Related Parties - Equity Investments and Other: (Balance Sheet and Earnings Activity) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "us-gaap:CostsAndExpensesRelatedParty", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R92": { "role": "http://www.pmi.com/role/SaleofAccountsReceivableDetails", "longName": "9954530 - Disclosure - Sale of Accounts Receivable: (Details)", "shortName": "Sale of Accounts Receivable: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "c-38", "name": "pm:AccountsReceivableArrangement", "unitRef": "arrangement", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsReceivableSale", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R93": { "role": "http://www.pmi.com/role/ProductWarrantyNarrativeDetails", "longName": "9954531 - Disclosure - Product Warranty: (Narrative) (Details)", "shortName": "Product Warranty: (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "c-1", "name": "pm:StandardProductWarrantyTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pm:StandardProductWarrantyTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R94": { "role": "http://www.pmi.com/role/ProductWarrantyMovementinProductWarrantyObligationsDetails", "longName": "9954532 - Disclosure - Product Warranty: (Movement in Product Warranty Obligations) (Details)", "shortName": "Product Warranty: (Movement in Product Warranty Obligations) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "c-39", "name": "us-gaap:StandardProductWarrantyAccrual", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-44", "name": "us-gaap:StandardProductWarrantyAccrual", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R95": { "role": "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails", "longName": "9954533 - Disclosure - Asset Impairment and Exit Costs: (Narrative) (Details)", "shortName": "Asset Impairment and Exit Costs: (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-634", "name": "us-gaap:PaymentsForRestructuring", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R96": { "role": "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "longName": "9954534 - Disclosure - Asset Impairment and Exit Costs: (Asset Impairment and Exit Costs by Segment) (Details)", "shortName": "Asset Impairment and Exit Costs: (Asset Impairment and Exit Costs by Segment) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-624", "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "unique": true } }, "R97": { "role": "http://www.pmi.com/role/AssetImpairmentandExitCostsMovementinExitCostLiabilitiesDetails", "longName": "9954535 - Disclosure - Asset Impairment and Exit Costs: (Movement in Exit Cost Liabilities) (Details)", "shortName": "Asset Impairment and Exit Costs: (Movement in Exit Cost Liabilities) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "c-39", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-39", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R98": { "role": "http://www.pmi.com/role/LeasesDetails", "longName": "9954536 - Disclosure - Leases: (Details)", "shortName": "Leases: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } }, "R99": { "role": "http://www.pmi.com/role/SupplyChainFinancingDetails", "longName": "9954537 - Disclosure - Supply Chain Financing: (Details)", "shortName": "Supply Chain Financing: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:SupplierFinanceProgramPaymentTimingPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-38", "name": "us-gaap:SupplierFinanceProgramPaymentTimingPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pm-20230930.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment", "negatedTerseLabel": "Impairment", "label": "Goodwill, Impairment Loss", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r16", "r361", "r367", "r372", "r885" ] }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/BenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Received a cash refund", "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)", "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses." } } }, "auth_ref": [ "r484", "r901" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of intangibles", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r16", "r66", "r71" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.pmi.com/role/BackgroundandBasisofPresentationNarrativeDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r313", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r339", "r345", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r393", "r399", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r885", "r1015", "r1127" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsParenthetical" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in foreign currency translation adjustments, unrealized gains (losses), tax", "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax", "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3", "r8", "r638", "r640", "r650" ] }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Net issuances (repayments) - maturities of 90 days or less", "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less", "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months." } } }, "auth_ref": [ "r1024", "r1025", "r1027" ] }, "us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayments - maturities longer than 90 days", "label": "Repayments of Short-Term Debt, Maturing in More than Three Months", "documentation": "The cash outflow from a repayment of a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year)." } } }, "auth_ref": [ "r59" ] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiability", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease, liability", "label": "Finance Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r654", "r661" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price allocation adjustments", "label": "Indefinite-Lived Intangible Assets, Purchase Accounting Adjustments", "documentation": "Amount of increase (decrease) of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit, from purchase accounting adjustments." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Issuances - maturities longer than 90 days", "label": "Proceeds from Short-Term Debt, Maturing in More than Three Months", "documentation": "The cash inflow from a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year)." } } }, "auth_ref": [ "r57" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r329", "r330", "r331", "r332", "r333", "r339" ] }, "us-gaap_RestructuringCostsAndAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostsAndAssetImpairmentCharges", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Asset impairment and exit costs, net of cash paid (Note 17)", "label": "Restructuring Costs and Asset Impairment Charges", "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r16" ] }, "us-gaap_MinorityInterestDecreaseFromRedemptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestDecreaseFromRedemptions", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of subsidiary shares from noncontrolling interests (Note 2)", "terseLabel": "Purchase of subsidiary shares from noncontrolling interests (Note 2)", "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests", "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests)." } } }, "auth_ref": [ "r106", "r184", "r193" ] }, "us-gaap_DividendsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrent", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends payable", "label": "Dividends Payable, Current", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r44" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "crdr": "debit", "calculation": { "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior service cost (credit)", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan." } } }, "auth_ref": [ "r471", "r510", "r531", "r901", "r902" ] }, "us-gaap_LossContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNatureDomain", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Nature [Domain]", "label": "Loss Contingency, Nature [Domain]", "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability." } } }, "auth_ref": [ "r403", "r404", "r405", "r408", "r1063", "r1064" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "crdr": "credit", "calculation": { "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Net loss", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan." } } }, "auth_ref": [ "r471", "r509", "r530", "r901", "r902" ] }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-tax impairment charge", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value." } } }, "auth_ref": [ "r16", "r27" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r585", "r586" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r943", "r954", "r964", "r989" ] }, "us-gaap_ReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesNetCurrent", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/WarinUkraineNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables", "label": "Receivables, Net, Current", "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value." } } }, "auth_ref": [ "r917" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "calculation": { "http://www.pmi.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of right-of-use assets", "label": "Finance Lease, Right-of-Use Asset, Amortization", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r655", "r657", "r916" ] }, "pm_LossContingencyDamagesSoughtNumberOfPatients": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesSoughtNumberOfPatients", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Damages sought, number of patients", "label": "Loss Contingency, Damages Sought, Number Of Patients", "documentation": "Loss Contingency, Damages Sought, Number Of Patients" } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative instruments, gains (losses) to be reclassified to earnings", "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months", "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months." } } }, "auth_ref": [ "r134" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Employment costs", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r44" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/BenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employer contributions", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r486", "r496", "r534", "r899", "r900", "r901", "r902" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedinAccumulatedOtherComprehensiveEarningsLossesNetofIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r250", "r251", "r644", "r646", "r647", "r648", "r649", "r651" ] }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "crdr": "credit", "calculation": { "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Expected return on plan assets", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan." } } }, "auth_ref": [ "r471", "r508", "r529", "r901", "r902" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity", "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r920", "r921", "r922", "r924", "r925", "r926", "r927", "r1034", "r1035", "r1110", "r1128", "r1129" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r944", "r955", "r965", "r990" ] }, "us-gaap_ProceedsFromUnsecuredLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromUnsecuredLinesOfCredit", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings under credit facilities", "label": "Proceeds from Unsecured Lines of Credit", "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is uncollateralized (where debt is not backed by the pledge of collateral)." } } }, "auth_ref": [ "r57" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/BenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Anticipated additional employer contributions during the remainder of the current fiscal year", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year", "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year." } } }, "auth_ref": [ "r534", "r902" ] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership percentage", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage", "documentation": "Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date." } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseInterestExpense", "crdr": "debit", "calculation": { "http://www.pmi.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest on lease liabilities", "label": "Finance Lease, Interest Expense", "documentation": "Amount of interest expense on finance lease liability." } } }, "auth_ref": [ "r655", "r657", "r916" ] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total PMI net revenues", "verboseLabel": "Net revenues, related parties", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r317", "r318", "r329", "r334", "r335", "r341", "r343", "r345", "r467", "r468", "r674" ] }, "us-gaap_DerivativeCollateralObligationToReturnCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeCollateralObligationToReturnCash", "crdr": "credit", "calculation": { "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross amounts not offset in the condensed consolidated balance sheets - cash collateral received / pledged", "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset", "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets." } } }, "auth_ref": [ "r33", "r131", "r236", "r877" ] }, "pm_OtherAccruedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "OtherAccruedLiabilitiesMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other accrued liabilities", "label": "Other Accrued Liabilities [Member]", "documentation": "Other Accrued Liabilities [Member]" } } }, "auth_ref": [] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails", "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r24", "r617" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r267", "r268", "r663", "r664", "r665", "r666", "r778", "r779", "r780", "r781", "r782", "r803", "r805", "r828" ] }, "pm_MegapolisMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "MegapolisMember", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Megapolis Group", "label": "Megapolis [Member]", "documentation": "Megapolis [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodTwoMember", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Five year tranche", "label": "Debt Instrument, Redemption, Period Two [Member]", "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r30" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt, Type [Domain]", "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r39" ] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodOneMember", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Three year tranche", "label": "Debt Instrument, Redemption, Period One [Member]", "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r30" ] }, "pm_USDollarNotes5625DueSeptember2033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "USDollarNotes5625DueSeptember2033Member", "presentation": [ "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "US Dollar Notes, 5.625%, Due September 2033", "label": "US Dollar Notes, 5.625%, Due September 2033 [Member]", "documentation": "US Dollar Notes, 5.625%, Due September 2033" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred income taxes", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r585", "r586", "r698" ] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentAssetsReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentAssetsReceivables", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivables", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Assets, Receivables", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Assets, Receivables" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShortTermDebtTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShortTermDebtTable", "presentation": [ "http://www.pmi.com/role/IndebtednessShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Short-term Debt [Table]", "label": "Schedule of Short-Term Debt [Table]", "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation." } } }, "auth_ref": [ "r42" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails", "http://www.pmi.com/role/WarinUkraineNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cumulative foreign currency translation losses", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses." } } }, "auth_ref": [ "r237", "r239", "r241", "r242", "r635" ] }, "pm_MarketingAdministrationAndResearchCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "MarketingAdministrationAndResearchCostsMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketing, administration and research costs", "label": "Marketing Administration And Research Costs [Member]", "documentation": "Marketing, administration and research costs" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r45", "r219", "r264", "r355", "r420", "r421", "r423", "r424", "r425", "r427", "r429", "r431", "r432", "r608", "r612", "r613", "r637", "r917", "r1072", "r1116", "r1117" ] }, "pm_MultiYearRevolvingCreditFacilityExpiringSeptember292027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "MultiYearRevolvingCreditFacilityExpiringSeptember292027Member", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Multi-year Revolving Credit Facility, Expiring September 29, 2027", "label": "Multi-year Revolving Credit Facility, Expiring September 29, 2027 [Member]", "documentation": "Multi-year Revolving Credit Facility, Expiring September 29, 2027" } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtWeightedAverageInterestRate", "presentation": [ "http://www.pmi.com/role/IndebtednessShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average Rate", "label": "Short-Term Debt, Weighted Average Interest Rate, at Point in Time", "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time." } } }, "auth_ref": [ "r40" ] }, "pm_A2.000Notesdue2036Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A2.000Notesdue2036Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "2.000% Notes due 2036", "label": "2.000% Notes due 2036 [Member]", "documentation": "2.000% Notes due 2036 [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other tax expense (benefit)", "label": "Other Tax Expense (Benefit)", "documentation": "Amount of other income tax expense (benefit)." } } }, "auth_ref": [ "r265", "r1103", "r1104" ] }, "pm_A4.875Notesdue2043Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A4.875Notesdue2043Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "4.875% Notes due 2043", "label": "4.875% Notes due 2043 [Member]", "documentation": "4.875% Notes due 2043 [Member]" } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtLineItems", "presentation": [ "http://www.pmi.com/role/IndebtednessShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt [Line Items]", "label": "Short-Term Debt [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility (as a percent)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r571" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedinAccumulatedOtherComprehensiveEarningsLossesNetofIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r250", "r251", "r644", "r646", "r647", "r648", "r649", "r651" ] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt, Type [Axis]", "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r42" ] }, "pm_A2.875Notesdue20242Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A2.875Notesdue20242Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "2.875% Notes due 2024", "label": "2.875% Notes due 2024 - 2 [Member]", "documentation": "2.875% Notes due 2024 - 2 [Member]" } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate (as a percent)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r573" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r447", "r496", "r501", "r633", "r668", "r892", "r893", "r899", "r900", "r901" ] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCosts" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Impairment and Exit Costs:", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r388", "r389", "r391", "r394", "r400" ] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCharges", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsMovementinExitCostLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Charges, net", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r16", "r395", "r397", "r1059" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r43", "r264", "r355", "r420", "r421", "r423", "r424", "r425", "r427", "r429", "r431", "r432", "r608", "r612", "r613", "r637", "r783", "r882", "r930", "r1072", "r1116", "r1117" ] }, "pm_AppellateRulingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "AppellateRulingMember", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Appellate Ruling", "label": "Appellate Ruling [Member]", "documentation": "Appellate Ruling [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofFairValueDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r447", "r496", "r501", "r633", "r667", "r899", "r900", "r901" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.pmi.com/role/StockPlansAdditionalInformationDetails", "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r545", "r546", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligations", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 }, "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt (Note 12)", "verboseLabel": "Long-term debt", "label": "Long-Term Debt and Lease Obligation", "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent." } } }, "auth_ref": [ "r38", "r699" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.pmi.com/role/StockPlansAdditionalInformationDetails", "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r545", "r546", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "crdr": "credit", "calculation": { "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0, "order": 1.0 }, "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt (Note 12)", "verboseLabel": "Less current portion of long-term debt", "label": "Long-Term Debt and Lease Obligation, Current", "documentation": "Amount of long-term debt and lease obligation, classified as current." } } }, "auth_ref": [ "r44" ] }, "pm_A0.800Notesdue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A0.800Notesdue2031Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.800% Notes due 2031", "label": "0.800% Notes due 2031 [Member]", "documentation": "0.800% Notes due 2031 [Member]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES", "label": "Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.pmi.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Calculation of basic and diluted EPS", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1039" ] }, "pm_TheAttorneyGeneralOfOgunStateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "TheAttorneyGeneralOfOgunStateMember", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The Attorney General Of Ogun State", "label": "The Attorney General Of Ogun State [Member]", "documentation": "The Attorney General Of Ogun State [Member]" } } }, "auth_ref": [] }, "us-gaap_ShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBorrowings", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets", "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term borrowings (Note 12)", "verboseLabel": "Amount Outstanding", "label": "Short-Term Debt", "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r144", "r198", "r917", "r1125" ] }, "pm_DepreciationAmortizationAndImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "DepreciationAmortizationAndImpairment", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation, amortization and impairment of goodwill and other intangibles", "label": "Depreciation, Amortization and Impairment", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets and amount of write-down of assets recognized in the income statement, includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails", "http://www.pmi.com/role/BenefitPlansComponentsofPensionandOtherEmployeeBenefitsCostsDetails", "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Axis]", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r470", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r519", "r522", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r538", "r539", "r540", "r543", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908" ] }, "pm_LossContingencyMotionforSecurityOrderedbyAppealsCourttobeFurnishedbyDefendantsandPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyMotionforSecurityOrderedbyAppealsCourttobeFurnishedbyDefendantsandPaid", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Motion for security ordered by appeals court, paid by defendant", "label": "Loss Contingency, Motion for Security Ordered by Appeals Court, to be Furnished by Defendants and Paid", "documentation": "Loss Contingency, Motion for Security Ordered by an Appeals Court and Paid" } } }, "auth_ref": [] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsMovementinExitCostLiabilitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Liability balance, January 1, 2023", "periodEndLabel": "Liability balance, September 30, 2023", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r391", "r396" ] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Other", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Other" } } }, "auth_ref": [] }, "pm_DefinedBenefitPlanPlanAssetsPensionPlanContributionsNetOfRefunds": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "DefinedBenefitPlanPlanAssetsPensionPlanContributionsNetOfRefunds", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Pension plan contributions, net of refunds (Note 5)", "label": "Defined Benefit Plan, Plan Assets, Pension Plan Contributions, Net Of Refunds", "documentation": "Defined Benefit Plan, Plan Assets, Pension Plan Contributions, Net Of Refunds" } } }, "auth_ref": [] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails", "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast", "label": "Forecast [Member]" } } }, "auth_ref": [ "r542", "r1037" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails", "http://www.pmi.com/role/BenefitPlansComponentsofPensionandOtherEmployeeBenefitsCostsDetails", "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Domain]", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r470", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r519", "r522", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r538", "r539", "r540", "r543", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908" ] }, "pm_TheAttorneyGeneralOfGombeStateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "TheAttorneyGeneralOfGombeStateMember", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The Attorney General Of Gombe State", "label": "The Attorney General Of Gombe State [Member]", "documentation": "The Attorney General Of Gombe State [Member]" } } }, "auth_ref": [] }, "pm_LossContingencyDamagesAwardedAmountToBeDepositedIntoTrust": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesAwardedAmountToBeDepositedIntoTrust", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount to be deposited into trust", "label": "Loss Contingency, Damages Awarded, Amount To Be Deposited Into Trust", "documentation": "Loss Contingency, Damages Awarded, Amount To Be Deposited Into Trust" } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r47", "r78" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 (DEFICIT) EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r154", "r202", "r706", "r917", "r1031", "r1043", "r1111" ] }, "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveTranslationAndOtherAdjustment", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsMovementinExitCostLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency/other", "label": "Restructuring Reserve, Translation and Other Adjustment", "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases)." } } }, "auth_ref": [ "r75", "r1060" ] }, "pm_NoncontrollingInterestPurchasePhilipMorrisPazarlamaVeSatAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "NoncontrollingInterestPurchasePhilipMorrisPazarlamaVeSatAMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest Purchase Philip Morris Pazarlama ve Sat\u0131\u015f A.\u015e.", "label": "Noncontrolling Interest Purchase Philip Morris Pazarlama ve Sat\u0131\u015f A.\u015e. [Member]", "documentation": "Noncontrolling Interest Purchase Philip Morris Pazarlama ve Sat\u0131\u015f A.\u015e." } } }, "auth_ref": [] }, "pm_SmokingAndHealthIndividualActionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SmokingAndHealthIndividualActionsMember", "presentation": [ "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Individual Action", "label": "Smoking And Health Individual Actions [Member]", "documentation": "Smoking And Health Individual Actions [Member]" } } }, "auth_ref": [] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails", "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r24" ] }, "pm_ChangeincurrencytranslationadjustmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ChangeincurrencytranslationadjustmentAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Change in currency translation adjustments:", "label": "Change in currency translation adjustment [Abstract]", "documentation": "Change in currency translation adjustment [Abstract]" } } }, "auth_ref": [] }, "pm_FiniteLivedIntangibleAssetsAccumulatedAmortizationForeignCurrencyTranslationIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationForeignCurrencyTranslationIncreaseDecrease", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Change in accumulated amortization, currency movements", "label": "Finite-Lived Intangible Assets, Accumulated Amortization, Foreign Currency Translation Increase (Decrease)", "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization, Foreign Currency Translation Increase (Decrease)" } } }, "auth_ref": [] }, "pm_AccountsReceivableArrangement": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "AccountsReceivableArrangement", "presentation": [ "http://www.pmi.com/role/SaleofAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivable, arrangement", "label": "Accounts Receivable, Arrangement", "documentation": "Accounts Receivable, Arrangement" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedCostIncurredCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostIncurredCost", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract termination charges:", "verboseLabel": "Restructuring and related cost, incurred cost", "label": "Restructuring and Related Cost, Incurred Cost", "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost." } } }, "auth_ref": [ "r390", "r393", "r397", "r399" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract", "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net assets acquired based on fair values:", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]" } } }, "auth_ref": [] }, "pm_LossContingencyDamagesAwardedtobeDepositedintoTrustPaymentPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesAwardedtobeDepositedintoTrustPaymentPeriod", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment period", "label": "Loss Contingency, Damages Awarded to be Deposited into Trust, Payment Period", "documentation": "Loss Contingency, Damages Awarded to be Deposited into Trust, Payment Period" } } }, "auth_ref": [] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock repurchased", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r23", "r82", "r184" ] }, "pm_CombustibleTobaccoProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CombustibleTobaccoProductsMember", "presentation": [ "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Combustible Tobacco Products", "label": "Combustible Tobacco Products [Member]", "documentation": "Combustible Tobacco Products" } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails", "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Domain]", "label": "Scenario [Domain]" } } }, "auth_ref": [ "r286", "r542", "r1008", "r1037" ] }, "us-gaap_InvestmentTypeCategorizationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeCategorizationMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments [Domain]", "label": "Investments [Domain]", "documentation": "Asset obtained to generate income or appreciate in value." } } }, "auth_ref": [ "r766", "r768", "r769", "r771", "r774", "r829", "r831", "r833", "r836", "r837", "r842", "r843", "r845", "r846", "r847", "r848", "r849", "r922" ] }, "pm_PMMMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "PMMMember", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "PMM", "label": "PMM [Member]", "documentation": "PMM [Member]" } } }, "auth_ref": [] }, "pm_LossContingencyDamagesAwardedIncludingInterestPunitiveDamagesValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesAwardedIncludingInterestPunitiveDamagesValue", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Punitive damages, value", "label": "Loss Contingency, Damages Awarded Including Interest, Punitive Damages, Value", "documentation": "Loss Contingency, Damages Awarded Including Interest, Punitive Damages, Value" } } }, "auth_ref": [] }, "pm_A6.375Notesdue2038Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A6.375Notesdue2038Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "6.375% Notes due 2038", "label": "6.375% Notes due 2038 [Member]", "documentation": "6.375% Notes due 2038 [Member]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Less comprehensive earnings (losses) attributable to:", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r994" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.pmi.com/role/EarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Weighted-average shares for diluted EPS (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r290", "r304" ] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/WarinUkraineNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r208", "r701", "r764", "r793", "r917", "r930", "r1016" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r996" ] }, "pm_StandardProductWarrantyTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "StandardProductWarrantyTerm", "presentation": [ "http://www.pmi.com/role/ProductWarrantyNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Standard product warranty term", "label": "Standard Product Warranty, Term", "documentation": "Standard Product Warranty, Term" } } }, "auth_ref": [] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r992" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings", "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for income taxes", "negatedLabel": "Income tax expense (benefit)", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r207", "r212", "r284", "r285", "r324", "r587", "r595", "r719" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r992" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.pmi.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average shares for basic EPS (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r288", "r304" ] }, "us-gaap_RestructuringPlanAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanAxis", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Axis]", "label": "Restructuring Plan [Axis]", "documentation": "Information by individual restructuring plan." } } }, "auth_ref": [] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r992" ] }, "us-gaap_RestructuringPlanDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanDomain", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Domain]", "label": "Restructuring Plan [Domain]", "documentation": "Identification of the individual restructuring plans." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of movements in goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r885", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r993" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Net gains (losses) and prior service costs, tax", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax", "documentation": "Amount, before reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r7", "r8", "r192" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r999" ] }, "us-gaap_PaymentsForProceedsFromHedgeInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromHedgeInvestingActivities", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net investment hedges and other derivatives (Note 7)", "label": "Payments for (Proceeds from) Hedge, Investing Activities", "documentation": "The cash outflow or inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r67", "r70", "r675" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r675" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r992" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of non-amortizable intangible assets", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment." } } }, "auth_ref": [ "r28", "r178" ] }, "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock", "presentation": [ "http://www.pmi.com/role/IndebtednessTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of committed credit facilities", "label": "Schedule of Line of Credit Facilities [Table Text Block]", "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r41" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of amortizable intangible assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r67", "r70" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r993" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets", "http://www.pmi.com/role/WarinUkraineNarrativeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "terseLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r197", "r225", "r264", "r316", "r331", "r337", "r355", "r420", "r421", "r423", "r424", "r425", "r427", "r429", "r431", "r432", "r607", "r612", "r637", "r697", "r798", "r917", "r930", "r1072", "r1073", "r1116" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r373", "r376", "r377", "r379", "r675", "r676" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnet" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Other Intangible Assets, net:", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r174" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "negatedLabel": "Net gains (losses) and prior service costs, net of income taxes", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax", "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit)." } } }, "auth_ref": [ "r7", "r157" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity investments and securities (income)/loss, net", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r16", "r158", "r203", "r323", "r350", "r708" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r67", "r70" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r995" ] }, "pm_CasesBroughtAgainstCompany": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CasesBroughtAgainstCompany", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cases brought against PM", "label": "Cases Brought Against Company", "documentation": "Cases Brought Against Company" } } }, "auth_ref": [] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillRollForward", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Other assets (less allowances of $24 in 2023 and $20 in 2022) (Note 2)", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r224" ] }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of share-based compensation arrangements by payment award", "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]", "documentation": "Tabular disclosure of share-based payment arrangement." } } }, "auth_ref": [ "r18", "r90" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeAsset", "crdr": "debit", "calculation": { "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative asset fair value", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r32", "r120", "r155", "r235", "r879" ] }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShortTermDebtTextBlock", "presentation": [ "http://www.pmi.com/role/IndebtednessTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of short-term debt", "label": "Schedule of Short-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation." } } }, "auth_ref": [ "r42" ] }, "country_IT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "IT", "presentation": [ "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Italy", "label": "ITALY" } } }, "auth_ref": [] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r997" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r998" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings", "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive earnings (losses), net of income taxes", "terseLabel": "Other comprehensive earnings (losses), net of income taxes", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r23", "r35", "r246", "r249", "r254", "r644", "r645", "r651", "r690", "r712", "r1019", "r1020" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency gain (loss)", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax", "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3", "r157", "r638", "r639", "r643" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r999" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Contingencies (Note 10)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r48", "r140", "r700", "r784" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r944", "r955", "r965", "r990" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Effective tax rate (as a percent)", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r588" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r981" ] }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeLiability", "crdr": "credit", "calculation": { "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative liability fair value", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement." } } }, "auth_ref": [ "r32", "r120", "r155", "r235", "r879" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r999" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuance of stock awards", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r91", "r148", "r149", "r184" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt proceeds", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r57", "r745" ] }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, at cost", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization", "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset." } } }, "auth_ref": [ "r1010", "r1018", "r1056" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails", "http://www.pmi.com/role/IncomeTaxesDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/WarinUkraineNarrativeDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r343", "r344", "r767", "r770", "r772", "r831", "r833", "r837", "r845", "r856", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r871", "r898", "r922", "r1075", "r1127" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r580", "r581", "r582", "r753", "r1034", "r1035", "r1036", "r1110", "r1129" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Less: accumulated depreciation", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization", "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease." } } }, "auth_ref": [ "r1013", "r1014", "r1057" ] }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total property, plant and equipment, net", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization", "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset." } } }, "auth_ref": [ "r1014", "r1055" ] }, "pm_ClaudiaMilanoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ClaudiaMilanoMember", "presentation": [ "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Claudia Milano", "label": "Claudia Milano [Member]", "documentation": "Claudia Milano" } } }, "auth_ref": [] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails", "http://www.pmi.com/role/IncomeTaxesDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/WarinUkraineNarrativeDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r343", "r344", "r767", "r770", "r772", "r831", "r833", "r837", "r845", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r871", "r898", "r922", "r1075", "r1127" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "presentation": [ "http://www.pmi.com/role/BenefitPlansTables" ], "lang": { "en-us": { "role": { "terseLabel": "Components of pension and other employee benefit costs", "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]", "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans." } } }, "auth_ref": [ "r20", "r86", "r87", "r88", "r89" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeExcludedComponentGainLossRecognizedInEarnings", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain/(Loss) Recognized in Earnings", "label": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings", "documentation": "Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method." } } }, "auth_ref": [ "r206", "r1108" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r273", "r274", "r275", "r309", "r674", "r744", "r765", "r777", "r778", "r779", "r780", "r781", "r782", "r785", "r788", "r789", "r790", "r791", "r792", "r794", "r795", "r796", "r797", "r799", "r800", "r801", "r802", "r803", "r805", "r808", "r809", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r825", "r923" ] }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateDuringPeriod", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average interest rate", "label": "Debt Instrument, Interest Rate During Period", "documentation": "The average effective interest rate during the reporting period." } } }, "auth_ref": [ "r46", "r138", "r452" ] }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems", "presentation": [ "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsofAccumulatedOtherComprehensiveEarningsLossesNetofTaxDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r252" ] }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails": { "parentTag": "pm_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment hedges", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge." } } }, "auth_ref": [ "r616" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "(Gains)/losses transferred to earnings, net of income taxes of $0 in 2023 and 2022", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax", "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation." } } }, "auth_ref": [ "r9", "r10", "r157", "r244", "r642" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership [Axis]", "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableNoncurrent", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets, allowances", "label": "Accounts Receivable, Allowance for Credit Loss, Noncurrent", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as noncurrent." } } }, "auth_ref": [ "r348", "r358" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Change in currency translation adjustments, transferred to earnings, tax", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax", "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation." } } }, "auth_ref": [ "r8", "r640", "r650" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest rate, stated percentage", "terseLabel": "Interest Rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r46", "r435" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivables, allowances", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r231", "r348", "r358" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/FinancialInstruments" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments:", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r195", "r620", "r628" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r341", "r674", "r731", "r732", "r733", "r734", "r735", "r736", "r870", "r897", "r918", "r1015", "r1065", "r1066", "r1075", "r1127" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/IncomeTaxesDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails", "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r404", "r405", "r406", "r407", "r493", "r541", "r571", "r572", "r573", "r670", "r673", "r737", "r775", "r776", "r830", "r832", "r834", "r835", "r844", "r867", "r868", "r884", "r896", "r909", "r919", "r922", "r1058", "r1074", "r1119", "r1120", "r1121", "r1122", "r1123" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.pmi.com/role/BackgroundandBasisofPresentationNarrativeDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r1040" ] }, "us-gaap_ScheduleOfUnusualOrInfrequentItemsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfUnusualOrInfrequentItemsTextBlock", "presentation": [ "http://www.pmi.com/role/WarinUkraineTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of pretax charges related to circumstances", "label": "Schedule of Unusual or Infrequent Items, or Both [Table Text Block]", "documentation": "Tabular disclosure of the nature and financial statement effect of an event or transaction that is unusual in nature or infrequent in occurrence, or both." } } }, "auth_ref": [ "r164" ] }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Employment costs", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent", "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent." } } }, "auth_ref": [ "r84", "r85", "r147", "r185" ] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership [Domain]", "label": "Ownership [Domain]" } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsofAccumulatedOtherComprehensiveEarningsLossesNetofTaxDetails", "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r23", "r50", "r214", "r250", "r251", "r252", "r273", "r274", "r275", "r277", "r283", "r285", "r309", "r356", "r357", "r466", "r580", "r581", "r582", "r592", "r593", "r622", "r623", "r624", "r625", "r626", "r627", "r629", "r644", "r646", "r647", "r648", "r649", "r651", "r662", "r738", "r739", "r740", "r753", "r825" ] }, "us-gaap_LitigationStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationStatusDomain", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Status [Domain]", "label": "Litigation Status [Domain]", "documentation": "Status of pending, threatened, or settled litigation." } } }, "auth_ref": [ "r1062" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets", "http://www.pmi.com/role/WarinUkraineNarrativeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total inventory, net", "terseLabel": "Inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r232", "r873", "r917" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PendingLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PendingLitigationMember", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pending Litigation", "label": "Pending Litigation [Member]", "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process." } } }, "auth_ref": [ "r1062" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Reinvested\u00a0in the Business", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r214", "r273", "r274", "r275", "r277", "r283", "r285", "r356", "r357", "r580", "r581", "r582", "r592", "r593", "r622", "r624", "r625", "r627", "r629", "r738", "r740", "r753", "r1129" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r341", "r674", "r731", "r732", "r733", "r734", "r735", "r736", "r870", "r897", "r918", "r1015", "r1065", "r1066", "r1075", "r1127" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/IncomeTaxesDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails", "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r404", "r405", "r406", "r407", "r541", "r673", "r737", "r775", "r776", "r830", "r832", "r834", "r835", "r844", "r867", "r868", "r884", "r896", "r909", "r919", "r1074", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123" ] }, "us-gaap_InventoryNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNetAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories:", "label": "Inventory, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedinAccumulatedOtherComprehensiveEarningsLossesNetofIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Gain/(loss) as of beginning of period,", "periodEndLabel": "Gain/(loss) as of September 30,", "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax", "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r239" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsofAccumulatedOtherComprehensiveEarningsLossesNetofTaxDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and other benefits", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r6", "r22", "r53", "r1019", "r1020", "r1021" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/IncomeTaxesDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails", "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r404", "r405", "r406", "r407", "r493", "r541", "r571", "r572", "r573", "r670", "r673", "r737", "r775", "r776", "r830", "r832", "r834", "r835", "r844", "r867", "r868", "r884", "r896", "r909", "r919", "r922", "r1058", "r1074", "r1119", "r1120", "r1121", "r1122", "r1123" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails": { "parentTag": "pm_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange contracts", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r238", "r239", "r614", "r615", "r621" ] }, "us-gaap_LitigationStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationStatusAxis", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Status [Axis]", "label": "Litigation Status [Axis]", "documentation": "Information by status of pending, threatened, or settled litigation." } } }, "auth_ref": [ "r1062" ] }, "country_AR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "AR", "presentation": [ "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Argentina", "label": "ARGENTINA" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings", "http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedinAccumulatedOtherComprehensiveEarningsLossesNetofIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Gains (losses) recognized, net of income taxes", "terseLabel": "Change in fair value", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax", "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r238", "r239" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsParenthetical" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Change in fair value of derivatives accounted for as hedges, gains (losses) recognized, tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax", "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r240" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/IncomeTaxesDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails", "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r404", "r405", "r406", "r407", "r541", "r673", "r737", "r775", "r776", "r830", "r832", "r834", "r835", "r844", "r867", "r868", "r884", "r896", "r909", "r919", "r1074", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails", "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r47", "r272", "r434", "r435", "r436", "r437", "r438", "r440", "r445", "r446", "r447", "r448", "r450", "r451", "r452", "r453", "r454", "r455", "r652", "r891", "r892", "r893", "r894", "r895", "r1030" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r992" ] }, "us-gaap_AccruedMarketingCostsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedMarketingCostsCurrent", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Marketing and selling", "label": "Accrued Marketing Costs, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of net losses, prior service costs and net transition costs, net of income taxes", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax", "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan." } } }, "auth_ref": [ "r9", "r157", "r186", "r244" ] }, "country_AU": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "AU", "presentation": [ "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Australia", "label": "AUSTRALIA" } } }, "auth_ref": [] }, "us-gaap_DerivativeCollateralRightToReclaimCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeCollateralRightToReclaimCash", "crdr": "debit", "calculation": { "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross amounts not offset in the condensed consolidated balance sheets - cash collateral received / pledged", "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset", "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities." } } }, "auth_ref": [ "r33", "r131", "r236", "r877" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "presentation": [ "http://www.pmi.com/role/AcquisitionsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of business acquisitions, by acquisition", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts." } } }, "auth_ref": [ "r93", "r96" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLineItems", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Line Items]", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r628" ] }, "us-gaap_OtherCurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentAssetsMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Current Assets [Member]", "documentation": "Primary financial statement caption encompassing other current assets." } } }, "auth_ref": [ "r117", "r132" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsofAccumulatedOtherComprehensiveEarningsLossesNetofTaxDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation adjustments", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r4", "r22", "r53", "r251", "r252", "r646", "r647", "r648", "r649", "r651", "r1019" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsofAccumulatedOtherComprehensiveEarningsLossesNetofTaxDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives accounted for as hedges", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r242", "r251", "r252", "r611", "r880", "r1019" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTable", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Table]", "label": "Derivative [Table]", "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r24", "r110", "r111", "r113", "r116", "r119", "r123", "r127", "r129", "r133", "r628" ] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsParenthetical" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization of net losses, prior service costs and net transition costs, tax", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax", "documentation": "Amount of tax (expense) benefit for reclassification adjustment from accumulated other comprehensive (income) loss of defined benefit plan." } } }, "auth_ref": [ "r8", "r192" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsofAccumulatedOtherComprehensiveEarningsLossesNetofTaxDetails", "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r23", "r214", "r250", "r251", "r252", "r273", "r274", "r275", "r277", "r283", "r285", "r309", "r356", "r357", "r466", "r580", "r581", "r582", "r592", "r593", "r622", "r623", "r624", "r625", "r626", "r627", "r629", "r644", "r646", "r647", "r648", "r649", "r651", "r662", "r738", "r739", "r740", "r753", "r825" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r98" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.pmi.com/role/IndebtednessTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-term debt", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r47", "r79", "r80", "r137", "r138", "r139", "r141", "r182", "r183", "r892", "r894", "r1033" ] }, "srt_LitigationCaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "LitigationCaseAxis", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Axis]", "label": "Litigation Case [Axis]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsofAccumulatedOtherComprehensiveEarningsLossesNetofTaxDetails", "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive\u00a0Losses", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r22", "r53", "r623", "r626", "r662", "r738", "r739", "r1019", "r1020", "r1021", "r1034", "r1035", "r1036" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r210", "r239", "r243" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Domain]", "label": "Counterparty Name [Domain]" } } }, "auth_ref": [ "r269", "r270", "r437", "r462", "r666", "r878", "r879" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings", "http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedinAccumulatedOtherComprehensiveEarningsLossesNetofIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gains) losses transferred to earnings, net of income taxes", "negatedTerseLabel": "Derivative (gains)/losses transferred to earnings", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r239", "r243" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net earnings to operating cash flows:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarningsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value of derivatives accounted for as hedges, (gains) losses transferred to earnings, tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax", "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r240" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "documentation": "Amount of investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r349" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.pmi.com/role/StockPlansAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102" ] }, "us-gaap_FinancialGuaranteeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialGuaranteeMember", "presentation": [ "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Guarantee", "label": "Financial Guarantee [Member]", "documentation": "An agreement (contract) that requires the guarantor to make payments to the guaranteed party based on another entity's failure to pay specified obligations, such as debt, to a lender." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_SupplierFinanceProgramTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramTextBlock", "presentation": [ "http://www.pmi.com/role/SupplyChainFinancing" ], "lang": { "en-us": { "role": { "terseLabel": "Supply Chain Financing:", "label": "Supplier Finance Program [Text Block]", "documentation": "The entire disclosure for supplier finance program." } } }, "auth_ref": [ "r382", "r383", "r384", "r886" ] }, "us-gaap_SupplierFinanceProgramPaymentTimingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramPaymentTimingPeriod", "presentation": [ "http://www.pmi.com/role/SupplyChainFinancingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supply chain payment terms", "label": "Supplier Finance Program, Payment Timing, Period", "documentation": "Period when payment is expected to be made to finance provider or intermediary in supplier finance program, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r383" ] }, "us-gaap_CostsAndExpensesRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesRelatedParty", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expenses", "label": "Costs and Expenses, Related Party", "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties." } } }, "auth_ref": [ "r162" ] }, "us-gaap_InProcessResearchAndDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InProcessResearchAndDevelopmentMember", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "In Process Research and Development", "label": "In Process Research and Development [Member]", "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process." } } }, "auth_ref": [] }, "us-gaap_SupplierFinanceProgramDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramDomain", "presentation": [ "http://www.pmi.com/role/SupplyChainFinancingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program [Domain]", "label": "Supplier Finance Program [Domain]", "documentation": "Supplier finance program." } } }, "auth_ref": [ "r383", "r385", "r386" ] }, "us-gaap_SupplierFinanceProgramObligationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramObligationCurrent", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/SupplyChainFinancingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supply chain financing, obligation, current", "label": "Supplier Finance Program, Obligation, Current", "documentation": "Amount of obligation for supplier finance program, classified as current." } } }, "auth_ref": [ "r385", "r386", "r387" ] }, "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StandardProductWarrantyAccrualWarrantiesIssued", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/ProductWarrantyMovementinProductWarrantyObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warranties issued", "label": "Standard Product Warranty Accrual, Increase for Warranties Issued", "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties." } } }, "auth_ref": [ "r1070" ] }, "us-gaap_StandardProductWarrantyAccrual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StandardProductWarrantyAccrual", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/ProductWarrantyMovementinProductWarrantyObligationsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "Standard Product Warranty Accrual", "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability." } } }, "auth_ref": [ "r1068", "r1071" ] }, "us-gaap_StandardProductWarrantyAccrualPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StandardProductWarrantyAccrualPayments", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ProductWarrantyMovementinProductWarrantyObligationsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Settlements", "label": "Standard Product Warranty Accrual, Decrease for Payments", "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties." } } }, "auth_ref": [ "r1069" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r932" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r943", "r954", "r964", "r989" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.pmi.com/role/AccumulatedOtherComprehensiveLosses" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Losses:", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r156", "r254", "r690", "r712" ] }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]", "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_SupplierFinanceProgramLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramLineItems", "presentation": [ "http://www.pmi.com/role/SupplyChainFinancingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program [Line Items]", "label": "Supplier Finance Program [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r383", "r385", "r386" ] }, "us-gaap_PensionContributions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionContributions", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Pension plan contributions, net of refunds (Note 5)", "label": "Payment for Pension Benefits", "documentation": "Amount of cash outflow for pension benefit. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree. Excludes other postretirement benefit." } } }, "auth_ref": [ "r14" ] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplierFinanceProgramAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramAxis", "presentation": [ "http://www.pmi.com/role/SupplyChainFinancingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program [Axis]", "label": "Supplier Finance Program [Axis]", "documentation": "Information by supplier finance program." } } }, "auth_ref": [ "r383", "r385", "r386" ] }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetImpairment", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and non-amortizable intangible assets impairment charge", "label": "Goodwill and Intangible Asset Impairment", "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill." } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulOtherReceivablesCurrent", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables, allowances", "label": "Allowance for Credit Loss, Receivable, Other, Current", "documentation": "Amount of allowance for credit loss on receivable, classified as other and current." } } }, "auth_ref": [ "r229" ] }, "us-gaap_SupplierFinanceProgramTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramTable", "presentation": [ "http://www.pmi.com/role/SupplyChainFinancingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program [Table]", "label": "Supplier Finance Program [Table]", "documentation": "Disclosure of information about supplier finance program." } } }, "auth_ref": [ "r383", "r385", "r386" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r941", "r952", "r962", "r987" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest acquired (as a percent)", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r94" ] }, "us-gaap_PensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionPlansDefinedBenefitMember", "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails", "http://www.pmi.com/role/BenefitPlansComponentsofPensionandOtherEmployeeBenefitsCostsDetails", "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Plan", "label": "Pension Plan [Member]", "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits." } } }, "auth_ref": [ "r470", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r519", "r522", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r538", "r539", "r543", "r901", "r902", "r906", "r907", "r908" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive earnings attributable to PMI", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r54", "r247", "r249", "r257", "r693", "r715" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/BenefitPlans" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit Plans:", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r469", "r493", "r495", "r501", "r518", "r520", "r521", "r522", "r523", "r524", "r536", "r537", "r538", "r901" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income tax (benefit) provision", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r16", "r189", "r211", "r596", "r597", "r1032" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsProFormaDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/IncomeTaxesDetails", "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r93", "r96", "r603", "r903", "r906" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables (less allowances of $33 in 2023 and $32 in 2022)", "label": "Other Receivables, Net, Current", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsProFormaDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/IncomeTaxesDetails", "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r603", "r903", "r906" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r932" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsProFormaDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r93", "r96", "r603" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r603" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r942", "r953", "r963", "r988" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r932" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r390", "r391", "r397", "r398" ] }, "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 2)", "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest", "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest." } } }, "auth_ref": [ "r21", "r81", "r193" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r390", "r391", "r392", "r393", "r397", "r398", "r399" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireProjects": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireProjects", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Altria Group, Inc. agreement (Note 2)", "label": "Payments to Acquire Projects", "documentation": "The cash outflow from the amount invested for projects in hopes of getting a future return or interest from it." } } }, "auth_ref": [ "r165" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Increase (Decrease)", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r167" ] }, "pm_CasesOnAppealSubjectToAnAppealOrWithThePossibilityToBeAppealedByASubsidiaryOfTheCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CasesOnAppealSubjectToAnAppealOrWithThePossibilityToBeAppealedByASubsidiaryOfTheCompanyMember", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cases Remaining On Appeal", "label": "Cases On Appeal, Subject To An Appeal, Or With The Possibility To Be Appealed By A Subsidiary Of The Company [Member]", "documentation": "Cases Remaining on Appeal" } } }, "auth_ref": [] }, "pm_ForeignDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ForeignDebtMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Debt", "label": "Foreign Debt [Member]", "documentation": "Foreign Debt" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital expenditures", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r166" ] }, "pm_ShareBasedCompensationComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ShareBasedCompensationComponentsAxis", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Components [Axis]", "label": "Share-based Compensation Components [Axis]", "documentation": "Share-based Compensation Components [Axis]" } } }, "auth_ref": [] }, "pm_LossContingencyDamagesSoughtPastReimbursementsPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesSoughtPastReimbursementsPeriod", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Damages sought, period of past reimbursements", "label": "Loss Contingency, Damages Sought, Past Reimbursements, Period", "documentation": "Loss Contingency, Damages Sought, Past Reimbursements, Period" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r60", "r167", "r262" ] }, "pm_TradeReceivablesSoldandDerecognizedthatRemainedUncollected": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "TradeReceivablesSoldandDerecognizedthatRemainedUncollected", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/SaleofAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivables sold and derecognized that remain uncollected", "label": "Trade Receivables Sold and Derecognized that Remained Uncollected", "documentation": "Trade accounts receivable sold and derecognized from the consolidated balance sheets that remain uncollected by unaffiliated financial institutions." } } }, "auth_ref": [] }, "pm_LossContingencyDamagesAwardedCompensatoryDamagesAmountToBeDepositedIntoTrust": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesAwardedCompensatoryDamagesAmountToBeDepositedIntoTrust", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Awarded compensatory damages that are to be deposited into trust", "label": "Loss Contingency, Damages Awarded, Compensatory Damages, Amount To Be Deposited Into Trust", "documentation": "Loss Contingency, Damages Awarded, Compensatory Damages, Amount To Be Deposited Into Trust" } } }, "auth_ref": [] }, "pm_CommercialAgreementInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CommercialAgreementInterestRate", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial agreement, interest rate", "label": "Commercial Agreement, Interest Rate", "documentation": "Commercial Agreement, Interest Rate" } } }, "auth_ref": [] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentAssetsOther", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Assets, Other", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Assets, Other" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "pm_USDollarNotes4875DueFebruary2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "USDollarNotes4875DueFebruary2026Member", "presentation": [ "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "US Dollar Notes, 4.875%, Due February 2026", "label": "US Dollar Notes, 4.875% Due February 2026 [Member]", "documentation": "US Dollar Notes, 4.875% Due February 2026" } } }, "auth_ref": [] }, "pm_LossContingencyPlaintiffRequirementMinimumNumberOfCigarettesSmoked": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyPlaintiffRequirementMinimumNumberOfCigarettesSmoked", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum number of cigarettes smoked", "label": "Loss Contingency, Plaintiff Requirement, Minimum Number Of Cigarettes Smoked", "documentation": "Loss Contingency, Plaintiff Requirement, Minimum Number Of Cigarettes Smoked" } } }, "auth_ref": [] }, "pm_A3.375Notesdue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A3.375Notesdue2029Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.375% Notes due 2029", "label": "3.375% Notes due 2029 [Member]", "documentation": "3.375% Notes due 2029 [Member]" } } }, "auth_ref": [] }, "pm_SaleofTradeAccountsReceivableDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SaleofTradeAccountsReceivableDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/SaleofAccountsReceivable" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of Accounts Receivable:", "label": "Sale of Trade Accounts Receivable Disclosure [Text Block]", "documentation": "Sale of Trade Accounts Receivable Disclosure [Text Block]" } } }, "auth_ref": [] }, "pm_EITAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "EITAMember", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EITA", "label": "EITA [Member]", "documentation": "EITA [Member]" } } }, "auth_ref": [] }, "pm_LossContingencyNumberOfAdditionalManufacturersFoundLiable": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyNumberOfAdditionalManufacturersFoundLiable", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of additional manufacturers found liable", "label": "Loss Contingency, Number Of Additional Manufacturers Found Liable", "documentation": "Loss Contingency, Number Of Additional Manufacturers Found Liable" } } }, "auth_ref": [] }, "pm_FairValueMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "FairValueMember", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total Fair Value", "label": "Fair Value [Member]", "documentation": "Fair value [Member]." } } }, "auth_ref": [] }, "pm_SSEACISMEASegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SSEACISMEASegmentMember", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SSEA, CIS & MEA", "label": "SSEA, CIS & MEA Segment [Member]", "documentation": "SSEA, CIS & MEA Segment" } } }, "auth_ref": [] }, "pm_PerformanceShareUnitsOtherPerformanceMetricsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "PerformanceShareUnitsOtherPerformanceMetricsMember", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Share Units, Other Performance Metrics", "label": "Performance Share Units, Other Performance Metrics [Member]", "documentation": "Performance Share Units, Other Performance Metrics" } } }, "auth_ref": [] }, "pm_ChangesInStandardProductWarrantyAccrualAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ChangesInStandardProductWarrantyAccrualAbstract", "presentation": [ "http://www.pmi.com/role/ProductWarrantyMovementinProductWarrantyObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Changes due to:", "label": "Changes In Standard Product Warranty Accrual [Abstract]", "documentation": "Changes In Standard Product Warranty Accrual [Abstract]" } } }, "auth_ref": [] }, "pm_NoncontrollingInterestPurchasePhilipMorrisTtnMamulleriSanayiVeTicaretAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "NoncontrollingInterestPurchasePhilipMorrisTtnMamulleriSanayiVeTicaretAMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest Purchase Philip Morris T\u00fct\u00fcn Mamulleri Sanayi ve Ticaret A.\u015e.", "label": "Noncontrolling Interest Purchase Philip Morris T\u00fct\u00fcn Mamulleri Sanayi ve Ticaret A.\u015e. [Member]", "documentation": "Noncontrolling Interest Purchase Philip Morris T\u00fct\u00fcn Mamulleri Sanayi ve Ticaret A.\u015e." } } }, "auth_ref": [] }, "pm_LossContingencyDamagesReducedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesReducedAmount", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Damages, reduced amount", "label": "Loss Contingency Damages, Reduced Amount", "documentation": "Loss Contingencies, Damages awarded, reduced amount" } } }, "auth_ref": [] }, "pm_CanadianGovernmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CanadianGovernmentMember", "presentation": [ "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Canadian Government", "label": "Canadian Government [Member]", "documentation": "Canadian Government" } } }, "auth_ref": [] }, "pm_LabelRelatedClassActionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LabelRelatedClassActionMember", "presentation": [ "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Label-Related Class Actions", "label": "Label Related Class Action [Member]", "documentation": "Label Related Class Action [Member]" } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling ownership percentage", "label": "Subsidiary, Ownership Percentage, Noncontrolling Owner", "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "pm_LossContingencyClaimsOnAppealSubjectToAnAppealOrWithThePossibilityToBeAppealedByASubsidiaryOfTheCompany": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyClaimsOnAppealSubjectToAnAppealOrWithThePossibilityToBeAppealedByASubsidiaryOfTheCompany", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cases on appeal", "label": "Loss Contingency Claims On Appeal, Subject To An Appeal Or With The Possibility To Be Appealed By A Subsidiary Of The Company", "documentation": "Loss Contingency Claims On Appeal, Subject To An Appeal Or With The Possibility To Be Appealed By A Subsidiary Of The Company" } } }, "auth_ref": [] }, "pm_TheAttorneyGeneralOfOyoStateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "TheAttorneyGeneralOfOyoStateMember", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The Attorney General Of Oyo State", "label": "The Attorney General Of Oyo State [Member]", "documentation": "The Attorney General Of Oyo State [Member]" } } }, "auth_ref": [] }, "pm_OperationalSustainabilityWeightPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "OperationalSustainabilityWeightPercentage", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operational sustainability weight (as a percentage)", "label": "Operational Sustainability Weight, Percentage", "documentation": "Operational Sustainability Weight, Percentage" } } }, "auth_ref": [] }, "pm_IndividualLabelRelatedCasesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "IndividualLabelRelatedCasesMember", "presentation": [ "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Individual Label-Related Cases", "label": "Individual Label Related Cases [Member]", "documentation": "Individual Label Related Cases [Member]" } } }, "auth_ref": [] }, "pm_CurrencyNeutralCompoundAnnualAdjustedDilutedEarningsGrowthRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CurrencyNeutralCompoundAnnualAdjustedDilutedEarningsGrowthRatePercent", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency-neutral compound annual adjusted diluted earnings per share growth rate (as a percent)", "label": "Currency-Neutral Compound Annual Adjusted Diluted Earnings Growth Rate Percent", "documentation": "Currency-Neutral Compound Annual Adjusted Diluted Earnings Growth Rate Percent" } } }, "auth_ref": [] }, "pm_ShareBasedCompensationByShareBasedPaymentAwardsTheAggregateWeightedPerformanceFactorThatResultsinTheVestingoftheTargetedNumberOfPerformanceShareUnits": { "xbrltype": "percentItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ShareBasedCompensationByShareBasedPaymentAwardsTheAggregateWeightedPerformanceFactorThatResultsinTheVestingoftheTargetedNumberOfPerformanceShareUnits", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate weighted performance factor", "label": "Share-Based Compensation By Share-Based Payment Awards, The Aggregate Weighted Performance Factor That Results in The Vesting of the Targeted Number Of Performance Share Units", "documentation": "Share-Based Compensation by Share-Based Payment Awards, the Aggregate Weighted Performance Factor that Results in the Vesting of the Targeted Number of Performance Share Units" } } }, "auth_ref": [] }, "pm_A0.125Notesdue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A0.125Notesdue2026Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.125% Notes due 2026", "label": "0.125% Notes due 2026 [Member]", "documentation": "0.125% Notes due 2026 [Member]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "pm_LossContingencyDamagesReturned": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesReturned", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Damages returned to subsidiary", "label": "Loss Contingency, Damages Returned", "documentation": "Loss Contingency, Damages Returned" } } }, "auth_ref": [] }, "pm_LossContingencyDamagesAwardedPunitiveDamagesValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesAwardedPunitiveDamagesValue", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Punitive damages awarded", "label": "Loss Contingency, Damages Awarded, Punitive Damages, Value", "documentation": "Loss Contingency, Damages Awarded, Punitive Damages, Value" } } }, "auth_ref": [] }, "pm_ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais", "label": "Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member]", "documentation": "Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member]" } } }, "auth_ref": [] }, "pm_PaymentsForFinesDemandedNoticesOrOtherLegalIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "PaymentsForFinesDemandedNoticesOrOtherLegalIssues", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/ContingenciesOtherLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts paid", "label": "Payments For Fines, Demanded Notices Or Other Legal Issues", "documentation": "The amount of cash paid for the fines, demanded notices or for other legal issues during the period." } } }, "auth_ref": [] }, "pm_EuropeSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "EuropeSegmentMember", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe", "label": "Europe Segment [Member]", "documentation": "Europe Segment" } } }, "auth_ref": [] }, "pm_A3.375Notesdue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A3.375Notesdue2025Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.375% Notes due 2025", "label": "3.375% Notes due 2025 [Member]", "documentation": "3.375% Notes due 2025 [Member]" } } }, "auth_ref": [] }, "pm_EquitySecuritiesFVNIUnrealizedGainLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "EquitySecuritiesFVNIUnrealizedGainLossNetOfTax", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities, unrealized gain (loss), net", "label": "Equity Securities, FV-NI, Unrealized Gain (Loss), Net Of Tax", "documentation": "Equity Securities, FV-NI, Unrealized Gain (Loss), Net Of Tax" } } }, "auth_ref": [] }, "pm_CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases", "label": "Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member]", "documentation": "Cecilia Letourneau &Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member]" } } }, "auth_ref": [] }, "pm_LossContingencyClaimsResolvedinFavorofPlaintiffsthathaveSubsequentlyReachedFinalResolutioninFavoroftheCompany": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyClaimsResolvedinFavorofPlaintiffsthathaveSubsequentlyReachedFinalResolutioninFavoroftheCompany", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of cases that reached final resolution in favor of PM", "label": "Loss Contingency Claims Resolved in Favor of Plaintiffs that have Subsequently Reached Final Resolution in Favor of the Company", "documentation": "Loss Contingency Claims Resolved in Favor of Plaintiffs that have Subsequently Reached Final Resolution in Favor of the Company" } } }, "auth_ref": [] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current assets", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets" } } }, "auth_ref": [] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Noncontrolling interests", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r51", "r201", "r264", "r355", "r420", "r423", "r424", "r425", "r431", "r432", "r637", "r705", "r787" ] }, "pm_NonEmployeeDirectorOwnershipLimit": { "xbrltype": "percentItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "NonEmployeeDirectorOwnershipLimit", "presentation": [ "http://www.pmi.com/role/StockPlansAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of voting shares that PMI may own, used in determining non-employee director status", "label": "Non Employee Director Ownership Limit", "documentation": "Represents the lower limit of ownership in a company by PMI used in defining Non-employee directors under the stock compensation plan." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityBeforeTreasuryStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityBeforeTreasuryStock", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity before treasury stock", "label": "Stockholders' Equity before Treasury Stock", "documentation": "Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings and including equity attributable to noncontrolling interests and before deducting the carrying value of treasury stock." } } }, "auth_ref": [] }, "pm_USDollarNotes5125DueFebruary2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "USDollarNotes5125DueFebruary2030Member", "presentation": [ "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "US Dollar Notes, 5.125%, Due February 2030", "label": "US Dollar Notes, 5.125%, Due February 2030 [Member]", "documentation": "US Dollar Notes, 5.125%, Due February 2030" } } }, "auth_ref": [] }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromOtherInvestingActivities", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Payments for (Proceeds from) Other Investing Activities", "documentation": "Amount of cash (inflow) outflow from investing activities classified as other." } } }, "auth_ref": [ "r1011", "r1022" ] }, "pm_RothmansBensonAndHedgesInc.RBHMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "RothmansBensonAndHedgesInc.RBHMember", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "RBH", "label": "Rothmans, Benson, And Hedges Inc. (RBH) [Member]", "documentation": "Rothmans, Benson, And Hedges Inc. (RBH) [Member]" } } }, "auth_ref": [] }, "pm_LossContingenciesByNameOfPlaintiffDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingenciesByNameOfPlaintiffDomain", "presentation": [ "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies by Name of Plaintiff [Domain]", "label": "Loss Contingencies By Name Of Plaintiff [Domain]", "documentation": "Loss Contingencies by Name of Plaintiff [Domain]" } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsMovementinExitCostLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Movement in exit cost liabilities", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "pm_BusinessCombinationFairValueAdjustmentToDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationFairValueAdjustmentToDebt", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business combination fair value adjustment to debt", "label": "Business Combination Fair Value Adjustment to Debt", "documentation": "Business Combination Fair Value Adjustment to Debt" } } }, "auth_ref": [] }, "pm_A0.625Notesdue2024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A0.625Notesdue2024Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.625% Notes due 2024", "label": "0.625% Notes due 2024 [Member]", "documentation": "0.625% Notes due 2024 [Member]" } } }, "auth_ref": [] }, "pm_LossContingencyDamagesAwardedPunitiveDamagesPaymentPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesAwardedPunitiveDamagesPaymentPeriod", "presentation": [ "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment period for awarded punitive damages to be deposited into trust", "label": "Loss Contingency, Damages Awarded, Punitive Damages, Payment Period", "documentation": "Loss Contingency, Damages Awarded, Punitive Damages, Payment Period" } } }, "auth_ref": [] }, "pm_AmountofLitigationChargeNetofTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "AmountofLitigationChargeNetofTax", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of litigation charge net of tax", "label": "Amount of Litigation Charge Net of Tax", "documentation": "Amount of Litigation Charge Net of Tax" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r931" ] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLiabilitiesAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLiabilitiesAccountsPayable", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Accounts Payable", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Accounts Payable" } } }, "auth_ref": [] }, "pm_A2.750Notesdue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A2.750Notesdue2026Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "2.750% Notes due 2026", "label": "2.750% Notes due 2026 [Member]", "documentation": "2.750% Notes due 2026 [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "verboseLabel": "Unrealized gains (losses), net of income taxes", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5", "r157", "r638", "r639", "r643" ] }, "pm_A3.125Notesdue2033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A3.125Notesdue2033Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.125% Notes due 2033", "label": "3.125% Notes due 2033 [Member]", "documentation": "3.125% Notes due 2033 [Member]" } } }, "auth_ref": [] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndEquivalents", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash And Equivalents", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash And Equivalents" } } }, "auth_ref": [] }, "pm_LossContingencyDamagesAwardedCompensatoryDamagesPaymentPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesAwardedCompensatoryDamagesPaymentPeriod", "presentation": [ "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment period for compensatory damages to be deposited into trust", "label": "Loss Contingency, Damages Awarded, Compensatory Damages, Payment Period", "documentation": "Loss Contingency, Damages Awarded, Compensatory Damages, Payment Period" } } }, "auth_ref": [] }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "presentation": [ "http://www.pmi.com/role/BackgroundandBasisofPresentation" ], "lang": { "en-us": { "role": { "terseLabel": "Background and Basis of Presentation:", "label": "Business Description and Basis of Presentation [Text Block]", "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r143", "r170", "r171" ] }, "pm_ScotlandMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ScotlandMember", "presentation": [ "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scotland", "label": "Scotland [Member]", "documentation": "Scotland" } } }, "auth_ref": [] }, "pm_ImperialTobaccoLtd.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ImperialTobaccoLtd.Member", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Imperial Tobacco Ltd.", "label": "Imperial Tobacco Ltd. [Member]", "documentation": "Imperial Tobacco Ltd. [Member]" } } }, "auth_ref": [] }, "pm_SeniorUnsecuredTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SeniorUnsecuredTermLoanMember", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Unsecured Term Loan", "label": "Senior Unsecured Term Loan [Member]", "documentation": "Senior Unsecured Term Loan" } } }, "auth_ref": [] }, "pm_A3.125Notesdue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A3.125Notesdue2028Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.125% Notes due 2028", "label": "3.125% Notes due 2028 [Member]", "documentation": "3.125% Notes due 2028 [Member]" } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Parent ownership percentage", "label": "Subsidiary, Ownership Percentage, Parent", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid to noncontrolling interests", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders." } } }, "auth_ref": [ "r184" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "pm_LossContingenciesByNameOfPlaintiffAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingenciesByNameOfPlaintiffAxis", "presentation": [ "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies by Name of Plaintiff [Axis]", "label": "Loss Contingencies by Name of Plaintiff [Axis]", "documentation": "Loss Contingencies by Name of Plaintiff [Axis]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r44" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r272", "r318", "r329", "r330", "r331", "r332", "r333", "r335", "r339", "r420", "r421", "r422", "r423", "r425", "r426", "r428", "r430", "r431", "r1072", "r1073" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Designated as Hedging Instrument", "terseLabel": "Foreign exchange contracts", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r24" ] }, "pm_ForeignCurrencyObligationsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ForeignCurrencyObligationsMember", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Obligations", "label": "Foreign Currency Obligations [Member]", "documentation": "Foreign Currency Obligations [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r117", "r119", "r132" ] }, "us-gaap_LongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermInvestments", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investments (Note 14)", "label": "Long-Term Investments", "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)." } } }, "auth_ref": [ "r221" ] }, "pm_GoodwillChangesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "GoodwillChangesAbstract", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Changes due to:", "label": "Goodwill Changes [Abstract]", "documentation": "Goodwill Changes [Abstract]" } } }, "auth_ref": [] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r272", "r318", "r329", "r330", "r331", "r332", "r333", "r335", "r339", "r420", "r421", "r422", "r423", "r425", "r426", "r428", "r430", "r431", "r1072", "r1073" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r939", "r950", "r960", "r985" ] }, "pm_ShareBasedCompensationArrangementByShareBasedPaymentAwardsLengthOfThePerformanceCyclePeriodWhichRequiresThatCertainPredeterminedPerformanceMetricsBeAchieved": { "xbrltype": "durationItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardsLengthOfThePerformanceCyclePeriodWhichRequiresThatCertainPredeterminedPerformanceMetricsBeAchieved", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Length of performance cycle period", "label": "Share-Based Compensation Arrangement By Share-Based Payment Awards, Length Of The Performance Cycle Period, Which Requires That Certain Predetermined Performance Metrics Be Achieved", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Duration of the Performance Cycle that Requires the Achievement of Predefined Performance Metrics" } } }, "auth_ref": [] }, "pm_RelatedPartiesEquityInvestmentsAndOtherTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "RelatedPartiesEquityInvestmentsAndOtherTextBlock", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOther" ], "lang": { "en-us": { "role": { "terseLabel": "Related Parties - Equity Investments and Other:", "label": "Related Parties, Equity Investments and Other [Text Block]", "documentation": "Related Parties, Equity Investments and Other" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive earnings", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r109", "r192", "r247", "r249", "r255", "r691", "r713" ] }, "pm_ForeignandU.S.StateJurisdictionsStatuteofLimitations": { "xbrltype": "durationItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ForeignandU.S.StateJurisdictionsStatuteofLimitations", "presentation": [ "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statute of limitations term", "label": "Foreign and U.S. State Jurisdictions Statute of Limitations", "documentation": "Foreign and U.S. State Jurisdictions Statute of Limitations" } } }, "auth_ref": [] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r403", "r404", "r405", "r408", "r1063", "r1064" ] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncontrollingInterestFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncontrollingInterestFairValue", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncontrolling Interest, Fair Value", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncontrolling Interest, Fair Value" } } }, "auth_ref": [] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense, net", "label": "Interest Income (Expense), Net", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r205" ] }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesAndExciseTaxPayableCurrent", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes, except income taxes", "label": "Sales and Excise Tax Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r39" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.pmi.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 }, "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings", "http://www.pmi.com/role/EarningsPerShareDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings attributable to PMI", "verboseLabel": "Net earnings attributable to PMI", "terseLabel": "Net Income (Loss) Attributable to Parent", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r159", "r169", "r204", "r217", "r245", "r248", "r252", "r264", "r276", "r278", "r279", "r280", "r281", "r284", "r285", "r300", "r316", "r330", "r336", "r339", "r355", "r420", "r421", "r423", "r424", "r425", "r427", "r429", "r431", "r432", "r631", "r637", "r711", "r806", "r823", "r824", "r883", "r928", "r1072" ] }, "pm_MedicagoIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "MedicagoIncMember", "presentation": [ "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medicago Inc.", "label": "Medicago Inc. [Member]", "documentation": "Medicago Inc." } } }, "auth_ref": [] }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesByNatureOfContingencyAxis", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency Nature [Axis]", "label": "Loss Contingency Nature [Axis]", "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur." } } }, "auth_ref": [ "r403", "r404", "r405", "r408", "r1063", "r1064" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.pmi.com/role/EarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings for basic EPS", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r259", "r278", "r279", "r280", "r281", "r288", "r289", "r301", "r304", "r316", "r330", "r336", "r339", "r883" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "STOCKHOLDERS\u2019 (DEFICIT) EQUITY", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r12", "r105", "r109", "r247", "r249", "r256", "r692", "r714" ] }, "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiUnrealizedGainLoss", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities, unrealized gain (loss)", "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)", "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r717", "r1041" ] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Axis]", "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r135", "r136" ] }, "pm_A3.250Notesdue2024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A3.250Notesdue2024Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.250% Notes due 2024", "label": "3.250% Notes due 2024 [Member]", "documentation": "3.250% Notes due 2024 [Member]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted earnings per share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r258", "r278", "r279", "r280", "r281", "r282", "r291", "r302", "r303", "r304", "r308", "r630", "r631", "r694", "r716", "r881" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofFairValueDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r447", "r496", "r497", "r498", "r499", "r500", "r501", "r633", "r667", "r668", "r669", "r892", "r893", "r899", "r900", "r901" ] }, "us-gaap_AccruedLiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrentAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued liabilities:", "label": "Accrued Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r403", "r404", "r405", "r408", "r1063", "r1064" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repurchases of common stock", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r58" ] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Identifiable net assets acquired", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net" } } }, "auth_ref": [] }, "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency", "label": "Goodwill, Translation and Purchase Accounting Adjustments", "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r0", "r1044" ] }, "pm_A1.875Notesdue2037Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A1.875Notesdue2037Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.875% Notes due 2037", "label": "1.875% Notes due 2037 [Member]", "documentation": "1.875% Notes due 2037 [Member]" } } }, "auth_ref": [] }, "pm_IncomeTaxesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "IncomeTaxesTable", "presentation": [ "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes [Table]", "label": "Income Taxes [Table]", "documentation": "Income Taxes [Table]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r939", "r950", "r960", "r985" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interests", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r103", "r466", "r1034", "r1035", "r1036", "r1129" ] }, "us-gaap_ExciseAndSalesTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExciseAndSalesTaxes", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Excise taxes on products", "label": "Excise and Sales Taxes", "documentation": "The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services." } } }, "auth_ref": [ "r253" ] }, "pm_TotalShareholderReturnTSRRelativetoaPredeterminedPeerGroupAbsoluteBasis": { "xbrltype": "percentItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "TotalShareholderReturnTSRRelativetoaPredeterminedPeerGroupAbsoluteBasis", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Absolute basis (as a percent)", "label": "Total Shareholder Return (TSR) Relative to a Predetermined Peer Group, Absolute Basis", "documentation": "Total Shareholder Return (TSR) Relative to a Predetermined Peer Group, Absolute Basis" } } }, "auth_ref": [] }, "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative fair value gain (loss) of hedged liability", "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)", "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk." } } }, "auth_ref": [ "r619" ] }, "pm_UsDollarNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "UsDollarNotesMember", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails", "http://www.pmi.com/role/IndebtednessShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. dollar credit facility borrowings related to Swedish Match AB acquisition", "verboseLabel": "U.S. Dollar Notes", "label": "US Dollar Notes [Member]", "documentation": "U.S. Dollar Notes" } } }, "auth_ref": [] }, "pm_ScheduleOfDerivativeInstrumentsRecognizedInStatementOfEarningsAndOtherComprehensiveIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ScheduleOfDerivativeInstrumentsRecognizedInStatementOfEarningsAndOtherComprehensiveIncomeTableTextBlock", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative contracts impact on the condensed consolidated statements of earnings and other comprehensive earnings", "label": "Schedule Of Derivative Instruments Recognized In Statement Of Earnings And Other Comprehensive Income [Table Text Block]", "documentation": "Schedule Of Derivative Instruments Recognized In Statement Of Earnings And Other Comprehensive Income [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r24" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/Acquisitions" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions:", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r190", "r604" ] }, "us-gaap_ProceedsFromMinorityShareholders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromMinorityShareholders", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of holdings", "label": "Proceeds from Noncontrolling Interests", "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership." } } }, "auth_ref": [ "r56" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r992" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsofAccumulatedOtherComprehensiveEarningsLossesNetofTaxDetails", "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets", "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 deficit", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "terseLabel": "Total accumulated other comprehensive losses", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r103", "r104", "r107", "r214", "r215", "r251", "r273", "r274", "r275", "r277", "r283", "r356", "r357", "r466", "r580", "r581", "r582", "r592", "r593", "r622", "r623", "r624", "r625", "r626", "r627", "r629", "r644", "r646", "r651", "r662", "r739", "r740", "r751", "r787", "r804", "r826", "r827", "r855", "r929", "r1031", "r1043", "r1111", "r1129" ] }, "pm_AltriaGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "AltriaGroupMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Altria Group", "label": "Altria Group [Member]", "documentation": "Altria Group" } } }, "auth_ref": [] }, "pm_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), Before Reclassification And Tax", "documentation": "Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), Before Reclassification And Tax" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preliminary purchase price allocation", "label": "Finite-Lived Intangible Assets, Purchase Accounting Adjustments", "documentation": "Amount of increase (decrease) to assets, excluding financial assets and goodwill, lacking physical substance with a finite life for purchase accounting adjustments." } } }, "auth_ref": [] }, "pm_IndividualSmokingAndHealthCasesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "IndividualSmokingAndHealthCasesMember", "presentation": [ "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Individual Smoking and Health Cases", "label": "Individual Smoking And Health Cases [Member]", "documentation": "Individual Smoking And Health Cases" } } }, "auth_ref": [] }, "pm_LossContingencyMotionforSecurityOrderedbyAppealsCourt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyMotionforSecurityOrderedbyAppealsCourt", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Motion for security ordered by appeals court", "label": "Loss Contingency, Motion for Security Ordered by Appeals Court", "documentation": "Loss Contingency, Motion for Security Ordered by Appeals Court" } } }, "auth_ref": [] }, "pm_A3.125Notesdue2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A3.125Notesdue2027Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.125% Notes due 2027", "label": "3.125% Notes due 2027 [Member]", "documentation": "3.125% Notes due 2027 [Member]" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r943", "r954", "r964", "r989" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings under credit facilities related to acquisition", "label": "Proceeds from Lines of Credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r57", "r1030" ] }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "presentation": [ "http://www.pmi.com/role/ProductWarrantyTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of accrued product warranties", "label": "Schedule of Product Warranty Liability [Table Text Block]", "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability." } } }, "auth_ref": [ "r419" ] }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillPurchaseAccountingAdjustments", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "verboseLabel": "Measurement period adjustments", "label": "Goodwill, Purchase Accounting Adjustments", "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r0", "r1051" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r940", "r951", "r961", "r986" ] }, "pm_USDollarNotes5375DueFebruary2033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "USDollarNotes5375DueFebruary2033Member", "presentation": [ "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "US Dollar Notes, 5.375%, Due February 2033", "label": "US Dollar Notes, 5.375%, Due February 2033 [Member]", "documentation": "US Dollar Notes, 5.375%, Due February 2033" } } }, "auth_ref": [] }, "pm_SwedishMatchABMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SwedishMatchABMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/IncomeTaxesDetails", "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Swedish Match AB", "label": "Swedish Match AB [Member]", "documentation": "Swedish Match AB" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments to acquire noncontrolling interests", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r55", "r605" ] }, "pm_USDollarNotes5250DueSeptember2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "USDollarNotes5250DueSeptember2028Member", "presentation": [ "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "US Dollar Notes, 5.250%, Due September 2028", "label": "US Dollar Notes, 5.250%, Due September 2028 [Member]", "documentation": "US Dollar Notes, 5.250%, Due September 2028" } } }, "auth_ref": [] }, "us-gaap_AdjustmentForAmortizationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentForAmortizationAbstract", "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization:", "label": "Amortization [Abstract]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r980" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsMovementinExitCostLiabilitiesDetails", "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future cash payments for exit costs expected to be paid", "negatedTerseLabel": "Cash spent", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r391", "r1026" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r938", "r949", "r959", "r984" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityBeforeTreasuryStock", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Earnings reinvested in the business", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r151", "r184", "r704", "r741", "r743", "r749", "r786", "r917" ] }, "us-gaap_NotesPayableOtherPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableOtherPayablesMember", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Notes Payable, Other Payables [Member]", "documentation": "A written promise to pay a note to a third party." } } }, "auth_ref": [] }, "us-gaap_SalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net revenues", "label": "Sales [Member]", "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business." } } }, "auth_ref": [ "r31" ] }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity investments", "label": "Payments to Acquire Equity Method Investments", "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence." } } }, "auth_ref": [ "r55" ] }, "us-gaap_IndefinitelivedIntangibleAssetsAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefinitelivedIntangibleAssetsAcquired", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trademark acquired", "label": "Indefinite-Lived Intangible Assets Acquired", "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition." } } }, "auth_ref": [] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquityParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends declared (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r184" ] }, "us-gaap_FairValueHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueHedgingMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hedging", "label": "Fair Value Hedging [Member]", "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk." } } }, "auth_ref": [ "r114" ] }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinitelivedIntangibleAssetsAcquired1", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-lived intangible assets", "label": "Finite-Lived Intangible Assets Acquired", "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition." } } }, "auth_ref": [ "r374" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other." } } }, "auth_ref": [ "r15" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NondesignatedMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails", "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Not Designated as Hedging Instrument", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r24" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_NetInvestmentHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentHedgingMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Investment Hedging", "label": "Net Investment Hedging [Member]", "documentation": "Hedges of a net investment in a foreign operation." } } }, "auth_ref": [ "r115" ] }, "us-gaap_BankLoanObligationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BankLoanObligationsMember", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bank loans", "label": "Bank Loan Obligations [Member]", "documentation": "Investments in debentures, bonds and other debt securities issued by a bank holding company, its subsidiaries, or affiliates." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes:", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r266", "r584", "r589", "r590", "r591", "r594", "r598", "r599", "r600", "r750" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Change in net loss and prior service cost:", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value of derivatives accounted for as hedges:", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive earnings (losses), net of income taxes:", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r213", "r226", "r227", "r228", "r264", "r291", "r295", "r302", "r304", "r310", "r311", "r355", "r420", "r423", "r424", "r425", "r431", "r432", "r460", "r461", "r463", "r464", "r465", "r637", "r745", "r746", "r747", "r748", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r765", "r785", "r807", "r825", "r850", "r851", "r852", "r853", "r854", "r1007", "r1029", "r1038" ] }, "us-gaap_GainLossOnContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnContractTermination", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Pre tax charge on termination", "label": "Gain (Loss) on Contract Termination", "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform." } } }, "auth_ref": [ "r169" ] }, "us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireAdditionalInterestInSubsidiaries", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments to acquire noncontrolling interests", "label": "Payments to Acquire Additional Interest in Subsidiaries", "documentation": "The cash outflow associated with the purchase of noncontrolling interest during the period." } } }, "auth_ref": [ "r55" ] }, "us-gaap_DerivativeExcludedComponentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeExcludedComponentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, Excluded Component, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "label": "Derivative, Excluded Component, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) recognized in earnings from excluded component of derivative hedge." } } }, "auth_ref": [ "r1108", "r1109" ] }, "us-gaap_JudicialRulingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "JudicialRulingMember", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Judicial Ruling", "label": "Judicial Ruling [Member]", "documentation": "Litigation outcome that occurs as a result of judicial intervention, supervision, or approval." } } }, "auth_ref": [ "r1062" ] }, "us-gaap_OtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedinAccumulatedOtherComprehensiveEarningsLossesNetofIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Comprehensive Income (Loss)", "label": "Other Comprehensive Income (Loss) [Member]", "documentation": "Primary financial statement caption in which reported facts about other comprehensive income have been included." } } }, "auth_ref": [ "r31" ] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValue", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Less: cost of repurchased stock (556,942,754 and 559,098,620 shares in 2023 and 2022, respectively)", "label": "Treasury Stock, Value", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r49", "r82", "r83" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r945", "r956", "r966", "r991" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r233", "r917" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r102" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r932" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r933" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1000" ] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails", "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Axis]", "label": "Scenario [Axis]" } } }, "auth_ref": [ "r286", "r542", "r1008", "r1009", "r1037" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://www.pmi.com/role/BackgroundandBasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r19", "r36" ] }, "pm_PaymentsToAcquireAdditionalInterestInSubsidiariesFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "PaymentsToAcquireAdditionalInterestInSubsidiariesFinancingActivities", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments to acquire Swedish Match AB noncontrolling interests (Note 2)", "verboseLabel": "Payments to acquire additional noncontrolling interests", "label": "Payments to Acquire Additional Interest in Subsidiaries, Financing Activities", "documentation": "Payments to Acquire Additional Interest in Subsidiaries, Financing Activities" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r932" ] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining useful life", "label": "Finite-Lived Intangible Asset, Useful Life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsGrossExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails_1": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total other intangible assets, gross", "label": "Intangible Assets, Gross (Excluding Goodwill)", "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill." } } }, "auth_ref": [ "r222" ] }, "pm_GeographicalSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "GeographicalSegmentMember", "presentation": [ "http://www.pmi.com/role/BackgroundandBasisofPresentationNarrativeDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical Segment", "label": "Geographical Segment [Member]", "documentation": "Geographical Segment" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Basic earnings per share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r258", "r278", "r279", "r280", "r281", "r282", "r288", "r291", "r302", "r303", "r304", "r308", "r630", "r631", "r694", "r716", "r881" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1000" ] }, "pm_A1.450Notesdue2039Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A1.450Notesdue2039Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.450% Notes due 2039", "label": "1.450% Notes due 2039 [Member]", "documentation": "" } } }, "auth_ref": [] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired intangible assets, estimated useful life", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r175" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1000" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r943", "r954", "r964", "r989" ] }, "pm_EIHMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "EIHMember", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EIH", "label": "EIH [Member]", "documentation": "EIH" } } }, "auth_ref": [] }, "pm_IncomeTaxesAndOtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "IncomeTaxesAndOtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Income taxes and other liabilities", "label": "Income Taxes And Other Liabilities, Noncurrent", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer and amount of liabilities classified as other, due after one year or the normal operating cycle." } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.pmi.com/role/StockPlans" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Plans:", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r544", "r548", "r576", "r577", "r579", "r910" ] }, "pm_LossContingencyAmountOfAllegedUnderpaymentsNotUnderpaidAsRuledByCourt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyAmountOfAllegedUnderpaymentsNotUnderpaidAsRuledByCourt", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesOtherLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of alleged underpayments not underpaid as ruled by court", "label": "Loss Contingency, Amount Of Alleged Underpayments Not Underpaid As Ruled By Court", "documentation": "Loss Contingency, Amount Of Alleged Underpayments Not Underpaid As Ruled By Court" } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1000" ] }, "pm_MultiYearRevolvingCreditFacilityExpiringFebruary102026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "MultiYearRevolvingCreditFacilityExpiringFebruary102026Member", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Multi-year Revolving Credit Facility, Expiring February 10, 2026", "label": "Multi-year Revolving Credit Facility, Expiring February 10, 2026 [Member]", "documentation": "Multi-year Revolving Credit Facility, Expiring February 10, 2026" } } }, "auth_ref": [] }, "pm_LossContingencyMotionforSecurityOrderedbyanAppealsCourttobeFundedbyDefendant": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyMotionforSecurityOrderedbyanAppealsCourttobeFundedbyDefendant", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of security ordered, funded by defendant", "label": "Loss Contingency, Motion for Security Ordered by an Appeals Court to be Funded by Defendant", "documentation": "Loss Contingency, Motion for Security Ordered by an Appeals Court to be Funded by Defendant" } } }, "auth_ref": [] }, "pm_ScheduleOfVerdictsAndPostTrialDevelopments1TableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ScheduleOfVerdictsAndPostTrialDevelopments1TableTextBlock", "presentation": [ "http://www.pmi.com/role/ContingenciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of verdicts and significant post trial developments where a verdict was returned in favor of the plaintiff(s)", "label": "Schedule Of Verdicts And Post Trial Developments1 [Table Text Block]", "documentation": "Schedule Of Verdicts And Post Trial Developments1 [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_CommercialPaperMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommercialPaperMember", "presentation": [ "http://www.pmi.com/role/IndebtednessShortTermBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial paper", "label": "Commercial Paper [Member]", "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds." } } }, "auth_ref": [ "r181", "r924", "r925", "r926", "r927" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r273", "r274", "r275", "r309", "r674", "r744", "r765", "r777", "r778", "r779", "r780", "r781", "r782", "r785", "r788", "r789", "r790", "r791", "r792", "r794", "r795", "r796", "r797", "r799", "r800", "r801", "r802", "r803", "r805", "r808", "r809", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r825", "r923" ] }, "pm_ShareBasedCompensationComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ShareBasedCompensationComponentDomain", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Component [Domain]", "label": "Share-based Compensation Component [Domain]", "documentation": "Share-based Compensation Component [Domain]" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r1000" ] }, "pm_AmountOfLitigationCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "AmountOfLitigationCharge", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of litigation charge", "label": "Amount Of Litigation Charge", "documentation": "Amount of Litigation Charge" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails_1": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0, "order": 1.0 }, "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortizable intangible assets, accumulated amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r223", "r377" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, cash equivalents and restricted cash:", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/Contingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Contingencies:", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r179", "r401", "r402", "r857", "r1061" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "pm_NoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "NoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 2)", "label": "Noncontrolling Interest, Increase (Decrease) From Redemptions Or Purchase Of Interests", "documentation": "Noncontrolling Interest, Increase (Decrease) From Redemptions Or Purchase Of Interests" } } }, "auth_ref": [] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r1001" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityBeforeTreasuryStock", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive losses (Note 13)", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r52", "r53", "r157", "r230", "r703", "r742", "r743" ] }, "pm_LossContingencyDamagesAwardedPercentageAllocated": { "xbrltype": "percentItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesAwardedPercentageAllocated", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Damages allocated to subsidiary (percent)", "label": "Loss Contingency, Damages Awarded, Percentage Allocated", "documentation": "Loss Contingency, Damages Awarded, Compensatory Damages, Percentage Allocated" } } }, "auth_ref": [] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Axis]", "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r351", "r352", "r354" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date." } } }, "auth_ref": [ "r98" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r1001" ] }, "us-gaap_InvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other investments", "label": "Investments, Fair Value Disclosure", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method." } } }, "auth_ref": [ "r632" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r1002" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r1001" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amortization expense, year one, assuming no additional transactions occur that require the amortization of intangible assets", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r177" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r1003" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amortization expense, year two, assuming no additional transactions occur that require the amortization of intangible assets", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r177" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amortization expense, year three, assuming no additional transactions occur that require the amortization of intangible assets", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r177" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total PMI stockholders\u2019 deficit", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r149", "r152", "r153", "r172", "r787", "r804", "r826", "r827", "r917", "r930", "r1031", "r1043", "r1111", "r1129" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r1002" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "presentation": [ "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award requisite service period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r910" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other acquisitions, net of acquired cash", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r55" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amortization expense, year four, assuming no additional transactions occur that require the amortization of intangible assets", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r177" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amortization expense, year five, assuming no additional transactions occur that require the amortization of intangible assets", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r177" ] }, "us-gaap_PaymentsOfDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividends", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid", "label": "Payments of Dividends", "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests." } } }, "auth_ref": [ "r58" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r641" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedinAccumulatedOtherComprehensiveEarningsLossesNetofIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RestrictedCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCash", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Restricted Cash", "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r1016", "r1028", "r1124", "r1126" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r1004" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "presentation": [ "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsofAccumulatedOtherComprehensiveEarningsLossesNetofTaxDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r252" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "crdr": "credit", "calculation": { "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, including current maturities", "totalLabel": "Long-term debt, including current maturities", "label": "Long-Term Debt and Lease Obligation, Including Current Maturities", "documentation": "Amount of long-term debt and lease obligation, including portion classified as current." } } }, "auth_ref": [] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r935", "r1005" ] }, "country_PH": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "PH", "presentation": [ "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Philippines", "label": "PHILIPPINES" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "terseLabel": "Payables", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r39", "r917" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityBeforeTreasuryStock", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r150" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r47" ] }, "us-gaap_EquityMethodInvestmentDividendsOrDistributions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentDividendsOrDistributions", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends from unconsolidated subsidiaries", "label": "Proceeds from Equity Method Investment, Distribution", "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities." } } }, "auth_ref": [ "r13", "r16", "r158", "r708" ] }, "country_RU": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "RU", "presentation": [ "http://www.pmi.com/role/IncomeTaxesDetails", "http://www.pmi.com/role/WarinUkraineNarrativeDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Russia", "label": "RUSSIAN FEDERATION" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "terseLabel": "Operating income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r316", "r330", "r336", "r339", "r883" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://www.pmi.com/role/BackgroundandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Product Information [Table]", "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "verboseLabel": "Cost of sales", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r161", "r674" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_OtherNonrecurringExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonrecurringExpense", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-tax charge", "label": "Other Nonrecurring Expense", "documentation": "Amount of other expense that is infrequent in occurrence or unusual in nature." } } }, "auth_ref": [ "r164" ] }, "country_TH": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "TH", "presentation": [ "http://www.pmi.com/role/ContingenciesOtherLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thailand", "label": "THAILAND" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityAxis", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lender Name [Axis]", "label": "Lender Name [Axis]", "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit." } } }, "auth_ref": [ "r41", "r1030" ] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesLongTermDebt", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Long-Term Debt", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Long-Term Debt" } } }, "auth_ref": [] }, "pm_FinanceLeaseTerminationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "FinanceLeaseTerminationMember", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Lease Termination", "label": "Finance Lease Termination [Member]", "documentation": "Finance Lease Termination" } } }, "auth_ref": [] }, "pm_LossContingencyDamagesSoughtFutureReimbursementsPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesSoughtFutureReimbursementsPeriod", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Damages sought, period of future reimbursements", "label": "Loss Contingency, Damages Sought, Future Reimbursements, Period", "documentation": "Loss Contingency, Damages Sought, Future Reimbursements, Period" } } }, "auth_ref": [] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends declared", "label": "Dividends, Common Stock", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r11", "r184" ] }, "pm_AmountOfPreTaxChargeRelatedToAllegedUnderpaymentOfExciseTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "AmountOfPreTaxChargeRelatedToAllegedUnderpaymentOfExciseTaxes", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash pre-tax charge", "negatedTerseLabel": "Non-cash pre-tax charge", "label": "Amount Of Pre-Tax Charge Related To Alleged Underpayment Of Excise Taxes", "documentation": "Amount Of Pre-Tax Charge Related To Alleged Underpayment Of Excise Taxes" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityTable", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Table]", "label": "Line of Credit Facility [Table]", "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r41", "r1030" ] }, "us-gaap_LineOfCreditFacilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLineItems", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Line Items]", "label": "Line of Credit Facility [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r1030" ] }, "pm_HugoLespadaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "HugoLespadaMember", "presentation": [ "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hugo Lespada", "label": "Hugo Lespada [Member]", "documentation": "Hugo Lespada [Member]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party, Type [Axis]", "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r519", "r663", "r664", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r778", "r779", "r780", "r781", "r782", "r803", "r805", "r828", "r1115" ] }, "pm_ShortTermCreditArrangementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ShortTermCreditArrangementMember", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short Term Credit Arrangement", "label": "Short Term Credit Arrangement [Member]", "documentation": "Short Term Credit Arrangement [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofFairValueDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r447", "r496", "r497", "r498", "r499", "r500", "r501", "r667", "r668", "r669", "r892", "r893", "r899", "r900", "r901" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r979" ] }, "pm_LossContingencyFinesOrDemandedPaymentsSought": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyFinesOrDemandedPaymentsSought", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesOtherLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency, damages sought, value", "label": "Loss Contingency, Fines Or Demanded Payments Sought", "documentation": "The monetary value related to fines, demanded payments or other legal matters sought by government and other governmental authorities." } } }, "auth_ref": [] }, "pm_SmokeFreeProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SmokeFreeProductsMember", "presentation": [ "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Smoke-Free Products", "label": "Smoke-Free Products [Member]", "documentation": "Smoke-Free Products" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r969" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r261" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r969" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r261" ] }, "pm_GrantDateFairValueMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "GrantDateFairValueMember", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grant Date Fair Value", "label": "Grant Date Fair Value [Member]", "documentation": "Grant date fair value [Member]." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r167", "r168", "r169" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r972" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r971" ] }, "us-gaap_LossContingencyNumberOfDefendants": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNumberOfDefendants", "presentation": [ "http://www.pmi.com/role/ContingenciesOtherLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of defendants", "label": "Loss Contingency, Number of Defendants", "documentation": "Number of defendants named in a legal action." } } }, "auth_ref": [ "r1063", "r1064" ] }, "pm_A3.600Notesdue2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A3.600Notesdue2023Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.600% Notes due 2023", "label": "3.600% Notes due 2023 [Member]", "documentation": "3.600% Notes due 2023 [Member]" } } }, "auth_ref": [] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r970" ] }, "pm_ProjectContributionFromGovernment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ProjectContributionFromGovernment", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Project contribution from government", "label": "Project Contribution From Government", "documentation": "Project Contribution From Government" } } }, "auth_ref": [] }, "pm_SenemYilmazelMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SenemYilmazelMember", "presentation": [ "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senem Yilmazel", "label": "Senem Yilmazel [Member]", "documentation": "Senem Yilmazel" } } }, "auth_ref": [] }, "us-gaap_StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/ProductWarrantyMovementinProductWarrantyObligationsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Currency/Other", "label": "Standard Product Warranty Accrual, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the standard product warranty accrual. Excludes extended product warranties." } } }, "auth_ref": [ "r1067" ] }, "pm_UTCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "UTCMember", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "UTC", "label": "UTC [Member]", "documentation": "UTC" } } }, "auth_ref": [] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r970" ] }, "us-gaap_ProceedsFromRepaymentsOfDebtAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfDebtAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term borrowing activity by original maturity:", "label": "Proceeds from (Repayments of) Debt [Abstract]" } } }, "auth_ref": [] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r971" ] }, "pm_TheNumberOfSharesOfCommonStockIssuedForEachVestedPerformanceShareUnit": { "xbrltype": "sharesItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "TheNumberOfSharesOfCommonStockIssuedForEachVestedPerformanceShareUnit", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock issued for each vested PSU (in shares)", "label": "The Number Of Shares Of Common Stock Issued For Each Vested Performance Share Unit", "documentation": "The Number of shares of Common Stock Issued for each Vested Performance Share Unit" } } }, "auth_ref": [] }, "pm_NoncontrollingInterestPurchaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "NoncontrollingInterestPurchaseMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest purchase", "label": "Noncontrolling interest purchase [Member]", "documentation": "Noncontrolling interest purchase" } } }, "auth_ref": [] }, "pm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables", "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables" } } }, "auth_ref": [] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r943", "r954", "r964", "r981", "r989" ] }, "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite lived intangible asset, currency movements increase (decrease)", "label": "Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [] }, "pm_A4.375Notesdue2041Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A4.375Notesdue2041Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "4.375% Notes due 2041", "label": "4.375% Notes due 2041 [Member]", "documentation": "4.375% Notes due 2041 [Member]" } } }, "auth_ref": [] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r972" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails", "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "verboseLabel": "Derivative Instrument Risk [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r118", "r121", "r123", "r126", "r773", "r776", "r790", "r791", "r792", "r794", "r795", "r796", "r797", "r799", "r800", "r801", "r802", "r813", "r814", "r815", "r816", "r819", "r820", "r821", "r822", "r838", "r839", "r840", "r841", "r879", "r920", "r922" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r972" ] }, "pm_EVaporProductsManufacturingOptimizationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "EVaporProductsManufacturingOptimizationMember", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "e-Vapor Products Manufacturing Optimization", "label": "e-Vapor Products Manufacturing Optimization [Member]", "documentation": "e-Vapor Products Manufacturing Optimization" } } }, "auth_ref": [] }, "pm_AssetImpairmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "AssetImpairmentMember", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Impairment", "label": "Asset Impairment [Member]", "documentation": "Asset Impairment" } } }, "auth_ref": [] }, "pm_ThreeHundredSixtyFourDayRevolvingCreditExpiringJanuary302024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ThreeHundredSixtyFourDayRevolvingCreditExpiringJanuary302024Member", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Three Hundred Sixty-Four Day Revolving Credit Expiring January 31, 2023", "label": "Three Hundred Sixty-Four Day Revolving Credit Expiring January 30, 2024 [Member]", "documentation": "Three Hundred Sixty-Four Day Revolving Credit Expiring January 30, 2023" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r972" ] }, "pm_IncomeTaxesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "IncomeTaxesLineItems", "presentation": [ "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes [Line Items]", "label": "Income Taxes [Line Items]", "documentation": "Income Taxes [Line Items]" } } }, "auth_ref": [] }, "pm_InventoryLeafTobacco": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "InventoryLeafTobacco", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Leaf tobacco", "label": "Inventory Leaf Tobacco", "documentation": "Carrying amount as of the balance sheet date of leaf tobacco inventory to be consumed in the manufacturing and production process." } } }, "auth_ref": [] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r936", "r947", "r957", "r982" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/Indebtedness" ], "lang": { "en-us": { "role": { "terseLabel": "Indebtedness:", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r180", "r263", "r433", "r439", "r440", "r441", "r442", "r443", "r444", "r449", "r456", "r457", "r459" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r969" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r935", "r1005" ] }, "country_TR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "TR", "presentation": [ "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Turkey", "label": "T\u00dcRKIYE" } } }, "auth_ref": [] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r935", "r1005" ] }, "country_BR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "BR", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Brazil", "label": "BRAZIL" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "country_UA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "UA", "presentation": [ "http://www.pmi.com/role/WarinUkraineNarrativeDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ukraine", "label": "UKRAINE" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "documentation": "The amount of inventory recognized as of the acquisition date." } } }, "auth_ref": [ "r97", "r98" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date." } } }, "auth_ref": [ "r97", "r98" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r160", "r264", "r316", "r330", "r336", "r339", "r355", "r420", "r421", "r423", "r424", "r425", "r427", "r429", "r431", "r432", "r637", "r883", "r1072" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total consideration transferred", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree." } } }, "auth_ref": [ "r98" ] }, "us-gaap_UnusualOrInfrequentItemLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualOrInfrequentItemLineItems", "presentation": [ "http://www.pmi.com/role/WarinUkraineNarrativeDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual or Infrequent Item, or Both [Line Items]", "label": "Unusual or Infrequent Item, or Both [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_LesseeFinanceLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeFinanceLeasesTextBlock", "presentation": [ "http://www.pmi.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases:", "label": "Lessee, Finance Leases [Text Block]", "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability." } } }, "auth_ref": [ "r653" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r943", "r954", "r964", "r989" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r934" ] }, "country_CA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CA", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Canada", "label": "CANADA" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Identifiable net assets acquired", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r97", "r98" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillLineItems", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r885" ] }, "country_VE": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "VE", "presentation": [ "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Venezuela", "label": "VENEZUELA" } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r967" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Components of accumulated other comprehensive earnings (losses), net of taxes", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r53", "r1112", "r1113" ] }, "us-gaap_UnusualRiskOrUncertaintyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualRiskOrUncertaintyNatureDomain", "presentation": [ "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/WarinUkraineNarrativeDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual Risk or Uncertainty, Nature [Domain]", "label": "Unusual Risk or Uncertainty, Nature [Domain]", "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost." } } }, "auth_ref": [] }, "country_CL": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CL", "presentation": [ "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Chile", "label": "CHILE" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Schedule of Goodwill [Table]", "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons." } } }, "auth_ref": [ "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r885" ] }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TechnologyBasedIntangibleAssetsMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed technology, including patents", "label": "Technology-Based Intangible Assets [Member]", "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights." } } }, "auth_ref": [ "r34" ] }, "us-gaap_UnusualOrInfrequentItemTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualOrInfrequentItemTable", "presentation": [ "http://www.pmi.com/role/WarinUkraineNarrativeDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual or Infrequent Item, or Both [Table]", "label": "Unusual or Infrequent Item, or Both [Table]", "documentation": "Disclosure of information about the nature and financial statement effect of an event or transaction that is unusual in nature or infrequent in occurrence, or both." } } }, "auth_ref": [ "r164" ] }, "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualOrInfrequentItemsDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/WarinUkraine" ], "lang": { "en-us": { "role": { "terseLabel": "War in Ukraine:", "label": "Unusual or Infrequent Items, or Both, Disclosure [Text Block]", "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both." } } }, "auth_ref": [ "r163" ] }, "us-gaap_IncreaseDecreaseInReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInReceivables", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" ], "lang": { "en-us": { "role": { "negatedLabel": "Receivables, net", "label": "Increase (Decrease) in Receivables", "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r15" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.pmi.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Antidilutive stock awards (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r305" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Per share data (Note 8):", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Face Value", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r138", "r139", "r434", "r652", "r892", "r893" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1006" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of outstanding long-term debt", "label": "Debt Instrument, Fair Value Disclosure", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r447", "r636", "r892", "r893" ] }, "pm_CaseDecidedInFavorOfPlaintiffMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CaseDecidedInFavorOfPlaintiffMember", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Case Decided In Favor Of Plaintiff", "label": "Case Decided In Favor Of Plaintiff [Member]", "documentation": "Case Decided in Favor of Plaintiff" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r936", "r947", "r957", "r982" ] }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest", "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value", "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date." } } }, "auth_ref": [ "r99" ] }, "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualRiskOrUncertaintyByNatureAxis", "presentation": [ "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/WarinUkraineNarrativeDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual Risk or Uncertainty, Nature [Axis]", "label": "Unusual Risk or Uncertainty, Nature [Axis]", "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost." } } }, "auth_ref": [] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r937", "r948", "r958", "r983" ] }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net revenues", "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual", "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period." } } }, "auth_ref": [ "r95" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.pmi.com/role/StockPlansRSUAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units (RSUs)", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodAxis", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Redemption, Period [Axis]", "label": "Debt Instrument, Redemption, Period [Axis]", "documentation": "Information about timing of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r30" ] }, "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings attributable to PMI", "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual", "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period." } } }, "auth_ref": [ "r95" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r60", "r220", "r872" ] }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodDomain", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Redemption, Period [Domain]", "label": "Debt Instrument, Redemption, Period [Domain]", "documentation": "Period as defined under terms of the debt agreement for debt redemption features." } } }, "auth_ref": [ "r30" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.pmi.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases:", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r653" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r218", "r234", "r264", "r355", "r420", "r421", "r423", "r424", "r425", "r427", "r429", "r431", "r432", "r607", "r612", "r637", "r917", "r1072", "r1073", "r1116" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.pmi.com/role/StockPlansAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails", "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofFairValueDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r272", "r434", "r435", "r436", "r437", "r438", "r440", "r445", "r446", "r447", "r448", "r450", "r451", "r452", "r453", "r454", "r455", "r458", "r652", "r891", "r892", "r893", "r894", "r895", "r1030" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.pmi.com/role/BackgroundandBasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "srt_LitigationCaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "LitigationCaseTypeDomain", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Domain]", "label": "Litigation Case [Domain]" } } }, "auth_ref": [] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://www.pmi.com/role/BackgroundandBasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "label": "Derivatives, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r24", "r110", "r111", "r116", "r128", "r271" ] }, "srt_ProFormaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProFormaMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pro Forma", "label": "Pro Forma [Member]" } } }, "auth_ref": [ "r286", "r1008", "r1009" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash effects of changes, net of the effects from acquired companies:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "pm_MeasurementPeriodAdjustmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "MeasurementPeriodAdjustmentsAbstract", "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Period Adjustments", "label": "Measurement Period Adjustments [Abstract]", "documentation": "Measurement Period Adjustments" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r15" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails", "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r38", "r145", "r146", "r198", "r200", "r272", "r434", "r435", "r436", "r437", "r438", "r440", "r445", "r446", "r447", "r448", "r450", "r451", "r452", "r453", "r454", "r455", "r652", "r891", "r892", "r893", "r894", "r895", "r1030" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Retirement Benefits [Abstract]", "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574" ] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities [Abstract]", "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails", "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofFairValueDetails", "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r47", "r79", "r80", "r137", "r138", "r139", "r141", "r182", "r183", "r272", "r434", "r435", "r436", "r437", "r438", "r440", "r445", "r446", "r447", "r448", "r450", "r451", "r452", "r453", "r454", "r455", "r458", "r652", "r891", "r892", "r893", "r894", "r895", "r1030" ] }, "pm_CommercialAgreementRemainingPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CommercialAgreementRemainingPayment", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial agreement, remaining payment", "label": "Commercial Agreement, Remaining Payment", "documentation": "Commercial Agreement, Remaining Payment" } } }, "auth_ref": [] }, "us-gaap_ServicingLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ServicingLiability", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/SaleofAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Servicing liability", "label": "Servicing Liability", "documentation": "Aggregate amount of servicing liabilities that are subsequently measured at fair value and servicing liabilities that are subsequently measured using the amortization method." } } }, "auth_ref": [ "r672" ] }, "pm_EAAUPMIDFSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "EAAUPMIDFSegmentMember", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EA, AU & PMI DF", "label": "EA, AU & PMI DF Segment [Member]", "documentation": "EA, AU & PMI DF Segment" } } }, "auth_ref": [] }, "us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtIssuanceCostsLineOfCreditArrangementsGross", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of debt costs", "label": "Debt Issuance Costs, Line of Credit Arrangements, Gross", "documentation": "Amount, before accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r37" ] }, "us-gaap_LossContingencyDamagesAwardedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyDamagesAwardedValue", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesOtherLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Damages awarded", "label": "Loss Contingency, Damages Awarded, Value", "documentation": "Amount of damages awarded to the plaintiff in the legal matter." } } }, "auth_ref": [ "r1062", "r1063", "r1064" ] }, "pm_PostemploymentBenefitPlansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "PostemploymentBenefitPlansMember", "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofPensionandOtherEmployeeBenefitsCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Postemployment Benefit Plans", "label": "Postemployment Benefit Plans [Member]", "documentation": "Postemployment Benefit Plans [Member]" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Shares", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable", "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofPensionandOtherEmployeeBenefitsCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]", "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans." } } }, "auth_ref": [ "r20", "r86", "r87", "r88", "r89" ] }, "pm_ScheduleOfDebtIssuancesDuringCurrentPeriodTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ScheduleOfDebtIssuancesDuringCurrentPeriodTableTextBlock", "presentation": [ "http://www.pmi.com/role/IndebtednessTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of debt issuances during current period", "label": "Schedule of Debt Issuances During Current Period [Table Text Block]", "documentation": "Schedule of Debt Issuances During Current Period" } } }, "auth_ref": [] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r98" ] }, "pm_OtherRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "OtherRelatedPartyMember", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Related Party [Member]", "documentation": "Other Related Party [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r98" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r98" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivables", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r98" ] }, "us-gaap_OtherComprehensiveIncomeLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLocationAxis", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedinAccumulatedOtherComprehensiveEarningsLossesNetofIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Comprehensive Income Location [Axis]", "label": "Other Comprehensive Income Location [Axis]", "documentation": "Information by location in other comprehensive income." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems", "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofPensionandOtherEmployeeBenefitsCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/SegmentReporting" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting:", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r312", "r313", "r314", "r315", "r316", "r328", "r333", "r337", "r338", "r339", "r340", "r341", "r342", "r345" ] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherReceivables", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Receivables", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Receivables" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "presentation": [ "http://www.pmi.com/role/IndebtednessTables" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate fair values of PMI's debt, excluding finance leases", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances." } } }, "auth_ref": [ "r26", "r135", "r136", "r196" ] }, "us-gaap_ReportingUnitAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReportingUnitAxis", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reporting Unit [Axis]", "label": "Reporting Unit [Axis]", "documentation": "Information by reporting unit." } } }, "auth_ref": [ "r371", "r372", "r885" ] }, "pm_IncomeTaxExaminationAmountAssessedByTaxingAuthorities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "IncomeTaxExaminationAmountAssessedByTaxingAuthorities", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount assessed by taxing authorities", "label": "Income Tax Examination, Amount Assessed By Taxing Authorities", "documentation": "Income Tax Examination, Amount Assessed By Taxing Authorities" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investments", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r326", "r350", "r1017", "r1042" ] }, "pm_CeciliaLetourneauMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CeciliaLetourneauMember", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cecilia Letourneau", "label": "Cecilia Letourneau [Member]", "documentation": "Cecilia Letourneau [Member]" } } }, "auth_ref": [] }, "pm_ProductSustainabilityWeightPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ProductSustainabilityWeightPercentage", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product sustainability weight (as a percent)", "label": "Product Sustainability Weight, Percentage", "documentation": "Product Sustainability Weight, Percentage" } } }, "auth_ref": [] }, "us-gaap_ReportingUnitDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReportingUnitDomain", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reporting Unit [Domain]", "label": "Reporting Unit [Domain]", "documentation": "Level of reporting at which goodwill is tested for impairment." } } }, "auth_ref": [ "r371", "r372", "r885" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt", "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r98" ] }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxesAndTaxCredits", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes and tax credits", "label": "Deferred Income Taxes and Tax Credits", "documentation": "Amount of deferred income tax expense (benefit) and income tax credits." } } }, "auth_ref": [ "r169" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherTables" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings and balance sheet activities with related parties - equity investments and other", "label": "Schedule of Related Party Transactions [Table Text Block]", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIncomeTaxes", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Income Taxes", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Income Taxes" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt", "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r98" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r380", "r392", "r810" ] }, "pm_TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember", "presentation": [ "http://www.pmi.com/role/ContingenciesOtherLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The Department of Special Investigations of the Government of Thailand", "label": "The Department of Special Investigations of the Government of Thailand [Member]", "documentation": "The Department of Special Investigations of the Government of Thailand [Member]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.pmi.com/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Segment data", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r61", "r62", "r63", "r64" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r98" ] }, "pm_ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp.", "label": "Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]", "documentation": "Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]" } } }, "auth_ref": [] }, "country_KR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "KR", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesOtherLitigationDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Korea", "label": "KOREA, REPUBLIC OF" } } }, "auth_ref": [] }, "pm_PerformanceShareUnitsTSRPerformanceMetricMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "PerformanceShareUnitsTSRPerformanceMetricMember", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Share Units, TSR Performance Metric", "label": "Performance Share Units, TSR Performance Metric [Member]", "documentation": "Performance Share Units, TSR Performance Metric" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r392", "r810" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other intangible assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date." } } }, "auth_ref": [ "r98" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r61", "r62", "r63", "r64" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date." } } }, "auth_ref": [ "r98" ] }, "pm_A4.125Notesdue2043Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A4.125Notesdue2043Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "4.125% Notes due 2043", "label": "4.125% Notes due 2043 [Member]", "documentation": "4.125% Notes due 2043 [Member]" } } }, "auth_ref": [] }, "us-gaap_ReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFVNINoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFVNINoncurrent", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities, noncurrent", "label": "Equity Securities, FV-NI, Noncurrent", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as noncurrent." } } }, "auth_ref": [ "r634" ] }, "pm_SeniorUnsecuredBridgeFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SeniorUnsecuredBridgeFacilityMember", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Unsecured Bridge Facility", "label": "Senior Unsecured Bridge Facility [Member]", "documentation": "Senior Unsecured Bridge Facility" } } }, "auth_ref": [] }, "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction", "crdr": "credit", "calculation": { "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross amounts not offset in the condensed consolidated balance sheets - financial instruments", "label": "Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset", "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative asset." } } }, "auth_ref": [ "r29", "r33", "r209" ] }, "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Difference between equity method investment carrying value and book value", "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity", "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee." } } }, "auth_ref": [ "r353" ] }, "pm_MultiYearRevolvingCreditFacilityExpiringSeptember292026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "MultiYearRevolvingCreditFacilityExpiringSeptember292026Member", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Multi-year Revolving Credit Facility, Expiring September 29, 2026", "label": "Multi-year Revolving Credit Facility, Expiring September 29, 2026 [Member]", "documentation": "Multi-year Revolving Credit Facility, Expiring September 29, 2026" } } }, "auth_ref": [] }, "pm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIncomeTaxes", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Income Taxes", "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Income Taxes" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership percentage", "label": "Equity Method Investment, Ownership Percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r351" ] }, "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofPensionandOtherEmployeeBenefitsCostsDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "verboseLabel": "Pension and other employee benefit costs (Note 5)", "terseLabel": "Total pension and other employee benefit costs", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component", "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits." } } }, "auth_ref": [ "r471" ] }, "us-gaap_TrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trademarks", "label": "Trademarks [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style." } } }, "auth_ref": [ "r101" ] }, "pm_A4.500Notesdue2042Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A4.500Notesdue2042Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "4.500% Notes due 2042", "label": "4.500% Notes due 2042 [Member]", "documentation": "4.500% Notes due 2042 [Member]" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction", "crdr": "debit", "calculation": { "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross amounts not offset in the condensed consolidated balance sheets - financial instruments", "label": "Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset", "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative liability." } } }, "auth_ref": [ "r29", "r33", "r209" ] }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "presentation": [ "http://www.pmi.com/role/BenefitPlansTables" ], "lang": { "en-us": { "role": { "terseLabel": "Components of net periodic benefit cost", "label": "Schedule of Net Benefit Costs [Table Text Block]", "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments." } } }, "auth_ref": [ "r187" ] }, "us-gaap_OtherComprehensiveIncomeLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLocationDomain", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedinAccumulatedOtherComprehensiveEarningsLossesNetofIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Comprehensive Income Location [Domain]", "label": "Other Comprehensive Income Location [Domain]", "documentation": "Location in other comprehensive income." } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Axis]", "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r269", "r270", "r437", "r462", "r666", "r876", "r879" ] }, "pm_A2.750Notesdue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A2.750Notesdue2025Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "2.750% Notes due 2025", "label": "2.750% Notes due 2025 [Member]", "documentation": "2.750% Notes due 2025 [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems", "presentation": [ "http://www.pmi.com/role/AcquisitionsProFormaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "pm_AmericasSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "AmericasSegmentMember", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Americas", "label": "Americas Segment [Member]", "documentation": "Americas Segment" } } }, "auth_ref": [] }, "pm_USDollarNotes4875DueFebruary2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "USDollarNotes4875DueFebruary2028Member", "presentation": [ "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "US Dollar Notes, 4.875%, Due February 2028", "label": "US Dollar Notes, 4.875%, Due February 2028 [Member]", "documentation": "US Dollar Notes, 4.875%, Due February 2028" } } }, "auth_ref": [] }, "us-gaap_GuaranteeObligationsNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteeObligationsNatureDomain", "presentation": [ "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Guarantor Obligations, Nature [Domain]", "label": "Guarantor Obligations, Nature [Domain]", "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees." } } }, "auth_ref": [ "r409", "r414", "r415", "r418" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, term", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.pmi.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Lease cost components", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1114" ] }, "us-gaap_LineOfCreditFacilityLenderDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLenderDomain", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility, Lender [Domain]", "label": "Line of Credit Facility, Lender [Domain]", "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility." } } }, "auth_ref": [ "r41", "r1030" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/IndebtednessNarrativeDetails", "http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Principal amount", "terseLabel": "Committed credit facilities", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r41" ] }, "country_NG": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "NG", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nigeria", "label": "NIGERIA" } } }, "auth_ref": [] }, "pm_CombustibleProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CombustibleProductsMember", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails", "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Combustible Products", "label": "Combustible Products [Member]", "documentation": "Combustible Products [Member]" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award vesting rights, percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r1077" ] }, "pm_AdamsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "AdamsMember", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adams", "label": "Adams [Member]", "documentation": "Adams [Member]" } } }, "auth_ref": [] }, "pm_ManagementEtDeveloppementDesActifsEtDesRessourcesHoldingMADARHoldingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ManagementEtDeveloppementDesActifsEtDesRessourcesHoldingMADARHoldingMember", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Management Et Developpement Des Actifs Et Des Ressources Holding (MADAR Holding)", "label": "Management Et Developpement Des Actifs Et Des Ressources Holding (MADAR Holding) [Member]", "documentation": "Management Et Developpement Des Actifs Et Des Ressources Holding (MADAR Holding) [Member]" } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-amortizable intangible assets, currency movements increase (decrease)", "label": "Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value." } } }, "auth_ref": [] }, "us-gaap_GuaranteeObligationsByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteeObligationsByNatureAxis", "presentation": [ "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Guarantor Obligations, Nature [Axis]", "label": "Guarantor Obligations, Nature [Axis]", "documentation": "Information by nature of guarantee." } } }, "auth_ref": [ "r409", "r414", "r415", "r418" ] }, "pm_SaleofAccountsReceivableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SaleofAccountsReceivableAbstract", "lang": { "en-us": { "role": { "terseLabel": "Sale of Accounts Receivable [Abstract]", "label": "Sale of Accounts Receivable [Abstract]", "documentation": "Sale of Accounts Receivable [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortizable intangible assets, net", "totalLabel": "Amortizable intangible assets, net", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r176", "r675" ] }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other intangible assets", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles", "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete." } } }, "auth_ref": [ "r100" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Domain]", "label": "Investment, Name [Domain]" } } }, "auth_ref": [ "r351", "r352", "r354" ] }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment", "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete." } } }, "auth_ref": [ "r100" ] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed technology, including patents", "label": "Developed Technology Rights [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r191" ] }, "us-gaap_PostretirementBenefitCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PostretirementBenefitCostsMember", "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofPensionandOtherEmployeeBenefitsCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Postretirement Benefit Costs", "label": "Postretirement Benefit Costs [Member]", "documentation": "Rate action of a regulator resulting in capitalization or accrual of postretirement benefit costs." } } }, "auth_ref": [ "r142" ] }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory", "crdr": "debit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory", "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete." } } }, "auth_ref": [ "r100" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.pmi.com/role/StockPlansTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of assumptions used to determine the grant date fair value of the PSU awards subject to the TSR performance metric", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r188" ] }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total consideration transferred", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred", "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete." } } }, "auth_ref": [ "r100" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails", "http://www.pmi.com/role/WarinUkraineNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill (Note 6)", "verboseLabel": "Goodwill", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r222", "r360", "r689", "r885", "r917", "r1045", "r1052" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortizable intangible assets, gross carrying amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r176", "r676" ] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money Market Funds", "label": "Money Market Funds [Member]", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r1076" ] }, "us-gaap_UnamortizedDebtIssuanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnamortizedDebtIssuanceExpense", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized at acquisition date", "label": "Unamortized Debt Issuance Expense", "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset." } } }, "auth_ref": [] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails", "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r773", "r776", "r790", "r791", "r792", "r794", "r795", "r796", "r797", "r799", "r800", "r801", "r802", "r813", "r814", "r815", "r816", "r819", "r820", "r821", "r822", "r838", "r839", "r840", "r841", "r920", "r922" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.pmi.com/role/BackgroundandBasisofPresentationNarrativeDetails", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r216", "r313", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r339", "r345", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r381", "r393", "r399", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r885", "r1015", "r1127" ] }, "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivative contracts", "label": "Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]", "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts." } } }, "auth_ref": [ "r121" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-amortizable intangible assets", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r178" ] }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of notional amounts of outstanding derivative positions", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions." } } }, "auth_ref": [ "r112" ] }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Qualifying hedging activity reported in accumulated other comprehensive earnings (losses), net of income taxes", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings." } } }, "auth_ref": [ "r125" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r617" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r24", "r118", "r123" ] }, "us-gaap_GuaranteesAndProductWarrantiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteesAndProductWarrantiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Guarantees and Product Warranties [Abstract]", "label": "Guarantees and Product Warranties [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets", "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade receivables (less allowances of $80 in 2023 and $42 in 2022)", "terseLabel": "Trade receivables, related parties", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r346", "r347" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]", "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r24", "r118", "r123", "r126", "r132", "r133", "r617" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarningsParenthetical", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party, Type [Domain]", "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r519", "r663", "r664", "r778", "r779", "r780", "r781", "r782", "r803", "r805", "r828" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.pmi.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings", "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings", "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings", "verboseLabel": "Net earnings", "terseLabel": "Net earnings", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r217", "r245", "r248", "r260", "r264", "r276", "r284", "r285", "r316", "r330", "r336", "r339", "r355", "r420", "r421", "r423", "r424", "r425", "r427", "r429", "r431", "r432", "r606", "r609", "r610", "r631", "r637", "r695", "r709", "r752", "r806", "r823", "r824", "r883", "r912", "r913", "r929", "r1021", "r1072" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.pmi.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share:", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r287", "r305", "r306", "r307" ] }, "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnFairValueHedgesRecognizedInEarnings", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain/(Loss) Recognized in Earnings", "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings", "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period." } } }, "auth_ref": [ "r124" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Income taxes", "label": "Increase (Decrease) in Income Taxes Payable", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r15" ] }, "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MovementInStandardProductWarrantyAccrualRollForward", "presentation": [ "http://www.pmi.com/role/ProductWarrantyMovementinProductWarrantyObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]", "label": "Movement in Standard Product Warranty Accrual [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r15" ] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.pmi.com/role/LeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease cost", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r656", "r916" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Income taxes", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r146", "r199" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermLeaseCost", "crdr": "debit", "calculation": { "http://www.pmi.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term lease cost", "label": "Short-Term Lease, Cost", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r659", "r916" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition related costs", "label": "Business Combination, Acquisition Related Costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r92" ] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.pmi.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease cost", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r658", "r916" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings attributable to noncontrolling interests", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r108", "r194", "r245", "r248", "r284", "r285", "r710", "r1021" ] }, "us-gaap_VariableLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableLeaseCost", "crdr": "debit", "calculation": { "http://www.pmi.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pmi.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable lease cost", "label": "Variable Lease, Cost", "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases." } } }, "auth_ref": [ "r660", "r916" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "calculation": { "http://www.pmi.com/role/EarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings for diluted EPS", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r259", "r290", "r296", "r297", "r298", "r299", "r301", "r304" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r979" ] }, "us-gaap_GainLossOnSaleOfAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfAccountsReceivable", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/SaleofAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on sale of accounts receivable", "label": "Gain (Loss) on Sale of Accounts Receivable", "documentation": "Amount of gain (loss) on sale of accounts receivable." } } }, "auth_ref": [ "r671" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r973" ] }, "pm_SwedishMatchABSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SwedishMatchABSegmentMember", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Swedish Match", "label": "Swedish Match AB Segment [Member]", "documentation": "Swedish Match AB Segment" } } }, "auth_ref": [] }, "pm_SmokingAndHealthClassActionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SmokingAndHealthClassActionsMember", "presentation": [ "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "http://www.pmi.com/role/ContingenciesSmokingandHealthLitigationDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Smoking and Health Class Actions", "label": "Smoking And Health Class Actions [Member]", "documentation": "Smoking And Health Class Actions" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r117", "r132" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r973" ] }, "pm_EuroNotesPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "EuroNotesPayableMember", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Euro Notes", "label": "Euro Notes Payable Member", "documentation": "Euro Notes Payable" } } }, "auth_ref": [] }, "pm_ScheduleOfGainLossOnSaleOfTradeReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ScheduleOfGainLossOnSaleOfTradeReceivablesTableTextBlock", "presentation": [ "http://www.pmi.com/role/ReceivablesLoansNotesReceivableandOthersTables" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on sale of trade receivables", "label": "Schedule Of Gain (Loss) On Sale Of Trade Receivables [Table Text Block]", "documentation": "Schedule Of Gain (Loss) On Sale Of Trade Receivables" } } }, "auth_ref": [] }, "pm_ScheduleOfTobaccoRelatedCasesPendingAgainstCompanyTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ScheduleOfTobaccoRelatedCasesPendingAgainstCompanyTableTextBlock", "presentation": [ "http://www.pmi.com/role/ContingenciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of tobacco related cases pertaining to combustible products pending against company", "label": "Schedule Of Tobacco Related Cases Pending Against Company [Table Text Block]", "documentation": "Schedule of tobacco related cases pertaining to combustible products pending against company and/or subsidiaries or indemnitees" } } }, "auth_ref": [] }, "pm_OtherLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "OtherLitigationMember", "presentation": [ "http://www.pmi.com/role/ContingenciesOtherLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Litigation", "label": "Other Litigation [Member]", "documentation": "Other Litigation [Member]" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "pm_USDollarNotes5500DueSeptember2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "USDollarNotes5500DueSeptember2030Member", "presentation": [ "http://www.pmi.com/role/IndebtednessDebtIssuancesOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "US Dollar Notes, 5.500%, Due September 2030", "label": "US Dollar Notes, 5.500%, Due September 2030 [Member]", "documentation": "US Dollar Notes, 5.500%, Due September 2030" } } }, "auth_ref": [] }, "pm_SmokeFreeProductsExcludingWellnessAndHealthcareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SmokeFreeProductsExcludingWellnessAndHealthcareMember", "presentation": [ "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total smoke-free products excluding Wellness and Healthcare", "label": "Smoke-Free Products Excluding Wellness And Healthcare [Member]", "documentation": "Smoke-Free Products Excluding Wellness And Healthcare" } } }, "auth_ref": [] }, "pm_SuppliersUsingSupplyChainFinancingProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SuppliersUsingSupplyChainFinancingProgramMember", "presentation": [ "http://www.pmi.com/role/SupplyChainFinancingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supply Chain Financing Program", "label": "Suppliers Using Supply Chain Financing Program [Member]", "documentation": "Suppliers Using Supply Chain Financing Program" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r973" ] }, "pm_A2022PerformanceIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A2022PerformanceIncentivePlanMember", "presentation": [ "http://www.pmi.com/role/StockPlansAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2022 Performance Incentive Plan", "label": "2022 Performance Incentive Plan [Member]", "documentation": "2022 Performance Incentive Plan" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r117", "r122" ] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain/(Loss) Recognized in Earnings", "label": "Derivative, Gain (Loss) on Derivative, Net", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r1107" ] }, "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "crdr": "debit", "calculation": { "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net amount", "label": "Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction", "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement." } } }, "auth_ref": [ "r33", "r130" ] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLiabilitiesLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLiabilitiesLongTermDebt", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Long-Term Debt", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Long-Term Debt" } } }, "auth_ref": [] }, "pm_WarInUkraineMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "WarInUkraineMember", "presentation": [ "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails", "http://www.pmi.com/role/WarinUkraineNarrativeDetails", "http://www.pmi.com/role/WarinUkrainePretaxChargesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "War In Ukraine", "label": "War In Ukraine [Member]", "documentation": "War In Ukraine" } } }, "auth_ref": [] }, "us-gaap_ContractTerminationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractTerminationMember", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract Termination", "label": "Contract Termination [Member]", "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [ "r887", "r888", "r889", "r890" ] }, "pm_SuzanneJacklinMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SuzanneJacklinMember", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Suzanne Jacklin", "label": "Suzanne Jacklin [Member]", "documentation": "Suzanne Jacklin [Member]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r978" ] }, "us-gaap_RepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLinesOfCredit", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.pmi.com/role/IndebtednessNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayments under credit facilities related to Swedish Match AB acquisition", "terseLabel": "Repayments under credit facilities related to acquisition", "label": "Repayments of Lines of Credit", "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r59", "r1030" ] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives, Fair Value [Line Items]", "label": "Derivatives, Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r973" ] }, "us-gaap_OtherLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes and other\u00a0liabilities", "label": "Other Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other liabilities." } } }, "auth_ref": [ "r117", "r132" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r390", "r391", "r397", "r398" ] }, "pm_IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentAssets", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accrued liabilities and other current assets", "label": "Increase Decrease In Accrued Liabilities And Other Current Assets", "documentation": "The net change during the reporting period in the aggregate amount of expenses incurred but not yet paid, as well as the net change during the reporting period in the aggregate value of other current assets, associated with transactions that are classified as operating activities" } } }, "auth_ref": [] }, "pm_NetRevenuesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "NetRevenuesMember", "presentation": [ "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Revenues", "label": "Net Revenues [Member]", "documentation": "Net Revenues" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Movement in exit cost liabilities", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period." } } }, "auth_ref": [ "r73", "r77" ] }, "pm_WellnessAndHealthcareSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "WellnessAndHealthcareSegmentMember", "presentation": [ "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetMovementinGoodwillDetails", "http://www.pmi.com/role/SegmentReportingSegmentDataDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Wellness & Healthcare", "label": "Wellness and Healthcare Segment [Member]", "documentation": "Wellness and Healthcare Segment" } } }, "auth_ref": [] }, "pm_MultiYearRevolvingCreditFacilityExpiringFebruary102027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "MultiYearRevolvingCreditFacilityExpiringFebruary102027Member", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Multi-year Revolving Credit Facility, Expiring February 10, 2027", "label": "Multi-year Revolving Credit Facility, Expiring February 10, 2027 [Member]", "documentation": "Multi-year Revolving Credit Facility, Expiring February 10, 2027" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Long-term debt repaid", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r59", "r748" ] }, "us-gaap_ExtraordinaryAndUnusualItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtraordinaryAndUnusualItemsAbstract", "lang": { "en-us": { "role": { "label": "Unusual or Infrequent Items, or Both [Abstract]" } } }, "auth_ref": [] }, "pm_LossContingencyClaimsResolvedinFavoroftheCompany": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyClaimsResolvedinFavoroftheCompany", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of cases decided in favor of PM", "label": "Loss Contingency Claims Resolved in Favor of the Company", "documentation": "Loss Contingency Claims Resolved in Favor of the Company" } } }, "auth_ref": [] }, "pm_TheAttorneyGeneralOfLagosStateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "TheAttorneyGeneralOfLagosStateMember", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The Attorney General Of Lagos State", "label": "The Attorney General Of Lagos State [Member]", "documentation": "The Attorney General Of Lagos State [Member]" } } }, "auth_ref": [] }, "pm_BusinessCombinationFairValueAdjustmentToInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationFairValueAdjustmentToInventories", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/SegmentReportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business combination fair value adjustment to inventories", "label": "Business Combination Fair Value Adjustment to Inventories", "documentation": "Business Combination Fair Value Adjustment to Inventories" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-tax asset impairment and exit costs by segment", "label": "Restructuring and Related Costs [Table Text Block]", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r72", "r74", "r76" ] }, "pm_MinimumRetirementAge": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "MinimumRetirementAge", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum retirement age", "label": "Minimum Retirement Age", "documentation": "Minimum Retirement Age" } } }, "auth_ref": [] }, "pm_SwissFrancNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SwissFrancNotesMember", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Swiss Franc Notes", "label": "Swiss Franc Notes [Member]", "documentation": "Swiss franc notes [Member]" } } }, "auth_ref": [] }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "crdr": "credit", "calculation": { "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net amount", "label": "Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction", "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement." } } }, "auth_ref": [ "r33", "r130" ] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails", "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange contracts", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r879", "r899", "r914" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r973" ] }, "pm_PMIAndSwedishMatchMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "PMIAndSwedishMatchMember", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsProFormaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "PMI and Swedish Match", "label": "PMI and Swedish Match [Member]", "documentation": "PMI and Swedish Match" } } }, "auth_ref": [] }, "pm_SwedishKronaNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "SwedishKronaNotesMember", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Swedish Krona Notes", "label": "Swedish Krona Notes [Member]", "documentation": "Swedish Krona Notes" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsTable", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Equity Method Investments [Table]", "label": "Schedule of Equity Method Investments [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available." } } }, "auth_ref": [ "r217", "r264", "r351", "r352", "r354", "r355", "r637" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r973" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings before income taxes", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r316", "r330", "r336", "r339", "r718", "r883" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interests activity and Other (Note 2)", "label": "Proceeds from (Payments for) Other Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r1012", "r1023" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Domain]", "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r25" ] }, "pm_HealthCareCostRecoveryActionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "HealthCareCostRecoveryActionsMember", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Health Care Cost Recovery Actions", "label": "Health Care Cost Recovery Actions [Member]", "documentation": "Health Care Cost Recovery Actions" } } }, "auth_ref": [] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r1105", "r1106" ] }, "us-gaap_InterestExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, net", "label": "Interest Expense [Member]", "documentation": "Primary financial statement caption encompassing interest expense." } } }, "auth_ref": [ "r31" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherBalanceSheetandEarningsActivityDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Equity Method Investments [Line Items]", "label": "Schedule of Equity Method Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r264", "r351", "r352", "r354", "r355", "r637" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r974" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r563" ] }, "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails": { "parentTag": "pm_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNet", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Other", "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities, Other" } } }, "auth_ref": [] }, "us-gaap_CommodityContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommodityContractMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commodity contracts", "label": "Commodity Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices." } } }, "auth_ref": [ "r899", "r915" ] }, "pm_CommercialAgreementInitialPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CommercialAgreementInitialPayment", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial agreement, initial payment", "label": "Commercial Agreement, Initial Payment", "documentation": "Commercial Agreement, Initial Payment" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average grant date fair value per RSU award granted (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r563" ] }, "us-gaap_InterestRateContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateContractMember", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsCashFlowandNetInvestmentHedgingActivitiesEffectonCondensedConsolidatedStatementsofEarningsandOtherComprehensiveEarningsDetails", "http://www.pmi.com/role/FinancialInstrumentsFairValueofDerivativeContractsDetails", "http://www.pmi.com/role/FinancialInstrumentsNotionalAmountsofOutstandingDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate contracts", "label": "Interest Rate Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate." } } }, "auth_ref": [ "r869", "r879", "r899" ] }, "pm_A4.250Notesdue2044Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A4.250Notesdue2044Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "4.250% Notes due 2044", "label": "4.250% Notes due 2044 [Member]", "documentation": "4.250% Notes due 2044 [Member]" } } }, "auth_ref": [] }, "pm_TheAttorneyGeneralOfKanoStateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "TheAttorneyGeneralOfKanoStateMember", "presentation": [ "http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The Attorney General Of Kano State", "label": "The Attorney General Of Kano State [Member]", "documentation": "The Attorney General Of Kano State [Member]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r977" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Unrecognized compensation cost related to non-vested stock awards", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r578" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r932" ] }, "pm_CommercialAgreementTotalCashConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "CommercialAgreementTotalCashConsideration", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial agreement, total cash consideration", "label": "Commercial Agreement, Total Cash Consideration", "documentation": "Commercial Agreement, Total Cash Consideration" } } }, "auth_ref": [] }, "pm_TheSouthKoreanBoardOfAuditAndInspectionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "TheSouthKoreanBoardOfAuditAndInspectionMember", "presentation": [ "http://www.pmi.com/role/ContingenciesOtherLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The South Korean Board Of Audit And Inspection", "label": "The South Korean Board Of Audit And Inspection [Member]", "documentation": "The South Korean Board Of Audit And Inspection [Member]" } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r974" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock awards vested during period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r564" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r213", "r226", "r227", "r228", "r264", "r291", "r295", "r302", "r304", "r310", "r311", "r355", "r420", "r423", "r424", "r425", "r431", "r432", "r460", "r461", "r463", "r464", "r465", "r637", "r745", "r746", "r747", "r748", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r765", "r785", "r807", "r825", "r850", "r851", "r852", "r853", "r854", "r1007", "r1029", "r1038" ] }, "pm_A2.875Notesdue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A2.875Notesdue2029Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "2.875% Notes due 2029", "label": "2.875% Notes due 2029 [Member]", "documentation": "2.875% Notes due 2029 [Member]" } } }, "auth_ref": [] }, "pm_TTIMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "TTIMember", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "TTI", "label": "TTI [Member]", "documentation": "TTI [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of vested stock awards", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash." } } }, "auth_ref": [ "r567" ] }, "pm_LossContingencyCourtEstimatedNumberOfMembersInClass": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyCourtEstimatedNumberOfMembersInClass", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Court-estimated number of members in class", "label": "Loss Contingency, Court-Estimated Number Of Members In Class", "documentation": "Loss Contingency, Court-Estimated Number Of Members In Class" } } }, "auth_ref": [] }, "pm_STAEMMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "STAEMMember", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "STAEM", "label": "STAEM [Member]", "documentation": "STAEM [Member]" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r974" ] }, "pm_LossContingencyClaimsResolvedinFavorofPlaintiffs": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyClaimsResolvedinFavorofPlaintiffs", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of cases decided in favor of plaintiff", "label": "Loss Contingency Claims Resolved in Favor of Plaintiffs", "documentation": "Loss Contingency Claims Resolved in Favor of Plaintiffs" } } }, "auth_ref": [] }, "pm_MarketingAdministrationAndResearchCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "MarketingAdministrationAndResearchCosts", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "verboseLabel": "Marketing, administration and research costs (Notes 3 & 9)", "label": "Marketing, Administration And Research Costs", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies. General and administrative expenses include costs such as salaries of nonsales personnel, rent, utilities, communication and realized and unrealized gains and losses on foreign currency transactions." } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal Entity [Axis]", "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.pmi.com/role/AssetImpairmentandExitCostsAssetImpairmentandExitCostsbySegmentDetails", "http://www.pmi.com/role/AssetImpairmentandExitCostsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Schedule of Restructuring and Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r390", "r391", "r392", "r393", "r397", "r398", "r399" ] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsProFormaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net revenues", "label": "Business Acquisition, Pro Forma Revenue", "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period." } } }, "auth_ref": [ "r601", "r602" ] }, "pm_A2.875Notesdue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A2.875Notesdue2026Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "2.875% Notes due 2026", "label": "2.875% Notes due 2026 [Member]", "documentation": "2.875% Notes due 2026 [Member]" } } }, "auth_ref": [] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r974" ] }, "pm_DefiniteLivedIntangiblesAndOtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "DefiniteLivedIntangiblesAndOtherAssetsMember", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Definite-Lived Intangibles And Other Assets", "label": "Definite-Lived Intangibles And Other Assets [Member]", "documentation": "Definite-Lived Intangibles And Other Assets" } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails", "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails", "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity [Domain]", "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r974" ] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/AcquisitionsProFormaDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings attributable to PMI", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r601", "r602" ] }, "pm_A2017NonEmployeeDirectorsPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A2017NonEmployeeDirectorsPlanMember", "presentation": [ "http://www.pmi.com/role/StockPlansAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non Employee Directors Plan", "label": "2017 Non Employee Directors Plan [Member]", "documentation": "2017 Non Employee Directors Plan [Member]" } } }, "auth_ref": [] }, "pm_LossContingencyDamagesAwardedCompensatoryDamagesValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyDamagesAwardedCompensatoryDamagesValue", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails", "http://www.pmi.com/role/ContingenciesVerdictsandPostTrialDevelopmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Compensatory damages awarded", "label": "Loss Contingency, Damages Awarded, Compensatory Damages, Value", "documentation": "Loss Contingency, Damages Awarded, Compensatory Damages, Value" } } }, "auth_ref": [] }, "pm_LossContingencyAmountOfTaxesNotUnderpaidAsRuledByTrialCourt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "LossContingencyAmountOfTaxesNotUnderpaidAsRuledByTrialCourt", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/ContingenciesOtherLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of taxes not underpaid as ruled by trial court", "label": "Loss Contingency, Amount Of Taxes Not Underpaid As Ruled By Trial Court", "documentation": "Loss Contingency, Amount Of Taxes Not Underpaid As Ruled By Trial Court" } } }, "auth_ref": [] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r974" ] }, "pm_IPMIndiaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "IPMIndiaMember", "presentation": [ "http://www.pmi.com/role/RelatedPartiesEquityInvestmentsandOtherNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IPM India", "label": "IPM India [Member]", "documentation": "IPM India [Member]" } } }, "auth_ref": [] }, "pm_PerformanceMetricsPredefinedAtTheTimeOfGrantIncludingMarketAndNonMarketMetricsUsedByTheCompanyToDetermineThePercentageOfPSUsThatWillVest": { "xbrltype": "integerItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "PerformanceMetricsPredefinedAtTheTimeOfGrantIncludingMarketAndNonMarketMetricsUsedByTheCompanyToDetermineThePercentageOfPSUsThatWillVest", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance metrics predefined at time of grant", "label": "Performance Metrics Predefined At The Time Of Grant, Including Market And Non-Market Metrics, Used By The Company To Determine The Percentage Of PSU's That Will Vest", "documentation": "Performance Metrics Predefined at Time of Grant, including Market and Non-Market Metrics, used by the Company to Determine the Percentage of PSU's that will Vest" } } }, "auth_ref": [] }, "pm_A3.875Notesdue2042Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A3.875Notesdue2042Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.875% Notes due 2042", "label": "3.875% Notes due 2042 [Member]", "documentation": "3.875% Notes due 2042 [Member]" } } }, "auth_ref": [] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r974" ] }, "pm_ReductionOfGuaranteeObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "ReductionOfGuaranteeObligation", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/ContingenciesThirdPartyGuaranteesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reduction of guarantee obligation", "label": "Reduction of Guarantee Obligation", "documentation": "Reduction of Guarantee Obligation" } } }, "auth_ref": [] }, "pm_EuroBankLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "EuroBankLoanMember", "presentation": [ "http://www.pmi.com/role/IndebtednessScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Euro Bank Loan", "label": "Euro Bank Loan [Member]", "documentation": "Euro Bank Loan" } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r975" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.pmi.com/role/StockPlansAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares available for grant under the plan (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r90" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r932" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.pmi.com/role/StockPlansAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r911" ] }, "pm_PublicCivilActionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "PublicCivilActionsMember", "presentation": [ "http://www.pmi.com/role/ContingenciesNumberofTobaccoRelatedCasesPertainingtoCombustibleProductsPendingAgainstUsandorOurSubsidiariesorIndemniteesDetails", "http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public Civil Actions", "label": "Public Civil Actions [Member]", "documentation": "Public Civil Actions" } } }, "auth_ref": [] }, "pm_A2.875Notesdue20241Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "A2.875Notesdue20241Member", "presentation": [ "http://www.pmi.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "2.875% Notes due 2024", "label": "2.875% Notes due 2024 - 1 [Member]", "documentation": "2.875% Notes due 2024 - 1 [Member]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r976" ] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "calculation": { "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest cost", "label": "Defined Benefit Plan, Interest Cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r471", "r475", "r507", "r528", "r901", "r902" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "calculation": { "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net periodic pension cost", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r505", "r526", "r901", "r902" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.pmi.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plus contingently issuable performance stock units (PSUs), (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r292", "r293", "r294", "r304", "r547" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r946", "r954", "r964", "r981", "r989", "r993", "r1001" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r68", "r178" ] }, "us-gaap_AccountsReceivableSale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableSale", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/SaleofAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative trade receivables sold", "label": "Accounts Receivable, Sale", "documentation": "Amount of decrease from sale of accounts receivable." } } }, "auth_ref": [ "r359" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails", "http://www.pmi.com/role/AcquisitionsSwedishMatchABDetails", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets [Axis]", "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r375", "r378" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r946", "r954", "r964", "r981", "r989", "r993", "r1001" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Finished product", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r173", "r874" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r149" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r981" ] }, "us-gaap_DefinedBenefitPlanServiceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanServiceCost", "crdr": "debit", "calculation": { "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service cost", "label": "Defined Benefit Plan, Service Cost", "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r473", "r506", "r527", "r901", "r902" ] }, "pm_BusinessCombinationFinalRedemptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.pmi.com/20230930", "localname": "BusinessCombinationFinalRedemptionPricePerShare", "presentation": [ "http://www.pmi.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Final redemption price (in usd per share)", "label": "Business Combination, Final Redemption Price Per Share", "documentation": "Business Combination, Final Redemption Price Per Share" } } }, "auth_ref": [] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other raw materials", "label": "Inventory, Raw Materials, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r173", "r875" ] }, "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted", "crdr": "debit", "calculation": { "http://www.pmi.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pmi.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less distributed and undistributed earnings attributable to share-based payment awards", "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted", "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method." } } }, "auth_ref": [ "r301" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityBeforeTreasuryStock", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock, no par value (2,109,316,331 shares issued in 2023 and 2022)", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r149", "r702", "r917" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/StockPlansPSUAwardsDetails", "http://www.pmi.com/role/StockPlansRSUAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Expense Related to RSU Awards", "verboseLabel": "Compensation Expense Related to PSU Awards", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r575", "r583" ] }, "us-gaap_ProductWarrantyDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyDisclosureTextBlock", "presentation": [ "http://www.pmi.com/role/ProductWarranty" ], "lang": { "en-us": { "role": { "terseLabel": "Product Warranty:", "label": "Product Warranty Disclosure [Text Block]", "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period." } } }, "auth_ref": [ "r410", "r411", "r412", "r413", "r416", "r417" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://www.pmi.com/role/BackgroundandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Information [Line Items]", "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedStatementsofStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of Repurchased Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r82" ] }, "us-gaap_HedgedLiabilityFairValueHedge": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgedLiabilityFairValueHedge", "crdr": "credit", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value hedge amount", "label": "Hedged Liability, Fair Value Hedge", "documentation": "Amount of liability hedged in fair value hedging relationship." } } }, "auth_ref": [ "r618" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Repurchased stock (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r82" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.pmi.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r20", "r86", "r87", "r88", "r89" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r981" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "presentation": [ "http://www.pmi.com/role/WarinUkraineNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r17", "r696", "r707", "r917" ] }, "us-gaap_InvestmentTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeAxis", "presentation": [ "http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Type [Axis]", "label": "Investment Type [Axis]", "documentation": "Information by type of investments." } } }, "auth_ref": [ "r766", "r768", "r769", "r771", "r774", "r829", "r831", "r833", "r836", "r837", "r842", "r843", "r845", "r846", "r847", "r848", "r849", "r922" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r981" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r968" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r992" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 }, "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pmi.com/role/CondensedConsolidatedBalanceSheets", "http://www.pmi.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other intangible assets, net (Note 6)", "totalLabel": "Total other intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r65", "r69" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "16", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i-k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-16" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21D", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2C", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b),(d)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(i)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "e", "SubTopic": "470", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(c)(2)", "SubTopic": "20", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-13" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "SubTopic": "30", "Topic": "835", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479359/835-30-S45-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29,30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-4A" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-24" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a),(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "980", "SubTopic": "715", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481691/980-715-50-1" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220/tableOfContent" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220-20/tableOfContent" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-12A" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(h)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r198": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r199": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r200": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r201": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r202": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r203": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r204": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r205": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-1A" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(ii)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-4" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//420/tableOfContent" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EE", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4EE" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EE", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4EE" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-5A" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "40", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481724/830-30-40-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-5" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481260/860-50-45-2" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r869": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r870": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r871": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r872": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r873": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r874": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r875": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r876": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r877": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-20" }, "r878": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r879": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r880": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r881": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r882": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r883": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r884": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r885": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r886": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477128/405-50-55-3" }, "r887": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r888": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r889": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r890": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r891": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r892": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r893": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r894": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r895": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r896": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r897": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r898": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r899": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r900": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r901": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r902": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r903": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r904": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r905": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r906": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r907": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r908": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r909": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r910": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r911": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r912": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r913": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r914": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r915": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r916": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r917": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r918": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r919": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r920": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r921": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r922": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r923": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r924": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r925": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r926": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r927": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r928": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r929": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r930": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r931": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r932": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r933": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r934": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r935": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r936": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r937": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r938": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r939": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r940": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r941": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r942": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r943": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r944": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r945": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r946": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r947": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r948": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r949": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r950": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r951": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r952": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r953": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r954": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r955": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r956": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r957": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r958": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r959": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r960": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r961": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r962": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r963": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r964": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r965": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r966": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r967": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r968": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r969": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r970": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r971": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r972": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r973": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r974": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r975": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r976": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r977": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r978": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r979": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r980": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r981": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r982": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r983": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r984": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r985": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r986": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r987": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r988": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r989": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r990": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r991": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r992": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r993": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r994": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r995": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r996": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r997": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r998": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r999": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r1000": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r1001": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r1002": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r1003": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r1004": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r1005": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r1006": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r1007": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r1008": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r1009": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1088": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1089": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1090": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1091": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1092": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1093": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1094": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1095": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1096": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1097": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1098": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1099": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1100": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1101": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1102": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1103": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r1104": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1105": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r1106": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r1107": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r1108": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r1109": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r1110": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1111": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1112": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r1113": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r1114": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1115": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r1116": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1117": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1118": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1119": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1120": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1121": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1122": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1123": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1124": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r1125": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1126": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1127": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1128": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1129": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 130 0001413329-23-000201-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001413329-23-000201-xbrl.zip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ṣ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b]&^/ZF M]24K'^H,JHH\&B66; DLD4LA$?0PUM-K8C#N0MM'.K;?%7V7Q^]7UL'9V?#3K; MD-)GFP)VP&CT>B5@+D+6A/+!9=TPKL9Y=06[J.8["\4]W/41>PRAF,(U@C=% MJM%80+!HU$/TR:)7?;\WA00B,8RJW=X4C&H!3$IBJ8I *WS?3C=BE_NP+&J, MO>6>VJT2ZZD4LU4/ 7]::>\2J*T#8N" &#@@!@Z(@0-BX)#K.B &7OZV'A # M^[MW!\3 WFW9 3&01PQP_5*[4_<$[TZ4;VG\+[[!2 M+P,O\*BKOBLH@3J2#20;ZPS>QA,A_W;A?[-#FPHSD)F0(UKR=[-DZ+G11":M M-"ED MXW!>C.>>[1AQT,9ZXZUDL,^V#CAH8[EQ[[0\2[U,'3$16"KIT-U9QS;SV[D8 METO3$!0/31!L8OLC^#V%6;]N56+UD?Q9K4I@#Z6S2];)=4\.I;.U M&,NA=/90.EN/2:U?.MLZJ:B=;=7O8F6)%#[9K93$Q82^9TLX71P,$5>"[,U. M,H)+%>PTY'WP$*;G>8JZG-C. \\+'N@Q\.V[ "7W3>4NR[0<6BR#K$VR]:6@ M)RY%QOR(VKR1D&,\K[^ S1!/#,KF-SM*1=.&HJ4;@4EB1_#,60B6=^@B+S98 M-'=@](@P(FWC^G\FRIL)A34, _2'T* Q7"%M(D46.E&^-11@&A$:TU9=*T)K MEH2S($2ID3\:ES^C:>DH??0##TB""@ACH%I?L$SI*=#H;-0K\/Y[F$R01/@! M$C+\9@@;!';L'*%1(R\A:?;%'0@4M+1A0,8"_:U)"@C MLY3Y!8N$^*87"OU N4HPH+&Y1@4H=L .CPG%1BGQ1S1,_">"$CD?SX]K6N^Q M^P&^-;3=B)N^F&/AM\&DW)$;6SC#>U[O=!EQ2H+%R9TV8/JC;[P^O.#JW]H% M94<+AAP MN _XAVV!^S_D.$=D**T)*RVI)N0EH$(>293SK>BHA7BLQ138?X3#\^,UQZXRB=FF.;J\P@=WP\7+" 8GK']>6DT MI@<>50G>D07MT6L&](K3N=_F!CT^D?G7?:93C<"Y!(L(;<)PSS='.K M#AY1L<\2C)*;1CQAB*V-#?'LZ+QT(2_!)Q)/&&%[8R,<8!"T;(C$P4:NVPR. M8?2$P78V-=C.2<6.<][F"4/L;FR(K=(ALH\["F(/_[+^.'L;&V>[8BG10K(1 M[4J-:];6K1L[0IT.**,2W1HE(W63!WZ%5=!^B^M^N(OWX"[>F$+K=(_.BS4D MN:LXX]61 R>J7;B-G8G-Z<%>Z1R7.A)+V?WEPO_$&/QS'Y%;KK=#[W3$+J@R M^<'@DC8".MH.5N>X0\R&#,&IMBCBP2D.>Z:[4=6I:19-;V$T)M= :TM@^A54 M5>OMQI,V>QE#DSMUB8)W&8#;^55& MA%8T$Y1<8",CRT_TW!Q_-W7]()11,QE+9^6I0G927G3D+:8T*7V^*A:X=IAO5U&^JEA=**9! M+'RA@L,8>EX4!(1%^&^"/T%^:0?&'7/YL[Q\8+"> '4P@=%&JBGA*S0@O'DC M1P0>(5"#FI4.8_A187)()8"#Q G-+3!M8.'=&>5 7)^79P@C'U--XC@,INP- M%H7@]?<:85S;!MR%855/E7 +?!$X9XMK$A#JKC%)_A'@F?%./;6"BR>W)T7L+%LC&7;&/Q ME&ZK_#@NYY-9>VTND%^F9+6/C[Y.#5M?K^HJ!&(MOO/3R:FR[6GY% M,<&3<1&#C>J#$?8SXTRHV0E?M?=-ZR9(_K:MRS#YV_H8@Y T+!&#NP/_5>U( MJ+*%4>$-ZSH(P:R\ &\H!/OSJQM8/X-O 3:J$U@W":2QT!9KH#+I3I.)"C$.5<3V1=8N!JQ$UF MD"^/3"%V.56J^%CA@1RP^Z6M;XW0 4,&,/ ]0FLN;/1[9O9<.;7HPRD;F@B' M,F\8)^CPUTQ1?\K M/?._P&M22A/C@0W^1T.OR4ZA6.J AV#XM*BPY>0,CWB-SK/ZYLR&;TK;\7-" M6Y&W$,\>+]^X(1/Q&I[UU1Q?= W/"[+T0["HHS=.$J+^,&Q')!S2[H(',M4VRJ8E%K*4@$C=)*/@.)5UQJ#2I]/Q!,,_&0(7[:\ZAWT/3.352]'G M_[+]8)/J/'U>@_Y>,V4^9X=U0.K\=(_5>>L9U'FW?NI\V6D_39WWGEN=YXO6 M:JBY]U5QQQ,W?(%Z^^< =-4F%;?QP ;_HU:J6S:=9?7-E/6/F>.YZI]%=9K? M7]UD*[Y5MUDJZ)N,M=4M*Z60H6A7R]#8*>9E5JX/.UG M<'GZ]7-YEIWVTUR>TRVY/&"%?Q##,$'X5_ND);L,L7N2(ZU..3TF-@+R8DX) MN"HYKGTF&#U2_<1BAJ6AU#@HG"NW15A)E.&>9W,0;AYX':R;2=P\3<@3..;O M(?<(89C(49O8\",^T!B7??+RG*$O@@7MU7+X!Z1;R!/ZI[S?\[@/H-JH* M3Z93PHNS@C?">;;!D#;/W73J"2_WHG/'+_*>NTO\3<;\TN"2ENR.3-]CY74 S^*Q" MI1*->^5'X/[ZL($WSMSZCHFZ3I=]E022KOBUGH>E:K2^C( M;H'P,U7@M/:^!>]-QO8(-4 8%;2WH;Y9-45LWAA2#EIG1,?)W/.)_;<=.I%! MH=. -X7?A&1*FP=)/,&J)8?.V5TH'!?5#M6%V=_(6'+#E$AM"H.%AX;3<<*5 M@]S%%!2&1#VZD2=2 JB(>_X-4#S<^LL<$ MD+?1&+U+/#LT&\1:1 C\^,'@:QY67Y[VE M6UV:Z_BBAGFBNGUY]E548<%>B M;!3*+\X6E%\LNNX^$[O3E_$U/S=:F?JYUSXZ[S3@?BT6;,BQ1AP[BZ;(^C<2 M\(=!@-RPHO\F2(P;E?R*"N*ROX9C"[/ *XCYD[&D#BVR#BXR'/*VW!KSGI*M M8^6A5.H68VU(% 0[.D?GY3/L#]/\7+0G[H/=GJ@)!LR+#5VVI25JIKZ6,=<;;W %%D5:%+(MHTQ*C]P24>T86"( M@-B^ ;7$TI/DLJT9^.&J/HMO2E6UC+2:9, H7ZE0 ML<[4FZC_=%4_[B)7B+&NQR.!QD+L4NDQ5<$G'KIHVIJP93$X';CGXPPH)=2D M8O= %5=K2H RODLDPVP68JJ/5[UCPVM<#'I-B9?&_)J+*N/+BMZS5>Y:':4D ME?AX)A*H8J=SYLY*6S=7%ALGETSL0G$W2G-PE$*X=',,Y]E.0@V\N6U%,H-$V:%[CW8R M>BU(5X.7F8RHR3L/&[QXDH&&B2>46@G);&AH.Y>O%%0_\&V.4S2R/S2M QEG MU;]#YSB>/Y\=D+7P&RK,PBQ"TDC)&@H;H+XIW/MZ\8:VST0\.B#0,"PU7&5) M*&96NZ(;$\EP#?7-B2@0!(][0,^6,W4>!9PE\,'%'B@ MIN U@0YA^B=)J<-!!1"JH@"YOC9O#G8#+/S:/,$;(^#ME3*QJ*T;D0J3@UMX MF=%I^UWXXN\$;(TGW,F;,XC.MLJ.VM\8.VJOE,8EO7+7(H+<^S-TY:=74$8, M33FK6_*:*1V4]W2IX^"H.W^+\&\7412,7'E;O9*N]8>??K^X_$VZUJ]5QAJ3 M&SK0"]^#_0>3')Z;'C-5[:I_XEN?7-^E%#!\D*/##9:9RR!5OL@W,;$5O7[N M"3?)#.G+.%5>ATPX)5-D&GQ@I,')\T+T!AX\V>Q.IT0:UC#)82LC*VVW:.,7 M,5 ^@^LL@<^C=<&!5NI+UZ#?C^2HVQJ1D=C-OPSV<2$0_W2$,'G M\F]SEI;:[1'HMK\%VTM9:2(0:!H12FDAB?6.TT;*YE-L=QC,Q!24?.@/>?N. MX]G\9#OZ%AD((/@,+7?^9?!SX<.!EUR,\ '.A4@KCU?.2)IQ?$)RVQ6H)GDM M4*,XCLN1CYQ@P+#*1D57A>^277,?>/=&.EJ^XU!HM:#0JGTHM*K%6 Z%5H=" MJWI,Z@F%5NV*0JM.31O4:2P>V@F>%XR8*78F0MP!4'KR,G9UA@7O+\J:2.)6 MG6S!VS!"\E>$/-K6F#H !XAGTTBT/,HG"VBK K*1M2++BZ5=]1@ZEV)(*EF) MHT ;C;_%%[S9G9A_-!4BCF1!.A@HD\##4 1EAF2D)D1VVY!EF,;T7HQ43KS5 M-@>%WXL5Y*S0W=KX 9&P58!$9]Z(PAZI3<>5\M*R*U3N%#OV,G^72NPK]J[- MN6//[]"7?8^K-B"/F+%+X MR>T$3&#J_7+T_N;JZ+5*2W(/9M=\ B.?5&Z4;F*%/AW.<\+4L+*7UROU'HUA MAA=>?]*O/P(/$=-XL)+!-$(&<5?&]\1?(Q<9H>V_1!;WZ$[11X@8M!+GF@)1 MT%/!*6>$."5@RS'6U7 K:N70M*B#=:LO.PNQ=WX=!I$88=\ZZ:^-)G9(4*/J M1O2541?MOQ4C0U4YCB0ZOK/M61YMI !&*?=>$4?K)],'L/3!9RH+S/1/CLXC M<2_\8G &'R2;J(\8O6H)4 +!7(B:517M%)C SM)A0?3+W]G^W;?@FW49PLGV M%>TG*PJ-D#3.NH[P&!D5 _7Y9^ B;IH^I>M$73+;\53!R8!R1(2V"P?L0)D6RG /L^(\&7?DV\N8;95DH#'Y0". T/]M([. MSTZ:)7VSP&KR<-BOLC/[W\II)9%3GVDA4V*SV%%/S>HU7#EIU<%I(ST+%!'B MV!V<1G7_V8@+NJ5BC ?\1\-ZF+@C. H!G#,Q)F2>FT%9XD/Q/HJQ"H2P> 1G M81,5,9\LV6.21#J1>@A@A'H.Y_%T;L] #R)4VSB\C'Q6#\$W5)PUR8S%-=^$ MX]6G^5).\W?;DT[1Q5TH= (./_)'$,*@;JD%QY?PSO;=OU.X(1UZSW[(&N:Y MG&GY;5,TON M$M>+R6\PU:(.YG,%OJM2J;A_$N7VL'D)&]FNXXL MW?0%C0N\ '7%NKI-#0F[!%W"*&,=!Q_I -'(#! -;8]4230A_YLZ/=&AOZ>( M_73&VM07,9ZW">HQF!N/%^MV92T<][Z6-_N"UT4Z"L4@0WCB&)LL:\H_?8_+ MJ36M=P&F)(K>P2+G E2"Q'?+0VGLX ^1UDI\)=@Y##UAKAVEB>F#:A%U'9FL M56XI3%/9<^SQV VG0N\:0\>K5,9$E F() MP;-'V!,JEM6/"_33E^P1FV"F5%9?2K"W/ NR<#.3 38C'SRHXM&D)WI14#BC M>7)/J6+Y]"ZM8;522(TS?5;D1=Q,K2[74+V4%:5XJ>W/M4Z=HJ54B,/@-HF_ M%"TI?IY>@+HVC%,U3AOQDM%+%"2[N>(-73?$99K!3PE67?E. $?9M:O"5"<8 MINHTS2@5U\JCE;]*E"KO=>.)E6$>NKE5?$?=9VNY\L9#]?.>Y,3ORHNG39"UZZ&VD8Z>9LZ,Z.;&@$T0VVYZEW=G29GQV=][HET+34ACXX MZAMWU!L[]=1M_A%=<8=41 ?;B6"!ZYYXY-T='3O$@W:*K0=$V,Y2P?#M>6BZH("T%@@Q &B5^A.T1= MW@%,!!/E9$4J1U8P2%T-BX<$>SP:P4.RMV-N)-0Y\?1M1HR6]W<7N;O/Y.WF M!?JQ9VU=IK?K $?1(P[P0N3KNB[Q]X>8[1P0L[48RP$Q>T#,UF-23T#,=BH0 ML]V:(F;QMKU!2C+%BO8NL$.R5"]P!4@@K_QH)L-2JGKJW<65*IW*ABMIW4QB M0/E8(PJE$M#Z8E5U'1J]2U'.AXD@>Q\#H#[Q;DS1_24CVYZ 2ZUN8@V4HPAD M#UV&4-A,JZ*-.0W#Y;@;7JORK;K>I&&4 V?IP-*J$#Z-T$"X2[/K)Z) M,*12J9+ 1>8+,!PF+N%ZF7PB7:+^\%,V?"L(V1NA1PII5+JA7'6*)2C#(>4< MDV%BUS%BCC,!*H=PM^E[95&0"EB"PZA,E[$^Q 1S;EAJ#=A[R[K&__KZ1[7/ M_RU\*'K'&3:SXX'A'2O_]T,0DF>L_.+/5*$%CC)A93^"9^==$;73RF'$4R3Q M/-U:*KY7&<[8TM1,[Y_:HY90M2GOGR"M' ]@N=59Z(7(SV@E[Y97R+XP#1^4W=KQ?1 M5QS_NSF%\"D7B6)0H,W&**@>2CW+BR03E9/15QIH6S8&A6IDIP!# MHB<[$8-T:4:*CC&Z! [-"(SE&.Q6HAD'"1ZB V^VJ2!MX'.,?V6=\-3#/UCU M\%^P>?V; <$H/R9KJH$!IH&WI04&JVJ!;KDVVM2[R6@EZB M<$A]RU)54;B!6D]2"8M?O(Q&J-UYQ."-^&\B6P.XF6;T&2,%7W7]Z8H(O$)' MLGOXQ]("$<>H+CG$CI]?24![)R>5 JHD\CH4<#5=T@LD1^UM4"*F7\8_$>:) M[K'5!;.UV(7"!6)R=Z;WB5PK21M9[ESE@I,Y1!>^D>&!Z MZ>_A:..@_A.$WQJ6I,6AH!/LVE!,;&],CD(")\".9-.<1Q0 1%*2FC/82U1X6K ML[C#)$(?%G2*=/)@((U,J,Y7^ "*^(4!17%)!\E0J*;KL20-@F0[5G>M&\IN M"-IO'($T$?E@%">.*[]BCNH:'HVCMEKJV7Q5JJWA'@D5?(QF!-;LAI/!/9G, M!!G'%8D.Q/+:1'4J<.&$V6%F.PU-S#EG>4@6RK_U"L4.;\UZ::E+E_%.SQIBZ^?D? "UOA:^'XT]^YM MW[6M2SN<408GDI*!OR;;Y@/FQ5=Z 0[T9]<;3>"#\2I?W:6.?%^3(>QB;$^\?=F&!JMF;/!+'+QE)]N$39ZN=!_FU<"O:%=CY@>NC?O Z,. M]!R\*L7429,^;0GL)-QIL40+E6-HOQ@T*=V&$=;(=BQ)+R)U *>!HG(TFZ$T MU. 4Z1YBG@)?]R0PJ>_X.2/F-2;E"N_ O4QW%A97N8-O MV8>53WD@D\1WV6TTXELM-;@OF1_KP14'!E8%:'U'."F;CDDSK59BW=WYH=P: MR ROQ:2JK84B_(.>/%M'**[&='XHF49.RC,$T12XRV/)-&CNM^9-,W6U+_BW MV@!F1_C2#4>);&S*!(2-4J:.RX<$[38D0XIEL8GG:82 K#,15*0" GH7 MA*2;7K"[ET<)@]GMN:1C'R./2J$'MP;T8 I;/R*"4,+@@\F,-3)LS1AZLW8W MZ<45W"V@!,2=.[)^ 1. 1VG>FWC'7G@8?[(N/9?,,VXT!G[DQ\M:W*Y2ZZM4 M%C'QJKBM_.%/=A3G3>;?7>SFBWUP'XB6FY5%-3O3M6J&=].\8 C&]WGTNMA8QS80(VA620Y<":C6"U*\ B)M&N<6 M@JP'>)LE,'^)Y4<()18V5;V12TQW7GKQ\MU!5PI61''K1QW3-8)Q]^2 6F"K MW D5787Q7V'G59O;*GX5K$SP'GDO.Y?Q)& %WO_X]?V167$LW?U%.\V*R(H? M HV\9P>5-%64J7%-U[9!)@(-)/,F7!8:.,B 8BC[Z2]PEADJ3QNA)$*^V^BE M$#5D,-)XM/HTR!2BI8[A \>.P&*FS+FJ^,XP8!01HZ5"$MHXXA>K\)'LK&< M/-\T@,R)P9F9$\4R7SB0DE=Q&%+#B4SBG<; ,'C%F6@A\7) +3ZE+,AC1'-7 M' H]XU08=N @/VFCY.+#>RW::"<':;U\)'%_GOQ5@.DWH"'+Y; 8?OU10.K^ZHVQ+,3F3"U[]*OVN,?B'"/.1( LV M<55;1UC_A H?\6'4^RO$,GSLIYVWA_*>1X1=14:"$TK8)@LK_6@-X>4? HSW MJ<1[QF25MB0C&QOFT@_%R)X*R92 ;D3.D%-NF;(699#/M(#!N%H87(IT=.F# M])]U>*E@,O+K.!B66INW+).YK]-C\3JSYVHHR?>6_BFX?>'OX(SN\2YC1P3?<]Q]R9;!="/&(-KK,]:?;>8RMH5)%W ;6E#N8V4;'X MUD5R!U:1A5T96&-^T1K-;'"H" =8Z])(TM1)<0RX""KR(06[^'8=\-3;!8^D M:RR_6VD8KC@DLEZ%;/8@E9M'X;B43\M""*G5ZZ+G#J-3PY<=+N0P^/T9\\5& M] K8C#!NBU!$ZPLA MF>A&4:T_A6/8)$J72TTYXW^:.3WYKLC]JS18F3LO\*AA0+G@;)9:EV6VE';% MJ9AA)Y8"D^\C=\[4V]DIGBO;3=V<#77L9(6+EW(?"D?-3PLM/ZQX=I8:F(&" M765\)D5E<6C\=<;=XAVGFMR9"4I%?J(N1QHJV*Z)%T?K"G'&J$+M179X'DEL ME"N<+C*;5#@]7:\H 3.&@ ]L4E&(&,9=("#ASL-R"T7%!KHKB(5^ YMOE8,E MBQ2.#;XU[3E(:WES??N% [R(:V:_@HYEJZ;:Y?D:FN[O:(J9+1UH" MEL^L_E""E3O,[NJ2:BR9*9#XX\[@[0(C:YD$7X&!);^06,'"RFE#UP<)AY0=4-^&'[)-T#-#=(@*62K=:Q M:TR*%,A;/NZ&&Z6&:K@Z\KR^\+ZTN=1HB06XMUB SR[2K/K84C.B>QS%0.7X M$&?WR?IY.OQ% R)WVM7>R#KK/?A9@!OB+\C?\_ IN\>&CSP07\4=!WLO%6+@ M$W9!GS3D(^?%K/.VT_/ZQ69E6@:>Q%I%N?I2J%0S6<'ZK^+"REE1>@$OC!A9 M-DQE8!/!:P7U@9="9C:@=()1YB=<0H=6FCP(,N#P4Q(&,^2;]L=9FO>RU5F=$C.A.W)?'!%^:F MO,I_J;$J7196M0!>5 M<5397WI2J,]6X5[@@ILHE?%-V5I]TIV8\3/^TI[.W MUJT837R8Q!T<)/R/;\.<9TWUAFPZCMX!OP^;B,*7*EN[&9^0]ZY!GT)M6:&G M,U"2Q?K:["P-+Z,'5ZKLB9 5+(P/Q$A;9%#>&, "K$HO9N-_ZQ[1Z@Y7T3D MLO%WN(I2'@Q:KK3'YX(3J&S04!IV6FOFKI#"%%3@=89+B: :XDU:=H%E;'K] MR5\IFUK'3?/TL46X=VC8V67#+J+3N7(I%2T5Y5-!'%QU#LRSNT[*WZU9ZCVI'F^ MVTNB7NM)*[;+!6DV2KT3VC$,G57[)_01M:>R!)*3VL>HX*F )P[=(3'12GUP M&WR;![G"H.=W5VCD%.%(/86.F4&U5^Z\2)K^ WAN$7BN M=P#/U6(L!_#< 3Q7CTD] 3S7JP#/]>L*GI,^2IKW\H.,.?B6PC>E?0F0I$>Q ML^>AZR4)92-9I[/(1B&K3 /S\T-Q)_$:E.TG8)%*!O('.;"5OPCKVI9YY(-+\H^,;X?)/Y(&-@%/?D' MZKTS1-,"E6#*68 979A7CKNGZ+CLG7>2R# M7!R^TC-I?FU^+(M/J4P)?V!)JUV'KS[:E*A[ER!'E4!4VJ5[[WJ4DD .ZL6F MO!F]8#IES!JP>&T_!".7AH(PNA@NGZ98-A!C5X1BFIF"Q J>-)F9S-1BRRR" MS%64MMXP/_]X4,C,W*NL.%0Z M_]$\4=/:?\6K>XJU#EK7X(<'60G@,Q]CI[GU62U5PZ#9,A5[D0 ;P;K$;I)8 MC)F+7#Q+Z*(T;(_MY U.Q.TL77NY]/8N]TV""U-8&BZA;!.03=D6T4+,[>AI M-'PIC(I4D80,EA8?RYZ&!-)Y6ZS$+3'9-1UFFK8V54+B1\D(FQN-$Z0%"$-9 M3BI3Q-*(+9NCJ4DU%R?'X'7@WNP/EK:G*E4T61M< FD[3>LB;:-F6.[9)R^; M("@SM+MPL%Z RL=4CZH?SF*G)#R7-_(7^%9ZF?Z*HV8X[$_^G6['^P?51!F M7O/B6(B%P6]74H2\NJ)&R104>*V_HK)D193$;_^BY%VDH.LX$(T4D#'/IFZA MV2A#BE/!=NJ,S:43A@P_5)(4Y%YKTBH9B*0< MYQ$>Q%!4445)>BCXWO3[((B"Y<3EH((?.%J!=\^Q+..:]C2++GS4C8P;F_MH M@O>(6I [0&%!@Z)*;5I_@!)EGT^R7QO0^DRX#8: H3:"\68XM9T OH/G7/S% M@4*UYXD74R58YLF,Q4L';#*<8K-';%0%#V6^(J MO<#3BJ9H&$2ZIB#2SV#/88T4O*_$DMNG15AX['X#2]]+8ZH:*?^)"M+O M7] M3/W[B#O9P$"QZRFLTU2 _G*H6UL$JU5&]*SM,^M=\_>F)G2[_G3U[G=%Z88= M89!6/DW6,]NBCKB<*CY#/3(LV%,%9L0L95/:A")_I"-T2_BT;SR<9\?-MJ5[ MA;^00[HTOZ];RFO:.6(MD]J\[%'T1H=;^\H'"5DZ>7GQOKHUQ<@NJ1-M5[B"K5XAB8ZW3SB,%HD]I/O',\^EB6_=6-7^_ZKQ >GML M17 0036_QIU2\M4@?M9D1@7>+G4>/^:[_?++[U?OCUL#,'E&(^S:ZX 1X 4S M#9[5Q)ADK49(>44>[$T,MPGQUZ'Y+^NT4$O'H;1[D3("7O7O1 S%R"(*YVD& MSPE_X^+S5T>2E)(?RL^,@SMNGJ@EWG@QF[[J\/&:*]$VR^-:61Q)V8E@'2!9 MTQX_0.BU^4[F*'&O9&R)P*TI]"6?.<+:NRD[;>L>K,YS"F(/VPQN]5P]ZW3Z M,)UB [?L=)8X6WEB59)/SCS(8KKL)12*D7#OA>[&3D<++)6)=JR7%QNJV)!, M9S+;FSDDV02&UO>R]:;B1\->[!R6BO!K,JN3]E#A1NV4;\AW*5I=8KN56_Q5 M2(_YRU@;+%^&GK0Z5]_?4VQCM]U[X/DF M$"ZQW8#:?WB]WS;R8K 1VF@DW)_@7DJ&;C1QK5LX54-L@&+#?L -@=T_)+>C MO 8^W5Y?:E6OW3H5.)"GKN*N4!C]QZX2##_=L9@$W&!$J0L=A@Z,;:.SS(0# M:!M:?P:N?%F$G=>PRLB.P%Q]I6^RXY_UT]-K\I9&9OS*,/I"02W)9*_&U 34 MU"]EZFCF)9%F-@(W,9W& 7&Y"''9/R N:S&6 ^+R@+BLQZ2>@+CL5R N3VN* MN$2>(MH_!US4@#VPHU)S17F;HQ0G&,VP%04>Q-0%C>**&Y2\2?,>?46FKQUQ M2'LTP0 XL[2!]30#:VSLCM#-AMLL\'68U9*^B+Q![]+@&J>>5>0RGH1!3IT36W%C*HSPE$DQ M[=A$B>@V2+']3?A,[(<'B!9")P,PFZ^W0LY9YD8XGJ28_^&P/+A8(SXKU1DJ MZ\+'0#^^F0^C+S1H]_YD++QO3NGD&%GK#--2F9L@=9YC:CS)F/6-.I.I[N*)+F)V#HT(J?GO"4)986F3)HR5FM5I-%1'ZG!# )159 M(D$C!E-L;ON>FT8FH;B%C[_S@M$W(P(R*-HU\$-\'-R']@P7/4P$0GVH(S U MRWVC(B9R*.?/@XTKS\A5G2(YB[+)M8_.*6-7T"X9^5GPW';YDZ$71$X8AEEEL#ZRH1JH M#) RQ,>5O:C!9,Z.;/G!G 9VVLP#PZAX,5*PI:$5D+H8$9\H#2C/99Y=C!C1 M,W7':=?/E!6,M ^327@/;8](H:.)$ CI>KE&F+D8*6,U[DO(7!/2S/B4IAE%>^\H0KY_@I_-1W@S';2>OO'Y28]1:["N,DTEO M$[#[OFB;08=U\5"J(SHX.3IO]YK%K,H_:%8K#K73W>I86T?GG4ZSF#+Y1T.9 MBO!L)-9XN>*)#E]1+$NELDH(N;4FN6^9H[;44AVK1ZX/M,59(SP1,_%+(;#YK6Y'7H-H9?$W )<_5*UJL5\QV]\GQ'X2;_Z:\9 M:K%WPA=C=_74W*!=GL)7*>_7JN4HS]K%5<"H=Y1$,]FBUR P5#-W@H1<8EC$ M&/O]ND+#V=1'[ 1<7]DI.F7#/-,;EZNN5&^0L8K(;/WL4O\O)WH+.^IR#@;[ M3#J<%\*!_ %WD?8M?A&V%T]&&$&X"P*'D%$H%\CFSM#%4&;FX'$H(EFI0%^= MI!!E &&I@I+R(+J^Q%V-YA8A6*D3 V%TY>WE!;9?$*6;!_"$(HQ=Q!@A&?TW M<27)OH15$1Z9F :=:O!%J^QW9^"WQF, ME[-0'.,^%-9\&MS+N8\3C\B@QF 5K+=B!*ADZT&MO!VEKZ(@A4P&VP[J2264 MY%DM]2YJ6\^AB.@'ZQ7F!D=N_%H"I+YCS;ZD?5&MV>NKU/O/=+*ZCREU+GS\ MOO1:[^3TF9:_AS"R8M\$O?PO.+*[3:>BO993T3G9JJ6.T*:39G]#7D5OJV,] M11A6\^3@53S%JVBS5U%^\X#Q2$4OF)I26FKJ_D7&K_T7JCPSFD(B0JVO0H5A M6O:^4L;WS$-;FL,?JZG#=JZE#"@PA#'!W_)B1Y4]&U"+9V#O%87/L/>,J!&E M(5:^P8E\]AZ[W1AF&5T9C#J/!-QD_$VJ$L6BM4]7*RY<5J$\P[H-\#I9<)L@ M"W2HNZ0Y(L8T+_5:LCA.W&W6K6Y>;MNUA'8=6S_Q!IFH?SPCN>@OMC0+M&6Y#(/10Z@NN)=USLYV^)E!S.FB[E7 M78) 4O]L60#?M&X00SO&(NTXY:E"PE[4W9*A2N4'N(:O+&'!%<6P/' )R'YT M^ $)5(P6*D(AVJ?M[A;34B]3E[3:4I?09J&P8*I?_&5S(H?E+1/OLT/9.!14 M21!ZCF+T3WD3. 7-S["5761;?#KQ0L^6"Q,ZB/H:C66G'/08$P9G4X-QF>=6 MK#X!W,C:Z$-=%X&R:PT8>^!CUSR^5<9L-@V>ZA?5_:>V?C-80[[CO M((X,N^I>WUJ_V/Z?]MQ&DGO']FSKQI[. H1C6K?#;]:KHU\^W2#B3=>+V"RR M6%@;J>H/ JX12!M?4WF!N$[Q]FAE(ZJ9532"#EK8+^@U%_1ZX;R;WY*^ODA/ MT'(V9,N\8KJPX96]'.-0UC7H9?.M,)FY]N1I51NMZNJ]++N&/"5#D2 )D)DE',V)9: MHZ!Z3O'AJ() QD$:81@N*\BB$)8RQ[2H\5E(P)W M\4OCX+8MFQ&+2=[;'J M31E$X//#/R7#CB?BV*S_0_$/)'N0V<%7]=^5!X%&R:P6:*7P)!65_$S%A"CJ+#3HF$&".S"CJK[)FD::BJY)/!?%)E M.[S@],Z5=,DKRA_0?I"K0DUS6FT53%?X#8I=I!9?Q+$D8K%6,0*NGV#B&7;[ M9#3#]2DW.0KN?,I.XK.&'%3%;DX!TF,S;(2CBZH\4G+N2A,(.S'Y.NZE$/=Z M'O)=(T3&QQCDFB(3)9'VP,SA2_E6< L-&@/N.5B$]GP:5AD[M=<=J]Q>%:O\ M7@SC13#E[DE)^17\L RF[,"SA(,(H$J8\D+M*A];]K9V);X7-GP'%$7EY_8& M/*CX&(-GUCNX_XEZ$]=B$WIJI5V]D8287\8TI%L8$6YTV?:>YO>QEAKQ8KVK MRKP3HW1SAGISZ-L:WXREYJ0!I48+)6^R'[D1?D!628T5K>I26ZO-'.KAG'I3 MZ$4>P_IY]BP2;]1?WCIN-//L^1O7IU6@+[V5\BY=,'0Z8*@QLMC(E]#[^-?2 M'QD,FMU6#UV2.(3_=]2+I;?2)&_EQ]@I_J[;:@[.SBI_?=)L5?YNT6-!-_5. M^VL]=O'O>IW>8;#[-=C!4H_]D227I1?.!QXUR@II?]W!C,V;$ZM%=X!ZGO[H MH/#1]NPO_/#;PO',GR<^2EM7=H5+GH((11R>UC/Y*7X'JZ%[J"FUGEF,1V1$ MJEDJ!)K%%KD;EAKS@G7PQ+B@8W>Z"J_ +)?1U.CU$N*P[L1#?&>M9L[A:NM+ M$H.+2(2VFYI^Y5%YD:LQ:%?EM[>V4?C;%3=LD:)] MTG@J-7E[@WJL]&3ND816X/NR0EK ]V5B57_0BX0C+Y,K&9/!.Z4'H^0=2Q[>;2Q/K/(B+#B"2V7Q:W>#[E7KG4%O$!9J=+RBZM\GZ;E M.V" E)3X'F1H3V6H5-\\PB.QK+[I@KX9/-DQ/D?GIT\/ M;FQ0AM8-Y=JIL^UGV5I(X-+H=I[L71Q$J2ZB5*6J%E-S M/,UB'& <8M]KLXNSI22XCJGJ& M.Z&--#N-5O?)YWFCF_A,\8?-*X#O^>T'Y7=0?AM4?H-G4'ZMH_->H]^IZM1\ M4'[[HG[(!/R12MK,NEZS3E17UNY+K?;/[KW@6FRD?=-$UIZXLST+B6$T(0Q\ MQ@T-"EC9J06;; =3=P0?OG?#@#I*1=QKJK0@D5AMACIO;-G#X)XJJ:U[9(^) M4H(W;\Y$6(X]IW:$]EQU&_3C<,X\._378BG]?NW!;8:45-&)+Z[\;&"7&^Z M(PG1K*D=?B,J>[/\LV'R+\(RAR'QX].;5ERWNI0I?PS\.UX.]"R+1:P;+T+& MUUSY41PF)-PE9WA.LHE]4<[PY>L/G+DD&\Z)Y MPB;&JC7)O;/FX.QT\\6H9\U.M[N5RMGJESYAL/W.1BMGZV6C;Z;PL:[%K>6V M]G9*??=U-9Y6ZKNKZC'YB&/\?,H_@PUI_?C-\5;Y299.7_L!F3(K1Z@S[MW5 MYP]E]#'IS6Y&I8D+S+D6(IVY^C\I'EVNB'^Z/;)EH?;/3KO-SNE MPWU5;JRO/(5,NX#>\A-XGX0@A-?$DE4^^!XADSM%COM_O&YP_S'9M[A]TNT> M2@\/11U+)D7;CW0R0W=#I;$N?.?2GJ&G\A&[3GQ)FR-?J4YSE^R-?;+C9$TZ MVG;_Z!RNT],24:\?#/]0D'4XNSL\NX^4#3__V:7N28W>H-CKJ:9G][FK6'8A M4Q_R'>J,KO9OEO!8UL<6[_(9SXUQK?(I6F?U<2I^2L)@76^BW=VR>7Z&WD2K MO2EOHK?EX0ZP64#Y<#?E3?2WY4UT3H[.6^"YE33Z+G@3G<$3BMM>(!RL]")^ M! '][!=QIW5T?M8XZ=<)0G: (6Y>[AY!+SV_W+51[EJM3=E_^VCB[8,AQRJ)6LM6(6>N,\@6#VPMD^?3%VVQR64^W"KD'NYH-9RV6++QJ8\ MJ$Y[:Y=4'_,Q[7[))57PH-KY!E8'2[:X4W4+979.$;=Z.G@R;O7@0=5:[A[A M-'M^N3M#N3OKU:F \.!!E7E0?']]"P/?7C>FVMERD+(S0%>J4\)?LE9,M=/? M[G"[)\@">MHO.A ;BZEV3K=E$72Q07FSTULFIMI^2DSU>W$SMA[;*BK?+K*+ M=9[,_U=C__5I6GO?1>J1>J>MB%0'/-=N$O 9BO*U@P!8%_&?_2?S7AZ3YV136,L:4(T\7OE; M:[#69:9&$0O(LL5E:Q'1/;9"2X%$]_MP;=^=6#'0TST%C=YK]/I/SI6ONKO/ M6_R^!2;\@S@_2MWP_.)\AAFZ1O=L;\3Y>R!!_2BB2%?(SX*0Y&HS=\KW89-M MYMJ0QVOU0S5 YJA^;U/-4@YV?RUE;".Z?%T9ZQ$[6;]5)]]R=VR#.U7J9TN) MUBYYDUY:]=B!&6R;U][JN@C[+[4;@]:F4C#?.5O802DLVS1[-&K?:"K%%K8=H(I4@2@-$F&\Q@2 )6Q@W6ELFF MW#?/MY(S&RPQ]\6S@.%:'"T1)MV7R>0'DI(,(]=Q[= EYKG(>A">A__]WTW> MO1]$LQV]5/5@:NV"F0F*9N(_VRUL3^B(C8T]N[1>:_*1%!C M=WUKS&^S/'P=[= Z1&\IYZ.'7(MY@ M*JJ3]"OV$)12$E=_I< 4M2-NO>Y9;G6,/R=A"O*[$\?#4-C?CNTQ#/:-[3W8 M\^CHQVS71]=7#^^?4AH[/_O*.8['6YLC:W\0UB"D_7X#]XT(I5JT:S,6:Q+B M"?T?%Z[1<6_<&IV>M%M=NR\&[7%;G+7.>JVS\;C7ZOZ_TZ/S6R(6#,;6)1YN M/X[^SX_V4D2B.Y6UZPEHDYGU*0A#-[((U^'3,M@>JNXF'?(;0T77?D:?$56* M0$W8!T?X2'@*?R-[A,HH6)NZ,#^"5TYYJVH^J5>_^7;BN##^/-3D28R857?W M2?^XC)T4?MRI*1]IE@\W3X<;)'$4@R1CBC@;Q6]8#Q-W-+% ^),8CL+?("$@ M*P*)A(/0GI9135^43 MX+GVO>UZI"Q 2&&4]"(WBA*\=HG)E_A0']QX8D4NK)4=6O@V?GHHIK;KXRNG M.N_4M!3<:TF>V@^P4K_C0EU$D8@C\#N470%/^P07/TS8^>)_%3AJ>!=\X'/@ MA^J?[^S(C4C?E?#:]GHEDM/K%7EMJREDF0JZL)T_+-Y(\9?,RS&1-*PJ'6Z0 M:]BEK%4#NPX&)OP?<\Q&;V !\_[$IBAG%WZOZ@#2>NT16>WI:;/5ZF^<_[5] MTNR?+4U66Q(V4DL#&RM6_^26.&4W[ZGF7;4\KRSQ")?3RI8#%O>53G4MM;9*!7??L1%:=*KP38? MJ5W- LZUP;)ZV .9,?L-L .WS:ZWQ>S'=C74@LCNBU!$[66@.LLN0NVA%&L< MQ4?*>3=V%$^/SON-3DDAR.*3N()\UNO,Z81%,5Z_3*#A>:W_P:!YUNNL8_RW M6\U6;_,M)4"=G"W7^V&EP7:;9ZW>%@;;.UOOFPO=JN999]U^'(M^=]9>;[L6 M]NKH-;M;:"RR'2EH]9O=T\XJC45RV8@.008VUJSB\-%U/_J(QF%IG#0O1 5:[N1V6B77:D]):W"33*7:RA0G=N+J9K74QHFZUF-*\#N!) MV%9WRP-?.$R=AKWP_<3VK*\"J^.PGRQLYM1JG1S_BY+9N%%S88>6\!U1A1$K M=I)]5$0?R; JVC,*^:AHY'/*^XJ[?LFDGQ^8]!,WUZ#ZQ#644!78?GDT\MU'*'80$YZ)L,)2C=XX2>C8O'",C:\CX?]_ M]KZTN6TD2?2O(#C=,W($Q2; VYY5A-J6>S3;LOTL>3IVOVR 8%'$& 38."1S M?OW+S*K"08 DP!,DL?%>CT6"A:JLO$\3B#&P/3 073=N.&M &,SJ/#0>%DSYCSH %Z%/D4 C 0BFOG?:Z MKGB_PYU_'G,2$10R?]!_F--@^JO$QMQ.PEC'$+.(*!_&8*ZOF[8"DM!& 6A;6+4,>R.4 M;RB?;>6?@0VRKK4"@__ZESZ\^-W2FV-!1J.HWC%OKJMBM\-T48.\.N4J-KO< MFA?%RN.>3<.SI?MUAV?3?4($S&-$%*"Y]_;SFS2E4U849MBG>908LRV$RH8H MT#\JF+ Y7".=A;\C%#CNV=IXMG3E^EH4\'$J!7R1EW$--F11?J-]OAHR==1-P]WMAV EJ;_SHR&?#P82-=+2V.#(Z26'4 M:R@9"AR9=R'CDFH)SP5=K7J@IF?Z4R$(1P+?#B*ZM]"_* <5/@\,U+E<9WI2 M*E1WM0J%*F-!7%>/>9P>#G=+=W.0QP%=&12J3\X+3RY,F@4TA $O6*%HHEC5%BX!(0A8_;/=AQ0<<:8 I M]G%-/YEC+DZKDXDH_1A*Z,) -J8;!LA$2BX/V9@$S7MG"L8Q6O:WAL^1!(\A;^L("16HIO^KP"H?!=#0YV5SC3JIE6 M]$+$7(:+Z)!B0S= EYK:XWG NWAP(@$]Z*<',YACQ8@,ND2@-BFJ),)G11$ M"/KH):R@*0B%UL&@ -IRKY$>,!FI5$6+ASN=]L$VW\5ALRMT72A,G+$>+5"2Q0I]##QZB!=/S%?5&=+#PB,Y?-=!/8GPNL M%WB#J)J:BVZR1D+=U]08,TMI%IRHQ%L*\N[^:G!^ MA47G9-=^'F\'SGX31Z^MP)H-!,_@8)O'#ED.*DOEQP-Y6X\YL]%]Z@E MJDXC'3MN!V1[&%)R"17O<6"!UFX@Y[2$ZIWU;.2113< KR:FV)^9-BG0."!T M!4G)@U4;=.3 36Q"\MWFZFL^3-/<.#9H*^H;,D^@ENT$K6Q!M2B#P'[,L/T&,"U,]1D'+HVK&3%?-S%WQX8%0/U.K(Z9.J7+ MT"%E.N;.\(Z4@D/[6#0\5G9.VM2S<7D=EQ9'RU4=EZJ.2U7'I:KCTM*.2RLZ M)[6R.R>UE[*^,N4E8DM'U**4^[ AD9+J&;6^T=!L^O;1F+!18+'/8PJLRN7X MN#BA@?&I<^4GF^=N#\SW5>^K]YO+53U.S)M'G* ML^EZO@)6)U.FL-"$C#RRZ$A=6VA45,3Q>#(=A#2UT6OV=E[HV6FT>_W=EX]J MC4%K'T7$/2U?46JAS:J-KKI9">T1-MMMM-N;+7NDS>:#[)Y:2>V7D2VVD>(J M;'8?J5(4 Y_IH_D:N!3N)'74_EW9N/4TG[$<*+7=E+2SA-Q'W6 *]651*@!N M D"9DZ+@4.,*A!N!4.BU%?0V@9YP1\^W&W*^P2# TL ENZ?CM\9C0QFAJ>)B MKD+,(;("+9;!95?#W_?IH5@[>(&K86NGCN]K_&\)<:1@0$Q;DVJ\V/',8+>4 MG52XY5F_5[M1ZUHG'7C?!1+GX8\7P" *9K 6O7ZI&*!>0 [,4930FIFWVN]C MND+6Z)V?JUO?V:W'\C=R=?FMX%H/[=J!M;CCT^-W7C)#&A MH%+1.IA2@:57]69&9<0N4'4C-GB2]UM8;RAVPX7UAD%SMWK#Q5[L]JI!!3H M77\GGHC3.G_E;-B?L^&T,*&@]&\?2OH/5)3^G5U)_QT:0:=UOX6E?[$;+B[] MJ?N+JI70:W!:%ULJQ\#)@J[5K&S_RO:O;/]\TK]S,.G?VJGTOU@[I[#T+W;# MQ:4_3N=NM"K;__C2OP(=2/]69?OOS?8_Y-%S"WCE:I@GF;/LY]V/>%_7:6VY M>,^0X)W:3;N$"0&G=8&%Y7>Q*RPNO[NEC?F?UL5BU^W*<*^"]N4TW$LJNHW- M1'>YSKL?T;VNHW-TO8N]V*U$]\5"K8JX M7[35/:JL[F6B>]TDAD*B>U"[Z54Q\T.+[F)76%1T=YK-*F9^?-%]L5"KPN47 M;76SRNI>)KH'NQ/=G:8*HKNRN@\MNHM=87'1K54![^.+[HN%6A7KOEBK>UQ9 MW$O$=F_=N+E"8KM5N^E6<>X#B^V"5UA<;%.>6E9#@\KB+G2Q80O_RN[>#G9; M^LQ/4GNY8,-[0^E=KK/N1WJO&Z!92'IW=N@OOU@KH[#T+G:%Q:5WEP:/9,U4 MK"[VP-*[@MT.W.9"?1'M=T2K:A6G+IQN+[.=FN:G 9F#6.ZG 8K]J :':GC7 M:?9VVINFV-7MH(/7>6!'8;UCOQWQ.LT^ZAW=7^P0[;IX> W/EF$34V M>(8]\T$FQQR8G/.(PS?*TX1YC&M=BHZ35\*Y=7)FBYP86[*FHYWF8&D6LS@/ MGH#/%\VND2WMO1A[O9?]-G7KJ,N;NIWZO8SV>B_[;;?34=6EJ8.G?B]LK_>R MWT8('75Y7DB1>_DE,::LE/>T=(8XQ'W076."X&BG)X-N(H+7# HM MS7"US_:RN>SZ;&:9.(=;F3DN@5D@OLW\:)2N^&QA.IOO\.GQ10C*ZF!&, \079@37E=>)";@"YP,,0XT98&19"JC=KO,*Z.0E!J"O M&*F.4,:!PFD0R]2D)*P1JO!%/WMY;OFOK2H<-\#%_F;ZKYP^OWT4#1$KNW+"H**1$GF88XX(S'#$<_>G6< M9_C* -=P\#T\GS1+PP>5B?X"Z,:8C0.J7TU$3CZZ&JE$>68V8(H%2./.<) L M4V8!_(L&3I\XJRN(&U_9BV.](,0X%U$^N,YCJU&1\N];(832X(&:(05 M?W*WLR'A6I-D(GY_[7*,[31ZG>0JAR*>Y>,DAZEQDNO:#!;P,.[ULM[*6+H]A8U _HP$L0Y(@![)9[M%C\&M2_+ MP-@E&\AJ!)L4LUU81-(?KD "+/:9H,F^?)<)QIOMO[WFCQT),UO=]O4(C(%% MU:>NL!\SDQ3^?^HVV0U">VIG$_#.[J*IE&O<\K)(_P*5[N[\\7,3SI3JX,5< M+NO!W?WXH;H$KW6;?C=SN,OIK=+NFO-?#$^*^6<'I\N4M#?*56L;QI2!.6?)F-9URMV:,?60,:7CNYMI M4F?#F#+3WK24>)X&@F@&_W1&,:"JPE( F"Y"NE?'O![\E4Y%1@C:@F!=UQ)ZKV#5 MFN@*'"SAV@*VC3SA]_/@ MI1N<"];5C!"):;N2:E0>HCA".EUP&2Z;XRI:B# M![@N\0[P(N!H!JAMVH#Q8E918A/^#)&Y0S-F8LEA GZ"5* M*3/'///0F)CLA7EU?,F8\L^0P?!/ZXH!\-3AE=X,,&V,*8H^( ;SO4;N3-9S MPZ1E&;$B$R@K04@#_$.K?C'9]8@(N>H4L%T%Q%8\XZVPX$JY8_8CN7;K!BC* M8M5L'\'^)%<$U58S$ETI6.] =NW6J"@*6 T!N\SBD+(K$T=;V^!H:P%'96;N M(JYFP;S?R$AF3S/))/W'V*2@SC:Y8U.<*4Q*^SGI"Q%F5#/ZB3X$DRGPE_]D M[^-:<^8C=IH+T(G]=^)&&3S/['H(HN_[M3Z&S;[5K5=][M5^2[>:)LC"!G[Q'A@':R]]_T7/E(Q\5U[Y,@$'- ME ?@3*;'"U9L73!;4,T:1.V/P= S1Z;NIAQW)3S1)ZHR D8$]S!B-N:;P[_( M6X+U2\I'T]9MPX3S44'3E%]5R0]U]%2)-730Q$1U#0MU MT,[T(H-SXKC^-6E;TG1U7=U^YIP,]5LTJ'G15_1B\2B>QJOSRCC ;!>@HTP9 M\Y57Q_W."[EF6+BBV(C9#5&(FO$>@4!H]CI8I.XNMU/T%6P%:6N;D_>;QSQY)]L)%C_Y!V;$#\Y=@EI#47[-YDE)_ #H M.&0C#'7[NV(Y0'$)I"D&++6SNB;S$:GB"8@BVEOAYD<:IMQH:AHFTYS84/!( MW0,<"8/U@PQ#?+KVF@M5(!^1_2];#$&P7G'O=VJQ'QV\A&:-+43%K&JKH12K MX'OO3&HOSN M@.3"8K<%=^=B&6*F9XU>N'&58FQKM+.,T^/NR#[+ L%@59%BS$<[*),2 KK! M7__2U]3>.P]+K,.[X2S72-R-17=3IV)?K/'5?^!?5*WMT6]XW2\O6,0XCT][#9OM;:!V1[W7R0 MW6W]YH&R8Y848W(V_$:YTUVL[\]3(E:@%/.T:NEN_>KTU>G/CL1-6RKO7IY^ MNF=[Q:F(7YZ.F&<+#6G$*=)^NV1@I%!#*\(-#E(ES)L%'*7$/'!=9AMSQ7=A M%8M;8K&DFVVZX>>"T"*Z507!EU$0?%7,.ZHN>L<\. '\*^4(\,&Y8+/"([)%7V'/6JM9N^G7VQF- M#E-2N:35Q!455U2\=RK62D[%*E)QLYG.J*JHN*+BBHH%%:<:HI:,BK7:3:_> M[)R"+#Y0%X[CV1=?,.J )D44 &8V&YL;6A9YIV2>9T^*@G3:+CF=MG"Z4*_3 MVX).]][0HD+!K5 PE:=1,A1L(PKVT2-4H>"9HF JKZ9D*-BIW6CU;B?=]OTH M*'B@%CS'4T@^P,]>J%B$4B5$!AK5%GG*A(V>=S-_>2.:O)"F-/W>FE2W'5%B M!K%U:S=MM?S=:BKTV@:]^D=#+\RO[*83B"OT.B?T&AP-O?K O3(RDH^'7B?7 MTJ4$#64.V4;LI$+1O"E8OO35W8T[W1":N5WEN[["O%VRN$/X7BHF4C&1TV BW9([P-I-9"*=3KKZL&(B%1.I MF$@YF$BSY$Q$12:B]=,C/4Z/B62T'=UD '*).GS0BD5&8!J6[GGF&$!$,U*5 ML>M,,PM-96630O]WTG-"5X($Y[1.G1=13<\'Z>8PD\..']0@B[H2_E#,Z0QH M@_=38[HQD16?N(!C\W)]WG*"&B[BQ'&JTHC=Q7FT/.%/:!AM\GQ,7CR>@B9 \P M1+8_D:=V6?@!@_4SNL*UZ$G1Q@!'#,=ZRYDV9T'PUZF,$E:NGC")GS,^3_D# MAR$G^6LX@]S;4Y?/G.B,EX8-3@!+ ]A.A)X2Q]87))0#_/6C@I%0LE,VE/R5 M)W@I7RS]N..ME15HQB?YSI9FI]%'!-]>V> ;M2R[MSW?#3B'+"DYC\)PNS(. M]VU&^\[HC[NT]6/>[@M;]@#IE[\'2#MO#Y#9].U7?AE?=!?[2DF=_(4)?GIK M\SX9&;TPVEI&.Y"VEFX'(EZAB'CS=/1N>XN(?F#\!#3%V_[L:7E]&[7QYNT'" M^NR62KRCVT0?B7GRC$-NRB%GQBBG:%?BUIH$"'Y'_(IB-U3D+Q%0EJ0F=QG1GWI& S M>V^"+X=U0H,('I0M?H!63#"L1MC?1W3R(V, W2]H(L#'$^S11A8EV&/,]2;F M+&R7SWEVPNQ@B)"(J,>7]3AH[S7>QC6+ IWV:$],$IP"9(OZ-PGV!0D\;6Z2M!0R5?I*H M#WP0;ESB+: _]LS2@;:0&#SJQ@GTKL<?'2R$[A'S063QO3O/$X2Q=,+[49#1;O MF#](>9++@FB]VDTK7?FY.4EU!JFB];(<%4RNCOK/->I"RE#W3(Y0IB<:SA*R28EI+E@!U!R9=[F]XM[!-[^@R!(]Z0KX M!*70:RA;J& @KQF1!XZ3 .OR&M\4R4[N?,Z272!>"N/_AB@A]O+9_6!ZD?PN M?O&#VDU&O=4V.)XJZ3[H@3H8/,XO&\[2!%$UW@%2P; ;4-CRMN8 4*"!]!TF M"GJU?%?X6:J+7YB+37_T9Q9>$)JQX0WA\)C[I2.U. \)RF*_SS\;WR]-_1+^M"2Q[)!6@FE/(U\#Q35ZX> M'^]NZ\K[^T?EK_IT]DYYN+L%=O2,!WI35UXGIC'!.A!8>1DW08--SU!P"Y)- MJH9Z/V9.1T-.OUQ1!)KX8V*2@K'BT+)I_D1_084*M"G;H3"2Z7)#Q1YAU,=Q M/90%7$C@A0T##SN,>Z(W*<:-:/\@V^22% OR83.*:WK?O:0"0^(D5-ETCS]ID.=#'4AT\#I8-35G,'&?!F^PE^_.&BT6$*?@]T $<7,&CD;S!D1 MM]?=[PR5,R^8S4#3 VO)M+FJ)D-A8.O9SM0TZ@JB'P5UN8QSR-.)4HP'9T2$ M">0H6Q);:I7(T4P\Y0^=:.?;=Q#V-CN2@YEV O(]C,RA1B)F. !&;--R/4V$ M2Y(:HI,Y-O00O[$_,_C)_U'<4IN@>C.R&\(93>&2/DNR=F^ MB-EQ@UT&ASW"4B2W5XP5+F6_0)5C"\0HU^IRAI[-?'H<[MN+)8U(7B'$PTJ^ M5"1X<'ESH]1J;E0I]E+-C:KF1I7C4'N:&[4BGM7*CF>UCQ?/6M='?W,KJKU/ M*PH@UDX;NIE6U#?T^(V46U>M=<+^=_FB(N!_KZ]=.M;**0=FC]'*KG"0 ]@M;S MU[]HK=8[G_^/@A.'@?/JAJ?<6L_\0]>Y%N!B(7 >GV[O'B1TT!# QP'5X!__ M=N 5R@ML,@#5E#+G@!46AE)WGU#J=!MG0\B4IBO?.#7^\(L9S;CG^+UW\*B8P\? MP+^^@M7J!+ K3_F'\#IT:1CP>&B M\"1-VL*T1QQ<6QA1$R&]]B*B_BH\%F#A#4VNPCSZ;!;+LI0)-)R=W-NW?""@-^L$\.,5C"_R-Q^.0,,=1.^>-X^JO: MMZ?W-1!Q\#\4X;!I+"+)4E#B9ZC'BR@&0E\2>W&>WFTV]WCR;K-VDY& D>#I M_^!Q_#B;@LL=!8:_R)\HRR"ARS^8GJO\_OY]B&=?'I(" ]6,,7&V2?\BY221/QLM9<\E-^(U)&W=C$CA9,^.2*C8!U+!^NB M4%QT>4/=0O^MXDT8#T#'4\YCP79O,=S&#D+9#0ZA&-) <+*]A M&,Z^GNFN+UQ8\E591Z#!XSJ%MX<@WE]7.E09TWI:>X^IA:>-G9OE_46AW?38 ML%,Z_>H$;#D:3>181/0A_+!??_T'TLZ#[@+WPS"SUE0'8;"9DZ(@+#2-<:5X MVI>-"\A UBM87]91ZI.!D4*N<&[S5PQZBHE\!)%X!? M)T=V)C-;PJGP3I"5X)6M8D%*!@NBQ( 5NRG(H\Z/4)Y2X;JXW.>Q [;(.*2F M%8DO65@FXA0 Q-\9F&^*6J<04+&@3SM7Y#7"]H__^G2/150\WE<SD+Y_,: >_P8LQR%4< M ABX2C=8#0%PM8LSS*:9%Y?>_L;QMRYZX%9D7$;C--\(O2G2@&()3XBPH0S( MUKKVDR*562BYK"[RQ)E20=V%%Q;'&?UYZR\K',0D(Z]#AP'\24X&1,EX+8]P M&=>>GNYK;S;UF'>;VDK#^,&T'3?F:\DPB7^=)^M;^2/9AG(G,[WS9P7^NHZ7 MR,8]Q5FV\.]@"]? "JX=W?Z%3< ?E@5<(6'&)[3G'Z"/ M4*Q^%+<@]6>7<8V& 4MQH9C^PGP<:V2LO1GFEQ'.TB-&/NZHR/=9Q MHD--]GB17RC;J1,8G-W29QY[*__Q3O9^-FTZ ?WHG5A+* 0H A<[+R.0^=>1 M=&PTN8047:/%F\77#?IJH;$9_Z[3;+2ZZM*OFXWEWZU:5FTV.H-.F99=_5U? M:^U^LVJCI77W 8-N<_G7\65S#K!?VL6_>Z*3O#\*%]8G=&$]W$GUG9![^<*G$M'!\':%IPX0IG;'!J[PJ-JG0+K[&$V7?GDU\KF;S&+YVT> MPMYXSE.UQ@;HMGXV\W'1+9ME1NF$O\%I9ML,G3S3CO GU-2]6.)7:D!TTIOT ME;.:CZXS?2^B,IC[]1Z0V)DR]^Z'R'B_Q7I?CXTV2JOHTQ!H-3W^M.!4L]V. MX:VP_GRQ/C63^@A8/R"L[Z43'8^*]9M(N:+C1RK**=/9BE%.:I+0#B@G31R] M9NVFTRH9:51H?;YHO68<]:[06JW=]'KIYFO'0^NSLZ>SD8'2.Y=:R]5$XVYS M39O;71& 5KL99,R*+,=T[ H/NLTU/8!WA0>MVDV_N[7!5TU)+S,NJ6O:_.X* ME]JUFY96\93RXL&:HJ-=X0%F]ZM;VPP[Q(,M9[WO9)9[N*/CIG)EA^GCP8S] M-+[L4J+QVH!+.ID;@7_=:F3D:&&5#(_%7.F+*9#%YDM>^GS5DY^?6FBZPCZX M8$&?8Z];N]'JW5:ZAG$S"_00PY0K6JIH*45+:SK.'X26>IR6=A6U*NE@\KT, M'J^(]9*(]4 A@W[MII\QV**\U%@12T4L*6+91R"BJ&2CR'2S?S*TE)W@J;97 M97@NL_MWEMI8O>"<7G!VB8!%\T[O1&'=9CFG:Q)&JC7RHYHL+ 2^S%:_]I2? MO.2X]-;Q@A-6_;*.>#[:75==X[AX[W@TCEURVW@)=Y:JUF^"JI;1*_&HL:\* M?\\7?]=T3BR,OVKMIIMN#%B.T.T6:0 5"9PO":RIF"A, AJ00,FR%RKT/5_T M75/Z4!A]6YD]%4\VZ4+T9M%2;H%-DS+*9^9'QOR&GKSM871N3&/G\#D?CK,F M[:$POVGOQ.+9 ]'O.0Q4$5U%=/G#2&M2;PM376<7=EJ)B.[@FL&&F1(5U5=4 MGY_J=VV:=G=AFI:(ZBNBJXANYT2W:X.ZMPN#NBQ$1];X+]3]]&9E;]5LJWG7 M]Y\N!\CLP[UU.<"!D9;/FDM44]!\AQ'#_\7YM[[^0W3(_=?MDS(T:6R#[RB& M2!SR5HQ[B=U2:]4MG47[G)Y6)\=;/V,NU7:GW*!$[EC=]B4(/C C/AE.)3 L MSN58G@;9.NL^EV>7)U0T+^\K8(?Y0L,DR]D.\NPR)ZL6BE7OH$1$=4U]RZUA MX"1<+Z)44-3?RUFB&09@'PS 0=4,L<+? ^'OFI*3PO@[J-VT,\;=5DVN]GSK M59.K=9B^ILE544P?-&LW6G?K8OJJ\\S>+GQ--ZO"%Z["A5]TBYGR&4<)$VA_ M):;GJ=-<8L"FO28WHC!3P 3>3N=4BF4KJJBH(HLJUN3I%::*%E!%?U=60%5" M7O(7G)V7KZ@?]HL^W\()>R$UQ9=LB%4X)L16X5N1W1G9.# MW'J[D.QE(;?3,(0/NHUD=KZXYT_!%)#4H)S((Z6S*PL9Z;@S1'+3#LC[4L[D M\K\O[#*DH[9V#3KR$^:4\RQS2B1?G6>NNTPQ;7H ",.T=7<.5QNX'OP]5H:! M!Z_WO#KE]>.S,Q<(WH5#8%]-@RI@Q^ 5N$4E9@0,' M8_A'X )IT4(6/&7#&_1GE[$I< 6OH7QYN%>894YA"[@_T_=@K]Z,X4DP>1Y? M#CO2+4OQX [,,1"@[?>8:SA3N8:[ ^VR/VW-$'''9XK::2A_3U![NG*?"XW9].TCB 5G_.3J(Y:. M!'PP/<-RO,!E3_#K7RW'^!Z3'WTNF^ >V>C6EQ_BZ@RDS0R)UPU@4_@*1"*Y MOA*]X&V*+1VQSF8IA?-#99U5JR'VIOA7 A%7K*IEK]I:FK)^7!;XY"A38&_/ MP"H4U_2^$U=A]H0*;0S=FP@V Y0_(MK7;?V9.$V=&(W'+,M#=C%"CAC&]K%< M*;#U\=BT3.)"8^!&MF'J%K -.*]/C Z8%?!89%\N\!N^K(>,R7FEQ6$17+^N M (@!-([]["#C&^J>B6P1= <=.6[JY,& M@]J-_^JDU$G%G\]@WRA#8O.$/@(YA[*32O\X:M#K1PX\8SM4)X;/#ME$M\:X:5PS%VXJ?TP8 MO&$V RF+[P39'3L!_'@(*P!-F!YA&FC#(Y+E)"IAH2E?73==Y46W B9?'H<* MZ1A3SD-USW,,OJ50Y&:][Y4!*A8J>UV&)]+">)1O^5V^)-F(?&S^8*/K_S#7 M":V.9H@GW6:SH+W3V>]V0/;;::Q-?8#Z%- YWKM.V!S6+XGJ'5'$1.B4_9T& M-_B-R!?O*H'Q&1@>HN3,=5[,$;*5^2(">\%L!@Q(21++V!>O2)/!1$>T9X"H MG$Z< OA=O/SS5,I&WP?3@%<#+^'Z=8"%:+^?*+NMAQ1LPZ+*%-XT\4 @(FVG MZ]L(-1 /ZIPH?]J\V5)_?1('*EWY!@0,8M2 4UP;Z0H%JBLVB8F.BNU[H5_- MWC:.8T=7;+P>LVJL.9D]8:6P,V-(3W"WI,*,L?*7WQ"O%L=?*":8.@9)ZSDW MZX@-2R:]3%E T<*0W8/E])_"J@#@R<0T)JA(@.H"7X.:XOFP*.XU9/IY-:=E MF_0GNI_]BD RJY32M2D'W 3S6TMBL*"VD-422Q)]A// VS_$0(ZG^RH.]\W& M0FR&UUAT=$:WV<:.*>D$85FD6R].&NTE_24.?+!.[::CICM 10=+4@ZADLU( M+AF,C3R!46PDG!K4G0 -?DY.0GP1X424%O.4"#?($HH 9/0%U@'*100J-C(R MQV, "M), 9^2X/YMK+5/=X0(2^Q_3IIAPA/0C'ZB#V&C@;_\)R4H-B8)UVDM M0"?VWTF8&S<#8^UZZ#+]^S4I$6]UZU6?>[5?DGX1TY:+=WO4-V/Q]$O/.![O M[8RKG")_UTNS%V7B(O'_9;U3J@?F-O64 +3'@4!( G__1<^E3AT5U[Y,0!C- ME ?'=<'6N<>=V 0&$$KWMM'@\B$8>N;(U%TS%J0NZXG0J4:&YON01[V/\ZB/ MH=!]#+E5Z0]U]A2H-H9;H+*IZ! MO:0*B4+X'1@=S[NSS'([C(T)&P46^SS^#92/WP$0GVW4V3^/%[46XE]IQW&W MV5WT$)<2GU"_R''/.3L&[=1*/IEN0^U!0QUH.V\+I&F-7FOYUQLOVV[T>OON M-G3$M(Q+;#7T47AH/J&'YH%[:.[2'IJS/?<3:)RY#[YI&O_2[(Y5B9.ERT_* M:D*UFY.?6WY6L<.?3_)5*O<*S47-*.WES'3%8$+6K@;&Y";)?54/ M5)1Q2921[E"]6]+HUV[4797/[)$SDQ\T1W1_(!Y94C Z8)1$FW MF'.E*S/8HC-"GWS^R(58?@%_GY@[3>>XC@*7\KEBJ Q@CQ(E)%K*K*\PM0># M-;BM6> :$QT+.EPXHS%1'&P>(?9-,0,72R1!F)H_)[ ;&YC"4),.$_90V*F"0A@UH\G42\7/<\AO^/YSB-8(.Z,<=U ML3!$-PP@U?*"[Y,-UR,W?#XFZ<, M Q\SD5&<8#87SU(1R*F H/&0Q*;FCWJXZ%@W+=R$BQNH*Y;S;,)V#'Y6F7(\ M8I8)OY[S !Y/ @JO +M&&R:3*=VZ+'_ VT-X9FQ?1 TYJDAXRV1>OE0Q7AU% MZQ:P/LR671:EPXG@:<;62G/N>#/_C%2P["[W=9E7)A"%\L(2<;1L[K]F$D?: M*;^*>>-A3BB8UFTU-&T/,S:ZC7:[M=&RJ[_K:YNMNF:SS68^&%0#04XG6G7+ M*T2 7>2,UQ6=&)*C\=:I0^Q_F.X*4$F>JZ2&BNPERK?&/UG&3EZ_BDQK4":& M#'@XYM*0UD;ZTLX\RN?ND"E\_C-RQZQIL;3$VKA%I2X[%5O%"=C-K>=#;$"M M>QVVNTUORXKP*L)+U4VL&8:[ >%U@/#V'UX\=H3QQ$3T>^$/& 5,\9VWL3S7 M,C5@/4 3UW/IGLK)*?[?/R+/A^EY 4LI7B$TJID7:_H^K>9Z$:#O"9I[L8M!=A4,XTF#?6-1#)79766R5N-R"N_+_/C+?MT3=R$;L->\@ MN/*1QM7!^.L7?4X0SJ2(?NVFFRZP33GQ"N+C7EEJ7HVGPIMM>>I*S,'D)37M M$#@*ZERLDLK_RQMI&O-?+G$8W^$8Z4?'A1?;$MI/V%K0HK"=S&K*(A0-Y_5M M02:5TEIFA-J2PVZ(4FII4*KJ>%\HGL/LT0:1G*HE=]62>]-(T)HI,<4=TAKV MX=I/UOIQ.N$?G&WE#B15=%_1?6DBP%IK)Q'@LA!^,D<_G0N]OE-7,DM_-RGY MO?*GY/>*IN1_99[O!J+9^ZT]^LIS?6_#-FLKD_2U=D:JI];.2/7T/.8K]].9 M;KKHM:#\H[L?IJ^\Q_S7T\C9YP?+.J\FAA/L(6N?5L]\:5G;*7TLT-J4MZP- M6R3YCJ];RLS%--D?E%/N4P/-&-(P1!K>]0AT]2U:H::X[A)20 2]MPTT NG? MA1LE:I@DT!PL;908YM?[#O9UBO80:W8H6YA+T!@3X&],9#_'6R?NO6U4H; MMB'MO6^.Y_B_V\?;W%76-[;7G55&&TAFOE0H?S[9F]A7300_87 M@RX'/18'/3O.Z!58*@&<%\*8-FC2SR;OY+];:?&;>!M@W7WX%E)S(BVGN*@8 MX(CTY.^P^F6_[$H+(X]HSOW@E+R0OZ[:&]CAE%0/T\ M7H"W=_=#]%B7=U(8[JV"LP76\:4][U;%Z%[:Q[P;M.$S-,:!2W ,=W><]^)').K*D>1Q@O2EVU7<"5Q2Z1OH"GUF3G-2&2KJHDX[73J-. M'TRIYV@#J '> LL$EK_ X?=E=&&(]2AF5TO+-KNX2TQP1K2K<)0/;_8;&E+A M+#RPA.D3#(V-&RU0W0)? TG7B#'\&YHP/:N,S1\@C@3.*J!&V,(P: MU8R%Y2*BTZYF+)1B+]6,A6K&0CD.M6;&PA:=^I?%&+)Z=L#'[:/'&%(Q&K7S M\]IX$C;&>>0&[0%G'*1;IZP0WUY&.*U5^OD&!/QDR :M&^J]@FIC7BL"[D2J>-QF]4$+\RMG/Y^0X6/DV7 &A D(% MA H(%1 J(%1 * L0-JF?+5U9P?O,@!L/'KS-H\SNM'G8>:+%BI+N7J/7*3F& MW 6N,V/;U*^?:8'-F=;(4&W!3D*C&=%/G)>VJRJY_16ZG0'/65',? (\Y_'Q M[K:NO+]_5/ZJ3V?OE(>[VPOKWU",8G>54)Y!L?W:C5;^%F-G0+$GKB4 O=Y^ M$^2*<:H/'R^L=54QBNWNCV)W.3^MHMBSE;&W%%+7O4JPKB#3WM[(M-T$5;B2 MJY5GJ@+"@36L8L.$U5;)^?@3E6YG)\YS/]XVBM@6,\%/G?>OZ1&T#>]75]0$ M;-@S9']CX\^3&9R@K_XV5?L@_/2;]=G/V\_PK*[]Q*WL3%]\95C'N/::#D_; M<&VL:]M5IZ>*-Y^M85TYKPM1[,Y:C610;*MVLZP.M;*Q*ZE:^:XW(MA=55)G M$&R[=M.M)&PE82O7]=94NJO. !E4VLEJM%Z)U_0=]%:UG3O.Q5V$U K'180MQNS8 M/('LT1"M=:,ARM)/\\%YH=9%V)PN;'.C_&[J0].BEM'I%IK[;68#?S#WA?TZ M?YK/X#O<3D9#FW8_JZ'-<7HJ/6'#S!@80U&C6#$P%NENK[SJ'E@,HOU-//Z] MV)(FAG(+=M#Q.M3TFCUDFD4[U/0[C;:Z_.M-.]2 B=@:Y%MVMYU?X$[V+J_V MWO;E!)J0;.H;WF5?ED/<=39 )*>>*T,^;["N_%.W ]V=*RIG)D4]EA<[5ZSP M^<]':UTW-RQ+0F?JJ(/:33L]96 SU_EAAH$=- Q\/#[QGKL;$^WJJ^#O5N:; M &D6'72:.TR +=&H]-- =>P/[:DG-A7'T[9/=@__"O/'I.;#K[K3VB,3"W(^P;RPWEHI\,VRGMB]E0:ZW&-N\=/N7F3[LMK?,+]\ #=C"K.=/YOG+>Q\F/>%K55K]=N_D8T+PF&H'FS:CK+9]7DGZ0.YZO=5!-N#K^7:L)- M->&F'(=:/^'FX$&Y-61,PT_5?D,I%C__G7D>8_R.V.\X=BYK\DNGDS%_I]/! MY1;BYQN\_/.,X7'LY^6O[V:]OIM^/5_A;::&E_B;7^GA;W"%.L;!F05E;=6O MNMF_ZN*O4,-(Z;89GZS60H0^L#H99<6IUFQ?*XXU<,F4T8$2( M=>JOF%"T[ MU3$2/@QG.G-L4KE!D'UYN/_K7_J:VGOGB0F0E/]!(PNC/([,')"\@[-;]"1. MT%Z1#E**_ ]5TS;)_^@T&ZU>>_?Y'\U&I[/\IT=8=O5WG59O]YM5&VI[#S# M9;N[3*U9FHW=S9.L4L(9,KN;473V('HB)I@31B<_)%S_-)Y MG5C;U8GSU,:<%>0N'5?*D 9Y5(B$QFA, Z]R'ZOTZHJ)RU@@_9^[X1H8>?R. MOE'?CTM98Z>5'B7'K]NI YOY#P],.F.%R.[:&5\''N,=EZH6>AL;OO',@J_X MBL_C;QZCYBIQN&=R8JUVT]J5 ;!K';^Z^'5FWC8WWP(9O*L"T"-8=VO9;AUC,T?;'3]'^8ZF4C0P_8W?4W5WI44%79A]E;H5$2_RL,[^A7O*/%E%]"I MMN$=@S+RCDN8:?>@Y\Y6HJ,Z*L485R(@K.-2PKHE27O$X%RGG)K9)=\B7$=_^E MNR95EVVIVER&KK]&M9' 7(WF;4S]+I$.7UUQ$\PR2K*UZGUN2[XEZYKO@4^@F68-C;U@5(5?? JGO@KO3*U0RF7[MI M-7><-'N\EH$5A544=@2U?C6)#9#$=EP:>%02.[CDW["36$J4-BN_/M'I["-6EMG-KL^SI#)E>WQ^)U4 M_SWU_Z:[#.9MPMRJ'1 )-VNW.BC:;O4QF,TLD[DB(^N+ZSR[^C2CAV5?R^CJ MV=?2+4]IQ;GR?J*;MNRU"WSE)%J>\O-D'7-I\])%9!)'.=\N_1P87Q[NE8F. M;3V?]6WC<$>/(X]!R#.6R*-_$(^7Z4J3Y7F,4,OZ[ +N [TT5IR)21Z1DNPQW6Z1W,LK ) MZM\\.8E <89P-[HX@X._]=B2,S:4I\1;L?W^#-N@VCXWGWE#:MB*"QN$!PFRJ]^#ES%RX.YMQX>=NG(.@FC^#[^4;\/GZ_"8RY\W M?;C$%QR= "!VW:FP#%,62(1_EI_=AG?5EV!GXJ1 B.&XX;HKL-#BG:QL1M% MU<%#"[A9VQ7\MCEC'Z1-6@,J2HD]!##Y, MD>2;P[LQIS.=!C2(,10IN*6@)=^0N=^&0BB6?-="W]X(_YZ9S5R:A#%R:#?L M!^B-H]4" V>XY)$88L0%L"" RQ=8R!DE,GF!#1EO1X$[TN!O!]TP^+KR/? 9QP8C["-OQ/O(B^E*BC=AS!?4KGN>8W#^%\XNP1=QE.$O MHLDF8]XYV76FBA-V>$/M_X6C,U+]N@UXLGT]WGFT*D".L"!L,\KUGD3#Y0_, MB'_%9^IJG$_Z%.SA4";,3@!X+5QIR/8+W$^Q23 [5VQ6 M&GF'_5+N]?+&U'1W,Z:F&UI(6XRI:5=#:HX]I&8YE1S9"7,/$DW1&DLI-U%E MK/:1?L4G+E^EG]4"]_!=L.DP#[>?;G^[>[C[]"2TM4?EP_WC^V^/C_>?/RFW MGS[ _[_]_7\>[Q^5SQ^7<^23.O/'^T^WG][?W_ZNO/_\ZHM?/.[GR,N8?UXF-SBV&ZAV\X&!G6K.9(.@SV #OW? MK#GFPF\ M)/2TAK8P(/BXKH@_Q'P_3$ :<:TS/J7*=X:HN]/L$C3W7AWW.SZ%LP&9!1(; M70S>U/G.KL?8BW_,!PS2A!)'86"J@@6,;H29X_ICT*Z=<**)Y> Z6.6&5B#7 MX5'1'04&3D@!XP3,3;P!KC?S?>#"MFF O6TSM%!]QVW0%1E F FNDT!CG5Y-2Q[ACC2P*_'D]]&XHSPY< M)1X:;M%B9#%_I$$2-#>,CUQ5C*"Q/UX](-A8%KT:_@1((0UNC8L,,YB MQZ5.6IY'/S7T6=@$ MTC&,*82^,&7JC3?8 XBFZ!WZ82 C/ M\[H2?HF &S*X#!/$M87:-M-=8U+'J3FO9-:#(>5X_C7<^G?F T$%(Q//=&\K MGYP7/AR"6V1PJ;KQ9V#BM,O'5S8RPU-PI)$O6=(!9& MSAK:0XB1@B;FX:,&G(^;G])G%[M:N(ZAR4E-L2+'!:!@'<_;["0'*!9+__9]/1X7(T 68""_)M\9C0_GH."/NBW"# M9^5V!!8 ,#ZNW0)B?_QP"^B,+F8]\">."^\:*8"W'CGEA..W7" ^.M9] 0L5 M706*BOS=-(3@0)D23%'Q!^9&XQSC3.-O7LG ^!OW4^Y[5ROWX-F!1]SZP1F! ML #4^VIZWY4G(>*_2(%W]?#UZ8OWIJ'\0?YP4,J&W*&/GRL4;T<9Q27QB/FZ M:4FQ4OLU\."]'DX%>C%=QYZ2JP<5!J'6^2C@A,53LCMZT&V=1RH ?3Z8GA%X MGO21W8)2-@QWMC*IRF?M-K]!'IPX*+R1NY?4%:YHN8ZKZ"SR=!;I"H,!3ZC=]&T@0\9 M3+ >6 $M,- 2Q3Q$52]6 _&;H5)U-N-+&GD48:^2\VMS][ID_ M4+,#52WPK#F]"*_%%XHRKB'T5GQ'4@7#3?X!^AR]$?_X!],M?V*@N2+?Q47> M\KUPVR:+H_[X>'<+*]T_*H3\RL,=X/\[_CQ_ MRVV 4MG"?^("&%?[$/ASY2/>>;@.KG+[32Q"SWS$=>B5%-6!$_*'*^*BL3Z( M5C'[#A'&L7@@*A$\47L=A5L)GJ0 B-(PS("/" 8T? MC#+QE__J*-+DF%"43+BJ28#Q4#"89"B1:&#U3,YC6E:DYN@8[U>!F(:"J M^$LJ=I\3%C0:""[8?)XR!/MOP6+G"R 1R!_O/MY0[NM_S#">KW3+/7SS0ATUNW9)+XI7%_ ;8&MH7O\9_Z)8E673X@C VBL%? M-.P0!.@.EIX+^60=&#YR-P]VH/O7\/CU,'#MNL*N7W2X8XZ(";.23%?)-^L* M;C=TF+S&.>0DXI#1ZV)F<2@Q8$?P&X>B]7([%H(052I<:8HL&(SF\\W!N4^* M(KQY6#,8ZT;HP4H[1KC+ +Z6J3EAN@9Y?,C?L>C8B5J-,[@1-@*J 6TWPLS: MUZ^(?D"G^(]%+%S$O23"S=#[@1(<]V29WY&IT4/B8^!.Q'APQ9F#,0F3G'KR M"<5"U*$-P0:!:TU#]Y'+W4S>JXG".$P?"=^/YF+@Q<4W_@S^M\'CWC&F%_([ M?D!;>0&Z HT @^S/C!35& #K2_Q(F7#EK)'611 0:1!D<%^8YP2_^L5Q17Z& M#[J"[B)_!6#^&: KCA("Q-G' 6>?(:0 FO)S)!W,EB&M@MQ^8\P2IIP#B1X< M<&4S)XYN.0N,E@YF$DOD.H.;HPL+)1O0P,KTBOJB6AQB(Q^;_0(F(,7@T%=* MU NOZ6M2BN]#%):)GP&(5.)0EFYR185PE#,@! E"#]WNO+F<,#;TZ=#DV5A# M-G?B_G4 WA+Q$L_3(LYI B/Q41\B?ZHG%H2;_!=#?JHKO[E.,%-FED$K?<1, M=UOY@M2E*[>_/,*V07.?R"PS!5XIF%7B/<0Y,8GO%/!MXU_.$ M3BM?GWQA9$V1BQS#S2Y&(V+@(OX/MTK.>QOSN6:XA$=0L&C=068SM3TZ=. MTF6'+@^_/C-R'D5WF$15^=8P!"@?2Q@=\C'8^*]SY=^.:9O$!5U#9$DFST($ MA(P0%D8S"(P(BVM5%,H#E %>+',F\42XHA]'RU#6U(5BB>\C_VV1R&;;%;Q6,SW25O $9-W- KQ_W)N$_8 M-M5_E,Y/?!L3M>NS=G;B]RD#2Q>C!F(L'4U[&=K&L%>44\^1^-;R75.H('6P MI8T&R6HTL\D!*6T*GO6,X)R8LP3O,QS@^XBKI<$ #H7CJ?;T?H7'[F]GKFDI M0DEODT\6I SF(];)7?EJ6E;D/ -KRN)CMXAZDSD0%7P3\(WCH/+95OX9H!== M;=L[8._:' M\#Q)3Y0-:K$+\A+$L)?P1R$'C8HLPD?.G8HJO+ MA%'N]?J11?; :![@&S+FB7D&'N=A(=/D;,%!.P^#=B!C7W0KB(<$$_$__$D4 M(73<5("0(IM@VCP#$["E%^-*VH"PS3=B3P8JQV$D++T5XJO D4F%$(Q-9MC M4V.3^D^$45$1 \CX!<45,GYQ%87IQ;[.5X92&-KQ8L(J3$"&R[.QS@\C#,[X M;1@D!"M]C#FR]K7\Q-5?,1@'.]!1*;/T(17>CF+!*A*8\![OW3)IRK^4:"OW M)-/8.)[(_%/3!43375]4<;N.;1K>PML (/A3Z:W%VG#E#D ]I=))>EV\6I., M,/XVY94*L6%U619,XC8JGPW+C,>\&#H)0*$/SZ@&EOXI"U4CD2Y*3Y]MS&H\ M8Q4-T8N3%5P)J#O))$^\;)D:+6Y$AHPE#I I$*[ /=[ OF2V3Z2J.,)_@C^) M;@H#W;$RX<4 ZF* _"K2FL0:L*([<\A_Q/A\(N]-783YQ'X#&:T77G[0WEYC M"?KH;9LB@L0]L>@)<&R*TXD]%((2XL\"4 CUY!;I(WD"_'=\R9?H*,LQ#U9_ M-FUJ%30HDYO\R\2TS)GRX+@NYD8FLDK(:6)RG_$S_(U:-A"Q])[QC#)R7X+ M(>7?#/LLB,P:\4>\4P#&^PRL$@=0HV&+ET6>@;I@5@$/'=)G\C8-0 D3%7%^ M.;YC?$?? ID&&-E.MFA L8@;<\UA$.5^RE'?*$SA\M'M2=B"3X<;G..!X:]_ M"W^G4.8=5WHO,#4@W SR*'2>1S^O4Q. 6?A;N&>RS"D\;>GF-$10Z9H$F#%K MK)!O7JY,#36&"9Y&45*=/"JA&11//C3X,'M,2AR";N%/B"U0O\> M]3AP>$QVQ(9^K/L#3RX(#3K8!S-G7("8R*IQ)4Y'X3ICO@:OP*<>(HD[_YS8 MYRN< \7@J\U&0K+]VX%7SZ_Y1XG6$J+,!YZ7N3:6.36%H1:%-NGU&/#D3O*P MQ880("9\1C%%GBT! *8*_^@\CAL"AR\11Z%8LD_<23V=6:8N78Z6_KH] ]BR MF$[5CE],=_<#\(CXXF,PG2)-G1Q;Y!FFF#^*E,/" WGB0$)CD:51(D4VF(TD M7XP+IPDL;''N$5)4K33>-5[_F)UQ?LP06XU3G,CBS;(9\I)$I[8'>CR"9ECP M3O_029G^]MW5,3J(_W>^BO%]>-"Z4/],FPMN9/A@7\/?GG!.CAE\Q#5?DG=S M*9+9%-/C663M@\R@W9J1&4(];=PYY?>&0-T27!NR<*[2X5RQU#HN5PY5X683) M0S%1SY_82TU/Q,B%XQKQ(988,C9=,%C^#$!-Q13RL8B9Y,$J %Y4 M+ H]A4+/S5XL&N+OAVM:(WVQK12I_IW M2EM,46 O7%7X_'@-%ID9%)CZ,S !%F233)@U(C<&+XOGQ1MA3.A*'L0-L,CT MS1E3Z*W(QT?W$N^X@#D#NJ*U?B: $2./^B<^ "N>.99)19*1@?_KOWC<;<$\ MIGC$/Q_?*T__'?VR+IK A>8==SIRD*\-C*OM$D7&"8)?A3_N"SI!X$6R#<$= MA]Y]*#TYM_F,!SNF8G_.[O\GJI>(I2<#S(?.BZR*L$<\+R:>W2;J)4*>IX\P MPL)$:TOIGXG7@H:5OA&;J\>;(.)KHHZ?,OQ;%WZ6N5@!<3[BKS+Z?GH>S-7D MVBH;M2:MLJ/6:$3%N%G-,",,"MMB>@L&0NG<&$\N)D9]@3,8\^/Z+I#6R@:= M]SH)2_1??>1I+:#.@K[Y #SAEG)?E(^\SD)T$]CW_E>CIVC7T].ODIRASCLN]SF!XH^ZI(G] G=*4^P&H3;#.#.0NA M08K)T$=EF.62-FB5EP(<.R]XBYIDIE?B'YG4,^3M-3YT)'Z+5J#6?7>8&\B< MK9($5[O105A\8C[0%$_;.2IV7"N?XDG!Z%C6N@TU=.%(@K>1X*>7J,-M()A(O(BCS%^AN..%%T9ZR\.QWK,@R6'ND#J>JQQ2T0!&'?G-8 9 MC5EH@3IE#E$^YMB#C5,^"?:)^,?3-^4*CO)&/LDS*:,=\*S77Z;FCW"SJ1?C M(B([-OGCJ'D$_9ZRET1::'(;T8.Q=0([6@E? 6OPK+BP!1@R@B4'&S-146\ MKF*,-)$G)7*<,BHP*"U3_$3F]=)-"L<1/IQ@5J;-62,RUGX4L8LXDBPSDU(;#2A;@SG88#? *'[ MC!'$0AH'TAZ7_9A.0#0P9("9;XNTM=^!*.4^A836*Y3>;-&JQ41K5VOV4J*U MOZ%HU?H=+EJ/HVQO-C(Q&T:M!(S4YNYA5+FQ-G9C#2HW5@GV745Y3KF!'N22O<95@JQ[#:@6\Z+!^882]?:OQY17!NOI./W'UYI$_4 M=V\*2?:U?@+J/;70X397@C6!_>^\-"]DQ#3 &J!KZ3./O97_@%-X,TN?OP7# M!F%$/]I$X@QZC4&GA?P,)UE'([<%JVL0JUL8QRU,Y79#Z[66?MULJ!M^UVEW M-_KEJLVJS4:_O?SKTFVV.>CD6I;FCXN; ]Q '/NO6JNVP ??-G' >6R]W3PJ M!J>GQPX=:;)]BK:6P6]*!I.?!G.V@M8MW. MKJ"IY+R( ^%H]EW\M C@W9T_?F[RI)7JX"A/D];GSB& WQ:$Q,'0?+\O*,S? MQO1_15G841&(=-#WHDG/0A'X:V966R'8+T!DZ?UIQ:":R97*1YV@DQ6ESFP4 MVBL!YKVC3=?85$TX.3+ZJ)NNJ(O01^@QH%@$VHDBYSTL38N*G[QM5(.MR"H# MRJ=#5JW-A-X1Y-HN1-=E2Z?;*;8TBJ8OF+8/I@A&?CPJV;2I;#J>YY1(Z4G_H9@X&[R2.H4!>(46T)M*XA27.(6]GNJ@S)3T M& QYHP/>?43;@J** &@;L;1=Y*%\M-ALM+3-9%9I// [N?J]O.!"S+36'CWP ME:14*TEY_K992[G%7C_QYA=\;(3I\W; E3FV$?%T\Q-/98J=KOQY= )_HORW MXS(]:O#L@XG&"X$JR;,)\:B5Y+D(R?.T4)>6G%GW,3FY5U?X5/N/.$7Q#\>U M1I5DVD@R]2K)= F2J4JJ.%@DJZ@?HY)9IRNSJJ2*72M[_4H>78(\JA(J]DU) M[79E-EV""%HPFPHT\Z@DU$864P&ZJB34Z4JH5#I2K#&3@HV2 EN,>.:Q)HP9 M5Y*J"BU5DFJISL?'B:,_7#1P7YL"*!IMV\^5K-IW>E,EJTY75H59@$HE@:H0 MTVFG 1X5%Q8R 5M5)N#AR5'=Q,2JL@"K+$#L5"\ZZ59B<".7894-?^Z&V+V8 M%U?94U5TJK*GLB1(.&, _12N[E=9>U461"5/EMWTYW#,8B51-B"3;J.8;J MRF7PF,=X>LM/:G.0_!Y'65&J%,1=J;7RS'\_A@S*N? MNM$H1/SX#?UHYCHOIB?+/B-6B(O\I+;"7PR9S<:F_T9Q;,'!<+P0#LXTXM.K M@0/ZC&\)0!?.JBDPA4;;6ASL&QW4%>B@Q= AG(E93G3H:.$YGH%9YT&'Z.3A M<_M'B-8Z(:BVRR8%OPK%X M.5X4772MW_([N%^Z(YH964O)@%Y.CGO 8MU R M]#U]K6#Y-2OLQPS9%+<2FNHR,Z'?7F$F"&;?S27[MY-F2T^2.$BKVU]V$*W? M64[B%S=#L]NL9FB68"_'G:%9FKG,ZSB,VL]M78BY[PE^(3F$G(=.L]FC8?4! M34Z76NJ(%V"YI%.&3$;'=F5>C!^!W@)_>8%%.T95-5:W)4>O:^M4MF[9-+;? MXA72I)6!KA9"@9JV<<6Y4M8.=B=%:MC/PI,1ZPHHW(XQ#^,(S&\;?;$6B.8L M&B6%1M66Z0&#_A9^SYBF\P8V-;:8XW%#B2[4Q-@Y8%;O.= M^60>"A[!V0?^'+@%HO 0,4;*GP&8Q7!Z40-"9(#SABV&X"218ML!X)'+7DS8 MQ"+QVXY]+>4.#]!Z#=1L//9G M %NTYHON+%XP@X*5C,ZF= (:I"16%JTMKV ! AO,M@ 6&O0 IL.\#5ZMP ^%NJ&OK9AQB5,PP MI/Y23U.SM;F*J;;B*F9DI<:X>MBL@&^[#I3NFB_DJI+? MH;2W@5$'D8M=JHS O6U/YXJF7)36 :L*) *(PR10%@\+\IMM+B"N8*TH)4$8 MYF]$K@4O&9*?ROA,:R$\@PY $&CK9,RE*J%%(P&K^[!+,CLJJ6_E.9;8K*\Y MJ#/..N/2%/.#'1X3HR0%8*I-PI;M;F7+'O-20R:72!_20RT6^5Q@ >-S M\# M>C>89"? U0PRCA$?8!_!6,>_A;;.KE]TL#I0,S8-D82%#"*84E(6,+DU0=1> MV90D3J'W2<2]0\1]'Y^44*E&^[Z(-5WW2^%Z^VPK_PR :M26Y(4H*V,[AQT% M0\\Y@9R9ZY\0\*RDR?AU+YAV%Z,IN"G$RVS;A"0FJ7#CL'$SAZ+,H@ MH7P.V#_W$2AZ, (R$.F%B4/^ZNCN"%]V2X_@[^YM;\9?PTW?Y&G$65U&1R>Q M\6(Z 3I##$KP\+@OA-0?V+2$7)BV2-DVBO"6^"ZJ8,2!9S,P2P$RBH6V.C"@ MVV3H !_G+Q<.(&G5TNMBMP''(]YN8O#"&2([6^TP"5TE&7FA6K.]-#&TMS[D MJZIY_"C"+E]P=PDS/')[+?A1D>UC_"8@GP:_!CGQTVSV"A^,2&ESU\-#&!_C>P1WWE-H04OF,!C,3=.1.YG7*M'Y_ZRLC8 M&RE?+#8"OA:M<54+_UU[ ]C^#2409\RPLB?7#!_BIR,.\Y/:CCS(@H'Y$]-- MN>OQ2Y>!XFF'UJ6?WO:,;RU"A"'S7QGCZ\YX6EQ")-17OI1O=$W*?WN9"_PG M-9:YN#2;IY?/13Z%XW@!-BZ(G"5@;P.GS@$&+H$7-E]ZS_,*D5,N25/COM0/ M473 JQV5M\3"D[\&GDE>^CO[Q70=FZC"$_H?H0LH. \?_JI/9^]N&Y=D7VS? M8?NHY#@YZIKZ*28]-EW/3S'I!0;8:VY;8Q8+(+Y9S\5$ MFI ,[,,:^$8T,NQ@TX#ZLO#7X^/=;5UY?_^H$.TH#W>WJ=#7SLGI\A(GU2IQ ML@1[N9S$R:).JBW:R9]0'&^)DW\6@$9(CJ+HI%%5D<@-BQ+ %NJP,Q\OKRA!P1+4.0\&QAN?DC8URQ$5* ME98@X^$\50HKC7F20/K0>6&<:D72^4+6YXB-&>4E(*5;ICXT+5ZX&&-4&!NG MRD,+?<.4(L.9A++1\(,HF8!.* W^\(2M34Z(.83R@(DS$8-"%A/8\!H+[F2$ M?P+P@7F)GKH4YB M;.3J!^4K2G:'+\9CBSAMK^IS'RR, 9,-742:')3PB,;%0Y%V> M[QC?)XX%!_/^IEQA1\-MRV=3T\9,0HKS5Q-\\Y6O@>68\&(8+B/?Q'YNX&&9Q>X$G:0Y^+M-H MY (C)\!=XUY\V")M1 2DY"-ZX$\<48$,B]P&SW!52C_48Y H08&8B;!WF-O- M(V;2T$.L W9NPIV.1/*F$?40G;"PCV@6J\J@86T]#:=J9/@+"<-"D$[-'W1@ M_0?N\-^@Q7DC4X39+JM.0S8%/VH 6*K33X3$40N J#H!TZ 3W1HBQ3M*V(:O M36>4R#_C4;LP&#RV, V#]^24;MYOC<<&4(1E8:<7PFA31R:H$TOGH=%;T'11 M50:5EGE.7;E[GL]\)),9!@OJRC]U@!IJO',&FJ*D(9>HC)H0O)H>;@.XNRAE MB!\SQ8>5B>Z)PPM:F+G.&.Z4V 9LS7 =6(]_@8>=2_>,\#]S-FPY!K""<'62 M8T,,2)HD%"VS##<(7.$F$\\#M13+B8F9B5M+#& MXJ%0CQY3"(!EBM5M4@_"G9'Z%C5.6MP"VU52A3&MI[5W]NF7(HYH0GA-O0;?:@VM MD^S46 @+ 0C/IBW;(7;1IRR6QQZK;]5^[),U+^0?F:@"^V^O\9='JM\3>;@\ WYZ;C1%QGC-E2DS#.0C9PC-.]4U!<5A=\ M_ O&8-#M-Q$+PJR!#Q_?*A]#4?GB6,&4_0+:>SW6* H8$=G,7.7!4CTOF,V M+X'F+_R+WKL-;C86P+,#5P0FV^5;S'-+HZN0B4JE!Z"'X6_ MBZ>,BQ(:1(6$C&/65H6I9(GH>K!A/0Y:GQXB?" M%9$/$RL%K!3(N*0<_:WR)>94"[7NA::;RZK\EUO^Z9L5GV#S^.*Z6)7WLY#W MHRW/^\'MFJ/_JJU/1E'5?JW*%KJP;*$8'0X.;/X4KU") H7"[P:\Z:OT_8O< MD*<))OH_\.20NW1R2-5"--Q.?%S2B531K.'\:7VA4@V6N$Z7J@:?0'?[*I* MCXH=U\JG>#XR^J\'#96T45G6)0LX88E:C=>I86J*V&OV?ZU'\ MD/(ZN.;*G8A4\2=26:+(-CK1$SG3:Q;@/O7$W(G(@7GU0E,EL"[<=BC8[AF8 M\T<1'.'2C&*=;]ZN".TEM:GK!<8>JBKF]%GQ7 .>GUXCD)J#5O/_GMN-?\^> M:PJHA/]5T_J#VH)6I;6;LQ_OD@H=2OS%87'X/OZU4 :Z?6WV ]6&C:CV^(W1 MQ!74$S=>QTI@D0 1!F IAS*6JU=/8M^@T0)CSA M83$ !]@V1#!1LHL%J. ME_>S1M^(.;7H(O_.\YI"*4!S2PU,!9UY[*W\Q[N1Z/,"8]57S"P7"N%Q1LJF4)2DJ> @7/<"BLPQG/RT#O@S/]I[8D;I M^;F;3[0_DXGU>3BOMH@5.P/1>4^$/_F)[VJCU=YJXGO9)KH7F-A>F#T();4@ M!SCJ_9+NE&.:7:$1]AEP.)$I]%C751#=LR]]KQB]\,KMD%:0Q\DA;9&I/AMA M<09@3@>+NYLQ[2/PY;)U$')$?DQ&/()6;SUG;8%0A<"T(F@.G#CP6;[)E/K]_,)7+PEO*> M.FBE>H"\ZJA'*]^^NSK\[L*X^Q7V$GMS:6S]Y%#W8]1*+NKB0W$ET83'8T;@ MXC]B-0(7ITLW6Y4N?1+HO&MGW$GS7[59\=^R(^R.9C9<""=&I:*7'ZDK+GP< MI"[:!O+VUZACXN6QZ>:@8M-EQ^BH%>OE<5RU@!EW)ASWO+USK>W=S6?EG0,< M;W4*\^!R>.9R;^;B^+9LB'J!#+M2DFNP!?"Q$%3+AK(/A-&+C1L42:DI9*@ M=UG6<-0K+E+9T-HPG6%[*)Y;Y6[ MV2NU4<"74H)+/0:0?DY7TOU"U:@[[*!0XDYO.:+T![Z5,G9ODS,?C@F26'ND MK)'PVL*PY*7W&@XOP29?6F_9B'@MQX1X+<>$^(:R9N.MO!OWDCMO=I9.M^_T MUNY=;>;:.Y7_BU9-B9W%)L"0&S]S3%;4BBHV232\!SZS+S4C&EN.X9:QTT"\ MLY5XE;9B^#R-TNR6;93F;_&2)CZ0_CZ"PBU!@3I]'77.YJ4,;^*#-@O4G"DG MR/QL2G80)Q1#=6,9P3C=T#9]=FV9+YDT2>.!56T9@QGT5_"7=5-]N[&IOO'& MS\F6X<_,IJ&#<"3;F9H&+J$Y,E>@($=K"6WP#3VY."60=S&]^@E4SM3S#N\HM8X=9DYFS]7O MY,*H/$_USRDH-(M&483+$8VI@^4&T!;Z29QNZW%(&J9K!%/ 2>J;G&RM_(J# M7J/YQ%S$<[G_Y>&> -Y[YRF3 'MXE]=A4V!DPF& M7Q1Y;U0A)2=R M[E#O4F(,5\*KTTH,!%_F&4''R.9[0T.!LPLN>\6S\4=PU^*W.##]BK.P-[]8 MCN=)D=J-&!U.EN;R%PR:%].3A1H1Y\-%?E+;X2_"YT@,%[9*BG5\7&?#J.VR M<;FO@O-_P<[C\*)KY8Y?TOW")9&! M"T%8V9-KA@_QT\UTT9WUJ$"$/FOS+& MUYUQD=50;J.02GWE2_E&U]A;L0,L&EQJCFA9+T?$"=M!PW&\ %,^(^<-Z!PX M$WX]&+A>MK#YA%>VJ*-C$X>M,HJKN]MI1^52BFK%% BOR>UL[=Q-I%NI_QPR;/$@MNQ,D_A5)9' ,B&KR)_M27X M;&@M%V.PGN\8WR>.!0?S_J9<81S3,/TWTGP&C AY*T_IBQALB')^6#^;'X7B MSOQ,%,)C2QRRDUZ#.$)9ICXT+6[0+^ &HMC4]/&3$*+<>_@W3_D:>!ZZ#+U@ MZ)DC4W=Q ?$^_F,3%\. J1=XZ%L7/$\&"^0"(R>@P5VP%Q^V2!L1+DSYB![X M$TX/7.*!%D$X-:Y921L148?L#K)*3N^*WQ MV ""L"STW1-"\P%S.G%TGVORH#^BC@LZ)?.$ZH-/P+_!\ M30Y#I_=:C@'$'ZY.DFL(!.5=F**3K&<\JKV[$JGC:3 <3<.PZ0H5)<)P8&\B M+6\QW*I0SHEM"\5W20 \IGQD#U<4J]ND#80[(VTM-<0Q? 9NG>4H,Q1)TVE M$$'5,BNS#KWAE=M+X.F2.(= UM: HR@R(2<\56Y$3%3E4WEM%R10^ZP"S MSUE/'# [Q][D7*[Z[O;NG+[32&'#ODO/WQ\JWS, M&#\L-"2<%NP%LQEP)3 -1&JF5UUF.2XS<$&TQ.]/CJ5>/E0:]98LI:6(@Y>& M5E<(<'P$>'Q$>GY__R@(^N'N-@,;=G/I]>A'=C &_L^M2I$]"H_']?8(X]YM MPBG6H,61D"!#Y:^(X/A$<#N%M0P=E.-OF1A8)^S<".-3=#->I*WEKH(T!L3& MGJJ=TF/[TN@:*GOEBK 18C;?O8\[P84E"1SJ*W=LT4-'SN"-BSE./MS1'([9,]27\(]BVM3+JG\%Y8;@*&O&R9$47% ]L4WHSU&XXR+7\8;);( MCTV$#<,"^%N/YU\&8&'J'C[#,:+\77PBGN4$2R:7,S%K@UDFIG6ZJ>/92R3)VS+4R9_)'Y%^ZN7#%[':Q@@P$&D-N*])X"NA2=A M5;P[KL+TC\/I"FLU*ST/A[F ; 7RI.0)[1AY#QI7H.1F&2/[="\NWC#UQU&;7;1]K@^NEQ"45AS7E<\"3@T0R&ERG^\DPVA39OV3S]Z MEW1DHQ=CH1TG^7;O;Z'=:2[]N-M2E MWZU:5E4; W7Y3R]HV7;>97?3,+R% +MBCR>XSAX'KU#_]%ZCURD-2F7W4.>YB]N, M(3FW&1)91RQW'_Q!?=!O'W6>3(4OIX4O_6:GPI<*7W*>K57O]HK.F:GPY9+Q M13LRONQ+U]MR'&7,,YQ(H>YR/3$K$?E(V009%0T+F5J7,'X"U>J_7JP"\3P#WR\(BRC52]G2D748U[A;2[G3GTK:!5Q1E MQGM2W,X5P.U.OP+P_@"LUCL5!N\7P.UF477BE&V[4_'CR^K;C2:IGZ[RI=9; M@Z*CU"OMMAB NY7YL$^5H%=4(:C 6PB\12-CIVR;G8JT2M2[;"2R3EF#ZJO' MC=:>.8"I.:#VK@+Q_D#6IIYG+E_=5!R<19/*"^J9^0#Q9EF8^4\?+E)5>O6 M56U#9WXQ0MA#RE^%?B>/?JUZ5VU6Z'?TB[A,]!O4U?:&H>(*^RKLV_+4_7JS MM6&.]-ZQ;TZVIY*]]JS8ZR>SB@B676ODEW&).^88% -L![$R3MG8#FW+S@GZ]6[@GVSYH M;7^%315J7RAJ#^JMPLVT*]2N4/L$4+M5;_6VJW:N4/OXMUBA=F;.[F#3AG#' M1NTBMLTO-(C])CWF70"C36EVCF?ZI@/O9Q8H^2\LFL7^1:]*]T*?:- M5(^""7"7)J[2R'+&-U'RT$PHZ,MG( M14<-, .$RSQ\"O9$2[,7,O'8^"]G?[+ZOAX_K<+R>&/\5^H$U M7A1$C7^$'G%2DXS(<$%FGFN&HX",:,">7&]!J,>(/W'G#CC=_!YRSLQDR&QW M?D6BHZ[9/F-&SV@?9/LK+>9\^V0%"3%K4.\)N .EWU),(^9^<8I8HG!I"1NW MZOZE:[FZ%$/X@B5AR=\G/I9<.1AHG:Z.C"GC//+%DFMO+P<>*F2"Q#9-@I7O.('M6TIN?95RZU;*K8P]=4)7F9^#%(9E M;0")OQ+7CL\VV!_AA9[NL^MQ'?,[?$+NX?&)3^X \29Y8+. 38?,(ZUFXV3/ M_0B&R.3-H+.-2E\=4 L]$T6J\90%/)$QOU.O'MA#I/FZL>3O+,BJY/ M_\1KZ/JMAP*4RPJ\=:=#=)_1CPM<..S(C;S7S1TF.T#G8'I3O>"47G#((GB] M5?XJ>#5NK?KC;;J-9K_8*Y,4O52)7CJ-P4"U?1^S.4$K9MI4$6=]KW1'E66! MT0 Z5;I#T1IS/HJ_N@CPK@ M?B>O_%$ SF-O:7FMK<. MWCQ7@/<-MIEF?1QL@#NE.2^^M,$L*[E':AV*M*I M+--(2VA\JG&DD?1I#O:\$4VYOKL!V-"+S6.<.(#/.UJ.T0ZG$E\7> MAG+JX!T4$Y*K"7C/=6U0/ZETR+%552@TJ>M4X$:KK:X3.2J C=P)*07@/)?S M:<7,M2Y>1-< M[ES_XIU\H"WH\![U%Q*,<'@XB53W:J4ZSRKNU662TY.$[RE MFG2L0'QZCO[IXS>W@ZNXIR+ E*KYFC4^HUZI8,6S^RY\1#=*W&H*EN_#PJ@/M-%<J.CJQKQXU9Y]M38D6,"N%_;F55J[HB:._+2O7LMU79^3/ :JD7BB.!MYA;M MIU(G>_JX-7+W)BK6R>,5Y[ZX3X$W3^NGT? Q)J7JSJXB47J/9.71KMD+*:R-#^>\4/39.BM=$ M=2:(5L/8MZ!=<>GQ"I):?864DB&EU=%Z)<-)\:+SL$'ADIOJ>-GK#HE)9YM GYY("WD9=ES*Q:XXU&]^[ND0D* M!K)?'L5]2AX;3C%P6$ \]LRU<0<,HM:XUN0S=>EX=Z M/:?M:R@H\E;D_5**J='57^>.%D?>>]C!QR#U\F%5;[XR=?[V."W>CE;R4LG+ M'<+<^BO# LH:* ,>%76O'2W4:+[R1C1E#)0.J7HK]\2=HG%:O#' @RL? CJT M633],#7)<4J])\OA!V\??ESCX*7]&KC?W]V 79&'<$K<<92.)B,:L"?7L^ M MKD>^L2?+=7PRQ:\1QPW(V(5_ A?^'T5'S!"OW"4<_8 Q7R/9F8_\'_&'H??A MX\J':T"R5%;X+[S9=[QX>[1R,'T)V-0G=#QFHP!;>X()P^N&9]2C0\NV@@6" MSV-^: <^&7LN@'/&Q 5G/IDSCQ$*?W=MVYVGKC3;<'K)*3JPRG4*((/4G$\Q M_+._%D3B3Y9C,B>XNL2'C@\6-HG1][\1HBN)TS> MC*@7"-&SC\>&R-;S/S!&4(:1KE8RS/PU349_<#+Z$I,1N?%]%O@-#"L7"3Z0 M21X79B8+J&7[2/_XZ[MNOPD"W[9!@&49PG&=2SIU0>/^!]5:BC5 Q.&9B)5P MTV@"X@MV:SG8$\E,^($OOZ$DF_CLB7\OVI4#&R93.,7$)\S!!1[8#$3Q$(#9 M:C:(T31:&OF\YFE<.)A@C=7VKQL-KK\\O(\2'P 4K.P?/K5!(YJHX4PVMAPK M8)>V]UDAKKE (#8,8A5/+XH.;?(?4"8#-W7%MXH'19]A^6I1OZ RE?2L2 HA!2D.4,FHDRIFC1D8NBRV<8_79X^)5[.WX _\&7+@(BKO^MF_M9 3G#W,(SLQ<(2.:S.'K&\P<'@.6Z90X(3 ,$ M]O985:ML/M,_E@AXH[Z1WVKSN]9L6Y 3!V/;?,8"(3@.EO2?743+Y" MAX"J,-C\E922&@%"F%=0PJO;R\(B_>\D[A*8T2=V.?08_7%)Q[#9*VK/Z<(_ M^Y!5UJ"6TP!K MW^N,.V-]U&L:>IMVV< 8&ZRO]SMZ?SSNZ.U_]L#/X@%Y8'L,!: (^.4#74VU M;L[#*BNK)%969H8YN?F5T-&_0TN($/AYY(8\U!.K8PL$<:$FQB6)\W"&5BX1 M3VX2V)4O+*;W5Z)BL] #Q0_J/X5H:B(O";6^9(/Y5/ \)Q&/*W;P[@)1O>$' M;#:#OX4S?'Q,+8\\4SM<-0.R%+=7&D[Y:B63(CS5ELYFHB''?EH!6(Q^4"PO ME$M&E,%+BP6HWBN;E2P(Z4N6D.Z0D&X+)Z2U0K4YV)!KR!> :F#\;,XPE8UQ M-&[GFN[O_AI%C% <201*6 [@/4<'SM+GCN[(-S; M%24UPK+Y#'BSR5\]"MBZB?&&[UA"*C=@& 9$R,U4,#,^]8WQ8(A)OMK,?&*I M-<[/XI_/+C1"OJ._%0?D8T$2$XLX'8@_$X1+.PGF6ULB:_BAQX+0R:VEI#ED 5SQL2Z,U@0K#C8X(V(XV,,O;'UK3L%I%(G&+E3>*T?@N/)!$O@ MTHQZ]F*7[?)(U=8,!&P6Y-P/AF8LR%,35L04AU@5L02G@M>!T2EDZ5[1+3/T MHHS*7E' C:%&6<3+72V1P)" 2-(X4O(+S0+B?9)H!_BRY9K^511D.W_7-3)A MOXOKM4F3\W?1O>;)P$%D3S*?(/+S]ZUCW0_A%>9< 7C^$BZ&UQ<8*/XFL0>AB7"=PA>G3+ M1?:+R)%SV!P6&8&1P2E]94A9W41$2+Z0C^"OQEC?P4&FQA*GQNC*K<71'?F<+?:^[5*CB9 UO!=]K-@,!BSF*?:B< M@ALNB7V5GI&(MHD%4")P0@(?A7/B.C,O*W=A(#DSRQA0M%%9' MBG\)H&F:R$?\:^09V#XN6#'X.'=X+&=".:&#'*0S%J+QE"('_ %<4H]>\E]- MAHT?8(3Y"Y_W!,8TN)/O@.2[J>$#J-?"OS?(W\&F Y>,?,;&5H=\!8ZC\\Q)S)KB+U -(#^$3_NV1NT%_W?"%PW-0%%KB_<97AF9T2N(B MZ08 [QLJ!P;BUT=F.L.@[ >NUL\B6KQ-V_&?8SO^(9P"4X!#$26.DX;>*)3C M6S\3%Q><:3=\FK@A>AQ6B5HA.1C./ED^J"H_\@9O'&HO0&R<%62?\TU%+IHO M?+300T0M+AV0,RA.GD$F48XY=WS%0R")>CU/;A+$[SZ[-NB1#U- "'\.VX]= M!_ "3G^N$,MYHLGH]A21#"=$[7[Q@E:F7S;5'*L1'@9N7BB?I8*,^"*C)F,^D=>?*;$EC/T6EL' M62?ZB@!O')Q:%[,13?(QV\1&39RXW10%S%GS>W#15K_*IKZJ;"K!7HJM;"J# M[A;9%'3>,R%N<,HX]PM11T#-^A/TKZ.P/P?%D-GN_(J\7"'/IZJ(Z2+BFS$# M\Z$K<$R;SGQV%?UP#=)H9M/%E>7PS?(O76>SETCI2S-7.#S%QPD3:$W!"'*Z MK'RS_%CC'RW-D!&?M=M:MS?8^'%3TS=^MFW9OM;L="JR:D]KM3=_6JZ]'FW5 M[N9OIE==.\'8T,\245[&><,K*>SF=M&=,>$?(B'Q=RXD\ERQ\^(@Z<$N@!,: MO$2@PT21L*]^Q]C-O4CXW:TF_#;>%U'U.!]^12,K/,L 8V=#W;R)_ M]B@C@-\=S,.=1_GN$'^]V.5JM4U#R? PU2(0S'#7[L1&O4Y\.T&OL5YG5G1] M^B=>0]<'NKNX)#IM_13)1*>]YFK,DYH_VN[JC7ZGL]^]F>48&WN::.DU^KFO M;%1H.3):SG6MM6+F%H:.(B"PW\6 IT@+.DA.O97W)@?%HF^ ED%WSXN@%5J. M)CF;6D=)SE>8VW+J>Y7,[74QH]?<*UM!LA_H#6.PYY4D!5R]4$$(]WH-O;WG M%0H*PCMIU+[6*@2^Q4OITT=NRVBT>TI '1'"1J_1:2H!=5P!M>78BD4K6V*D>(U3:WH8 MM!K=W+:<8M.CVW\#<&+:"BWE0HNAE2U_6;STE/;Z4I>(WA&5Y/N%@C>6G*HU MRK/&D2I#MS7#'+6"Z _L+/LJ1Z@LU4TG=:$C>,/%*Q0K MERUM3;?%D/I,5(6?ZTFN2G2Z;*:#'"13^4?K4"3V>S2HX*L;XN" UUB_5=3: M@XZVIRE5@,%410!K>]:,'!J\K^/;\@'V_^!_:L:MNM[6]HSF*6[=!U\WU:1K[IF>5Z[,+@/FX:N-:@?@T M05Q\,NST\=MJ[9L#5?Q3=OY1(*Z!B*I#3(K/$ZV9E]M23F[YA(8"<45 7+Q< M/GW\-K6!8I_39!\%XAI(*-6999-TD:#JP8J;?7J#?8L*5+'ZT:+)[7W+LMX. M)\>2'N7#QJM+N4Z*-HWF('>&7PF,8TOQTG6W*'E18.#N\(T8':V_W.&P[O"; M.QST75L<#KKMP4X((W?Q)4P^YJX;XC_$9G3,N_B_:P\:&4W8?.<^C&KV!9W2 M&ISG/O"K33YNOSDERUA'NBKF14H4U^&Z ;O"*]O(E"[XC9=C%_[!.T&Y#V.& M>.$5X4" $_M9>MSC?%6Y.S![0SC>GA'=E"&OV,)+%V^I0TT+-Q<.?0M^\A8- M,N<7S0>6(T''+W1.7;8FKJQU/8_Y,Y=#%<"[H':P2"Z?A/6''CSGHTXRR7!! MOOWZ&[_L:SZQ1A-Y%2]>J1>_&6\ Q0L?^74^'C49WB^&UXHSCU_2C3>C1G<> MEN:*/0[JW^[N'A^*O.ZZ43* _ Y,H."1[.?KQ+*M&;D'GK'\(@'#6;=%L\O7LXGW<3]T6MDW)S)FY>G-(#M@ H"&8J"#H4?7M<\@[^Z)MZ] M"RLX>-OXZ5Y@*XZCW)?EE< M&8W6B=^06B12!ZC*RD75O_[/W>^?E$Y([>?3W?]\N5$ *9/54"YX$ X0NYQX;H5NW6SY-*H#S^=L?]^3^YMO__/K'MS\* MM37.33:&OW+/%"][MIX9OVB^C& K$E 799-,$7\52CWE DE:",7B!ZV;A\ : M_8 _?H4_6I1/44G^K*1[@L^'N]\?"S8 2@:1Q[MO=X4"I(3>((<)N?UV\_GQ M[M.Q$?8"<'QP2L!?H\)+^=LCO];^KY=P$! %H-:$\UQEI ;!KYE\KO:'^#G"?F;"V;NA4;0$R;4]MW8E_T/\]S8YT47^-)Q@\MA MZ#EI#YBO-%Q'YN M^0S>CW&9!L'X/ N(/\&H/4:W.#%;/HGL?BDY+>I0BZ(QB5 PO MVJ1/3$;79/Z&P=&G/ YD.2; P5NLKC):FB .BVKDA#'R#2-DS!G!BG&>*X). M0_XN(-[@H3$_FN^7BG#BWS,(! 0 +&%O(X8A.'38E@$[61/-:\!_UM+'"42_*9S]*L4K%EY4Z_#H28H"[FX:Y.8[X=8+W\2GS^0;>X*'&GQ??!D, M9ION%+EM)+^IU8Z#UD$O);/\\\H?? MV,JX?.$TM: H]=SP:0+F _QHE2V*ACRXRW_L- ''A6_Y9SFW>8,JD MW*&#[6%!3Z0C(KWE"S:G/R]GU#+)3%93$ZSD 2GL<,*P\4' ^3.U;#3OB$D# M2L:>.P7-Z(33(?-0*TH*M3F @97$+SZ\;B0E])0"'8%HB*C6Q3UFZ?47 @?-T*OZ7VR:\GZ=W[2^;@Z+J MQ@^'_T(JEL"UIC,*OP&9QJ #1K&<9_@>FA]3]YGA&H I7M/C F( .>L?23&. MP GHT@FFR=$:,5W8 >;+?0RVP.M3+_0OA(F2. %95OT@4;S303;L[!DL*S?T M1>1.9RRP\!"P+\$A@:57H@(+WBXE$_Q]9+M^"+)!(P_A:!(O@C5P MT:;Q*$\)NP!5A?B8D#-^.)O!&^ 9"\S F"*F+)BX&-,2H0; )Y9A.>#L 0 X M:XU1D:"5#RH-7^4Q4&1P>D^6=%G.V ZE984GPAW1\9AC! W5>)F8E\%J",#R MQ"*O+UB(QO/ZL=H"#&&M(F=<7ASP;#%N*_/:L6C?&WE2\D4;:VE7*VW!F LF MLJ0U_2U1%GS53+Y"AS[ /MC\E13SHQ_+O()XOSM8JKA-_3N)+RZ8@9]].03< M_;BD8]CL%;7G=.&??A: P/5$3 M_0LMS5[(!,R"OYS]R>KW.N/.6!_UFH;>IETV,,8&Z^O]CMX?CSMZ^Y\]\">Y MS0<\<0LO1&'RRP>ZJF8VZZ#R:J)8,&--E50!NPIS="02T0?VLN5CS,D!TN4\ M+T2!+RNQIB"'4"#RKZ',P(-'WQ.B2%K _A8%)\WB'>0]V,CWR5YX!'?(;(L] M1X)/"ND5494&R:Z@L*1<'%G>*)Q*V2@ =*SSX0*>^RQ70VU&OM.E'(8T,/IY1BUAC[G!'NHR;NJ(.;M6HW6IL%4/'?V.+R)SDUKK'GJ@G M_/JTTXY+9D-N_JH;P8V4B3MW$*U<)XJ(/I"/.[\J1Q2;;RG1AKS)"*LXZ,QG M5]$/UT!9,YLNKBR'+\6_="WKZ*4*7=/#PH63^%AJE,% ZW1U5"JRXT>^6.H; MC>N;I?XL^5E;:^G]C1\W-7W/SSJM]E[?W+;9CC9H[[?7XZQ:! 1 "99H504! M!8&WAT!7:_4/+P?V7[4(&N@T>\=85>_LM.H>U[B5\T(G]:AZM/!'=[P;[Q [ MZ>A);ZNP2J6=F>U^;VYO@!RK$P?2,-^E-?E5ZQCMG>E@IQ=5@T@PCO 0.Y;G0WE+ M(Z_#N,B0QC%@KG>.#O.71C04%VS=C)![X=L_<-_^_/UQIC(<][9,8]UMF?O? M>%I"SA%(VH%%O)PFZVZA02H%O M'_#)]NE'65F&]6.*2Q67OC69O:&CD1-/U8"OT31:AZ+,RIS8.(2D.E7@*')0 MY*#(09&#(@=%#HH<%#DH5)%$HFVRX *$Q, ;:8!?94 ]H='5-?PTT%'UEY^5W6J^#YRG!HMW1FHJV M#@;/-O"JDEP1+'JO@X6BK0P\![JVD\%< U#T>DHC'O):G[ZBK @4/:VK*.MP M.N!UT#PI2#1?]OT'NY3D%'C%XGH'_B[TW-DN=1'E+/I5CZI']XW$E9--UTN@ MSQ[VN!:MW*HEM0U#ZQT"8A4Y;5OK*_K(%9UK:KMD>$[GM(H^\D+L(.&URIRV M<.>I6A"KE?@XT&'K0QUMXW5QF8J=MG486ZL^]-&LDW&Z?-CJWZN\X\'_RG Z MT>*M*B3R7>V\O4*B]9KJB"-<$EP-2N^T]C0:JWG:]IYF06WI0Q_LZ895\K3& MOM4O]:6/WIYV035/.SB,M*P/?1B'$;A5.:R2'KD UCH0/U7DM/W#R,KZT$>G M3M*CM61IU2%/^"6@]D(%8O*5%!^F'JTRIRV\9KA:$#,&=:*/UH'BDC6BCP,E M5BMRVGT=D-K21U]KUX<\^EI'44?.>'&-\D"=Y4I:11\O1)%"H8G" M(@[]U;6I8ZI QIO4&U3SM,:>S7BUI0^]?YC0<45.V]VS=J^^]+&L:$[[M YA1RU&!C%Q2 M9%\;I)JG58&NG!![Y=2P:AU6-5OE)X\:-5L=B!?J0QVU2L&J#'W^"HX:I6!; MS<,T'M:(/NJD6_0ER^,%=RVZ7-UQL2EL&WS4D^K)TWWRA$9^/3SK2RC]8AX'CWM)CMLNK2M68U<@J[^W9^U98^]BX1 MJ>9I]VW]JB]]].H4-=!?.>VW?O11LP$^JJX_;[JS1N._5%?0:\-P)WW8Y?1, M':KZOSBFZS#?HJIT*M_$H'W;;:MYW-:^E0"UI9#NOC> 5?.T'44?BCX4?1P. M8O_UI[ZA&]?U(9$#'K@^5&+TZ]0!8NS;MU];^MB=J:I_KCHDV+Y.+-N:S>#O MO@IDY ITU:IZJMT\3%*@/O2A]^O4]V&T5: \=YJM1FEZ8]^^\]K2A[IE1U'' MEB*?;IVT2U>UC163MZ[*8=NU2[-]"WV58\M="V;4:4R\#DI"#;#(Y^8N#W4X M]=.J'$J^H$_W,/'BBIRV=QANJ ]]Z'J=LB=P6D4?^3A*K].$I%93C>_,!['> M3@"KVIER-5Z?1%;M,?1^,'4?3<[90/M>FEC)X_;W+6"J+8%T#C3@HQJG51E7 M11^*/LI2#UCW ]>'2MK[7E1=S=/V5.9529'#5$96N9ZUN!Y3I7'K-I8#VSZ\"=75VV^+>7X45]A@N"ITI;= MBL7V3>]7]+C[MF#4ED+:O3I5Y[<&BCYRW^9[D'+"BIRV>QAQ61_ZV/NFQ4J> MUMAWT&I]Z>- $KDRE#O-> M*E*CVLI.1UTJ4LS%OO4Z;7WHHUNGHDI54YG75JT3=2S;78HZ7I*V^_IM53VM MDAXYQ6V-2E.6HX)KO3;=J&0I]LT4OC>BNPRB+6?MK7KT1!^M0VSDQGL"<6.GF^AJ'F_.;.6M:HZ$UO*^]&T8>B#U44688#UX=*NOJ>M3'5/.V^ ME4"UI0\E15[VXDS+G]ET<>6X6.:[#4;J2?7DZ3Y9A_'I]^RG-7)5?53.2,=^ MF8EJGM90P[%S>[(UH@]]WQNOZDP?=6H VC?245OZ:-:)/ YTV/I01W??H0S5 M/.V^];:UI8\#M5M6Y;!K:_>C;43/&ASW:4AT>GLDNE-?*K?S-]@)>.?Z!;FG MW@\6$']"/4:8'UA3&L +\#?8Y"BTX5>3A#X#',#,)-?\5^OB#Y5Q&SU(@/?+LVN&4R2^25?A] M".C09M%@ OAG22*T<;+!ZMB#N64&$[G']+<$K*Z:R5?HT(47M.%_[9A\R9IH"&- "7S[[Q MA./QT4XHR-QD(]>C'#/ &,P3$RI^H:79"YD >?_E[$]6O]<9=\;ZJ-Z8W,(+@7C\7S[0CUDTQM#^^,O0^_!Q M'8Y?($;.(0F!>[!3%"@VG?GL*OKA.HJ+6@X_+/_2-;#B$Y""Y(HU0T+X^\3' MDD@& ZW?:2&=2-$F7RQ)2.,D%-DKV<_:FM%K;?P8_(<]/^NTC+V^N6VS7:W9 M:Y=HU;>'0$?3!YT2K:H@H"!0A!QH=7LE6K4(&FCW^\=8=7<:J$22L=0ISD-6 MEG?TQ(41UH:T'^!Y L:T99+(&BYK#&)]M\9GUR/@")-',/$8N8?G)SZY \O/ M) ]L%K#ID'FDU6SL$)4I'X'4ACR[R]2)(_ VD^8N\<17K6.T=V:7G5Y4#5[" MH,##Q)I-T>LAYT/+ML&/(J%C!?[%+F'-5\%<[QP=YB^-H"PN?+ 9(3)&^,"# M+>?O8SP<=#^KHRK7;>@-1E663PI60@970[X(4CY$7V6WHA 0X6K)TOD%[*'U M:(6 =G3U6@\S*9ZQ4 MPE0Z;)_^"5&AT31V*O8YJ1/O4LRER*$V)U;DH,A!D8,B!T4.BAP4.2AR.#0Y ME,]K*K7/MG$*P+$20$5&A2N8V-&/DXW:$6Q5A-BK;FT[X-R02HK>#4U*W?[K M;@4X)5CTV\7/[3TA>.J#5UZ?>DJPZ!]H K:B+7FUVKY749XB+ YTL[NB+3'= M_Y4#4D\(%,:^-Y IREH+SO[KAMZ=%BB4S#K@Q;O*THHAL8M=4+YH3@EC28-= M"@5+=P7%7>BYLUUJMLIY3X%Z5#U:%:E10IF5PW0HES!;K\T^>]09[52 J@8E M)Y=)U>@VCW[Q#EJU &9HO?I01TM11U[JJ)'L4-=8Y@18[4;P[SOBLK84TMYW MQ&4U3]LZS)7R]:&/9IVLC]T.6S['LF)N[2N'*+Y!Y=9Z\O@K\V"-Q5M5(JW; MQ+Z52*W75"+5=KZO/CC,1.1JG-9H'F;:=7WHH[MG=K22A^VIZ>!YJ6._A'%% M#ZMNKLEI:]9(=NSK1=26.EK]P]SD4IG3*MV2LVBD1M*CI=QRE6U>2QE? FHO M5$ OIT][D!1;94ZK4D;Y(+9\S\^IG[;PJMYJ0:RK]>M#'KWB^^NJ!;!7-M!5 MZ[#&85BA/M31.5 !1V5.^ZKFF?K1A[YOR+2:IU5^;172S460QE?7IHZI0F*Y MV*E3I\MZX;3JJN^J ],,(ROI01WO? M%IUJGG;? '%MZ:-?)_(8**=6)6O74L;#C%J."HCE4L7Z84*(%3FMH9*UA;3+ M5N6P!\DMU8DZ#M(,697#JLZ^G#6Y!P%8K0Y;'^HP!G6J\V@UE6[)6_M0(^FA M*Y_V\#YM^3:LGE1/JB?+^>0)S?M\>+B[:9#;+P_DO^AT=DWN[V[4\$_UZ(D] M6CX14D(!=F(1_KNGQ6R7RZR5'Y4N>:W1_"VCI=IM\A9RU:EB7E%'7NJH482_ MK=IM\@:]:Z1:#G38^E!'NU;D8>P6PU7TD8KPUZ@7:[=I3.7S*BOFTU:P%>N+ M8\*)?8NJFM=VH>Y#+0^U-'2ZT0>K7W+DVM+'[TZU0?M=O=R^5S+ MBCFV%4S9/H;>#Z:N0,PG;/>5'=4\K>J,RFO*[ULU5LW3[GN7L*(/11^*/@Y< M55CW ]>'2CJU2LVU!RJSKZ2(JDU^.T>WFL/Q<#3>S7_K_1?RZ;,:CJ<> M/;%'RR="2BC 3BQ2=Q/Z@0?[V*\*I;9FD%ZG.?2&,I+S5OS5J+'B0(=5U*$. MJZA#.=B*2G9*G_7KU'_3ZB@+1$D1%:8KAY?[RD8+TWHNAD3^F^)+(PHYZ ZZ M6F>'+5S/7-\*+->Y\IA- ^N970?N[.JRQ;^]#"_J,US@[..Y<1&3-0>>*L7; M4476J52SOV>[=FWI0^_4J593;QV&&^I#'^W##+^KRF$/TA13'^K0:]4(T%># M('.JXT&=E$OK0&.5ZT,?1K=.]&&T=XK?E,\WKIAG7L'\\X,;!A/R-]=C*@.= MM]R[1BEH?7"8&\?J0Q_[-G[7^;#UH0ZC3A?X&8>99%@?ZM#W=/EC5B)A7 M%]=H,BB<5HT5SCD6H$:E"1UU1=NA/%O=J&1OR,T4OC>BN\RF+[S"7SVJ'BV? M-"BA+#JQ*-N-]P2JTW)4C"WG1>8U,G1[RDM^F^%Y%3VLNCY#48>B#E6?7?B! MZT,EW0/%)BMRVGU+%&M+'TJ*%.X]5N7)%[S<\FU8/:F>5$^6\\DZW,USSWY: M(U=5M;[%+8J5/.R^'=BUI8X#]9A4X[ =U3'Q-B&D2A[V0'>8U87/+9[!Q?$ZQM:*S=71F7)!'-Z VF0IJHXX9_;A, M>)8SLD,3B,]ZHIYEVR[^B? )28JZ%'6MHZ[6!9]\GR$HCXUM-@K\F+),0LU_ MA3[^8#F7T;,4Q!AY=NUPRL07-?*;Y0G\\[NCM?^I& M^RS]+?F>%!/V6%JNWSO"*8[7_'* H*T1MNYSVB^%W+! M9"/7HWQ^'$@2YHGI<+>NX[NV97+F^V/&\ DP(KXQ/[2!,<>N1\!\(+_#P^0> MWC/QR1U\VR0/;!:PZ9!YI-449'R4T7A['OGL(\F/IQ+A=^O1'@$A8Q>T[AQ1 M!6PQ"GT?\ I,,YV!] &3+_3@EQ1FW1BSWA)F'<3L5&"6;FZPLX.X3? C6@T] -'J,^K#\<$%TK?L> MK5G\VMCR_"!-\XW(9N&6M0 %C\*+!S8"^*.QSZ0%.P(X T&-]]A]*HU-PK%WZ=X('_D64,. M+_Z\^ P@YN/>03+ \O"!Y9/[3WR1FVHS[5;J^2Q%W3BT;;)@U(N$&C@PH>0^O(H;6?*^1PW.QA$4; MI\2NCI"=6V8PD49Z^EO"6;AJ)E^A0] G8;#Y*RL!S8+PW=.SL$C_.XEC:@IF?!N#RV3>><#P^V@FWV7._T-+LA4Q M5O[E[$\O&^(]4*-HPB,W@$$: /'XOWR@JR2]F=Y7J!Y\LR? G21CC,!>E]B* M>)A8LRDNIY[Y%UM=]TR]IB!* 5T MZ;V!UB=#R[;1>@H=*P!D("IG'JAK#[81(?7KQ+*MV0Q-LQ.V:A+V ]%K Q1< M,QP%VSGO_Z#B JAYH/F=F';G#'S("?@PP6@"C/;OT!(:7R-H.0FGTO(!Z+/0 M VN ^6AC^N$461<7X-%@[H""_,ZL]F=_U8068;'E;0(2T4ISN>N:VD,C]QGU MMM:&,R94D1(T3YX[!T<6!(-CC=P -S5SP]$$L'*.?&UA*L6#[TBSF;L-:P5- MVNSSG1"^/Z66([[Y, +) :;>LT6!^YMP MHS*1:YM\%L0*=\M)I%T2E/K1PCNB+8H>2)CR1!/Q 6-44WZ3!5CY8SC/#**M_#.NW-/R:RPO96;%*BD8R M1+7%W8FFD)>@9;7-\)3V$=X@T47'0*02+C%O<*6+*R5602?^!"X0[.#J4CQ6 M$#BQPLGH7A>GIY9 UD1(K,,0ALXD:]KNG'ED0NTQ(@KP!8PV\]BSY0('ZD8' ML % ;5Y*)7>)2HYXU'EB&7.)RUS@8" 46(8"17F8X@699-,%BY-V-@V=$1=V MC]2:4Q"EP.L+8EM3"YW;1!9^P_"A<$R___! C#$>1)@S(%3XK^_"*6 IY@7P M68 "U9;N,4'6=8!U85GVS.Q8"&5"'7RUP*,FXY+4 8DCTRB1Q@YG( ?P: C ML4V?@9R'/.PA5OM^K>CX+>GX9HWAO!SP0-*;@0;[R8,E]B(6/!C'V!E?IRS6 MJ>V[D43/VALK0 5@M@9-A%Y;;Y*I-'+!CO!7.'_DXBB6$(/Z8> '5)@!DIMA MG7+Y$__O__Y>J"N1,N1>(LF=0@4E(LN E1LRRNVH 08D*L:S/+8U"))>-$5P%IFJR]3 MD, :4O^BK*GNK"['VK1=#$Y>0)1DOCR3>5AJ9].9SZZB M'ZZC B3+X3OB7[K.OG#-38S\A>+C)'ND-44&25;]R3?+CS7^450)E?FLU]2Z M_=;&CYL@ALM1F'6D)W<&5%_K#CJ[PJG@57M:Q^CMM.J&]H+V2GL! !+$KOAY M=2YN23L-!BL;+5NKS/H1ONGBN/\+]@*&<3Z!E,S46:=JL(*2G*QYK<^*=VHY/Y\2W$XR]@FLQNUC'R[MW M +YRYN\;W'F]'@"BN#%K14KC41B3;W0=]KK=[7L=MG[Q-@&I]1!=LEQ+*ZD/ M]Z3Q,E]L%!D9CFF2-7SC(6Q+90T8J=M.W]A?EZW_>K>YTOE_&!3@1QP5Y4;! M^XUJJG;$F!K+K8A1$6.AD&@F\[T4+1YT%)[ ?RN'25D$ N)HXRZ7W93;J#F, M^;,&F:5CY0UW(K:T7DY^VD*YI9'@ZP^[GP2O-'*["KDGBMRFIA>"VT,&3JJA M[GY[_*[TW"8L5H1;VKDEX1:*/4E)6&7<-A5N3Q2WS8+X=DNJK[\ET[=1Z;[L M?98TEWOD/.)1X56-U4\P"?5"V("XL+=4S5(1F:AU6]PW$V52VM8%"[HDBMZFURF8GKAD6O+ZX!K6+L@@/"YBBEEEKS.FKE9N%3OKL M[SRO^!,;P]]-[/L47:[91N8)D_VCP%XCE\]RV#1.$U:@V'^!U6'TB5>O1\TN M<@[3RTNG%WQI'E/2M_#2;-M30IFQ%64'0,T14; Z_3,K3VLT]\I8\B?4W*LB M]E*FN5=+#3"\MS7;[ZUE_N:) VK+3; Q7;]MI\Q@H'6Z^CZ-,D9+:QO&7JT: MVS_K[]BJD6>S7:W5[Y=HU=.!P*#7K0@$.MJ@?0P(-(_0L'29/$9+$!G9&%_:C@%';'8I6UJUXZW?9M1 M"BPF6-OKL,7R>6$T^Z$Z=G)ZO=5?IWNZ'4W#[U+3C\>$-2M8NJ?O7KKW M8@G),B4=C!+6UN 4R*OK2>'=@?MR5Z#P8E5.H<"7LH$E0D^&9F9J.OE]"B4&18 M-S)L-??LW5-DJ,CP4 ?O*EE8&ES4E@C/]7ZW?#;A@>9?EC_AA-316Q3:]4;L8KKMP0AC7:S<+%\FL UFF\ZG[ENX#WO-CN*=W5%N&4*HB@0*Q"7"<2@VUJ]-[=\]IW)IYY43^XQM7'W:W_D-$=CI,82#/>2)?G)$[W3J\]_A@;'[P0E]%XXK&4[ 9-%I&WMNLRD+CQ6J1/-G/(W);^4CJO*?E+P4J MC)C*%1Q5M+1$2_M4DRI:4K9U&5"S>_=1G2R.\VXG?[U=X;:&HFM%UR^9/;W\ ME7B*KDN$0477:Q.G Q4#4;1]FK2]S\@(1=V*NJM!W>>MOC)(%%F?'%GKC5ZG M0E&A)%^\\?)B^09Q2>L@2Y7_"OW &B_$GRS'9$YP=3G@09>#0K^C]5_LA3"V M]4+HNPY1/^BV!SOL^>SCVNZ1C:3R1IOB5S;PVQK(L[Q:3%Z'#:\83:CWQ/A5 MV'AQ%DX3*1!^[_K-Z(J%,D*2C%W;=N? 0D72&%YJ'C!O:CFBB0E01HF)34W6 M,!1M39Z'-_)-@8<1L?B%>RXFR!WU@^3NIPW7/".C=6=+=SKO)RZ.A[%CRQ%C MK1PIG (+)+Q=Y4@9X1;)MG>Z'@F8(D'):9&9)' Y<\ZIAX#[_L.C\&B#3%T/ M6'Q"D;?'/@O(<+$DJ UY&",^36I)^)XUG5'+XP) ?!&?=SGN+"< X6#AC>O4 MA\5]W@7YKBT+U]>LM[I%C7QV/;%-DP74LOT&\1DCO[L!(RWMR*#E"UY9 ?#L M: =@_R.S]2(E-P*:@ZBKE0I"Y*^N:\X!\7R'@L6_)&1RP\FD01P6% @]I;9V M45NM0LW?O*;F.[TY6"O!D.+20@SIDOVT0)IADW:#BZ0'-PPFY&\@A"BL:5H> M&P4DH#]3$N^=T6Q'ZS?6R\4Q"+*G-/DO2TF?+]1-+-/&>@ML9C,3UJ-/'A.6 MU]R"[>&CGY&0Q)/X-DH>INX/=OD9'B3_<#W;%*!H-]-;!9'<7P>:=?IB1H$< MJ&TO7M 7?2.'C!=[,+IK$<31@&AR1Q;_6WS8ASD#6W1"[FDPFI";7W%+S'M! M891+&I9&830B;5$NA;JSMF@4:6-QT.G-DM'6+3P"RHDY(^M8(SMW T]LB^B] M4D%($P1$OF2%_QT*?SZA0R/D#2R!C_R.RXTO6EWH[:.4'%PH5E'L.BBQI_#X MQ"<,3F.2!S8+V'0(S-EJ-KC&Y3P)4ES+,K+\9%Q'-+7QY93]1C 7 &__XZW2JV MD3R86B=TDI7P%;"&1AXG+(8C:%E_T\'&# @#3801V'>P[VQ4AX=_?3($R2N5 M, #.G3*/*_GH*U,^[$8X=30R0J.GP$^$H 9LA172/OK[FDQ UISR P-Q@8H M5=-UF(]_\<*912<-\M\43L: BA9,3B\*??D O',]M7+4@/$\PI69[VYVI"J/ M@]^S1,X=#_)NH+6$W3N4=!Z1/[=P>^L_-=+FKL\-]C$:[#//-<,1JJ'3!6/2 M5V?QOCJPV3-*H/D>E/#R0SOJD\Q2'4U_GU8/&9V"=,O1=#BG#5<:\9'I O_; MWDZ?T*K# M1:6!XD[!.@#XVK#(,_,#!(YLSE&;^B@V)AUZR M2FTDZS! M,8)-3R.J' +[SX"\?O(_ 2S?M;N)*0R+@1;A-..'4T2/8&ED]O$W:U(GC0,TAM"[?HA\-_ /3_*/)R5KBG5#'YW?#I[(21U M J]Q",)@Z401X$=N" K$![*PQFAD(A/$WD[6I8"_)6\\6JU!0D4Y8P]?_O>/ MAV-O:>L&$HD= 5DZ?5)F?]<>-#+VW"FYL4&\4?)7SPUGZ"F,R'D<3S6.%'?; M&ZXW*0NP2/!>"+)&U1/R,!P7&O.)!:S 34F3 4DGS(8:34I?;Q1._0 E/_ K M&"2HDL"THPNB\^!*NP'K@$_V]?Z+6&KBVD)5C4/X3:#Q#47R"]^38&EC,FDU MU32WS& BR^#2WY)%;=TX9]]R$89+>>2 K^0DNS%S(!4^@O9W^R^KW.N#/61[VFH;=IEPV,L<'Z>K^C]\?CCM[^ M9^_LXR.W@$!+8- <3==?/M!5DMY,[Z=G^/R/]8.A=;Z0KLR3#8:TC88^;,9" M.W8.XLWCHDN8[BCF0E#@\LF,S0Z& Q@W'C=_8^->6-:1W8_0]_GM8B@I7;!R MAJ$/V_+!(5ACZ2?6][+%'QGXW&Z:@161>$"V^P3&NC7R+X0K_PQ^EFVO=2]0 M,N=SIZ)-@$9_$QW=CP%W@GQ5IZ_" BC0;XWW>.<^6YSH\+.*S4>(8 -[N/_T7 MGTG$=1R)I0W0LY4VM#V'(U3'6$;\ABNDN9\3B!T!(L-..;P/O)D8\ MAEH][GX[V= TQL70: 7506:N)16"T=%Z[[?)+Y%5UX]4M+&_H&YNDBZ@$$"EB^<@J/_"8) B;4>CC_N@0K""-_$I] M:\2_:EKH^9GD[NL#/U9+Z^K9\^C(*OQ9?I(&FD,S\19[H9&[.%\$B%J?.HUU M[[NFU@8+(_W.I4Q2^_TZD669?SE[V=G0C=[9]G*2UJZ5(6N_4S3W;_,.P;GB M36CM^DY3J6%N#C!)-%]\($O-M@ I9+XNU4)[2^+*C &H(D8BIY#X4! M]_ \---#S.ND,);PO+>$L8!C[$6C/38M=GG>J+KTSDE"C^ ^VD1<($5(Q<^^ M]:2?1+(/">'?(5B2##S;)/[/%8C(-?,H@@E[!8=2%CZ=)YG_6_ Y:)RFPWCU MA " M35#Y6K0;/H7!@O!\_3GNZ>9[^K//R:Y093-_!'8'QQI?6GP&>),NGU^DSU<\ M3S],K!GW@$4&]Z2Y&CV=@,NP)($L^8_X$1PD%V?<'T,SWF2.9C=$(8C98/0)^% MWLSU6;J>(9C(WBQ?1@$SJ_W9SVIA4;6UO$510P3(0[,T$XS*>SY]P$O+$XI( MB9XGSYV#"L2.LB\OA/"]V6!#GSS802B M XR79XL"XZ\ (^=Y#"[EGIGGPUN X $9'GJ_KL/-I$32K3-Y9(&B$149I3#I M1VON@*W((9"@). P4.(#JD98T8%5!+@Q]#)L5^:!Z#.U;.Z#TX#,YW/-%Z^9 MXELTV,8'44GF>EO[,*K HGG#9ZDT0)1/N7>?1:*H4)%[VGY)$B0215U!JB@O M"0\EGDI<^.>F,U_3"%.9.L98F*([ A(#+ E^1U/O.F)XR[D4^<94%G2=*Y/A M_:;6S]I.>A.LJ4B,X1+XG:T""H[4Q-A9]GVBD^3U,(BV(&*) @H)6& CO,T@ M#:K481 -(+[&@1 AU.(*P&<4?N>(NSAAU7UCXONY:[5*&*N4H+>Y5A.="%E5 M)JU:P)O>Y57P N;XNQY%3;&L#U^6?$NT>_ /94WU=:KL7M0K!W,WZ@+"%'F^ M#?/D1FDR@/4K4VJK,J42[.7$RI1*)%US)RW3<<>'"=8V :1E0/8RY9_'JIB< MWVV*1CI_=)U]PYJ9'OR%XN.$<[6FX%YY(YQ\L_Q8XQ\MS2D4G_6:6K??VOAQ$Q30 MIL^V+=O7NH-.15;M:1VCM^NJ:RZW*.W=@$NZ4F_SK./2,F! B)^3FU]>O'!H ML/+HFF&F0ENN#*3A='MT'=I;.[CS$3WAR_\5GO .UY8< PM&:QT6LI)B=01H MMAG4[Z;KL9YJ1.;-3KQ+>B#^E\-EL9AELE.;G[K47K+P5^ M:81S+/.VF=;'%7P\9)$UF:2E)"RGHX2INMKR0+-UN]L\T*R0<;X[0G3)0MSG M$NU#WY-6J&HU^MJ@H%BGO$%]GZO3#SURNU 4['>IWXD28U,1HR+&4D"BJ01C M"@,EL/J.:!_*6;#K8*2WY*B&$OOM\?MK#,\*\D!;Z^YG MXM5&OE49M[K"[8GBMJEU"L%M"332:U-H_6T9M!=NW]OBT6Y,=ZK57UZ]M+1S M2LF=%QQW,8PF^;6(#,^Z+>Z;X4G=9K]WDJ6"FL'HY'99E=JO$'+S!IL4?_FSO]0N/6%RZ)Z8N("\;7G]8* 9W<$^U?6&H?4Z_;TJUK=_UF]M?NG^=?#- MYC%6U=L[5]<7#(&NUM;WV\]QX/KV$.AH?>/P$*C6JD;+.,*JK?YQZ'6PTZHG MK%[J_.1:M+:-92=#*KNJMQM\!@/+X9<6/813T..+=1;4DE]I[-KTM&];1H$I M\+75]%O::&7CT]HAC8=J7,GI^59_G>[I-O;PWN#/]%G[O\4P?EW>378"P#=HV%P%S+?TN%9#?"]U$IX"@?AYVG13%(^74U3!*0(Z$6]'GJ7G'[X$/7ZPH&SS.72O7/U \-7 MO."GOL?_NVM_X-QP;_VL+Q1N73\08/@#;RS9P2)=/TADOUQ1H4<_MYSH(AY_ M%]\FAU/YVD?WK5X[9!@CQDUAI6UX:1-S]0K87IH1D*,8<9F,#D8&:RMK M"F34]73P[L!=K"M0>+'6IM#C#QIZ>\].@#SR8,>RHQ@4BACK2(S]1K-EE)<8 M#R%=\Y0IOHZXRX=>O:7URX?=RE6OGAI9#/8M6ZX/52AS;F<-6E?=J3?TYIZ] M'*=;0AM3$6'-B% OH4FKB+!>1&AT]QP# MH8A0$>'A[,%^^N(KZ-R*HI^50/(=!3[EBQB>*UY;6 MK3=>%<]O%LJM9N$B^31!F]>35,#-0[>ZD2-FKD";ZXJ"OJ$;UXIZCTF] T6] M1ZJ,>-/+ UX9(]EOQF7Q,1(QRA*VW" WYM1R\!ISWM_,!^Y\8SZCWFA",)12 MR1#*BZ,NWZB:K8+\!UY^MYG#W7C5R+W]A%NE@9O+[CD2H7+Y!,%;;^E('LD397'!56@/7H 18%8@;A, M(#X?O+G!HV8CJB??<#+C[I?QR(F-QDIEU5'Z^XO@]C]F#"-XSA/YXHSFKB%T1^VK1>F.0NX&G M1,1>N&K)DQ$]+N>5C[;T5NZ+,4M 6N6*G"JR6B6KOB*K-RAJ5)9XF=J4:F:6 MM)MYYQ*5@,45D2LBS]FKER/WIPA<$7C%"%QOJSB*(O(3)_+\LR<4D2LBKQB1 M=_/>AJUH7-%XQ6C\?(]NQL+I6U4\J"??NN*A?!M63Y;_2454ZDE%5.K)\C_) MB>I#0("'^9#DF MRTHL9V2')KQC- $\P7\M9VT3\?%@OMOF\2)4G!3W3M>C>ZN.T^R\VW8X MWIE) I< /,F<>@BX[S\\"H\VR(P"!5#;7L"6QSX+R'"1!C!>>BH/8\2G22T) MQ[&F,VIY4^ ^45\WN6XLYR .D\6"7[\D M.+_A.&\0AP4%0B^Y<_7X\K[T8MU08OTU8CV1?$6"$>5XP+RIY8CI&B!O*9G9 MS 392Y\\QK@PGEO!A#_Z&8$FGAR#]*7D8>K^8)>?X4'R#]>S32'@V\U(P#= M6I,Y0[;VR;M^+/?AL0A)+V@5+N&#"75>T"HR]KQ&L:RNRF7,.T/OQ?N)5DI] M;<1GBX"R<4<6_UL,A8&\5I^TD^AASTGB+9_AV"@,(\K$4"TN&6R0=A/E!KXT"CT^#W)G#PHOV5; MW!C<0-'B,9!])I+?0&N]!\($R(&MX[&QS4;8V'(%_#"FSZZ'/@&9>=8(%XVD M4P/_ FH"CDA,#\2L@TM-8*L@PD;N=(A@PB\&+LBGD1LM<,UWDZS[[-KAE'V8 M6C_C+:PL]]OC=_GO@LWL.7%8M8R?]>(\L/[2-AL7K[?5IB9L0L ML@L=^@QM/E#]W(:96)X927A!(Y&1<#B7D^\:WR;6SVD?\(VD;(X- M!!CT7MV 0RJ%UCD%/%\<7KU*OFVC#[?JXPV2MJS^G"/_N0]>;!E4\# M8+*1*^CP"OB;><(7_X669B]D I+Z+V=_LOJ]SK@SUD>] MIJ&W:9<-C+'!^GJ_H_?'XX[>_FQJ3<$7D^9M- S FO" 6,#;*H@\*QAR/.*2#E?[[\(J:'I M)/*"0/"FI$8K(S1TK8N$]CBQ_/BY]9XKC;AX#5FCC;-!S$A)MF*!R<>7#44> M 3Y,P(7 ,A^XST\BOU+=&_"VFA=:%2>Z^/@B+5&L9V0/JX KP1W7N$\!> M9F*[]@(.>A?[%H"X]6X\M[[XXDU-[S4RKUSAW_=OZ8-O^IYE_N7L906JMYIG M.ZG)-YCBO,X5WF:Q)$[B-^:'-DA)@/^OH0\?^CYY8$_HS>P/F-;9&C1$21E/ M[+"C]3IK,S.E%1_KXPTQU.Z<9\MS'>X'XO]>2E9)8U\WX#6I_!7__2U/MU$G MK3\O5T8-\C_LR?*%C]4 (GH*[<0]$WDA,'A =/GX(?7,* I\3YUP# (A]$ V MI<:,XVUL_,O??6Z2/LHP[%<95"H3(6P.9$;!8\LQ82^>"+2X(8\PPY86X'./ MX)C$":=#$9(83< 9 Y&&X()#<#QA2^9SP X$+"$21G1,':'(-'+@(F8\L!EQ_,3!(YE5P_87 A>7>#S"<6FJ>8/8FUQ9#! M*GP1L&UQ(I^1-!>4PT"ZI6'DY7\&HG*!W!X1BO< Q1L!N\\ATEHDYXJTHAH< MA/IU%'Z].KBF2XF1UG(:O-7=(0^N]P^?"-\1.APXW6/3U]9,?!I<>ANO$,"B M&R[:7 _#1L#2%G?O@.D^5FL QZ-/Z(&X\C$*"LU?%_G#'K% MFLY<4%H^X- :@P/A!%D?* IGIVQ1QCVCQ,XYZ0S#/1KELE+&2T)EW&'S)W3& MG3<61WC22$&TB=#,G$6X))A;B'.!^$U14?(;HS:X;7]X3]2Q_L/?\6>?G.,# M9__X[8^S"_+9HU,V=[T?F/&%[XM*%B<.MJ'(]UQ;?N?S[>/MV444&N+%!5QA M <;'KL<+OHG1;'8T3C=3[@T._R5S&?*XN ;N%[X#%$&'-J9"*7FRX8TVH:!= M3,HK9"+"3>#32'*HL]#C% :+6!Q/E%T*?(>6ZQ 30-(C>-X35ZUDLJ1C" MZKX9 \Q_=_#(YV=WWP$<&.WZBCE8YD0HMD[<-B*W,7!!_ MBV1'0K)G:J^E+8EO'-FBB"O&)B?;)Y<,V<*5X$5.BTO!.-@ AE\<\L<(8,(+ MPO1^=*RO_,4@*?[#Q)<=!C^,H]IM'ZP-H,LQYJ? 0/)]S@4\!CD%#^>9"Y^9 MZP6"!HC)QEA1+L\$N)TP>8JHC#Q MA$KV#QK1PE) ,;2 '_FI/R B' %_O. MAC17>",*06#5]6C">-B!(&Z%V-Z!NR)1CXZMC8EC;J2L"W.D /TE0'7BN '" MTI<5^_@V$UEN/F$\5B+(:8Z2"H@<)8C B,D E^X,98I/>+O;D$6UK<(9 WO/ M$FB,)"FL(5 !0LJVW3GN%\7I,$JY"$D.0.>7%O6N_1CQJ&!PJY$@EL%@Q,^] M0.)#P(TS!Z.^S@9E=+J,_P]D"]MBSTQH%4 ?V#0H;CW09O"OP^LE.4!2,3'V MT_(#0>IFS'=@2?'8-X5/4Q M8^[,QG5ES7MZ0X%K4M#;PQ $O3LG8XK;0P)&5N 6' U(*I,PCNTP>.64_@3% M]!\FI3XG.UY!-K%L+)1U\%.DGM#AX2$3:)(;/4!U0+HN)E+!.*3FL\MC]V.> M&UA]E[^9D.I7K=I5U:HEV(NJ5N74R&4?ZHHA+X7"$"%W(BPG#*?<;&E]D\[H5(81AU!L<_"]P3NAQMZ6$LI&D9& MS!8>J ^";321)OBF+36X*&(_Z72&;5?@J])(?RZE%KE4G3'EE0+J9Z34S<7CAKTQAK8!# M4<0#\+NRN6I"O6ETE)F+1"[*@Z._(\ "*PB1^C.MO4LM.1$VL-;CVPJNN9\8 M(1RK^;BWY87HZ"'&X&QH3HF7@&9$UU'$LR.$I7+%HLD8TTEB<>8@_0CR$:X[ MF-4CM-EBB I,X(<3$;&(XTQ(PFE*BE"ZKC_SI308F(I3M,*H$]B+1IKDIZ&H MJ?)@ M0G=N<9*E0 O^@F U.+" $GVF0$("+5=&YAM'GGGY#=5! M[,F=?_OVU3_.,(A=(\^^:'I0R0%N8'T691FW<5E&L6F!N[@41%9]>.$L2"I# M&KP"*5-HD*]4A+,45J>/XLD-W'1A<:24.E%)8UP-'E=/C0'@H@:I$378R&9" MKFMF<5%IK'M,=^YU]VP?GA>7D!QFTP M&,$I>\JC,$+S2.4&&C&R#T6I263,X99#CS>Q9O2,4&M@^%E@DF%U*U\9 9PD M'*,>]223X#U4"!XPC7,3"@+2H2L[@1 ;R>?K*Y/5M M'/2,_9"T)3X"*X@](RCBVCR1P8IL)]'"E82N1+&OE:['BE-><0\^[/>#&[% MU<.[!Y.=(I-U"_MUIWXFE44^I6)W10K4*^1WHVDT&ZGC-E*:[B%5O#:&FP[H;LQ+IQ$=*,VRWMS$*RH\FPJM#-H+?4NU- ME-OX_PV2".NU]0;OXQ=?>Z8^6L__3)1;$6XORDRT MOWXZNRC6YL&L"&A!&S./;<&GL.LXHI\N5>#E$,\6>@.P\>W9;FPK@!6[&KD! M3Q56S$;Q,X2(7A[J/;PV 2<: 0E MMO;QE'>J!)TGHP6#I=/F:[C[:.T%,NZKJJT.4VVU%"L &@!C" FFVWD?903' M8.:(+#@.SR.P?C4)N%(T9 M#>)J(D#>Z$=<90R_X,_9<-^*^97HK\%.%;4*D0=FV"3KRS5WMA@0)&K6 LVX M[]E"I'1=QI(]L*Q,1"PSR8+8C(YM/LJ7QL5)L@@P2F/$(EV4=:7*PD3PV.3Q M^D9<3;.L&!R7EV^)]V4VB/YU".+%BQPD>"6LQVG6XC$BFB0P8@N?5C^T^,*0 MCTBZRE*EN%CQ%J!@B>*&I#H)RW3&EH=37WB52514@FFI".K2:D!K\T@A;&,W M.[Q()^!Q$E5@$"(\^R9*%,4%=7W+N!)CAT#O@TPIFCZ278,7 @[::3G59S, MF2 7F&2IG#3R3/BO.*(D2E6Y@1C,E\ZHP8YAZ1'P]G_ E\!0'6[*XC(C:PYR M:\"'%Z TX2E G$UBFAPNN&+H9]I38[$D,R1WW[78E1'09B8VKH\F&%.4\_K> MI]*< 8[6BZM%93PX5>K)-Y1,((FR8)B2HS9/<-(I;I9GX\2[)99Y&@S (Z=0 M1T"66!H!3RTC*!VLI?C"5 .EP[T^47T:I&HQ,0K52&\83I+)F/)4>53%A%%1 MH#XO&06XIISP-.(++PFY-469VR7=&D[T7&I.Z0QI5'SWSS[Y509X;I%M//+5 MIC+R=H8_GEV LPZ$ZT7I EY*#1^@!N2._Q*' ZV :^,XLB@9-MM6P=F5P,^= MZ.3(A'WN"@_[/ J1FJ(FB]=YSRAWJ&DB;)]Y5&_F^L#2B366I0:PE'6R[G M-\&^6^#8D*@H,@I@R=Z26]<&J,G"JPBNF.:1*HPY?):IN"O%@P5 I/%#B#\" M\WQB44]D9*I$)8Y8+/'2>X2DB)$5%>VFII0L(E5ZZX;.R+(CU82Y(*&\A0QYIB4T$R M<5E4%:[$XANR6%_*AR@,'YGSR.T\M)^RZV(S7,K+J/XN%4(QH_IJ'.4T CO] MB47"(Q*KH@4J_3J,NZ2W]N>U+VV@J@(1U:VV$7@P6^,K#R]_C6,1R5RQY&_E M:;W]F@V&9YRZ(2R<]J2&0!TF#[#;[I/KR^(6&X.V;GH-66F ?0B\.]3CNIW* ML=IBE'>0V"!#/E_2"7@!LO%5D>;BZ"G6/DE6B-C82_-[]*')L&1+E-[- M)AXOKDLS?$/V":.NX\/ZF;< ]L,[$9X\.ILDE5=Q=)>#PV:\*]\* IN)JF"N MHB(Q4_4&L@/.;%@:2? K3>:SR:F37Y) 3O&>;-2R*OK%(Z\F6X0G"_&#A>"' MN,N2MTFG"\R1,W"-A]8 MLL'"9RLA2Z%THM]LEV\'\#/ Z6%3UAB08 M5'YG0Q^Z#%(,18QIR7?WP&J]7,"A+G$ Q\KQ>7!T?<8W*G#A>-+$9 MZV'83S;ENI+/FPIPEO7:=^(9-/(;6-G/>*^7FX[QM41Y5R/QS==$^"A&']B3 M&&.8#:MP/S\-:Z%E_S/?L"RP7:JUCJ>+)$@=8A0TKJM>Z>D29T23*28_@!D?Y&)A9H^.HKMJ M9EB^%TF6%&B$"2M9(YK'(6V^;/]J=)YL+?($@'.)O(ESSD"@5_ QK&VZO+M,E*HO84(X :7()Q%2.")/&!Y.S?\6;.:O=9&HDIX+X_53Q6>1Y\N@Y MCHF)J%WLS/3H/)4I6G>4F,7_9A:;S*!\SE8',R+Y?;A'@AM[2%N7M M8FW9.FW%1$=_2<0'Y)-QYSZ? MQ4'Y0 FPLE;!D]*/.":&^R.1*(]4A1 L4<5,I!^9MZ(05]TJG,+NT?]8(D$D MW!F5?1#V6V2N?1*WP:\;$HXQZ6^\E:OP\M/TC&\4OY(34A)+S M B81:3C!& M(WS<7-E(-$A'5")*3(Q B>*R:2[()$V]"X:8>M=D&ES7MAT7.%%*I(K\4 M^7&<+#5NWJ0;-U,3[8$HIVYB#3_,X"?0BQ-K5K!OP>_)13,7]:7,K_!Q.%A^ M($?"@EIN1,9VVGN/>V6DVEKC6$2YK3184C.O9UFP^"FPI-7Y, +WECY9WD]# M34LDT@)4!CR!QYNP>#!,^$]"'_ [H1P6S;G#$__9WS0G*W:DHG%7"?_%,YW0 M7T+OQ8\JEN*.Z/3\[*A/6''1BA..$V^D7OW$NZ^+Y0L15A1653SR;).[S44F M4 "WB&3 9[6N.JD?6I;,PT42ZED:E"""7(E?*")=2;Q5MI*;%ITR?J&R'! H MFONGR+#B@B%9(>R#?B'I^D%N.45AIG0@(*D'QWLC;#Z&QS$S1>8S?G46(FNY M\1$VC;5I4\;D_4/IB@^]F\Q/>V%$7 1G?E8-*64Y ;V%MSS((NX M4O>[_!Z5/=PF90]?4ZZS^&;Q03@>3^6*BA>0\7:L=)%6D;T*(AD3&A6R9 MEB,^>, /EJQ#4$WWF?@3B!F\2):_8\X;#=?&T&WK!Y,Y"_RDL9K42 \E1+'@ MIS B-[_UOHED[H3L6^5US'S@GIQE0<%=YEF>(?6B.A2 )>CSH2\S-EE9^H2S MZ228EJT.?RG! ^<1/F9:$?-@ NI<:T9QO/9R!Y;HKI7V2F2>1 ?'Z$08F"X^ M)$^1FJ>RYND1'NL\6,Q$OV]##"L#88RQ#D3"#&^E=8(+,;W%LYY13DW@(+71 M_;JQ_=(QKAQ3HY._X.#!PHQAV"WP."?,U#CC)5>(LUC42S/B.9LL!ZX;MY(> M)2/#U#RJ%/)XY!H-%-_(%*6BTOP;#WW+KI:XEQ[W>'FXB0F#9(VUL61C)&-T M82F75X+9J263:;Q\+@I@'J\E\%.S\H0<<>),V=(M-IF(=285#>YJ@.E=/YT; MDY)A3$>6X.0H9K.$F96\ZA-H=5E<*\98(.(^LZ$OL+O29I;/&50^*FG>L)(T@Y(BB;0\T3(U*&)*,1!+9&I\/#UF="BB>0=;VT="7641^ M74/TC51*7UY4$&1[,[FW32;"+MT$"%IEYHJ9GRZ_110O@$8#3-9<\!XZ M.O7)..1&JJS&7[Z'I.(!DI?H)SO4IH7" 05#:L)Y4G@B>R.6NS2 :WE#&LX. M%9E?X-0'VWVF/RP:Y5773) FTEWW46#+T" 6._#;-3\7FE';&A_W:2^U%H,QGF*1#(=\"@,@XA1?9(H[/!#=0A?B#'L:M64L M]?:NA89,XO[.IWBCGJUZC.TE$OK,AIZ@H4Y"1/^?O6]M;MO(TOXK*&VR(U51 MC$B*NM@S6R7+^L&U M'PE.V@*Z38Q=R" =7IL/K Y![>MX:[KTC,0<)D5+"@=E#@R*LT5]>%2"Q2SB M"VHH._*6RY^^?6OMTHYGT),C%7!>TPEU._!]#?X!P[U1-AP2YCZ(VK7C,#<8 M&Y8,Z!%&T!V VAP="9=M$&1M5.AIYV-5FF)IRHEJ62'W8J@?*+=@'B&*L&N) M89_S*Z!A6Y<8)P1;NG3J7G?,Z;;-(A-UV'!8+TZ2$6Z$*( 1?81_,/W54&B1 M\)HDSD9CB348S?-%D4^-_]4]Z/Y$$R_*Y]-P&-"9][/_'Y2GAN/MZ^Y4(LK MF ;U9%,B9%'!D6YU\Y;#Y:5XKF6?(_C59X 9[LI=?*1W\>581U*Q1G1@B#G" MN5M$(#'@7"\AU>.T6NNL=ZE00WL-UGDRQ1H3IW\?#ODI%LPAUP+M/>QJI ;P MR,LQYE$-T94?.HSNXD%1>B#H.OO\96O'2^'DF. !4[X)_YF!O) :;QT[S36I33#K MLKUW=7 KE2#Q+RV#=8KM>PBD,,\"RIS+Z$^&7HWT)7ZF_4:HP M6!?AWWFJW=EJ0:P$UWOJ56JA:]:5<< ;B:?:@U $&Q,A3K , M:";\-=Y=Y]%"HBQ7#ZO+C]TT=@%:&*D],A+:"B@8)EWS#-Z/D,8>R J::ZP>'? M&8Q9#2R&"KL@+EX'LNCI/TAG?P$F24>V"A]"097"QVQO7?Y^BN2)SDR@K/&# MG*G-)&J&+E)5( HD%])4*\4"0F/YW_YD^M8[^9P8 M2D;$3*$.U=*P^YJ <"UU>O)"5V.)P[D0$#SWK*%R *R M4;5$[@:JCU,S,(*G-!G4S*(TF3K.O@:)'W 1BF8;H82[N'WLS1-6EAI0WU>9 M$(1"?-HHD^QNY?HOO C:+'Z*@B73()L M09IG9]'<#;C A;&D4"8PC^%,NIHDLN?+R MA'_#HNJG&.ZC!(#-[R^"7H&A26$3:A1Q +#@Y/8GV)!*IX(T_FBC2>D^O)DB M8SAC-3(%/W3N)?A]>/3"31+CD?,6Y3TA,\NR0,#Z$&V$.+,\SM0%[D>L&P&W M)U8!SLSC<-'&F' 3EP^J$/2PF"BGXR#RC6K\VKQH-O*, >0[X<1EDFOR4\Y1 MP#];^X2.*TS"]A1PDB)OM54I(79ZCDJ&"N.=%(OW>Z359 0P,2FH&L6=6;#% MB7Q+ -SUP. 0PLB2@+G+F415(U9'D,9&[2OQ5M*0F-5RV0=,=@ .K!S%<4_A MY'!:2 TTZX0\4I]N?L2*(_=$@TPG[:!1[(J%[H8YU:<#V=&YU2E,OS5*9!$$ M%(L\W!M-XW#$,,54!5ZZ#M+9TUY/4YPTQ(D3/P-P<=H/CC0O:Q'! GTK M]DK\&1FH0D#4@O0)_VH9UHZBE,]0, NM ME[C0U\@A953.\]SXUM@0^9-(SN,9A?FPTG8F11O@F_=YI8@(LM3VH#KWE+S0HQS$:+$B$8N7A)3D]@LT"BZXD4LW80"%AJ U:NTFN4QS_ ^+)@O MP9W0+JETJ,58D^6$H=98X(@V;>^85<(IO'32PUP]ZJE@$/BDL7/I-/CQ/+H" M.>*B"RIOD3G&OFN# 4E*A\I?]9G,,8J2GB&R:_C-H@8FJ"L#^YH@THW/]E7, M<3P+=@M! _F;B2KH4(YPH9D!,O@Z?-X/, '>!'47&Q%8-$?G_Q6U&+3W=JF[ M0 A9'"3V@%IEC""S$J1SE",#CN-M#VJ1,NVN_#OS0RXY&>"_P]@91P3! 3&T M@% GIC5BO>50$WDUO,\?S[W0SZ(^EJSA?YQ__'QR>HGQ:&,FF:2D,&1.N6 7 M=G(RV,4CC6.A1S:)?A6V65\J>52:A2I,U=6!UG:Q3"<819#.XM6G'2 M^P8>\9P&SZ$%R0'0%IH&BIDT[">AGO/).$*,9"SVN*$8.7ZA+69 +958$!7P M:L,!;1NJ616!S\4"L=#1]>A-@6C(JAM#F!D+*^T9JHZ@$@@1?HWMS*>-,^ 1 M=10B;SW\#2UKL P&F"KYH>5L(R*TXEIS7@)I.7(>)%4"&"G0+Z6^2MFHY70/ M_'8L^^)F+DX(47$K+GS^23BYVN2_A[-4M1#]87'#'.Y7DW>:QL5,>HO_^ZI5 MUZ.E3SXAG)Z%,R)+Z*FS*/<:_ OSP_S)<(FCB.CO2+-+VL4Q>/M^AND/? 7B M3@^"U+)BFPJ$'B88KWUNP+Z* XXZ@D<]T;TN= :0XQ%AI0,Z/_X ]P7PG%/5#%,78!Q9%WMT*.ZGVZCT.HC"".Z@ JQMQ@WE"B6V0L?.'!> M'/ZW@7]X1*O9HEIC.G? 4)D&,QNU)F_?25(QQS;1+,NWK6M[",G)J96&'M-: M2ZTPA\K9 4$9P66 F3A)J>8A1? 7.4JT3ZTIKU)!W>&5@[-V3+VKB.D<$R[F M3=#7_GM?]QVQ[8G%!.33B%?A#DD'O!E53S<&%) 'F%U=2AZP$!7$=)BQR6PP MS\.Y^;M;O(/A?65!HQ[Y(!]0 QB:0@0/FP&KD\?2TVQQEP#?,WB-]1D))5RXN0X3,I.&QZ.2O ,/%1( M7 $OTL)^27$*&.J0/C@SVP*>!5HMS5(S(X."K,#HW^I.I!T/#0UBM,^3N8O& M^KYYI[^907(/W'I7RR\YYKB.$JO+; B63H?\7)&6H3,%(W14>)D_]M*I4@/) MIKG/HGO8HZ R)CSJLBF^Q.]3)W]/S3'XC1)KR,U<"!Y\ ,B%QNO)A1-=0 3 M0YS&8&_,-:((!I\GO02!6WAG81\,]4I@9"%7&12ODLLFJW*LW9$"6KZ1@@KV M:C?;V5B"6]F'8STQ.+:%^8)CG0N7<$+0*6/V9[LW\RE4#AT,\2A@E%*"L@7! MLF&S*NER) .7/\:FQF+(U#C=CW0\HJ^ $I M,[28Z*1DB9Q,%1QX-(\.AP<]R%ET*OK2/26I"DW9MHXDK;-.H:,J5>J;+*Q8 MG>[<+9DR4[O]5P:FK32B) I,#J*H8,!_R54L4TH41D@(IE?YDY #P;1V%JC, M="ZO\2HH#0V74*(-FYEP>F#FM24)FW+$2"M.?3PHVW[ A)C]7%=;P2"0"F/: M* GKD& FD2W,7F8,79 $L+?H965/37/]Y**7^"QV=(8Y5.:Z! [+GZ@<':XD MFY-S/!K<&BT>?8\+\2Y&2Z, BV7^C!2Y!)0\=AE^[!7WMW;@29,[&#FD;Q!_ MF8]"+!/W)QR%PX";GKQ4@P)$(UAO?!MM M_K$<9^75JBA?]HKRXMJ%V/M&#!^4$?$8R$I>XTLZOIN MK&,=FPH#?CI,@^J/,#4-(@/CG:/"1B\QIA8@&(4-"3[: 2G\\;-X6I/'/Q)Y M/$;=9.GIB.?NE^]SAY&*6N>?85NGPSFE:*Q[E.K;T$>O5_OY5IN]-HQ/Y):8 M8SRC&#-VM#8<'!(_'1TV1_=PL7C.+:.PDB7B!IMI&(1B>FG> U148,>$\')L M-+!4&]S.5/X$T$2(#8/O8#IQ'4<'_>1S(7XM/L^J+ JVM7+XUQ$;#,U;'1I M .:K8("U3ZZTF>+IW)W:(&;S>:I+8O#QY73"B#3V( YS3 MB[$$C$*.M4P^JTSZ@ZNXK^NY4 HHO,E$>7*!1<>-=.,[OUG[=[7:6;[ M\D\6$SPGML2_):J2NEREA4?DTDD97E&M&F?XL()15])P[#N(HOB*P]D&T4\ M-6R:R9?>7P*,P*(WQJ&9^K.QE,&!AN;V=9UDTIX(R[-G;9+[&IH4^2BD(")L MA45,$#,U%#3WJ0_9$^[5/']&CBY,0[#0=/*X3<0/9\^M)[?HR<[C*4*FN/YM M0.W%_=DJ'XPLOJEFZK9WK:P2[4?M%@M4[W6B_:@$U5.#YN MR7Y KHDD#I$U0.M$QLG" U\P*W5:H%JGT?F_/ET@R,5,L/I>=%Y-S^.\P377 MTL_LV6YS@V8O@+Y35)P(5.B6T7M4U ZCT!W+IM1>0[036;.ODCB-.?G&^!>< M1R"X2/P&@87'G X89# =&75L\.F#%5$BC@WQ3;#*AF[11UYB0/2YZ1J6'VPZ M ]TBO@OVFGL?XIC'^C[)1M[)8,*@<:R(MJ5#]L/[$]T79!3%4]W5L^&EK(7"T+E1_A((<99<$G M4S_1_+Q@6EQC;YS.&",X"IP$SL?)2])&H92);'Y_YILJ-L0O-M]!N<&@GZ#A=RAU+NS8UQY3!\VH+*D'+T/]B6H+U-D#BT%JY4V3J: MZH@@S5?6N,7#U5)&[S[]_O[B1340H?:LL>6T]+2OQ*G>?NE3?<"G.N'F"_06 M[BR/:P!X'PK7#E:)$.>*/E$&#HRQVQ,FIPR&B1 M5'MG=%YZ9Z0N2'<*0L,]772T,"P<1E.O8ZK'2M]XVZT=ZN_1>/^><.<9='", MNC*"3$85W1&SU]%&RK]H&E\/) 2\W<:G(@F !_2YWZ$*ZOPS*^Z8Q#@'(!128-8DQ9!+)!$1FJ=XGYE:A, M)(Q33.>Y17.Y>EC?:K6.?G^M>UY(]^R_J.XA4%T$=+_RI[$E-&PX6%<]'Z5K MOCO%9@(+4:T+QZDCPO'W\"2FAS&#O EG4I&[%P;_SH*!IW&MN5+*A)F09$7M M\C5\3E(516%PU)?"W"A436AA*_QTI@H;[JL.?BI"M')]8.;UU/R%FH6% '6) M1I0(S!"B-YS;CAK]KE#Y5Q(K!-7*G?"$9['J<)NFLB"%)[IPTXHK)&&L,6W0TYX@C*2:C(8V6XN@\F*.@K6CY MT8)KZ72(*B=G)W*3,$:P$XPJ@+6ZBV!W:-#-"$HR2$Q$4]T$,XM%_4-K[UCW MJ9)8"TK.N?[(4Q,XZ%)J/.54_,Q?9T!Q7?-* M7GT>)\"!'_/SJ "_^F">A-X[AH8]=TOX&]YOOYT2:L@_,]CD<[C:NLR<% M5M S#>];A$WR4MQ,821I6GAW_OXQ2SH?RMB $@[,8J2IGE:!3S" MYHKH TJW)VH29),RR6VXC5L-R0N!WJ3@G=:C MR6PK/Q=UR6Q=,ELL7<'REB<7SUNLWVX5K-\TRC3*!BP<\A B_$:!I:KI7>!E M%$EG$S1!%$CPPU)C%5+/ 3$.&7!-$^6AXMPT"H9#79^B/3_=6$1^<8R,73 0 MT,/Y9]L'3C.#0#U!7.!-'&!HR>J2$#=@G M&@D)N6E\!B,L:=B8A!C-3>_CBKGB=G*F/"<,73*D,-U :A0-*WNACN0YO(=) M<&6ZV'4P[VN*\T[\W50!($VRYL,7OIRI*_ M9K/T#M-H2+H&D7W+!:FU5HO4T5]@6NPU^'UBGAAX)S^S MKCCYA@W9*DR_^3UO>TO^O+63(^[\@$Q1D?>9IM,[^>FB08$^RJ9%F//*^S/P MZI^(U$+3"R[J*3@>'@V./9D MO25"!67Q$]'F&@2C@"@.R1Y3,) M^EPM9)9G(#.O!YT:4-!I_^*)[[#&>^# MSF(ILB(#GHI!0I]K)WI9$ X*3\ C@G:8SBMSPB+7SJ#AH*VE'T_A@,)>%KPC M_\ B,!,3%&C78]5.X_ #K$ .;-\HQC_Y2,[2U*2/L(TSS9>UE"$]483/,)$9 M9]OX/_ DJ76NEME[ZE-^'"O-/PAPV"5N4\1N/B&H*^]#1K/\A!QW2,NTSKU^Z <3BJWFR,9]!R1-(/7<:( 8\+J\;1+<-"S=-2P.[AC4RG 3 M@58F9-I ONT8S@OODJ# M M9;ZA$U'$A!U+JMAO".XX>1VX:\+1R1QVX/J5Q@DA8'5[1\(+N,]1@GX0"U M9^OP;G,]2!T . R-S1+J>##-B'.!.EEY>,V__U_2PN%!FG6IVP)56>) M:\V!Y3RU8BM?OIW)<>")<6P,'LIT:A# -/G,,P[NQYT*K_>*[ 890OAL^& Q!%/-550!VF_AL:5&9;CI+$/0Y MMS]RMW%RENRR7BS>A*G$*B2P!=69@I3YARP4<5 -C6:]=J+0*'+=IQ.YS:LP M;>?GHJXPW< *TUK1?K^B+0!-Y-6;TY"U8(IX!)@PD:Y.![.!RK9"A->9%[$) M%M1E3_DF5UH9*X66ZV(<)/'++98IK>K-^00<#L&\1T])E_=1MV?T=$=*-0MM M4(Y7J$:, 'RQQ*DX@9?^#5_VHHM)T*D+A5*:7B!'Q4,=8=?4L-]/@IXJ1KP) M0H7+*YD?LAS/4'__3+[?XA226+E(*LON2,<$OC8(AH3?PAB?NNJYP-5;RNCS MO.#X;C/; DR^-$E+&3I_F(6*\_65#*QM84L=NBOI,"I!@3#!#6783:?@'!HY^!PY.[^< MYED7B&O<+>!ZSA)8*\UKAO %DR"U3#X6UI,Y;'*456N\$"0=1<,/16#Q,5,*X[\OA98D*CG9 MZ2(QBY%U4])25KV5E@LD*D2=I7+C]C"8F9H@1!PU0F0,JN VY3X7/"U.M\;_ M="AT&5JQP$GKKAIC;R2Y6GY=A:(KA-=8C/]45"B=$C99A,F;'A9YX%0[PJN, M\-*<6?P-F;_[GG4,9F;X;Y8SO7COY@Y;HV,2.$#(/<)'4R M'PF6!5-;*!Z7KA+S-E-N$T WW1Q]+%$'R![:V3SY]_D3WN@\6)$#?8W#C+53@O*!]NDA-L M4:I\&""P+3%Q4HR=GL%07XD:"V&0P]6F!0!V$\)NV9UYV) TE18B76I"H720 M#2-50OP95Q&6\L7%I>/ 6[@+2_OPUEUXR^*OM3+[9P8F]8(4%E49A2--'J:, M*@1,>V2>IDHU>T^0IIFND^,^4F8)=)'2N..&6Q/8 NJI93M[$I=O[(5E5TY[ M+2''WED5UUOKWIJ8\?;0,C&*:W3OXX.?_M MY-UO9]X9N,MGOY^>>9>?O/UFE%%OM94E$H**UV#U8[$ KYL$>F%PW+>G'P0B'#I!&WI5B^:80AK@GN)4$DFEJ)%I'D;W(%14JMG^"$895D=CPC37[C+O9 M5^2IBK$F/J;NVD8[+G ZXDT\TEIS.5/.F&_DN$YT;,NLA)O(Z5FF"'X^7!4D MW)HTQ,6<*U_3:0N=A$%GHAM> V7;;N%V&6@A0)ADZB.3P^"WT\>6/6T427< M(C\R( L,_"H'=,=UD?Y&Y%H^(0)[)UA$)]28JSUNZUP'G,#6B0D4%\;VV%H0 MB"T1!7H&8@HA. .::KJA"1^V\*#(VRH5%_TTQP M_%DN","PHTNC !C40P"0OD3*=:Z$6$C9U3<(;25TI@S.SOA5I-D&MT0=:LDN MB:71+"(X/<[.-?&]Q@;NWNAX%%K#1:BHCL(!8,I1<2*@'6HYC35"(+:4@BC! M4>$W\+G.),C26+G&<;AB=!GCQ*1=G$- T4A]HL3E!N!@IAKC:_!]8R2+XUT M<1]K6CCVN>PZS7H:J%L*"OY&KQ?*]4>9C%ZJR7%-Y M_DBA@K*AH@:18P1]V-D)V&?!T#/\5'XN=YY-9TCB"C=SD0_VXL?1KG A"_*X M)9Q 617<&OA)5%DA)&5U6UT@;@K$._FYJ O$-ZA _'6IT$\Z =TZ:@B@Y_72 MM#OA:W"Y3D@Z]L3;WDKI7[9V:IN@++\F'@(I_YRW: _S'$V/Z%2=ED,%3H=9 M[G0O]0P)@+:>_Z*W0:"PFOJ@91T'FCB,9C#?D30X#H-0NAM9K#G%J3'>KG(Y M/.V*V*2+CU!*03RP9C]GVQQ[CVKD(H;PH]IZ6SQ2F@0J#*5>W\+^ZLT=KRY? M%O0S&5$#[Q-Y+&0D@FUWIO?.QYQ78]0@HS^TU]AJQNRU'V6(.-0^T)!VL[OD M'Z]C@FXR/#^$3YW/:GK;U1)16-6P%[]8-PV+Z07HC,BOV.9%;F:B<'E11"G2 MNM6:F$J(S+LDCOY3M?.\&B(C96@V4%[L_[,JK%K35PG!.J'ZN6I-3#7DJBGA M'8M,2/UCD1 ^,;.Z)B$HR%ZJA6_EV8@6' ,#Z^,6DPA3-"09L)3R&0,#UH3G M[DBL&$D\G$=4,6EK)%>'PKGZ2$?1<9#URI=L"N&$9Q9W;I(1,C*],JY=M&*) MU]MLY KN]E'#LA4ZD0*8L),H0I*W+Q3PK(MNRX5-]P_\(J3=%YR@W]ZZ_.5B M:\>)N#2%]9=33C9+Q!E]N%G[H%KYA,$,D;TS$F:!QV,75$+5!135>F'R"_/+ MA>DP%F^0G4$R.#ZH7L).D\B_866F]0$E( N$RK>!E,1CPVU55OFKJP*$U)5: MZ1ADZ2H.KX1H24Z>*TKD^[+XV'AC>E)^N?R;#"#N2=RG3HE%]F9I^ M68M90PIH5<)%#[D9TZE84CN?/_^"K66SK()'7!7$>LT[BZ@8OUMZ*N&>B=0U MLIL[;5I.5-L)T"9J=WF,MM:6Y1" FD2HI&Y)2A.<0G6J?M +HBNJKOW4UAT( M_1BN3.=@#[3>'.ND H)#T%40 6=Z"K5-P2BPY*H4L:+\K^$.4)0;-9P.A;C7 M8C@8(Z]ZJ!2 9?N=53#A9!3BMTQ.IP:HE"VMH9S00EQG7Z@3^U135EX $%,3 M.0/L9[T4+R;:662-D0;I&!T0V'O"%F+O=3?!>ANE!4#BH@+H9=$ 8_I8&V") MU:NWE[WSW[Y^/'G12E&T?QRF^9&B2@7:WK(!EF:SBB5*E*FB7PK[T?6IM&M; M)S86J>U"Y)34P85FH16:JU"LYDD]I@)0JU]SZ4Q_S4V[QD;KRP\P7HFO> M&+IJYH1P:PR*X#H;#H3ODC+M(N%G(+)*,/6%NRI-!?!M.N>O<[YS2 M8>V MT]_M)OR%9+TG&T2==\D?I-O@$9O9-_.G8+MFUGR!H$+/!F9F<^OUO+&>P MT,S02 GGIG7JB*]1&-4H3J#E#(TS&$##@U545X+/@*.D76*Q_;G==(*E9"(" MNX;)3G=XIX(Y5!SL]1B\/YVR%7LJY8Y%6+9@D%F>7"_']BK5ZX*0K]GX3.>K M\"X;AH%51F&%3QYTXM,*!$2I?M#UD8C>EW&^O8]Q OZ[C3!<-$$[D=1.8@&; MNIQ=D& M!IB,U'<@[08:1Z3P&@Q!*'_07/D!1%@^L75/7+)!K\\I0/%X=%=2 Q5BA@W< M#1/[6(G"!292&F"460;)H1 _3>-^0-N,'D\38+#=\/P?$RH/6J_H4:3YDF*! M5W+=$;')4(68W2?@2:@*.+KHJ)UKYN(VM:QP/QZ%(UVE;H]#IDI)O2N_3P/F M0O9K7+P>A7PN5P&BS6MPJ )5]FAK+--8LKQ MCHJ%&=C7'R,F%ZZG6SVZJ'C*$I4Y;IF3'G1']N M/P<&B&>P'1ISN^J,1ZMM5B/V0 AQH,[+3$T7::X42ZR1,48E!=-.&2S&1C$J M+,!^,YR-P57<]_OH'L79-#5!4!D=#]K.-N[<,=8)8OL&8<%-T'7(X!\U@-PTQIE$$'#N$H;VMKQEWH$!1Z?H.I92!FM M=OQ>JJ21#/9D#Z=5RDU3Y7P3;J*ZB<,T<>S731P5&,O+HOQ71AM-<).2Z@6- M\\X?)SZ2=9^-YM-9P_LG>+7(BWSA@ZGAG21^+_ ;WJ7_5_ MP.T-_P[&18I_ M)!O^Y(S4TM?_])2^ /_["C8F&%?\CI-P!".%.TX24%CX+YK4"?\-;O*^@!*" M\SE&C=>'&?FBV,Q /K]!'"EZWZ_^?_QO8W['K_-D-/\/_SO8_C$8K#P@ASZJ MX7W)4KKSCT#-(G\B0V[^RF['UV_XY9IX'DO[A2#:&;W6: P\JA7R,B6L3>>Q ME&,(F>-:VP3PV6KWRI_&UK;WMMU Y4[9F0?3R?3$=SSB''CB04PY-9 KS7EL M*']+CZ&L8;Q"0BJ-B??5[:)8)FUGJ=]_N?2M !2@Q[#LBG ?ECX$F'OM$)WB): M&L>=RI@C#0!A/$*<1AC"Q&WR-/8@3F+"SKV";4^A+,DT,QPV*)&4' M'H46+KK\_+X8+*#X8ZKS.OF97R0**&.99W7FZO4F'+RI\>07!J?3#CZ&X&QW ME$T]IL$-!FIGX]1%HD'662+[ X^\+Y$3VSU$L/)9GM&'"M8(SUZ_R\_ANO,_2Q*KX\8G?P;E_ M8/'!)$AM?TI\0S @DH3-*.WJ:M$\]\,BX\,E=:8+@G>A4]1V0=/^?J.Q5? > MK"A1T2PQ>2F-'*=;JQ&*3CK@C7] @SIU 9AS05GUZ\4 MCZ:'E:O";42/ 7\/(<=*? /.TX>ZI+"I<9;^Y#P-/MLU^1JDY.6QF"=36 8K M<78T+\!(8R1*/CY[06FJZ206"F!7K.%C?,3=I8H^ MB_3O$P]I->TD@=>4NJU-/;L$6T8[N> 1O]!^H(&S-_ZB4V?9D$2?8! 61NA3E"8-!H&/Y27Y"JO?L$(&ILNR4_VF&P$; M;J]45-8D=8&\.EF(8G$JY7&FZP;L@,2?J@RK,GZ.,0%],IAP&,#(@1FA>?WE MSY8;R^'/5#=J,IUQF2I5TO24!!/'02^0&*]Y&K7"GV0CQ&:V);7P:%U2B^4@ MQED9J&ANLN'.-W*YD\Z4:W!(YP(-(:O;'_&,5"'-ANGDQ+%KAK5<%1$5. D4 M*WT1;%9_EBNA=CE5N2IOG>-'1HGH+)"-1&.'GA25\&:G:4R%TRG(!>@$)E?7 MG8/5/O\/1R+1>-VU5J"E/'0*\HF1,L_1NX2/TXG(KC&=R'F>\>ZPH;M)='N: M;'9*9KU7>&;KV.@OUD'XS%(O?SF+1IR&,S/-UO.2=H'8CTG\,Y'$M'+W+ MX&+=MQ=;Q"4*/L.Z.XVI/XM%<32L.6[*V;Y%V%W!M8W,A."(ZI(I\BFV#F!G M2&VT88?FZFN<4G2(!D':AYE2QC#(!Z*X.@]WCB/"&R3![[,93./ONO@D+\%Y MA83*Z"RZ"I(XRLGSE_,_/I8*-!:]P[]B1G)9/M5J)Y R*4B'62$M)=P8Z+HA^O=>NOTLE! MNM7TKM*)QV9[=!]5*B;RK]26SCPZ#%CWW::W>:P );E*U![WU!Z'SC<;%S($ ML0IRV98<+B"AQ6'P 'W8D9"NW@03GRC*CO=^+$DQ<6/W1/EH+9AW%,TF R(X M!1_WROV]!T8/MQU<$',#+5K3^X4;=64A2UIU^]2 A1$,&Z*PZ(#\P2L\AU7& M-T5@+/H&BA,NAXB3C4:90AP#^,* ,6'<-SV".@SD=DORUJ6PS:]N Y'VW1IR M0AI@1AUY,>+(0V0#0T>(^'W4!@R#^M72L9!AIV,$F%A*!JGK(_$JPLSIH)+0 M=A MD;KIC]$J30V &%5P87A;">A+WT^YQ[(?8IA[O8TZ$YC32N8"G6R8X/_V M)].WWB4VM\!H1O/%F")%"WZ)Q=3!GW%Y2[Q.^#6@G!X6D&&M+L;ABE'EVH6)@!A8LS(@U M80T#$>6&L]3)1[\Y'@XQLK@D_#A0Z31@Q(\@L:X;QA(*.'9^&$IGO,_H<-1K MF)!!/LMUC"G'^#8@<'=< 6F5GI7.>CHFK24\-ZRS?021\V^0[,:E?,0JP]C^ M1*IER1N'/L=MW1TZN]:KM!BD.K$-Y][G!'OHB"@] B^U+R8]-;QS=-'W3*1: M@$F)]B>N,,]FD\ M (\[+8CCGYESFT[ >R")$N7-:F0B'(U_TX^&HV@ M*UG(>+JH@OIF1%@BJ\,F[&&NJH]V*WY763+\2(/Y6%!(9&M8H\8$2I;ZG#GR MR4HF_9]#U@P' N72G" P&(N!OWS!9V9!Y#^H&<6&+#3^YK^D^^$BFX+*EYHY M[#9!$^@4JXB4,:M/?[_\U\6E,:QY34R^ZAYQ T:F*"PCR1"_0F)LQ@+$V\E2 M)=E$O:^NT9RDOOJ\8#4L[VO,41GN'QC[HJ)]!OLICUSPP\ LFVJ$6HGJ.^.PCPP$.C(O>!!62"%>60I9_31P5/83LL:D^F&*J3R!U> M_Q,E).PS";\D/]V)V7R$QF5/S_7>3H(-;>QL$GO$;=0!8#PV SHJ0>^.@FQB MI/_BE].2>%U!Q^;,O%56'3RM*(#+W$F.G!%#J#]$V"/,._J<4!@BN+> @=M" M5'1E%OT@ZX9AV1G%?44WH*E 'L5LOM"R( X-6CO)3'9<--I%$'<$*_!IB.P. MWB!P,!D$1@414!(:R?DM[^!%J!O&N:"MIBD.C8V*"6B=YX]#>1/.';H^"/Q@ M9D_ X+3E9WHR%@TV3)S/O>7KL]8;0'-,M>U46F%&T!8P_=""C*,%J\]P IA# M?IDKHIFHJ&9JT3DWBYLSP6E C*'<*$=E(Y8K5EYV$YG066JUZ16:X1/_KS@) M9N8 -%C.IM96AJ%!IOM^EO*QI:VA!F7N!-Q.?X)30VL Y,_.=J&J#KX&LODR6.<@\8%6U/%TW"=3;E+-F/4**:Y+JD2@4FV=2:V MR@2=9G/64[H0MX*LB$3J4M>0 %,(A(Y$^H3VGNA.1BI?DA ],A;[8 M!LSCS50F%L?.]Y(8=29_R124F5OQHGH8U<&?%K%%Y4SG.=0"ZCUV'7ELM[?8\'B.+4G_\6-1TV$H14^WFMW)VLZ5L$,0Q]W62P MRU!RH-=39:##8$*'?I@JQ!HS:'VP(EED3UE.!Q0'DD\'2/QHX>'V6^BP7O78 MF-<]4 9,/9TE,8.=H37 5_4"/Q7W/1GHV#)].YVO=''&;B8!JK'LNR>"3V(B MHF-J(S'O"Z]%"R0N,0YTB[A@MAIN!MUXK)=EC57;0FLQ%2&'?C+"A ],!!K3 M:,$$41%]*;8!4SE+I+%FH5G;6DO6LAADAHNH%,-)4A I+4:#+4A\#(<*J*X> MXZ)2'\UN;(H5?+CSL#YFA)&SF'X1_+V%!G,Q3N=3$>1YH,)!NN D^3=>H@MN M\M[1B69"N2[@%S,L&^)&1 R(235MLW$1FQ@<28:\O^(E$!^]0)/NS#,AV6F1 MY==H=+,G* ?;O(*&@[J@H0)CJ0L:M/V?D$[ XS^*L> V(YP>5@O7BM4!:6G. MO*,&!HLI3AC^)%$(6^&6/?$I3*869>A\-_C!CV-,_4P.QPD8E]B2",/FV]!P M"PW(44-?A0CS9/3D#!K7HA6,E(+QD#<=R#.T,4A.,#4\X4C!%@,>A(Z08I:@ M4"[\RJMB[]5AN6H[_Z9&X%J<:F.=EA/GSI3[OTA#YI]XLO:9MQ%;=GVG&.>* M3>:0!MZW W>HW9Q&!X+^O JX"L%*&=XUDE >]30G;EX*)2I-#?Q+(Y>T=/D& MT)U*IC%;$T:\^1<;N4=,47<8CI'OR#6]2-^$[D 0&OYN?U/0[T+Z@D9@P%Q3<#2AC J;^&*ZB\K(O<=V,CDPOV8I MG*D7%SLAQP,5).K"B#Z9K#D#R?:J=<-]$A4PJR!F9+9B7@(C.>G8.X&I)41# MG^O=R>763@Y5*,3 OJ&X^_SQO-AXEX,V;Z EG 2^]S,".R-*8K\I M[%2SU-9+X4(]C?9IW6F*>B^I^BRF%'8*) :$D!M?W/ MJ7V[Q4%?N,)M!OQ 4/?OA257ZAJW/KS?VFF8#LFS&PG.>)^(*&)[Z[>S3UO, M.'V*@6BND%183F N.7W_"4="NQC?F4T)3YSRJQS]HB16-,24KI)&)/KYPWMZ M'B=E?9?EZRJ(0XF>F.>:>DL8DY6Z50)G*E(T_CAC8.L0A0S)3<'JE*S/'<"I MY'/AODC2O6!18#*89N3])\OP*,)]&J)VAS5)"$83IO:W4[Y:'TN2T+-[3_N8 MUSPS6,;%VDXBKPKU+(?H#O9V!Z -/\,IA'U%U-JG&=8PW4C!*5M%PBCZ+9C# M/\5S!S\0G$K)ZD]]X@NA><4XS@<.PDTH41+ZUVF& ^VYN07.Z?)]M -,OR+% M!,"6)-<^G,O!%6"CH6!5")( 3('IZJ9J1!/0LW__S&_XA% 72D>8=,"&6Z_A MA0)3G\UP,KAVB%$O+P2*#($^=61QH&#V,7R:*JPI@F.HM=>L&!3&*9VQ$J!_ M:< I/&L1> 0;EICD.0Z# 1E9R)H1X>F;JS5]W>?FO? E5MG4G\1&>8<9,4Q1 MOF=R6U)\YR"@ <<5G]K&OB=@QHMB3A1Z<)G$T%1L2Y$]VMDC3*F =:NNX^0; M&Y*+5H6IK."?G&;[F62D0+$J+"5#;2+<<#J@S)0=\.$A>*EDVA?XB?,V[@*. M\.(EV$SKIB]<*IESC*/.=#N"?(I;9"F,4^ASTPB1H6VF]#/TVVTL,\*@IZ2. M_(B#FN8JK*N*YC;EKM_7%WXC'[%K.;=-Y3^P C1$ES44J\7XOK^E*S 7OEZ< MY-?B\T?\F\5=Z($'%I48\E1+*LQ_J_$GS21^-7 A!@X$AD/O$W95^3[,!O7' M%('5IS$(,WPEPG7G. .Q\I9^QQ-0L55T15D.KL/"P254Z<+<3(8,918=7BE M]LFIA27!)>95HSV,Q#AL&6?(-H./+'&-MEDTI&WOFC/M2MDSM' 3U"O M8#)^ZH-WKL7B./I<^WV?BP>,;]>4F?3 MSUA@IXL)2J$0'1O$Z>1K&)3K4H- /]WTP%%6GT'SC>&E_4"XWGDR56M$SA$. M[FR0TN&J/[#C,F<['VGHSZGB#0]P;9-P2C4A( :< TV!O7[_N#?9H61I>(\>-?.'\3-$C."SL'"KYRJ:Z M2Y$B?89S3EKK+F@'$ZK?GW$"1M$V7K9EK\.0XF7^3MQTA&VBIEB?C59^%$=4 MEHXMK>!/:)TQ4(Q_,C"@)3H$*#454F!.A4JZ6I<)S- Y%+O_1 ,6[.8;)%GPD5)B4B@G58*2*NK(P'^BA^%QP3J5B;J_'#_M=]"A"Z=_@ M)_^POU?X8PO^V#IL%J]M<^ 1G0/.\1BX7WF!ETWQ#S]T[)VPBAG%ZRACBFK1 MN)/P'\=D[ H'F],K/M'\!_GO75A!0LH"6UC@#*_YTL&B:T+%^Y23*TZA?43* M5(],X4J0B. BSS6M!VX[N/^'EIVMAG ZIEQZ9Q8#7"[TFIVXN$CMPO>LISXZ M+-WF/[O8=.?1%;BUPD";ONII6$T-M5A#>ZUT[P'1 B,%JCLS06YFR-RP"$V2 MPLQ1F_@W((?PD?&$FE5FP2R!_VHL$CQ3 KL&VZ]33F*/U!I'S:O$\"0+"FJ M1(80,!1,KAE$K7=CK#PFG-0*N@.O/P*^OMNBT)N,J6,YMCDS^W_KS$ MI"&,4X6E<*0$8S8(TFE&0&"V']UA$LM);,,MT\ :3DH3(S8O7*!W$Z>1_!O; MO,!5 X6.($X"]T"A[_#(S2+(TKX*4F9C1 M+FSD2VU<9>Z()GF]SGBMI82R3/5L&A)TF%'KL.VX95GF&GP9AK6H,,0XSY4 MS9S)YA:TA4V7PB)K\**9KOMV%H)1KYU'!RY")VQ\V?:6)T7G0\@U<&J*)+N- MMYQ,$508;;)W\4!XR1?_CO8_OCRF'FH2)MOMR8EM:A"P4T''=CIEXQ3]AB$& MVE4X)XO=R3CIKMVZR-D4.1_614,@MN\QD[N6JMNW^L%J,FHE0_[\<(95[-.%';V!>FD8=7H*&90'4KI ML]A'#Q30,A/N&]6'47=H2DT]?:-OYG%KH8:X+3^CF)4]7/0!)-W)JX M>VB+PHMAJ<[!FILWA&U2(F?XM]5\!GR%=]%,FF$NP*Y$Q'U]!8:[D\B1598T\PXTX347(GVW245;&\['+L0PP* * 5,*6Q,)RR,N1>,#8L,B#8%@$+8\^W.DA,Z8>@?WJJ=8V#EN[,OVAW_^F!MS6 M-4VPC# 7 .6%FR5QF.:[0969:%] H,7F=6:@-)Q):621"H,.3BA>_BHVJ_IG?! 7.$82RT?%8[&C%G8:KG%K']E&(E#JW*@H[J$ M]Q92%T "J_D3F'>HGC#\MYWOD3:UECO<(@*KQ*(Q#!(40OR#&0,X!M\\;HF) M<_/0UM64[TXNR1(VM= PMIJ:+U4]'=\\%70EX8&4]_/HA^!>8[]KH-8 MU\HR._3*K:HA(\^^?O&Z-B"\G4?C_*';;;;UCSO4H.E/P&@3G M&@\3^"NZ6 MQC_Q9Q#G&:TQ,L5J9\=^%9;2H,F=&"Q//U6PME32XGKH8/K.L'I63I7\E'9= M&E4>#(P>&Y56=!N]*KF0*W&J==H=F,-^("98#B(G <>[;E&?)YUE1 M;I"(,Q0@+K=\LL;AN)DJ\O_LPDB+*1_:LC6\'D7P;:U^8,!'2I1CPJ%Q3(1@ M)\#,?@H/BY7V53"*X:EI^*S4X7+GMSD* _-GU/VBM-20VG+PYK]S,GDXJ)]#,R!>R9- M.B\:4UVZWM^] J_%6/PM^(:G(FA\H:(/XYX?VDH\VV-/6SO@J$F@5QG/2J1B MXO"F9/F,<\)*D1"=A:2>)'A MXMCPY&AXV%T_ JM42.NDHT*CYHTP<]=/7>.3U",&T#B.+J_QIQC,U$W^NN"4 MVNC-Y:DW2,#AB;2Z8L+05.[0CS3SPX48I+:=6>#XCSUV;,$'M^#S;J(\;.'P MW-MS$J,#IUF.F#Z=GKB9AFB57"D?1=AZX/T;S$ \%&4MA'947HIF!'9.-%8_ MGY I&@7D2S X\=22F>$0$PH.NUU\^"9!G_))4B7C=L*1?28* L0!V2'0J.7V M/NTKVD15!>J:3)3U]),5DBAQ5QPVLQSSO( M-!(D@HY0D\N*3,O&*)+SLNFV>V4,EX+,T89E?<*KA:DK]$[X8+>[3)J\A\C_ M(LCD9D%%)$08ZJE>3()E,5I39PK5&7"9.9F)'M)']@3IO?9A?--?[C&T2<+_+N9F^(#)J+?5#51REK(:^I*A879R3J9^2 M0D9PY"5JEO/".JX>#QB;D7B(S8#HM5B# \9@DM/%@3OH;,9N"$VMFZ4>^6)@ MHD D&O^1.]K@G[!6(-*VE4N^E_2(!C&Y9M_@ZS><+W -OOC7SB=K^!Q=) CJ M<\B"BBB0A!^'+BOV- RR1&).W+5@YA;+="*7VZA4!YE$KKL^).BY@ J=N[ T1 MZH&6U61>4CHM^0TV;X:' O;E4,)53G<.^TP80-.TZ+/_'\/6MT%,=P'LAU'6 M:?7VT?V30;I0YD2'I_Z\]0U!ZNY.1-^+#&*'5 M-QN1+L%W#S0NB':7$5K4*CHR6P7VPQLI1$*8CNFA>*C9K"UM*:G@24'2V4K: M#JYV]&YS*Y@+,FD5$H7\48K=!/=5'&833G#:X)Y6GMOPAG@Z"R:6M7T2W"QL M@#@)1H%$V?HY\(4CF+! MH.!WX*\(OD$CU\OD?#;.H*RI**WMX&;'&ZL!-5/K5CV-QKL-O[&[4V:/"O2A MHPT"VR3YBF(+^^U5L05*O[QI-]OE%ND+!1*0#G'F83@!28(D@GMV Z;;*6W> M6^WLNWW6*]*CDBJD0H@9G7#.S*@;2G"DLYS&(T@8$&9V5!R\$5-F=UBUXJ!; MUKTNO*NQ\.Y8)G*TO$SD/KJS:W1G75RRYL4E+W/2G884U4.L,\R\_J:SR%\< M5/_%X^Z5'5^(!M:P97N47!+@K"'8ZC0#N_KDD2BN MS!K:V$XT0E?DH[&L;Y=1>5P 8#_3(O(7BD:#' X4.@C)@&:>6%4HWB)H&-@* MC55+/ET EC8LP#34-CC;WY@=94#X#,Y3XHXYN_$G4PZ)D(_'=:$:C#>4.NA9 M+'147[TS0R*#M=\XA(MY"B:W6]SSZ6J>@M=V)!&8I%1!([OO1A;3[$ M":?<3PLK]\$(TWLPSD(BG-:$'6>G9L&):0;MA23C"!S23CMSONL4C.2?DG_] M[\3/WPV2<&@# "]CZ/EPKB?TO9H'>4[B"P'OEIDO_!KF\YH[R,;^])PBP M5**4)1=\IL_$(A3JHULZ@/>9@E>#5B+8Y,(@\NABA3LOM!1Y[V(_&=B)=<3K M]/UGH5S_Y6<%TG[2PXR2?V.A"&V@D'"SB Q]T6I;J6T?QT<[*O/1 MJN..W:,[][ZGU8M[5%2(XWZ@=H^JA-NPL ROWA6JG ESS\70O?^>]\H!QE9^ M92D<01[KQW?XL2P\%2,RYQ 8G+8_8_H63+6D4\\YY9)H%)(8 MQG?%E0%L$8&I@N" ?7"-O S3W;]!M;%?8S=EX[N-RM M##ZVOYD0E["V$%Q>,+XQY\X V@:/@T ^.T=2+^X VNX*%&1_;J KP>"-^PR; MS:0H4H9G0!TY6-TP"5I-%TXA7I]HN6!D#$O%V7>ZEO&_AR$8MDXEH[J2"GK. MY3K&_QHG7_++-R+*$-RYEC/$@H_X1)6!$[@*TD3(SB4LCG'R7;W-D/(JF*J0 M.,2<(E>3:"=^K_AZEX/_P6 0*K@9D94=-'8"AL>"/A6-"0G9=9QLZST8L$,X M;6*-DE! 7%EGH&0#))LB8%>V"##'\]?+]84[WB5"OB'. &7 M0:5C8TX2N[)$WC6!^L\TGTGHPQ$P1H)G)Y'OKAEF2*UYCNOU;Z%?I032,L3Q MIAPQ R..0A: ;2Q8I!8IXDFDT9J!,Y=*F5/SN"+88K/38K[\8$1JI(^NI-UKW@^;,K?28'L M5\W(_R+^_6?!_=SU%I?3\<%>T@]XS(S(XR3N[NAN=UME[K:SG0]>K(2:<0L^ MPRSVYZ6NQ2L[K\C@H'9L3:*&IP0F^/O27(3?Z[)72%C5'D*N00%CZ9L(9.YH M,N"Q@>[$5DR\YU2@N&U)N@J%2"%M\2X^$C=@.K/O#P7UD2 MI(/ KI>&I?<&L0GZFW9#WD 7>NULTZ$#=3/6NMB5U4DA^T M]QY)V@SL <5H$P+UF/\M%51X_.$#.(=(>T+I[)0R4TD\''0H#HPES>@[^9P/LML2":";>Q3S!MKEZ)FDF:<[R+.:G M6<\73]'/ X7G\?!2+;VHUZ<(.C>3&EI23:%_;9[R&^\6I&514P.>>#("A9^% MLPR3GZ=2;LD,5]RQN5R3GG(P3WG;[^"4]3-N(1O ;$JI[056,X(5O,,'@][% MA A($'M<\H0[TWQBG*P0B\VKB#FN@5,J,):7!4[9(&5X*MV"Y'RFNK;;Z!_N M98RX3\ I<]":3PHDV _AXF'T&J8"MCS,,!**%2T85YT15V^/LM7?-PQ(8.W5@1=YSMF24&?>N\4TTT7S&)\B"5X8AO1 M/'41DR5O9"XB=14L&,USK-$?!TBA*B>T MX3QYFAF4?B:'3JP%S5E,'3ON"F*1$"*S^;9"2%<;1=+A(78Z/7?L8X]!;3]P MLB^+E(<@ !;AXNPK%ON0&8:U%F;I;2'+.S@VD\R!,#)&=JJX>5.<)7TANUSS M!9],DH!\%\CTA2%>0S0:[!^)$%EY%X9D=\8V&(1P1C6\\[YB)_*W0/7'"(L^ M4X$Q&#_Z,/PX0MR2=W$:!0P]^HM*_J-&\540P=\_DI95HR1F*^,D[,$F]7>* MQ"84_Q9?CM:-(2HF8'R!Q(IG9T,#$_\OYJZ168#1I]8%<-Q?QQ?\530484!H M]]G.O:;"1*72Q_(5B5SD'EV+-(GT23:"(7@Y"D)2F28J$8)FR0674%%HK2DR M&S#"MT'CX?:A&1?43QT'$ZX[NT'("LRK$16A[@-C:E*!,^EQ.Z24\=%0 M,O MXP:Y9(. 1$YB/),P)(*)4K"+L]D8!,OTZS@/@5\QR( /*_\ZA@Q*=7DD]_,M M[L$E&Y=Z3&DZ=RU,2CZJ8P,Y10'7;6!EP1UJ_2&7A*<)\<&4)IEWOB ,L->A M-W>Y>/@+]*G;%AQC3Y%INX)2V@/B8:8?C?^:TR**\?%"] MA+/\^YKQZ8YKWI"RN@9L1&S (N0H_([_53[_?@$#01XPU23\%VC,E<3Q&(H&\?X-[)0]MAB.NBEDQ8P54'+.I2'.'!A 5_C]9-VY M0HM[WOWOAIL>!9%#RDD^(QC;)Q_J3I33MLPBRD$( 41B,V_"FR;.SXN4OKPY=>*T9O*B6(_U+=LI(S6@HV+>;O5'6'<]**G1//E=5VY>O*C.3$@%[63'H6M#*);Q5ZX M)+@)70,M2087OBADV"_4NJ.8N@])L.!0C\Q)OTQ7_D7&*2@P )J7=0,K^PG M+$P%&=J[$P:D0X'5JWW& H^,Z30L%SHES&XR_8G\!OY:,CS :(I 8WF"IL \O="D&Y(;39][AK]"S)%%I[P4Y(T;1RI7^$[<3HQ+H-%(1:F(GY)ILL&+)T<8.T M4&'J#/C8 MN494I<2FN,2E\WQBI!&]J_PAKL7ZWLMWS3\>/Z=:;5O-'-ZY+<"JM: 1&!0% M5&6_N-VUOVB00C5^BD<,K.Q#Z.)8H^;!S#]="$31EG=>/U ADFF3DC3[VSRB M80!5''A]]Z@Q.(C]N;F]0?U$660:FWHN>!S,J#_2-:F1AB.Q]T[B5()92J*<:X%I1#2SE9\VO32>@:>%1TBO5OY<0]".A5.+[0Y'$^:"07PLF5XGC2@._%21)?DU9/U-1'0%5M#Y(KKW0]*^E871)"PI-RQDFC MDH%'$A)Z-FEV74]L[3/Z$C$MQB"!X%)H>\*Q>#0>:(R!6JY661U:X[G9J;U6 M4TO$Q)X\<7S7BK3]K;MJF)>I2[M0(YK;3\8/ M^2)-MN0,@)A?$I(WFN+BS?R.)H#\]]D2J,/7KETO"4]11U,LGC]KAB3GN.FN M9$E%41>#3D+P[-J (,.B3^QDW@TWTK@N#[F_O<;E:E^CD*I*T,2_#G1J:M!@ MN&YL126-0OC)&.>ERH.&_#>7D7<3'CS2H&"1)*29^]6OOLGQ&!\U(MHQ>PX3<+K6I3E/U1O_+6R2I"?WYFR"B]]%-;Z4A0)0A M*@!BPNS[H;R$WL<_BVXX/FYV#UJH'F8)_/] OU@T1Y,TQT^SP>)O

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�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≾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

:?_I* M/XMXO_Y*K'?]?:G_ *4PHHHKZ8^="BBB@ HHHH **** "BBB@ HHHH **** M/VL_X-W_ /DQK6_^RE7_ /Z16%?>%?!__!N__P F-:W_ -E*O_\ TBL*^\*_ MB3Q _P"2TQW_ %\?Z']D<"_\DA@O\""BBBOCCZP**** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** /YP/V_\ _D^7XO\ _92M:_\ 2V6O(J]=_;__ .3Y?B__ -E*UK_TMEKR M*O[YR7_D38;_ *]P_P#24?PYG'_(VQ'^.?\ Z4PHHHKTSS@HHHH **** "BB MB@ HHHH **** "BBB@#^@O\ X)#_ /*.+X7?]@FZ_P#2ZXKZ1KYN_P""0_\ MRCB^%W_8)NO_ $NN*^D:_A#BC_DIL=_U^J_^ER/[9X:_Y)S!_P#7JG_Z0@HH MHKPCVPHHHH **** "BBB@ HHHH **** /P@_X+G_ /*1WQ;_ -@G2?\ TAAK MY"KZ]_X+G_\ *1WQ;_V"=)_](8:^0J_N;@O_ ))' ?\ 7FG_ .DH_BWB_P#Y M*K'?]?:G_I3"BBBOICYT**** "BBB@ HHHH **** "BBB@ HHHH _:S_ (-W M_P#DQK6_^RE7_P#Z16%?>%?!_P#P;O\ _)C6M_\ 92K_ /\ 2*PK[PK^)/$# M_DM,=_U\?Z']D<"_\DA@O\""BBBOCCZP**** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /YP M/V__ /D^7XO_ /92M:_]+9:\BKUW]O\ _P"3Y?B__P!E*UK_ -+9:\BK^^&O\ DG,'_P!>J?\ Z0@HHHKP MCVPHHHH **** "BBB@ HHHH **** /P@_P""Y_\ RD=\6_\ 8)TG_P!(8:^0 MJ^O?^"Y__*1WQ;_V"=)_](8:^0J_N;@O_DDJ?_ *0@HHHKPCVPHHHH **** "B MBB@ HHHH **** /P@_X+G_\ *1WQ;_V"=)_](8:^0J^O?^"Y_P#RD=\6_P#8 M)TG_ -(8:^0J_N;@O_DD% M?!__ ;O_P#)C6M_]E*O_P#TBL*^\*_B3Q _Y+3'?]?'^A_9' O_ "2&"_P( M****^./K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH _G _;_ /\ D^7XO_\ 92M:_P#2 MV6O(J]=_;_\ ^3Y?B_\ ]E*UK_TMEKR*O[YR7_D38;_KW#_TE'\.9Q_R-L1_ MCG_Z4PHHHKTSS@HHHH **** "BBB@ HHHH **** "BBB@#^@O_@D/_RCB^%W M_8)NO_2ZXKZ1KYN_X)#_ /*.+X7?]@FZ_P#2ZXKZ1K^$.*/^2FQW_7ZK_P"E MR/[9X:_Y)S!_]>J?_I""BBBO"/;"BBB@ HHHH **** "BBB@ HHHH _"#_@N M?_RD=\6_]@G2?_2&&OD*OKW_ (+G_P#*1WQ;_P!@G2?_ $AAKY"K^YN"_P#D MDJ?_I""BBBO"/;"BBB@ HHHH **** "BN,^,WQ-\7_ RTRRO_ A\'=:\ M8R74[1S6VBR1JUNH7(=MY'!/'%>??\-8?&S_ *,?\=_^!5M_\50![I17A?\ MPUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 ?DI_P %S_\ E([X MM_[!.D_^D,-?(5?IQ^W/_P $_?C9^VE^T=JW[0/_ K?QWX:_M2TM(/[(_X1 M:VO/*\B!(L^;]NBW;MF<;!C..>M>0_\ #E+XV?\ /IX[_P#""MO_ )9U_5O# M'B5P5EW#F$PN(Q7+4A3A&2Y*CLU%)JZ@T]>SL?S%Q'X><88_B#%8FAAN:$ZD MY1?/35TY-IV)9]6_M+^S[:QV>;#!%Y7E_:)?^&L/C9_T8_X M[_\ JV_^*K^6N,,PPF:\3XO%X67-3G-N+LU=>C2:^:/Z6X3P.*RSAS"X7$Q MY:D()-73L_5-K[F>Z45X7_PUA\;/^C'_ !W_ .!5M_\ %4?\-8?&S_HQ_P = M_P#@5;?_ !5?-GT)[I17A?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'? M_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q M5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17 MA?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8 M?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C M'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X% M6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_ MPUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ M *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'? M_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q M5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17 MA?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8 M?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C M'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X% M6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_ MPUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ M *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'? M_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q M5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17 MA?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8 M?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C M'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X% M6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_ MPUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ M *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'? M_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q M5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17 MA?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8 M?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C M'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X% M6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_ MPUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ M *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'? M_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q M5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17 MA?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8 M?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C M'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X% M6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_ MPUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ M *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'? M_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q M5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17 MA?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8 M?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C M'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X% M6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_ MPUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ M *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'? M_@5;?_%4 >Z45X7_ ,-8?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q M5 'NE%>%_P##6'QL_P"C'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17 MA?\ PUA\;/\ HQ_QW_X%6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 >Z45X7_ ,-8 M?&S_ *,?\=_^!5M_\51_PUA\;/\ HQ_QW_X%6W_Q5 'NE%>%_P##6'QL_P"C M'_'?_@5;?_%4?\-8?&S_ *,?\=_^!5M_\50![I17A?\ PUA\;/\ HQ_QW_X% M6W_Q5'_#6'QL_P"C'_'?_@5;?_%4 ?AI^W__ ,GR_%__ +*5K7_I;+7D5?H1 M^T!_P2F^-GQT^.?C#XT?\(MX[TO_ (2OQ+>ZM_9O_"&6T_V7[1,\OE>9_:"; M]N[&[:N<9P.E%O&4Y-/GI[-MK[9\2T5]M?\.4OC9_SZ>._P#P M@K;_ .6='_#E+XV?\^GCO_P@K;_Y9UW?\16X!_Z#/_*=7_Y XO\ B&/''_0) M_P"5*7_R9\2T5]M?\.4OC9_SZ>.__""MO_EG1_PY2^-G_/IX[_\ ""MO_EG1 M_P 16X!_Z#/_ "G5_P#D _XACQQ_T"?^5*7_ ,F?$M%?;7_#E+XV?\^GCO\ M\(*V_P#EG1_PY2^-G_/IX[_\(*V_^6='_$5N ?\ H,_\IU?_ ) /^(8\._P#P M@K;_ .6='_$5N ?^@S_RG5_^0#_B&/''_0)_Y4I?_)GQ+17VU_PY2^-G_/IX M[_\ ""MO_EG1_P .4OC9_P ^GCO_ ,(*V_\ EG1_Q%;@'_H,_P#*=7_Y /\ MB&/''_0)_P"5*7_R9\2T5]M?\.4OC9_SZ>.__""MO_EG1_PY2^-G_/IX[_\ M""MO_EG1_P 16X!_Z#/_ "G5_P#D _XACQQ_T"?^5*7_ ,F?$M%?;7_#E+XV M?\^GCO\ \(*V_P#EG1_PY2^-G_/IX[_\(*V_^6='_$5N ?\ H,_\IU?_ ) / M^(8\1X:M@\EPU"LK3A3A%K1V:BDU=:;]M#W2BO"_P#AK#XV?]&/^.__ *MO_BJ M/^&L/C9_T8_X[_\ JV_^*KR3U#W2BH-+NY[_3+:^N;&2UDF@222VE(W1,5! M*''<$X/TJ>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH _.;_@MM_P %OO$'[ 'CWP-^Q7^R1X TOQI\?_BC=6EO MH&G:P[FPT6*[N?LMM-<+&RM++--E(X@R@!&=SM"I)W?QT^!/_!6OX,?LJZK\ M:?AC_P %(KSQK\5?#&@2ZO>>"]?^&?A^/PMKDL$1EEL+=+6RAU"W#A62.1[Q MSDKN"Y)7\FO^"HNDZ]\//^#P/X6^,/BDCPZ'KGQ ^'E[X9GN\B(6FVSL]ZD\ M!5OH+C)Z AB>]?T<>(-5TC0]!O=;\0W$<-A9VDD]]--]Q(44L[-[!02: /B; M_@C]_P %J?!/_!53]C[Q%\9= ^&=Q:?$CP!;F/QI\.='N%EDGN3"\EL]D\I4 M&*Z,3K'YA&QT='8A!(WQ)_P5U_;W_P"#BK_@EGJ/A+]L_P")?Q*^#5Q\,?$7 MBM-*D^&'A71A>6^G3O%+<165S=W-M'>3%X()@;B&5%WQO^[0% ?"_P#@R.\( M>-[O]IKXY_$/3;2XC\*VO@K3]/O7.?+:^FO3+;KGHS+%#<^X#?[7/TM_P=2? MLO?\%!K+P1X>_P""A7P>_:7AU?P'\&/$EGKL?PRN_"MH5T"[\R.&/5U+JZZE MMD=59)T/DI([+E3)@ _8+X:^+;OQ_P##G0/'=_X!RIKY2_X*<^+/^"O?C"_B^"'_!)_POX0\/7UIHJZIXF^)_Q# MP+=6D>18-,TR*2&:.>Y(B9Y9)(VBC5XE)#.2OL'_ 3G_:.\7?M>_L)?";]I MOQ]H$.F:YXW\"Z?JNKV=LA6%;F2$&1XE8DK&[9= 22%91D]3U?[3G[1OPX_9 M.^!^O?'CXI7-Q_9FB6P,5C80&:\U.[D81VUC:Q#YIKF>9XX8HQRSR*/>@#\U MO^#=K_@L;^VO^V9\=_BO^P-_P4-\-VDGQ*^%T$]U-K]GI4-E+FVOEL;RRNXK M<"#S8YI(]CQ*H90^0=H8N\%_\%5?VJ_^"A?Q2_;+UO\ 9-^. ^'7@K]E;PW( M/!46G^'-.U ^,M5CCU-C/J$E]!,RV3OIDBK':FWEV3(QEW @^R_\$5O^">>O M?L@2^/\ ]L;]K5M,TSX]?M.>,;SQ!K^@_;$(T.*:6YOX]&MR3^^EC5YI9BG' M[L*,K!O;\R_^#8G2-=\+?LE_\%%_#WC!)%U?3?!5M;ZLDWWUGCL/$JR!O?>K M9]Z /T[_ &&O^"N/QF_X*"?\$HK']K;]G#]G^RU_XRW.JOX3G\%QW,D>D6?B M%"F^YN)R2UOIZP21WK;FW[&$"L\K(6^%/%'_ 5O_P""\'_!+/\ X*3_ X^ M!G_!4G4O _CCP+\4=6M8;6+P=HMLEM#:SW26\CZ?<1007!FMWD0M%WQ/UV^CD73+[XPRII^\$!Y(]+L?-9?4?/&,^JD=J] M?\9?LZ:#_P %;?\ @J]X9_;7\8F&']GC]E(7%MX2UJ]<);^,O%<5P)KRZ@=L M*VFV4L$"-/\ 85 /18-,TR*2&:.>Y(B9Y9)(VBC5XE)#.2OS#_P;M?\%C?V MU_VS/CO\5_V!O^"AOANTD^)7PN@GNIM?L]*ALI65W%;@0>;'-)'L> M)5#*'R#M#'])?VD/VF?A;^R]\!-9_:(^(6IR3Z+I=DDMG;Z4GVBYU>XF*I:V M=G&F3/<7$KQQ1(OWWD4=#FOD'_@BM_P3SUW]D"7Q_P#MC?M;-IFF?'K]ISQC M=^(-?T$7J$:)%-+<7Z:-;DG]]+&KS2S%./W8496#>P!]_P!%%% !1110 444 M4 %%%% !1110 5^4$/\ P6%_:U_X*D_\%&/$'_!/[_@DUXE\.^"? WP_BGG^ M(?QZUS0DUB=TAF6!AIEI(PMV#S-Y<9EW^:%:4;$3#_I9^T?I7CC7?V>/'NA_ M#*21/$EYX+U2#P\\+;76^>TE6 J>Q\PI@U^#W_!CWK6@:1\3/VDO FKQK#X@ MN-)\,W-K;S+MF6WMYM3CN1@\C$EQ;!AV)7- 'Z1?MU:1_P %;OV*?V./''QW M_9F_;%LOC'K/ACPM>7^IZ-\4?AWI<%XD$<+/+>:=+HT5G%YT"@RK;W$,ZRA" MF=V WW)'K^D1>3:WNLVJ7+HG[J2=5:NNB2*4=0RL,$$9!%?A%_P< MZ>&?#NG?\%BOV(O$^GZ%9P:CJ?BK3X]1OX;95FNEBUZP$0D<#+A [ABRWO]FQZO:MBO>_V:FKVIN-Q7[.+A=^1 MU&W.K?"U_#VA6=B=1\/B]O_LELL?VBY?PYJ8>9]H&Y MV"KECR<#)KEO^"F'P7MO&W_!V_\ "/X>>!=6G\(R>+?#>G-K^K^&BMI>R126 M>I)>R),@#1W$EJCQ+<#]XA*NK!D4@ _?2R\;>#-2CNI=.\7:9.MC>M9WS0W\ M;BWN5&6A?#?)( 02AP1GI2WWC'PAI<=E+J?BK3;==2NUM=.:>^C074[9VQ1D MGYW.#A5R3@\5^5'[?G_!'O\ 8V_X)K_\$5_VM=%_9^TK7K^R\8V_L_ M?M'_ +37COQY<:OX%\;:KJ7@*UT'Q+]EL]/L[;7;F1[)K=HWC*S7<"_ EE%J7CCQ?I>C6\\ZPPSZKJ$=NDDK?=16D8 L>P M')J[>:IIFG1+/J&HP0(YPCS3*H8^Q)YK\+_V:/C?XU_;_P#^"\_[7OA/XS?L M[P?&&#P)HFL>!?!'@S6=9LX+3P_HT&I#3[NXMXKWY!).8T9Y$&__ $AAG:P% M5OVNOV1?VS/V6?\ @U%^*GP$_P""BEEHNK>*OAYXMT7_ (5UJ,6K)JDEAH\F MN:/'$JSD;HW0SWT /RP,L8^7Y: /W*U#Q[X%TG4--TG5/&FDVUWK$ACTBUN M-1B22^<=5A4MF4CT7-:D\\%K ]SOB;X5_ M\$2?AO\ "+_@IE\3_P!MSPG\1+.W^''Q7\"IH/BGX"P>$X8]&NYO)MX6FE D M\J2,B!I/+,&[S+F7Y]K,K?F/_P $WO$7PM_X(!?\%O/VAOV+/CMHMO#\//&G MA&[U3P3K=Y9K-<26%M#/J5C:I(XS()+9KJT= ?WUU;Q+@G:* /Z%;'4]-U-& MDTW4(+A5.&:"57 /H<&IZ\)_X)S?LF^&/V/_ -EO1? MA\.]%\.^(==EG\1> M.K;1+..*+^VM0F>[NXU* ;HH9)FMXO[L,$:@ * /=J "BBB@ HHHH **** " MO@/_ (+Y?\%CHO\ @DE\*/AOJ?A2RM]2\5>-/']F)-)D56=O#]G-%-JKJ&X5 MWC:.V1C]TW1<VOK739+1UU2>XU1_.2788+NS\P@P< '['?#[QY MX2^*?@/1/B=X!UN'4]"\1Z1;:GHNHVYS'=6EQ$LL,JGT9'5A[&G>+O'7@CX? MZ:NL^//&.E:)9O*(DNM7U"*VC9ST4-(P!)].M?E'_P &@O[?S?M'?L':C^R# MXXUDR^*?@IJ"VVGI/)F2?0+MGDM3SRWDRBX@('"1K;C^(5Y;^Q_XG\*_\%:_ M^"['[:GP*_:_B@UBU\+>"/$'@+X;:)JMNEQ%X>TN#4ETR[O+*&4%8KAV$4S3 M ;]TY&[;@ _<"WN+>[MTNK6=)8I4#QR1L&5U(R""."".]9.D_$;X>Z_J.I: M1H7CO1KV[T8D:Q:VFJ1226)'43*K$Q=#]['2OQ*_X*G>%OVD?^" G_!O[HW[ M'?PY_:OUSQ=K7C+XFR:!!XWBLGTV71M$N(+F[ELK1?/E: $6VSA\@74^W;A< M>8?\' W[./PI_90_X(=_LH^(?@-X7M/#&N26NF:#K.O^'XQ:7>L6>H:!)=7\ M=W+%M:X2XN($FD5RRLV3CF@#^A"3Q)X=B@AN9=>LECN(A+;R-=(%E0C(93GY M@1W'%.EUW0X+E;*;6;1)FQMB:X4,<],#.>>U?@[_ ,'9GAGP[)_P2A_9:\9/ MH5F=6AU'3;*+4S;+]H6V?0G=H1)C<$+HC%.M_\ M!7:+]O#X$:?^PQK?@B/X,?VM$OQKM]:N-/%V83(])\/V5MJ&K>+O"9U2]M[94EO#'XIA2,RL!F0JO MR@MD@ #H*P_^"T'Q1_:%_P"":_\ P66\2_ML_M5_L@:-\$+2%?#6A76V/Q%XH-HAEMK('Y MOL_V@LQDP?+A&\YP ?RI_P""[=G^R1XQ_P"#:WX ?$/]DV]?7?!EE\2;*U\" MZUK5BJZII]@T&LB33I7)9@\+QB"4!BKO:AN<*:Y?_@Y6^'_@THZ]]C3[7]A'AU)OLWFXW>5YAW[,XWOV;[OXS#]G+P1?_M-W>C'Q\/"%A)XZGT-Q]@_M/[,ANFA(X\OS=Y! M'RXZ<8K\B_\ @Y)_9(_9;^ '_!"+13\#?V=O!7@\GQYX>U$MX;\,VUD?M=Q: M&*>?,2+^\DCCC5VZL(T!SM&/!_\ @K]^TI\5O#__ 24_P""=/[$?A/Q!?:5 MX3^+WPT\.OXZ>RN&A.IVUKI^C0QV3,I!:(F\>1T/!9(2>E ']!_A'QYX&^(% MC+J?@/QGI.MVT$QAFN-(U&*Y2.0=49HV(##T/-7(],'/TK\2/^"FWC6V_P"":O\ P<3?LFW?[(/A6P\&:5\1]%T3PIXZ M\+>%;)+*QUK3[C6I;!?.MH0L([#29WL1J;'PC?33+,T!1G2SFU#P7XLTS5[>WN&MYY]+OX[A(YEQNC9HR0&&1E3R,U#$OC(G[ /Q[^(_P#P3D_X+F?LR0W$/C[XB7'BC1?VC+?0EEUW3-3EF3R= M<@NB-U_8%HHW:.-UDC5IXF5\M"H!_4'14=I=VM_:Q7UC/[%_P\_;"T73AX=MO'6C/JS6=S#/);7,(.3:7D9=EI&F64LCE%-5/^#L+]E/X#_LK_ /!%7X,_!WX+_#^S MTW2? ?Q7TK1?#0!B,@8 /VKN/%WA.TU> M'P_=^)].BO[FT>ZM[*2]C6:6!/O2JA.YD&1E@,#/6OD'_@E[JW_!7O4_CC\< MA_P4BU?P5=>"D\3I_P *>'AF;3W=;(RW&[9]D_>"W\K[/C[9_I&_=VS7EO\ MP3K_ .")?[,$T_[/_P#P4L^)WBOQKXB^+-G\'-/BU@:EX@$^CZB+W1/LIA>T MDC;9!!;7+V\4,31Q[$4R)(Y9V_/W_@WD^*,O[)^N?\%+?C3X \.6S/\ #;PY M=ZUHFDQPXASI[^()X8 BXPG[E5P,8% ']!>H_$+P#H_B>T\$:MXXT>UUJ_7= M8Z1(?&GQE&D?''5/V@[SQ#KGQBO-'74 MM6BU.WB@\N%W\R*40FUN%V1I*B1LZLJ\;3W7_!5CXY?%:'_@M7^QQ_P33\>R MW_Q+\$>%_"^DZYK'A[6+^&T3QSXAQ>PP75[YQ\F4B6QAD5)-RAY9@,EZ /VP MT#Q#H'BO1X/$7A;7+/4M/NDWVM]I]RDT,RYQE70E6&0>0:N5^>W_ 2R_8]_ M;E_9?_X*!_M!^/?&OPSTCP1\ _BI<)XA\)^"+'Q-;W9T;7=T*SLD$ \N 3A[ MEW,?#>7"#R!C]": "BBB@ HHHH **** "BBB@ KSC]K3PQ^T)XJ_9^\367[* M?Q,3PK\0X-+GN/"5_1(^U69"KKPP; *MZ/10!^0 M_P#P;8_\%?/VK/\ @H_\5_BG\(_VV_B\R>./ D%O=:9X/L/#-AI\%Q9F22WN MWE"P>>98+CR%($B*/.4$-SC[,_:WM/LDLT&^*XN[F25%\XS+M@N'50(2C_C]_P %-=,O M_P#@A/\ \''G@G_@H!X5LI;/X9?%Z_;5O$<=M&?*:*Y86VOP;1_K'1Y$U!5Z M;YXA_#Q^UW[!EC=_$G2?%7[;'B*UD2^^,FJ17_AU+B,K)9^$[56AT2#!Y420 M-+J+(>4FU6=>PH ]K\7>./!7@#2QKGCSQAI>B61D$8O-7U".VB+GHN^1@,G! MXSVKE_VC]:\3VW[-WC+Q7\+_ !V^BZM9^$[S4=#UVRMK>Z$4L4#31OLF1XY8 MV* ,".48[65L,/R!_9)^(U[_ ,%$_P#@ZI^.7@K]J'0+/Q-X5^"W@#7],^'_ M (1\0V:76GZ7]FU#2]/>XCMY0R>;.+BXD:0@L1,!G:B!>>_X(&?M"?$#1?&/ M[>7_ 3W35KNZ^'/P\;Q)>_#[39YF>+P_$MWJ%I):P;L[(I%$+B,856B=@,R M.2 ?6W_!M/\ \%,?VG?^"D_[('CSXS_M@^,='OM6\/\ Q'?1]/NK#28-/BCM M186DP5EC 4GS)GY//(':OT9/B+P^ML+UM=LQ"SE%E-TFTMUQG.,^U?SV_P#! M /PSX=\6?\&VO[;FE^)]"L]1MH[;Q;&?#NM?\ !F;\8]9UC0K.ZN]'^-=M<:3=7%LKR6^D'5(59@96]ER:_$CX^>&?#FO?\ !E!H>I:W MH5G=W.D^#-"NM*N+FV5Y+.<^*K:(R1,1F-C')(A9<$K(R]&(/R)^VA^R9\"O M!_\ P:[?LX_M=Z3X/9OB7>^/;>V?QG=7TTM[#9-)K6+*%F;$%LK0Q.L,85!( MK28WN[, ?TZWWC?P7IGB:T\%ZEXNTNWUF_B:2QTF?4(TN;E%SN:.(MO<#!R0 M"!@U=U+4]-T;3YM6UC4(+2UMHS)<7-S*(XXD R69F("@#N:_FH_X+S_"KPE^ MS]^QU^PW^W;\.3J,/QC\6Z5:>(?%GQ+O-5GN-9UC43IVEWJS3W,CEF\N9F\I M1A84.R,*@"U]A_\ !?']I[Q[KG_!9G]D;]@#5/#TGB'X=WU[IGBO6_ KZA'; M6GBS4Y=3N;>SM;LS'RI8XY+)<1R90FX;<"2N #]C?#GB;PWXQT6#Q)X1\0V. MJZ==+NMK_3;M)X9AG&5="589!'!KY8TGXR_'_P#:0_X*7?%K]GSX7?&W4?"? MP\^$7PST6QUE])T73;B:;QAJLKWJ2"2[MIB5M].BA#1 A2;W+#<$9?%_V"?V M9?VR/V//^"CW[1?[3GQ%^'FA?#3]F;X@^'5\11>$(/%-MS%Q>>1; MCRX1,J:A)(T>-V8=V2@QZU_P1#\,:]J_['-[^UOXZTR2U\2_M%>.]7^)FIP3 MC+V]IJ$VW2X >I2/3(;$*.@R<9SD@'YO_P#!/#_@OO\ \%&/#O\ P5'^&W[( M_P#P4C\:>&]0\%?%?PYITGAO5-.\+V^GXFU:TBN-,N%DC +AIS]C=2=HD=S_ M "OT\_X*_\ [77Q;_9'_8\UKQ#^S?+8CXEZI9WS^$VU&T%Q!:0Z?87&J:C> M2Q'ADBL;*Y"[OE,TD"'_ %@!_'W_ (+D?L.ZKXL_X(O?LH?\%)/A7;36WB3X M5> ] TGQ)J%CE9DTJYCB:TN-XY7[/?%57&,&^8]J^Q_A)^TMXE_X*B_\$O?C M'_P4?\>>'9["+1/V3O$7@KP_;7$&Q)=9?1Y+CQ+J, Z&"6YAL;6,\%?[/F'1 MZ -3_@VD_P""BG[:G_!3OX4?$'X]_M=?'2"ZA\(>)XM(T[0=&\,Z=86 M<\UQ(L)E8@R)M"21@;#NWAL#WW_@E%KW_!7.?Q1\:+K_ (*HZ[X'DT2'Q7$? MA5)X8N-/(CL2UQYO-HZ[X;L+S0=1L(Y[.>U\[Q ODO$X*,FT ;2,<4 ?NZOBCPRZL MR>(K A%RY%VGRC(&3SQR0/QJU:7EI?P"ZL;J.:)L[9(G#*<<'D5_-'X4_9M^ M'_\ P2I_X+9^./\ @DU\7+K1(_@#^TQ/I5H-3U.SCNKNWT2:\>XL;-9F.^V9 MYTETR24D$+(+D;6CB=?Z2/ 'P]\!?"GP?8?#WX8>"M*\.Z#I4 ATS1=#T^.U MM;6,?P1Q1*%0=3@ =: -BBBB@ HHHH **** "BBB@ HHHH _.C_@ME_P6]U[ M]@#Q_P"!?V*_V2O &E^-/C]\4;NTM_#^FZS(_P#9^BQW=S]EMIKA8V5I9)IM MR1Q!EX1G<@!5D]'^.GP:_P""K'P:_9.UCXQ?#+_@H&_C3XK^&?#\NKW/A+7O MAMHL?A?6YH(C++8016UM%?VXDVLD@(8^M?T;^(=5TC0M O MM;\03QQ6%G9RSWTLN-B0HA9RV>P4$F@#XU_X(L?\%F/A9_P5K_9BU/XI7&C6 MOA#QIX(DCM_B-X;:]W6]B71WBO89'P?LLJQRE=_S(T4B,6""1^W_ &$/^"FW MP6_X*/>,/C!I'[/_ (@@E\,?#SQ7%X:T7Q7:7",VM3FT$L]W;JX*M"LC%(V* MLL@CW\JX%?AM_P &C?P/'QY^@O^#+G]G+X >/?@E\1_CQXW^"WA?5_&WA/XC01 M>&/%NHZ'!-J.DH^G+O6WN'4R0@[WR%(SN/K0!]%?\$1O^"J_[7?[4_[=?[4' M[._[7'QC*ZDA@?4'%?SB_\$F?V3O@5^UE_P % M$_\ @H9X;_:!\'-XCT?2;OQ+=6NAW5],EDUT=8U 1W,D*,JRRQ8)B9\^6SEU M 8*P[;_@@'^V9\9_V;/^#=/]J?XK>$-?N+G4OAGK>IS>!A='SDTJXN=-M-K( MC9 C2XD-P8_NEBY(^=L@'[\IXY\$R>*W\!Q^,-*;7(X//?1EU",W:Q?WS#NW MA>1SC'-6IM:_GR_9'_9&_;#_ &[O^")O MP@^('[%OP5M(/C=9?%R_\<2_M ZMXXLX=5OM4BU+4(+@SRMNNRQC\B,I(2LB MP(S @@UH_P#!RKX*\6ZO_P %7OV(M2L+?3_"OQ$\2OHL&IZYI5K%*UMJ8UFT M2.3)O#>JZO>^']+\06-S?Z88QJ5E;W:/-:;P M63S$!W1[@"1N R!Q5ZOE/]A7_@CI^R5_P3Q_: ^(?[2'P!U?QS<:]\2[2"'Q M!%XK\5OJ<2LDAEDF1Y4\]Y9I6,DCS2RG<3LV*2I^K* "BBB@ HHHH **** " MBBB@ HHHH **** /RP^(/_!9#]HG]N7_ (*N2_\ !*#_ ()BZ]HGAC3/!YO) MOBO\:=4T=-4FLX[)UCNXM-M9#Y!VSO':B699%>63(4(F^3>_X*G_ +2__!1K M_@C)\-- _;.\/_M%77Q_^&-KX@M=+^(W@WXD>&='T_4[.*X)6.[LK[1;*S2, M&0"+;-!-M:6,_."=OYV_\&BNDZ]\,O\ @L-\>?A5\7D>#QK9?#_6++4X[W(F M-W;:]8I=H=W);S,$CK\I/8U^G?\ P=,ZOH>F?\$-_C):ZQ+&);^Y\.6^G(YY MDG_X2#3Y,+[A(Y&^BF@#W;3/VT?&_P"U[^PUX3_:5_X)J>&]&\2ZO\2[9$\+ MW7C.X>WTSP\Y$HN9]4$&Z4BVDADA:&'#?BKH/Q2M%O-(NO"'ANWM%LK"9;H)>V[PP0RJ(9;.99H M[@2?)&Y5L;'/M/\ P:2^"OB%X9_X(R:%=>*_M%K!KWC77;_PPTZ$[+$RI"'5 M6_A-Q#<,.QSGOFOC?]N&P_X*7?\ !)/_ (+R?"7]LKXB_'"S^,>A_&S6K3P? M::K=^%;:UECTIKN"*?1$@C5A921K<)+%+ R^<^YG#$S(0#^@*OR9_P""NG[1 M_P#P<1>%/#OCO]JK]B#0?"'P^^#/PR:]D?3-5TZVO/%/B"PLF87>KR6U[;R1 MPVF(Y)8XU:.J_LR:C^PK^SCHJZY\7_V@=)O M?"GA72-^(].TR>,0ZIK5XX!^SV=K;3-F7!)FE@C4,S@4 >8_\$W?^"WL'[1O M_!&;Q/\ \%,/VD/!EOIFI_#*WU:U\9V6B@Q6^JWMC!%+&;02%C']H$]N@5B0 MLKL,[0*^7];_ ."SO_!0+X8_\$JOAE_P6\\4_$33]9TOQO\ %JXTK7?@:GAZ MQ@T:S\/K>ZC9JMI>+!_:"WP:Q#B:6XDB/F\P87#>B?\ !3#]A3X>_L"_\&R7 MQ2_86^ /B&/5=3\&^%]%U3Q1=(Z"\OI)=?L[F]OYH@Q:*.40700-D".#8&;R MR:^'OVE)(A_P99_ H*0=WQ+F QZ_V_KV?Y&@#]AOVSOC_P#\%!OCW\%?!%E_ MP1[\,^%AJ/Q"\*0>)V^*?Q$W1Z1HFE3Q1R6J0H(Y1&46:I;S6\L,@EBF1%/"YWB0;/LW_@F1\1/#?[+W_!$GX)_%3]H M;Q+'H6C>%O@7HVIZU?W^1]FM/L,&U MMFDB7+1K %X9I44 Q_\ @KW\3/\ @O/X7^%WQ _:?_8A\9_#OX:?#KX765]J M$FB:OIT6H>)O$FGV(=[R_875M-:6\12)Y(8%(E>$;F=9'6%?+8" M?[.>])\VQ63!4LF5<-LD&QFKP#_@U"_;#^-_[2__ 3WU?X4?'+P_;6UY\&? M%I\(Z3=VNDQV6^RCMHI([>6*)53SH"S(S!064QELON=@#]0J*** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH ^4/\ @JA_P2"_9N_X*K>!=%LO MB;J6J>%/&_A"X:Y\#?$;PT574='E+*Y0AN)H2Z(QC)4AE!1XV))_-K_@HA_P M4O\ ^"B_PG^-EG_P1S_X*%_$?PI\+? 'Q#MCH6H?M9:+X+N=VO:++!L:XCMW MO!;V,TS$6]TX=A;>=)(J*@1C^ZE8'Q(^%7PO^,?AF3P7\7OAOH'BK1I7#RZ3 MXDT>"^MG8="8IE9"1D\X[T ?(OP#_P"":?[,'PZ_X)B^(_V#O^"9G[3]SX(_ MMS31*WQ>\%:[#?ZQ_:,IC;^TI9[:2/<\J0B/$;18BRL1CV@C)\&?\$VO^"@G MQ:_9.G_8;_X*$?MX^&_B%X"O4@M-?US0O MQ:>*->TV.5)#93W\MZT,>_P M M(WG%N\[QL_[P2'S1]B_"CX$_!#X#Z1-H'P.^#?A7P987#*UQ9>%/#UMIT,K* M"%+);HBL0"0,CC)KJJ ,SP5X,\*_#GP=I/P]\"Z#;:5HFA:9!I^CZ791A(;. MUAC6.*&-1]U$154#L *^%?\ @L#_ ,$>&?^"E%_P#"3PAX M*87FB>%M ^'\MU,=5(96U"6\35;=GD",8XP$41*TF"3(Y/W[10!^VDDNHY)M M3N_F,=N8MH5-/A]\9/VB/B%^Q!\=_#_@;2/VI_#S:?\ M$_1/$GA*;4O[+OG6Z275=,:&Z@ D=;Z[^F54NK417,[-M$P8 M^3&2L:@B-X_@_P *?\&B/Q\T:PTWP3X@_P""U_CK4O!EIY-O>^#5\#WD-E=: M>I >R$?]NM&D;1@IC8R@'[IQBOVVHH ^ ?\ @K]_P1O_ &E_^"IOC?PA<>%? M^"DM]\(O!W@@B[T+PIX?^'TES*-4*LC:A)=QZI;L\BQL8XP$41*SX),CDX/_ M 2I_P""#/Q2_P"">?[4MS^TY\;O^"COBKXYSQ^#[S1-!TCQ+X?N;9=*DN9[ M:22ZCDFU.[^8QVYBVA5R)22W %?HY10 4444 %%%% !1110 4444 %%%% !7 MYW?%S_@@Y_P@7[=-Q_P4G_X)E_M'CX*?$K5GN&\7^']2\,C5_#7B07#![A)K M99H9(!,X6238[#S$61%C<;Z_1&B@#YFA_9K_ &Z_CQ!;^&?VR/VG?!UCX15D M;6?"OP5\*7^D3:^%()M[K4KR^N)H[1\8>&V2&1U)5IRC,C>4?\%FO^",>K?\ M%//%?PE^-OPG^/T7P[^(GP>UQ[[0-4O]"_M&SND::WG"RQ"1"&CEMHW1@2"& M=64[@R_>%% 'YIZ?_P $$?CK/^")'Q1^,G_!8#PK_P M5KTW]LG1-)O_ ;%;VNC>!Y_A5+=0M9Q03PF.:Z&KQL\C+B@#P[_@I!^R)XG_;S_8S\:_LC>&?BS9>"?^$XL4L-0\0WGAEM6,%KYBO( M(X%NK;]XVP .7(4$_*>,:KHP7;[1^VC_P2N^*?[9?_ 3G\3?L+^+?VRYSKOC_ %>QU+Q_\2]=\$+> MR7TMM=6MRJ6=A!>6T-A$&LK:-(U9PL:-N\R61YF^S** /RQ_:*_X-P_B-^T5 M_P $QO@[_P $S-;_ &\M(T_1_A'KT^IP>*+;X/R/F16_A7XE:/X M8,<)(@B@FCDL'NI&\B=8(69!/N62)&5L HWWS10!\??L3?LP?M@?L;?#8>// M^"B7_!2^^^)ND_#WPU<-910>&X=&L+"RA@/FWFHS1EKC4Y8X$;#3-L7+2,DD MH25?"_CQ^SY^PQ_P6?\ VW/V/_VZ_@-XYMO%FE>%I=;U[4-0M],FA34]&TJY M06T=Q'^&/$ND6VH:;J5I):ZA M87L"RPW,$BE)(I$8$.C*2I4C!!(->7_LF_L(_LB?L+Z!J?AC]DWX%:/X*L]9 MN%FU---,LCW!4NR*9)G=Q&IDE*Q@A%,KE5!=B0#UNBBB@ HHHH **** "BBB M@#R_]L;X0?''X^?L]>(_@Y^S]\?;+X9:YXCT^73Y/&5SX4?6)K"VFC:.1K:) M;RU\NXPWR2L[!",["<$7/VB44 ?EO^QC_P &[?QA_88_X*-> M(O\ @H)\$_V_-!LE\6ZMJLOB#X=0_!B:/2Y].O[DW#V"-_;9>-8I!&T3\[6A M0E67*]1UN/Q#!\3[O2X(FTW6XH_*BEM-.B*P6]HL)>'[*C#6>:2YN5BB6)?+$*!2Y=9G8.G]%M>)?M@?\$Z?V./V^(-+L?VO/A MWC6ST1S)I>F7WB/4H+.WE(8&86]O<1Q&7#LOFE2^T[=V !0!\Y?\%"/^"3V@ M?\%?/^"6WPN^ 4_Q0?P;KF@:5H6O>&M?_L[[7"EPFF>0\,T0="T3QSN,JP96 M5&^8 HWD'QU_X-V?VG_VI/B?\"?VA?CI_P %/+:]\;?!*/3UT^!/@^C:3*+* MY@N($C@BU&!T+-#^^D=W>4M\OE*B1K^G?PO^&?A#X-_#[2?A;\/[2[M]$T*R M6TTJVOM6N;Z2"!>$C\ZYDDE95&%4,QVJ HP -Z@#\]O^"B?_!$7XI?M\?M[ M?"#]NF/]LK0_"-U\&;C2;KP[X<_X53+?QW=Q9WZWY:XF_M>(E'F7 544JG&Y MC\Y[G]I/_@GG^UW\7;[X[>'/#'[2OP]OO GQYLK>WU;P-X]^&MQJ$.@SIHMG MIDFH64L=_&?,8VBS""16172)E=&#M)]H44 ?FC^TW_P;I:+\9?\ @EA\+?\ M@E/\)?VJ$\&^%?AYKXUW4O$FI> SJU_K6HD7C22!5U"W2WC>6_N'V8D( C4, M I+=/^WM_P $*#^WM_P3+^%W["/Q _:4AT_Q/\([?38_#GC[2_![16UY]CL3 M8A;BP>\D($D."Q6?*R*&4;,OCS_P48\$?\%)OV]?BUX:\3^( M?AAX9M]+\ ^#?!'AJ>PTNVNXI)IO[3N'N;B:2:7S;B1TB78L9CB)9RASS_BK M_@B/\2/$G_!:K2/^"QR?MB:/;WNBR?9[/P ?A=*\1T\Z9+IK0M>?VL"9C!/( MWG"(*),'RBHV']!J* /SY_80_P""(_Q)_8P_X*=?%+_@I+JO[8NC^*[GXMKJ MZ>(_!\/PMET^.V6]OX;T?9KDZM,4,)(_AM+#XKLK&'"/ MA#XTO1/JOA*]^'MIJNHP(NX1K%-=N\ N$1BBW7E D;=\4FP"O3O^"LO_ 06 MT#_@H5=_"_XP_!K]I#7?AO\ %[X06=K9^%_']ZLNJ3WMO;2":W%U(TJ3&>.< M-,ER'+;Y92ROO!7]"J* /!_V,/V:=X M7@T/2M-M=RO(L-I;DB6:5T0R7$A)(B18TB4.']XHHH **** "BBB@ HHHH * M*** "BBB@#Y:_P""J_\ P2O^#?\ P56^%W@GX;?%J[^QKX-^(>F^(([R.',E MQ9)($O[#<""BW%LSKN'W9$B8@[,5]06-C9:990Z;IMI%;V]O$L4$$$81(T48 M554< < "I:* /B3Q_P#\$E_$7@+_ (*97_\ P53_ &)_BCX?\+^-_%7A M2;0/B%X4\7^'YKW2=?S]L<&G1W2,L$9N;A@AN-S M/(69MH5%^Y:* /S]_P""6'_!"T_\$Z?V1OBU^Q/X[_:=@^(_@OXLI>C4GM? MK:+>VGVRP6PN LIO[I'4PJ-HV*5;)R1Q7S]\/O\ @V+_ &C?#O[ /Q _X)I: MO_P4YCMOAEXD\71:_H4&E?"R-I_M*W%I(3?%[T--%LM5(@C>/;,5E,C*GDM^ MP=% 'P#XM_X(J_$OQ;_P19M/^".L_P"V#HT-I!':V4WQ 3X72F633[?4H]1C MB%G_ &MA9O-B5&F\TJ4R!$&.X>?_ !K_ .#>'XE?&O\ X)+_ T_X)1:K^W3 MHUEH_P .?%3ZNGC�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pm-20230930_g5.jpg begin 644 pm-20230930_g5.jpg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ཷ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end GRAPHIC 20 pm-20230930_g6.jpg begin 644 pm-20230930_g6.jpg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pm-20230930_g7.jpg begin 644 pm-20230930_g7.jpg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end GRAPHIC 22 pm-20230930_g8.jpg begin 644 pm-20230930_g8.jpg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end GRAPHIC 23 pm-20230930_g9.jpg begin 644 pm-20230930_g9.jpg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end XML 24 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page - shares
 9 Months Ended
Sep. 30, 2023
Oct. 20, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 001-33708  
Entity Registrant Name Philip Morris International Inc.  
Entity Incorporation, State or Country Code VA  
Entity Tax Identification Number 13-3435103  
Entity Address, Address Line One 677 Washington Blvd, Suite 1100  
Entity Address, City or Town Stamford  
Entity Address, State or Province CT  
Entity Address, Postal Zip Code 06901  
City Area Code (203)  
Local Phone Number 905-2410  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   1,552,405,991
Entity Central Index Key 0001413329  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Common Stock    
Document Information [Line Items]    
Title of 12(b) Security Common Stock, no par value  
Trading Symbol PM  
Security Exchange Name NYSE  
3.600% Notes due 2023    
Document Information [Line Items]    
Title of 12(b) Security 3.600% Notes due 2023  
Trading Symbol PM23A  
Security Exchange Name NYSE  
2.875% Notes due 2024    
Document Information [Line Items]    
Title of 12(b) Security 2.875% Notes due 2024  
Trading Symbol PM24  
Security Exchange Name NYSE  
2.875% Notes due 2024    
Document Information [Line Items]    
Title of 12(b) Security 2.875% Notes due 2024  
Trading Symbol PM24C  
Security Exchange Name NYSE  
0.625% Notes due 2024    
Document Information [Line Items]    
Title of 12(b) Security 0.625% Notes due 2024  
Trading Symbol PM24B  
Security Exchange Name NYSE  
3.250% Notes due 2024    
Document Information [Line Items]    
Title of 12(b) Security 3.250% Notes due 2024  
Trading Symbol PM24A  
Security Exchange Name NYSE  
2.750% Notes due 2025    
Document Information [Line Items]    
Title of 12(b) Security 2.750% Notes due 2025  
Trading Symbol PM25  
Security Exchange Name NYSE  
3.375% Notes due 2025    
Document Information [Line Items]    
Title of 12(b) Security 3.375% Notes due 2025  
Trading Symbol PM25A  
Security Exchange Name NYSE  
2.750% Notes due 2026    
Document Information [Line Items]    
Title of 12(b) Security 2.750% Notes due 2026  
Trading Symbol PM26A  
Security Exchange Name NYSE  
2.875% Notes due 2026    
Document Information [Line Items]    
Title of 12(b) Security 2.875% Notes due 2026  
Trading Symbol PM26  
Security Exchange Name NYSE  
0.125% Notes due 2026    
Document Information [Line Items]    
Title of 12(b) Security 0.125% Notes due 2026  
Trading Symbol PM26B  
Security Exchange Name NYSE  
3.125% Notes due 2027    
Document Information [Line Items]    
Title of 12(b) Security 3.125% Notes due 2027  
Trading Symbol PM27  
Security Exchange Name NYSE  
3.125% Notes due 2028    
Document Information [Line Items]    
Title of 12(b) Security 3.125% Notes due 2028  
Trading Symbol PM28  
Security Exchange Name NYSE  
2.875% Notes due 2029    
Document Information [Line Items]    
Title of 12(b) Security 2.875% Notes due 2029  
Trading Symbol PM29  
Security Exchange Name NYSE  
3.375% Notes due 2029    
Document Information [Line Items]    
Title of 12(b) Security 3.375% Notes due 2029  
Trading Symbol PM29A  
Security Exchange Name NYSE  
0.800% Notes due 2031    
Document Information [Line Items]    
Title of 12(b) Security 0.800% Notes due 2031  
Trading Symbol PM31  
Security Exchange Name NYSE  
3.125% Notes due 2033    
Document Information [Line Items]    
Title of 12(b) Security 3.125% Notes due 2033  
Trading Symbol PM33  
Security Exchange Name NYSE  
2.000% Notes due 2036    
Document Information [Line Items]    
Title of 12(b) Security 2.000% Notes due 2036  
Trading Symbol PM36  
Security Exchange Name NYSE  
1.875% Notes due 2037    
Document Information [Line Items]    
Title of 12(b) Security 1.875% Notes due 2037  
Trading Symbol PM37A  
Security Exchange Name NYSE  
6.375% Notes due 2038    
Document Information [Line Items]    
Title of 12(b) Security 6.375% Notes due 2038  
Trading Symbol PM38  
Security Exchange Name NYSE  
1.450% Notes due 2039    
Document Information [Line Items]    
Title of 12(b) Security 1.450% Notes due 2039  
Trading Symbol PM39  
Security Exchange Name NYSE  
4.375% Notes due 2041    
Document Information [Line Items]    
Title of 12(b) Security 4.375% Notes due 2041  
Trading Symbol PM41  
Security Exchange Name NYSE  
4.500% Notes due 2042    
Document Information [Line Items]    
Title of 12(b) Security 4.500% Notes due 2042  
Trading Symbol PM42  
Security Exchange Name NYSE  
3.875% Notes due 2042    
Document Information [Line Items]    
Title of 12(b) Security 3.875% Notes due 2042  
Trading Symbol PM42A  
Security Exchange Name NYSE  
4.125% Notes due 2043    
Document Information [Line Items]    
Title of 12(b) Security 4.125% Notes due 2043  
Trading Symbol PM43  
Security Exchange Name NYSE  
4.875% Notes due 2043    
Document Information [Line Items]    
Title of 12(b) Security 4.875% Notes due 2043  
Trading Symbol PM43A  
Security Exchange Name NYSE  
4.250% Notes due 2044    
Document Information [Line Items]    
Title of 12(b) Security 4.250% Notes due 2044  
Trading Symbol PM44  
Security Exchange Name NYSE